FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Nabity, SA
   Araujo, GC
   Hagan, JE
   Damiao, AO
   Reis, MG
   Ko, AI
   Ribeiro, GS
AF Nabity, Scott A.
   Araujo, Guilherme C.
   Hagan, Jose E.
   Damiao, Alcineia O.
   Reis, Mitermayer G.
   Ko, Albert, I
   Ribeiro, Guilherme S.
TI Anicteric Leptospirosis-Associated Meningitis in a Tropical Urban
   Environment, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB While studying aseptic meningitis in Salvador, Brazil, we diagnosed anicteric leptospirosis in 1.7% (5/295) of patients hospitalized for aseptic meningitis. Leptospirosis-associated meningitis patients had lower mean cerebrospinal fluid cell counts and protein than other-cause aseptic meningitis (p<0.05). Clinicians must consider leptospirosis-associated meningitis in appropriate clinical-epidemiologic contexts.
C1 [Nabity, Scott A.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Araujo, Guilherme C.; Damiao, Alcineia O.; Reis, Mitermayer G.; Ko, Albert, I; Ribeiro, Guilherme S.] Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Hagan, Jose E.; Reis, Mitermayer G.; Ko, Albert, I] Yale Univ, New Haven, CT USA.
   [Reis, Mitermayer G.; Ribeiro, Guilherme S.] Univ Fed Bahia, Salvador, BA, Brazil.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM guilherme.ribeiro@fiocruz.br
RI Ribeiro, Guilherme/B-6624-2008; Ko, Albert Icksang/P-2343-2015
OI Ribeiro, Guilherme/0000-0002-6798-2059; Ko, Albert
   Icksang/0000-0001-9023-2339
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R44 AI072856, U01
   AI088752, R01 AI121207, D43 TW00919]; Fogarty International Clinical
   Research Scholars ProgramUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC); Duke Global Health Institute; Brazilian
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by the National Institutes of Health (grant nos.
   R44 AI072856, U01 AI088752, R01 AI121207, D43 TW00919), the Fogarty
   International Clinical Research Scholars Program, the Duke Global Health
   Institute, and the Brazilian National Council for Scientific and
   Technological Development (CNPq). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. M.G.R. and G.S.R. had scholarships from
   CNPq.
CR Amato Neto V, 1982, Rev Inst Med Trop Sao Paulo, V24, P322
   BEESON PB, 1952, ARCH INTERN MED, V89, P575, DOI 10.1001/archinte.1952.00240040054007
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   COSTA E., 1977, Revta Med, Bahia, V23, P107
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Coyle P K, 1990, Infect Dis Clin North Am, V4, P731
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   Galvao PAA, 1968, PEDIATR PRAT, V39, P155
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   HUBBERT WT, 1967, PUBLIC HEALTH REP, V82, P429, DOI 10.2307/4593034
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Nabity SA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006285
   WALCH-SORGDRAGER B., 1939, Bulletin Health Organisation (League of Nations), V8, P143
NR 14
TC 0
Z9 0
U1 1
U2 1
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD SEP
PY 2020
VL 26
IS 9
BP 2190
EP 2192
DI 10.3201/eid2609.191001
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA NK5VB
UT WOS:000566799800031
PM 32818405
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Holzapfel, M
   Bonhomme, D
   Cagliero, J
   Vernel-Pauillac, F
   d'Andon, MF
   Bortolussi, S
   Fiette, L
   Goarant, C
   Wunder, EA
   Picardeau, M
   Ko, AI
   Werling, D
   Matsui, M
   Boneca, IG
   Werts, C
AF Holzapfel, Marion
   Bonhomme, Delphine
   Cagliero, Julie
   Vernel-Pauillac, Frederique
   d'Andon, Martine Fanton
   Bortolussi, Sophia
   Fiette, Laurence
   Goarant, Cyrille
   Wunder, Elsio A., Jr.
   Picardeau, Mathieu
   Ko, Albert, I
   Werling, Dirk
   Matsui, Mariko
   Boneca, Ivo G.
   Werts, Catherine
TI Escape of TLR5 Recognition byLeptospiraspp.: A Rationale for Atypical
   Endoflagella
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Leptospira; toll-like receptor; innate immunity; Flagelin genes; TLR5;
   mouse model
ID LEPTOSPIRA-INTERROGANS; GENE-EXPRESSION; MOTILITY; PROTEIN;
   LIPOPOLYSACCHARIDE; ACTIVATION; FLAGELLINS; RESISTANT; VIRULENCE;
   PATHOGEN
AB Leptospira (L.) interrogansare invasive bacteria responsible for leptospirosis, a worldwide zoonosis. They possess two periplasmic endoflagellae that allow their motility.L. interrogansare stealth pathogens that escape the innate immune recognition of the NOD-like receptors NOD1/2, and the human Toll-like receptor (TLR)4, which senses peptidoglycan and lipopolysaccharide (LPS), respectively. TLR5 is another receptor of bacterial cell wall components, recognizing flagellin subunits. To study the contribution of TLR5 in the host defense against leptospires, we infected WT and TLR5 deficient mice with pathogenicL. interrogansand tracked the infection byin vivolive imaging of bioluminescent bacteria or by qPCR. We did not identify any protective or inflammatory role of murine TLR5 for controlling pathogenicLeptospira. Likewise, subsequentin vitroexperiments showed that infections with different live strains ofL. interrogansandL. biflexadid not trigger TLR5 signaling. However, unexpectedly, heat-killed bacteria stimulated human and bovine TLR5, but did not, or barely induced stimulation via murine TLR5. Abolition of TLR5 recognition required extensive boiling time of the bacteria or proteinase K treatment, showing an unusual high stability of the leptospiral flagellins. Interestingly, after using antimicrobial peptides to destabilize live leptospires, we detected TLR5 activity, suggesting that TLR5 could participate in the fight against leptospires in humans or cattle. Using differentLeptospirastrains with mutations in the flagellin proteins, we further showed that neither FlaA nor Fcp participated in the recognition by TLR5, suggesting a role for the FlaB. FlaB have structural homology toSalmonellaFliC, and possess conserved residues important for TLR5 activation, as shown byin silicoanalyses. Accordingly, we found that leptospires regulate the expression of FlaB mRNA according to the growth phasein vitro, and that infection withL. interrogansin hamsters and in mice downregulated the expression of the FlaB, but not the FlaA subunits. Altogether, in contrast to different bacteria that modify their flagellin sequences to escape TLR5 recognition, our study suggests that the peculiar central localization and stability of the FlaB monomers in the periplasmic endoflagellae, associated with the downregulation of FlaB subunits in hosts, constitute an efficient strategy of leptospires to escape the TLR5 recognition and the induced immune response.
C1 [Holzapfel, Marion; Bonhomme, Delphine; Vernel-Pauillac, Frederique; d'Andon, Martine Fanton; Bortolussi, Sophia; Boneca, Ivo G.; Werts, Catherine] Inst Pasteur, Unite Biol & Genet Paroi Bacterienne, Paris, France.
   [Holzapfel, Marion; Bonhomme, Delphine; Vernel-Pauillac, Frederique; d'Andon, Martine Fanton; Bortolussi, Sophia; Boneca, Ivo G.; Werts, Catherine] CNRS, UMR 2001 Microbiol Integrat & Mol, Paris, France.
   [Holzapfel, Marion; Bonhomme, Delphine; Vernel-Pauillac, Frederique; d'Andon, Martine Fanton; Bortolussi, Sophia; Boneca, Ivo G.; Werts, Catherine] Inst Natl Sante & Rech Med, Equipe Avenir, Paris, France.
   [Bonhomme, Delphine] Univ Paris, Sorbonne Paris Cite, Paris, France.
   [Cagliero, Julie; Matsui, Mariko] Inst Pasteur Nouvelle Caledonie, Inst Pasteur Int Network, Immun & Inflammat Grp, Noumea, France.
   [Fiette, Laurence] Inst Pasteur, Unite Histopathol Humaine & Modeles Anim, Paris, France.
   [Goarant, Cyrille] Inst Pasteur Nouvelle Caledonie, Inst Pasteur Int Network, Leptospirosis Res & Expertise Unit, Noumea, France.
   [Wunder, Elsio A., Jr.; Ko, Albert, I] Brazilian Minist Hlth, Goncalo Moniz Inst, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   [Wunder, Elsio A., Jr.; Ko, Albert, I] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, Paris, France.
   [Werling, Dirk] Royal Vet Coll, Dept Pathobiol & Populat Sci, Hatfield, Herts, England.
   [Fiette, Laurence] IMMR, Paris, France.
RP Werts, C (corresponding author), Inst Pasteur, Unite Biol & Genet Paroi Bacterienne, Paris, France.; Werts, C (corresponding author), CNRS, UMR 2001 Microbiol Integrat & Mol, Paris, France.; Werts, C (corresponding author), Inst Natl Sante & Rech Med, Equipe Avenir, Paris, France.
EM cwerts@pasteur.fr
RI Ko, Albert Icksang/P-2343-2015; Goarant, Cyrille/D-4267-2018; Boneca,
   Ivo G/H-1677-2014
OI Ko, Albert Icksang/0000-0001-9023-2339; Goarant,
   Cyrille/0000-0002-0690-9464; Boneca, Ivo G/0000-0001-8122-509X
FU French Government's Investissement d'Avenir program, Laboratoire
   d'Excellence "Integrative Biology of Emerging Infectious Diseases"French
   National Research Agency (ANR) [ANR-10-LABX-62-IBEID]; Ecole Doctorale
   Frontieres de l'Innovation en Recherche et Education (FIRE), Program
   Bettencourt; Calmette and Yersin fellowship from Institut Pasteur
   International network; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI121207]
FX This study received funding from the French Government's Investissement
   d'Avenir program, Laboratoire d'Excellence "Integrative Biology of
   Emerging Infectious Diseases" (grant nffi ANR-10-LABX-62-IBEID) to IB.
   DB received funding from the Ecole Doctorale Frontieres de l'Innovation
   en Recherche et Education (FIRE), Program Bettencourt. JC was supported
   by a Calmette and Yersin fellowship from Institut Pasteur International
   network and EW by a NIH fund (R01AI121207).
CR Bens M, 2014, CELL MICROBIOL, V16, P1503, DOI 10.1111/cmi.12306
   Biedma ME, 2019, VACCINE, V37, P652, DOI 10.1016/j.vaccine.2018.12.009
   Bonhomme D, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008639
   Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005
   Cagliero Julie, 2020, Methods Mol Biol, V2134, P243, DOI 10.1007/978-1-0716-0459-5_22
   Carrillo-Casas EM, 2008, CURR MICROBIOL, V56, P539, DOI 10.1007/s00284-008-9096-x
   Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145
   Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506
   Chou LF, 2018, J INFECT DIS, V218, P1411, DOI 10.1093/infdis/jiy339
   d'Andon MF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002664
   Ferrer MF, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00384
   Forstneric V, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006574
   Forstneric V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158894
   Gibson KH, 2020, ELIFE, V9, DOI 10.7554/eLife.53672
   Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235
   Gomes-Solecki M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00058
   Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279
   Ivicak-Kocjan K, 2018, J LEUKOCYTE BIOL, V104, P767, DOI 10.1002/JLB.3VMA0118-035R
   Ivicak-Kocjan K, 2013, BIOCHEM BIOPH RES CO, V435, P40, DOI 10.1016/j.bbrc.2013.04.030
   Jiang CH, 2017, EXP CELL RES, V361, P46, DOI 10.1016/j.yexcr.2017.09.040
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kim JH, 2018, BIOCHEM BIOPH RES CO, V505, P872, DOI 10.1016/j.bbrc.2018.09.179
   Kim MI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24254-w
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Kurniyati K, 2017, MOL MICROBIOL, V103, P67, DOI 10.1111/mmi.13544
   Lacroix-Lamande S, 2012, J IMMUNOL, V188, P2805, DOI 10.4049/jimmunol.1101987
   Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12
   Li C, 2008, J BACTERIOL, V190, P5607, DOI 10.1128/JB.00319-08
   Li CH, 2010, J BACTERIOL, V192, P2596, DOI 10.1128/JB.01502-09
   Lindow JC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005943
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Martin FS, 2017, ACTA CRYSTALLOGR F, V73, P123, DOI 10.1107/S2053230X17002096
   Matsui M, 2012, APPL ENVIRON MICROB, V78, P6372, DOI 10.1128/AEM.00911-12
   Matsui M, 2011, INFECT IMMUN, V79, P4480, DOI 10.1128/IAI.05727-11
   Matusiak M, 2015, P NATL ACAD SCI USA, V112, P1541, DOI 10.1073/pnas.1417945112
   Metcalfe HJ, 2014, VET IMMUNOL IMMUNOP, V157, P197, DOI 10.1016/j.vetimm.2013.12.006
   Mouville Clemence, 2020, Methods Mol Biol, V2134, P215, DOI 10.1007/978-1-0716-0459-5_20
   Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022
   Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x
   Ratet G, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006725
   Ratet G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003359
   Rossez Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004483
   Ruby J, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00251-18
   Sambri V, 2002, J ANTIMICROB CHEMOTH, V50, P895, DOI 10.1093/jac/dkf220
   Santecchia I, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007811
   Song WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep40878
   STERLING CR, 1981, VET PATHOL, V18, P628, DOI 10.1177/030098588101800508
   Tahoun A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17935-5
   Vernel-Pauillac Frederique, 2020, Methods Mol Biol, V2134, P149, DOI 10.1007/978-1-0716-0459-5_14
   Vijayan A, 2018, TRENDS MICROBIOL, V26, P423, DOI 10.1016/j.tim.2017.10.008
   Vincent AT, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007270
   Wang FB, 2019, NAT MICROBIOL, V4, P1401, DOI 10.1038/s41564-019-0458-x
   Werts C, 2006, CELL DEATH DIFFER, V13, P798, DOI 10.1038/sj.cdd.4401890
   Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354
   Werts C, 2018, CURR TOP MICROBIOL, V415, P163, DOI 10.1007/82_2017_46
   Wunder EA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00130
   Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403
   Xu M, 2019, J CELL MOL MED, V23, P7490, DOI 10.1111/jcmm.14617
   Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584
NR 60
TC 1
Z9 1
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD AUG 11
PY 2020
VL 11
AR 2007
DI 10.3389/fimmu.2020.02007
PG 20
WC Immunology
SC Immunology
GA NI4KH
UT WOS:000565322300001
PM 32849665
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Matovu, JKB
   Bogart, LM
   Nakabugo, J
   Kagaayi, J
   Serwadda, D
   Wanyenze, RK
   Ko, AI
   Kurth, AE
AF Matovu, Joseph K. B.
   Bogart, Laura M.
   Nakabugo, Jennifer
   Kagaayi, Joseph
   Serwadda, David
   Wanyenze, Rhoda K.
   Ko, Albert I.
   Kurth, Ann E.
TI Feasibility and acceptability of a pilot, peer-led HIV self-testing
   intervention in a hyperendemic fishing community in rural Uganda
SO PLOS ONE
LA English
DT Article
ID MEN; CARE; PREVENTION; PARTNERS; LINKAGE
AB Background Novel interventions are needed to reach young people and adult men with HIV services given the low HIV testing rates in these population sub-groups. We assessed the feasibility and acceptability of a peer-led oral HIV self-testing (HIVST) intervention in Kasensero, a hyperendemic fishing community (HIV prevalence: 37-41%) in Rakai, Uganda. Methods This study was conducted among young people (15-24 years) and adult men (25+ years) between May and August 2019. The study entailed distribution of HIVST kits by trained "peer-leaders," who were selected from existing social networks and trained in HIVST distribution processes. Peer-leaders received up to 10 kits to distribute to eligible social network members (i.e. aged 15-24 years if young people or 25+ years if adult man, not tested in the past 3 months, and HIV-negative or of unknown HIV status at enrolment). The intervention was evaluated against the feasibility benchmark of 70% of peer-leaders distributing up to 70% of the kits that they received; and the acceptability benchmark of >80% of the respondents self-testing for HIV. Results Of 298 enrolled into the study at baseline, 56.4% (n= 168) were young people (15-24 years) and 43.6% (n= 130) were adult males (25+ years). Peer-leaders received 298 kits and distributed 296 (99.3%) kits to their social network members. Of the 282 interviewed at follow-up, 98.2% (n = 277) reported that they used the HIVST kits. HIV prevalence was 7.4% (n = 21). Of the 57.1% (n = 12) first-time HIV-positives, 100% sought confirmatory HIV testing and nine of the ten (90%) respondents who were confirmed as HIV-positive were linked to HIV care within 1 week of HIV diagnosis. Conclusion Our findings show that a social network-based, peer-led HIVST intervention in a hyperendemic fishing community is highly feasible and acceptable, and achieves high linkage to HIV care among newly diagnosed HIV-positive individuals.
C1 [Matovu, Joseph K. B.; Nakabugo, Jennifer; Serwadda, David; Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda.
   [Matovu, Joseph K. B.] Busitema Univ, Fac Hlth Sci, Mbale, Uganda.
   [Bogart, Laura M.] RAND Corp, Santa Monica, CA USA.
   [Kagaayi, Joseph] Rakai Hlth Sci Program, Kalisizo, Uganda.
   [Ko, Albert I.; Kurth, Ann E.] Yale Sch Publ Hlth, New Haven, CT USA.
   [Kurth, Ann E.] Yale Sch Nursing, New Haven, CT USA.
RP Matovu, JKB (corresponding author), Makerere Univ, Sch Publ Hlth, Kampala, Uganda.; Matovu, JKB (corresponding author), Busitema Univ, Fac Hlth Sci, Mbale, Uganda.
EM jmatovu@musph.ac.ug
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU National Institutes of Health Fogarty International CenterUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [NIH FIC D43TWO10540];
   Africa Research Excellence Fund [RF-1570024-F-MATOV]
FX This work was implemented as part of JKBM's Post-Doctoral Research
   Fellowship with a grant from the National Institutes of Health Fogarty
   International Center (NIH FIC D43TWO10540; Pls: Riley LW, Barry M, Ko
   Al, Madhivanan P) and another grant from the Africa Research Excellence
   Fund (RF-1570024-F-MATOV). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ajayi AI, 2019, J BIOSOC SCI, V51, P549, DOI 10.1017/S0021932018000330
   Billioux VG, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21590
   Bogart LM, 2016, AIDS BEHAV, V20, P2464, DOI 10.1007/s10461-016-1331-z
   Brown W, 2016, AIDS BEHAV, V20, P2000, DOI 10.1007/s10461-016-1309-x
   Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806
   Chang LW, 2016, LANCET HIV, V3, pE388, DOI 10.1016/S2352-3018(16)30034-0
   Choko AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208191
   Conserve DF, 2019, AIDS CARE, V31, P169, DOI 10.1080/09540121.2018.1537466
   Dyson YD, 2018, J ASSOC NURSE AIDS C, V29, P53, DOI 10.1016/j.jana.2017.11.003
   Fishbein M., 1975, BELIEF ATTITUDE INTE
   Fisher WA, 2003, BLACKW SER HLTH PSYC, P82, DOI 10.1002/9780470753552.ch4
   Gibbs A, 2015, CULT HEALTH SEX, V17, P85, DOI 10.1080/13691058.2015.1092260
   Grabowski MK, 2017, NEW ENGL J MED, V377, P2154, DOI [10.1056/nejmoa1702150, 10.1056/NEJMoa1702150]
   Hatzold K, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25244
   Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176
   Kagaayi J, 2019, LANCET HIV, V6, pE680, DOI 10.1016/S2352-3018(19)30190-0
   Grabowski MK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14636-y
   Knight L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1164
   Korte JE, 2020, JAIDS-J ACQ IMM DEF, V84, P271, DOI 10.1097/QAI.0000000000002341
   Lightfoot MA, 2018, JAIDS-J ACQ IMM DEF, V79, P38, DOI [10.1097/qai.0000000000001726, 10.1097/QAI.0000000000001726]
   Lubogo M, 2019, AFR HEALTH SCI, V19, P2545, DOI 10.4314/ahs.v19i3.40
   Mafigiri R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4166-2
   Maheswaran H, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0577-7
   Matovu JKB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-618
   McCarty C, 2007, SOC NETWORKS, V29, P300, DOI 10.1016/j.socnet.2006.12.005
   Ministry of Health, 2018, CONS GUID PREV TREAT
   Mugisha E, 2010, J ASSOC NURSE AIDS C, V21, P503, DOI 10.1016/j.jana.2010.02.005
   Musheke M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3396-z
   Nabukenya AM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6027-z
   Nyamhanga TM, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21812
   Okoboi S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227741
   SERWADDA D, 1985, LANCET, V2, P849, DOI 10.1016/S0140-6736(85)90122-9
   Sileo KM, 2019, CULT HEALTH SEX, V21, P774, DOI 10.1080/13691058.2018.1516299
   Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13
   Smith Joanna, 2011, Nurse Res, V18, P52
   Tumwine C, 2019, AJAR-AFR J AIDS RES, V18, P205, DOI 10.2989/16085906.2019.1648306
   Tun W, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25124
   Uganda Bureau of Statistics (UBOS) and ICF, 2018, UG DEM HLTH SURV 201
   Uganda National Council for Science and Technology, NAT GUID RES INV HUM
   UNAIDS, 2017, MEN BOYS
NR 40
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 7
PY 2020
VL 15
IS 8
AR e0236141
DI 10.1371/journal.pone.0236141
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA NC2FE
UT WOS:000561029000030
PM 32764751
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Vogels, CBF
   Brito, AF
   Wyllie, AL
   Fauver, JR
   Ott, IM
   Kalinich, CC
   Petrone, ME
   Casanovas-Massana, A
   Muenker, MC
   Moore, AJ
   Klein, J
   Lu, PW
   Lu-Culligan, A
   Jiang, XD
   Kim, DJ
   Kudo, E
   Mao, TY
   Moriyama, M
   Oh, JE
   Park, A
   Silva, J
   Song, E
   Takahashi, T
   Taura, M
   Tokuyama, M
   Venkataraman, A
   Weizman, OE
   Wong, P
   Yang, YX
   Cheemarla, NR
   White, EB
   Lapidus, S
   Earnest, R
   Geng, B
   Vijayakumar, P
   Odio, C
   Fournier, J
   Bermejo, S
   Farhadian, S
   Dela Cruz, CS
   Iwasaki, A
   Ko, AI
   Landry, ML
   Foxman, EF
   Grubaugh, ND
AF Vogels, Chantal B. F.
   Brito, Anderson F.
   Wyllie, Anne L.
   Fauver, Joseph R.
   Ott, Isabel M.
   Kalinich, Chaney C.
   Petrone, Mary E.
   Casanovas-Massana, Arnau
   Muenker, M. Catherine
   Moore, Adam J.
   Klein, Jonathan
   Lu, Peiwen
   Lu-Culligan, Alice
   Jiang, Xiaodong
   Kim, Daniel J.
   Kudo, Eriko
   Mao, Tianyang
   Moriyama, Miyu
   Oh, Ji Eun
   Park, Annsea
   Silva, Julio
   Song, Eric
   Takahashi, Takehiro
   Taura, Manabu
   Tokuyama, Maria
   Venkataraman, Arvind
   Weizman, Orr-El
   Wong, Patrick
   Yang, Yexin
   Cheemarla, Nagarjuna R.
   White, Elizabeth B.
   Lapidus, Sarah
   Earnest, Rebecca
   Geng, Bertie
   Vijayakumar, Pavithra
   Odio, Camila
   Fournier, John
   Bermejo, Santos
   Farhadian, Shelli
   Dela Cruz, Charles S.
   Iwasaki, Akiko
   Ko, Albert, I
   Landry, Marie L.
   Foxman, Ellen F.
   Grubaugh, Nathan D.
TI Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR
   primer-probe sets
SO NATURE MICROBIOLOGY
LA English
DT Article
ID PCR; QUANTIFICATION; GENE
AB The recent spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exemplifies the critical need for accurate and rapid diagnostic assays to prompt clinical and public health interventions. Currently, several quantitative reverse transcription-PCR (RT-qPCR) assays are being used by clinical, research and public health laboratories. However, it is currently unclear whether results from different tests are comparable. Our goal was to make independent evaluations of primer-probe sets used in four common SARS-CoV-2 diagnostic assays. From our comparisons of RT-qPCR analytical efficiency and sensitivity, we show that all primer-probe sets can be used to detect SARS-CoV-2 at 500 viral RNA copies per reaction. The exception for this is the RdRp-SARSr (Charite) confirmatory primer-probe set which has low sensitivity, probably due to a mismatch to circulating SARS-CoV-2 in the reverse primer. We did not find evidence for background amplification with pre-COVID-19 samples or recent SARS-CoV-2 evolution decreasing sensitivity. Our recommendation for SARS-CoV-2 diagnostic testing is to select an assay with high sensitivity and that is regionally used, to ease comparability between outcomes.
   This is a comparative analysis of the performance of the primer-probe sets from four open-source molecular diagnostic assays for SARS-CoV-2 recommended by the World Health Organization.
C1 [Vogels, Chantal B. F.; Brito, Anderson F.; Wyllie, Anne L.; Fauver, Joseph R.; Kalinich, Chaney C.; Petrone, Mary E.; Casanovas-Massana, Arnau; Muenker, M. Catherine; Moore, Adam J.; White, Elizabeth B.; Lapidus, Sarah; Earnest, Rebecca; Ko, Albert, I; Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Ott, Isabel M.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.
   [Klein, Jonathan; Lu, Peiwen; Lu-Culligan, Alice; Jiang, Xiaodong; Kim, Daniel J.; Kudo, Eriko; Mao, Tianyang; Moriyama, Miyu; Oh, Ji Eun; Park, Annsea; Silva, Julio; Song, Eric; Takahashi, Takehiro; Taura, Manabu; Tokuyama, Maria; Venkataraman, Arvind; Weizman, Orr-El; Wong, Patrick; Yang, Yexin; Iwasaki, Akiko; Foxman, Ellen F.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA.
   [Cheemarla, Nagarjuna R.; Landry, Marie L.; Foxman, Ellen F.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT USA.
   [Geng, Bertie; Vijayakumar, Pavithra] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA.
   [Odio, Camila] Yale New Haven Hlth, Northeast Med Grp, Dept Med, New Haven, CT USA.
   [Fournier, John; Farhadian, Shelli; Landry, Marie L.] Yale Univ, Sch Med, Dept Med, Sect Infect Dis, New Haven, CT 06510 USA.
   [Bermejo, Santos; Dela Cruz, Charles S.] Yale Univ, Sch Med, Dept Internal Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06510 USA.
   [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD USA.
   [Landry, Marie L.] Yale New Haven Med Ctr, Clin Virol Lab, New Haven, CT USA.
RP Vogels, CBF; Grubaugh, ND (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
EM chantal.vogels@yale.edu; nathan.grubaugh@yale.edu
RI Oh, Ji Eun/AAX-2355-2020; Ko, Albert Icksang/P-2343-2015
OI Oh, Ji Eun/0000-0003-2511-7064; Ko, Albert Icksang/0000-0001-9023-2339;
   Casanovas-Massana, Arnau/0000-0002-3301-6143; Klein,
   Jonathan/0000-0002-3552-7684; Mao, Tianyang/0000-0001-9251-8592;
   Kalinich, Chaney/0000-0001-9675-0065; Kim, Daniel/0000-0003-4351-8224;
   Fauver, Joseph/0000-0001-8099-2991; Venkataraman,
   Arvind/0000-0003-1148-4402; Muenker, M. Catherine/0000-0002-0450-0868;
   Vogels, Chantal/0000-0003-0027-6480; Cheemarla,
   Nagarjuna/0000-0002-8860-2457
FU Yale Institute for Global Health; Yale School of Public Health; NWO
   RubiconNetherlands Organization for Scientific Research (NWO)
   [019.181EN.004]
FX We thank K. Plante and the University of Texas Medical Branch World
   Reference Center for Emerging Viruses for providing SARS-CoV-2 RNA, the
   Yale COVID-19 Laboratory Working Group for technical support, P. Jack
   and S. Taylor for discussions and A. Greninger and X. Lu for feedback on
   a previous version of this manuscript. We also thank scientists from
   around the world who openly shared their SARS-CoV-2 genomic data on
   GISAID, and they are acknowledged in Source Data Fig. 4. This research
   was funded by generous support from the Yale Institute for Global Health
   and the Yale School of Public Health start-up package provided to N.D.G.
   C.B.F.V. is supported by NWO Rubicon (no. 019.181EN.004).
CR [Anonymous], 2020, CDC REV SARS COV 2 A
   Broeders S, 2014, TRENDS FOOD SCI TECH, V37, P115, DOI 10.1016/j.tifs.2014.03.008
   Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07
   Centers for Disease Control and Prevention, 2020, RES US ONL 2019 NOV
   Chu DKW, 2020, CLIN CHEM, V66, P549, DOI 10.1093/clinchem/hvaa029
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8
   Gorbalenya AE, 2020, SEVERE ACUTE RESP SY, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]
   Harcourt J, 2020, EMERG INFECT DIS, V26, P1266, DOI 10.3201/eid2606.200516
   Nalla AK, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00557-20
   National Institute For viral Disease Control and prevention of PRC, 2020, SPEC PRIM PROB DET 2
   Ott I. M., 2020, SALIVA COLLECTION RN, DOI [10.17504/protocols.io.bh6mj9c6, DOI 10.17504/PROTOCOLS.IO.BH6MJ9C6]
   Svec David, 2015, Biomol Detect Quantif, V3, P9, DOI 10.1016/j.bdq.2015.01.005
   The Nextstrain Team, 2020, GEN EP NOV COR GLOB
   Vogels C. B. F., 2020, GENERATION SARS COV, DOI [10.17504/protocols.io.bdv6i69e, DOI 10.17504/PROTOCOLS.IO.BDV6I69E]
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zulkower V., 2020, DNA FEATURES VIEWER, DOI [10.1101/2020.01.09.900589, DOI 10.1101/2020.01.09.900589]
NR 18
TC 21
Z9 20
U1 12
U2 12
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD OCT
PY 2020
VL 5
IS 10
BP 1299
EP +
DI 10.1038/s41564-020-0761-6
EA JUL 2020
PG 13
WC Microbiology
SC Microbiology
GA NS0UN
UT WOS:000547221000001
PM 32651556
OA Bronze
DA 2020-11-30
ER

PT J
AU Vinholo, TF
   Ribeiro, GS
   Silva, NF
   Cruz, J
   Reis, MG
   Ko, AI
   Costa, F
AF Vinholo, Thais Faggion
   Ribeiro, Guilherme S.
   Silva, Nanci F.
   Cruz, Jaqueline
   Reis, Mitermayer G.
   Ko, Albert, I
   Costa, Federico
TI Severe leptospirosis after rat bite: A case report
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
C1 [Vinholo, Thais Faggion; Reis, Mitermayer G.; Ko, Albert, I; Costa, Federico] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Ribeiro, Guilherme S.; Cruz, Jaqueline; Reis, Mitermayer G.; Ko, Albert, I; Costa, Federico] Fundacao Oswaldo Cruz, Minist Saude, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.; Reis, Mitermayer G.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Silva, Nanci F.] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Costa, Federico] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
RP Costa, F (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Costa, F (corresponding author), Fundacao Oswaldo Cruz, Minist Saude, Inst Goncalo Moniz, Salvador, BA, Brazil.; Costa, F (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.; Costa, F (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
EM Federico.costa@ufba.br
RI Ko, Albert Icksang/P-2343-2015; Ribeiro, Guilherme/B-6624-2008; Costa,
   Federico/G-1838-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Ribeiro,
   Guilherme/0000-0002-6798-2059; Costa, Federico/0000-0001-6951-2336
FU Fogarty International Center from the National Institutes of Health [R25
   TW009338, R01 TW009504]; National Institute of Allergy and Infectious
   Diseases from the National Institutes of Health [F31 AI114245, R01
   AI121207]; UK Medical Research CouncilMedical Research Council UK (MRC)
   [MR/P0240841]; Wellcome TrustWellcome Trust [102330/Z/13/Z]; Fulbright
   Foundation
FX The study was supported by grants from the Fogarty International Center
   (R25 TW009338, R01 TW009504) and National Institute of Allergy and
   Infectious Diseases (F31 AI114245, R01 AI121207) from the National
   Institutes of Health; the UK Medical Research Council (MR/P0240841), the
   Wellcome Trust (102330/Z/13/Z), and the Fulbright Foundation. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Cerny A, 1992, Eur J Med, V1, P315
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Dalal P., 1959, INDIAN J MED SCI, V14, P295
   Donovan CM, 2018, J WILDLIFE DIS, V54, P635, DOI 10.7589/2017-08-194
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Gostic KM, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2019.0367
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Hacker KP, 2020, EMERG INFECT DIS, V26, P311, DOI 10.3201/eid2602.190102
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Jimenez JIS, 2017, J CRIT CARE, V43, P361, DOI DOI 10.1016/J.JCRC.2017.11.005
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Leptospirosis R, 1960, ALERTS NOTICES CASE
   LUZZI GA, 1987, J INFECTION, V15, P57, DOI 10.1016/S0163-4453(87)91451-4
   McBride AJA, 2007, CLIN VACCINE IMMUNOL, V14, P1245, DOI 10.1128/CVI.00217-07
   Roczek A, 2008, J MED MICROBIOL, V57, P658, DOI 10.1099/jmm.0.47677-0
NR 17
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2020
VL 14
IS 7
AR e0008257
DI 10.1371/journal.pntd.0008257
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA MQ0ON
UT WOS:000552596700003
PM 32645040
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Matovu, JK
   Bogart, L
   Nakabugo, J
   Gitta, JM
   Kagaayi, J
   Serwadda, D
   Wanyenze, RK
   Ko, A
   Kurth, A
AF Matovu, J. K.
   Bogart, L.
   Nakabugo, J.
   Gitta, J. M.
   Kagaayi, J.
   Serwadda, D.
   Wanyenze, R. K.
   Ko, A.
   Kurth, A.
TI Feasibility of implementation, acceptability and preliminary effects of
   a pilot, peer-led HIV self-testing intervention in a hyperendemic
   fishing community in rural Uganda
SO JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
LA English
DT Meeting Abstract
C1 [Matovu, J. K.] Makerere Univ, Sch Publ Hlth Dis Control & Environm Hlth, Kampala, Uganda.
   [Matovu, J. K.] Busitema Univ, Fac Hlth Sci, Mbale, Uganda.
   [Bogart, L.] RAND Corp, Santa Monica, CA USA.
   [Nakabugo, J.; Gitta, J. M.; Serwadda, D.; Wanyenze, R. K.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda.
   [Kagaayi, J.] Rakai Hlth Sci Program, Kalisizo, Uganda.
   [Ko, A.] Yale Univ, Epidemiol Microbial Dis, New Haven, CT USA.
   [Kurth, A.] Yale Univ, Sch Nursing, New Haven, CT 06536 USA.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 1758-2652
J9 J INT AIDS SOC
JI J. Int. AIDS Soc.
PD JUL
PY 2020
VL 23
SU 4
SI SI
MA OAC0402
BP 39
EP 40
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA MP1RO
UT WOS:000551988900070
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Anjos, RO
   Mugabe, VA
   Moreira, PSS
   Carvalho, CX
   Portilho, MM
   Khouri, R
   Sacramento, GA
   Nery, NRR
   Reis, MG
   Kitron, UD
   Ko, AI
   Costa, F
   Ribeiro, GS
AF Anjos, Rosangela O.
   Mugabe, Vanio Andre
   Moreira, Patricia S. S.
   Carvalho, Caroline X.
   Portilho, Moyra M.
   Khouri, Ricardo
   Sacramento, Gielson A.
   Nery Jr, Nivison R. R.
   Reis, Mitermayer G.
   Kitron, Uriel D.
   Ko, Albert, I
   Costa, Federico
   Ribeiro, Guilherme S.
TI Transmission of Chikungunya Virus in an Urban Slum, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID ZIKA; SURVEILLANCE; ENVIRONMENT; INFECTION; OUTBREAK; IMPACT; FEVER
AB After a chikungunya outbreak in Salvador, Brazil, we performed a cross-sectional, community-based study of 1,776 inhabitants to determine chikungunya virus (CHIKV) seroprevalence, identify factors associated with exposure, and estimate the symptomatic infection rate. From November 2016 through February 2017, we collected sociodemographic and clinical data by interview and tested serum samples for CHIKV IgG. CHIKV seroprevalence was 11.8% (95% CI 9.8%-13.7%), and 15.3% of seropositive persons reported an episode of fever and arthralgia. Infections were independently and positively associated with residences served by unpaved streets, a presumptive clinical diagnosis of chikungunya, and recall of an episode of fever with arthralgia in 2015-2016. Our findings indicate that the chikungunya outbreak in Salvador may not have conferred sufficient herd immunity to preclude epidemics in the near future. The unusually low frequency of symptomatic disease points to a need for further longitudinal studies to better investigate these findings.
C1 [Anjos, Rosangela O.; Moreira, Patricia S. S.; Carvalho, Caroline X.; Portilho, Moyra M.; Khouri, Ricardo; Sacramento, Gielson A.; Nery Jr, Nivison R. R.; Reis, Mitermayer G.; Kitron, Uriel D.; Ko, Albert, I; Costa, Federico; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Mugabe, Vanio Andre] Univ Licungo, Quelimane, Mozambique.
   [Mugabe, Vanio Andre; Khouri, Ricardo; Nery Jr, Nivison R. R.; Reis, Mitermayer G.; Costa, Federico; Ribeiro, Guilherme S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Reis, Mitermayer G.; Ko, Albert, I; Costa, Federico] Yale Univ, New Haven, CT USA.
   [Kitron, Uriel D.] Emory Univ, Atlanta, GA 30322 USA.
   [Costa, Federico] Univ Liverpool, Liverpool, Merseyside, England.
   [Costa, Federico] Univ Lancaster, Lancaster, England.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Ko, Albert Icksang/P-2343-2015; Ribeiro, Guilherme/B-6624-2008; Costa,
   Federico/G-1838-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Ribeiro,
   Guilherme/0000-0002-6798-2059; Costa, Federico/0000-0001-6951-2336
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [400830/2013-2, 440891/2016-7, 421522/2016-0, 439967/2016-3];
   Coordination for the Improvement of Higher Education Personnel,
   Brazilian Ministry of Education [88887.130746/2016-00]; Research Support
   Foundation for the State of Bahia [FAPESB PET0022/2016]; US National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIAID 5 R01 AI121207,
   FIC 5 R01 TW009504, FIC 5 R25 TW009338, NIAID 5 U01 AI088752]; Wellcome
   TrustWellcome Trust [102330/Z/13/Z]; Yale School of Public Health;
   Oswaldo Cruz Foundation; Federal University of Bahia; Department of
   Science and Technology, Secretariat of Science, Technology and Strategic
   Inputs, Brazilian Ministry of Health
FX We thank the study participants and the community leaders from the Pau
   da Lima Urban Health Council who provided support for the investigation
   and the team members from Fundacao Oswaldo Cruz (especially Perla
   Santana, Renan Rosa, Paula Sousa Barbosa, Leile Camila Jacob Nascimento,
   and Isabele de Pa ' dua Carvalho), who participated in the data
   collection, laboratory experiments, or provided assistance with data
   management and administrative matters. This study was supported by the
   Brazilian National Council for Scientific and Technological Development
   (grants 400830/2013-2, 440891/2016-7, and 421522/2016-0 to G.S.R., grant
   439967/2016-3 to R.K., and scholarships to M.G.R., U.K., and G.S.R.);
   the Coordination for the Improvement of Higher Education Personnel,
   Brazilian Ministry of Education (grant 88887.130746/2016-00 to G.S.R.);
   the Research Support Foundation for the State of Bahia (grant FAPESB
   PET0022/2016 to G.S.R.); the US National Institutes of Health (grants
   NIAID 5 R01 AI121207, FIC 5 R01 TW009504, FIC 5 R25 TW009338, and NIAID
   5 U01 AI088752 to A.I.K.); the Wellcome Trust (102330/Z/13/Z to F.C.);
   the Yale School of Public Health; the Oswaldo Cruz Foundation; the
   Federal University of Bahia; and the Department of Science and
   Technology, Secretariat of Science, Technology and Strategic Inputs,
   Brazilian Ministry of Health.
CR Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Bozza FA, 2019, EMERG INFECT DIS, V25, P311, DOI 10.3201/eid2502.180166
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chaaithanya IK, 2013, IMMUNOLOGY, V140, P202, DOI 10.1111/imm.12128
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   De Salazar PM, 2017, REV PANAM SALUD PUBL, V41
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gordon A, 2018, CLIN INFECT DIS, V67, P1760, DOI 10.1093/cid/ciy356
   Grossi-Soyster EN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005998
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Harvey LA, 2018, SPINAL CORD, V56, P625, DOI 10.1038/s41393-018-0169-9
   Hennessey MJ, 2018, AM J TROP MED HYG, V99, P1321, DOI 10.4269/ajtmh.18-0437
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Kolopp-Sarda MN, 2018, AUTOIMMUN REV, V17, P457, DOI 10.1016/j.autrev.2017.11.035
   Krystosik AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181208
   Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773
   Langsjoen RM, 2018, MBIO, V9, DOI 10.1128/mBio.02449-17
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Oliver M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000374
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Higuera-Mendieta DR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005016
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rogier EW, 2018, EMERG INFECT DIS, V24, P995, DOI 10.3201/eid2406.171447
   Secretaria de Vigilancia em Saude/Ministerio da Saude, 2016, B EPIDEMIOLOGICO, V47
   Secretaria de Vigilancia em Saude/Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude/Ministerio da Saude, 2017, B EPIDEMIOLOGICO, V48
   Sharp TM, 2014, MMWR-MORBID MORTAL W, V63, P1121
   Silva MMO, 2019, CLIN INFECT DIS, V69, P1353, DOI 10.1093/cid/ciy1083
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Snyder Robert E, 2017, Trop Med Infect Dis, V2, DOI 10.3390/tropicalmed2030047
   StataCorp, 2015, STAT STAT SOFTW REL
   Tauro LB, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760180597
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Unger A, 2015, J URBAN HEALTH, V92, P446, DOI 10.1007/s11524-015-9956-1
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Whiteman A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6172-4
   World Bank, 2018, PIEC TOG POV PUZZL
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
NR 47
TC 1
Z9 1
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2020
VL 26
IS 7
BP 1364
EP 1373
DI 10.3201/eid2607.190846
PG 10
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA MO0MP
UT WOS:000551231700002
PM 32568045
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Togami, E
   Gyawali, N
   Ong, O
   Kama, M
   Cao-Lormeau, V
   Aubry, M
   Ko, IA
   Nilles, EJ
   Collins-Emerson, JM
   Devine, GJ
   Weinstein, P
   Lau, CL
AF Togami, Eri
   Gyawali, Narayan
   Ong, Oselyne
   Kama, Mike
   Cao-Lormeau, Van -Mai
   Aubry, Maite
   Ko, I. Albert
   Nilles, Eric J.
   Collins-Emerson, Julie M.
   Devine, Gregor J.
   Weinstein, Philip
   Lau, Colleen L.
TI First evidence of concurrent enzootic and endemic transmission of Ross
   River virus in the absence of marsupial reservoirs in Fiji
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Ross River virus; Arbovirus; Zoonoses; Endemic diseases; Emerging
   infectious diseases
ID INFECTION; DISEASE
AB Background: Ross River virus (RRV) is a zoonotic alphavirus transmitted by several mosquito species. Until recently, endemic transmission was only considered possible in the presence of marsupial reservoirs.
   Methods: RRV seroprevalence was investigated in placental mammals (including horses, cows, goats, pigs, dogs, rats, and mice) in Fiji, where there are no marsupials. A total of 302 vertebrate serum samples were collected from 86 households from 10 communities in Western Fiji.
   Results: Neutralizing antibodies against RRV were detected in 28% to 100% of sera depending on the species, and neutralization was strong even at high dilutions.
   Conclusions: These results are unlikely to be due to cross-reactions. Chikungunya is the only other alphavirus known to be present in the Pacific Islands, but it rarely spills over into non-humans, even during epidemics. The study findings, together with a recent report of high RRV seroprevalence in humans, strongly suggest that RRV is circulating in Fiji in the absence of marsupial reservoirs. Considering that all non-human vertebrates present in Fiji are pan-global in distribution, RRV has the potential to further expand its geographic range. Further surveillance of RRV and access to RRV diagnostics will be critical for the early detection of emergence and outbreaks. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Togami, Eri; Ko, I. Albert] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06510 USA.
   [Gyawali, Narayan; Ong, Oselyne; Devine, Gregor J.] QIMR Berghofer Med Res Inst, 300 Herston Rd, Brisbane, Qld 4006, Australia.
   [Kama, Mike] Minist Hlth, Ctr Communicable Dis Control, 88 Amy St,Toorak POB 2223,Govt Bldg, Suva, Fiji.
   [Cao-Lormeau, Van -Mai; Aubry, Maite] Inst Louis Malarde, POB 30, F-98713 Tahiti, French Polynesi, France.
   [Ko, I. Albert] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Nilles, Eric J.] Harvard Humanitarian Initiat, 14 Story St,Fl Second, Cambridge, MA 02138 USA.
   [Nilles, Eric J.] Harvard Med Sch, Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
   [Collins-Emerson, Julie M.] Massey Univ, Hopkirk Res Inst, Sch Vet Sci, Palmerston North 4410, New Zealand.
   [Weinstein, Philip] Univ Adelaide, Sch Publ Hlth, North Terrace Campus, Adelaide, SA 5005, Australia.
   [Lau, Colleen L.] Australian Natl Univ, Res Sch Populat Hlth, Coll Hlth & Med, Canberra, ACT 0200, Australia.
RP Togami, E (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06510 USA.
EM eri.togami1@gmail.com
RI Devine, Gregor J/H-1141-2014; Ko, Albert Icksang/P-2343-2015;
   Cao-Lormeau, Van-Mai/H-4879-2018
OI Devine, Gregor J/0000-0001-6312-0390; Ko, Albert
   Icksang/0000-0001-9023-2339; Nilles, Eric/0000-0001-7044-5257;
   Weinstein, Philip/0000-0001-9860-7166; Cao-Lormeau,
   Van-Mai/0000-0001-5606-7480; Aubry, Maite/0000-0002-9913-5794
FU Australian National Health and Medical Research Council
   FellowshipNational Health and Medical Research Council of Australia
   [1109035]
FX CLL was supported by an Australian National Health and Medical Research
   Council Fellowship (#1109035).
CR AASKOV JG, 1981, AM J TROP MED HYG, V30, P1053, DOI 10.4269/ajtmh.1981.30.1053
   Aubry M, 2019, EMERG INFECT DIS, V25, P827, DOI 10.3201/eid2504.180694
   Aubry M, 2017, EMERG INFECT DIS, V23, P1751, DOI 10.3201/eid2310.170583
   Australian Department of Health, 2019, NAT NOT DIS AUSTR NO
   CALISHER CH, 1980, INTERVIROLOGY, V14, P229, DOI 10.1159/000149190
   Flies EJ, 2018, BIOSCIENCE, V68, P288, DOI 10.1093/biosci/biy011
   Gyawali N, 2020, VECTOR-BORNE ZOONOT, V20, P33, DOI 10.1089/vbz.2019.2467
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Lau C, 2017, INT J INFECT DIS, V57, P73, DOI 10.1016/j.ijid.2017.01.041
   Lau C, 2012, TRAVEL MED INFECT DI, V10, P129, DOI 10.1016/j.tmaid.2012.04.001
   Stephenson EB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2733-8
NR 11
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2020
VL 96
BP 94
EP 96
DI 10.1016/j.ijid.2020.02.048
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA MJ9ZY
UT WOS:000548446200003
PM 32114197
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Farhadian, S
   Glick, L
   Vogels, CBF
   Thomas, J
   Chiarella, J
   Casanovas-Massana, A
   Zhou, J
   Odio, C
   Vijayakumar, P
   Geng, B
   Fournier, J
   Bermejo, S
   Fauver, JR
   Alpert, T
   Wyllie, AL
   Turcotte, C
   Steinle, M
   Paczkowski, P
   Dela Cruz, C
   Wilen, C
   Ko, AI
   MacKay, S
   Grubaugh, ND
   Spudich, S
   Barakat, LA
AF Farhadian, Shelli
   Glick, Laura
   Vogels, Chantal B. F.
   Thomas, Jared
   Chiarella, Jennifer
   Casanovas-Massana, Arnau
   Zhou, Jing
   Odio, Camila
   Vijayakumar, Pavithra
   Geng, Bertie
   Fournier, John
   Bermejo, Santos
   Fauver, Joseph R.
   Alpert, Tara
   Wyllie, Anne L.
   Turcotte, Cynthia
   Steinle, Matthew
   Paczkowski, Patrick
   Dela Cruz, Charles
   Wilen, Craig
   Ko, Albert, I
   MacKay, Sean
   Grubaugh, Nathan D.
   Spudich, Serena
   Barakat, Lydia Aoun
TI Acute encephalopathy with elevated CSF inflammatory markers as the
   initial presentation of COVID-19
SO BMC NEUROLOGY
LA English
DT Article
DE COVID-19; SARS-CoV-2; Neuroinflammation
ID RESPIRATORY SYNDROME CORONAVIRUS; BRAIN; ENCEPHALITIS; INFECTION
AB Background COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2. It is widely recognized as a respiratory pathogen, but neurologic complications can be the presenting manifestation in a subset of infected patients. Case presentation We describe a 78-year old immunocompromised woman who presented with altered mental status after witnessed seizure-like activity at home. She was found to have SARS-CoV-2 infection and associated neuroinflammation. In this case, we undertake the first detailed analysis of cerebrospinal fluid (CSF) cytokines during COVID-19 infection and find a unique pattern of inflammation in CSF, but no evidence of viral neuroinvasion. Conclusion Our findings suggest that neurologic symptoms such as encephalopathy and seizures may be the initial presentation of COVID-19. Central nervous system inflammation may associate with neurologic manifestations of disease.
C1 [Farhadian, Shelli; Fournier, John; Ko, Albert, I; Barakat, Lydia Aoun] Yale Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA.
   [Farhadian, Shelli; Chiarella, Jennifer; Spudich, Serena] Yale Sch Med, Dept Neurol, New Haven, CT 06510 USA.
   [Glick, Laura; Thomas, Jared; Odio, Camila; Vijayakumar, Pavithra; Geng, Bertie] Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA.
   [Vogels, Chantal B. F.; Casanovas-Massana, Arnau; Fauver, Joseph R.; Alpert, Tara; Wyllie, Anne L.; Ko, Albert, I; Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Zhou, Jing; Turcotte, Cynthia; Steinle, Matthew; Paczkowski, Patrick; MacKay, Sean] Isoplexis, Branford, CT 06540 USA.
   [Bermejo, Santos; Dela Cruz, Charles] Yale Sch Med, Sect Pulm Crit Care & Sleep Med, Dept Internal Med, New Haven, CT 06510 USA.
   [Wilen, Craig] Yale Sch Med, Dept Lab Med, New Haven, CT 06510 USA.
RP Farhadian, S (corresponding author), Yale Sch Med, Dept Internal Med, Sect Infect Dis, New Haven, CT 06510 USA.; Farhadian, S (corresponding author), Yale Sch Med, Dept Neurol, New Haven, CT 06510 USA.
EM shelli.farhadian@yale.edu
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Casanovas-Massana,
   Arnau/0000-0002-3301-6143
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [K23MH118999]; American Federation for
   Aging Research; Robert E. Leet and Clara Guthrie Patterson Trust;
   NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [5 R01 AI121207]; Beatrice Kleinberg
   Neuwirth Fund
FX Dr. Farhadian is supported by NIH K23MH118999, the American Federation
   for Aging Research, the Robert E. Leet and Clara Guthrie Patterson
   Trust. Dr. Ko is supported by NIAID 5 R01 AI121207. This work was
   supported by the Beatrice Kleinberg Neuwirth Fund. The funding bodies
   did not have roles in the design of the study and data collection,
   analysis, and interpretation and did not play any role in writing the
   manuscript.
CR Arabi YM, 2015, INFECTION, V43, P495, DOI 10.1007/s15010-015-0720-y
   Arbour N, 1999, J VIROL, V73, P3338, DOI 10.1128/JVI.73.4.3338-3350.1999
   Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410
   Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597
   Jacomy H, 2003, VIROLOGY, V315, P20, DOI 10.1016/S0042-6822(03)00323-4
   Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9
   Mahad DJ, 2003, SEMIN IMMUNOL, V15, P23, DOI 10.1016/S1044-5323(02)00125-2
   Mao L, 2020, JAMA NEUROL, V1, pe201127
   Mastroianni CM, 1998, CLIN EXP IMMUNOL, V114, P210
   Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187
   Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]
   Weiss JM, 1999, J IMMUNOL, V163, P2953
   Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031
   Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461
   Yao Y, 2014, CELL MOL LIFE SCI, V71, P683, DOI 10.1007/s00018-013-1459-1
NR 17
TC 12
Z9 11
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2377
J9 BMC NEUROL
JI BMC Neurol.
PD JUN 18
PY 2020
VL 20
IS 1
AR 248
DI 10.1186/s12883-020-01812-2
PG 5
WC Clinical Neurology
SC Neurosciences & Neurology
GA MC0RP
UT WOS:000543005600001
PM 32552792
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Fauver, JR
   Petrone, ME
   Hodcroft, EB
   Shioda, K
   Ehrlich, HY
   Watts, AG
   Vogels, CBF
   Brito, AF
   Alpert, T
   Muyombwe, A
   Razeq, J
   Downing, R
   Cheemarla, NR
   Wyllie, AL
   Kalinich, CC
   Ott, IM
   Quick, J
   Loman, NJ
   Neugebauer, KM
   Greninger, AL
   Jerome, KR
   Roychoudhury, P
   Xie, H
   Shrestha, L
   Huang, ML
   Pitzer, VE
   Iwasaki, A
   Omer, SB
   Khan, K
   Bogoch, II
   Martinello, RA
   Foxman, EF
   Landry, ML
   Neher, RA
   Ko, AI
   Grubaugh, ND
AF Fauver, Joseph R.
   Petrone, Mary E.
   Hodcroft, Emma B.
   Shioda, Kayoko
   Ehrlich, Hanna Y.
   Watts, Alexander G.
   Vogels, Chantal B. F.
   Brito, Anderson F.
   Alpert, Tara
   Muyombwe, Anthony
   Razeq, Jafar
   Downing, Randy
   Cheemarla, Nagarjuna R.
   Wyllie, Anne L.
   Kalinich, Chaney C.
   Ott, Isabel M.
   Quick, Joshua
   Loman, Nicholas J.
   Neugebauer, Karla M.
   Greninger, Alexander L.
   Jerome, Keith R.
   Roychoudhury, Pavitra
   Xie, Hong
   Shrestha, Lasata
   Huang, Meei-Li
   Pitzer, Virginia E.
   Iwasaki, Akiko
   Omer, Saad B.
   Khan, Kamran
   Bogoch, Isaac I.
   Martinello, Richard A.
   Foxman, Ellen F.
   Landry, Marie L.
   Neher, Richard A.
   Ko, Albert, I
   Grubaugh, Nathan D.
TI Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the
   United States
SO CELL
LA English
DT Review
AB The novel coronavirus SARS-CoV-2 was first detected in the Pacific Northwest region of the United States in January 2020, with subsequent COVID-19 outbreaks detected in all 50 states by early March. To uncover the sources of SARS-CoV-2 introductions and patterns of spread within the United States, we sequenced nine viral genomes from early reported COVID-19 patients in Connecticut. Our phylogenetic analysis places the majority of these genomes with viruses sequenced from Washington state. By coupling our genomic data with domestic and international travel patterns, we show that early SARS-CoV-2 transmission in Connecticut was likely driven by domestic introductions. Moreover, the risk of domestic importation to Connecticut exceeded that of international importation by mid-March regardless of our estimated effects of federal travel restrictions. This study provides evidence of widespread sustained transmission of SARS-CoV-2 within the United States and highlights the critical need for local surveillance.
C1 [Fauver, Joseph R.; Petrone, Mary E.; Shioda, Kayoko; Ehrlich, Hanna Y.; Vogels, Chantal B. F.; Brito, Anderson F.; Wyllie, Anne L.; Kalinich, Chaney C.; Pitzer, Virginia E.; Omer, Saad B.; Ko, Albert, I; Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Hodcroft, Emma B.; Neher, Richard A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Hodcroft, Emma B.; Neher, Richard A.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland.
   [Watts, Alexander G.; Khan, Kamran] BlueDot, Toronto, ON M5J 1A7, Canada.
   [Alpert, Tara; Neugebauer, Karla M.] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06510 USA.
   [Muyombwe, Anthony; Razeq, Jafar; Downing, Randy] Connecticut State Dept Publ Hlth, Hartford, CT 06510 USA.
   [Cheemarla, Nagarjuna R.; Foxman, Ellen F.; Landry, Marie L.] Yale Sch Med, Dept Lab Med, New Haven, CT 06510 USA.
   [Ott, Isabel M.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06510 USA.
   [Quick, Joshua; Loman, Nicholas J.] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
   [Greninger, Alexander L.; Jerome, Keith R.; Roychoudhury, Pavitra; Xie, Hong; Shrestha, Lasata; Huang, Meei-Li] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.
   [Greninger, Alexander L.; Jerome, Keith R.; Roychoudhury, Pavitra; Huang, Meei-Li] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.
   [Iwasaki, Akiko; Foxman, Ellen F.] Yale Univ, Dept Immunobiol, New Haven, CT 06510 USA.
   [Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
   [Omer, Saad B.] Yale Univ, Yale Inst Global Hlth, New Haven, CT 06510 USA.
   [Omer, Saad B.; Martinello, Richard A.; Landry, Marie L.] Yale Sch Med, Dept Med, Sect Infect Dis, New Haven, CT 06510 USA.
   [Omer, Saad B.] Yale Univ, Yale Sch Nursing, New Haven, CT 06510 USA.
   [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1A6, Canada.
   [Khan, Kamran; Bogoch, Isaac I.] Univ Toronto, Dept Med, Sect Infect Dis, Toronto, ON M5S 3H2, Canada.
   [Martinello, Richard A.] Yale Sch Med, Dept Pediat, New Haven, CT 06510 USA.
   [Martinello, Richard A.] Yale New Haven Hlth, Dept Infect Prevent, New Haven, CT 06510 USA.
   [Landry, Marie L.] Yale New Haven Hlth, Clin Virol Lab, New Haven, CT 06510 USA.
RP Fauver, JR; Grubaugh, ND (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
EM joseph.fauver@yale.edu; nathan.grubaugh@yale.edu
RI Bogoch, Isaac/AAS-9631-2020; Ko, Albert Icksang/P-2343-2015; CHEEMARLA,
   NAGARJUNA/I-5539-2019
OI Ko, Albert Icksang/0000-0001-9023-2339; CHEEMARLA,
   NAGARJUNA/0000-0002-8860-2457; Ott, Isabel/0000-0002-7134-0956; Brito,
   Anderson F/0000-0001-5785-7222
FU Yale Institute for Global Health; Yale School of Public Health;
   NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI112970, R01 AI137093]; Wellcome
   TrustWellcome Trust [206298/A/17/Z]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   GM112766]; Canadian Institutes of Health ResearchCanadian Institutes of
   Health Research (CIHR); NWONetherlands Organization for Scientific
   Research (NWO) [019.181EN.004]; Medical Research Council fellowship as
   part of the CLIMB project; UKRI Future Leaders fellowship
FX The authors of this study would like to acknowledge S. Cordey, I.
   Eckerle, and L. Kaiser from Geneva University Hospital for directly
   sharing their genome sequence data with our team; everyone who openly
   shared their genomic data on GenBank and GISAID (authors listed in Data
   S2); D. Ferguson, R. Garner, and J. Criscuolo at the Yale Clinical
   Virology Laboratory for laboratory support; the staff of the Yale Center
   for Research Computing for technical support; S. Taylor and P. Jack for
   enlightening discussions; our friends, families, and the Yale community
   for support during this difficult time; and all of the health care
   workers, public health employees, and scientists for efforts in the
   COVID-19 response. This research was funded with generous support from
   the Yale Institute for Global Health and the Yale School of Public
   Health start-up package provided to N.D.G. C.B.F.V. is supported by NWO
   Rubicon 019.181EN.004. V.E.P. is funded by NIH/NIAID R01 AI112970 and
   R01 AI137093. N.J.L. is funded by a Medical Research Council fellowship
   as part of the CLIMB project. The ARTIC resources were funded by
   Wellcome Trust collaborative award project number 206298/A/17/Z. J.Q. is
   funded by a UKRI Future Leaders fellowship. K.M.N. is funded by NIH R01
   GM112766. I.I.B. is funded by a COVID-2019 grant through the Canadian
   Institutes of Health Research.
CR [Anonymous], 2020, 1 TRAV REL CAS 2019
   [Anonymous], 2020, CDC 2019 NOV COR 201
   Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa011
   Centers for Disease Control and Prevention, 2020, EV REP PERS INV PUI
   Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757
   Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
   Ferguson Neil M, 2020, IMPACT NONPHARMACEUT
   Gorbalenya AE, 2020, SEVERE ACUTE RESP SY, DOI [10.1101/2020.02.07.937862, DOI 10.1101/2020.02.07.937862]
   Grubaugh ND, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1618-7
   Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2
   Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]
   Moon S, 2020, CNN
   Niehus Rene, 2020, medRxiv, DOI 10.1101/2020.02.13.20022707
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020419
   Perkins T. A., 2020, ESTIMATING UNOBSERVE, DOI [10.1101/2020.03.15.20036582, DOI 10.1101/2020.03.15.20036582]
   Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6
   Quick J., 2020, NCOV 2019 SEQUENCING
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   R Core Team, 2017, R LANG ENV STAT COMP
   Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042
   Taylor D.B., 2020, NY TIMES        0414
   Tindale L, 2020, TRANSMISSION INTERVA, DOI [10.1101/2020.03.03.20029983, DOI 10.1101/2020.03.03.20029983]
   World Health Organization, 2020, 63 WHO
   World Health Organization, 2020, 1 WHO
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Zhao Z., 2020, MATH MODEL ESTIMATIN, DOI [10.1101/2020.03.05.20031849, DOI 10.1101/2020.03.05.20031849]
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 31
TC 29
Z9 28
U1 6
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 28
PY 2020
VL 181
IS 5
BP 990
EP +
DI 10.1016/j.cell.2020.04.021
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA LT9QF
UT WOS:000537399500007
PM 32386545
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Pollitt, KJG
   Peccia, J
   Ko, AI
   Kaminski, N
   Dela Cruz, CS
   Nebert, DW
   Reichardt, JKV
   Thompson, DC
   Vasiliou, V
AF Godri Pollitt, Krystal J.
   Peccia, Jordan
   Ko, Albert I.
   Kaminski, Naftali
   Dela Cruz, Charles S.
   Nebert, Daniel W.
   Reichardt, Juergen K. V.
   Thompson, David C.
   Vasiliou, Vasilis
TI COVID-19 vulnerability: the potential impact of genetic susceptibility
   and airborne transmission
SO HUMAN GENOMICS
LA English
DT Review
ID ACUTE RESPIRATORY SYNDROME; INFECTIOUS AGENTS; CORONAVIRUS; VENTILATION;
   ENVIRONMENT; FILTRATION; OUTBREAK; RECEPTOR; ACE2; AIR
AB The recent coronavirus disease (COVID-19), caused by SARS-CoV-2, is inarguably the most challenging coronavirus outbreak relative to the previous outbreaks involving SARS-CoV and MERS-CoV. With the number of COVID-19 cases now exceeding 2 million worldwide, it is apparent that (i) transmission of SARS-CoV-2 is very high and (ii) there are large variations in disease severity, one component of which may be genetic variability in the response to the virus. Controlling current rates of infection and combating future waves require a better understanding of the routes of exposure to SARS-CoV-2 and the underlying genomic susceptibility to this disease. In this mini-review, we highlight possible genetic determinants of COVID-19 and the contribution of aerosol exposure as a potentially important transmission route of SARS-CoV-2.
C1 [Godri Pollitt, Krystal J.; Vasiliou, Vasilis] Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06510 USA.
   [Peccia, Jordan] Yale Univ, Sch Engn & Appl Sci, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Kaminski, Naftali; Dela Cruz, Charles S.] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, 333 Cedar St, New Haven, CT 06520 USA.
   [Nebert, Daniel W.] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA.
   [Nebert, Daniel W.] Univ Cincinnati, Med Ctr, Ctr Environm Genet, Cincinnati, OH 45267 USA.
   [Reichardt, Juergen K. V.] James Cook Univ, Australian Inst Trop Hlth & Med, Smithfield, Qld, Australia.
   [Thompson, David C.] Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Dept Clin Pharm, Aurora, CO 80045 USA.
RP Pollitt, KJG; Vasiliou, V (corresponding author), Yale Univ, Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT 06510 USA.
EM krystal.pollitt@yale.edu; vasilis.vasiliou@yale.edu
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Reichardt,
   Juergen/0000-0001-6458-2773
CR Asadi S, 2020, AEROSOL SCI TECH, V54, P635, DOI 10.1080/02786826.2020.1749229
   Asadi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38808-z
   Asselta R, 2020, ACE2 TMPRSS2 VARIANT, DOI [10.1101/2020.03.30.20047878, 10.1101/2020.03.30.20047878., DOI 10.1101/2020.03.30.20047878]
   Bourouiba L, 2014, J FLUID MECH, V745, P537, DOI 10.1017/jfm.2014.88
   Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1
   CDC, 2020, US CLOTH FAC COV HEL
   Cecchinato V, 2017, J IMMUNOL, V198, P184, DOI 10.4049/jimmunol.1600568
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003
   Chia PY, 2020, DETECTION AIR SURFAC, DOI [10.1101/2020.03.29.20046557, DOI 10.1101/2020.03.29.20046557]
   Davies A, 2013, DISASTER MED PUBLIC, V7, P413, DOI 10.1017/dmp.2013.43
   Dietz L, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00245-20
   Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387
   Fernstrom A, 2013, J PATHOG, V2013, DOI [10.1155/2013/493960, 10.1155/013/493960]
   Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100
   Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570
   Hoffmann M, 2020, CELL, V181, P271, DOI [10.1016/j.cell.2020.02.052, 10.1007/978-3-030-58342-2_15]
   Hospodsky D, 2015, INDOOR AIR, V25, P641, DOI 10.1111/ina.12172
   Huang S, 2020, CORONAVIRUS
   Hussain M, 2020, J MED VIROL, V92, P1580, DOI 10.1002/jmv.25832
   Johnson GR, 2011, J AEROSOL SCI, V42, P839, DOI 10.1016/j.jaerosci.2011.07.009
   Kaiser J, 2020, SCIENCE, DOI [10.1126/science.abb9192, DOI 10.1126/SCIENCE.ABB9192, 10.1126/science.abb9192.]
   Kim SH, 2016, CLIN INFECT DIS, V63, P363, DOI 10.1093/cid/ciw239
   Kwan SE, 2020, BUILD ENVIRON, V177, DOI 10.1016/j.buildenv.2020.106800
   Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685
   Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x
   Lin KS, 2020, ENVIRON SCI TECHNOL, V54, P1024, DOI 10.1021/acs.est.9b04959
   Lindsley W. G, 2017, SAMPLING CHARACTERIZ
   Liu, PREPRINT WAS INCLUDE
   LOUDON RG, 1968, AM REV RESPIR DIS, V98, P297
   Lu JY, 2020, EMERG INFECT DIS, V26, P1628, DOI 10.3201/eid2607.200764
   Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073
   Luostari K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102519
   MillerLeiden S, 1996, J AIR WASTE MANAGE, V46, P869, DOI 10.1080/10473289.1996.10467523
   Morawska L., 2020, CAN AIRBORNE TRANSMI
   National Research Council, 2020, RAP EXP CONS POSS BI, DOI 10.17226/25769
   Nguyen A., 2020, HUMAN LEUKOCYTE ANTI, DOI [10.1101/2020.03.22.20040600, DOI 10.1101/2020.03.22.20040600]
   Pyankov OV, 2018, J AEROSOL SCI, V115, P158, DOI 10.1016/j.jaerosci.2017.09.009
   Pyankov OV, 2012, J AEROSOL SCI, V53, P21, DOI 10.1016/j.jaerosci.2012.05.011
   Qian J, 2014, ATMOS ENVIRON, V89, P464, DOI 10.1016/j.atmosenv.2014.02.035
   Read R, 2020, LOS ANGELES TIME
   Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044
   Rodpothong Patsarin, 2012, World J Virol, V1, P131, DOI 10.5501/wjv.v1.i5.131
   Santarpia J.L., 2020, TRANSMISSION POTENTI, DOI [10.1101/2020.03.23.20039446, DOI 10.1101/2020.03.23.20039446]
   Schrode N, 2019, NAT GENET, V51, P1475, DOI 10.1038/s41588-019-0497-5
   Tang JLW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021392
   Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus
   Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426
   van der Sande M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002618
   van Doremalen N, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.38.20590
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI 10.1056/NEJMc2004973
   Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08
   Walls AC, 2020, CELL, V181, P281, DOI 10.1016/j.cell.2020.02.058
   Wei JJ, 2016, AM J INFECT CONTROL, V44, pS102, DOI 10.1016/j.ajic.2016.06.003
   Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x
   World Health Organization, 2020, 66 WHO
   Xiao S, 2018, INDOOR AIR, V28, P51, DOI 10.1111/ina.12430
   Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x
   Xu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041137
   Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867
   Yu P, 2020, J INFECT DIS, V221, P1757, DOI 10.1093/infdis/jiaa077
   Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3
NR 62
TC 15
Z9 15
U1 5
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1473-9542
EI 1479-7364
J9 HUM GENOMICS
JI Hum. Genomics
PD MAY 12
PY 2020
VL 14
IS 1
AR 17
DI 10.1186/s40246-020-00267-3
PG 7
WC Genetics & Heredity
SC Genetics & Heredity
GA LR6LB
UT WOS:000535803100001
PM 32398162
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Corburn, J
   Vlahov, D
   Mberu, B
   Riley, L
   Caiaffa, WT
   Rashid, SF
   Ko, A
   Patel, S
   Jukur, S
   Martinez-Herrera, E
   Jayasinghe, S
   Agarwal, S
   Nguendo-Yongsi, B
   Weru, J
   Ouma, S
   Edmundo, K
   Oni, T
   Ayad, H
AF Corburn, Jason
   Vlahov, David
   Mberu, Blessing
   Riley, Lee
   Caiaffa, Waleska Teixeira
   Rashid, Sabina Faiz
   Ko, Albert
   Patel, Sheela
   Jukur, Smurti
   Martinez-Herrera, Eliana
   Jayasinghe, Saroj
   Agarwal, Siddharth
   Nguendo-Yongsi, Blaise
   Weru, Jane
   Ouma, Smith
   Edmundo, Katia
   Oni, Tolu
   Ayad, Hany
TI Slum Health: Arresting COVID-19 and Improving Well-Being in Urban
   Informal Settlements
SO JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
LA English
DT Article
DE Slums; Informal settlements; Equity; Coronavirus; Community health;
   Global health
ID FOOD INSECURITY; DISPLACED PERSONS; NAIROBI; SERVICES; PEOPLE; POOR
AB The informal settlements of the Global South are the least prepared for the pandemic of COVID-19 since basic needs such as water, toilets, sewers, drainage, waste collection, and secure and adequate housing are already in short supply or non-existent. Further, space constraints, violence, and overcrowding in slums make physical distancing and self-quarantine impractical, and the rapid spread of an infection highly likely. Residents of informal settlements are also economically vulnerable during any COVID-19 responses. Any responses to COVID-19 that do not recognize these realities will further jeopardize the survival of large segments of the urban population globally. Most top-down strategies to arrest an infectious disease will likely ignore the often-robust social groups and knowledge that already exist in many slums. Here, we offer a set of practice and policy suggestions that aim to (1) dampen the spread of COVID-19 based on the latest available science, (2) improve the likelihood of medical care for the urban poor whether or not they get infected, and (3) provide economic, social, and physical improvements and protections to the urban poor, including migrants, slum communities, and their residents, that can improve their long-term well-being. Immediate measures to protect residents of urban informal settlements, the homeless, those living in precarious settlements, and the entire population from COVID-19 include the following: (1) institute informal settlements/slum emergency planning committees in every urban informal settlement; (2) apply an immediate moratorium on evictions; (3) provide an immediate guarantee of payments to the poor; (4) immediately train and deploy community health workers; (5) immediately meet Sphere Humanitarian standards for water, sanitation, and hygiene; (6) provide immediate food assistance; (7) develop and implement a solid waste collection strategy; and (8) implement immediately a plan for mobility and health care. Lessons have been learned from earlier pandemics such as HIV and epidemics such as Ebola. They can be applied here. At the same time, the opportunity exists for public health, public administration, international aid, NGOs, and community groups to innovate beyond disaster response and move toward long-term plans.
C1 [Corburn, Jason] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Corburn, Jason] Univ Calif Berkeley, Dept City & Reg Planning, Berkeley, CA 94720 USA.
   [Vlahov, David] Yale Sch Nursing, Orange, CT USA.
   [Mberu, Blessing] APHRC, Urbanizat & Wellbeing Unit, Nairobi, Kenya.
   [Riley, Lee] Univ Calif Berkeley, Sch Publ Hlth, Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Caiaffa, Waleska Teixeira] Univ Fed Minas Gerais, Epidemiol & Publ Hlth, Sch Med, Belo Horizonte, MG, Brazil.
   [Rashid, Sabina Faiz] Brac Univ, Brac Sch Publ Hlth, Dhaka, Bangladesh.
   [Ko, Albert] Yale Sch Publ Hlth, Epidemiol Microbial Dis, New Haven, CT USA.
   [Patel, Sheela; Jukur, Smurti] SPARC, Mumbai, Maharashtra, India.
   [Martinez-Herrera, Eliana] Univ Antioquia, Res Grp Epidemiol, Medellin, Colombia.
   [Jayasinghe, Saroj] Univ Colombo, Colombo, Sri Lanka.
   [Agarwal, Siddharth] Urban Hlth Resource Ctr, Delhi, India.
   [Nguendo-Yongsi, Blaise] Univ Yaounde II Cameroon, Soa, Cameroon.
   [Weru, Jane] AMT, Nairobi, Kenya.
   [Ouma, Smith] Cardiff Law & Global Justice, Cardiff, Wales.
   [Edmundo, Katia] Ctr Promocao Saude, Rio De Janeiro, Brazil.
   [Oni, Tolu] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England.
   [Oni, Tolu] Sch Publ Hlth & Family Med, Cambridge, England.
   [Oni, Tolu] Univ Cape Town, Cape Town, South Africa.
   [Ayad, Hany] Alexandria Univ, Alexandria, Egypt.
RP Corburn, J (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.; Corburn, J (corresponding author), Univ Calif Berkeley, Dept City & Reg Planning, Berkeley, CA 94720 USA.
EM jcorburn@berkeley.edu; David.Vlahov@yale.edu; bmberu@aphrc.org;
   lriley@berkeley.edu; caiaffa.waleska@gmail.com; sabina@bracu.ac.bd;
   albert.ko@yale.edu; sparc84@gmail.com; smrutisj@gmail.com;
   eliana.martinez@udea.cdu.co; saroj@clinmed.cmb.ac.lk;
   a.siddharth.in@gmail.com; sir_nguendoyongsi@hotmail.com;
   janeweru1@gmail.com; oumaso@cardiff.ac.uk
RI Ko, Albert Icksang/P-2343-2015; Ayad, Hany/X-2627-2019; Agarwal,
   Siddharth/L-5337-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Agarwal,
   Siddharth/0000-0002-4293-435X; Martinez-Herrera,
   Eliana/0000-0001-6524-4709
CR Adams AM, 2015, HEALTH POLICY PLANN, V30, pi32, DOI 10.1093/heapol/czu094
   Agarwal A, 2020, J ORTHOP SURG-HONG K, V28, DOI 10.1177/2309499020910974
   Agarwal S, 2009, FOOD SECUR, V1, P239, DOI 10.1007/s12571-009-0034-y
   Alam K, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-29
   Amiresmaili Mohammadreza, 2019, J Educ Health Promot, V8, P210, DOI 10.4103/jehp.jehp_358_19
   Bittencourt BK, 2013, 2013 IEEE SYSTEMS AND INFORMATION ENGINEERING DESIGN SYMPOSIUM (SIEDS), P58, DOI 10.1109/SIEDS.2013.6549494
   Buyana K, 2019, URBAN FORUM, V30, P191, DOI [10.1007/s12132-018-9358-z, DOI 10.1007/S12132-018-9358-Z]
   Campbell L, 2017, LEARNING EBOLA RESPO
   Chandran, 2020, CHANDRAN SLUMS WIND
   Chandran R, 2019, FORCED EVICTIONS ILL
   Checkley W, 2016, LANCET RESP MED, V4, P852, DOI 10.1016/S2213-2600(16)30245-4
   Choueiry Nathalie, 2007, J Migr Refug Issues, V3, P1
   Corburn J., 2016, SLUM HLTH CELL STREE
   Corburn J, 2015, J ENVIRON PUBLIC HEA, V2015, DOI 10.1155/2015/209505
   Corburn J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040342
   Dandabathula Giribabu, 2019, J Family Med Prim Care, V8, P1202, DOI 10.4103/jfmpc.jfmpc_144_19
   de Schueler AS, 2018, URBE-CURITIBA, V10, P213, DOI [10.1590/2175-3369.010.001.AO15, 10.1590/2175-3369.010.001.ao15]
   Deola Claudio, 2014, Disaster Health, V2, P92, DOI 10.4161/21665044.2014.990306
   Dianati K, 2019, SCI TOTAL ENVIRON, V660, P1108, DOI 10.1016/j.scitotenv.2018.12.430
   Dufalo E, INDIAN EXPRESS
   Ebrahim S, 2020, MAVERICK CITIZE 0327
   Ellis P, 2016, LEVERAGING URBANIZAT
   Emina J, 2011, J URBAN HEALTH, V88, P200, DOI 10.1007/s11524-011-9594-1
   Fox S, 2014, WORLD DEV, V54, P191, DOI 10.1016/j.worlddev.2013.08.005
   Galal O, 2010, ASIA-PAC J PUBLIC HE, V22, p254S, DOI 10.1177/1010539510372993
   Gentilini U, 2015, 98253 WORLD BANK
   Getachew A., 2020, COVID 19 ETHIOPIA PR
   Glennie J., 2011, UK GUARDIAN
   Hadley C, 2012, SOC SCI MED, V75, P2412, DOI 10.1016/j.socscimed.2012.09.018
   Hopewell MR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-208
   Iftikhar MN, 2020, URBAN BOOK SERIES, P1, DOI 10.1007/978-3-030-15164-5_1
   Joshi A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214461
   Kareem Buyana, 2020, UNDERSTANDING DIFFER
   Kendi I., 2020, ATLANTIC
   Kerrigan D, 2017, GLOB PUBLIC HEALTH, V12, P185, DOI 10.1080/17441692.2015.1064459
   Kim G, 2007, AM J PUBLIC HEALTH, V97, P353, DOI 10.2105/AJPH.2005.073635
   Kimani NG, 2007, ENV POLLUTION IMPACT
   Kimani-Murage EW, 2014, J URBAN HEALTH, V91, P1098, DOI 10.1007/s11524-014-9894-3
   Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943
   Kouadio IK, 2012, EXPERT REV ANTI-INFE, V10, P95, DOI [10.1586/eri.11.155, 10.1586/ERI.11.155]
   Krystosik A, 2020, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00405
   Kulshreshtha P, 2008, INDOOR AIR, V18, P488, DOI 10.1111/j.1600-0668.2008.00550.x
   Lilford RJ, 2017, LANCET, V389, P559, DOI [10.1016/S0140-6736(16)31848-7, 10.1016/s0140-6736(16)31848-7]
   Lopez O, 2020, CORONAVIRUS CHASES S
   Macarthy JM, 2017, EXPLORING ROLE EMPOW
   Mannan MA, 2018, BURDEN DIS URBAN POO
   Mberu BU, 2014, AFR DEV REV, V26, P172, DOI 10.1111/1467-8268.12073
   Mberu BU, 2013, POPUL SPACE PLACE, V19, P275, DOI 10.1002/psp.1711
   McIntosh K, CORONAVIRUS DIS 2019
   Mould-Millman NK, 2015, GLOB HEALTH-SCI PRAC, V3, P577, DOI 10.9745/GHSP-D-15-00170
   Mudgapalli V, 2016, TECHNOL HEALTH CARE, V24, P57, DOI 10.3233/THC-151097
   Mukama T, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/6830163
   NAS, 2018, P WORKSH FOR MICR TH, V3
   Osorio L, 2004, AM J TROP MED HYG, V71, P380, DOI 10.4269/ajtmh.2004.71.380
   Patel R, 2017, PLOS CURR DISASTERS, DOI 10.1371/currents.dis.83315629ac7cae7e2c4f78c590a3ce1c.
   Patel S, 2001, ENVIRON URBAN, V13, P45, DOI 10.1177/095624780101300204
   Puertas G, 2006, REV PANAM SALUD PUBL, V20, P324, DOI 10.1590/S1020-49892006001000005
   Rashid SF, 2009, J HEALTH POPUL NUTR, V27, P574
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Schipani A., 2020, DRUG GANGS BRAZILS F
   Sholihah PI, 2018, INT J URBAN SUSTAIN, V10, P263, DOI 10.1080/19463138.2018.1534737
   Simiyu S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-4009-6
   Snyder RE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005287
   Snyder RE, 2014, LANCET GLOB HEALTH, V2, pE685, DOI 10.1016/S2214-109X(14)70339-0
   Sommer M, 2015, ENVIRON URBAN, V27, P105, DOI 10.1177/0956247814564528
   Sphere Humanitarian, HUM CHART MIN STAND
   Srivastava A, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-8
   Steyn NP, 2014, PUBLIC HEALTH NUTR, V17, P1363, DOI 10.1017/S1368980013001158
   Subbaraman R, 2012, ENVIRON URBAN, V24, P643, DOI 10.1177/0956247812456356
   Teaching Tolerance, 2020, RESP COR RAC
   Thiele-Eich I, 2013, ERDKUNDE, P21
   UN, 2019, TURN WAST BUS SLUMS
   UN ECA, 2020, 3 THINGS G20 MUST DO
   Vaidyanathan Iyer P., INDIAN EXPRESS
   van de Vijver S, 2015, LANCET, V386, P2114, DOI 10.1016/S0140-6736(15)00385-2
   van der Heijden J, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6750-0
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI 10.1056/NEJMc2004973
   Wikipedia, LIST INC XEN RAC REL
   World Bank, 2018, POV SHAR PROSP 2018
   World Health Organization, 2020, AIR POLLUTION
   Ziraba AK, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0166-4
NR 82
TC 26
Z9 26
U1 24
U2 35
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1099-3460
EI 1468-2869
J9 J URBAN HEALTH
JI J. Urban Health
PD JUN
PY 2020
VL 97
IS 3
BP 348
EP 357
DI 10.1007/s11524-020-00438-6
EA APR 2020
PG 10
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA LZ4ZT
UT WOS:000528415900001
PM 32333243
OA Green Published, Other Gold
DA 2020-11-30
ER

PT J
AU Gibson, KH
   Trajtenberg, F
   Wunder, EA
   Brady, MR
   San Martin, F
   Mechaly, A
   Shang, ZG
   Liu, J
   Picardeau, M
   Ko, A
   Buschiazzo, A
   Sindelar, CV
AF Gibson, Kimberley H.
   Trajtenberg, Felipe
   Wunder, Elsio A.
   Brady, Megan R.
   San Martin, Fabiana
   Mechaly, Ariel
   Shang, Zhiguo
   Liu, Jun
   Picardeau, Mathieu
   Ko, Albert
   Buschiazzo, Alejandro
   Sindelar, Charles Vaughn
TI An asymmetric sheath controls flagellar supercoiling and motility in the
   leptospira spirochete
SO ELIFE
LA English
DT Article
ID PERIPLASMIC FLAGELLA; CRYO-EM; TOMOGRAPHIC RECONSTRUCTION;
   CRYSTAL-STRUCTURE; FILAMENT; PROTEIN; VIRULENCE; CONSTRUCTION;
   INVOLVEMENT; INTERROGANS
AB Spirochete bacteria, including important pathogens, exhibit a distinctive means of swimming via undulations of the entire cell. Motility is powered by the rotation of supercoiled 'endoflagella' that wrap around the cell body, confined within the periplasmic space. To investigate the structural basis of flagellar supercoiling, which is critical for motility, we determined the structure of native flagellar filaments from the spirochete Leptospira by integrating high-resolution cryo-electron tomography and X-ray crystallography. We show that these filaments are coated by a highly asymmetric, multi-component sheath layer, contrasting with flagellin-only homopolymers previously observed in exoflagellated bacteria. Distinct sheath proteins localize to the filament inner and outer curvatures to define the supercoiling geometry, explaining a key functional attribute of this spirochete flagellum.
C1 [Gibson, Kimberley H.; Brady, Megan R.; Shang, Zhiguo; Sindelar, Charles Vaughn] Yale Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.
   [Trajtenberg, Felipe; San Martin, Fabiana; Mechaly, Ariel; Buschiazzo, Alejandro] Inst Pasteur Montevideo, Lab Mol & Struct Microbiol, Montevideo, Uruguay.
   [Wunder, Elsio A.; Ko, Albert] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Wunder, Elsio A.; Ko, Albert] Brazilian Minist Hlth, Goncalo Moniz Inst, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   [Liu, Jun] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA.
   [Picardeau, Mathieu] Inst Pasteur, Biol Spirochetes Unit, Paris, France.
   [Picardeau, Mathieu; Buschiazzo, Alejandro] Inst Pasteur, Dept Microbiol, Integrat Microbiol Zoonot Agents, Paris, France.
   [Mechaly, Ariel] Inst Pasteur, Dept Struct Biol & Chem, Crystallog Platform, Paris, France.
   [Shang, Zhiguo] UT Southwestern Med Ctr, Bioinformat Dept, Dallas, TX USA.
RP Sindelar, CV (corresponding author), Yale Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA.; Buschiazzo, A (corresponding author), Inst Pasteur Montevideo, Lab Mol & Struct Microbiol, Montevideo, Uruguay.; Ko, A (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Ko, A (corresponding author), Brazilian Minist Hlth, Goncalo Moniz Inst, Oswaldo Cruz Fdn, Salvador, BA, Brazil.; Buschiazzo, A (corresponding author), Inst Pasteur, Dept Microbiol, Integrat Microbiol Zoonot Agents, Paris, France.
EM albert.ko@yale.edu; alebus@pasteur.edu.uy; charles.sindelar@yale.edu
RI Wunder, Elsio Augusto/C-2733-2013; Ko, Albert Icksang/P-2343-2015
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Ko, Albert
   Icksang/0000-0001-9023-2339; Mechaly, Ariel/0000-0002-5305-7495;
   Trajtenberg, Felipe/0000-0003-0427-5549; Gibson,
   Kimberley/0000-0001-8881-1411
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 GM 110530, U01 AI
   088752, R01 TW009504, R01 AI052473, R0 AI121207]; Agencia Nacional de
   Investigacion e Innovacion [FCE_3_2016_1_126797, ALI_1_2014_1_4982,
   ANR-18-CE15-0027-1]; Agence Nationale de la RechercheFrench National
   Research Agency (ANR) [ANR-18-CE15-0027-1, ANR-08-MIE-018]; Pasteur
   International Joint Research Unit Integrative Microbiology of Zoonotic
   Agents (IMiZA); Institut Pasteur
FX National Institutes of Health R01 GM 110530 Kimberley H Gibson Megan R
   Brady Zhiguo Shang Charles Vaughn Sindelar; National Institutes of
   Health U01 AI 088752 Elsio A Wunder Albert Ko; National Institutes of
   Health R01 TW009504 Elsio A Wunder Albert Ko; National Institutes of
   Health R01 AI052473 Elsio A Wunder Albert Ko; National Institutes of
   Health R0 AI121207 Elsio A Wunder Albert Ko; Agencia Nacional de
   Investigacion e Innovacion FCE_3_2016_1_126797 Felipe Trajtenberg
   Fabiana San Martin Ariel Mechaly Alejandro Buschiazzo; Agencia Nacional
   de Investigacion e Innovacion ALI_1_2014_1_4982 Felipe Trajtenberg
   Fabiana San Martin Ariel Mechaly Alejandro Buschiazzo; Agencia Nacional
   de Investigacion e Innovacion FCE_3_2016_1_126797 Mathieu Picardeau;
   Agence Nationale de la Recherche ANR-18-CE15-0027-1 Mathieu Picardeau;
   Agence Nationale de la Recherche ANR-08-MIE-018 Mathieu Picardeau;
   Pasteur International Joint Research Unit Integrative Microbiology of
   Zoonotic Agents (IMiZA) Mathieu Picardeau; Institut Pasteur Mathieu
   Picardeau; The funders had no role in study design, data collection and
   interpretation, or the decision to submit the work for publication.
CR Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692
   Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266
   Beeby M, 2016, P NATL ACAD SCI USA, V113, pE1917, DOI 10.1073/pnas.1518952113
   Berg HC, 1978, S SOC GEN MICROBIOL, P285
   Bharat TAM, 2015, STRUCTURE, V23, P1743, DOI 10.1016/j.str.2015.06.026
   BRAHAMSHA B, 1988, J BACTERIOL, V170, P4023, DOI 10.1128/jb.170.9.4023-4032.1988
   Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694
   Bricogne G, 2017, SMART O BUSTER V 2 1
   BROMLEY DB, 1979, J BACTERIOL, V137, P1406, DOI 10.1128/JB.137.3.1406-1412.1979
   Calladine CR, 2013, J MOL BIOL, V425, P914, DOI 10.1016/j.jmb.2012.12.007
   CALLADINE CR, 1976, J THEOR BIOL, V57, P469, DOI 10.1016/0022-5193(76)90016-3
   CALLADINE CR, 1975, NATURE, V255, P121, DOI 10.1038/255121a0
   Carazo J-M, 2006, ELECT TOMOGRAPHY MET, DOI 10.1007/978-0-387-69008-7
   CASPAR DLD, 1963, ADV PROTEIN CHEM, V18, P37
   CHARON NW, 1992, J BACTERIOL, V174, P832, DOI 10.1128/jb.174.3.832-840.1992
   Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359
   Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145
   Cope Julia, 2011, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1713s65
   Crenshaw HC, 2000, J EXP BIOL, V203, P961
   Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838
   Dombrowski C, 2009, BIOPHYS J, V96, P4409, DOI 10.1016/j.bpj.2009.02.066
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299
   Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X
   Fujii M, 2008, J MOL BIOL, V379, P273, DOI 10.1016/j.jmb.2008.04.012
   Galkin VE, 2008, SCIENCE, V320, P382, DOI 10.1126/science.1155307
   GOLDSTEIN SF, 1988, CELL MOTIL CYTOSKEL, V9, P101, DOI 10.1002/cm.970090202
   Himes BA, 2018, NAT METHODS, V15, P955, DOI 10.1038/s41592-018-0167-z
   Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357
   Huehn A, 2018, J BIOL CHEM, V293, P5377, DOI 10.1074/jbc.AC118.001843
   Jiang JZ, 1999, P NATL ACAD SCI USA, V96, P3572, DOI 10.1073/pnas.96.7.3572
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   KAMIYA R, 1980, NATURE, V286, P628, DOI 10.1038/286628a0
   KAMIYA R, 1976, J MOL BIOL, V106, P167, DOI 10.1016/0022-2836(76)90306-5
   Kan WX, 2007, BIOPHYS J, V93, P54, DOI 10.1529/biophysj.106.103143
   Kato T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13252-9
   Klug A., 1967, FORMATION FATE CELL, P1, DOI 10.1016/B978-0-12-395580-7.50006-X
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kovacs JA, 2018, BMC STRUCT BIOL, V18, DOI 10.1186/s12900-018-0089-0
   Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12
   Lamzin VS, 2012, INT TABLES CRYSTALLO, P525, DOI [DOI 10.1107/97809553602060000001, 10.1107/97809553602060000001]
   Li CH, 2000, J MOL MICROB BIOTECH, V2, P345
   Li CH, 2000, J BACTERIOL, V182, P6698, DOI 10.1128/JB.182.23.6698-6706.2000
   Li C, 2008, J BACTERIOL, V190, P5607, DOI 10.1128/JB.00319-08
   Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020
   Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Martin FS, 2017, ACTA CRYSTALLOGR F, V73, P123, DOI 10.1107/S2053230X17002096
   Mastronarde DN, 2017, J STRUCT BIOL, V197, P102, DOI 10.1016/j.jsb.2016.07.011
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Miller MR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.134, 10.1038/nmicrobiol.2016.134]
   Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797
   NAMBA K, 1989, NATURE, V342, P648, DOI 10.1038/342648a0
   NAUMAN RK, 1969, J BACTERIOL, V98, P264, DOI 10.1128/JB.98.1.264-280.1969
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x
   Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5
   Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/nmeth.1365, 10.1038/NMETH.1365]
   Rohou A, 2014, J STRUCT BIOL, V186, P234, DOI 10.1016/j.jsb.2014.03.012
   Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504
   Sasaki Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194923
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678
   Schrodinger L. L. C, 2015, PYMOL MOL GRAPHICS S
   Sheikh MA, 2008, PROTEINS, V71, P1563, DOI 10.1002/prot.21993
   Shibata S, 2019, NAT STRUCT MOL BIOL, V26, P941, DOI 10.1038/s41594-019-0301-3
   Sultan SZ, 2013, INFECT IMMUN, V81, P2012, DOI 10.1128/IAI.01228-12
   Tahara H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar7975
   Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]
   TRACHTENBERG S, 1987, J MOL BIOL, V195, P603, DOI 10.1016/0022-2836(87)90185-9
   TRACHTENBERG S, 1986, J MOL BIOL, V190, P569, DOI 10.1016/0022-2836(86)90242-1
   Vernel-Pauillac F, 2018, MICROBES INFECT, V20, P578, DOI 10.1016/j.micinf.2018.02.001
   Wang F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01075-5
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Wolgemuth CW, 2006, J MOL MICROB BIOTECH, V11, P221, DOI 10.1159/000094056
   Wolgemuth CW, 2015, SEMIN CELL DEV BIOL, V46, P104, DOI 10.1016/j.semcdb.2015.10.015
   Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791
   Wunder EA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00130
   Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403
   Wunder EA, 2016, INFECT IMMUN, V84, P2105, DOI 10.1128/IAI.00094-16
   Yamashita I, 1998, NAT STRUCT BIOL, V5, P125
   Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830
   Yoon SS, 2008, INFECT IMMUN, V76, P1282, DOI 10.1128/IAI.00736-07
   Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166
NR 86
TC 2
Z9 2
U1 3
U2 6
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD MAR 10
PY 2020
VL 9
AR e53672
DI 10.7554/eLife.53672
PG 24
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA KU7SW
UT WOS:000519913900001
PM 32157997
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Ribeiro, GS
   Hamer, GL
   Diallo, M
   Kitron, U
   Ko, AI
   Weaver, SC
AF Ribeiro, Guilherme S.
   Hamer, Gabriel L.
   Diallo, Mawlouth
   Kitron, Uriel
   Ko, Albert, I
   Weaver, Scott C.
TI Influence of herd immunity in the cyclical nature of arboviruses
SO CURRENT OPINION IN VIROLOGY
LA English
DT Review
ID WEST-NILE-VIRUS; ZIKA VIRUS; CHIKUNGUNYA VIRUS; LOS-ANGELES; EPIDEMIC;
   TRANSMISSION; INFECTION; HUMANS; PERSISTENCE; ANTIBODIES
AB We review and contrast the evidence for an effect of amplifying host herd immunity on circulation and human exposure to arboviruses. Herd immunity of short-lived West Nile virus avian amplifying hosts appears to play a limited role in levels of enzootic circulation and spillover infections of humans, which are not amplifiers. In contrast, herd immunity of nonhuman primate hosts for enzootic Zika, dengue, and chikungunya viruses is much stronger and appears to regulate to a large extent the periodicity of sylvatic amplification in Africa. Following the recent Zika and chikungunya pandemics, human herd immunity in the Americas quickly rose to similar to 50% in many regions, although seroprevalence remains patchy. Modeling from decades of chikungunya circulation in Asia suggests that this level of herd immunity will suppress for many years major chikungunya and Zika epidemics in the Americas, followed by smaller outbreaks as herd immunity cycles with a periodicity of up to several decades.
C1 [Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Hamer, Gabriel L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
   [Diallo, Mawlouth] Inst Pasteur, Dakar, Senegal.
   [Kitron, Uriel] Emory Univ, Populat Biol Ecol & Evolut Grad Program, Grad Div Biol & Biomed Sci, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Ko, Albert, I] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Weaver, Scott C.] Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Ko, Albert Icksang/P-2343-2015; Ribeiro, Guilherme/B-6624-2008
OI Ko, Albert Icksang/0000-0001-9023-2339; Ribeiro,
   Guilherme/0000-0002-6798-2059
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R24 AI120942] Funding Source: Medline
CR Althouse BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03332-7
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Althouse BM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001928
   Borchering RK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13628-x
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chung WM, 2013, JAMA-J AM MED ASSOC, V310, P297, DOI 10.1001/jama.2013.8267
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Cortes-Escamilla A, 2018, SALUD PUBLICA MEXICO, V60, P63, DOI 10.21149/9149
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   David S, 2016, INFECT DIS-NOR, V48, P571, DOI 10.3109/23744235.2016.1164890
   Dias JP, 2018, EMERG INFECT DIS, V24, P617, DOI 10.3201/eid2404.171370
   Dobson A, 2009, ECOLOGY, V90, P920, DOI 10.1890/08-0736.1
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Farner D. S., 1945, Wilson Bulletin Ann Arbor, V57, P56
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121
   Flamand C, 2019, J INFECT DIS, V220, P1915, DOI 10.1093/infdis/jiz396
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gay N, 2016, AM J TROP MED HYG, V94, P393, DOI 10.4269/ajtmh.15-0308
   Gibbs SEJ, 2005, CLIN DIAGN LAB IMMUN, V12, P665, DOI 10.1128/CDLI.12.5.665-667.2005
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gordon A, 2018, CLIN INFECT DIS, V67, P1760, DOI 10.1093/cid/ciy356
   Hamer GL, 2008, VECTOR-BORNE ZOONOT, V8, P57, DOI 10.1089/vbz.2007.0123
   Kading RC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006761
   Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773
   Kwan JL, 2010, AM J TROP MED HYG, V83, P1137, DOI 10.4269/ajtmh.2010.10-0078
   Kwan JL, 2010, AM J TROP MED HYG, V83, P400, DOI 10.4269/ajtmh.2010.10-0076
   Kwan JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035241
   Levine RS, 2016, AM J TROP MED HYG, V95, P1174, DOI 10.4269/ajtmh.15-0809
   Levine RS, 2013, VECTOR-BORNE ZOONOT, V13, P812, DOI 10.1089/vbz.2013.1342
   Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Lustig Y, 2017, INT J INFECT DIS, V64, P20, DOI 10.1016/j.ijid.2017.08.011
   Martinez D, 2017, EMERG INFECT DIS, V23, P1372, DOI 10.3201/eid2308.170384
   Mckee EM, 2015, J WILDLIFE DIS, V51, P601, DOI 10.7589/2014-07-175
   Ministerio del Poder Ciudadano para la Salud de Nicaragua, 2017, REV PANAM SALUD PUBL, V41
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Pan-American Health Organization HIPftAP, 2019, HIPFTAP CAS ZIK VIR
   Paull SH, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2078
   Perez F, 2019, TROP MED INT HEALTH, V24, P442, DOI 10.1111/tmi.13200
   Perez-Guzman EX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12295-2
   Poh KC, 2019, SCI TOTAL ENVIRON, V675, P260, DOI 10.1016/j.scitotenv.2019.04.109
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rogier EW, 2018, EMERG INFECT DIS, V24, P995, DOI 10.3201/eid2406.171447
   Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sam IC, 2019, T ROY SOC TROP MED H, V113, P678, DOI 10.1093/trstmh/trz056
   Shand L, 2016, J MED ENTOMOL
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Sornjai W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35643-6
   Wasser DE, 2010, J ZOOL, V280, P103, DOI 10.1111/j.1469-7998.2009.00671.x
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338
   Worwa G, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007135
NR 60
TC 3
Z9 3
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD FEB
PY 2020
VL 40
BP 1
EP 10
DI 10.1016/j.coviro.2020.02.004
PG 10
WC Virology
SC Virology
GA NM1VJ
UT WOS:000567891600002
PM 32193135
DA 2020-11-30
ER

PT J
AU Briskin, EA
   Casanovas-Massana, A
   Ryff, KR
   Morales-Estrada, S
   Hamond, C
   Perez-Rodriguez, NM
   Benavidez, KM
   Weinberger, DM
   Castro-Arellano, I
   Wunder, EA
   Sharp, TM
   Rivera-Garcia, B
   Ko, AI
AF Briskin, Emily A.
   Casanovas-Massana, Arnau
   Ryff, Kyle R.
   Morales-Estrada, Shirley
   Hamond, Camila
   Perez-Rodriguez, Nicole M.
   Benavidez, Kathryn M.
   Weinberger, Daniel M.
   Castro-Arellano, Ivan
   Wunder Jr, Elsio A.
   Sharp, Tyler M.
   Rivera-Garcia, Brenda
   Ko, Albert, I
TI Seroprevalence, Risk Factors, and Rodent Reservoirs of Leptospirosis in
   an Urban Community of Puerto Rico, 2015
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE leptospirosis; public health; Puerto Rico; rodent; seroprevalence
ID HURRICANE; EPIDEMIC; OUTBREAK
AB Background. The burden of leptospirosis in Puerto Rico remains unclear due to underreporting.
   Methods. A cross-sectional survey and rodent trapping was performed in a community within San Juan, Puerto Rico to determine the seroprevalence and risk factors for Leptospira infection. The microscopic agglutination test was used to detect antiLeptospira antibodies as a marker of previous infection. We evaluated Leptospira carriage by quantitative polymerase chain reaction among rodents trapped at the community site.
   Results. Of 202 study participants, 55 (27.2%) had Leptospira agglutinating antibodies. Among the 55 seropositive individuals, antibodies were directed most frequently against serogroups Icterohaemorrhagiae (22.0%) and Autumnalis (10.6%). Of 18 captured rodents, 11 (61.1%) carried pathogenic Leptospira (Leptospira borgpetersenii, 7 and Leptospira interrogans, 2). Four participants showed their highest titer against an isolate obtained from a rodent (serogroup Ballum). Increasing household distance to the canal that runs through the community was associated with decreased risk of infection (odds ratio = 0.934 per 10-meter increase; 95% confidence interval,.952-.992).
   Conclusions. There are high levels of Leptospira exposure in an urban setting in Puerto Rico, for which rodents may be an important reservoir for transmission. Our findings indicate that prevention should focus on mitigating risk posed by infrastructure deficiencies such as the canal.
C1 [Briskin, Emily A.; Casanovas-Massana, Arnau; Hamond, Camila; Weinberger, Daniel M.; Wunder Jr, Elsio A.; Ko, Albert, I] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ryff, Kyle R.; Morales-Estrada, Shirley; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol, San Juan, PR USA.
   [Perez-Rodriguez, Nicole M.; Sharp, Tyler M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Dengue Branch, San Juan, PR USA.
   [Benavidez, Kathryn M.; Castro-Arellano, Ivan] Texas State Univ, Dept Biol, San Marcos, TX USA.
   [Wunder Jr, Elsio A.; Ko, Albert, I] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Hamond, Camila] INIA, Estn Expt La Estanzuela, Colonia, Uruguay.
RP Ko, AI (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, LEPH319B,60 Coll St, New Haven, CT 06510 USA.
EM albort.ko@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Casanovas-Massana, Arnau/H-5806-2019;
   Wunder, Elsio Augusto/C-2733-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Casanovas-Massana,
   Arnau/0000-0002-3301-6143; Wunder, Elsio Augusto/0000-0002-5239-8511;
   Briskin, Emily/0000-0002-3100-750X
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI052473, U01
   AI088752, R25 TW009338, R01 TW009504, R01 AI121207]; Yale University
   Downs Fellowship; Yale School of Medicine Office of Student Research
   Summer Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863] Funding
   Source: NIH RePORTER
FX This work was funded by the National Institutes of Health research
   grants (R01 AI052473, U01 AI088752, R25 TW009338, R01 TW009504, and R01
   AI121207). E. A. B. was supported by the Yale University Downs
   Fellowship and the Yale School of Medicine Office of Student Research
   Summer Fellowship.
CR Adams Deborah A, 2017, MMWR Morb Mortal Wkly Rep, V64, P1, DOI 10.15585/mmwr.mm6453a1
   Adesiyun AA, 2011, REV PANAM SALUD PUBL, V29, P350
   ALEXANDER A. D., 1963, ZOONOSES RES, V2, P152
   [Anonymous], 2006, INT PEST MAN COND UR
   Benavidez KM, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007236
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Boonsilp S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001954
   Bovet P, 1999, INT J EPIDEMIOL, V28, P583, DOI 10.1093/ije/28.3.583
   Bruce MG, 2005, ACTA TROP, V96, P36, DOI 10.1016/j.actatropica.2005.07.001
   Casanovas-Massana A, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00507-18, 10.1128/aem.00507-18]
   Casanovas-Massana A, 2018, WATER RES, V130, P176, DOI 10.1016/j.watres.2017.11.068
   Concepcion-Acevedo J, 2018, MMWR-MORBID MORTAL W, V67, P333, DOI 10.15585/mmwr.mm6711a5
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   EVERARD COR, 1985, T ROY SOC TROP MED H, V79, P96, DOI 10.1016/0035-9203(85)90246-9
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4
   Goarant C, 2009, TROP MED INT HEALTH, V14, P926, DOI 10.1111/j.1365-3156.2009.02310.x
   Gorbea H, 2018, AM J TROP MED HYG, V98, P258, DOI 10.4269/ajtmh.17-0538
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595
   Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957
   Kishore N, 2018, NEW ENGL J MED, V379, P162, DOI [10.1056/nejmsa1803972, 10.1056/NEJMsa1803972]
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1
   Lau CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004405
   MORSHED MG, 1994, EPIDEMIOL INFECT, V112, P527, DOI 10.1017/S0950268800051220
   Naranjo M, 2008, MEDICC REV, V10, P38
   Panti-May JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152511
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Rivera B., 2012, Morbidity and Mortality Weekly Report, V61, P421
   Sanders E. J., 1997, Clinical Infectious Diseases, V25, P411
   Sanders EJ, 1999, AM J TROP MED HYG, V61, P399, DOI 10.4269/ajtmh.1999.61.399
   Schneider AG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006415
   Sharp TM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004482
   Sheffield P, 2014, ANN GLOB HEALTH, V80, P296, DOI 10.1016/j.aogh.2014.07.001
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Suwanpakdee S, 2015, EPIDEMIOL INFECT, V143, P2106, DOI 10.1017/S0950268815000205
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752
   World Health Organization, 2003, HUM LEPT GUID DIAGN, P122
NR 43
TC 3
Z9 3
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV 1
PY 2019
VL 220
IS 9
BP 1489
EP 1497
DI 10.1093/infdis/jiz339
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JE9EU
UT WOS:000490992100014
PM 31342075
OA Green Published
DA 2020-11-30
ER

PT J
AU Silva, MMO
   Inure, LB
   Kikuti, M
   Anjos, RO
   Santos, VC
   Gonsalves, TSF
   Paploski, IAD
   Moreira, PSS
   Nascimento, LCJ
   Campos, GS
   Ko, AI
   Weaver, SC
   Reis, MG
   Kitron, U
   Ribeiro, GS
AF Silva, Monaise M. O.
   Inure, Laura B.
   Kikuti, Mariana
   Anjos, Rosangela O.
   Santos, Viviane C.
   Gonsalves, Thaiza S. F.
   Paploski, Igor A. D.
   Moreira, Patricia S. S.
   Nascimento, Leile C. J.
   Campos, Gubio S.
   Ko, Albert, I
   Weaver, Scott C.
   Reis, Mitermayer G.
   Kitron, Uriel
   Ribeiro, Guilherme S.
TI Concomitant Transmission of Dengue, Chikungunya, and Zika Viruses in
   Brazil: Clinical and Epidemiological Findings From Surveillance for
   Acute Febrile Illness
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE dengue virus; chikungunya virus; Zika virus; arbovirus; coinfection
ID OUTBREAK; SALVADOR; TIME
AB Background. Since their emergence in the Americas, chikungunya (CHIKV) and Zika (ZIKV) viruses co-circulate with dengue virus (DENV), hampering clinical diagnosis. We investigated clinical and epidemiological characteristics of arboviral infections during the introduction and spread of CHIKV and ZIKV through northeastern Brazil.
   Methods. Surveillance for arboviral diseases among febrile patients was performed at an emergency health unit of Salvador, Brazil, between September 2014 and July 2016. We interviewed patients to collect data on symptoms, reviewed medical records to obtain the presumptive diagnoses, and performed molecular and serological testing to confirm DENV, CHIKV, ZIKV, or nonspecific flavivirus (FLAV) diagnosis.
   Results. Of 948 participants, 247 (26.1%) had an acute infection, of which 224 (23.6%) were single infections (DENV, 32 [3.4%]; CHIKV, 159 [16.7%]; ZIKV, 13 [1.4%]; and FLAV, 20 [2.1%]) and 23 (2.4%) coinfections (DENV/CHIKV, 13 [1.4%]; CHIKV/FLAV, 9 [0.9%]; and DENV/ZIKV, 1 [0.1%]). An additional 133 (14.0%) patients had serological evidence for a recent arboviral infection. Patients with ZIKV presented with rash and pruritus (69.2% each) more frequently than those with DENV (37.5% and 31.2%, respectively) and CHIKV (22.9% and 14.7%, respectively) (P <.001 for both comparisons). Conversely, arthralgia was more common in CHIKV (94.9%) and FLAV/CHIKV (100.0%) than in DENV (59.4%) and ZIKV (53.8%) (P <.001). A correct presumptive clinical diagnosis was made for 9%-23% of the confirmed patients.
   Conclusions. Arboviral infections are frequent causes of febrile illness. Coinfections are not rare events during periods of intense, concomitant arboviral transmission. Given the challenge to clinically distinguish these infections, there is an urgent need for rapid, point-of-care, multiplex diagnostics.
C1 [Silva, Monaise M. O.; Inure, Laura B.; Kikuti, Mariana; Anjos, Rosangela O.; Santos, Viviane C.; Gonsalves, Thaiza S. F.; Moreira, Patricia S. S.; Nascimento, Leile C. J.; Ko, Albert, I; Reis, Mitermayer G.; Kitron, Uriel; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Inure, Laura B.] Consejo Nacl Invest Cient & Tecn, Inst Nacl Med Trop, Puerto Iguazu, Argentina.
   [Kikuti, Mariana; Paploski, Igor A. D.; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Paploski, Igor A. D.] Univ Minnesota, St Paul, MN 55108 USA.
   [Campos, Gubio S.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Ko, Albert, I] Yale Sch Publ Hlth, New Haven, CT USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Reis, Mitermayer G.; Ribeiro, Guilherme S.] Med Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Reis, Mitermayer/AAO-9742-2020; Kikuti, Mariana/G-2313-2017; Ko, Albert
   Icksang/P-2343-2015; Paploski, Igor AD/D-7015-2014; Ribeiro,
   Guilherme/B-6624-2008
OI Reis, Mitermayer/0000-0002-3051-9060; Kikuti,
   Mariana/0000-0001-8119-7236; Ko, Albert Icksang/0000-0001-9023-2339;
   Paploski, Igor AD/0000-0002-3689-2042; Ribeiro,
   Guilherme/0000-0002-6798-2059
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [400830/2013-2, 440891/2016-7]; Bahia Foundation for Research
   Support [PET0026/2013, APP0044/2016, PET0022/2016]; Coordination for the
   Improvement of Higher Education Personnel, Brazilian Ministry of
   Education [440891/2016-7]; US National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 TW009504, R01 AI121207, U01 AI088752, R24 AI AI120942]; Yale
   School of Public Health; Federal University of Bahia; Oswaldo Cruz
   Foundation
FX This work was supported by the Brazilian National Council for Scientific
   and Technological Development (grant numbers 400830/2013-2 and
   440891/2016-7 to G.S.R.; and scholarships to I. A. D. P., L. B. T., U.
   K., M. G. R., and G. S. R.); the Bahia Foundation for Research Support
   (grant numbers PET0026/2013, APP0044/2016, and PET0022/2016 to G. S. R.,
   and scholarship to M. M. O. S.); the Coordination for the Improvement of
   Higher Education Personnel, Brazilian Ministry of Education (grant
   number 440891/2016-7 to G. S. R. and scholarship to M. K.); the US
   National Institutes of Health (grant numbers R01 TW009504, R01 AI121207,
   and U01 AI088752 to A. I. K. and R24 AI AI120942 to S. C. W.); the Yale
   School of Public Health; the Federal University of Bahia; and the
   Oswaldo Cruz Foundation.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Azeredo E.L., 2018, PLOS CURR, V10, P1, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f529588874
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P368, DOI 10.1309/AJCPMPSINQ9BRMU6
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, P1, DOI [10.1371/joureatpred.0004199, DOI 10.1371/JOUREATPRED.0004199]
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 17
Z9 17
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 15
PY 2019
VL 69
IS 8
BP 1353
EP 1359
DI 10.1093/cid/ciy1083
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA JD5DW
UT WOS:000490004300012
PM 30561554
OA Green Published
DA 2020-11-30
ER

PT J
AU Musso, D
   Ko, AI
   Baud, D
AF Musso, Didier
   Ko, Albert I.
   Baud, David
TI Zika Virus Infection - After the Pandemic
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Review
ID PREGNANCY OUTCOMES; BIRTH-DEFECTS; INFANTS; BRAZIL; SURVEILLANCE;
   PATHOGENESIS; ENHANCEMENT; TERRITORIES; EMERGENCE; OUTBREAK
AB Zika is a mosquito-borne flavivirus that can cause congenital defects, including microcephaly. Although most Zika virus infections are asymptomatic, rash, fever, arthralgia, myalgia, and conjunctivitis can develop in some people. The Guillain-Barre syndrome occurs in 2 to 3 patients per 10,000 with Zika virus infection.
C1 [Musso, Didier] Aix Marseille Univ, AP HM, IRD, Serv Sante Armees,Vecteurs Infect Trop & Mediterr, Marseille, France.
   [Musso, Didier] Inst Hosp Univ Mediterranee Infect, Marseille, France.
   [Musso, Didier] Lab Eurofins Labazur Guyane, Eurofins, French Guiana.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Infect Dis, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Baud, David] Univ Lausanne, Ctr Hosp Univ Vaudois, Dept Femme Mere Enfant, Maternofoetal & Obstet Res Unit, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland.
RP Musso, D (corresponding author), POB 380,222 Tamanu Punaauia, F-98713 Tahiti, French Polynesi, France.
EM didiermusso@mail.pf
RI Musso, Didier/AAO-8178-2020; Ko, Albert Icksang/P-2343-2015; Musso,
   Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Ko, Albert
   Icksang/0000-0001-9023-2339; Musso, Didier/0000-0002-9226-0971; Baud,
   David/0000-0001-9914-6496
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], 2016, ASS MAN GUILL BARR S
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bloch EM, 2018, NEW ENGL J MED, V378, P1837, DOI 10.1056/NEJMsb1704752
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Centers for Disease Control and Prevention, 2017, OV ZIK VIR TEST GUID
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto SR, 2019, ECOHEALTH, V16, P61, DOI 10.1007/s10393-019-01394-7
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Grubaugh ND, 2019, CELL, V178, P1057, DOI 10.1016/j.cell.2019.07.018
   Grubaugh ND, 2019, TRENDS MICROBIOL, V27, P381, DOI 10.1016/j.tim.2019.02.004
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Halpin AL, 2018, EPIDEMIOL INFECT, V146, P1740, DOI 10.1017/S0950268818001802
   Hay JA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006991
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hill SC, 2019, EMERGENCE ZIKA VIRUS
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Mann TZ, 2018, PAEDIATR PERINAT EP, V32, P358, DOI 10.1111/ppe.12478
   Masmejan S, 2018, EXPERT REV ANTI-INFE, V16, P471, DOI 10.1080/14787210.2018.1483239
   Maykin MM, 2019, CLIN INFECT DIS
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/nejmoa1711038, 10.1056/NEJMoa1711038]
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morain SR, 2017, NEW ENGL J MED, V377, P1505, DOI 10.1056/NEJMp1707273
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/S1473-3099(18)30269-X, 10.1016/s1473-3099(18)30269-x]
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan American Health Organization , ZIK CAS CONG SYNDR A
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rossi SL, 2018, TRENDS MICROBIOL, V26, P877, DOI 10.1016/j.tim.2018.05.007
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Von Seidlein L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002219
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilder-Smith A, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay044
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   World Health Organization, 2016, MOSQ VECT CONTR EM R
   World Health Organization (WHO), 2016, PREV SEX TRANSM ZIK
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 75
TC 52
Z9 53
U1 9
U2 18
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD OCT 10
PY 2019
VL 381
IS 15
BP 1444
EP 1457
DI 10.1056/NEJMra1808246
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA JC9YG
UT WOS:000489631900009
PM 31597021
OA Bronze
DA 2020-11-30
ER

PT J
AU Robbiani, DF
   Olsen, PC
   Costa, F
   Wang, Q
   Oliveira, TY
   Nery, N
   Aromolaran, A
   do Rosario, MS
   Sacramento, GA
   Cruz, JS
   Khouri, R
   Wunder, EA
   Mattos, A
   Freitas, BD
   Sarno, M
   Archanjo, G
   Daltro, D
   Carvalho, GBS
   Pimentel, K
   de Siqueira, IC
   de Almeida, JRM
   Henriques, DF
   Lima, JA
   Vasconcelos, PFC
   Schaefer-Babajew, D
   Azzopardi, SA
   Bozzacco, L
   Gazumyan, A
   Belfort, R
   Alcantara, AP
   Carvalho, G
   Moreira, L
   Araujo, K
   Reis, MG
   Keesler, RI
   Coffey, LL
   Tisoncik-Go, J
   Gale, M
   Rajagopal, L
   Waldorf, KMA
   Dudley, DM
   Simmons, HA
   Mejia, A
   O'Connor, DH
   Steinbach, RJ
   Haese, N
   Smith, J
   Lewis, A
   Colgin, L
   Roberts, V
   Frias, A
   Kelleher, M
   Hirsch, A
   Streblow, DN
   Rice, CM
   MacDonald, MR
   de Almeida, ARP
   Van Rompay, KKA
   Ko, AI
   Nussenzweig, MC
AF Robbiani, Davide F.
   Olsen, Priscilla C.
   Costa, Federico
   Wang, Qiao
   Oliveira, Thiago Y.
   Nery Jr, Nivison
   Aromolaran, Adeolu
   do Rosario, Mateus S.
   Sacramento, Gielson A.
   Cruz, Jaqueline S.
   Khouri, Ricardo
   Wunder, Elsio A., Jr.
   Mattos, Adriana
   Freitas, Bruno de Paula
   Sarno, Manoel
   Archanjo, Gracinda
   Daltro, Dina
   Carvalho, Gustavo B. S.
   Pimentel, Kleber
   de Siqueira, Isadora C.
   de Almeida, Joo R. M.
   Henriques, Daniele F.
   Lima, Juliana A.
   Vasconcelos, Pedro F. C.
   Schaefer-Babajew, Dennis
   Azzopardi, Stephanie A.
   Bozzacco, Leonia
   Gazumyan, Anna
   Belfort Jr, Rubens
   Alcantara, Ana P.
   Carvalho, Gustavo
   Moreira, Licia
   Araujo, Katiaci
   Reis, Mitermayer G.
   Keesler, Rebekah, I
   Coffey, Lark L.
   Tisoncik-Go, Jennifer
   Gale, Michael, Jr.
   Rajagopal, Lakshmi
   Waldorf, Kristina M. Adams
   Dudley, Dawn M.
   Simmons, Heather A.
   Mejia, Andres
   O'Connor, David H.
   Steinbach, Rosemary J.
   Haese, Nicole
   Smith, Jessica
   Lewis, Anne
   Colgin, Lois
   Roberts, Victoria
   Frias, Antonio
   Kelleher, Meredith
   Hirsch, Alec
   Streblow, Daniel N.
   Rice, Charles M.
   MacDonald, Margaret R.
   de Almeida, Antonio R. P.
   Van Rompay, Koen K. A.
   Ko, Albert, I
   Nussenzweig, Michel C.
TI Risk of Zika microcephaly correlates with features of maternal
   antibodies
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID DENGUE VIRUS; DEPENDENT ENHANCEMENT; PREGNANCY OUTCOMES;
   CROSS-REACTIVITY; INFECTION; DISEASE; TRANSMISSION; TERRITORIES; RNA
AB Zika virus (ZIKV) infection during pregnancy causes congenital abnormalities, including microcephaly. However, rates vary widely, and the contributing risk factors remain unclear. We examined the serum antibody response to ZIKV and other flaviviruses in Brazilian women giving birth during the 2015-2016 outbreak. Infected pregnancies with intermediate or higher ZIKV antibody enhancement titers were at increased risk to give birth to microcephalic infants compared with those with lower titers (P < 0.0001). Similarly, analysis of ZIKV-infected pregnant macaques revealed that fetal brain damage was more frequent in mothers with higher enhancement titers. Thus, features of the maternal antibodies are associated with and may contribute to the genesis of ZIKV-associated microcephaly.
C1 [Robbiani, Davide F.; Olsen, Priscilla C.; Oliveira, Thiago Y.; Schaefer-Babajew, Dennis; Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.
   [Azzopardi, Stephanie A.; Bozzacco, Leonia; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.
   [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.
   [Olsen, Priscilla C.] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil.
   [Wang, Qiao] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.
   [Nery Jr, Nivison; Sacramento, Gielson A.; Cruz, Jaqueline S.; Khouri, Ricardo; de Siqueira, Isadora C.; Reis, Mitermayer G.; Ko, Albert, I] Fundacao Oswald Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Aromolaran, Adeolu; Wunder, Elsio A., Jr.; Reis, Mitermayer G.; Ko, Albert, I] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Costa, Federico; Sarno, Manoel; de Almeida, Joo R. M.; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Costa, Federico; Sarno, Manoel; de Almeida, Joo R. M.; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [do Rosario, Mateus S.; Mattos, Adriana; Freitas, Bruno de Paula; Archanjo, Gracinda; Daltro, Dina; Carvalho, Gustavo B. S.; Pimentel, Kleber] Hosp Geral Roberto Santos, Secreteria Saude Estado Bahia, Salvador, BA, Brazil.
   [Henriques, Daniele F.; Lima, Juliana A.; Vasconcelos, Pedro F. C.] Minist Saude Ananindeua, Inst Evandro Chagas, Ananindeua, Para, Brazil.
   [Freitas, Bruno de Paula; Belfort Jr, Rubens] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Araujo, Katiaci] Hosp Alianca, Salvador, BA, Brazil.
   [Alcantara, Ana P.; Carvalho, Gustavo; Moreira, Licia] Hosp Santo Amaro, Salvador, BA, Brazil.
   [Keesler, Rebekah, I; Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Coffey, Lark L.; Van Rompay, Koen K. A.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.; Waldorf, Kristina M. Adams] Washington Natl Primate Res Ctr, Seattle, WA USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.; Waldorf, Kristina M. Adams] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Tisoncik-Go, Jennifer; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Gale, Michael, Jr.; Rajagopal, Lakshmi; Waldorf, Kristina M. Adams] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Rajagopal, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA.
   [Dudley, Dawn M.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA.
   [Simmons, Heather A.; Mejia, Andres] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [Steinbach, Rosemary J.; Roberts, Victoria; Frias, Antonio; Kelleher, Meredith] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR USA.
   [Haese, Nicole; Colgin, Lois; Hirsch, Alec; Streblow, Daniel N.] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA.
   [Lewis, Anne] Oregon Natl Primate Res Ctr, Pathol Serv Unit, Div Comparat Med, Beaverton, OR USA.
   [Haese, Nicole; Smith, Jessica; Hirsch, Alec; Streblow, Daniel N.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA.
   [Frias, Antonio] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.
   [Bozzacco, Leonia] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.
RP Robbiani, DF; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.
EM drobbiani@rockefeller.edu; nussen@rockefeller.edu
RI Haese, Nicole/AAN-4551-2020; Olsen, Priscilla C/I-8994-2012; Wunder,
   Elsio Augusto/C-2733-2013; Nussenzweig, Michel/AAE-7292-2019; Costa,
   Federico/G-1838-2015; Robbiani, Davide F./AAF-7662-2019; Reis,
   Mitermayer/AAO-9742-2020; de Siqueira, Isadora Cristina/R-9953-2016; Ko,
   Albert Icksang/P-2343-2015
OI Olsen, Priscilla C/0000-0002-8795-037X; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Costa, Federico/0000-0001-6951-2336;
   Robbiani, Davide F./0000-0001-7379-3484; Reis,
   Mitermayer/0000-0002-3051-9060; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Ko, Albert Icksang/0000-0001-9023-2339;
   Rocha Nery Junior, Nivison Ruy/0000-0002-8164-0602; Kelleher,
   Meredith/0000-0002-5313-004X; Schaefer-Babajew,
   Dennis/0000-0002-5380-2950; do Rosario, Mateus/0000-0001-7404-6392;
   Wang, Qiao/0000-0001-6416-1733
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5R01AI121207,
   R01TW009504, R25TW009338, U19AI111825, UL1TR001866, R01AI037526,
   UM1AI100663, P01AI138938, R21AI129479, R01AI124690, U19AI057229,
   R01AI100989, R01AI133976, AI083019, AI104002, P51OD010425, P51 OD011092,
   R21-HD091032, R01-HD08633]; Rockefeller University Development Office;
   Fundacao de Amparo a Pesquisa do Estado da Bahia grant [PET0021/2016];
   National Institutes of Health Office of Research Infrastructure
   Programs/OD [P51OD011107, P51OD011106]; United States Food and Drug
   Administration [HHSF223201610542P]; DHHS/PHS/National Institutes of
   Health [R01Al116382-01A1]; Research Facilities Improvement ProgramUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR)
   [RR15459-01, RR020141-01]; Conselho Nacional de De-senvolvimento
   Cientifico e TecnologicoNational Council for Scientific and
   Technological Development (CNPq) [303999/2016-0, 439971/20016-0,
   440405/2016-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (Zika fast-track); Pew Latin American Fellows Program in the
   Biomedical Sciences; Studienstiftung des Deutschen Volkes; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, R25TW009338,
   R01TW009504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI133976, U19AI111825,
   U19AI083019, U19AI111825, R21AI129479, U19AI111825, U19AI111825,
   R01AI121207, U19AI111825, R01AI133976, U19AI111825, U19AI111825,
   U19AI111825, R01AI133976, U19AI111825, U19AI111825, U19AI083019,
   U19AI111825, R01AI121207, U19AI083019, R01AI145296, R21AI129479,
   U19AI083019, U19AI083019, U19AI083019, R01AI104002, R01AI145296,
   U19AI111825, U19AI111825, U19AI111825, R01AI121207, U19AI083019,
   U19AI111825, U19AI083019, U19AI083019, U19AI111825, U19AI111825,
   U19AI083019, R01AI104002, U19AI083019, U19AI083019, U19AI111825,
   U19AI111825, U19AI083019, U19AI111825, U19AI111825, U19AI083019,
   U19AI111825, U19AI111825, U19AI083019, R01AI121207, U19AI083019,
   U19AI111825, U19AI111825, U19AI111825, U19AI111825, U19AI111825,
   U19AI083019, U19AI083019, U19AI111825] Funding Source: NIH RePORTER;
   OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [P51OD011092, P51OD010425, P51OD011092, P51OD011092, P51OD011092,
   P51OD010425, P51OD010425, P51OD011092, P51OD011092, P51OD011107,
   P51OD011092, P51OD010425, P51OD010425, P51OD011106, P51OD011092,
   P51OD011092, P51OD011092, P51OD010425, P51OD010425, P51OD011092,
   P51OD010425, P51OD011107, P51OD011092, P51OD011106, P51OD010425,
   P51OD011107, P51OD011107, P51OD011092, P51OD011092, P51OD011107,
   P51OD011092, P51OD010425, P51OD011092, P51OD010425, P51OD011092,
   P51OD011106, P51OD010425, P51OD011107, P51OD011106, P51OD011107,
   P51OD011092, P51OD011107, P51OD011107, P51OD010425, P51OD010425,
   P51OD011092, P51OD011092, P51OD011092, P51OD011107, P51OD010425,
   P51OD011092, P51OD011092, P51OD011092, P51OD011092, P51OD010425,
   P51OD011092, P51OD011092, P51OD011092, P51OD010425, P51OD010425,
   P51OD010425, P51OD011107, P51OD011092, P51OD010425, P51OD011092,
   P51OD010425, P51OD010425, P51OD011092, P51OD010425, P51OD011106,
   P51OD010425, P51OD011092, P51OD011092, P51OD011107, P51OD011092,
   P51OD011106, P51OD011092, P51OD011092, P51OD010425, P51OD011092,
   P51OD011092, P51OD011092, P51OD010425, P51OD011106, P51OD010425,
   P51OD011107, P51OD010425, P51OD011092, P51OD011092, P51OD011092,
   P51OD011107, P51OD011107, P51OD010425, P51OD011092, P51OD010425,
   P51OD010425, P51OD011106, P51OD010425] Funding Source: NIH RePORTER
FX This work was supported by National Institutes of Health grants
   5R01AI121207, R01TW009504, and R25TW009338 to A.I. Ko; National
   Institutes of Health pilot awards U19AI111825 and UL1TR001866 to D.F.
   Robbiani; National Institutes of Health grants R01AI037526, UM1AI100663,
   U19AI111825, UL1TR001866, and P01AI138938 to M.C. Nussenzweig; National
   Institutes of Health grants R01AI124690 and U19AI057229 (Cooperative
   Center for Human Immunology pilot project); The Rockefeller University
   Development Office and anonymous donors (to C.M. Rice); Fundacao de
   Amparo a Pesquisa do Estado da Bahia grant PET0021/2016 (to M.G. Reis);
   National Institutes of Health grant R21AI129479-Supplement (to K.K.A.
   Van Rompay) and the National Institutes of Health Office of Research
   Infrastructure Programs/OD (P51OD011107 to the CNPRC); the United States
   Food and Drug Administration contract HHSF223201610542P (to L.L.
   Coffey); National Institutes of Health grants R01AI100989 and
   R01AI133976 (to L. Rajagopal and K.M. Adams Waldorf); and National
   Institutes of Health grants AI083019 and AI104002 (to M. Gale Jr.) and
   grant P51OD010425 to the WaNPRC (to K.M. Adams Waldorf, J. Tisoncik-Go,
   and M. Gale Jr.). Studies at WNPRC were supported by DHHS/PHS/National
   Institutes of Health grant R01Al116382-01A1 (to D.H. O'Connor), in part
   by the National Institutes of Health Office of Research Infrastructure
   Programs/OD (grant P51OD011106) awarded toWNPRC, at a facility
   constructed in part with support from Research Facilities Improvement
   Program grants RR15459-01 and RR020141-01; and National Institutes of
   Health core and pilot grant P51 OD011092 and grants R21-HD091032 and
   R01-HD08633 (to ONPRC). P.F.C. Vasconcelos was supported by Conselho
   Nacional de De-senvolvimento Cientifico e Tecnologico (projects
   303999/2016-0, 439971/20016-0, and 440405/2016-5) and Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Zika fast-track). P.C.
   Olsen is supported by the Pew Latin American Fellows Program in the
   Biomedical Sciences. D. Schaefer-Babajew is supported by Studienstiftung
   des Deutschen Volkes. F. Costa is a Wellcome Trust Fellow in Public
   Health and Tropical Medicine, and M.C. Nussenzweig is a Howard Hughes
   Medical Institute Investigator.
CR Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/mmbr.00055-16, 10.1128/MMBR.00055-16]
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miner JJ, 2017, IMMUNITY, V46, P771, DOI 10.1016/j.immuni.2017.04.023
   Ministry of Health of Brazil, 2017, HLTH BRAZ 2015 2016
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Oliveira J, 2018, AM J TROP MED HYG, V98, P1860, DOI 10.4269/ajtmh.17-1020
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 60
TC 11
Z9 11
U1 0
U2 6
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD OCT
PY 2019
VL 216
IS 10
BP 2302
EP 2315
DI 10.1084/jem.20191061
PG 14
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA JC2PM
UT WOS:000489118900009
PM 31413072
OA Other Gold, Green Published
DA 2020-11-30
ER

PT J
AU Gostic, KM
   Wunder, EA
   Bisht, V
   Hamond, C
   Julian, TR
   Ko, AI
   Lloyd-Smith, JO
AF Gostic, Katelyn M.
   Wunder Jr, Elsio A.
   Bisht, Vimla
   Hamond, Camila
   Julian, Timothy R.
   Ko, Albert, I
   Lloyd-Smith, James O.
TI Mechanistic dose-response modelling of animal challenge data shows that
   intact skin is a crucial barrier to leptospiral infection
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE dose-response; leptospirosis; Leptospira; zoonotic spillover; animal
   model; emerging infectious disease
ID PATHOGENIC LEPTOSPIRA; RATTUS-NORVEGICUS; INTERROGANS; EPIDEMIC;
   DYNAMICS
AB Leptospirosis is a widespread and potentially life-threatening zoonotic disease caused by spirochaetes of the genus Leptospira. Humans become infected primarily via contact with environmental reservoirs contaminated by the urine of shedding mammalian hosts. Populations in high transmission settings, such as urban slums and subsistence farming communities, are exposed to low doses of Leptospira on a daily basis. Under these conditions, numerous factors determine whether infection occurs, including the route of exposure and inoculum dose. Skin wounds and abrasions are risk factors for leptospirosis, but it is not known whether broken skin is necessary for spillover, or if low-dose exposures to intact skin and mucous membranes can also cause infection. To establish a quantitative relationship between dose, route and probability of infection, we performed challenge experiments in hamsters and rats, developed mechanistic dose-response models representing the spatial dynamics of within-host infection and persistence, and fitted models to experimental data. Results show intact skin is a strong barrier against infection, and that broken skin is the predominant route by which low-dose environmental exposures cause infection. These results identify skin integrity as a bottleneck to spillover of Leptospira and underscore the importance of barrier interventions in the prevention of leptospirosis.
   This article is part of the theme issue 'Dynamic and integrative approaches to understanding pathogen spillover'.
C1 [Gostic, Katelyn M.; Lloyd-Smith, James O.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.
   [Wunder Jr, Elsio A.; Bisht, Vimla; Hamond, Camila; Ko, Albert, I] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Wunder Jr, Elsio A.; Ko, Albert, I] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Inst, BR-40296710 Salvador, BA, Brazil.
   [Julian, Timothy R.] Eawag, Swiss Fed Inst Aquat Sci & Technol, Uberlandstr 133, CH-8600 Dubendorf, Switzerland.
   [Julian, Timothy R.] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland.
   [Julian, Timothy R.] Univ Basel, CH-4003 Basel, Switzerland.
   [Lloyd-Smith, James O.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Hamond, Camila] INIA, Estn Expt INIA La Estanzuela, Plataforma Salud Anim, Colonia, Uruguay.
RP Lloyd-Smith, JO (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.; Ko, AI (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Ko, AI (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Inst, BR-40296710 Salvador, BA, Brazil.; Lloyd-Smith, JO (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
EM albert.ko@yale.edu; jlloydsmith@ucla.edu
RI Wunder, Elsio Augusto/C-2733-2013; Ko, Albert Icksang/P-2343-2015
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Ko, Albert
   Icksang/0000-0001-9023-2339; Gostic, Katelyn/0000-0002-9369-6371
FU Cota Robles Foundation; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [F31AI134017, T32-GM008185]; Programa Ciencias sem Fronteiras;
   CNPq, BrazilNational Council for Scientific and Technological
   Development (CNPq); NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI052473,
   U01AI088752, R25TW009338, R01TW009504, R01AI121207]; NSFNational Science
   Foundation (NSF) [OCE-1335657, DEB-1557022, SERDP RC-2635]; DARPA
   PREEMPT [D18AC00031]; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R25TW009338, R01TW009504,
   R25TW009338, R25TW009338, R25TW009338] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207] Funding Source: NIH
   RePORTER
FX K.M.G. was supported by the Cota Robles Foundation, and the National
   Institutes of Health (F31AI134017, T32-GM008185). C.H. was supported by
   Programa Ciencias sem Fronteiras, CNPq, Brazil. A.I.K. was supported by
   NIH grant nos R01AI052473, U01AI088752, R25TW009338, R01TW009504 and
   R01AI121207. J.O.L.-S. was supported by NSF grant nos OCE-1335657 and
   DEB-1557022, SERDP RC-2635 and DARPA PREEMPT D18AC00031.
CR Agampodi SB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002626
   Ashford DA, 2000, AM J TROP MED HYG, V63, P249, DOI 10.4269/ajtmh.2000.63.249
   Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Casanovas-Massana A, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00507-18, 10.1128/aem.00507-18]
   Casanovas-Massana A, 2018, WATER RES, V130, P176, DOI 10.1016/j.watres.2017.11.068
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Haas CN, 2015, ENVIRON SCI TECHNOL, V49, P1245, DOI 10.1021/es504422q
   Haas CN, 2014, QUANTITATIVE MICROBIAL RISK ASSESSMENT, 2ND EDITION, P1, DOI 10.1002/9781118910030
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Lunn TJ, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2019.0016
   Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Minter A, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00014
   Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180
   Plowright RK, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0336
   Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45
   Pujol JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000399
   R Core Team, 2018, R LANG ENV STAT COMP
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Schneider AG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006415
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   Togami E, 2018, AM J TROP MED HYG, V99, P849, DOI 10.4269/ajtmh.18-0335
   Wunder EA, 2016, INFECT IMMUN, V84, P2105, DOI 10.1128/IAI.00094-16
   Zhang Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-20
NR 29
TC 2
Z9 3
U1 1
U2 3
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
EI 1471-2970
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD SEP 30
PY 2019
VL 374
IS 1782
AR 20190367
DI 10.1098/rstb.2019.0367
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA IQ4IZ
UT WOS:000480715600020
PM 31401957
OA Bronze, Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Lebov, JF
   Arias, JF
   Balmaseda, A
   Britt, W
   Cordero, JF
   Galvao, LA
   Garces, AL
   Hambidge, KM
   Harris, E
   Ko, A
   Krebs, N
   Marques, ETA
   Martinez, AM
   McClure, E
   Miranda, DB
   Moreira, MEL
   Mussi-Pinhata, MM
   Ochoa, TJ
   Osorio, JE
   Scalabrin, DMF
   Schultz-Cherry, S
   Seage, GR
   Stolka, K
   Ugarte-Gil, CA
   Vega, CMV
   Welton, M
   Ximenes, R
   Zorrilla, C
AF Lebov, Jill F.
   Arias, Juan F.
   Balmaseda, Angel
   Britt, William
   Cordero, Jose F.
   Galvao, Luiz Augusto
   Garces, Ana Lucia
   Hambidge, K. Michael
   Harris, Eva
   Ko, Albert
   Krebs, Nancy
   Marques, Ernesto T. A.
   Martinez, Alexander M.
   McClure, Elizabeth
   Miranda-Filho, Democrito B.
   Lopes Moreira, Maria Elisabeth
   Mussi-Pinhata, Marisa M.
   Ochoa, Theresa J.
   Osorio, Jorge E.
   Scalabrin, Deolinda M. F.
   Schultz-Cherry, Stacey
   Seage, George R., III
   Stolka, Kristen
   Augusto Ugarte-Gil, Cesar
   Vega, Carmen Milagros Velez
   Welton, Michael
   Ximenes, Ricardo
   Zorrilla, Carmen
TI International prospective observational cohort study of Zika in infants
   and pregnancy (ZIP study): study protocol
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Zika virus; Pregnancy; Latin America; Microcephaly
ID VIRUS-INFECTION; BIRTH-DEFECTS; CLINICAL-MANIFESTATIONS; EMERGENCE;
   EXPOSURE; FETUSES; HISTORY; UPDATE; STATES; BRAZIL
AB Background Until recently, Zika virus (ZIKV) infections were considered mild and self-limiting. Since 2015, they have been associated with an increase in microcephaly and other birth defects in newborns. While this association has been observed in case reports and epidemiological studies, the nature and extent of the relationship between ZIKV and adverse pregnancy and pediatric health outcomes is not well understood. With the unique opportunity to prospectively explore the full spectrum of issues related to ZIKV exposure during pregnancy, we undertook a multi-country, prospective cohort study to evaluate the association between ZIKV and pregnancy, neonatal, and infant outcomes. Methods At research sites in ZIKV endemic regions of Brazil (4 sites), Colombia, Guatemala, Nicaragua, Puerto Rico (2 sites), and Peru, up to 10,000 pregnant women will be recruited and consented in the first and early second trimesters of pregnancy and then followed through delivery up to 6 weeks post-partum; their infants will be followed until at least 1 year of age. Pregnant women with symptomatic ZIKV infection confirmed by presence of ZIKV RNA and/or IgM for ZIKV will also be enrolled, regardless of gestational age. Participants will be tested monthly for ZIKV infection; additional demographic, physical, laboratory and environmental data will be collected to assess the potential interaction of these variables with ZIKV infection. Delivery outcomes and detailed infant assessments, including physical and neurological outcomes, will be obtained. Discussion With the emergence of ZIKV in the Americas and its association with adverse pregnancy outcomes in this region, a much better understanding of the spectrum of clinical outcomes associated with exposure to ZIKV during pregnancy is needed. This cohort study will provide information about maternal, fetal, and infant outcomes related to ZIKV infection, including congenital ZIKV syndrome, and manifestations that are not detectable at birth but may appear during the first year of life. In addition, the flexibility of the study design has provided an opportunity to modify study parameters in real time to provide rigorous research data to answer the most critical questions about the impact of congenital ZIKV exposure.
C1 [Lebov, Jill F.; McClure, Elizabeth; Stolka, Kristen] RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
   [Arias, Juan F.; Schultz-Cherry, Stacey] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA.
   [Balmaseda, Angel] Complejo Nacl Salud, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Britt, William] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA.
   [Cordero, Jose F.; Welton, Michael] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Galvao, Luiz Augusto] Fiocruz MS, Ctr Global Hlth CRIS, Rio De Janeiro, Brazil.
   [Garces, Ana Lucia] Fdn Alimentac & Nutr Cent Amer & Panama INCAP, Guatemala City, Guatemala.
   [Hambidge, K. Michael; Krebs, Nancy] Univ Colorado, Sect Nutr, Pediat, Aurora, CO USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert; Scalabrin, Deolinda M. F.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA.
   [Marques, Ernesto T. A.] Fiocruz MS, Dept Virol & Expt Therapeut, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Martinez, Alexander M.] Imbanaco Med Ctr, Res Inst, Cali, Colombia.
   [Miranda-Filho, Democrito B.] Univ Pernambuco, Programa Posgrad Ciencias Saude PPGCS, Microcephaly Epidem Res Grp, Recife, PE, Brazil.
   [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Mussi-Pinhata, Marisa M.] Ribeirao Preto Med Sch, Ribeirao Preto, Brazil.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.
   [Ochoa, Theresa J.; Augusto Ugarte-Gil, Cesar] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru.
   [Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [Seage, George R., III] Harvard Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Vega, Carmen Milagros Velez] Univ Puerto Rico, San Juan, PR 00936 USA.
   [Ximenes, Ricardo] Univ Fed Pernambuco, Microcephaly Epidem Res Grp, Dept Med Trop, Recife, PE, Brazil.
   [Zorrilla, Carmen] Maternal Infant Studies Ctr CEMI, San Juan, PR USA.
RP Lebov, JF (corresponding author), RTI Int, Social Stat & Environm Sci, Durham, NC 27709 USA.
EM jlebov@rti.org
RI Moreira, Maria Elisabeth Lopes/AAA-3775-2020; Ugarte-Gil,
   Cesar/E-6074-2013; Marques, Ernesto T. A/L-4967-2013; Ko, Albert
   Icksang/P-2343-2015
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; Ugarte-Gil,
   Cesar/0000-0002-2833-9087; Marques, Ernesto T. A/0000-0003-3826-9358;
   Ko, Albert Icksang/0000-0001-9023-2339; McClure,
   Elizabeth/0000-0001-8659-5444; Galvao, Luiz Augusto/0000-0002-3918-0286;
   Martinez-Blanco, Alexander Maximiliano/0000-0001-5755-1776
FU U.S. National Institute of Child Health and Human Development
   (NICHD)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD); National
   Institute of Allergy and Infectious Diseases (NIAID)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID);
   National Institute of Environmental Health Sciences (NIEHS)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Environmental Health Sciences (NIEHS);
   Fundacao Oswaldo Cruz-Fiocruz, Brazil; EUNICE KENNEDY SHRIVER NATIONAL
   INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [U01HD040636, U01HD040636, U01HD040636, U01HD040636]
   Funding Source: NIH RePORTER
FX This study is funded through grants from the U.S. National Institute of
   Child Health and Human Development (NICHD); National Institute of
   Allergy and Infectious Diseases (NIAID); National Institute of
   Environmental Health Sciences (NIEHS); and Fundacao Oswaldo
   Cruz-Fiocruz, Brazil. Representatives from each institution provided
   general support, scientific input, and peer review of the study design,
   protocol, consent forms, data collection forms, and analysis plan.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 33
TC 5
Z9 5
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD AUG 7
PY 2019
VL 19
IS 1
AR 282
DI 10.1186/s12884-019-2430-4
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IO2TY
UT WOS:000479235900001
PM 31391005
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Minter, A
   Costa, F
   Khalil, H
   Childs, J
   Diggle, P
   Ko, AI
   Begon, M
AF Minter, Amanda
   Costa, Federico
   Khalil, Hussein
   Childs, Jamie
   Diggle, Peter
   Ko, Albert I.
   Begon, Mike
TI Optimal Control of Rat-Borne Leptospirosis in an Urban Environment
SO FRONTIERS IN ECOLOGY AND EVOLUTION
LA English
DT Article
DE leptospirosis; Norway rat; mathematical model; intervention; urban
   system; control; prevention
ID NORVEGICUS; MANAGEMENT; RODENTS; IMPACT
AB Humans acquire leptospirosis through direct contact with animal reservoirs, or more commonly, contact with the environment contaminated with leptospires shed in animal urine. Reservoir populations can be difficult to control through rodenticide application, and resource reduction via habitat management is costly and logistically complicated to implement. When resources are limited, simulation of different combinations of control methods can inform their application in the field. Here we present a framework to find time-dependent control measures for rodent-borne leptospirosis using optimal control mathematical model theory. An age-structured model for leptospire infection in a Norway rat (Pettus norvegicus) population was developed, informed by empirical analyses of data from the city of Salvador, Brazil. We extended this model to include two temporary control measures, rodenticide, and resource reduction, and two permanent control measures, reducing rat carrying capacity and leptospire lifespan in the environment. Optimal control theory seeks the optimum time-dependent controls while taking into account both the cost of the control measures and the "cost" of infection. Multiple control scenarios and the predicted effect of the optimal controls on the population and infection dynamics are presented to illustrate the applications of combinations of temporary and permanent controls. Permanent controls lead to a reduction in prevalence of leptospiral carriage in the rodent population. However, temporary controls can also achieve a reduction in the number of infected rats low enough to reduce risk to humans. Although we focus our modeling on a well-studied species, the Norway rat, our approach can be applied to other disease systems with animal and environmental reservoirs to inform decisions to reduce the risk of human infection.
C1 [Minter, Amanda] London Sch Hyg & Trop Med, Ctr Math Modeling Infect Dis, London, England.
   [Costa, Federico; Khalil, Hussein; Begon, Mike] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
   [Costa, Federico; Khalil, Hussein] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Costa, Federico; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Childs, Jamie; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Diggle, Peter] Univ Lancaster, Med Sch, CHICAS, Lancaster, England.
RP Begon, M (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
EM mbegon@liverpool.ac.uk
RI Costa, Federico/G-1838-2015; Ko, Albert Icksang/P-2343-2015
OI Costa, Federico/0000-0001-6951-2336; Ko, Albert
   Icksang/0000-0001-9023-2339; Diggle, Peter/0000-0003-3521-5020; ,
   Amanda/0000-0003-1171-5688
FU Oswaldo Cruz Foundation; Wellcome TrustWellcome Trust [102330/Z/13/Z];
   NSF-NIH grant from the Ecology and Evolution of Infection Diseases
   (EEID) program [1 R01 TW009504]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [5 R01 AI052473,
   5 U01 AI088752, 1 R25 TW009338, 1 R01 AI121207]; Research and Policy for
   Infectious Disease Dynamics (RAPIDD) program of the Science and
   Technology Directorate (US Department of Homeland Security); Secretariat
   of Health Surveillance, Brazilian Ministry of Health
FX This work was supported by the Oswaldo Cruz Foundation and Secretariat
   of Health Surveillance, Brazilian Ministry of Health; the Wellcome Trust
   (102330/Z/13/Z); and a NSF-NIH grant from the Ecology and Evolution of
   Infection Diseases (EEID) program (1 R01 TW009504), NIH grants (5 R01
   AI052473, 5 U01 AI088752, 1 R25 TW009338, and 1 R01 AI121207), and by
   the Research and Policy for Infectious Disease Dynamics (RAPIDD) program
   of the Science and Technology Directorate (US Department of Homeland
   Security).
CR Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53
   Buckle A, 2013, PEST MANAG SCI, V69, P334, DOI 10.1002/ps.3309
   BUTLER FT, 1994, J ZOOL, V233, P277, DOI 10.1111/j.1469-7998.1994.tb08588.x
   CALHOUN JB, 1962, US PUBLIC HLTH SERVI, V1008
   Casanovas-Massana A, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00507-18, 10.1128/aem.00507-18]
   Clapperton B. K., 2006, REV CURRENT KNOWLEDG, P1
   Costa F, 2017, TRENDS PARASITOL, V33, P660, DOI 10.1016/j.pt.2017.05.010
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   de Masi E, 2009, INT J ENVIRON HEAL R, V19, P291, DOI 10.1080/09603120802592723
   De Oliveira D, 2016, EPIDEMIOL INFECT, V144, P2420, DOI 10.1017/S0950268816000637
   Ellis WA, 2015, CURR TOP MICROBIOL, V387, P99, DOI 10.1007/978-3-662-45059-8_6
   Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102
   Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4
   Galef B.G. Jr, 1981, P211
   Glass G.E., 1989, Occasional Papers of the Museum of Natural History University of Kansas, VNo. 130, P1
   Villafane IEG, 2013, MAMMALIA, V77, P187, DOI 10.1515/mammalia-2012-0075
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Hein S, 2015, WILDLIFE RES, V42, P108, DOI 10.1071/WR14165
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Holt J, 2006, ACTA TROP, V99, P218, DOI 10.1016/j.actatropica.2006.08.003
   Joseph MB, 2013, J APPL ECOL, V50, P702, DOI 10.1111/1365-2664.12084
   Lambert MS, 2008, J APPL ECOL, V45, P1753, DOI 10.1111/j.1365-2664.2008.01543.x
   Malik T, 2016, J THEOR BIOL, V393, P179, DOI 10.1016/j.jtbi.2016.01.004
   MEANEY MJ, 1981, ANIM BEHAV, V29, P34, DOI 10.1016/S0003-3472(81)80149-2
   Minter A, 2017, EPIDEMIOL INFECT, V145, P3438, DOI 10.1017/S0950268817002539
   Minter A, 2018, EPIDEMICS-NETH, V25, P26, DOI 10.1016/j.epidem.2018.05.002
   Mlynareikova H, 1999, P 3 INT C URB PESTS
   Neilan RLM, 2010, B MATH BIOL, V72, P2004, DOI 10.1007/s11538-010-9521-8
   Panti-May JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152511
   Posny D, 2015, MATH BIOSCI, V264, P38, DOI 10.1016/j.mbs.2015.03.006
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Sharomi Oluwaseun, 2017, Annals of Operations Research, V251, P55, DOI 10.1007/s10479-015-1834-4
   Shilova S. A., 2009, Current Zoology, V55, P81
   Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z
   van Adrichem Marjolein H. C., 2013, Lutra, V56, P77
   Williams BK, 2007, ECOL MODEL, V200, P234, DOI 10.1016/j.ecolmodel.2006.07.039
   Zhang YZ, 2010, EMERG INFECT DIS, V16, P1195, DOI 10.3201/eid1608.090470
NR 40
TC 0
Z9 0
U1 1
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-701X
J9 FRONT ECOL EVOL
JI Front. Ecol. Evol.
PD JUN 19
PY 2019
VL 7
AR 209
DI 10.3389/fevo.2019.00209
PG 10
WC Ecology
SC Environmental Sciences & Ecology
GA IE0QZ
UT WOS:000472093200001
OA DOAJ Gold, Green Accepted
DA 2020-11-30
ER

PT J
AU Richardson, JL
   Silveira, G
   Medrano, IS
   Arietta, AZ
   Mariani, C
   Pertile, AC
   Pereira, TC
   Childs, JE
   Ko, AI
   Costa, F
   Caccone, A
AF Richardson, Jonathan L.
   Silveira, Georgianna
   Medrano, Ivanna Soto
   Arietta, A. Z.
   Mariani, Carol
   Pertile, Arsinoe C.
   Pereira, Ticiana Carvalho
   Childs, James E.
   Ko, Albert I.
   Costa, Federico
   Caccone, Adalgisa
TI Significant Genetic Impacts Accompany an Urban Rat Control Campaign in
   Salvador, Brazil
SO FRONTIERS IN ECOLOGY AND EVOLUTION
LA English
DT Article
DE genetic bottleneck; eradication; invasive species; public health; vector
   control; intervention; integrated pest management; Rattus
ID EFFECTIVE POPULATION-SIZE; NORWAY RATS; LEPTOSPIRA-INTERROGANS; LINKAGE
   DISEQUILIBRIUM; ADAPTIVE EVOLUTION; SINGLE-SAMPLE; N-E; ERADICATION;
   RELATEDNESS; NORVEGICUS
AB Rats thrive in human-dominated landscapes and have expanded to a near global distribution. Norway rats (Rattus norvegicus) contaminate food, damage infrastructure, and are reservoirs for zoonotic pathogens that cause human diseases. To limit these negative impacts, entities around the world implement intervention and control strategies designed to quickly and drastically reduce the number of rats in a population. While the primary goal of these interventions is to reduce rat numbers and their detrimental activities, there are important, yet unexplored, population genetic implications for these rapid population declines. Here, we compare the population genetics of R. norvegicus before, immediately after, and several months following a rodenticide-based eradication campaign targeting rats in an urban slum of Salvador, Brazil. This slum has been the focus of long-term research designed to understand and reduce the risk of leptospirosis for people in this area. We also look for a clear source of rats contributing to population recovery, by either rebounding through breeding of local survivors, or by immigration/reinvasion of the site. We found evidence of severe genetic bottlenecks, with the effective population size dropping 85-91% after eradication, consistent with declines in population sizes. These rapid declines also led to a strong shift in the genetic structure of rats before and after the eradication campaign. Relatedness increased in two of the three study areas after eradication, suggesting reduced population sizes and an uneven impact of the campaign across colonies within the population. Lastly, dozens of low-frequency alleles (mean frequency of 0.037) observed before the campaign were undetected after the campaign, potentially lost from the population via drift or selection. We discuss the public health and ecological implications of these rapid genetic impacts of urban control efforts. Our data suggests that targeting the genetic viability of rat populations may be another important component for integrated pest management (IPM) strategies, designed to reduce urban rats.
C1 [Richardson, Jonathan L.; Silveira, Georgianna] Providence Coll, Dept Biol, Providence, RI 02918 USA.
   [Richardson, Jonathan L.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA.
   [Medrano, Ivanna Soto; Arietta, A. Z.; Mariani, Carol; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.
   [Pertile, Arsinoe C.; Costa, Federico] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Pereira, Ticiana Carvalho; Costa, Federico] Univ Fed Bahia, UFBA, Inst Saude Colet, Salvador, BA, Brazil.
   [Childs, James E.; Ko, Albert I.] Yale Univ, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Richardson, JL (corresponding author), Providence Coll, Dept Biol, Providence, RI 02918 USA.; Richardson, JL (corresponding author), Univ Richmond, Dept Biol, Richmond, VA 23173 USA.
EM jrichardson4@gmail.com
RI Ko, Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336; Arietta, A. Z. Andis/0000-0002-3368-1346;
   Carvalho Pereira, Ticiana/0000-0003-2370-2198
FU U.S. National Science FoundationNational Science Foundation (NSF)
   [1738789]; Oswaldo Cruz Foundation; Secretariat of Health Surveillance,
   Brazilian Ministry of Health; Wellcome TrustWellcome Trust
   [102330/Z/13/Z]; NSF-NIH grant from the Ecology and Evolution of
   Infection Diseases (EEID) program [1 R01 TW009504]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [5 R01 AI052473, 5 U01 AI088752, 1 R25 TW009338, 1 R01 AI121207,
   F31 AI114245]
FX We thank the staff of Fiocruz and the Zoonosis Control Center in
   Salvador for their assistance in conducting the study. We thank the
   collaborative groups from the Urban Health Council of Pau da Lima,
   including residents and community leaders, as well as the Oswaldo Cruz
   Foundation. J. Shirvell, B. Kajdacsi, C. Hernandez, and C. Manole all
   contributed to the genotype data generation in this study. This work was
   funded by a U.S. National Science Foundation grant to JR (1738789), the
   Oswaldo Cruz Foundation and Secretariat of Health Surveillance,
   Brazilian Ministry of Health; the Wellcome Trust (102330/Z/13/Z); and a
   NSF-NIH grant from the Ecology and Evolution of Infection Diseases
   (EEID) program (1 R01 TW009504) and NIH grants (5 R01 AI052473, 5 U01
   AI088752, 1 R25 TW009338, 1 R01 AI121207, F31 AI114245. Comments from
   Matt Combs, Jeff Markert, Lianne Bisch, and two reviewers greatly
   improved this manuscript.
CR Abdelkrim J, 2005, CONSERV BIOL, V19, P1509, DOI 10.1111/j.1523-1739.2005.00206.x
   Abdelkrim J, 2007, CONSERV BIOL, V21, P719, DOI 10.1111/j.1523-1739.2007.00696.x
   Angley LP, 2018, ZOONOSES PUBLIC HLTH, V65, pE113, DOI 10.1111/zph.12418
   Bonnefoy X., 2008, PUBLIC HLTH SIGNIFIC
   Briskie JV, 2004, P NATL ACAD SCI USA, V101, P558, DOI 10.1073/pnas.0305103101
   Burns JH, 2006, ECOL APPL, V16, P1367, DOI 10.1890/1051-0761(2006)016[1367:RAEATA]2.0.CO;2
   Calhoun J.B., 1963, ECOLOGY SOCIOLOGY NO, DOI [10.5962/bhl.title.112283, DOI 10.5962/BHL.TITLE.112283]
   Capizzi D, 2014, MAMMAL REV, V44, P148, DOI 10.1111/mam.12019
   Clapperton B. K., 2006, REV CURRENT KNOWLEDG
   Combs M, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0245
   Costa F, 2016, J HERED, V107, P181, DOI 10.1093/jhered/esv098
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   DAVIS H, 1977, URBAN RAT SURVEYS
   de Masi E, 2009, INT J ENVIRON HEAL R, V19, P291, DOI 10.1080/09603120802592723
   Desvars-Larrive A, 2019, J PEST SCI, V92, P691, DOI 10.1007/s10340-018-1043-4
   Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x
   Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157
   Donihue CM, 2015, AMBIO, V44, P194, DOI 10.1007/s13280-014-0547-2
   Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746
   Elam DR, 2007, P NATL ACAD SCI USA, V104, P549, DOI 10.1073/pnas.0607306104
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14
   FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455
   Fraser CI, 2015, BIOL INVASIONS, V17, P1, DOI 10.1007/s10530-014-0714-1
   Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x
   Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x
   Goudet J, 2018, MOL ECOL, V27, P4121, DOI 10.1111/mec.14833
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Harris SE, 2017, MOL ECOL, V26, P6336, DOI 10.1111/mec.14369
   HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553
   Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270
   Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195
   HONE J, 1995, J APPL ECOL, V32, P311, DOI 10.2307/2405098
   Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x
   Husemann M, 2016, HEREDITY, V117, P191, DOI 10.1038/hdy.2016.75
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Jombart T., 2016, ADEGENET R PACKAGE E
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x
   Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455
   Kalinowski ST, 2002, CONSERV BIOL, V16, P129, DOI 10.1046/j.1523-1739.2002.00134.x
   Klaassen CHW, 2012, MOL ECOL, V21, P57, DOI 10.1111/j.1365-294X.2011.05364.x
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Kuriwada T, 2010, J ECON ENTOMOL, V103, P1144, DOI 10.1603/EC09361
   Lee MJ, 2018, EMERG INFECT DIS, V24, P356, DOI 10.3201/eid2402.171371
   Li SP, 2015, ECOL LETT, V18, P1285, DOI 10.1111/ele.12522
   Low GW, 2018, HEREDITY, V120, P138, DOI 10.1038/s41437-017-0026-1
   Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238
   MARUYAMA T, 1985, GENETICS, V111, P675
   Milligan BG, 2003, GENETICS, V163, P1153
   Minter A, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00014
   Murphy R. G., 2002, P 4 INT C URB PESTS, P351
   NEI M, 1975, EVOLUTION, V29, P1, DOI [10.2307/2407137, 10.1111/j.1558-5646.1975.tb00807.x]
   Panti-May JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152511
   Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696
   Park S.D.E., 2001, EXCEL MICROSATELLITE
   Parsons Michael H., 2017, Journal of Urban Ecology, V3, pjux005, DOI 10.1093/jue/jux005
   Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x
   Pichlmueller F, 2018, BIOL CONSERV, V227, P213, DOI 10.1016/j.biocon.2018.09.020
   Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002
   Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502
   Pritchard JK, 2000, GENETICS, V155, P945
   QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.1111/j.1558-5646.1989.tb04226.x, 10.2307/2409206]
   Reed DH, 2005, CONSERV BIOL, V19, P563, DOI 10.1111/j.1523-1739.2005.00444.x
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Richardson JL, 2017, EVOL APPL, V10, P323, DOI 10.1111/eva.12449
   Richardson JL, 2016, MOL ECOL, V25, P849, DOI 10.1111/mec.13527
   Richardson JL, 2014, TRENDS ECOL EVOL, V29, P165, DOI 10.1016/j.tree.2014.01.002
   Russell JC, 2010, BIOL INVASIONS, V12, P1747, DOI 10.1007/s10530-009-9586-1
   Savidge JA, 2012, BIOL INVASIONS, V14, P2343, DOI 10.1007/s10530-012-0233-x
   SMITH L, 1963, PUBLIC HEALTH REP, V78, P807, DOI 10.2307/4591943
   Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd
   Stenseth NC, 2003, FRONT ECOL ENVIRON, V1, P367, DOI 10.1890/1540-9295(2003)001[0367:MRAPTB]2.0.CO;2
   Stokes VL, 2009, J APPL ECOL, V46, P1239, DOI 10.1111/j.1365-2664.2009.01735.x
   Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x
   Taylor SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036748
   Townsend A. K., 2018, MOL ECOL
   Vadell MV, 2010, INT J PEST MANAGE, V56, P327, DOI 10.1080/09670874.2010.499479
   Vucetich JA, 1997, EVOLUTION, V51, P2017, DOI 10.1111/j.1558-5646.1997.tb05123.x
   Wang JL, 2016, MOL ECOL, V25, P4692, DOI 10.1111/mec.13725
   Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x
   Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963
   Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x
   Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y
   Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x
NR 85
TC 2
Z9 2
U1 2
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-701X
J9 FRONT ECOL EVOL
JI Front. Ecol. Evol.
PD JUN 6
PY 2019
VL 7
AR 115
DI 10.3389/fevo.2019.00115
PG 12
WC Ecology
SC Environmental Sciences & Ecology
GA IC2NG
UT WOS:000470796200001
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Rodriguez-Morales, AJ
   Ramirez-Vallejoa, E
   Alvarado-Arnez, LE
   Paniz-Mondolfi, A
   Zambrano, LI
   Ko, AI
AF Rodriguez-Morales, Alfonso J.
   Ramirez-Vallejoa, Eduardo
   Elena Alvarado-Arnez, Lucia
   Paniz-Mondolfi, Alberto
   Zambrano, Lysien I.
   Ko, Albert I.
TI Fatal Zika virus disease in adults: A critical reappraisal of an
   under-recognized clinical entity
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
ID INFECTION; COINFECTION
C1 [Rodriguez-Morales, Alfonso J.; Ramirez-Vallejoa, Eduardo] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.; Ramirez-Vallejoa, Eduardo; Paniz-Mondolfi, Alberto; Zambrano, Lysien I.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Ramirez-Vallejoa, Eduardo] Univ Franz Tamayo UNI FRANZ, Natl Res Coordinat, Cochabamba, Bolivia.
   [Paniz-Mondolfi, Alberto] Inst Invest Biomed IDB, Clin IDB Cabudare, Dept Infect Dis & Trop Med, Lara 3023, Venezuela.
   [Paniz-Mondolfi, Alberto] Venezuelan Sci Incubator & Zoonosis & Emerging Pa, Infect Dis Res Branch, Cabudare 3023, Lara, Venezuela.
   [Paniz-Mondolfi, Alberto] Inst Estudios Avanzados IDEA, Lab Senalizac Celular & Bioquim Parasitos, Caracas, Venezuela.
   [Paniz-Mondolfi, Alberto] Acad Nacl Med, Caracas, Venezuela.
   [Zambrano, Lysien I.] Univ Nacl Autonoma Honduras, Sch Med, Dept Morphol Sci, Sci, Tegucigalpa, Honduras.
   [Zambrano, Lysien I.] Univ Fed Sao Paulo, Escola Paulista Med UNIFESP EPM, Dept Physiol, Cardiovasc Div, Sao Paulo, Brazil.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.; Rodriguez-Morales, AJ (corresponding author), Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI Ko, Albert Icksang/P-2343-2015; Arnez, Lucia Elena Alvarado/D-4690-2016;
   AJ, Rodriguez-Morales/R-9765-2016; Zambrano, Lysien Ivania/R-5628-2019
OI Ko, Albert Icksang/0000-0001-9023-2339; Arnez, Lucia Elena
   Alvarado/0000-0002-3537-6361; AJ, Rodriguez-Morales/0000-0001-9773-2192;
   Zambrano, Lysien Ivania/0000-0001-9002-5807; Paniz-Mondolfi, Alberto
   E./0000-0003-1259-1736
CR Abdalla LF, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0938-2
   Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1
   Andrade P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08845-3
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   de la Hoz JM, 2015, J CLIN VIROL, V69, P27, DOI 10.1016/j.jcv.2015.05.021
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005
   Mercado M, 2018, J CLIN VIROL, V103, P16, DOI 10.1016/j.jcv.2018.03.009
   Mercado-Reyes M, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881800359X, 10.1017/s095026881800359x]
   Minhas AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1399
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/S1473-3099(18)30269-X, 10.1016/s1473-3099(18)30269-x]
   Neaterour P, 2017, AM J TROP MED HYG, V97, P1085, DOI 10.4269/ajtmh.17-0250
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Rajahram GS, 2019, INT J INFECT DIS, V83, P163, DOI 10.1016/j.ijid.2019.01.047
   Ramacciotti E, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029618821184
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rodriguez-Morales AJ, 2018, INT J INFECT DIS, V73, P195, DOI 10.1016/j.ijid.2018.04.3856
   Rodriguez-Morales AJ, 2018, INT J INFECT DIS, V73, P71, DOI 10.1016/j.ijid.2018.04.3587
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Villamil-Gomez WE, 2018, MAYO CLIN PROC, V93, P393, DOI 10.1016/j.mayocp.2017.12.006
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Villannil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P510, DOI 10.1016/j.tmaid.2016.06.004
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zonneveld R, 2016, IDCases, V5, P49, DOI 10.1016/j.idcr.2016.07.009
NR 33
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2019
VL 83
BP 160
EP 162
DI 10.1016/j.ijid.2019.03.002
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA IA1LJ
UT WOS:000469322300028
PM 30858118
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Grubaugh, ND
   Ishtiaq, F
   Setoh, YX
   Ko, AI
AF Grubaugh, Nathan D.
   Ishtiaq, Farah
   Setoh, Yin Xiang
   Ko, Albert I.
TI Misperceived Risks of Zika-related Microcephaly in India
SO TRENDS IN MICROBIOLOGY
LA English
DT Editorial Material
AB After the discovery that Zika virus (ZIKV) could cause microcephaly and other birth defects, we have scrambled to understand how. Now, spreading along with the virus is misinformation that a ZIKV mutation is responsible for microcephaly. Putting too much onus on a single mutation could enhance a crisis in India.
C1 [Grubaugh, Nathan D.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Ishtiaq, Farah] Indian Inst Sci, Ctr Ecol Sci, Bangalore, Karnataka, India.
   [Setoh, Yin Xiang] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.
   [Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
RP Grubaugh, ND (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
EM nathan.grubaugh@yale.edu
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Grubaugh,
   Nathan/0000-0003-2031-1933
CR Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Ishtiaq F, 2018, TRENDS PARASITOL, V34, P92, DOI 10.1016/j.pt.2017.10.008
   Jaeger A, 2018, BIORXIV, DOI [10.1101/387118, DOI 10.1101/387118]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Rosenstierne MW, 2018, EMERG INFECT DIS, V24, P948, DOI 10.3201/eid2405.180153
   Setoh YX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100541
   Siraj Amir S, 2017, BMJ Glob Health, V2, pe000309, DOI 10.1136/bmjgh-2017-000309
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 15
TC 8
Z9 7
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD MAY
PY 2019
VL 27
IS 5
BP 381
EP 383
DI 10.1016/j.tim.2019.02.004
PG 4
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA HS4XL
UT WOS:000463873700001
PM 30826180
DA 2020-11-30
ER

PT J
AU Rodriguez-Barraquer, I
   Costa, F
   Nascimento, EJM
   Nery, N
   Castanha, PMS
   Sacramento, GA
   Cruz, J
   Carvalho, M
   De Olivera, D
   Hagan, JE
   Adhikarla, H
   Wunder, EA
   Coelho, DF
   Azar, SR
   Rossi, SL
   Vasilakis, N
   Weaver, SC
   Ribeiro, GS
   Balmaseda, A
   Harris, E
   Nogueira, ML
   Reis, MG
   Marques, ETA
   Cummings, DAT
   Ko, AI
AF Rodriguez-Barraquer, Isabel
   Costa, Federico
   Nascimento, Eduardo J. M.
   Nery Junior, Nivison
   Castanha, Priscila M. S.
   Sacramento, Gielson Almeida
   Cruz, Jaqueline
   Carvalho, Mayara
   De Olivera, Daiana
   Hagan, Jose E.
   Adhikarla, Haritha
   Wunder, Elsio A., Jr.
   Coelho, Danilo F.
   Azar, Sasha R.
   Rossi, Shannan L.
   Vasilakis, Nikos
   Weaver, Scott C.
   Ribeiro, Guilherme S.
   Balmaseda, Angel
   Harris, Eva
   Nogueira, Mauricio L.
   Reis, Mitermayer G.
   Marques, Ernesto T. A.
   Cummings, Derek A. T.
   Ko, Albert I.
TI Impact of preexisting dengue immunity on Zika virus emergence in a
   dengue endemic region
SO SCIENCE
LA English
DT Article
ID INFECTION; ANTIBODY; ENHANCEMENT; OUTBREAK; SALVADOR
AB The clinical outcomes associated with Zika virus (ZIKV) in the Americas have been well documented, but other aspects of the pandemic, such as attack rates and risk factors, are poorly understood. We prospectively followed a cohort of 1453 urban residents in Salvador, Brazil, and, using an assay that measured immunoglobulin G3 (IgG3) responses against ZIKV NS1 antigen, we estimated that 73% of individuals were infected during the 2015 outbreak. Attack rates were spatially heterogeneous, varying by a factor of 3 within a community spanning 0.17 square kilometers. Preexisting high antibody titers to dengue virus were associated with reduced risk of ZIKV infection and symptoms. The landscape of ZIKV immunity that now exists may affect the risk for future transmission.
C1 [Rodriguez-Barraquer, Isabel] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Costa, Federico; Nery Junior, Nivison; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Costa, Federico; Nery Junior, Nivison; Sacramento, Gielson Almeida; Cruz, Jaqueline; Carvalho, Mayara; De Olivera, Daiana; Hagan, Jose E.; Wunder, Elsio A., Jr.; Ribeiro, Guilherme S.; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Hagan, Jose E.; Adhikarla, Haritha; Wunder, Elsio A., Jr.; Reis, Mitermayer G.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Nascimento, Eduardo J. M.; Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA.
   [Castanha, Priscila M. S.; Coelho, Danilo F.; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz MS, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [Coelho, Danilo F.] Univ Fed Pernambuco, Dept Fundamental Chem, BR-50740540 Recife, PE, Brazil.
   [Azar, Sasha R.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Ribeiro, Guilherme S.; Reis, Mitermayer G.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Balmaseda, Angel] Sustainable Sci Inst, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Sao Paulo, Brazil.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA.
   [Cummings, Derek A. T.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA.
   [Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
RP Ko, AI (corresponding author), Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.; Ko, AI (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Cummings, DAT (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.; Cummings, DAT (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
EM datc@ufl.edu; albert.ko@yale.edu
RI Vasilakis, Nikos/ABE-7318-2020; Da Silva Castanha, Priscila
   Mayrelle/G-1785-2012; Wunder, Elsio Augusto/C-2733-2013; Marques,
   Ernesto T. A/L-4967-2013; Costa, Federico/G-1838-2015; Ribeiro,
   Guilherme/B-6624-2008; Coelho, Danilo Fernandes/AAC-9206-2020; Nogueira,
   Mauricio L/B-7599-2012; Reis, Mitermayer/AAO-9742-2020; Ko, Albert
   Icksang/P-2343-2015
OI Da Silva Castanha, Priscila Mayrelle/0000-0002-1220-5308; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Marques, Ernesto T. A/0000-0003-3826-9358;
   Costa, Federico/0000-0001-6951-2336; Ribeiro,
   Guilherme/0000-0002-6798-2059; Coelho, Danilo
   Fernandes/0000-0002-1111-0825; Nogueira, Mauricio L/0000-0003-1102-2419;
   Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; CRUZ, JAQUELINE/0000-0003-4128-1008; Hagan,
   Jose/0000-0002-1837-6319; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602
FU Yale School of Public Health; Oswaldo Cruz Foundation, Brazilian
   Ministry of Health; Brazilian National Council for Scientific and
   Technological DevelopmentNational Council for Scientific and
   Technological Development (CNPq) [400830/2013-2, 440891/2016-7];
   Brazilian National Council for Scientific and Technological Development
   (INCT-Dengue); Coordination for the Improvement of Higher Education
   Personnel, Brazilian Ministry of Education [440891/2016-7]; Research
   Support Foundation for the State of Bahia [FAPESB PET0026/2013,
   APP0044/2016, 10206/2015, PET0022/2016]; Research Support Foundation for
   the State of Sao Paulo [FAPESP 2013/21719-3, 2016/15021-1]; CuraZika
   Foundation; Wellcome TrustWellcome Trust [102330/Z/13/Z]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01 AI121207, R01 TW009504, R01 AI052473, U01
   AI088752, R25 TW009338, R01 NS064905, R24 AI120942, U01 AI115577, R01
   AI099631, U54 AI065359, P01 AI106695, U19 AI118610, U54 GM088491, R01
   AI114703]; McLaughlin Fellowship Fund; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R25TW009338, R01TW009504, R25TW009338] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P01AI106695, U19AI118610, P01AI106695, U19AI118610, U19AI118610,
   R24AI120942, U19AI118610, U19AI118610, U19AI118610, R01AI099631,
   P01AI106695, U01AI115577, P01AI106695, U19AI118610, R01AI121207,
   U19AI118610, R01AI099631, R01AI121207, P01AI106695, U19AI118610,
   U19AI118610, U19AI118610, U19AI118610, P01AI106695, U01AI115577,
   U19AI118610, P01AI106695, P01AI106695, U19AI118610, U19AI118610,
   U19AI118610, U19AI118610, U19AI118610, U19AI118610, P01AI106695,
   U19AI118610, R01AI099631, U19AI118610, R24AI120942, U19AI118610,
   P01AI106695, P01AI106695, R24AI120942, P01AI106695, U19AI118610,
   P01AI106695, P01AI106695, R24AI120942, U19AI118610, U19AI118610,
   R01AI114703, P01AI106695, U19AI118610, U19AI118610, U19AI118610,
   U19AI118610, P01AI106695, P01AI106695, U19AI118610, P01AI106695,
   U19AI118610, R01AI099631, P01AI106695, U19AI118610, U19AI118610,
   R01AI114703, R01AI121207, U19AI118610, P01AI106695, U19AI118610,
   P01AI106695, U19AI118610, U19AI118610, U19AI118610, P01AI106695,
   R01AI099631, U19AI118610, P01AI106695, P01AI106695, P01AI106695,
   U19AI118610, P01AI106695, P01AI106695, U19AI118610, U19AI118610,
   P01AI106695, P01AI106695, U19AI118610, P01AI106695, U19AI118610,
   U19AI118610, U19AI118610, U19AI118610, U19AI118610, U19AI118610,
   U19AI118610, R01AI099631, R01AI114703, P01AI106695] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491,
   U54GM088491, U54GM088491, U54GM088491, U54GM088491, U54GM088491] Funding
   Source: NIH RePORTER
FX Supported by grants from the Yale School of Public Health; Oswaldo Cruz
   Foundation, Brazilian Ministry of Health; Brazilian National Council for
   Scientific and Technological Development (400830/2013-2, 440891/2016-7,
   and INCT-Dengue); Coordination for the Improvement of Higher Education
   Personnel, Brazilian Ministry of Education [440891/2016-7, National
   Postdoctoral Program (PNPD)]; Research Support Foundation for the State
   of Bahia (FAPESB PET0026/2013, APP0044/2016, 10206/2015, and
   PET0022/2016); Research Support Foundation for the State of Sao Paulo
   (FAPESP 2013/21719-3 and 2016/15021-1); CuraZika Foundation
   (curazika.pitt.edu); Wellcome Trust (102330/Z/13/Z); and NIH grants R01
   AI121207, R01 TW009504, R01 AI052473, U01 AI088752, R25 TW009338, R01
   NS064905, R24 AI120942, U01 AI115577, R01 AI099631, U54 AI065359, P01
   AI106695, U19 AI118610, R01 AI114703, and U54 GM088491. S.R.A. was
   funded in part by the McLaughlin Fellowship Fund.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   ANDERSON R M, 1991
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Brazilian Institute of Geography and Statistics, EST POP 2017 CIT BAH
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Narvaez F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001397
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   R Core Team, 2016, R LANG ENV STAT COMP
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Salvador Secretary of Health, 2018, SIT EP DENG CHIK ZIK
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
NR 43
TC 78
Z9 77
U1 1
U2 16
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD FEB 8
PY 2019
VL 363
IS 6427
BP 607
EP +
DI 10.1126/science.aav6618
PG 36
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA HK6SM
UT WOS:000458114200043
PM 30733412
OA Bronze
DA 2020-11-30
ER

PT J
AU Minter, A
   Himsworth, CG
   Byers, KA
   Childs, JE
   Ko, AI
   Costa, F
AF Minter, Amanda
   Himsworth, Chelsea G.
   Byers, Kaylee A.
   Childs, Jamie E.
   Ko, Albert I.
   Costa, Federico
TI Tails of Two Cities: Age and Wounding Are Associated With Carriage of
   Leptospira interrogans by Norway Rats (Rattus norvegicus) in
   Ecologically Distinct Urban Environments
SO FRONTIERS IN ECOLOGY AND EVOLUTION
LA English
DT Article
DE age-prevalence; bite wound; intraspecific transmission leptospira;
   leptospirosis; Norway rat (Rattus norvegicus); urban ecology
ID INNER-CITY NEIGHBORHOOD; BARTONELLA SPP.; TRANSMISSION; PATHOGENS;
   VANCOUVER; EXPOSURE; PREVALENCE; INFECTION; PATHOLOGY; DYNAMICS
AB Leptospirosis is a zoonotic disease for which rats are the primary reservoir in urban environments. It is transmitted from rats to people via urine, and is responsible for significant human morbidity and mortality in under-resourced settings. To mitigate the risks posed to people, it is important to understand the ecology of the causative agent Leptospira interrogans. The overarching objective of this study was to compare L. interrogans carriage in urban Norway rats in two ecologically distinct urban environments. We trapped Norway rats (Rattus norvegicus) in Vancouver, Canada (N = 525) and Salvador, Brazil (N = 433) to evaluate whether rat characteristics (i.e., sex, weight, sexual maturity, pregnancy, and the presence of wounds) and location of capture were associated with L. interrogans status. Using generalized linear mixed models to control for clustering by trapping location, we found a greater prevalence of L. interrogans in Salvador (79%) than in Vancouver (12%), and greater spatial heterogeneity in pathogen prevalence in Vancouver than in Salvador. In both locations, we found that older rats and rats with more bite wounds had greater odds of L. interrogans carriage, although wounding influenced pathogen status more for younger animals. Additionally, we found that juvenile rats in Salvador were more likely to leave the nest infected with L. interrogans than were rats in Vancouver, suggesting that potential differences in early-life transmission dynamics exist between the two locations. Together, these results elucidate both general L. interrogans ecology, as well as the importance of geographical location in determining transmission among rats.
C1 [Minter, Amanda] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Himsworth, Chelsea G.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.
   [Himsworth, Chelsea G.] British Columbia Minist Agr, Anim Hlth Ctr, Abbotsford, BC, Canada.
   [Himsworth, Chelsea G.; Byers, Kaylee A.] Anim Hlth Ctr, Canadian Wildlife Hlth Cooperat, Abbotsford, BC, Canada.
   [Byers, Kaylee A.] Univ British Columbia, Dept Interdisciplinary Studies, Vancouver, BC, Canada.
   [Byers, Kaylee A.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC, Canada.
   [Childs, Jamie E.; Ko, Albert I.] Yale Univ, Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert I.; Costa, Federico] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
RP Himsworth, CG (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Himsworth, CG (corresponding author), British Columbia Minist Agr, Anim Hlth Ctr, Abbotsford, BC, Canada.; Himsworth, CG (corresponding author), Anim Hlth Ctr, Canadian Wildlife Hlth Cooperat, Abbotsford, BC, Canada.
EM chelsea.himsworth@gov.bc.ca
RI Costa, Federico/G-1838-2015; Ko, Albert Icksang/P-2343-2015
OI Costa, Federico/0000-0001-6951-2336; Ko, Albert
   Icksang/0000-0001-9023-2339; , Amanda/0000-0003-1171-5688
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR) [MOP-119530, CGV-104833]; Oswaldo Cruz Foundation;
   Secretariat of Health Surveillance; Brazilian Ministry of Health;
   Wellcome TrustWellcome Trust [102330/Z/13/Z]; NSF-NIHNational Science
   Foundation (NSF)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5 R01 AI052473, 5 U01
   AI088752, 1 R25 TW009338, 1 R01 AI121207, F31 AI114245, R01 AI052473,
   U01 AI088752, R01 TW009504, R25 TW009338]; Ecology and Evolution of
   Infection Diseases (EEID) [1 R01 TW009504]; Research and Policy for
   Infectious Disease Dynamics (RAPIDD) program of the Science and
   Technology Directorate (US Department of Homeland Security)
FX This study was supported by the Canadian Institutes of Health Research
   (MOP-119530 and CGV-104833); Oswaldo Cruz Foundation; Secretariat of
   Health Surveillance; Brazilian Ministry of Health; Wellcome Trust,
   Grant/Award Number: 102330/Z/13/Z; NSF-NIH, Grant/Award Number: 5 R01
   AI052473, 5 U01 AI088752, 1 R25 TW009338, 1 R01 AI121207, F31 AI114245,
   R01 AI052473, U01 AI088752, R01 TW009504, and R25 TW009338; Ecology and
   Evolution of Infection Diseases (EEID), Grant/Award Number: 1 R01
   TW009504; and by the Research and Policy for Infectious Disease Dynamics
   (RAPIDD) program of the Science and Technology Directorate (US
   Department of Homeland Security).
CR Aviat F, 2009, COMP IMMUNOL MICROB, V32, P463, DOI 10.1016/j.cimid.2008.05.004
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148
   Burthe SJ, 2010, OECOLOGIA, V162, P653, DOI 10.1007/s00442-009-1495-6
   Calhoun J.B., 1963, ECOLOGY SOCIOLOGY NO
   Casanovas-Massana A, 2018, WATER RES, V130, P176, DOI 10.1016/j.watres.2017.11.068
   Combs M, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0245
   Costa F, 2017, TRENDS PARASITOL, V33, P660, DOI 10.1016/j.pt.2017.05.010
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   De Oliveira D, 2016, EPIDEMIOL INFECT, V144, P2420, DOI 10.1017/S0950268816000637
   Donovan CM, 2018, J WILDLIFE DIS, V54, P635, DOI 10.7589/2017-08-194
   Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746
   Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x
   Himsworth CG, 2015, J WILDLIFE DIS, V51, P589, DOI 10.7589/2014-09-242
   Himsworth CG, 2015, VECTOR-BORNE ZOONOT, V15, P21, DOI 10.1089/vbz.2014.1657
   Himsworth CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091654
   Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270
   Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195
   Jensen PM, 2016, INFECT DIS-NOR, V48, P156, DOI 10.3109/23744235.2015.1092579
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Koizumi N, 2009, J MED MICROBIOL, V58, P1227, DOI 10.1099/jmm.0.011528-0
   Krojgaard LH, 2009, EPIDEMIOL INFECT, V137, P1586, DOI 10.1017/S0950268809002647
   Lee MJ, 2018, EMERG INFECT DIS, V24, P356, DOI 10.3201/eid2402.171371
   Maas Miriam, 2018, Infection Ecology & Epidemiology, V8, P1490135, DOI 10.1080/20008686.2018.1490135
   McVea DA, 2018, VECTOR-BORNE ZOONOT, V18, P82, DOI 10.1089/vbz.2017.2179
   Minter A, 2017, EPIDEMIOL INFECT, V145, P3438, DOI 10.1017/S0950268817002539
   Puckett EE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1762
   R Core Team, 2018, R LANG ENV STAT COMP
   Richardson JL, 2017, EVOL APPL, V10, P323, DOI 10.1111/eva.12449
   Rothenburger JL, 2015, VET PATHOL, V52, P1210, DOI 10.1177/0300985815593123
   Rothenburger JL, 2015, VET PATHOL, V52, P201, DOI 10.1177/0300985814528220
   Santos ND, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/01021-311x00132115, 10.1590/01021-311X00132115, 10.1590/0102-311X00132115]
   Scialfa E, 2010, REV ARGENT MICROBIOL, V42, P126, DOI 10.1590/S0325-75412010000200012
   Smith H. A., 2000, WORLDS COLLIDE SOCIA
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   THIERMANN AB, 1977, AM J TROP MED HYG, V26, P970, DOI 10.4269/ajtmh.1977.26.970
   Vanasco NB, 2003, PREV VET MED, V60, P227, DOI 10.1016/S0167-5877(03)00144-2
NR 43
TC 7
Z9 7
U1 2
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-701X
J9 FRONT ECOL EVOL
JI Front. Ecol. Evol.
PD JAN 30
PY 2019
VL 7
AR 14
DI 10.3389/fevo.2019.00014
PG 8
WC Ecology
SC Environmental Sciences & Ecology
GA HX4NK
UT WOS:000467375200002
OA DOAJ Gold, Green Accepted
DA 2020-11-30
ER

PT J
AU Lindow, JC
   Tsay, AJ
   Montgomery, RR
   Reis, EAG
   Wunder, EA
   Araujo, G
   Nery, NRR
   Mohanty, S
   Shaw, AC
   Lee, PJ
   Reis, MG
   Ko, AI
AF Lindow, Janet C.
   Tsay, Annie J.
   Montgomery, Ruth R.
   Reis, Eliana A. G.
   Wunder, Elsio A., Jr.
   Araujo, Guilherme
   Nery, Nivison R. R., Jr.
   Mohanty, Subhasis
   Shaw, Albert C.
   Lee, Patty J.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Elevated Activation of Neutrophil Toll-Like Receptors in Patients with
   Acute Severe Leptospirosis: An Observational Study
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID LIPOPOLYSACCHARIDE; INNATE
AB Leptospirosis is the leading cause of zoonotic morbidity and mortality globally, yet little is known about the immune mechanisms that may contribute to pathogenesis and severe disease. Although neutrophils are a key component of early immune responses to infection, they have been associated with tissue damage and inflammation in some febrile infections. To assess whether neutrophils contribute to the pathogenesis observed in severe leptospirosis, we quantitated levels of neutrophil activation markers in patients with varying disease severities. Hospitalized leptospirosis patients had significantly higher levels of toll-like receptors 2 and 4 (TLR2 and TLR4, respectively) on peripheral neutrophils than healthy controls, with the highest levels detected in patients with organ dysfunction. We observed no significant differences in other neutrophil baseline activation markers (CD62L and CD11b) or activation capacity (CD62L and CD11b levels following stimulation), regardless of disease severity. Our results provide preliminary evidence supporting the hypothesis that higher initial bacterial loads or inadequate or delayed neutrophil responses, rather than TLR-driven inflammation, may drive severe disease outcomes.
C1 [Lindow, Janet C.; Tsay, Annie J.; Wunder, Elsio A., Jr.; Reis, Mitermayer G.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Lindow, Janet C.; Reis, Eliana A. G.; Wunder, Elsio A., Jr.; Araujo, Guilherme; Nery, Nivison R. R., Jr.; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz, Brazilian Minist Hlth, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Montgomery, Ruth R.] Yale Sch Med, Rheumatol Sect, Dept Internal Med, New Haven, CT USA.
   [Mohanty, Subhasis; Shaw, Albert C.] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT USA.
   [Lee, Patty J.] Yale Sch Med, Sect Pulm Crit Care & Sleep Med, Dept Internal Med, New Haven, CT USA.
   [Reis, Mitermayer G.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Lindow, Janet C.] Biomed Res & Educ Fdn Southern Arizona, 3601 S 6th Ave Bldg 77,MC 0-151, Tucson, AZ 85723 USA.
   [Lindow, Janet C.] Univ Arizona, Dept Psychiat, Tucson, AZ USA.
   [Lindow, Janet C.] Southern Arizona Virginia Hlth Care Syst, Tucson, AZ USA.
   [Araujo, Guilherme] Univ Privada Este, Ciudad Del Este, Paraguay.
   [Lee, Patty J.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care, Durham, NC USA.
   [Reis, Mitermayer G.] Univ Fed Bahia, Fac Med Bahia, Praca Conselheiro Almeida Couto, Salvador, BA, Brazil.
RP Lindow, JC (corresponding author), Biomed Res & Educ Fdn Southern Arizona, 3601 S 6th Ave Bldg 77,MC 0-151, Tucson, AZ 85723 USA.
EM jlindow@alum.mit.edu; tsayorama@gmail.com; ruth.montgomery@yale.edu;
   eagreis@gmail.com; elsio.wunder@yale.edu; guyaraujo@gmail.com;
   nivison@conveniado.bahia.fiocruz.br; subhasis.mohanty@yale.edu;
   albert.shaw@yale.edu; patty.lee@duke.edu; miter@bahia.fiocruz.br;
   albert.ko@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013; Reis,
   Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Reis, Mitermayer/0000-0002-3051-9060;
   Lindow, Janet/0000-0003-3235-3698; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602; Montgomery, Ruth/0000-0002-8661-4454
FU National Institute of Allergy and Infectious Diseases at the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U01AI088752, AI 089992, AG
   042489]; American Society for Tropical Medicine and Hygiene Gorgas
   Memorial Institute Research Award; Fogarty International Center, Global
   Health Equity Scholars Fellowship [R25 TW009338]; Fundacao Oswaldo
   Cruz/Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-Ciencia Sem Fronteiras Bolsa Jovens Talentos; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, R25TW009338]
   Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI089992, U19AI089992, U19AI089992,
   U19AI089992, U19AI089992, U19AI089992, U19AI089992, U19AI089992,
   U19AI089992, U19AI089992, U19AI089992, U19AI089992, U19AI089992,
   U19AI089992, U19AI089992, U19AI089992, R01AI121207, U19AI089992,
   U19AI089992, U19AI089992, U19AI089992, R01AI121207, U19AI089992,
   U19AI089992, U19AI089992] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE ON AGINGUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) [K24AG042489] Funding Source: NIH RePORTER
FX We would like to thank the patients and families for their
   participation, the medical workers at the Hospital Couto Maia, the Flow
   Cytometry Platform at Fiocruz-Bahia, and the entire Leptospirosis Team
   at Fiocruz-Bahia for their continuous support and collaboration. This
   work was supported by funding from the National Institute of Allergy and
   Infectious Diseases at the National Institutes of Health [grant number
   U01AI088752 to A. I. K.; AI 089992 to R. R. M. and A. C. S.; and AG
   042489 to A. C. S.]; an American Society for Tropical Medicine and
   Hygiene Gorgas Memorial Institute Research Award to J. C. L.; a Fogarty
   International Center, Global Health Equity Scholars Fellowship [grant
   number R25 TW009338 to J. C. L.]; and a Fundacao Oswaldo Cruz/Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico-Ciencia Sem
   Fronteiras Bolsa Jovens Talentos to J. C. L.
CR AREAN VM, 1962, AM J PATHOL, V40, P393
   Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506
   Chen X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181014
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Craig SB, 2013, TROP BIOMED, V30, P579
   Craig SB, 2009, ANN TROP MED PARASIT, V103, P333, DOI 10.1179/136485909X435058
   De Silva Nipun Lakshitha, 2014, Int Arch Med, V7, P31, DOI 10.1186/1755-7682-7-31
   Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034
   Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Guo Y, 2015, ANIM SCI J, V86, P238, DOI 10.1111/asj.12254
   Guo YJ, 2015, ASIAN AUSTRAL J ANIM, V28, P273, DOI 10.5713/ajas.14.0440
   Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Lindo A, 2013, J CLIN CELL IMMUNO S, V13, DOI DOI 10.4172/2155-9899.S13-003
   Lindow JC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005943
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Murgia R, 2002, INFECT IMMUN, V70, P7172, DOI 10.1128/IAI.70.12.7172-7175.2002
   Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022
   Pillai PS, 2016, SCIENCE, V352, P463, DOI 10.1126/science.aaf3926
   Qian F, 2014, AGING-US, V6, P131, DOI 10.18632/aging.100642
   Raffray L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165716
   Reis EAG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002457
   Scharrig E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003927
   SITPRIJA V, 1970, American Journal of Medicine, V49, P780, DOI 10.1016/S0002-9343(70)80059-6
   Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Vieira Silvia R R, 2002, Braz J Infect Dis, V6, P135, DOI 10.1590/S1413-86702002000300006
   Viriyakosol S, 2006, INFECT IMMUN, V74, P887, DOI 10.1128/IAI.74.2.887-895.2006
   WANG B, 1984, INFECT IMMUN, V44, P459, DOI 10.1128/IAI.44.2.459-464.1984
   Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354
   Zhang WL, 2016, INFECT IMMUN, V84, P3350, DOI 10.1128/IAI.00708-16
   Zuerner RL, 2015, CURR TOP MICROBIOL, V387, P223, DOI 10.1007/978-3-662-45059-8_9
NR 33
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 101
IS 3
BP 585
EP 589
DI 10.4269/ajtmh.19-0160
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JB4IJ
UT WOS:000488518900022
PM 31333152
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU Lescano, AG
   Cohen, CR
   Raj, T
   Rispel, L
   Garcia, PJ
   Zunt, JR
   Hamer, DH
   Heimburger, DC
   Chi, BH
   Ko, AI
   Bukusi, EA
AF Lescano, Andres G.
   Cohen, Craig R.
   Raj, Tony
   Rispel, Laetitia
   Garcia, Patricia J.
   Zunt, Joseph R.
   Hamer, Davidson H.
   Heimburger, Douglas C.
   Chi, Benjamin H.
   Ko, Albert I.
   Bukusi, Elizabeth A.
TI Strengthening Mentoring in Low- and Middle-Income Countries to Advance
   Global Health Research: An Overview
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID ACADEMIC-MEDICINE; PROGRAMS; INSTITUTIONS; MENTORSHIP; UNIVERSITY
AB Mentoring is a proven path to scientific progress, but it is not a common practice in low-and middle-income countries (LMICs). Existing mentoring approaches and guidelines are geared toward high-income country settings, without considering in detail the differences in resources, culture, and structure of research systems of LMICs. To address this gap, we conducted five Mentoring-the-Mentor workshops in Africa, South America, and Asia, which aimed at strengthening the capacity for evidence-based, LMIC-specific institutional mentoring programs globally. The outcomes of the workshops and two follow-up working meetings are presented in this special edition of the American Journal of Tropical Medicine and Hygiene. Seven articles offer recommendations on how to tailor mentoring to the context and culture of LMICs, and provide guidance on how to implement mentoring programs. This introductory article provides both a prelude and executive summary to the seven articles, describing the motivation, cultural context and relevant background, and presenting key findings, conclusions, and recommendations.
C1 [Lescano, Andres G.] Univ Peruana Cayetano Heredia, Emerge Emerging Dis & Climate Change Res Unit, Sch Publ Hlth & Adm, Lima, Peru.
   [Cohen, Craig R.] Univ Calif San Francisco, Global Hlth Inst, Dept Global Hlth, San Francisco, CA 94143 USA.
   [Raj, Tony] St Johns Res Inst, Bangalore, Karnataka, India.
   [Rispel, Laetitia] Univ Witwatersrand, Ctr Hlth Policy, Sch Publ Hlth, Johannesburg, South Africa.
   [Rispel, Laetitia] Univ Witwatersrand, Res Chair, Sch Publ Hlth, Johannesburg, South Africa.
   [Rispel, Laetitia] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.
   [Garcia, Patricia J.] Univ Peruana Cayetano Heredia, Epidemiol Sexually Transmitted Infect & Human Imm, Sch Publ Hlth & Adm, Lima, Peru.
   [Zunt, Joseph R.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA.
   [Zunt, Joseph R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Zunt, Joseph R.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Zunt, Joseph R.] Univ Washington, Dept Med Infect Dis, Seattle, WA 98195 USA.
   [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA.
   [Heimburger, Douglas C.] Vanderbilt Inst Global Hlth, Nashville, TN USA.
   [Chi, Benjamin H.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Res Care Training Program, Ctr Microbiol Res, Nairobi, Kenya.
   [Lescano, Andres G.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru.
   [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA.
   [Rispel, Laetitia] Univ Witwatersrand, DST NRF Res Chair, Sch Publ Hlth, Johannesburg, South Africa.
   [Garcia, Patricia J.] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Lima, Peru.
   [Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Ctr Int Hlth & Dev, Dept Int Hlth, Boston, MA USA.
   [Heimburger, Douglas C.] Vanderbilt Univ, Inst Global Hlth, 221 Kirkland Hall, Nashville, TN 37235 USA.
RP Lescano, AG (corresponding author), Univ Peruana Cayetano Heredia, Emerging Dis & Climate Change Res Unit, Sch Publ Hlth & Adm, Lima, Peru.
EM andres.lescano.g@upch.pe; craig.cohen@ucsf.edu; tonyraj@sjri.res.in;
   laetitia.rispel@wits.ac.za; patricia.garcia@upch.pe;
   jzunt@u.washington.edu; dhamer@bu.edu;
   douglas.heimburger@vanderbilt.edu; benjamin_chi@med.unc.edu;
   albert.ko@yale.edu; ebukusi@kemri.org
RI Hamer, Davidson/J-2020-2019; Ko, Albert Icksang/P-2343-2015
OI Hamer, Davidson/0000-0002-4700-1495; Ko, Albert
   Icksang/0000-0001-9023-2339
FU FIC Global Health Program for Fellows and Scholar consortia; University
   of California GloCal Health Fellowship [FIC D43TW009343];
   Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows
   [D43TW009337]; UNC-Johns Hopkins-Morehouse-Tulane Fogarty Global Health
   Fellowship Program [D43TW009340]; Northern Pacific Global Health
   Research Fellows Consortium [D43TW009345]; Harvard-Boston
   University-Northwestern University-University of New Mexico Fogarty
   Global Health Training Program [D43TW010543]; Yale-Berkeley-FIU-Stanford
   Global Health Equity Scholars Program [D43TW010540]; Fogarty
   International Center of the U.S. National Institutes of Health (NIH/FIC)
   [D43 TW007393]; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [K24 AI120796]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW010540, D43TW009337, D43TW009340, D43TW009343, D43TW009345,
   D43TW009343, D43TW010540, D43TW009343, D43TW009343, D43TW009343,
   D43TW009345, D43TW009337, D43TW010540, D43TW009340, D43TW009340,
   D43TW009345, D43TW010540, D43TW010543, D43TW009337, D43TW010543,
   D43TW009345, D43TW010540, D43TW009345, D43TW010543, D43TW009337,
   D43TW009340, D43TW009337, D43TW009337, D43TW009337, D43TW009345,
   D43TW010540, D43TW009340, D43TW009337, D43TW009340, D43TW010540,
   D43TW009337, D43TW007393, D43TW009345, D43TW010540, D43TW010543,
   D43TW009340, D43TW009337, D43TW010540, D43TW009345, D43TW009337,
   D43TW009337, D43TW009345, D43TW009345, D43TW010543, D43TW009340,
   D43TW007393, D43TW010543, D43TW009340, D43TW009337, D43TW009343,
   D43TW009343, D43TW009340, D43TW009337, D43TW009345, D43TW009343,
   D43TW009345, D43TW009337, D43TW007393, D43TW009343, D43TW010540,
   D43TW010543, D43TW010540, D43TW009337, D43TW009343, D43TW007393,
   D43TW009345, D43TW009343, D43TW009340, D43TW009340, D43TW009343,
   D43TW010540, D43TW009345, D43TW010540, D43TW010543] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [K24AI120796, K24AI120796, K24AI120796] Funding Source:
   NIH RePORTER
FX The authors received support from the FIC Global Health Program for
   Fellows and Scholar consortia, including the University of California
   GloCal Health Fellowship (FIC D43TW009343), the
   Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows
   (D43TW009337), the UNC-Johns Hopkins-Morehouse-Tulane Fogarty Global
   Health Fellowship Program (D43TW009340), the Northern Pacific Global
   Health Research Fellows Consortium (D43TW009345), the Harvard-Boston
   University-Northwestern University-University of New Mexico Fogarty
   Global Health Training Program (D43TW010543), and
   Yale-Berkeley-FIU-Stanford Global Health Equity Scholars Program
   (D43TW010540). A. G. L. is supported by the grant D43 TW007393 "Peru
   Infectious Diseases Epidemiology Research Training Consortium,"
   sponsored by the Fogarty International Center of the U.S. National
   Institutes of Health (NIH/FIC). Investigator support for B. H. C. is
   also provided by the National Institute of Allergy and Infectious
   Diseases (K24 AI120796). We are grateful for the assistance of Ludwing
   Zeta and Martha Bravo for providing multiple references for this
   manuscript.
CR Aikens ML, 2017, CBE-LIFE SCI EDUC, V16, DOI 10.1187/cbe.16-07-0211
   Aveling EL, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0096-x
   Beckett Andrew, 2015, Can J Surg, V58, pS98
   Bennett Sara, 2013, Educ Health (Abingdon), V26, P183, DOI 10.4103/1357-6283.126001
   Bukusi EA, 2019, AM J TROP MED HYG, V100, P42, DOI 10.4269/ajtmh.18-0562
   Chi BH, 2019, AM J TROP MED HYG, V100, P36, DOI 10.4269/ajtmh.18-0561
   Cohen JG, 2012, GYNECOL ONCOL, V125, P8, DOI 10.1016/j.ygyno.2012.01.005
   Cole DC, 2016, GLOB PUBLIC HEALTH, V11, P1093, DOI 10.1080/17441692.2015.1057091
   Detsky AS, 2007, JAMA-J AM MED ASSOC, V297, P2134, DOI 10.1001/jama.297.19.2134
   Eby LT, 2004, J VOCAT BEHAV, V65, P255, DOI 10.1016/j.jvb.2003.07.001
   Gray J, 2003, CLIN INVEST MED, V26, P315
   HALSTEAD SB, 1991, J CLIN EPIDEMIOL, V44, P579, DOI 10.1016/0895-4356(91)90222-U
   Hamer DH, 2019, AM J TROP MED HYG, V100, P15, DOI 10.4269/ajtmh.18-0558
   Hansoti B, 2019, AM J TROP MED HYG, V100, P48, DOI 10.4269/ajtmh.18-0563
   Hurwitz M, 2018, GRADE INFLATION ROLE
   Kashiwagi DT, 2013, ACAD MED, V88, P1029, DOI 10.1097/ACM.0b013e318294f368
   Lee S, 2015, MENTORING CONTINUUM
   Marjanovic S, 2017, EVALUATION-US, V23, P80, DOI 10.1177/1356389016682759
   Nakanjako D, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-9
   Noormahomed E, 2019, AM J TROP MED HYG, V100, P29, DOI 10.4269/ajtmh.18-0560
   Nowell L, 2017, J PROF NURS, V33, P334, DOI 10.1016/j.profnurs.2017.02.007
   Nundulall R, 2012, IND HIGHER EDUC, V26, P127, DOI 10.5367/ihe.2012.0087
   Okereke CD, 2000, J ACCID EMERG MED, V17, P133
   Oluchina S, 2016, AM J HLTH RES, V4, P23
   Omaswa F, 2017, LANCET GLOB HEALTH, V5, pE965, DOI 10.1016/S2214-109X(17)30329-7
   Prasad S, 2019, AM J TROP MED HYG, V100, P9, DOI 10.4269/ajtmh.18-0557
   Raghavendran K, 2017, JAMA SURG, V152, P123, DOI 10.1001/jamasurg.2016.3107
   Schwerdtle P, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0301-1
   Ssemata AS, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-0962-8
   Vieira BP, 2017, IBIS, V159, P443, DOI 10.1111/ibi.12445
   Warner N, IEASA C 2002
   Zunt JR, 2016, AM J TROP MED HYG, V95, P728, DOI 10.4269/ajtmh.16-0190
NR 32
TC 8
Z9 8
U1 1
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
SU 1
BP 3
EP 8
DI 10.4269/ajtmh.18-0556
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HK3ZY
UT WOS:000457860000002
PM 30430982
OA Green Published, Other Gold
DA 2020-11-30
ER

PT J
AU Mabud, TS
   Alves, MDD
   Ko, AI
   Basu, S
   Walter, KS
   Cohen, T
   Mathema, B
   Colijn, C
   Lemos, E
   Croda, J
   Andrews, JR
AF Mabud, Tarub S.
   Delgado Alves, Maria de Lourdes
   Ko, Albert I.
   Basu, Sanjay
   Walter, Katharine S.
   Cohen, Ted
   Mathema, Barun
   Colijn, Caroline
   Lemos, Everton
   Croda, Julio
   Andrews, Jason R.
TI Evaluating strategies for control of tuberculosis in prisons and
   prevention of spillover into communities: An observational and modeling
   study from Brazil
SO PLOS MEDICINE
LA English
DT Article
ID LATENT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; RISK; TB;
   POPULATION; INFECTION; OUTBREAK; DISEASE; STRAIN
AB Background
   It has been hypothesized that prisons serve as amplifiers of general tuberculosis (TB) epidemics, but there is a paucity of data on this phenomenon and the potential population-level effects of prison-focused interventions. This study (1) quantifies the TB risk for prisoners as they traverse incarceration and release, (2) mathematically models the impact of prisonbased interventions on TB burden in the general population, and (3) generalizes this model to a wide range of epidemiological contexts.
   Methods and findings
   We obtained individual-level incarceration data for all inmates (n = 42,925) and all reported TB cases (n = 5,643) in the Brazilian state of Mato Grosso do Sul from 2007 through 2013. We matched individuals between prisoner and TB databases and estimated the incidence of TB from the time of incarceration and the time of prison release using Cox proportional hazards models. We identified 130 new TB cases diagnosed during incarceration and 170 among individuals released from prison. During imprisonment, TB rates increased from 111 cases per 100,000 person-years at entry to a maximum of 1,303 per 100,000 person-years at 5.2 years. At release, TB incidence was 229 per 100,000 person-years, which declined to 42 per 100,000 person-years (the average TB incidence in Brazil) after 7 years. We used these data to populate a compartmental model of TB transmission and incarceration to evaluate the effects of various prison-based interventions on the incidence of TB among prisoners and the general population. Annual mass TB screening within Brazilian prisons would reduce TB incidence in prisons by 47.4% (95% Bayesian credible interval [BCI], 44.4%-52.5%) and in the general population by 19.4% (95% BCI 17.9%-24.2%). A generalized model demonstrates that prison-based interventions would have maximum effectiveness in reducing community incidence in populations with a high concentration of TB in prisons and greater degrees of mixing between ex-prisoners and community members. Study limitations include our focus on a single Brazilian state and our retrospective use of administrative databases.
   Conclusions
   Our findings suggest that the prison environment, more so than the prison population itself, drives TB incidence, and targeted interventions within prisons could have a substantial effect on the broader TB epidemic.
C1 [Mabud, Tarub S.; Basu, Sanjay; Walter, Katharine S.; Andrews, Jason R.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.
   [Delgado Alves, Maria de Lourdes] Agencia Estadual Adm Sist Penitenciario, Campo Grande, Brazil.
   [Ko, Albert I.; Cohen, Ted] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Mathema, Barun] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA.
   [Colijn, Caroline] Imperial Coll London, Dept Math, London, England.
   [Colijn, Caroline] Simon Fraser Univ, Dept Math, Burnaby, BC, Canada.
   [Lemos, Everton; Croda, Julio] Univ Fed Mato Grosso do Sul, Sch Med, Campo Grande, Brazil.
   [Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, Brazil.
RP Andrews, JR (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.
EM jandr@stanford.edu
RI Ko, Albert Icksang/P-2343-2015; Lemos, Everton EFL Ferreira/J-5831-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Lemos, Everton EFL
   Ferreira/0000-0001-6652-9191; Mabud, Tarub/0000-0002-0192-2395; Colijn,
   Caroline/0000-0001-6097-6708; Cohen, Ted/0000-0002-8091-7198
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI30058, DP2
   MD010478, U54 MD010724, R25 TW009338, D43 TW010540]; Engineering and
   Physical Sciences Research CouncilEngineering & Physical Sciences
   Research Council (EPSRC) [EP/K026003/1, EP/N014529/1]; Stanford Medical
   Scholars Program; Infectious Disease Society of America Medical Scholars
   Program; FOGARTY INTERNATIONAL CENTERUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW010540, R25TW009338, D43TW010540,
   D43TW010540, R25TW009338, D43TW010540, D43TW010540, D43TW010540,
   R25TW009338, D43TW010540, D43TW010540, R25TW009338, D43TW010540,
   D43TW010540, D43TW010540, D43TW010540, D43TW010540, D43TW010540,
   D43TW010540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI130058, R01AI130058,
   R01AI130058, R01AI130058] Funding Source: NIH RePORTER; National
   Institute on Minority Health and Health DisparitiesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Minority Health & Health Disparities
   (NIMHD) [U54MD010724, U54MD010724, U54MD010724, U54MD010724,
   U54MD010724, U54MD010724, U54MD010724, U54MD010724, U54MD010724,
   U54MD010724, U54MD010724, U54MD010724, U54MD010724, U54MD010724,
   U54MD010724, U54MD010724, U54MD010724, U54MD010724, U54MD010724,
   U54MD010724, U54MD010724, U54MD010724, U54MD010724, U54MD010724,
   U54MD010724, U54MD010724, U54MD010724, U54MD010724, U54MD010724,
   U54MD010724, U54MD010724, U54MD010724, U54MD010724, U54MD010724,
   U54MD010724, U54MD010724, U54MD010724, U54MD010724] Funding Source: NIH
   RePORTER
FX This work was supported by the National Institutes of Health
   (https://www.nih.gov/) (grant #R01 AI30058 [JRA]; #DP2 MD010478 [JRA,
   SB]; #U54 MD010724 [SB]; #R25 TW009338 [Al K]; #D43 TW010540 [AIK]), the
   Engineering and Physical Sciences Research Council
   (https://epsrc.ukri.org/) (grant #EP/K026003/1 [CC]; #EP/N014529/1
   [CC]), the Stanford Medical Scholars Program
   (http://med.stanford.edu/medscholars.html) (TSM), and the Infectious
   Disease Society of America Medical Scholars Program
   (http://www.idsociety.org/Medical_Scholars_Program/) (TSM). The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951
   Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001540
   Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381
   Behr MA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2738
   Bishara H, 2014, INT J TUBERC LUNG D, V18, P1502, DOI 10.5588/ijtld.14.0429
   BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Bourdillon PM, 2017, EMERG INFECT DIS, V23, P496, DOI 10.3201/eid2303.161006
   Bur S, 2003, INT J TUBERC LUNG D, V7, pS417
   Coyle A., 2016, IMPRISONMENT WORLDWI
   Dara M, 2015, INT J INFECT DIS, V32, P111, DOI 10.1016/j.ijid.2014.12.029
   Sgarbi RVE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139487
   Estevan AO, 2013, REV SOC BRAS MED TRO, V46, P515, DOI 10.1590/0037-8682-1441-2013
   Glynn JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132840
   Paiao DSG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1868-5
   Gutierrez MC, 1998, J CLIN MICROBIOL, V36, P486
   Hess K, 2015, MUHAZ HAZARD FUNCTIO
   Jones TF, 2003, SOUTH MED J, V96, P155, DOI 10.1097/01.SMJ.0000053678.62096.6F
   Kimerling ME, 2003, INT J TUBERC LUNG D, V7, P866
   Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3
   Maceda EB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19589-3
   Medecins Sans Frontieres, 2018, MED SANS FRONTIERES
   Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403
   Lemos ACM, 2009, J BRAS PNEUMOL, V35, P63, DOI 10.1590/S1806-37132009000100009
   Pacheco AG, 2008, AM J EPIDEMIOL, V168, P1326, DOI 10.1093/aje/kwn249
   Fonseca MGP, 2010, CAD SAUDE PUBLICA, V26, P1431, DOI 10.1590/S0102-311X2010000700022
   R Core Team, 2014, R LANG ENV STAT COMP
   Sacchi FPC, 2015, EMERG INFECT DIS, V21, P452, DOI 10.3201/eid2103.140896
   Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0
   Carbone ADS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0764-8
   Sekandi JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117009
   Shah NS, 2017, NEW ENGL J MED, V376, P243, DOI 10.1056/NEJMoa1604544
   Shea KM, 2014, AM J EPIDEMIOL, V179, P216, DOI 10.1093/aje/kwt246
   STEAD WW, 1978, JAMA-J AM MED ASSOC, V240, P2544, DOI 10.1001/jama.240.23.2544
   Stuckler D, 2008, P NATL ACAD SCI USA, V105, P13280, DOI 10.1073/pnas.0801200105
   SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5
   Therneau T., 2009, SURVIVAL SURVIVAL AN
   Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0
   Verborgh R., 2013, USING OPENREFINE
   WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1
   2012, GLOB TUB REP 2012, P1
NR 41
TC 5
Z9 5
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD JAN
PY 2019
VL 16
IS 1
AR e1002737
DI 10.1371/journal.pmed.1002737
PG 16
WC Medicine, General & Internal
SC General & Internal Medicine
GA HJ7CL
UT WOS:000457349900014
PM 30677013
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Minter, A
   Diggle, PJ
   Costa, F
   Childs, J
   Ko, AI
   Begon, M
AF Minter, Amanda
   Diggle, Peter J.
   Costa, Federico
   Childs, James
   Ko, Albert, I
   Begon, Mike
TI A model for leptospire dynamics and control in the Norway rat (Rattus
   norvegicus) the reservoir host in urban slum environments
SO EPIDEMICS
LA English
DT Article
DE Leptospirosis; Norway rats; Target reproduction number
ID GENETICS; RISK; INFECTIONS; PATHOGENS; DISEASES; NUMBERS; RODENT
AB Leptospirosis is a zoonosis that humans can contract via contact with animal reservoirs directly or with water contaminated with their urine. The primary reservoir of pathogenic leptospires within urban slum environments is the Norway rat (Rattus norvegicus). Motivated by the annual outbreaks of human leptospirosis in slum urban settings, the within population infection dynamics of the Norway rat were investigated in Pau da Lima, an community in Salvador, Brazil. A mechanistic model of the dynamics of leptospire infection was informed by extensive field and laboratory data was developed and explored analytically. To identify the intraspecific transmission route of most importance, a global sensitivity analysis of the basic reproduction number to its components was performed. In addition, different methods of rodent control were investigated by calculating target reproduction numbers. Our results suggest environmental transmission plays an important role in the maintenance of infection in the rodent population. To control numbers of wild Norway rats, combinations of controls are recommended but environmental control should also be investigated to reduce prevalence of infection in rats.
C1 [Minter, Amanda; Costa, Federico; Begon, Mike] Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 7ZB, Merseyside, England.
   [Diggle, Peter J.] Univ Lancaster, Lancaster Med Sch, CHICAS, Lancaster, England.
   [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Costa, Federico; Ko, Albert, I] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Childs, James; Ko, Albert, I] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Begon, M (corresponding author), Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 7ZB, Merseyside, England.
EM mbegon@liv.ac.uk
RI Ko, Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336; , Amanda/0000-0003-1171-5688; Diggle,
   Peter/0000-0003-3521-5020
FU Oswaldo Cruz Foundation; Secretariat of Health Surveillance, Brazilian
   Ministry of Health; Wellcome TrustWellcome Trust [102330/Z/13/Z];
   NSF-NIH grant from the Ecology and Evolution of Infection Diseases
   (EEID) program [1 R01 TW009504]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [5 R01 AI052473,
   5 U01 AI088752, 1 R25 TW009338, 1 R01 AI121207, F31 AI114245]; Research
   and Policy for Infectious Disease Dynamics (RAPIDD) program of the
   Science and Technology Directorate (US Department of Homeland Security);
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R01TW009504, R25TW009338, R01TW009504, R25TW009338, R25TW009338,
   R25TW009338, R01TW009504, R01TW009504, R01TW009504, R25TW009338] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI052473, R01AI121207, R01AI052473,
   R01AI052473, U01AI088752, U01AI088752, U01AI088752, U01AI088752,
   R01AI052473, U01AI088752, R01AI121207, F31AI114245, U01AI088752,
   R01AI052473, R01AI121207, R01AI121207, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, F31AI114245, R01AI121207,
   R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the Oswaldo Cruz Foundation and Secretariat
   of Health Surveillance, Brazilian Ministry of Health; the Wellcome Trust
   (102330/Z/13/Z); and a NSF-NIH grant from the Ecology and Evolution of
   Infection Diseases (EEID) program (1 R01 TW009504), NIH grants (5 R01
   AI052473, 5 U01 AI088752, 1 R25 TW009338, 1 R01 AI121207, F31 AI114245)
   and by the Research and Policy for Infectious Disease Dynamics (RAPIDD)
   program of the Science and Technology Directorate (US Department of
   Homeland Security).
CR Baca-Carrasco D, 2015, J BIOL SYST, V23, pS55, DOI 10.1142/S0218339015400057
   Bani-Yaghoub M, 2012, J BIOL DYNAM, V6, P923, DOI 10.1080/17513758.2012.693206
   Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   BOLLES RC, 1960, J COMP PHYSIOL PSYCH, V53, P306, DOI 10.1037/h0045421
   COSTA F, 2014, PLOS NEGLECT TROP D, V8
   COSTA F, 2015, PLOS NEGLECT TROP D, V9
   Costa F, 2017, TRENDS PARASITOL, V33, P660, DOI 10.1016/j.pt.2017.05.010
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   DAVIS DE, 1953, Q REV BIOL, V28, P373, DOI 10.1086/399860
   Davis S, 2011, PARASITOLOGY, V138, P516, DOI 10.1017/S0031182010001496
   De Oliveira D, 2016, EPIDEMIOL INFECT, V144, P2420, DOI 10.1017/S0950268816000637
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Ellis WA, 2015, CURR TOP MICROBIOL, V387, P99, DOI 10.1007/978-3-662-45059-8_6
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4
   Glass G.E., 1989, Occasional Papers of the Museum of Natural History University of Kansas, VNo. 130, P1
   Glass GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005794
   GRANT E. C., 1963, BEHAVIOUR, V21, P260, DOI 10.1163/156853963X00194
   Haake DA, 2015, CURR TOP MICROBIOL, V387, P187, DOI 10.1007/978-3-662-45059-8_8
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Hein S, 2015, WILDLIFE RES, V42, P108, DOI 10.1071/WR14165
   Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195
   Holt J, 2006, ACTA TROP, V99, P218, DOI 10.1016/j.actatropica.2006.08.003
   Jansen MJW, 1999, COMPUT PHYS COMMUN, V117, P35, DOI 10.1016/S0010-4655(98)00154-4
   Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455
   Keeling M.J., 2008, MODELING INFECT DIS
   Khan M., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.7873/DATE.2014.232
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kongnuy R, 2012, 2011 BIOMEDICAL ENG, P17, DOI [10.1109/BMEiCon.2012.6172009, DOI 10.1109/BMEICON.2012.6172009]
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522
   Minter A, 2017, EPIDEMIOL INFECT, V145, P3438, DOI 10.1017/S0950268817002539
   Panti-May JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152511
   Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011
   Pimpunchat B., 2013, APPL MATH, V4, P77
   Pongsumpun P., 2008, P 3 INT S BIOM ENG, P411
   Pongsumpun P., 2012, P WORLD ACAD SCI ENG, V6, P242
   Pongsumpun P., 2014, J BASIC APPL SCI RES, V4, P245
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Restif O, 2012, ECOL LETT, V15, P1083, DOI 10.1111/j.1461-0248.2012.01836.x
   Richardson JL, 2017, EVOL APPL, V10, P323, DOI 10.1111/eva.12449
   Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339
   Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018
   Santos ND, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/01021-311x00132115, 10.1590/01021-311X00132115, 10.1590/0102-311X00132115]
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7
   Shilova S. A., 2009, Current Zoology, V55, P81
   Shuai ZS, 2013, J MATH BIOL, V67, P1067, DOI 10.1007/s00285-012-0579-9
   Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6
   Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122
   Triampo W., 2007, INT J BIO MED SCI, V2, p22 
   UN-Habitat, 2007, STATE WORLDS CITIES
   Xiao YN, 2007, THEOR POPUL BIOL, V71, P408, DOI 10.1016/j.tpb.2007.02.003
   Zaman G., 2012, APPL MATH SCI, V6, P1287
NR 57
TC 4
Z9 4
U1 1
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD DEC
PY 2018
VL 25
BP 26
EP 34
DI 10.1016/j.epidem.2018.05.002
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA GZ8KV
UT WOS:000449741100004
PM 29773482
OA DOAJ Gold, Green Accepted
DA 2020-11-30
ER

PT J
AU Colombe, S
   Watanapalachaigool, E
   Ekgatat, M
   Ko, AI
   Hinjoy, S
AF Colombe, Soledad
   Watanapalachaigool, Ekkarin
   Ekgatat, Monaya
   Ko, Albert, I
   Hinjoy, Soawapak
TI Cross-sectional study of brucellosis and Q fever in Thailand among
   livestock in two districts at the Thai-Cambodian border, Sa Kaeo
   province
SO ONE HEALTH
LA English
DT Article
DE Brucellosis; Q fever; Public health; Thailand; Zoonotic diseases
ID RUMINANTS; EPIDEMIOLOGY; MELITENSIS; PREVALENCE
AB Brucellosis and Q fever impart high morbidity in humans and economic losses among livestock worldwide. However their prevalence is still not fully known in Thailand. We conducted a sero-survey of brucellosis and Q fever in beef, dairy cattle, goat, and sheep herds from Thai communities at the border with Cambodia, a cross-border trading center. Serum samples were tested for brucellosis and Q fever by antibody-based tests at the National Institute of Animal Health, Thailand. We surveyed a total of 520 individuals from 143 herds. Brucellosis herd-level seroprevalence for beef cattle and small ruminants (goats and sheep) was 2.6% (3/117) and 13.3% (2/15) respectively. Q fever herd-level seroprevalence for beef cattle, dairy cattle, and small ruminants was 4.3% (5/117), 27.3% (3/11) and 33.3% (5/15) respectively. This study identified a significant burden of brucellosis and Q fever among small ruminants and dairy cattle at the Thai-Cambodian border.
C1 [Colombe, Soledad; Ko, Albert, I] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St,POB 208034, New Haven, CT 06520 USA.
   [Colombe, Soledad] Weill Cornell Med, Ctr Global Hlth, New York, NY USA.
   [Watanapalachaigool, Ekkarin] Dept Livestock Dev, Sa Kaeo Prov Livestock Off, Bangkok, Thailand.
   [Ekgatat, Monaya] Dept Livestock Dev, Natl Inst Anim Hlth, Bangkok, Thailand.
   [Ko, Albert, I] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Rio De Janeiro, Brazil.
   [Hinjoy, Soawapak] Minist Publ Hlth, Dept Dis Control, Bur Epidemiol, Bangkok, Thailand.
RP Colombe, S (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St,POB 208034, New Haven, CT 06520 USA.
EM soledad.colombe@gmail.com
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Colombe,
   Soledad/0000-0003-0300-902X
FU Wilbur G Downs Fellowship; Coca-Cola foundation grant; Yale South-East
   Asia Studies Council grant; USAIDUnited States Agency for International
   Development (USAID); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER
FX The project was funded by the Wilbur G Downs Fellowship, the Coca-Cola
   foundation grant, Yale South-East Asia Studies Council grant and USAID.
   The funding sources had no involvement in the study design, collection
   of data, analysis nor in the writing of the report or the decision to
   submit the article for publication.
CR Al-Talafhah AH, 2003, PREV VET MED, V60, P297, DOI 10.1016/S0167-5877(03)00127-2
   Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2304
   Anka MS, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-230
   Bamaiyi PH, 2015, PREV VET MED, V119, P232, DOI 10.1016/j.prevetmed.2015.02.001
   Bina RS, 2011, OSIR, V4, P1
   Chemsripong S., 2012, EXTENT INTRA IND TRA
   Department of Livestock Development (DLD), 2012, AN HLTH THAIL 2011
   Aparicio ED, 2013, REV SCI TECH OIE, V32, P53
   Doung-Ngern P, 2017, AM J TROP MED HYG, V96, P786, DOI 10.4269/ajtmh.16-0336
   Ekgatat M., 2010, Kasetsart Veterinarians, V20, P19
   Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4
   Horigan MW, 2011, J VET DIAGN INVEST, V23, P924, DOI 10.1177/1040638711416971
   Manosuthi Weerawat, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P109
   Musallam II, 2015, PREV VET MED, V118, P387, DOI 10.1016/j.prevetmed.2014.12.020
   Pachirat O, 2012, INFECT DIS REP, V4, P17, DOI 10.4081/idr.2012.e7
   Porter S. R., 2011, INT J MICROBIOL
   Suputtamongkol Y, 2003, EMERG INFECT DIS, V9, P1186
   Wongkasemjit S., 2014, 3 THAIL JAP JOINT C
NR 18
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2352-7714
J9 ONE HEALTH-AMSTERDAM
JI One Health
PD DEC
PY 2018
VL 6
BP 37
EP 40
DI 10.1016/j.onehlt.2018.10.001
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA HC1RX
UT WOS:000451581100007
PM 30386815
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Dias, JRD
   Ventura, CV
   Freitas, BD
   Prazeres, J
   Ventura, LO
   Bravo, V
   Aleman, T
   Ko, AI
   Zin, A
   Belfort, R
   Maia, M
AF de Oliveira Dias, Joao Rafael
   Ventura, Camila V.
   Freitas, Bruno de Paula
   Prazeres, Juliana
   Ventura, Liana O.
   Bravo-Filho, Vasco
   Aleman, Tomas
   Ko, Albert Icksang
   Zin, Andrea
   Belfort, Rubens, Jr.
   Maia, Mauricio
CA Zika Virus Study Grp
TI Zika and the Eye: Pieces of a Puzzle
SO PROGRESS IN RETINAL AND EYE RESEARCH
LA English
DT Review
ID WEST-NILE-VIRUS; OPTICAL COHERENCE TOMOGRAPHY; ASYMPTOMATIC
   BLOOD-DONORS; SEXUAL TRANSMISSION; YELLOW-FEVER; OPHTHALMIC
   MANIFESTATIONS; NEUTRALIZING ANTIBODIES; INVASIVE MOSQUITOS; INTERIM
   GUIDANCE; FRENCH-POLYNESIA
AB Zika virus (ZIKV) is an arbovirus mainly transmitted to humans by mosquitoes from Aedes genus. Other ways of transmission include the perinatal and sexual routes, blood transfusion, and laboratory exposure. Although the first human cases were registered in 1952 in African countries, outbreaks were only reported since 2007, when entire Pacific islands were affected. In March 2015, the first cases of ZIKV acute infection were notified in Brazil and, to date, 48 countries and territories in the Americas have confirmed local mosquito-borne transmission of ZIKV. Until 2015, ZIKV infection was thought to only cause asymptomatic or mild exanthematous febrile infections. However, after explosive ZIKV outbreaks in Polynesia and Latin American countries, it was confirmed that ZIKV could also lead to Guillain-Barre syndrome and congenital birth abnormalities. These abnormalities, which can include neurologic, ophthalmologic, audiologic, and skeletal findings, are now considered congenital Zika syndrome (CZS). Brain abnormalities in CZS include cerebral calcifications, malformations of cortical development, ventriculomegaly, lissencephaly, hypoplasia of the cerebellum and brainstem. The ocular findings, which are present in up to 70% of infants with CZS, include iris coloboma, lens subluxation, cataract, congenital glaucoma, and especially posterior segment findings. Loss of retinal pigment epithelium, the presence of a thin choroid, a perivascular choroidal inflammatory infiltrate, and atrophic changes within the optic nerve were seen in histologic analyses of eyes from deceased fetuses. To date, there is no ZIKV licensed vaccines or antiviral therapies are available for treatment. Preventive measures include individual protection from mosquito bites, control of mosquito populations and the use of barriers measures such as condoms during sexual intercourse or sexual abstinence for couples either at risk or after confirmed infection. A literature review based on studies that analyzed ocular findings in mothers and infants with CZS, with or without microcephaly, was conducted and a theoretical pathophysiologic explanation for ZIKV-ocular abnormalities was formulated.
C1 [de Oliveira Dias, Joao Rafael; Ventura, Camila V.; Freitas, Bruno de Paula; Prazeres, Juliana; Ventura, Liana O.; Belfort, Rubens, Jr.; Maia, Mauricio] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Sao Paulo, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.; Bravo-Filho, Vasco] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.; Bravo-Filho, Vasco] HOPE Eye Hosp, Recife, PE, Brazil.
   [Freitas, Bruno de Paula] Roberto Santos Gen Hosp, Dept Ophthalmol, Salvador, BA, Brazil.
   [Aleman, Tomas] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Ctr Adv Med,Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Ko, Albert Icksang] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert Icksang] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Zin, Andrea] Fundacao Oswaldo Cruz, Clin Res Unit, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Maia, Mauricio] Brazilian Inst Fight Blindness Assts & Presidente, Sao Paulo, Brazil.
RP Maia, M (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Pedro de Toledo St 781,2nd Floor, BR-04023062 Sao Paulo, SP, Brazil.
EM mmaia@unifesp.br
RI Maia, Mauricio/I-5892-2015; Ventura, Liana Vieira O/N-6151-2018; Ko,
   Albert Icksang/P-2343-2015; Ventura, Camila V/N-2654-2018; Bravo-Filho,
   Vasco/N-6993-2018
OI Maia, Mauricio/0000-0002-7034-8091; Ventura, Liana Vieira
   O/0000-0001-6529-6883; Ko, Albert Icksang/0000-0001-9023-2339; Ventura,
   Camila V/0000-0002-2927-4684; Bravo-Filho, Vasco/0000-0003-4460-3236
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Alpuche-Lazcano SP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020053
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2016, EURO SURVEILL, V21
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bonafede L, 2015, INVEST OPHTH VIS SCI, V56, P7875, DOI 10.1167/iovs.15-17857
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buechler CR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00392-16
   Bueno MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005073
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Diasease Control and Prevention, 2017, MORB MORT WEEK REP M
   Centers for Disease Control and Prevention, 2014, ZIK VIR TRANSM RISKS
   Centers for Disease Control and Prevention, 2016, CFDCAP ZIK VIR
   Centers for Disease Control and Prevention, 2018, ZIK CAS US
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira Dias Joao Rafael, 2018, Retin Cases Brief Rep, V12, P382, DOI 10.1097/ICB.0000000000000518
   de Paula Freitas B., 2017, OPHTHALMOLOGY
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   European Centre for Disease Prevention and Control (ECDC), 2017, ZIK TRANSM
   European Centre for Disease Prevention and Control (ECDC), 2017, ZIK VIR TRANSM LIST
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Favoretto S., 2016, 1 DETECTION ZIKA VIR
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez M. P., 2017, JAMA OPHTHALMOLOGY
   Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   Freitas B de Paula, 2016, JAMA OPHTHALMOL
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   FUNG JC, 1985, ANN CLIN LAB SCI, V15, P204
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Garg S, 2009, RETINA-J RET VIT DIS, V29, P631, DOI 10.1097/IAE.0b013e318198d8de
   Gasperi G., 2014, PLOS NEGLECTED TROP, V6, pe1836
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Goldenberg D, 2013, GRAEF ARCH CLIN EXP, V251, P2037, DOI 10.1007/s00417-013-2334-3
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Intergrowth-21st Fetal, 2017, PRETERM NEWBORN APPL
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Lindsey NP, 2015, MMWR-MORBID MORTAL W, V64, P929, DOI 10.15585/mmwr.mm6434a1
   MacNamara F., 1952, ANN REPORT, P1951
   Mani RS, 2016, NATL MED J INDIA, V29, P339
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P41, DOI 10.1007/s11604-016-0599-2
   Mehrjardi MZ, 2017, VIROLOGY AUCKL, V8
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Ministerio da Saude do Brasil, 2016, MIN SAUD BRAS B
   Ministerio da Saude do Brasil, 2017, MIN SAUD BRAS B EP, V48
   Ministerio da Saude do Brasil, 2016, NFORM EP 47 SEMANA E
   Mladinich M. C., 2017, ZIKA VIRUS PERSISTEN
   Mlalcar J., 2016, ENGL J MED, V374, P951
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/msphere.00523-17, 10.1128/mSphere.00523-17]
   Morris G., 2017, MOL NEUROBIOL
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pan American Health Organization/World Health Organization, 2016, ZIK VIR INF STEP STE
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   POLAND JD, 1981, B WORLD HEALTH ORGAN, V59, P895
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Reuters, 2016, BRAZ REP ZIK INF BLO
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robin Y, 1978, B SOC PATHOL EXOT, V68, P249
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Roth A., 2014, EURO SURVEILL, V16
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Secretaria de Estado de Saude do Estado de Sao Paulo, 2016, DISTR CAS NOT CONF F
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Subissi L, 2017, INT J INFECT DIS, V65, P116, DOI 10.1016/j.ijid.2017.10.009
   Sun Lisa L, 2012, Digit J Ophthalmol, V18, P1, DOI 10.5693/djo.02.2012.04.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tognarelli J., 2015, ARCH VIROL, P665
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura CV, 2014, ARQ BRAS OFTALMOL, V77, P300, DOI 10.5935/0004-2749.20140076
   Ventura L. O., 2017, J AAPOS
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   WHO, 2016, INT GUID
   WHO, 2016, WHO STAT 1 M INT HLT
   WHO/Institut Pasteur/ISARIC/CONSISE, 2017, STAND PROT CROSS SEC
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2018, HIST ZIK VIR
   World Health Organization, 2017, ZIK SIT REP
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization, 2017, INF TRAV VIS ZIK AFF
   World Health Organization (WHO), 2016, ZIK VIR VECT RISK SP
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 195
TC 9
Z9 9
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1350-9462
EI 1873-1635
J9 PROG RETIN EYE RES
JI Prog. Retin. Eye Res.
PD SEP
PY 2018
VL 66
BP 85
EP 106
DI 10.1016/j.preteyeres.2018.04.004
PG 22
WC Ophthalmology
SC Ophthalmology
GA GW6ZN
UT WOS:000447113700004
PM 29698814
DA 2020-11-30
ER

PT J
AU Terzian, ACB
   Estofolete, CF
   Nery, N
   Zini, N
   Da Silva, GCD
   Guimaraes, GF
   Rahal, P
   Costa, PF
   de Mattos, CCB
   de Mattos, LC
   Vasilakis, N
   Oliani, AH
   Oliani, DCMV
   Ko, AI
   Nogueira, ML
AF Bernardes Terzian, A. C.
   Estofolete, C. F.
   Nery-Junior, N.
   Zini, N.
   Celestino Dutra Da Silva, G.
   Guimaraes, G. F.
   Rahal, P.
   Fv Costa, P.
   Brandao de Mattos, C. C.
   de Mattos, L. C.
   Vasilakis, N.
   Helio Oliani, A.
   Mos Vaz Oliani, D. C.
   Ko, A. Icksang
   Lacerda Nogueira, M.
TI Newborn virological outcome after intrauterine ZIKV exposure
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Bernardes Terzian, A. C.; Estofolete, C. F.; Zini, N.; Celestino Dutra Da Silva, G.; Guimaraes, G. F.; Lacerda Nogueira, M.] FAMERP, DDDIP, Sao Jose Do Rio Preto, Brazil.
   [Nery-Junior, N.] Fiocruz MS, Salvador, BA, Brazil.
   [Rahal, P.] UNESP, Sao Jose Do Rio Preto, Brazil.
   [Fv Costa, P.] Inst Evandro Chagas, Ananindeua, Brazil.
   [Brandao de Mattos, C. C.; de Mattos, L. C.; Helio Oliani, A.; Mos Vaz Oliani, D. C.] FAMERP, Sao Jose Do Rio Preto, Brazil.
   [Vasilakis, N.] UTMB, Pathol, Galveston, TX USA.
   [Ko, A. Icksang] Yale Univ, New Haven, CT USA.
RI Ko, Albert Icksang/P-2343-2015; DE MATTOS, LUIZ CARLOS/F-6739-2010;
   Estofolete, Cassia/N-6673-2019; de Mattos, Luiz Carlos/P-3574-2019;
   Rahal, Paula/D-3871-2012; Vasilakis, Nikos/ABE-7318-2020; Nogueira,
   Mauricio L/B-7599-2012; OLIANI, ANTONIO/O-1673-2019
OI Ko, Albert Icksang/0000-0001-9023-2339; DE MATTOS, LUIZ
   CARLOS/0000-0002-8572-8177; Estofolete, Cassia/0000-0001-7324-1591;
   Rahal, Paula/0000-0001-5693-6148; Nogueira, Mauricio
   L/0000-0003-1102-2419; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD AUG
PY 2018
VL 73
SU S
MA UMP. 779
BP 375
EP 375
DI 10.1016/j.ijid.2018.04.4262
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA GO8MP
UT WOS:000440345100828
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Casanovas-Massana, A
   Pedra, GG
   Wunder, EA
   Diggle, PJ
   Begon, M
   Ko, AI
AF Casanovas-Massana, Arnau
   Pedra, Gabriel Ghizzi
   Wunder, Elsio A., Jr.
   Diggle, Peter J.
   Begon, Mike
   Ko, Albert I.
TI Quantification of Leptospira interrogans Survival in Soil and Water
   Microcosms
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
DE Leptospira; survival; soil; water; sewage; qPCR; persistence; soil
   microbiology; statistical modeling; waterborne pathogens
ID PATHOGENIC LEPTOSPIRA; PHILIPPINES; OUTBREAK; SEROVAR; SPP.; PCR;
   BACTEROIDES; ENVIRONMENT; INSIGHTS; POMONA
AB Leptospira interrogans is the etiological agent of leptospirosis, a globally distributed zoonotic disease. Human infection usually occurs through skin exposure with water and soil contaminated with the urine of chronically infected animals. In this study, we aimed to quantitatively characterize the survival of Leptospira interrogans serovar Copenhageni in environmental matrices. We constructed laboratory microcosms to simulate natural conditions and determined the persistence of DNA markers in soil, mud, spring water and sewage using a quantitative PCR (qPCR) and a propidium monoazide (PMA)-qPCR assay. We found that L. interrogans does not survive at high concentrations in the tested matrices. No net growth was detected in any of the experimental conditions and in all cases the concentration of the DNA markers targeted decreased from the beginning of the experiment following an exponential decay with a decreasing decay rate over time. After 12 and 21 days of incubation the spiked concentration of 106 L. interrogans cells/ml or g decreased to approximately 100 cells/ml or g in soil and spring water microcosms, respectively. Furthermore, culturable L. interrogans persisted at concentrations under the limit of detection by PMA-qPCR or qPCR for at least 16 days in soil and 28 days in spring water. Altogether, our findings suggest that the environment is not a multiplication reservoir but a temporary carrier of L. interrogans Copenhageni, although the observed prolonged persistence at low concentrations may still enable the transmission of the disease.
   IMPORTANCE Leptospirosis is a zoonotic disease caused by spirochetes of the genus Leptospira that primarily affects impoverished populations worldwide. Although leptospirosis is transmitted by contact with water and soil, little is known about the ability of the pathogen to survive in the environment. In this study, we quantitatively characterized the survival of L. interrogans in environmental microcosms and found that although it cannot multiply in water, soil or sewage, it survives for extended time periods (days to weeks depending on the matrix). The survival parameters obtained here may help to better understand the distribution of pathogenic Leptospira in the environment and improve the predictions of human infection risks in areas where such infections are endemic.
C1 [Casanovas-Massana, Arnau; Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Pedra, Gabriel Ghizzi; Begon, Mike] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
   [Diggle, Peter J.] Univ Lancaster, Fac Hlth & Med, Lancaster, England.
   [Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
RP Casanovas-Massana, A; Ko, AI (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.; Ko, AI (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
EM arnau.casanovas@yale.edu; albert.ko@yale.edu
RI Casanovas-Massana, Arnau/H-5806-2019; Ko, Albert Icksang/P-2343-2015;
   Wunder, Elsio Augusto/C-2733-2013
OI Casanovas-Massana, Arnau/0000-0002-3301-6143; Ko, Albert
   Icksang/0000-0001-9023-2339; Wunder, Elsio Augusto/0000-0002-5239-8511;
   Diggle, Peter/0000-0003-3521-5020
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 TW009504, U01
   AI0088752, R01 AI052473]; Brazilian Ministry of Education [CAPES-BEX
   13715/13-5]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI088752, R01AI121207, U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, U01AI088752, R01AI121207, R01AI121207,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, U01AI088752,
   U01AI088752, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI121207] Funding Source: NIH RePORTER
FX This study was supported by grants from the National Institutes of
   Health (R01 TW009504, U01 AI0088752, and R01 AI052473). G.G.P. received
   a Science Without Borders scholarship from the Brazilian Ministry of
   Education (CAPES-BEX 13715/13-5). The funders had no role in study
   design, data collection and interpretation, or the decision to submit
   the work for publication.
CR Agampodi SB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002626
   Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   Andre-Fontaine G, 2015, CURR MICROBIOL, V71, P136, DOI 10.1007/s00284-015-0836-4
   Babudieri B., 1961, 6 C IT SOC MICR CAGL, P408
   Bae S, 2012, APPL ENVIRON MICROB, V78, P922, DOI 10.1128/AEM.05157-11
   Bae S, 2009, WATER RES, V43, P4850, DOI 10.1016/j.watres.2009.06.053
   Balleste E, 2010, APPL ENVIRON MICROB, V76, P7608, DOI 10.1128/AEM.00883-10
   Barragan V, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01190-17
   Barragan VA, 2011, CURR MICROBIOL, V62, P1802, DOI 10.1007/s00284-011-9931-3
   Casanovas-Massana A, 2018, WATER RES, V130, P176, DOI 10.1016/j.watres.2017.11.068
   Chakraborty A, 2011, MICROBIOL IMMUNOL, V55, P494, DOI 10.1111/j.1348-0421.2011.00347.x
   CHANG SL, 1948, J INFECT DIS, V82, P256, DOI 10.1093/infdis/82.3.256
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377
   Easton JH, 2005, J AM WATER RESOUR AS, V41, P1187, DOI 10.1111/j.1752-1688.2005.tb03793.x
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Goarant C, 2009, TROP MED INT HEALTH, V14, P926, DOI 10.1111/j.1365-3156.2009.02310.x
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Green HC, 2011, ENVIRON MICROBIOL, V13, P3235, DOI 10.1111/j.1462-2920.2011.02549.x
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   HELLSTROM JS, 1978, RES VET SCI, V25, P29, DOI 10.1016/S0034-5288(18)33003-0
   HENRY RA, 1978, APPL ENVIRON MICROB, V35, P492, DOI 10.1128/AEM.35.3.492-499.1978
   Hu WL, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02377-16, 10.1128/aem.02377-16]
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Khairani-Bejo S., 2004, Journal of Animal and Veterinary Advances, V3, P123
   KIRSCHNER L, 1957, N Z Med J, V56, P385
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kumar KV, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv051
   Lau CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004405
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Nkuipou-Kenfack E, 2013, J MICROBIOL METH, V93, P20, DOI 10.1016/j.mimet.2013.01.018
   OKAZAKI W, 1957, AM J VET RES, V18, P219
   Olson GW., 1984, FIELD GUIDE SOILS EN
   Parker J, 2011, VET MICROBIOL, V152, P146, DOI 10.1016/j.vetmic.2011.04.028
   Peleg M, 1998, CRIT REV FOOD SCI, V38, P353, DOI 10.1080/10408699891274246
   Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607
   R Core Team, 2013, R A LANG ENV STAT CO
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Rogers SW, 2011, APPL ENVIRON MICROB, V77, P4839, DOI 10.1128/AEM.02427-10
   Saito M, 2014, APPL ENVIRON MICROB, V80, P6926, DOI 10.1128/AEM.02568-14
   Saito M, 2013, APPL ENVIRON MICROB, V79, P601, DOI 10.1128/AEM.02728-12
   Schneider AG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006415
   SMITH CE, 1961, B WORLD HEALTH ORGAN, V24, P35
   SMITH D. J. W., 1955, JOUR HYG, V53, P436
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Tanaka Yoshinori, 1999, Yonago Acta Medica, V42, P147
   Tangkanakul W, 2000, AM J TROP MED HYG, V63, P204, DOI 10.4269/ajtmh.2000.63.204
   Trueba G, 2004, INT MICROBIOL, V7, P35
   van Boekel MAJS, 2002, INT J FOOD MICROBIOL, V74, P139, DOI 10.1016/S0168-1605(01)00742-5
   Weinberger D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002798
NR 53
TC 25
Z9 25
U1 1
U2 31
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD JUL
PY 2018
VL 84
IS 13
AR e00507-18
DI 10.1128/AEM.00507-18
PG 11
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA GJ6CS
UT WOS:000435471900020
PM 29703737
OA Green Published, Bronze, Green Accepted
DA 2020-11-30
ER

PT J
AU Santos, LA
   Adhikarla, H
   Yan, XT
   Wang, Z
   Fouts, DE
   Vinetz, JM
   Alcantara, LCJ
   Hartskeerl, RA
   Goris, MGA
   Picardeau, M
   Reis, MG
   Townsend, JP
   Zhao, HY
   Ko, AI
   Wunder, EA
AF Santos, Luciane A.
   Adhikarla, Haritha
   Yan, Xiting
   Wang, Zheng
   Fouts, Derrick E.
   Vinetz, Joseph M.
   Alcantara, Luiz C. J.
   Hartskeerl, Rudy A.
   Goris, Marga G. A.
   Picardeau, Mathieu
   Reis, Mitermayer G.
   Townsend, Jeffrey P.
   Zhao, Hongyu
   Ko, Albert, I
   Wunder Jr, Elsio A.
TI Genomic Comparison Among Globa Isolates of L. interrogans Serovars
   Copenhageni and Icterohaemorrhagiae Identified Natural Genetic Variation
   Caused by an Indel
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Leptospira; leptospirosis; Copenhageni; Icterohaemorrhagiae;
   whole-genome sequencing; SNPs; Indels; phylogeny
ID SINGLE NUCLEOTIDE POLYMORPHISMS; LEPTOSPIRA-INTERROGANS;
   MYCOBACTERIUM-BOVIS; SEQUENCING DATA; EVOLUTION; VIRULENCE; BRAZIL;
   DIFFERENTIATION; RESOLUTION; DISCOVERY
AB Leptospirosis is a worldwide zoonosis, responsible for more than 1 million cases and 60,000 deaths every year. Among the 13 pathogenic species of the genus Leptospira, serovars belonging to L. interrogans serogroup Icterohaemorrhagiae are considered to be the most virulent strains, and responsible for majority of the reported severe cases. Serovars Copenhageni and Icterohaemorrhagiae are major representatives of this serogroup and despite their public health relevance, little is known regarding the genetic differences between these two serovars. In this study, we analyzed the genome sequences of 67 isolates belonging to L. interrogans serovars Copenhageni and Icterohaemorrhagiae to investigate the influence of spatial and temporal variations on DNA sequence diversity. Out of the 1072 SNPs identified, 276 were in non-coding regions and 796 in coding regions. Indel analyses identified 258 Indels, out of which 191 were found in coding regions and 67 in non-coding regions. Our phylogenetic analyses based on SNP dataset revealed that both serovars are closely related but showed distinct spatial clustering. However, likelihood ratio test of the indel data statistically confirmed the presence of a frameshift mutation within a homopolymeric tract of lic12008 gene (related to LPS biosynthesis) in all the L. interrogans serovar Icterohaemorrhagiae strains but not in the Copenhageni strains. Therefore, this internal indel identified can genetically distinguish L. interrogans serovar Copenhageni from serovar Icterohaemorrhagiae with high discriminatory power. To our knowledge, this is the first study to identify global sequence variations (SNPs and Indels) in L. interrogans serovars Copenhageni and Icterohaemorrhagiae.
C1 [Santos, Luciane A.; Adhikarla, Haritha; Ko, Albert, I; Wunder Jr, Elsio A.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Santos, Luciane A.; Alcantara, Luiz C. J.; Reis, Mitermayer G.; Ko, Albert, I; Wunder Jr, Elsio A.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Yan, Xiting; Wang, Zheng; Townsend, Jeffrey P.; Zhao, Hongyu] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA.
   [Fouts, Derrick E.] J Craig Venter Inst, Rockville, MD USA.
   [Vinetz, Joseph M.] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA.
   [Hartskeerl, Rudy A.; Goris, Marga G. A.] KIT Biomed Res, Royal Trop Inst, Amsterdam, Netherlands.
   [Picardeau, Mathieu] Inst Pasteur, Biol Spirochetes Unit, Paris, France.
RP Ko, AI; Wunder, EA (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Ko, AI; Wunder, EA (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
EM albert.ko@yale.edu; elsio.wunder@yale.edu
RI Reis, Mitermayer/AAO-9742-2020; Wang, Zheng/A-2318-2011; Ko, Albert
   Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013; Townsend,
   Jeffrey/H-2747-2019
OI Reis, Mitermayer/0000-0002-3051-9060; Wang, Zheng/0000-0002-8849-8549;
   Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Townsend, Jeffrey/0000-0002-9890-3907;
   Alcantara, Luiz/0000-0002-6769-9931
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [HHSN272200900007C]; Programa Ciencias sem fronteiras
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of
   Brazil; Brasil Sem Miseria Program of the Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superios (Capes) of Brazil;  [R01AI052473]; 
   [U01AI088752];  [R25TW009338];  [R01TW009504];  [R01AI121207]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R01TW009504, R01TW009504, R25TW009338, R01TW009504,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R01TW009504,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R01TW009504] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI121207, R01AI121207, R01AI121207,
   R01AI052473, U01AI088752, U01AI088752, U01AI088752, R01AI052473,
   U01AI088752, R01AI052473, R01AI052473, R01AI121207, U01AI088752,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI121207,
   R01AI052473, R01AI052473, R01AI052473, U01AI088752] Funding Source: NIH
   RePORTER
FX Draft genome sequences used in this study are part of a project which
   was funded with federal funds from the National Institute of Allergy and
   Infectious Diseases, National Institutes of Health, Department of Health
   and Human Services under contract number HHSN272200900007C. This project
   has also been partially funded by the following grants: R01AI052473
   (AK), U01AI088752 (AK), R25TW009338 (AK), R01TW009504 (AK), and
   R01AI121207 (AK). LS was supported by Programa Ciencias sem fronteiras
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) of
   Brazil and Brasil Sem Miseria Program of the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superios (Capes) of Brazil.
CR Ajawatanawong P, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-140
   BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Bartling CM, 2009, BIOCHEMISTRY-US, V48, P8672, DOI 10.1021/bi901025v
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   de Jong WW, 2003, MOL PHYLOGENET EVOL, V28, P328, DOI 10.1016/S1055-7903(03)00116-7
   de la Pena-Moctezuma A, 1999, FEMS MICROBIOL LETT, V177, P319, DOI 10.1111/j.1574-6968.1999.tb13749.x
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Eshghi A, 2015, INFECT IMMUN, V83, P4314, DOI 10.1128/IAI.00897-15
   Faine S., 1994, LEPTOSPIRA LEPTOSPIR, DOI [10.1016/j.vetmic.2009.03.012, DOI 10.1016/J.VETMIC.2009.03.012]
   Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960
   Fournier PE, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0114-2
   Galloway RL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000824
   Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100
   Gutacker MM, 2002, GENETICS, V162, P1533
   Harrison F, 2013, BIOESSAYS, V35, P108, DOI 10.1002/bies.201200154
   HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540
   Ido Y, 1917, J EXP MED, V26, P341, DOI 10.1084/jem.26.3.341
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Jordan IK, 2002, THEOR POPUL BIOL, V61, P435, DOI 10.1006/tpbi.2002.1588
   Joshi D, 2012, J CLIN MICROBIOL, V50, P3853, DOI 10.1128/JCM.01499-12
   Kmety E, 1993, CLASSIFICATION SPECI
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Lehmann JS, 2014, PATHOGENS, V3, P280, DOI 10.3390/pathogens3020280
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Liu MM, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0040-4
   Llanes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159387
   Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110
   MADDISON WP, 1989, FOLIA PRIMATOL, V53, P190, DOI 10.1159/000156416
   Majed Z, 2005, J CLIN MICROBIOL, V43, P539, DOI 10.1128/JCM.43.2.539-545.2005
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140
   Moreno LZ, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.16
   Nalam K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012637
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986
   Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5
   Price EP, 2013, MBIO, V4, DOI 10.1128/mBio.00388-13
   Puckett EE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1762
   Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Rogers JS, 1998, SYST BIOL, V47, P77, DOI 10.1080/106351598261049
   Romero EC, 2011, J CLIN MICROBIOL, V49, P3940, DOI 10.1128/JCM.01119-11
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   Williams LE, 2013, GENOME BIOL EVOL, V5, P599, DOI 10.1093/gbe/evt033
   Wunder EA, 2016, INFECT IMMUN, V84, P2105, DOI 10.1128/IAI.00094-16
   Zilber AL, 2014, J CLIN MICROBIOL, V52, P564, DOI 10.1128/JCM.02482-13
NR 55
TC 7
Z9 7
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JUN 19
PY 2018
VL 8
AR 193
DI 10.3389/fcimb.2018.00193
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GK0RJ
UT WOS:000435818900001
PM 29971217
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Nogueira, ML
   Nery, NRR
   Estofolete, CF
   Terzian, ACB
   Guimaraes, GF
   Zini, N
   da Silva, RA
   Silva, GCD
   Franco, LCJ
   Rahal, P
   Bittar, C
   Carneiro, B
   Vasconcelos, PFC
   Henriques, DF
   Barbosa, DMU
   Rombola, PL
   de Grande, L
   Reis, AFN
   Palomares, SA
   Catelan, MW
   Cruz, LEAA
   Necchi, SH
   Mendonca, RCV
   dos Santos, INP
   Caron, SBA
   Costa, F
   Bozza, FA
   de Souza, AS
   de Mattos, CCB
   de Mattos, LC
   Vasilakis, N
   Oliani, AH
   Oliani, DCMV
   Ko, AI
AF Nogueira, M. L.
   Nery Junior, N. R. R.
   Estofolete, C. F.
   Bernardes Terzian, A. C.
   Guimaraes, G. F.
   Zini, N.
   Alves da Silva, R.
   Dutra Silva, G. C.
   Junqueira Franco, L. C.
   Rahal, P.
   Bittar, C.
   Carneiro, B.
   Vasconcelos, P. F. C.
   Freitas Henriques, D.
   Barbosa, D. M. U.
   Lopes Rombola, P.
   de Grande, L.
   Negri Reis, A. F.
   Palomares, S. A.
   Wakai Catelan, M.
   Cruz, L. E. A. A.
   Necchi, S. H.
   Mendonca, R. C. V.
   Penha dos Santos, I. N.
   Alavarse Caron, S. B.
   Costa, F.
   Bozza, F. A.
   Soares de Souza, A.
   Brandao de Mattos, C. C.
   de Mattos, L. C.
   Vasilakis, N.
   Oliani, A. H.
   Vaz Oliani, D. C. M.
   Ko, A. I.
TI Adverse birth outcomes associated with Zika virus exposure during
   pregnancy in Sao Jose do Rio Preto, Brazil
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Adverse outcome; Arbovirus; Birth; Pregnancy; Zika virus
ID INFECTION; RUBELLA
AB Objectives: We aimed to report the first 54 cases of pregnant women infected by Zika virus (ZIKV) and their virologic and clinical outcomes, as well as their newborns' outcomes, in 2016, after the emergence of ZIKV in dengue-endemic areas of Sao Paulo, Brazil.
   Methods: This descriptive study was performed from February to October 2016 on 54 quantitative realtime PCR ZIKV-positive pregnant women identified by the public health authority of Sao Jose do Rio Preto, Sao Paulo, Brazil. The women were followed and had clinical and epidemiologic data collected before and after birth. Adverse outcomes in newborns were analysed and reported. Urine or blood samples from newborns were collected to identify ZIKV infection by reverse transcription PCR (RT-PCR).
   Results: A total of 216 acute Zika-suspected pregnant women were identified, and 54 had the diagnosis confirmed by RT-PCR. None of the 54 women miscarried. Among the 54 newborns, 15 exhibited adverse outcomes at birth. The highest number of ZIKV infections occurred during the second and third trimesters. No cases of microcephaly were reported, though a broad clinical spectrum of outcomes, including lenticulostriate vasculopathy, subependymal cysts, and auditory and ophthalmologic disorders, were identified. ZIKV RNA was detected in 18 of 51 newborns tested and in eight of 15 newborns with adverse outcomes.
   Conclusions: Although other studies have associated many newborn outcomes to ZIKV infection during pregnancy, these same adverse outcomes were rare or nonexistent in this study. The clinical presentation the newborns we studied was mild compared to other reports, suggesting that there is significant heterogeneity in congenital Zika infection. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Nogueira, M. L.; Estofolete, C. F.; Bernardes Terzian, A. C.; Guimaraes, G. F.; Zini, N.; Alves da Silva, R.; Dutra Silva, G. C.; Junqueira Franco, L. C.; Soares de Souza, A.; Brandao de Mattos, C. C.; de Mattos, L. C.; Oliani, A. H.; Vaz Oliani, D. C. M.] Sao Jose do Rio Preto Sch Med, Sao Jose Do Rio Preto, SP, Brazil.
   [Rahal, P.; Bittar, C.; Carneiro, B.] Sao Paulo State Univ, Sao Jose Do Rio Preto, SP, Brazil.
   [Barbosa, D. M. U.; Lopes Rombola, P.; de Grande, L.; Negri Reis, A. F.; Palomares, S. A.; Wakai Catelan, M.; Cruz, L. E. A. A.; Necchi, S. H.; Mendonca, R. C. V.; Penha dos Santos, I. N.; Alavarse Caron, S. B.] Hlth Secretariat, Sao Jose Do Rio Preto, SP, Brazil.
   [Nery Junior, N. R. R.; Costa, F.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Vasconcelos, P. F. C.; Freitas Henriques, D.] Evandro Chagas Inst, Ananindeua, Para, Brazil.
   [Costa, F.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Bozza, F. A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Vasilakis, N.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Costa, F.; Ko, A. I.] Yale Sch Publ Hlth, New Haven, CT USA.
RP Nogueira, ML (corresponding author), Sao Jose do Rio Preto Sch Med FAMERP, 5416 Brigadeiro Faria Lima Ave, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI OLIANI, ANTONIO/O-1673-2019; Costa, Federico/G-1838-2015; de Mattos,
   Luiz Carlos/P-4005-2019; amsalu, ribka/G-8780-2019; Estofolete,
   Cassia/N-6673-2019; Bozza, Fernando A/A-2618-2013; de Mattos, Luiz
   Carlos/P-3574-2019; Carneiro, Bruno/P-2415-2019; DE MATTOS, LUIZ
   CARLOS/F-6739-2010; Vasconcelos, Pedro/AAH-3142-2019; Vasilakis,
   Nikos/ABE-7318-2020; Rahal, Paula/D-3871-2012; Ko, Albert
   Icksang/P-2343-2015; Nogueira, Mauricio L/B-7599-2012; Bittar,
   Cintia/A-5042-2015; de Mattos, Cinara Brandao/B-3650-2008
OI Costa, Federico/0000-0001-6951-2336; de Mattos, Luiz
   Carlos/0000-0002-8572-8177; Estofolete, Cassia/0000-0001-7324-1591;
   Bozza, Fernando A/0000-0003-4878-0256; DE MATTOS, LUIZ
   CARLOS/0000-0002-8572-8177; Rahal, Paula/0000-0001-5693-6148; Ko, Albert
   Icksang/0000-0001-9023-2339; Nogueira, Mauricio L/0000-0003-1102-2419;
   Bittar, Cintia/0000-0002-2048-4589; de Mattos, Cinara
   Brandao/0000-0002-4836-3113; Spegiorin, Ligia Cosentino Junqueira
   Franco/0000-0003-4405-8098; Oliani, Antonio Helio/0000-0003-1242-4364;
   Carneiro, Bruno/0000-0002-2355-7907; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/21719-3, 2016/15021-1, 2015/12295-0,
   2016/05115-9]; Zika Virus Fast Track program by the Coordination for the
   Improvement of Higher Level Education Personnel; Brazilian National
   Council for Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [303999/2016-0, 440405/2016-5, 457664/2013-4]
FX Supported by the Sao Paulo Research Foundation (FAPESP) via grants
   2013/21719-3 and 2016/15021-1 to MLN, grant 2015/12295-0 to ACBT and
   grant 2016/05115-9 to LCM. The opinions, assumptions and conclusions or
   recommendations expressed in this material are the responsibility of the
   authors and do not necessarily reflect the views of FAPESP. PFCV was
   supported by the Zika Virus Fast Track program provided by the
   Coordination for the Improvement of Higher Level Education Personnel and
   the Brazilian National Council for Scientific and Technological
   Development (CNPq) by grants 303999/2016-0, 440405/2016-5 and
   457664/2013-4. MLM is a CNPq research fellow. All authors report no
   conflicts of interest relevant to this article.
CR [Anonymous], 2000, ASS PREN MAN TECN, P66
   [Anonymous], 2016, PROC SER AD VIG FEBR
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, 2015, MMWR RECOMM REP, V64, P138
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Enright Andrea M, 2002, Semin Neonatol, V7, P283, DOI 10.1016/S1084-2756(02)90115-6
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Figueiredo L T, 1990, Rev Soc Bras Med Trop, V23, P13, DOI 10.1590/S0037-86821990000100003
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MILLER E, 1982, LANCET, V2, P781
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI [10.1590/S0034-89102005000300016, 10.1590/s0034-89102005000300016]
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nei M, 2000, MOL EVOLUTION PHYLOG, P333, DOI DOI 10.1371/JOURNAL.PONE.0118669
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   RORKE LB, 1973, ARCH OTOLARYNGOL, V98, P249
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Shope RE, 1979, DIAGNOSTIC PROCEDURE, P767
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Singh Sarman, 2016, Trop Parasitol, V6, P113
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization, 2016, ASS INF MICR CONT ZI, P2
NR 28
TC 26
Z9 26
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUN
PY 2018
VL 24
IS 6
BP 646
EP 652
DI 10.1016/j.cmi.2017.11.004
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GG1KS
UT WOS:000432446500017
PM 29133154
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU Wunder, EA
   Slamti, L
   Suwondo, DN
   Gibson, KH
   Shang, ZG
   Sindelar, CV
   Trajtenberg, F
   Buschiazzo, A
   Ko, AI
   Picardeau, M
AF Wunder, Elsio A., Jr.
   Slamti, Leyla
   Suwondo, David N.
   Gibson, Kimberley H.
   Shang, Zhiguo
   Sindelar, Charles V.
   Trajtenberg, Felipe
   Buschiazzo, Alejandro
   Ko, Albert I.
   Picardeau, Mathieu
TI FcpB Is a Surface Filament Protein of the Endoflagellum Required for the
   Motility of the Spirochete Leptospira
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Leptospira; spirochetes; flagella; motility; flagellar system
ID INTERROGANS; VIRULENCE; BACTERIA; SHEATH; SPP.
AB The spirochete endoflagellum is a unique motility apparatus among bacteria. Despite its critical importance for pathogenesis, the full composition of the flagellum remains to be determined. We have recently reported that FcpA is a novel flagellar protein and a major component of the sheath of the filament of the spirochete Leptospira. By screening a library of random transposon mutants in the spirochete Leptospira biflexa, we found a motility-deficient mutant harboring a disruption in a hypothetical gene of unknown function. Here, we show that this gene encodes a surface component of the endoflagellar filament and is required for typical hook-and spiral-shaped ends of the cell body, coiled structure of the endoflagella, and high velocity phenotype. We therefore named the gene fcpB for flagellar-coiling protein B. fcpB is conserved in all members of the Leptospira genus, but not present in other organisms including other spirochetes. Complementation of the fcpB(-)mutant restored the wild-type morphology and motility phenotypes. Immunoblotting with anti-FcpA and anti-FcpB antisera and cryo-electronmicroscopy of the filament indicated that FcpB assembled onto the surface of the sheath of the filament and mostly located on the outer (convex) side of the coiled filament. We provide evidence that FcpB, together with FcpA, are Leptospira-specific novel components of the sheath of the filament, key determinants of the coiled and asymmetric structure of the endoflagella and are essential for high velocity. Defining the components of the endoflagella and their functions in these atypical bacteria should greatly enhance our understanding of the mechanisms by which these bacteria produce motility.
C1 [Wunder, Elsio A., Jr.; Suwondo, David N.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   [Slamti, Leyla; Picardeau, Mathieu] Inst Pasteur, Biol Spirochetes Unit, Paris, France.
   [Gibson, Kimberley H.; Shang, Zhiguo; Sindelar, Charles V.] Yale Univ, Sch Med, Dept Mol Biophys, New Haven, CT 06510 USA.
   [Gibson, Kimberley H.; Shang, Zhiguo; Sindelar, Charles V.] Yale Univ, Sch Med, Dept Biochem, New Haven, CT 06510 USA.
   [Trajtenberg, Felipe; Buschiazzo, Alejandro] Inst Pasteur Montevideo, Lab Mol & Struct Microbiol, Montevideo, Uruguay.
   [Buschiazzo, Alejandro] Inst Pasteur, Dept Microbiol, Paris, France.
   [Slamti, Leyla] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, Jouy En Josas, France.
RP Wunder, EA (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Wunder, EA (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Salvador, BA, Brazil.; Picardeau, M (corresponding author), Inst Pasteur, Biol Spirochetes Unit, Paris, France.
EM elsio.wunder@yale.edu; mpicard@pasteur.fr
RI Wunder, Elsio Augusto/C-2733-2013; Buschiazzo, Alejandro/W-1095-2018;
   Ko, Albert Icksang/P-2343-2015
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Buschiazzo,
   Alejandro/0000-0002-2509-6526; Ko, Albert Icksang/0000-0001-9023-2339;
   Trajtenberg, Felipe/0000-0003-0427-5549; Gibson,
   Kimberley/0000-0001-8881-1411
FU Institut Pasteur, Paris, France; French Ministry of ResearchMinistry of
   Research, France [ANR-08-MIE-018]; AK NIH grants [NIAID U01 AI088752,
   Fogarty R01 TW009504-05, NIAID R01 AI052473]; ANII-Uruguay
   [FCE_3_2016_1_126797, ALI_1_2014_1_4982]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW009504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI121207,
   R01AI121207, R01AI121207, R01AI121207, R01AI121207] Funding Source: NIH
   RePORTER
FX This work was supported by the Institut Pasteur, Paris, France, and the
   French Ministry of Research ANR-08-MIE-018 and AK NIH grants NIAID U01
   AI088752, Fogarty R01 TW009504-05 and NIAID R01 AI052473. AB
   acknowledges partial support from ANII-Uruguay (grants
   FCE_3_2016_1_126797 and ALI_1_2014_1_4982). We thank Priscilla Oliveira
   de Giuseppe and Lucas Villasboas de Oliveira for preliminary screening
   of the library of random mutants, as well as Morven Graham and Xinran
   Liu of the electron microscopy core facility at the Yale School of
   Medicine (Center for Cellular and Molecular Imaging) for assistance with
   the immunogold labeling and aiding in cryo-EM data acquisition,
   respectively. We thank staff in the High-Performance Computing facility
   for their maintenance of these facilities.
CR Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Fontana C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152916
   Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403
   GOLDSTEIN SF, 1988, CELL MOTIL CYTOSKEL, V9, P101, DOI 10.1002/cm.970090202
   GOLDSTEIN SF, 1990, P NATL ACAD SCI USA, V87, P4895, DOI 10.1073/pnas.87.13.4895
   Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12
   Li CH, 2010, J BACTERIOL, V192, P2596, DOI 10.1128/JB.01502-09
   Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Martin FS, 2017, ACTA CRYSTALLOGR F, V73, P123, DOI 10.1107/S2053230X17002096
   Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007
   Pallen MJ, 2005, TRENDS MICROBIOL, V13, P143, DOI 10.1016/j.tim.2005.02.008
   Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x
   Picardeau M, 2008, APPL ENVIRON MICROB, V74, P319, DOI 10.1128/AEM.02172-07
   Picardeau M, 2018, CURR TOP MICROBIOL, V415, P141, DOI 10.1007/82_2017_45
   Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5
   Qin Z, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00695-16
   Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010
   Slamti Leyla, 2012, Methods Mol Biol, V859, P169, DOI 10.1007/978-1-61779-603-6_9
   Stewart PE, 2016, APPL ENVIRON MICROB, V82, P1183, DOI 10.1128/AEM.03056-15
   Takabe K, 2017, BIOCHEM BIOPH RES CO, V491, P1040, DOI 10.1016/j.bbrc.2017.08.007
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122
   Wolgemuth CW, 2015, SEMIN CELL DEV BIOL, V46, P104, DOI 10.1016/j.semcdb.2015.10.015
   Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403
   Wunder EA, 2016, INFECT IMMUN, V84, P2105, DOI 10.1128/IAI.00094-16
   Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830
   Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003
   Zhao XW, 2014, BIOCHEMISTRY-US, V53, P4323, DOI 10.1021/bi500059y
   Zhu SW, 2017, P NATL ACAD SCI USA, V114, P10966, DOI 10.1073/pnas.1712489114
NR 32
TC 3
Z9 3
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD MAY 8
PY 2018
VL 8
AR 130
DI 10.3389/fcimb.2018.00130
PG 10
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GF1HW
UT WOS:000431685800001
PM 29868490
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Ribeiro, GS
   Kikuti, M
   Tauro, LB
   Cardoso, CW
   Paploski, IAD
   Ko, AI
   Weaver, SC
   Reis, MG
   Kitron, U
AF Ribeiro, Guilherme S.
   Kikuti, Mariana
   Tauro, Laura B.
   Cardoso, Cristiane W.
   Paploski, Igor A. D.
   Ko, Albert I.
   Weaver, Scott C.
   Reis, Mitermayer G.
   Kitron, Uriel
TI Can Zika virus antibodies cross-protect against dengue virus?
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID INFECTION
C1 [Ribeiro, Guilherme S.; Kikuti, Mariana; Tauro, Laura B.; Paploski, Igor A. D.; Ko, Albert I.; Reis, Mitermayer G.; Kitron, Uriel] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.; Kikuti, Mariana; Paploski, Igor A. D.; Reis, Mitermayer G.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Cardoso, Cristiane W.] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Univ, New Haven, CT USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015; Ribeiro,
   Guilherme/B-6624-2008; Kikuti, Mariana/G-2313-2017; Paploski, Igor
   AD/D-7015-2014
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; Ribeiro, Guilherme/0000-0002-6798-2059;
   Kikuti, Mariana/0000-0001-8119-7236; Paploski, Igor
   AD/0000-0002-3689-2042; Cardoso, Cristiane/0000-0001-5432-1174
CR BRASIL, 2018, B EPIDEMIOLOGICO, V49, P1, DOI DOI 10.1111/are.13485
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 4
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD MAY
PY 2018
VL 6
IS 5
BP E495
EP E495
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GC5ZU
UT WOS:000429870700014
PM 29653620
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Carvalho-Pereira, T
   Souza, FN
   Santos, LRN
   Walker, R
   Pertile, AC
   de Oliveira, DS
   Pedra, GG
   Minter, A
   Rodrigues, MG
   Bahiense, TC
   Reis, MG
   Diggle, PJ
   Ko, AI
   Childs, JE
   da Silva, EM
   Begon, M
   Costa, F
AF Carvalho-Pereira, Ticiana
   Souza, Fabio N.
   Santos, Luana R. N.
   Walker, Ruth
   Pertile, Arsinoe C.
   de Oliveira, Daiana S.
   Pedra, Gabriel G.
   Minter, Amanda
   Rodrigues, Maria Gorete
   Bahiense, Thiago C.
   Reis, Mitermayer G.
   Diggle, Peter J.
   Ko, Albert I.
   Childs, James E.
   da Silva, Eduardo M.
   Begon, Mike
   Costa, Federico
TI The helminth community of a population of Rattus norvegicus from an
   urban Brazilian slum and the threat of zoonotic diseases
SO PARASITOLOGY
LA English
DT Article
DE Rattus norvegicus; helminth community; slum settlements; human
   pathogens; Angiostrongylus cantonensis; risk factors; spillover risk;
   urban
ID ANGIOSTRONGYLUS-CANTONENSIS; NORWAY RATS;
   IMMUNOLOGICAL-UNRESPONSIVENESS; NIPPOSTRONGYLUS-BRASILIENSIS;
   LEPTOSPIRA-INTERROGANS; HYMENOLEPIS-DIMINUTA; LARVAL RECOVERY;
   TOXOCARA-CATI; EGG COUNTS; INFECTION
AB Urban slums provide suitable conditions for infestation by rats, which harbour and shed a wide diversity of zoonotic pathogens including helminths. We aimed to identify risk factors associated with the probability and intensity of infection of helminths of the digestive tract in an urban slum population of Rattus norvegicus. Among 299 rats, eleven species/groups of helminths were identified, of which Strongyloides sp., Nippostrongylus brasiliensis and, the human pathogen, Angiostrongylus cantonensis were the most frequent (97, 41 and 39%, respectively). Sex interactions highlighted behavioural differences between males and females, as eg males were more likely to be infected with N. brasiliensis where rat signs were present, and males presented more intense infections of Strongyloides sp. Moreover, rats in poor body condition had higher intensities of N. brasiliensis. We describe a high global richness of parasites in it norvegicus, including five species known to cause disease in humans. Among these, A. cantonensis was found in high prevalence and it was ubiquitous in the study area - knowledge which is of public health importance. A variety of environmental, demographic and body condition variables were associated with helminth species infection of rats, suggesting a comparable variety of risk factors for humans.
C1 [Carvalho-Pereira, Ticiana; Bahiense, Thiago C.; Reis, Mitermayer G.; da Silva, Eduardo M.; Costa, Federico] Univ Fed Bahia, UFBA, Salvador, BA, Brazil.
   [Carvalho-Pereira, Ticiana; Souza, Fabio N.; Santos, Luana R. N.; Walker, Ruth; Pertile, Arsinoe C.; de Oliveira, Daiana S.; Reis, Mitermayer G.; Costa, Federico] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Pedra, Gabriel G.; Minter, Amanda; Begon, Mike; Costa, Federico] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
   [Rodrigues, Maria Gorete] Minist Saude, Ctr Controle Zoonoses, Secretaria Municipal Saude, Salvador, BA, Brazil.
   [Reis, Mitermayer G.; Ko, Albert I.; Childs, James E.; Costa, Federico] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Diggle, Peter J.] Univ Lancaster, Lancaster Med Sch, Lancaster, England.
RP Carvalho-Pereira, T (corresponding author), Univ Fed Bahia, UFBA, Salvador, BA, Brazil.; Carvalho-Pereira, T (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
EM carvalhopereira.tsa@hotmail.com
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020; Costa,
   Federico/G-1838-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Costa, Federico/0000-0001-6951-2336;
   NEVES, FABIO/0000-0002-3542-8918; Diggle, Peter/0000-0003-3521-5020; ,
   Amanda/0000-0003-1171-5688; Carvalho Pereira,
   Ticiana/0000-0003-2370-2198
FU Oswaldo Cruz Foundation; Secretariat of Health Surveillance, Brazilian
   Ministry of Health; National Institutes of Health of the United
   StatesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [F31 AI114245, R01 AI052473, U01
   AI088752, R01 TW009504, R25 TW009338]; Wellcome TrustWellcome Trust
   [102330/Z/13/Z]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW009504, R25TW009338,
   R01TW009504, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R01TW009504, R01TW009504, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R01TW009504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, R01AI052473,
   F31AI114245, U01AI088752, R01AI052473, U01AI088752, R01AI052473,
   U01AI088752, R01AI052473, R01AI052473, R01AI052473, U01AI088752,
   R01AI052473, U01AI088752, R01AI052473, F31AI114245, R01AI052473,
   U01AI088752, R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the Oswaldo Cruz Foundation and Secretariat
   of Health Surveillance, Brazilian Ministry of Health, the National
   Institutes of Health of the United States (grant numbers F31 AI114245,
   R01 AI052473, U01 AI088752, R01 TW009504 and R25 TW009338) and by the
   Wellcome Trust (102330/Z/13/Z).
CR Adejinmi JO, 2011, S AFR J WILDL RES, V41, P214, DOI 10.3957/056.041.0209
   Alicata J. E., 1965, Advances in Parasitology, V3, P223
   Almeida A., 2013, SUBURBAN SUSTAINABIL, V1, P1, DOI DOI 10.5038/2164-0866.1.1.2
   Alruzug IM, 2016, BACTERIOLOGY PARASIT, V7, P265
   Araujo P, 1967, REV FAC FARM BIOQUIM, V5, P141
   BARTLETT MS, 1978, J CLIN MICROBIOL, V7, P524
   Beldomenico PM, 2010, TRENDS ECOL EVOL, V25, P21, DOI 10.1016/j.tree.2009.06.015
   CALHOUN JB, 1962, PUBLIC HLTH SERVICE, V1008
   Carvalho OD, 2012, MEM I OSWALDO CRUZ, V107, P740, DOI 10.1590/S0074-02762012000600006
   Childs JE, 1998, AM J EPIDEMIOL, V148, P78, DOI 10.1093/oxfordjournals.aje.a009563
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   Crawley MJ, 2007, R BOOK
   Cringoli G, 2004, VET PARASITOL, V123, P121, DOI 10.1016/j.vetpar.2004.05.021
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   DINEEN JK, 1973, IMMUNOLOGY, V25, P141
   Falcon-Ordaz J, 2010, REV MEX BIODIVERS, V81, P669
   Faust E. C., 1938, American Journal of Tropical Medicine, V18, P169
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Garcia MHO, 2008, SECRETARIA VIGILANCI, V8, P1
   Gillespie TR, 2006, CONSERV BIOL, V20, P441, DOI 10.1111/j.1523-1739.2006.00290.x
   GLASS GE, 1988, EPIDEMIOL INFECT, V101, P459, DOI 10.1017/S0950268800054418
   Villafane IE, 2008, HELMINTHOLOGIA, V45, P126, DOI 10.2478/s11687-008-0024-1
   Gordon H. McL., 1939, Journal of the Council for Scientific and Industrial Research Australia, V12, P50
   Hacker KP, 2016, URBAN ECOSYST, V19, P561, DOI 10.1007/s11252-015-0519-8
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Hancke D, 2011, HELMINTHOLOGIA, V48, P167, DOI 10.2478/s11687-011-0025-3
   Himsworth CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091654
   Hoffman W.A., 1934, PUERTO RICO J PUBL H, V9, P283
   HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663
   JARRETT EEE, 1968, EXP PARASITOL, V23, P151, DOI 10.1016/0014-4894(68)90053-2
   JARRETT EEE, 1966, NATURE, V211, P1310, DOI 10.1038/2111310a0
   Kataranovski D, 2010, ARCH BIOL SCI, V62, P1091, DOI 10.2298/ABS1004091K
   Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Kunwar CB, 2005, JIOM NEPAL, V27, P66
   Lescano SZ, 2004, MEM I OSWALDO CRUZ, V99, P627, DOI 10.1590/S0074-02762004000600016
   Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201
   Lo Re III V, 2003, AM J MED, V114, P217, DOI 10.1016/S0002-9343(02)01495-X
   Long J.L., 2003, INTRO MAMMALS WORLD
   Lynsdale CL, 2015, INT J PARASITOL-PAR, V4, P307, DOI 10.1016/j.ijppaw.2015.06.001
   Martins AV, 1977, PESSOA PARASITOLOGIA
   McGarry JW, 2015, ZOONOSES PUBLIC HLTH, V62, P44, DOI 10.1111/zph.12116
   Mercer JG, 2000, PARASITOLOGY, V120, P641, DOI 10.1017/S0031182099005922
   Mills JN, 1995, METHODS TRAPPING SAM
   Mirdha BR, 2002, J TROP PEDIATRICS, V48, P331, DOI 10.1093/tropej/48.6.331
   Morassutti AL, 2014, MEM I OSWALDO CRUZ, V109, P399, DOI 10.1590/0074-0276140023
   Moreira VLC, 2013, ACTA TROP, V125, P90, DOI 10.1016/j.actatropica.2012.10.001
   Nursyazana MT, 2013, TROP BIOMED, V30, P199
   Ooi GL, 2007, J URBAN HEALTH, V84, pI27, DOI 10.1007/s11524-007-9167-5
   Panti-May JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152511
   Patamia I, 2010, KOREAN J PARASITOL, V48, P167, DOI 10.3347/kjp.2010.48.2.167
   Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x
   Pinto HA, 2014, REV BRAS PARASITOL V, V23, P522, DOI 10.1590/S1984-29612014074
   Puckett EE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1762
   R Development Core Team, 2011, R LANG ENV STAT COMP
   Rafique A, 2009, PAK VET J, V29, P141
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Santos ND, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/01021-311x00132115, 10.1590/01021-311X00132115, 10.1590/0102-311X00132115]
   Santos SV, 2009, MEM I OSWALDO CRUZ, V104, P933, DOI 10.1590/S0074-02762009000600020
   Schantz PM, 1996, GASTROENTEROL CLIN N, V25, P637, DOI 10.1016/S0889-8553(05)70267-3
   Schnyder M, 2011, PARASITOL RES, V109, P63, DOI 10.1007/s00436-010-2221-3
   Simoes RO, 2016, J HELMINTHOL, V90, P21, DOI 10.1017/S0022149X14000704
   Singleton GR, 2003, AUSTR CTR INT AGR RE, V96
   Tena D, 1998, J CLIN MICROBIOL, V36, P2375, DOI 10.1128/JCM.36.8.2375-2376.1998
   Thiengo SC, 2007, BIOL INVASIONS, V9, P693, DOI 10.1007/s10530-006-9069-6
   Tiwari Shreekant, 2014, J Lab Physicians, V6, P58, DOI 10.4103/0974-2727.129096
   UN (United Nations), 2005, INV DEV PRACT PLAN A
   United Nations, 2003, CHALL SLUMGLOB REP
   United Nations, 2016, URB DEV EM FEAT UN H
   Vadell MV, 2014, WILDLIFE RES, V41, P172, DOI 10.1071/WR14005
   Vicente Joaquim Julio, 1997, Revista Brasileira de Zoologia, V14, P1
   Walker R, 2017, EPIDEMIOL INFECT, V145, P334, DOI 10.1017/S0950268816002259
   Wang QP, 2012, EUR J CLIN MICROBIOL, V31, P389, DOI 10.1007/s10096-011-1328-5
   Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9
   Waugh CA, 2006, J PARASITOL, V92, P1014, DOI 10.1645/GE-795R1.1
   WEBSTER JP, 1995, PARASITOLOGY, V111, P247, DOI 10.1017/S0031182000081804
   Wolff JO, 2003, RATS MICE PEOPLE ROD, V96, P124
   Zain SNM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-47
   ZUK M, 1990, PARASITOL TODAY, V6, P231, DOI 10.1016/0169-4758(90)90202-F
NR 83
TC 7
Z9 7
U1 2
U2 8
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
EI 1469-8161
J9 PARASITOLOGY
JI Parasitology
PD MAY
PY 2018
VL 145
IS 6
BP 797
EP 806
DI 10.1017/S0031182017001755
PG 10
WC Parasitology
SC Parasitology
GA GL4VP
UT WOS:000437158300012
PM 29113595
OA Green Accepted
DA 2020-11-30
ER

PT J
AU Schneider, AG
   Casanovas-Massana, A
   Hacker, KP
   Wunder, EA
   Begon, M
   Reis, MG
   Childs, JE
   Costa, F
   Lindow, JC
   Ko, AI
AF Schneider, Andrew G.
   Casanovas-Massana, Arnau
   Hacker, Kathryn P.
   Wunder, Elsio A., Jr.
   Begon, Mike
   Reis, Mitermayer G.
   Childs, James E.
   Costa, Federico
   Lindow, Janet C.
   Ko, Albert I.
TI Quantification of pathogenic Leptospira in the soils of a Brazilian
   urban slum
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID NORWAY RATS; SP NOV.; SOURCE TRACKING; INTERROGANS; PCR; PHILIPPINES;
   RAINFALL; MANURE; SPP.; TRANSPORT
AB Background
   Leptospirosis is an important zoonotic disease that causes considerable morbidity and mortality globally, primarily in residents of urban slums. While contact with contaminated water plays a critical role in the transmission of leptospirosis, little is known about the distribution and abundance of pathogenic Leptospira spp. in soil and the potential contribution of this source to human infection.
   Methods/Principal findings
   We collected soil samples (n = 70) from three sites within an urban slum community endemic for leptospirosis in Salvador, Brazil. Using qPCR of Leptospira genes 1ipl32 and 16S rRNA, we quantified the pathogenic Leptospira load in each soil sample. 1ipl32 qPCR detected pathogenic Leptospira in 22 (31%) of 70 samples, though the median concentration among positive samples was low (median = 6 GEq/g; range: 4-4.31x10(2) GEq/g). We also observed heterogeneity in the distribution of pathogenic Leptospira at the fine spatial scale. However, when using 16S rRNA qPCR, we detected a higher proportion of Leptospira-positive samples (86%) and higher bacterial concentrations (median: 4.16x10(2) GEq/g; range: 4-2.58x10(4) GEq/g). Sequencing of the qPCR amplicons and qPCR analysis with all type Leptospira species revealed that the 16S rRNA qPCR detected not only pathogenic Leptospira but also intermediate species, although both methods excluded saprophytic Leptospira. No significant associations were identified between the presence of pathogenic Leptospira DNA and environmental characteristics (vegetation, rat activity, distance to an open sewer or a house, or soil clay content), though samples with higher soil moisture content showed higher prevalences.
   Conclusion/Significance
   This is the first study to successfully quantify the burden of pathogenic Leptospira in soil from an endemic region. Our results support the hypothesis that soil may be an under-recognized environmental reservoir contributing to transmission of pathogenic Leptospira in urban slums. Consequently, the role of soil should be considered when planning interventions aimed to reduce the burden of leptospirosis in these communities.
C1 [Schneider, Andrew G.; Casanovas-Massana, Arnau; Hacker, Kathryn P.; Wunder, Elsio A., Jr.; Reis, Mitermayer G.; Childs, James E.; Costa, Federico; Lindow, Janet C.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Hacker, Kathryn P.; Wunder, Elsio A., Jr.; Reis, Mitermayer G.; Costa, Federico; Lindow, Janet C.; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Begon, Mike; Costa, Federico] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
   [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
RP Casanovas-Massana, A; Ko, AI (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.; Ko, AI (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
EM arnau.casanovas@yale.edu; albert.ko@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015; Reis,
   Mitermayer/AAO-9742-2020; Wunder, Elsio Augusto/C-2733-2013;
   Casanovas-Massana, Arnau/H-5806-2019
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336; Reis, Mitermayer/0000-0002-3051-9060;
   Wunder, Elsio Augusto/0000-0002-5239-8511; Casanovas-Massana,
   Arnau/0000-0002-3301-6143; Lindow, Janet/0000-0003-3235-3698; Hacker,
   Kathryn/0000-0001-5267-1699
FU National Institutes for HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI052473, U01
   AI088752, R25 TW009338, R01 TW009504, R01 AI121207]; Downs International
   Health Student Travel Fellowship; Field Research Grant from the Tinker
   Foundation; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207, R01AI121207]
   Funding Source: NIH RePORTER
FX This research was supported by the National Institutes for Health
   research grants R01 AI052473, U01 AI088752, R25 TW009338, R01 TW009504
   and R01 AI121207. AGS was supported by a Downs International Health
   Student Travel Fellowship and a Field Research Grant from the Tinker
   Foundation. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR ALEXANDER AD, 1975, APPL MICROBIOL, V29, P30, DOI 10.1128/AEM.29.1.30-33.1975
   Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   Arzouni JP, 2002, EMERG INFECT DIS, V8, P865, DOI 10.3201/eid0808.010445
   Azali MA, 2016, J TROP MED-US, V2016, DOI 10.1155/2016/2060241
   Benacer D, 2016, ASIA-PAC J PUBLIC HE, V28, P290, DOI 10.1177/1010539516640350
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Casanovas-Massana A, 2018, WATER RES, V130, P176, DOI 10.1016/j.watres.2017.11.068
   Chiriboga J, 2015, EMERG INFECT DIS, V21, P2141, DOI 10.3201/eid2112.140659
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746
   FAINE S., 1994, LEPTOSPIRA LEPTOSPIR
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Garcia-Aljaro C, 2017, WATER RES, V112, P248, DOI 10.1016/j.watres.2017.02.003
   Gouveia EL, 2008, EMERG INFECT DIS, V14, P1, DOI [10.1017/S0950268806007746, DOI 10.1017/S0950268806007746]
   Guber AK, 2006, APPL ENVIRON MICROB, V72, P7531, DOI 10.1128/AEM.01121-06
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hacker KP, 2016, URBAN ECOSYST, V19, P561, DOI 10.1007/s11252-015-0519-8
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   HELLSTROM JS, 1978, RES VET SCI, V25, P29, DOI 10.1016/S0034-5288(18)33003-0
   HENRY RA, 1978, APPL ENVIRON MICROB, V35, P492, DOI 10.1128/AEM.35.3.492-499.1978
   Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195
   Khairani-Bejo S., 2004, Journal of Animal and Veterinary Advances, V3, P123
   KIRSCHNER L, 1957, N Z Med J, V56, P385
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0
   Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McGechan MB, 2003, SOIL USE MANAGE, V19, P321, DOI 10.1079/SUM2003321
   Munoz-Zanzi C, 2014, INT J ENV RES PUB HE, V11, P6666, DOI 10.3390/ijerph110706666
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Petersen AM, 2001, J MED MICROBIOL, V50, P96, DOI 10.1099/0022-1317-50-1-96
   Puche R, 2018, INT J SYST EVOL MICR, V68, P513, DOI 10.1099/ijsem.0.002528
   Ramirez NE, 2009, J ENVIRON QUAL, V38, P2394, DOI 10.2134/jeq2008.0432
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Reischer GH, 2008, ENVIRON MICROBIOL, V10, P2598, DOI 10.1111/j.1462-2920.2008.01682.x
   Riediger IN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160523
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Saito M, 2014, APPL ENVIRON MICROB, V80, P6926, DOI 10.1128/AEM.02568-14
   Saito M, 2013, APPL ENVIRON MICROB, V79, P601, DOI 10.1128/AEM.02728-12
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Semenov AV, 2009, APPL ENVIRON MICROB, V75, P3206, DOI 10.1128/AEM.01791-08
   Slack AT, 2009, INT J SYST EVOL MICR, V59, P705, DOI 10.1099/ijs.0.002766-0
   Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Sumanta H., 2015, OPEN J EPIDEMIOLOGY, V5, P22, DOI DOI 10.4236/0JEPI.2015.51004
   Tangkanakul W., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P281
   Thibeaux R, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000144
   Thibeaux R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005414
   Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122
   UN-HABITAT, 2003, CHALL SLUMS GLOB REP
   Viau EJ, 2011, J WATER HEALTH, V9, P637, DOI 10.2166/wh.2011.064
   Villanueva SYAM, 2010, AM J TROP MED HYG, V82, P889, DOI 10.4269/ajtmh.2010.09-0711
   Yang W, 1994, Zhonghua Liu Xing Bing Xue Za Zhi, V15, P289
NR 60
TC 15
Z9 15
U1 1
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2018
VL 12
IS 4
AR e0006415
DI 10.1371/journal.pntd.0006415
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH5QP
UT WOS:000433487700050
PM 29624576
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Costa, F
   Ko, AI
AF Costa, Federico
   Ko, Albert I.
TI Zika virus and microcephaly: where do we go from here?
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID INFECTION; BRAZIL; PREGNANCY; JANUARY; INFANTS; BIRTH
C1 [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Costa, Federico; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
RP Ko, AI (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.; Ko, AI (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
EM albert.ko@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   deAraujo T.V.B, 2017, LANCET INFECT DIS
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 13
TC 6
Z9 6
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2018
VL 18
IS 3
BP 236
EP 237
DI 10.1016/S1473-3099(17)30697-7
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA FX2ZO
UT WOS:000425938000011
PM 29242092
OA Bronze
DA 2020-11-30
ER

PT J
AU Casanovas-Massana, A
   Costa, F
   Riediger, IN
   Cunha, M
   de Oliveira, D
   Mota, DC
   Sousa, E
   Querino, VA
   Nery, N
   Reis, MG
   Wunder, EA
   Diggle, PJ
   Ko, AI
AF Casanovas-Massana, Arnau
   Costa, Federico
   Riediger, Irina N.
   Cunha, Marcelo
   de Oliveira, Daiana
   Mota, Diogenes C.
   Sousa, Erica
   Querino, Vladimir A.
   Nery, Nivisson, Jr.
   Reis, Mitermayer G.
   Wunder, Elsio A., Jr.
   Diggle, Peter J.
   Ko, Albert I.
TI Spatial and temporal dynamics of pathogenic Leptospira in surface waters
   from the urban slum environment
SO WATER RESEARCH
LA English
DT Article
DE Leptospira; Leptospirosis; Surface water; Public health; Sewage; Urban
   slum
ID REAL-TIME PCR; RISK-FACTORS; INTERROGANS; OUTBREAK; INFECTION; FLOOD;
   DISSEMINATION; PHILIPPINES; EPIDEMIC; SURVIVAL
AB Leptospirosis has emerged as an important urban health problem as slum settlements have expanded worldwide. Yet the dynamics of the environmentally transmitted Leptospira pathogen has not been well characterized in these settings. We used a stratified dense sampling scheme to study the dynamics of Leptospira abundance in surface waters from a Brazilian urban slum community. We collected surface water samples during the dry, intermediate and rainy seasons within a seven-month period and quantified pathogenic Leptospira by quantitative PCR (qPCR). We used logistic and linear mixed models to identify factors that explained variation for the presence and concentration of Leptospira DNA. Among 335 sewage and 250 standing water samples, Leptospira DNA were detected in 36% and 34%, respectively. Among the 236 samples with positive results geometric mean Leptospira concentrations were 152 GEq/ mL The probability of finding Leptospira DNA was higher in sewage samples collected during the rainy season when increased leptospirosis incidence occurred, than during the dry season (47.2% vs 12.5%, respectively, p = 0.0002). There was a marked spatial and temporal heterogeneity in Leptospira DNA distribution, for which type of water, elevation, and time of day that samples were collected, in addition to season, were significant predictors. Together, these findings indicate that Leptospira are ubiquitous in the slum environment and that the water-related risk to which inhabitants are exposed is low. Seasonal increases in Leptospira presence may explain the timing of leptospirosis outbreaks. Effective prevention wilt need to consider the spatial and temporal dynamics of pathogenic Leptospira in surface waters to reduce the burden of the disease. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Casanovas-Massana, Arnau; Costa, Federico; Reis, Mitermayer G.; Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Costa, Federico; Riediger, Irina N.; de Oliveira, Daiana; Mota, Diogenes C.; Sousa, Erica; Querino, Vladimir A.; Nery, Nivisson, Jr.; Reis, Mitermayer G.; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, Salvador, BA, Brazil.
   [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Rua Basilio da Gama S-N,Campus Univ Canela, Salvador, BA, Brazil.
   [Riediger, Irina N.] Lab Cent Estado Parana, Curitiba, Parana, Brazil.
   [Riediger, Irina N.] Rua Sebastiana Santana Fraga 1001, Sao Jose Dos Pinhais, Parana, Brazil.
   [Cunha, Marcelo] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rua Leopoldo Bulhoes 1480, Manguinho, RJ, Brazil.
   [Diggle, Peter J.] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YG, England.
RP Ko, AI (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.; Ko, AI (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, Salvador, BA, Brazil.
EM albert.ko@yale.edu
RI Wunder, Elsio Augusto/C-2733-2013; Ko, Albert Icksang/P-2343-2015;
   Costa, Federico/G-1838-2015; Casanovas-Massana, Arnau/H-5806-2019; Reis,
   Mitermayer/AAO-9742-2020
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Ko, Albert
   Icksang/0000-0001-9023-2339; Costa, Federico/0000-0001-6951-2336;
   Casanovas-Massana, Arnau/0000-0002-3301-6143; Reis,
   Mitermayer/0000-0002-3051-9060; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602; Diggle, Peter/0000-0003-3521-5020
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI052473, U01
   AI088752, R25 TW009338, R01 TW009504, R01 AI121207]; Brazilian Ministry
   of Education [BEX 066509-6]; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R01TW009504, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R01TW009504, R01TW009504,
   R01TW009504, R25TW009338, R25TW009338, R01TW009504, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, U01AI088752, U01AI088752, U01AI088752,
   R01AI121207, R01AI121207, R01AI121207, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, R01AI052473, U01AI088752, R01AI121207,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, R01AI121207,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX The authors thank the joint collaborative effort of the resident
   associations, community leaders and residents, which constitute the
   Urban Health Council of Pau da Lima. This research was supported by the
   National Institutes of Health research grants R01 AI052473, U01
   AI088752, R25 TW009338, R01 TW009504 and R01 AI121207. INR was supported
   by Ph.D. scholarship (BEX 066509-6) from the Brazilian Ministry of
   Education.
CR Agampodi SB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002626
   Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59
   Barragan VA, 2011, CURR MICROBIOL, V62, P1802, DOI 10.1007/s00284-011-9931-3
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Bourhy P, 2012, J CLIN MICROBIOL, V50, P307, DOI 10.1128/JCM.05931-11
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   CHANG SL, 1948, J INFECT DIS, V82, P256, DOI 10.1093/infdis/82.3.256
   Chusri Sarunyou, 2012, Journal of the Medical Association of Thailand, V95, P874
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   de Araujo WN, 2013, AM J TROP MED HYG, V88, P359, DOI 10.4269/ajtmh.2012.12-0245
   Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377
   FELZEMBURGH RDM, 2014, PLOS NEGL TROP DIS, V8
   Fox J, 2003, J STAT SOFTW, V8, P1, DOI [DOI 10.18637/JSS.V008.I15, 10.18637/jss.v008.i15]
   Fox J, 2009, J STAT SOFTW, V32, P1
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   HELLSTROM JS, 1978, RES VET SCI, V25, P29, DOI 10.1016/S0034-5288(18)33003-0
   Hochedez P, 2011, AM J TROP MED HYG, V84, P621, DOI 10.4269/ajtmh.2011.10-0502
   Karande S, 2005, J TROP PEDIATRICS, V51, P174, DOI 10.1093/tropej/fmh100
   Karande Sunil, 2002, Indian Journal of Pediatrics, V69, P855, DOI 10.1007/BF02723705
   Khairani-Bejo S., 2004, Journal of Animal and Veterinary Advances, V3, P123
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kurilung A, 2017, RES VET SCI, V115, P146, DOI 10.1016/j.rvsc.2017.03.017
   Kuznetsova A., 2013, IMERTEST TESTS RANDO
   Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1
   Lau CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004405
   Leal-Castellanos CB, 2003, EPIDEMIOL INFECT, V131, P1149, DOI 10.1017/S0950268803001201
   Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01
   Lourdault K, 2009, J MED MICROBIOL, V58, P648, DOI 10.1099/jmm.0.008169-0
   Munoz-Zanzi C, 2014, INT J ENV RES PUB HE, V11, P6666, DOI 10.3390/ijerph110706666
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Nocker A, 2009, FEMS MICROBIOL LETT, V291, P137, DOI 10.1111/j.1574-6968.2008.01429.x
   OKAZAKI W, 1957, AM J VET RES, V18, P219
   Oliveira DSC, 2009, ANN TROP MED PARASIT, V103, P149, DOI 10.1179/136485909X398221
   PALMER MF, 1987, EPIDEMIOL INFECT, V98, P191, DOI 10.1017/S0950268800061902
   Panti-May JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152511
   R Core Team R, 2013, LANG ENV STAT COMP
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Riediger IN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160523
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Saito M, 2013, APPL ENVIRON MICROB, V79, P601, DOI 10.1128/AEM.02728-12
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Smith JKG, 2013, EPIDEMIOL INFECT, V141, P585, DOI 10.1017/S0950268812001021
   Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Sumanta H., 2015, OPEN J EPIDEMIOLOGY, V5, P22, DOI DOI 10.4236/0JEPI.2015.51004
   Tangkanakul W., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P281
   Tassinari Wagner de Souza, 2004, Cad. Saúde Pública, V20, P1721, DOI 10.1590/S0102-311X2004000600031
   Thibeaux R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005414
   Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Trueba G, 2004, INT MICROBIOL, V7, P35
   [UN-HABITAT U. Nations], 2013, STAT WORLDS CIT 2012
   Unger A., 2016, SLUM HLTH, P105
   Viau EJ, 2011, J WATER HEALTH, V9, P637, DOI 10.2166/wh.2011.064
   Weinberger D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002798
   Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403
   Wunder EA, 2016, INFECT IMMUN, V84, P2105, DOI 10.1128/IAI.00094-16
   Zhang Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-20
NR 63
TC 18
Z9 18
U1 0
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0043-1354
J9 WATER RES
JI Water Res.
PD MAR 1
PY 2018
VL 130
BP 176
EP 184
DI 10.1016/j.watres.2017.11.068
PG 9
WC Engineering, Environmental; Environmental Sciences; Water Resources
SC Engineering; Environmental Sciences & Ecology; Water Resources
GA FU9KG
UT WOS:000424174200019
PM 29220718
OA Green Accepted
DA 2020-11-30
ER

PT J
AU Adhikarla, H
   Wunder, EA
   Mechaly, AE
   Mehta, S
   Wang, Z
   Santos, L
   Bisht, V
   Diggle, P
   Murray, G
   Adler, B
   Lopez, F
   Townsend, JP
   Groisman, E
   Picardeau, M
   Buschiazzo, A
   Ko, AI
AF Adhikarla, Haritha
   Wunder, Elsio A., Jr.
   Mechaly, Ariel E.
   Mehta, Sameet
   Wang, Zheng
   Santos, Luciane
   Bisht, Vimla
   Diggle, Peter
   Murray, Gerald
   Adler, Ben
   Lopez, Francesc
   Townsend, Jeffrey P.
   Groisman, Eduardo
   Picardeau, Mathieu
   Buschiazzo, Alejandro
   Ko, Albert I.
TI Lvr, a Signaling System That Controls Global Gene Regulation and
   Virulence in Pathogenic Leptospira
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Leptospira; pathogenic; branched signaling; two-component system; hybrid
   histidine kinase; hybrid response regulator; virulence; gene duplication
ID HISTIDINE KINASE; RESPONSE REGULATOR; INTERROGANS; PROTEIN; EXPRESSION;
   IDENTIFICATION; INSIGHTS; DOMAINS; COMPLEX; SENSOR
AB Leptospirosis is an emerging zoonotic disease with more than 1 million cases annually. Currently there is lack of evidence for signaling pathways involved during the infection process of Leptospira. In our comprehensive genomic analysis of 20 Leptospira spp. we identified seven pathogen-specific Two-Component System (TCS) proteins. Disruption of two these TCS genes in pathogenic Leptospira strain resulted in loss-of-virulence in a hamster model of leptospirosis. Corresponding genes lvrA and lvrB (leptospira virulence regulator) are juxtaposed in an operon and are predicted to encode a hybrid histidine kinase and a hybrid response regulator, respectively. Transcriptome analysis of lvr mutant strains with disruption of one (lvrB) or both genes (lvrA/B) revealed global transcriptional regulation of 850 differentially expressed genes. Phosphotransfer assays demonstrated that LvrA phosphorylates LvrB and predicted further signaling downstream to one or more DNA-binding response regulators, suggesting that it is a branched pathway. Phylogenetic analyses indicated that lvrA and lvrB evolved independently within different ecological lineages in Leptospira via gene duplication. This study uncovers a novel-signaling pathway that regulates virulence in pathogenic Leptospira (Lvr), providing a framework to understand the molecular bases of regulation in this life-threatening bacterium.
C1 [Adhikarla, Haritha; Wunder, Elsio A., Jr.; Santos, Luciane; Bisht, Vimla; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Mechaly, Ariel E.; Buschiazzo, Alejandro] Inst Pasteur Montevideo, Lab Mol & Struct Microbiol, Montevideo, Uruguay.
   [Mehta, Sameet; Lopez, Francesc] Yale Ctr Genome Anal, West Haven, CT USA.
   [Wang, Zheng; Townsend, Jeffrey P.] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT USA.
   [Santos, Luciane; Ko, Albert I.] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Diggle, Peter] Lancaster Med Sch, Lancaster, England.
   [Murray, Gerald; Adler, Ben] Monash Univ, Biomed Discovery Inst, Dept Microbiol, Clayton, Vic, Australia.
   [Adler, Ben] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia.
   [Groisman, Eduardo] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA.
   [Picardeau, Mathieu] Inst Pasteur, Biol Spirochetes Unit, Paris, France.
   [Buschiazzo, Alejandro] Inst Pasteur, Dept Microbiol, Paris, France.
RP Ko, AI (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Buschiazzo, A (corresponding author), Inst Pasteur Montevideo, Lab Mol & Struct Microbiol, Montevideo, Uruguay.; Ko, AI (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.; Buschiazzo, A (corresponding author), Inst Pasteur, Dept Microbiol, Paris, France.
EM alebus@pasteur.edu.uy; albert.ko@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013;
   Mehta, Sameet/A-1936-2011; Townsend, Jeffrey/H-2747-2019; Buschiazzo,
   Alejandro/W-1095-2018; Wang, Zheng/A-2318-2011
OI Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Mehta, Sameet/0000-0002-3029-3217;
   Townsend, Jeffrey/0000-0002-9890-3907; Buschiazzo,
   Alejandro/0000-0002-2509-6526; Wang, Zheng/0000-0002-8849-8549; Mechaly,
   Ariel/0000-0002-5305-7495; Murray, Gerald/0000-0003-3330-4433
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U01 AI0038752, R01
   AI052473, R01 TW009504]; Institut Pasteur [A11-2010, 407]; ANII Program
   Alianzas [ALI_1_2014_1_4982]; Program Fondo Sectorial Innovagro
   [FSA_1_2013_1_12557]; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI121207, R01AI121207,
   R01AI052473, R01AI052473, R01AI121207, R01AI121207, R01AI052473,
   R01AI121207] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR,
   NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [S10OD018521] Funding
   Source: NIH RePORTER
FX This work was supported by grants from the National Institutes of Health
   (U01 AI0038752, R01 AI052473, R01 TW009504), Institut Pasteur (ACIP #
   A11-2010 and PTR # 407), ANII Program Alianzas (ALI_1_2014_1_4982) and
   Program Fondo Sectorial Innovagro (FSA_1_2013_1_12557).
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Asuthkar S, 2007, INFECT IMMUN, V75, P4582, DOI 10.1128/IAI.00324-07
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005
   Busch A, 2007, P NATL ACAD SCI USA, V104, P13774, DOI 10.1073/pnas.0701547104
   Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004
   Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12
   Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Eshghi A, 2014, INFECT IMMUN, V82, P2542, DOI 10.1128/IAI.01803-14
   Espinosa J, 2014, P NATL ACAD SCI USA, V111, pE2423, DOI 10.1073/pnas.1404097111
   Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403
   Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002
   Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214
   Garzon A, 1996, J BACTERIOL, V178, P6752, DOI 10.1128/jb.178.23.6752-6758.1996
   Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009
   Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631
   Ibn-Salem J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0423-1
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Kaczmarczyk A, 2015, J BACTERIOL, V197, P1466, DOI 10.1128/JB.00019-15
   Kassegne K, 2014, J INFECT DIS, V209, P1105, DOI 10.1093/infdis/jit659
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104
   Lambert A, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu054
   Lenz O, 1998, P NATL ACAD SCI USA, V95, P12474, DOI 10.1073/pnas.95.21.12474
   Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095
   Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844
   Louvel H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-25
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06
   Miras I, 2015, ACTA CRYSTALLOGR D, V71, P1351, DOI 10.1107/S139900471500704X
   Morero NR, 2014, MOL MICROBIOL, V94, P340, DOI 10.1111/mmi.12763
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135
   Phillips ZEV, 2002, CELL MOL LIFE SCI, V59, P392, DOI 10.1007/s00018-002-8431-9
   Pinne M, 2012, J BACTERIOL, V194, P6074, DOI 10.1128/JB.01119-12
   Powell AJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-147
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Reitzer LJ, 1996, ESCHERICHIA COLI SAL, P391
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Uhl MA, 1996, J BIOL CHEM, V271, P33176, DOI 10.1074/jbc.271.52.33176
   van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008
   Vieira ML, 2014, FEMS MICROBIOL LETT, V352, P129, DOI 10.1111/1574-6968.12349
   Wojnowska M, 2013, CHEM BIOL, V20, P1411, DOI 10.1016/j.chembiol.2013.09.008
   Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002
   Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011
   Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403
   Yamada S, 2009, STRUCTURE, V17, P1333, DOI 10.1016/j.str.2009.07.016
NR 54
TC 4
Z9 4
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD FEB 23
PY 2018
VL 8
AR 45
DI 10.3389/fcimb.2018.00045
PG 13
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FX3RZ
UT WOS:000425991300001
PM 29600195
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Gibson, KH
   Wunder, EA
   Liu, J
   Trajtenberg, F
   Buschiazzo, A
   Ko, AI
   Sindelar, CV
AF Gibson, Kimberley H.
   Wunder, Elsio A., Jr.
   Liu, Jun
   Trajtenberg, Felipe
   Buschiazzo, Alejandro
   Ko, Albert I.
   Sindelar, Charles V.
TI Novel Architecture and Composition of a Bacterial Flagellum in the
   Spirochete Leptospira biflexa
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 62nd Annual Meeting of the Biophysical-Society
CY FEB 17-21, 2018
CL San Francisco, CA
SP Biophys Soc
C1 [Gibson, Kimberley H.; Sindelar, Charles V.] Yale Univ, Mol Biophys & Biochem, New Haven, CT USA.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Liu, Jun] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT USA.
   [Trajtenberg, Felipe; Buschiazzo, Alejandro] Inst Pasteur Montevideo, Lab Mol & Struct Microbiol, Montevideo, Uruguay.
RI Ko, Albert Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511
NR 0
TC 0
Z9 0
U1 1
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB 2
PY 2018
VL 114
IS 3
SU 1
MA 1831-Plat
BP 371A
EP 371A
PG 1
WC Biophysics
SC Biophysics
GA GD4CL
UT WOS:000430450000345
DA 2020-11-30
ER

PT J
AU Ribeiro, GS
   Kikuti, M
   Tauro, LB
   Nascimento, LCJ
   Cardoso, CW
   Campos, GS
   Ko, AI
   Weaver, SC
   Reis, MG
   Kitron, U
AF Ribeiro, Guilherme Sousa
   Kikuti, Mariana
   Tauro, Laura B.
   Nascimento, Leile Camila J.
   Cardoso, Cristiane W.
   Campos, Gubio S.
   Ko, Albert I.
   Weaver, Scott C.
   Reis, Mitermayer G.
   Kitron, Uriel
CA Salvador Arboviral Res Grp
TI Does immunity after Zika virus infection cross-protect against dengue?
SO LANCET GLOBAL HEALTH
LA English
DT Letter
C1 [Ribeiro, Guilherme Sousa; Kikuti, Mariana; Tauro, Laura B.; Nascimento, Leile Camila J.; Ko, Albert I.; Reis, Mitermayer G.; Kitron, Uriel] Fundacao Oswaldo Cruz, BR-40296710 Salvador, BA, Brazil.
   [Ribeiro, Guilherme Sousa; Kikuti, Mariana; Campos, Gubio S.; Reis, Mitermayer G.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Cardoso, Cristiane W.] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Univ, New Haven, CT USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, BR-40296710 Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Reis, Mitermayer/AAO-9742-2020; Kikuti, Mariana/G-2313-2017; Cardoso,
   Cristiane W/U-3350-2019; Ko, Albert Icksang/P-2343-2015; Ribeiro,
   Guilherme/B-6624-2008; Araujo, Joselio M G/B-5502-2013; Paploski, Igor
   AD/D-7015-2014; sardi, silvia ines/P-9349-2016
OI Reis, Mitermayer/0000-0002-3051-9060; Kikuti,
   Mariana/0000-0001-8119-7236; Ko, Albert Icksang/0000-0001-9023-2339;
   Ribeiro, Guilherme/0000-0002-6798-2059; Araujo, Joselio M
   G/0000-0003-3548-2786; Paploski, Igor AD/0000-0002-3689-2042; Cardoso,
   Cristiane/0000-0001-5432-1174; sardi, silvia ines/0000-0002-2002-8436
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq) [550160/2010-8, 400830/2013-2, 440891/2016-7]; Bahia Foundation
   for Research Support [PNX0010/2011, PPP0055/2011, JCB0020/2013,
   PET0026/2013, APP0044/2016, PET0022/2016]; Coordination for the
   Improvement of Higher Education Personnel, Brazilian Ministry of
   Education [440891/2016-7]; Federal University of Bahia [PROPI/2011,
   PROPI/2013, PRODOC/2013]; Oswaldo Cruz Foundation; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [D43 TW010540, U01 AI088752, R01
   TW009504, R01 AI121207]
FX We thank the municipal and state surveillance and laboratory staff. This
   study was supported by the Brazilian National Council for Scientific and
   Technological Development (grant 550160/2010-8 to MGR, grants
   400830/2013-2 and 440891/2016-7 to GSR; and scholarships to IADP, LBT,
   UK, MGR, and GSR); the Bahia Foundation for Research Support (grant
   PNX0010/2011 to MGR, grants PPP0055/2011, JCB0020/2013, PET0026/2013,
   APP0044/2016, and PET0022/2016 to GSR, and scholarship to MMOS and ROA);
   the Coordination for the Improvement of Higher Education Personnel,
   Brazilian Ministry of Education (grant 440891/2016-7 to GSR and
   scholarship to MK); the Federal University of Bahia (grants: PROPI/2011,
   PROPI/2013, and PRODOC/2013 to GSR); the Oswaldo Cruz Foundation
   (scholarship to: AMK, MMOS, AST, and JSC); and National Institutes of
   Health (grants D43 TW010540, U01 AI088752, R01 TW009504, R01 AI121207 to
   AIK).
CR Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Teixeira  M G, 2001, Rev Soc Bras Med Trop, V34, P269
NR 5
TC 30
Z9 30
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD FEB
PY 2018
VL 6
IS 2
BP E140
EP E141
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FT3NR
UT WOS:000423054400011
PM 29389533
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Nabity, SA
   Hagan, JE
   Araujo, G
   Damiao, AO
   Cruz, JS
   Nery, N
   Wunder, EA
   Reis, MG
   Ko, AI
   Ribeiro, GS
AF Nabity, Scott A.
   Hagan, Jose E.
   Araujo, Guilherme
   Damiao, Alcineia O.
   Cruz, Jaqueline S.
   Nery, Nivison
   Wunder, Elsio A., Jr.
   Reis, Mitermayer G.
   Ko, Albert I.
   Ribeiro, Guilherme S.
TI Prospective evaluation of accuracy and clinical utility of the Dual Path
   Platform (DPP) assay for the point-of-care diagnosis of leptospirosis in
   hospitalized patients
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; URBAN EPIDEMIC; NEUROLEPTOSPIROSIS; DENGUE
AB Early detection of leptospirosis with field-ready diagnostics may improve clinical management and mitigate outbreaks. We previously validated the point-of-care Dual Path Platform (DPP) for leptospirosis with sera in the laboratory. This prospective study compares the diagnostic accuracy and clinical utility of the DPP using finger stick blood (FSB) against the serum DPP, venous whole blood (VWB) DPP, IgM-ELISA, and clinical impression. We sequentially enrolled 98 patients hospitalized for acute febrile illnesses, of which we confirmed 32 by leptospirosis reference tests. Among syndromes consistent with classic leptospirosis, the FSB DPP showed similar sensitivity and specificity (Se 93% and Sp 80%), and positive and negative predictive values (PPV 74% and NPV 95%), to VWB DPP (Se 96%, Sp 75%, PPV 68%, and NPV 97%), serum DPP (Se 85%, Sp 87%, PPV 79%, and NPV 91%) and IgM-ELISA (Se 81%, Sp 100%, PPV 100%, and NPV 90%). The FSB DPP provided a favorable likelihood ratio profile (positive LR 4.73, negative LR 0.09) in comparison to other assays and clinical impression alone. Additionally, we identified four of five leptospirosis-associated meningitis patients by whole blood DPP, none of which clinicians suspected. This demonstrates potential for the DPP in routine detection of this less common syndrome. The FSB DPP demonstrated similar discrimination for severe human leptospirosis compared with serum assays, and it is a simpler option for diagnosing leptospirosis. Its performance in other epidemiological settings and geographic regions, and for detecting atypical presentations, demands further evaluation.
C1 [Nabity, Scott A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA USA.
   [Nabity, Scott A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA USA.
   [Nabity, Scott A.; Hagan, Jose E.; Araujo, Guilherme; Damiao, Alcineia O.; Cruz, Jaqueline S.; Nery, Nivison; Reis, Mitermayer G.; Ko, Albert I.; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol & Biol Mol, Salvador, BA, Brazil.
   [Hagan, Jose E.; Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Dept Saude Colet, Salvador, BA, Brazil.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Lab Patol & Biol Mol, Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Inst Saude Colet, Dept Saude Colet, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Wunder, Elsio Augusto/C-2733-2013; Ko, Albert Icksang/P-2343-2015;
   Ribeiro, Guilherme/B-6624-2008; Reis, Mitermayer/AAO-9742-2020
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Ko, Albert
   Icksang/0000-0001-9023-2339; Ribeiro, Guilherme/0000-0002-6798-2059;
   Reis, Mitermayer/0000-0002-3051-9060; Hagan, Jose/0000-0002-1837-6319;
   Rocha Nery Junior, Nivison Ruy/0000-0002-8164-0602
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R44 A1072856, U01
   A1088752, R01 A1052473, D43 TW00919]; Duke Global Health Institute;
   Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); CNPqNational Council for Scientific and Technological
   Development (CNPq); FOGARTY INTERNATIONAL CENTERUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI121207, R01AI121207, R01AI121207, R01AI121207,
   R01AI121207] Funding Source: NIH RePORTER
FX The National Institutes of Health [grant numbers R44 A1072856, U01
   A1088752, R01 A1052473, D43 TW00919, R44 A1072856], the Duke Global
   Health Institute, and the Brazilian National Council for Scientific and
   Technological Development (CNPq) supported this work. CNPq provided
   scholarships for MGR and GSR. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035
   Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010
   Bruce MG, 2005, ACTA TROP, V96, P36, DOI 10.1016/j.actatropica.2005.07.001
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Goarant C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002289
   Goris MGA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002290
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hartskeerl RA, 2015, CURR TOP MICROBIOL, V387, P273, DOI 10.1007/978-3-662-45059-8_11
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Lessa-Aquino C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005349
   Lessa-Aquino C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002499
   Mathew T, 2006, INDIAN J MED RES, V124, P155
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McBride AJA, 2007, ACTA TROP, V102, P206, DOI 10.1016/j.actatropica.2007.05.002
   MCCLAIN JBL, 1984, ANN INTERN MED, V100, P696, DOI 10.7326/0003-4819-100-5-696
   Mullan S, 2016, J CLIN DIAGN RES, V10, pDC8, DOI 10.7860/JCDR/2016/22462.9010
   Nabity SA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001878
   NIELSEN K, 1994, VET RES COMMUN, V18, P433, DOI 10.1007/BF01839419
   Panicker JN, 2001, POSTGRAD MED J, V77, P589, DOI 10.1136/pmj.77.911.589
   Picardeau M, 2014, DIAGN MICR INFEC DIS, V78, P1, DOI 10.1016/j.diagmicrobio.2013.09.012
   TAKAFUJI ET, 1984, NEW ENGL J MED, V310, P497, DOI 10.1056/NEJM198402233100805
   Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122
   Yang JS, 2014, CLIN VACCINE IMMUNOL, V21, P854, DOI 10.1128/CVI.00012-14
NR 28
TC 9
Z9 9
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2018
VL 12
IS 2
AR e0006285
DI 10.1371/journal.pntd.0006285
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FZ0RM
UT WOS:000427279700054
PM 29462146
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Maceda, EB
   Goncalves, CCM
   Andrews, JR
   Ko, AI
   Yeckel, CW
   Croda, J
AF Maceda, Elisangela B.
   Goncalves, Crhistinne C. M.
   Andrews, Jason R.
   Ko, Albert I.
   Yeckel, Catherine W.
   Croda, Julio
TI Serum vitamin D levels and risk of prevalent tuberculosis, incident
   tuberculosis and tuberculin skin test conversion among prisoners
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; HIGH-DOSE
   VITAMIN-D-3; D DEFICIENCY; PULMONARY TUBERCULOSIS; DOUBLE-BLIND; D
   METABOLISM; MYCOBACTERIUM-TUBERCULOSIS; PROSPECTIVE COHORT; POPULATION
AB Poor vitamin D status has been associated with tuberculosis (TB); whether poor status is cause orconsequence of disease is uncertain. We conducted a case-control study and two nested case-control studies to determine whether vitamin D levels were associated with active TB, tuberculin skin test (TST) conversion, and risk of progression to the active TB in prisoners in Brazil. In multivariable conditional logistic regression, subnormal vitamin D levels (OR, 3.77; 95% CI, 1.04-13.64) were more likely in prisoners with active TB. In contrast, vitamin D was not found to be a risk factor for either TST conversion (OR, 2.49; 95% CI, 0.64-9.66) or progression to active disease (OR, 0.59; 95% CI, 0.13-2.62). Black race (OR, 11.52; 95% CI, 2.01-63.36), less than 4 years of schooling (OR, 2.70; 95% CI, 0.90-8.16), cigarette smoking (OR, 0.23; 95% CI, 0.06-0.79) were identified as risk factors for TST conversion. Risk of progression to active TB was found to be associated with cigarette smoking (OR, 7.42; 95% CI, 1.23-44.70). Our findings in the prison population show that poor vitamin D status is more common in individuals with active TB, but is not a risk factor for acquisition of latent TB or progression to active TB.
C1 [Maceda, Elisangela B.; Croda, Julio] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil.
   [Goncalves, Crhistinne C. M.; Croda, Julio] Univ Fed Mato Grosso do Sul, Sch Med, Campo Grande, Brazil.
   [Andrews, Jason R.] Stanford Univ, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Yeckel, Catherine W.] Yale Sch Publ Hlth, Dept Environm Hlth Sci, New Haven, CT USA.
   [Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, Brazil.
RP Croda, J (corresponding author), Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil.; Croda, J (corresponding author), Univ Fed Mato Grosso do Sul, Sch Med, Campo Grande, Brazil.; Croda, J (corresponding author), Fundacao Oswaldo Cruz, Campo Grande, Brazil.
EM julio.croda@fiocruz.br
RI Goncalves, Crhistinne/AAF-7367-2020; Croda, Julio/I-5172-2013; Ko,
   Albert Icksang/P-2343-2015
OI Croda, Julio/0000-0002-6665-6825; Ko, Albert Icksang/0000-0001-9023-2339
FU Foundation for Support and Development of Education, Science and
   Technology of the State of Mato Grosso do Sul (Fundacao de Apoio ao
   Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado do Mato Grosso
   do Sul)Fundect [07/2015]; U.S. Department of Health & Human Services,
   NIH, National Institute of Allergy and Infectious Diseases (NIAID) [R01
   AI130058-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Advancing Translational
   Sciences (NCATS) [UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI130058, R01AI130058, R01AI130058,
   R01AI130058] Funding Source: NIH RePORTER
FX Financial supports provided by the Foundation for Support and
   Development of Education, Science and Technology of the State of Mato
   Grosso do Sul (Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e
   Tecnologia do Estado do Mato Grosso do Sul) [07/2015] and U.S.
   Department of Health & Human Services, NIH, National Institute of
   Allergy and Infectious Diseases (NIAID) [R01 AI130058-01] are gratefully
   appreciated.
CR Abel L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0428
   [Anonymous], 2014, MIN JUST DEP PEN NAC
   Arnedo-Pena A, 2015, EPIDEMIOL INFECT, V143, P1731, DOI 10.1017/S0950268814002386
   Arnedo-Pena A, 2015, INT J TUBERC LUNG D, V19, P65, DOI 10.5588/ijtld.14.0348
   Arnedo-Pena A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-349
   Bender D. A., 2016, BIOQUIMICA ILUSTRADA, P546
   Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454
   Bothamley GH, 2005, THORAX, V60, P527, DOI 10.1136/thx.2004.036012
   Bourdillon PM, 2017, EMERG INFECT DIS, V23, P496, DOI 10.3201/eid2303.161006
   Brasil, 2011, MAN REC CONTR TUB BR
   BRODIE MJ, 1980, CLIN PHARMACOL THER, V27, P810, DOI 10.1038/clpt.1980.115
   BRODIE MJ, 1982, CLIN PHARMACOL THER, V32, P525, DOI 10.1038/clpt.1982.197
   BRODIE MJ, 1981, CLIN PHARMACOL THER, V30, P363, DOI 10.1038/clpt.1981.173
   Cantwell MF, 1998, AM J RESP CRIT CARE, V157, P1016, DOI 10.1164/ajrccm.157.4.9704036
   Chang JM, 2004, J LAB CLIN MED, V143, P14, DOI 10.1016/j.lab.2003.08.002
   Coninx R, 2000, BRIT MED J, V320, P440, DOI 10.1136/bmj.320.7232.440
   Daley P, 2015, LANCET INFECT DIS, V15, P528, DOI 10.1016/S1473-3099(15)70053-8
   DAVIES PDO, 1985, THORAX, V40, P187, DOI 10.1136/thx.40.3.187
   den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924
   Dusso AS, 1997, J CLIN ENDOCR METAB, V82, P2222, DOI 10.1210/jc.82.7.2222
   Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108
   Edge CL, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20960
   Balcells ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175400
   Fabri M., SCI TRANSL MED, V3
   Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192
   Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10
   Paiao DSG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1868-5
   Ho-Pham LT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-306
   Hoffmann SC, 2002, AM J TRANSPLANT, V2, P560, DOI 10.1034/j.1600-6143.2002.20611.x
   Hong JY, 2014, INT J TUBERC LUNG D, V18, P73, DOI 10.5588/ijtld.13.0536
   Huang SJ, 2017, DRUG DES DEV THER, V11, P91, DOI 10.2147/DDDT.S79870
   Iftikhar R, 2013, JCPSP-J COLL PHYSICI, V23, P780, DOI 11.2013/JCPSP.780783
   Jacobs ET, 2015, NUTRITION, V31, P659, DOI 10.1016/j.nut.2014.10.010
   Kalonji Guillaume MuasaPatoka, 2016, Trop Med Health, V44, P30, DOI 10.1186/s41182-016-0030-9
   Keflie TS, 2015, NUTRITION, V31, P1204, DOI 10.1016/j.nut.2015.05.003
   Kiggundu DS, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0053-y
   Kim JH, 2014, CLIN NUTR, V33, P1081, DOI 10.1016/j.clnu.2013.11.014
   Kim S, 2005, PUBLIC HEALTH NURS, V22, P108, DOI 10.1111/j.0737-1209.2005.220204.x
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933
   Maeda SS, 2014, ARQ BRAS ENDOCRINOL, V58, P411, DOI 10.1590/0004-2730000003388
   Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2
   Maurya V, 2002, INT J TUBERC LUNG D, V6, P942
   Mily A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138340
   Ness RB, 2004, AM J EPIDEMIOL, V160, P1033, DOI 10.1093/aje/kwh325
   Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333
   Nursyam Elly Wijaya, 2006, Acta Med Indones, V38, P3
   Nwosu BU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090623
   O'Leary SM, 2014, AM J RESP CRIT CARE, V190, P1430, DOI 10.1164/rccm.201407-1385OC
   Oh J, 2017, J INFECTION, V74, P272, DOI 10.1016/j.jinf.2016.10.009
   Pilarski A, 2016, EUR RESPIR J, V48, P1507, DOI 10.1183/13993003.00057-2016
   Plant AJ, 2002, EPIDEMIOL INFECT, V128, P37, DOI 10.1017/S0950268801006434
   Chiavegatto ADP, 2013, CAD SAUDE PUBLICA, V29, P1572, DOI [10.1590/0102-311X00139012, 10.1590/S0102-311X2013001200010]
   Ralph AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070032
   Salahuddin N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-22
   San Pedro A, 2013, REV PANAM SALUD PUBL, V33, P294, DOI 10.1590/S1020-49892013000400009
   Carbone ADS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0764-8
   Santos LG, 2012, TUBERCULOSIS, V92, P293, DOI 10.1016/j.tube.2012.03.006
   Selvaraj P, 2015, CAN J PHYSIOL PHARM, V93, P377, DOI 10.1139/cjpp-2014-0386
   Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x
   Sita-Lumsden A, 2007, THORAX, V62, P1003, DOI 10.1136/thx.2006.070060
   Sloan DJ, 2015, INT J TUBERC LUNG D, V19, P904, DOI 10.5588/ijtld.15.0071
   STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702
   Talat N, 2010, EMERG INFECT DIS, V16, P853, DOI 10.3201/eid1605.091693
   Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567
   Tsiaras WG, 2011, ACTA DERM-VENEREOL, V91, P115, DOI 10.2340/00015555-0980
   Tukvadze N, 2015, AM J CLIN NUTR, V102, P1059, DOI 10.3945/ajcn.115.113886
   Urrego J, 2015, AM J TROP MED HYG, V93, P739, DOI 10.4269/ajtmh.15-0166
   Valenca MS, 2015, INT J TUBERC LUNG D, V19, P1182, DOI 10.5588/ijtld.15.0126
   Wejse C, 2007, AM J CLIN NUTR, V86, P1376
   Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC
   Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6
   Winetsky DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086046
   World Health Organization, 2016, GLOB TUB REP
   Zhang HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175183
NR 74
TC 9
Z9 9
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 17
PY 2018
VL 8
AR 997
DI 10.1038/s41598-018-19589-3
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FS9DR
UT WOS:000422716900131
PM 29343733
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Aguilar, JP
   Costa, F
   Nery, N
   Lim, J
   Gambrah, C
   Sacramento, G
   Freitas, B
   Bouzon, J
   Oliveira, J
   Adhikarla, H
   Montoya, M
   Wunder, EA
   Chin, A
   Reis, M
   Harris, E
   Ko, A
AF Aguilar, Juan
   Costa, Federico
   Nery, Nivison, Jr.
   Lim, Joseph
   Gambrah, Claudia
   Sacramento, Gielson
   Freitas, Bruno
   Bouzon, Joseane
   Oliveira-Filho, Jamary
   Adhikarla, Haritha
   Montoya, Magelda
   Wunder, Elsio, Jr.
   Chin, Athena
   Reis, Mitermayer
   Harris, Eva
   Ko, Albert
TI PROSPECTIVE INVESTIGATION OF A COMMUNITY-BASED COHORT OF PREGNANT WOMEN
   BEFORE AND DURING THE ZIKA EPIDEMIC IN NORTHEAST BRAZIL: SILENT
   TRANSMISSION AND INFANT OUTCOMES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Aguilar, Juan; Costa, Federico; Nery, Nivison, Jr.; Bouzon, Joseane; Oliveira-Filho, Jamary] Univ Fed Bahia, Salvador, BA, Brazil.
   [Lim, Joseph; Gambrah, Claudia; Adhikarla, Haritha; Wunder, Elsio, Jr.; Ko, Albert] Yale Sch Publ Hlth, New Haven, CT USA.
   [Sacramento, Gielson; Reis, Mitermayer] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Freitas, Bruno] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Montoya, Magelda; Chin, Athena; Harris, Eva] Univ Calif Berkeley, Berkeley, CA 94720 USA.
RI Oliveira-Filho, Jamary/B-6441-2016; Ko, Albert Icksang/P-2343-2015;
   Reis, Mitermayer/AAO-9742-2020
OI Oliveira-Filho, Jamary/0000-0003-1915-0423; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1422
BP 448
EP 448
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604122
DA 2020-11-30
ER

PT J
AU Nery, NR
   Costa, F
   Aromolaran, A
   Cruz, JS
   Sarno, M
   Freitas, B
   Mattos, A
   Baltazar, G
   Pimentel, K
   Khouri, R
   Maltez, JR
   Oliveira, J
   Oliveira, DB
   Durigon, EL
   Henriques, DF
   Vasconcelos, PF
   Vasilakis, N
   Almeida, AR
   Reis, MG
   Ko, AI
AF Nery, Nivison, Jr.
   Costa, Federico
   Aromolaran, Adeolu
   Cruz, Jaqueline
   Sarno, Manoel
   Freitas, Bruno
   Mattos, Adriana
   Baltazar, Gustavo
   Pimentel, Kleber
   Khouri, Ricardo
   Maltez, Joao
   Oliveira-Filho, Jamary
   Oliveira, Danielle
   Durigon, Edison
   Henriques, Daniele
   Vasconcelos, Pedro
   Vasilakis, Nikos
   Almeida, Antonio
   Reis, Mitermayer
   Ko, Albert
TI MATERNAL DENGUE ANTIBODIES AND RISK FOR CONGENITAL ZIKA
   SYNDROME-ASSOCIATED MICROCEPHALY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Nery, Nivison, Jr.; Costa, Federico; Oliveira-Filho, Jamary; Almeida, Antonio] Univ Fed Bahia, Salvador, BA, Brazil.
   [Aromolaran, Adeolu; Ko, Albert] Yale Sch Publ Hlth, New Haven, CT USA.
   [Cruz, Jaqueline; Khouri, Ricardo; Reis, Mitermayer] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   [Sarno, Manoel; Freitas, Bruno; Mattos, Adriana; Baltazar, Gustavo; Pimentel, Kleber; Maltez, Joao] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Oliveira, Danielle; Durigon, Edison] Univ Sao Paulo, Sao Paulo, Brazil.
   [Henriques, Daniele; Vasconcelos, Pedro] Evandro Chagas Inst, Ananindeua, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Galveston, TX 77555 USA.
RI Khouri, Ricardo/M-3184-2018; Reis, Mitermayer/AAO-9742-2020; Ko, Albert
   Icksang/P-2343-2015; Vasilakis, Nikos/ABE-7318-2020; Vasconcelos,
   Pedro/AAH-3142-2019; Oliveira-Filho, Jamary/B-6441-2016
OI Khouri, Ricardo/0000-0001-5664-4436; Reis,
   Mitermayer/0000-0002-3051-9060; Ko, Albert Icksang/0000-0001-9023-2339;
   Oliveira-Filho, Jamary/0000-0003-1915-0423
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1479
BP 466
EP 467
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604179
DA 2020-11-30
ER

PT J
AU Adhikarla, H
   Montoya, M
   Nery, N
   Aromolaran, A
   Cruz, JS
   Pastor, A
   Petrone, M
   Wunder, EA
   Costa, F
   Harris, E
   Ko, AI
AF Adhikarla, Haritha
   Montoya, Magelda
   Jr Nery, Nivison
   Aromolaran, Adeolu
   Cruz, Jaqueline
   Pastor, Andrew
   Petrone, Mary
   Wunder, Elsio
   Costa, Federico
   Harris, Eva
   Ko, Albert
TI KINETICS OF ANTI ZIKA-IGG ANTIBODIES DURING FOLLOW-UP OF INFANTS EXPOSED
   TO ZIKA VIRUS <it>IN UTERO</it>
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Adhikarla, Haritha; Aromolaran, Adeolu; Petrone, Mary; Wunder, Elsio; Costa, Federico; Ko, Albert] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Montoya, Magelda; Pastor, Andrew; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Jr Nery, Nivison; Cruz, Jaqueline] Univ Fed Bahia, Oswaldo Cruz Fdn, Brazilian Minist Hlth, Salvador, BA, Brazil.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1660
BP 522
EP 522
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604360
DA 2020-11-30
ER

PT J
AU Gambrah-Sampaney, CO
   Aguilar, P
   Nery, N
   Freitas, B
   Bouzon, J
   Guerra, A
   Oliveira, J
   Adhikarla, H
   Montoya, M
   Wunder, EA
   Harris, E
   Reis, M
   Costa, F
   Ko, A
AF Gambrah-Sampaney, Claudia
   Aguilar, Pablo
   Nery, Nivison, Jr.
   Freitas, Bruno
   Bouzon, Joseane
   Guerra, Ailema
   Oliveira-Filho, Jamary
   Adhikarla, Haritha
   Montoya, Magelda
   Wunder, Elsio, Jr.
   Harris, Eva
   Reis, Mitermayer
   Costa, Federico
   Ko, Albert
TI GROWTH AND DEVELOPMENTAL OUTCOMES OF CONGENITAL ZIKA INFECTION DURING
   FOLLOW-UP OF A CHILD COHORT FROM SALVADOR, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Gambrah-Sampaney, Claudia; Adhikarla, Haritha; Wunder, Elsio, Jr.; Ko, Albert] Yale Sch Publ Hlth, New Haven, CT USA.
   [Aguilar, Pablo; Bouzon, Joseane; Oliveira-Filho, Jamary] Univ Fed Bahia, Salvador, BA, Brazil.
   [Nery, Nivison, Jr.; Guerra, Ailema; Reis, Mitermayer; Costa, Federico] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Freitas, Bruno] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Montoya, Magelda; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
RI Ko, Albert Icksang/P-2343-2015; Oliveira-Filho, Jamary/B-6441-2016;
   Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Oliveira-Filho,
   Jamary/0000-0003-1915-0423; Reis, Mitermayer/0000-0002-3051-9060
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1659
BP 522
EP 522
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386604359
DA 2020-11-30
ER

PT J
AU Togami, E
   Kama, M
   Goarant, C
   Craig, SB
   Lau, C
   Ritter, JM
   Imrie, A
   Ko, AI
   Nilles, EJ
AF Togami, Eri
   Kama, Mike
   Goarant, Cyrille
   Craig, Scott B.
   Lau, Colleen
   Ritter, Jana M.
   Imrie, Allison
   Ko, Albert I.
   Nilles, Eric J.
TI A Large Leptospirosis Outbreak following Successive Severe Floods in
   Fiji, 2012
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
AB Severe flooding has been linked to outbreaks of leptospirosis. Two sequential extreme flood events in Western Fiji caused the largest outbreak of leptospirosis recorded in the South Pacific, with 1,217 total suspected cases, of which 314 were probable and confirmed. Most (83%) cases occurred within 6 weeks of the flood events, displaying a biphasic epidemic curve associated with the floods. Given the temporal proximity of cases to flooding events, most of the transmission appeared to occur during or immediately after the floods; therefore, prevention of exposure to contaminated environments is a priority in the immediate flood and post-flood period. In addition, genotyping studies suggest that multiple animal reservoirs were implicated in the outbreak, reaffirming the importance of integrated human and animal health strategies for leptospirosis control.
C1 [Togami, Eri; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Kama, Mike] Minist Hlth, Ctr Communicable Dis Control, Suva, Fiji.
   [Goarant, Cyrille] Inst Pasteur New Caledonia, Leptospirosis Unit, Noumea, New Caledonia.
   [Craig, Scott B.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia.
   [Craig, Scott B.] WHO Leptospirosis Lab, Forens & Sci Serv, Brisbane, Qld, Australia.
   [Lau, Colleen] Australia Natl Univ, Res Sch Populat Hlth, Canberra, ACT, Australia.
   [Ritter, Jana M.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Imrie, Allison] Univ Western Australia, Fac Hlth & Med Sci, Sch Biomed Sci, Perth, WA, Australia.
   [Nilles, Eric J.] World Hlth Org, Div Pacific Tech Support, Suva, Fiji.
   [Togami, Eri] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA.
   [Kama, Mike] Fiji Ctr Communicable Dis Control, Dept Influenza, Suva, Fiji.
   [Goarant, Cyrille] Inst Pasteur Nouvelle Caledonie, Reseau Int Inst Pasteur, Leptospirosis Res & Expertise Unit, Noumea, New Caledonia.
   [Nilles, Eric J.] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA.
   [Nilles, Eric J.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [Nilles, Eric J.] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA.
RP Togami, E (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Nilles, EJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Harvard Humanitarian Initiat, Boston, MA 02115 USA.
EM eri.togami1@gmail.com; mnkama02@gmail.com; cgoarant@pasteur.nc;
   scott.craig@health.qld.gov.au; colleen.lau@anu.edu; vtr0@cdc.gov;
   allison.imrie@uwa.edu.au; albert.ko@yale.edu; enilles@bwh.harvard.edu
RI Imrie, Allison/AAH-2421-2019; Goarant, Cyrille/D-4267-2018; Lau, Colleen
   L/F-5974-2012; Ko, Albert Icksang/P-2343-2015
OI Goarant, Cyrille/0000-0002-0690-9464; Lau, Colleen
   L/0000-0001-8288-4169; Ko, Albert Icksang/0000-0001-9023-2339; Nilles,
   Eric/0000-0001-7044-5257
FU French Government through the fonds de cooperation economique, sociale
   et culturelle pour le Pacifique ("FondsPacifique"); Yale Global Health
   Initiative Field Experience Award; NIHUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R01 TW009504,
   R01 AI121207]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207, R01AI121207]
   Funding Source: NIH RePORTER
FX This study was supported by a grant of the French Government through the
   fonds de cooperation economique, sociale et culturelle pour le Pacifique
   ("FondsPacifique"), as well as support from Yale Global Health
   Initiative Field Experience Award 2015, and NIH grants R01 TW009504 and
   R01 AI121207. We would like to thank the Immunohistochemistry Laboratory
   of the Infectious Diseases Pathology Branch at the US Centers for
   Disease Control and Prevention for developing and performing the
   immunohistochemistry assay.
CR Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59
   Casanovas-Massana A, 2018, WATER RES, V130, P176, DOI 10.1016/j.watres.2017.11.068
   Centers for Disease Control and Prevention, 2013, NAT DIS SURV SYST DI
   Dechet AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039672
   Edenhofer O, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1
   Fiji Bureau of Statistics, 2012, 2007 CENS POP HOUS
   Fiji Ministry of Health, 2010, FIJ NAT COMM DIS SUR
   Ghosh A, 2010, FIJI MED J, V29, P8
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Lau CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004405
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McIver L, 2016, ENVIRON HEALTH PERSP, V124, P1707, DOI 10.1289/ehp.1509756
   Perez J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-325
   Ram P, 1977, FIJI MED J, V3, P68
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Reller ME, 2011, EMERG INFECT DIS, V17, P1678, DOI [10.3201/eid1709.100915, 10.3201/eid1709.100915.]
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147
   World Health Organization, 2005, INT HLTH REG 2005
   Zaki SA, 2010, INFECTION, V38, P285, DOI 10.1007/s15010-010-0030-3
   Zinsstag J, 2015, ONE HEALTH: THE THEORY AND PRACTICE OF INTEGRATED HEALTH APPROACHES, P427, DOI 10.1079/9781780643410.0427
NR 25
TC 8
Z9 8
U1 1
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
BP 849
EP 851
DI 10.4269/ajtmh.18-0335
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HD3CP
UT WOS:000452390900011
PM 30141390
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Oliveira, J
   Felzemburgh, R
   Costa, F
   Nery, N
   Mattos, A
   Henriques, DF
   Ko, AI
AF Oliveira-Filho, Jamary
   Felzemburgh, Ridalva
   Costa, Federico
   Nery, Nivison, Jr.
   Mattos, Adriana
   Henriques, Daniele F.
   Ko, Albert I.
CA Salvador Zika Response Team
TI Seizures as a Complication of Congenital Zika Syndrome in Early Infancy
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VIRUS SYNDROME
AB Zika virus transmission in Brazil was linked to a large outbreak of microcephaly but less is known about longer term anthropometric and neurological outcomes. We studied a cohort of infants born between October 31, 2015, and January 9, 2016, in a state maternity hospital, followed up for 101 +/- 28 days by home visits. Microcephaly (< 2 standard deviations, Intergrowth standard) occurred in 62 of 412 (15%) births. Congenital Zika syndrome (CZS) was diagnosed in 29 patients. Among CZS patients, we observed a significant gain in anthropometric measures (P < 0.001) but no significant gain in percentile for these measures. The main neurological outcome was epilepsy, occurring in 48% of infants at a rate of 15.6 cases per 100 patient-months, frequently requiring multiple anti-seizure medications. The cumulative fatality rate was 7.4% (95% confidence interval: 2.1-23.4%). Health-care professionals should be alerted on the high risk of epilepsy and death associated with CZS in early infancy and the need to actively screen for seizures and initiate timely treatment.
C1 [Oliveira-Filho, Jamary] Univ Fed Bahia, Postgrad Program Hlth Sci, Fac Med Bahia, Salvador, BA, Brazil.
   [Felzemburgh, Ridalva; Costa, Federico] Univ Fed Bahia, Inst Saude, Escola Enfermagem, Salvador, BA, Brazil.
   [Felzemburgh, Ridalva; Costa, Federico] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
   [Nery, Nivison, Jr.; Ko, Albert I.] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Mattos, Adriana] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Henriques, Daniele F.] Inst Evandro Chagas, Belem, Para, Brazil.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Oliveira-Filho, Jamary] Univ Fed Bahia, Inst Ciencias Saude, Dept Biomorphol, Salvador, BA, Brazil.
   [Felzemburgh, Ridalva] Univ Fed Bahia, Escola Enfermagem, Salvador, BA, Brazil.
   [Costa, Federico; Nery, Nivison, Jr.] Fundacao Oswaldo Cruz, Lab Pathol & Mol Biol, Salvador, BA, Brazil.
   [Costa, Federico] Yale Univ, Yale Sch Publ Hlth, New Haven, CT USA.
   [Mattos, Adriana] Univ Fed Bahia, Postgrad Program Hlth Sci, Salvador, BA, Brazil.
   [Henriques, Daniele F.] Inst Evandro Chagas, Rio De Janeiro, Brazil.
   [Ko, Albert I.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
RP Oliveira, J (corresponding author), Inst Ciencias Saude, Rua Reitor Miguel Calmon,Sala 415, BR-40110100 Salvador, BA, Brazil.
EM jamary@mail.harvard.edu; ridalva@gmail.com; fcosta2001@gmail.com;
   nivisonjr@hotmail.com; dricamattos@gmail.com;
   danielehenriques@iec.gov.br; albert.ko@yale.edu
RI Costa, Federico/G-1838-2015; Oliveira-Filho, Jamary/B-6441-2016; Ko,
   Albert Icksang/P-2343-2015
OI Costa, Federico/0000-0001-6951-2336; Oliveira-Filho,
   Jamary/0000-0003-1915-0423; Ko, Albert Icksang/0000-0001-9023-2339;
   Rocha Nery Junior, Nivison Ruy/0000-0002-8164-0602
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1 NS064905, R01 AI052473, U01
   AI088752, R25 TW009338]; Oswaldo Cruz Foundation; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW009504, R01TW009504, R01TW009504, R01TW009504, R01TW009504]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI121207, R01AI121207,
   R01AI121207, R01AI121207, R01AI121207] Funding Source: NIH RePORTER
FX This study was supported by NIH Grants RO1 NS064905, NIH R01 AI052473,
   U01 AI088752, and R25 TW009338, and the Oswaldo Cruz Foundation.
CR Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ito Y, 2013, PEDIATR INT, V55, P566, DOI 10.1111/ped.12122
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
NR 8
TC 6
Z9 6
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 6
BP 1860
EP 1862
DI 10.4269/ajtmh.17-1020
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GL4CN
UT WOS:000437095000050
PM 29692307
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Cordeiro, SM
   Cardoso, CW
   de Araujo, LG
   Ribeiro, LE
   Azevedo, J
   Silva, RDV
   dos Reis, MG
   Ko, AI
   Reis, JN
AF Cordeiro, Soraia Machado
   Cardoso, Cristiane Wanderley
   de Araujo, Lorena Galvao
   Ribeiro, Luis Eduardo
   Azevedo, Jailton
   Vilasboas Silva, Rita de Cassia
   dos Reis, Mitermayer Galvao
   Ko, Albert Icksang
   Reis, Joice Neves
TI Dissemination of the ST-103 clonal complex serogroup C meningococci in
   Salvador, Brazil
SO MICROBES AND INFECTION
LA English
DT Article
DE Meningococcal disease; Neisseria meningitidis; Meningococcal serogroup C
ID CEREBROSPINAL FLUID/BLOOD GLUCOSE; DISEASE; MENINGITIS; EPIDEMIC;
   VACCINATION; PREVENTION; INDICATOR; OUTBREAKS; CARRIAGE
AB Invasive meningococcal disease (IMD) is a major public health problem worldwide. An epidemic of serogroup C (NmC) IMD occurred in 2010 in the city of Salvador. In this study, we describe the antigenic and genetic characterization of meningococcal isolates collected from meningitis cases in Salvador from 2001 to 2012. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were performed for the analysis of IMD isolates. A total of 733 cases were identified, and the serogroup was determined for 391 (53.0%) of these. Most cases were caused by NmC (53%) or B (47%). The most prevalent strains were B:4,7:P1.19,15 (32.9%; 129/ 391) and C:23:P1.14-6 (28.6%; 112/391). Based on PFGE/MLST analysis, 71.3% (77/108 PFGE-tested isolates) clustered as two clones of sequence type ST-3779 and ST-3780, both belonging to the ST-103 clonal complex. ST-3779 has been detected in Salvador since 1996 and together with ST-3780 became predominant after 2005. There was a predominance of C: 23:P1.14-6, ST-3779/3780 in Salvador during the period of 2007-2012, establishing a major clonal lineage, which remained in the community for a long time; this has serious implications for public health, particularly in terms of prevention and control strategies of IMD. (c) 2017 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
C1 [Cordeiro, Soraia Machado; Cardoso, Cristiane Wanderley; de Araujo, Lorena Galvao; Azevedo, Jailton; dos Reis, Mitermayer Galvao; Ko, Albert Icksang; Reis, Joice Neves] Brazil Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Inst, Rua Waldemar Falcao,141, BR-40296710 Salvador, BA, Brazil.
   [Cardoso, Cristiane Wanderley] Municipal Secretary Hlth Salvador, Rua Grecia 3, BR-40010010 Salvador, BA, Brazil.
   [Vilasboas Silva, Rita de Cassia] Publ Hlth Cent Lab LACEN BA, Rua Waldemar Falcao,123, BR-40295010 Salvador, BA, Brazil.
   [Ko, Albert Icksang] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06520 USA.
   [Cordeiro, Soraia Machado; Ribeiro, Luis Eduardo; Reis, Joice Neves] Univ Fed Bahia, Sch Pharm, Rua Bar do Jeremoabo 147, BR-40170115 Salvador, BA, Brazil.
RP Reis, JN (corresponding author), Univ Fed Bahia, Fac Farm, Rua Barao Jeremoabo S-N, BR-40170115 Salvador, BA, Brazil.
EM joice@ufba.br
RI Ko, Albert Icksang/P-2343-2015; Cardoso, Cristiane W/U-3350-2019
OI Ko, Albert Icksang/0000-0001-9023-2339; Cardoso,
   Cristiane/0000-0001-5432-1174
CR Bartley SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055798
   Bilukha Oleg O., 2005, Morbidity and Mortality Weekly Report, V54, P1
   Black SB, 2012, VACCINE, V30, pB37, DOI 10.1016/j.vaccine.2011.12.074
   Brasil, SIST INF AGR NOT SIN
   Brasil, HOSP COUT MAIA
   Cardoso CW, 2012, VACCINE, V30, P5541, DOI 10.1016/j.vaccine.2012.06.044
   Cardoso CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123734
   Center for Disease Control and Prevention, AG RISK FACT
   Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209
   Cordeiro SM, 2007, T ROY SOC TROP MED H, V101, P1147, DOI 10.1016/j.trstmh.2007.06.012
   Feavers IM, 2000, NATURE, V404, P451, DOI 10.1038/35006546
   Greenwood B, 2012, VACCINE, V30, pB63, DOI 10.1016/j.vaccine.2011.12.063
   Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063
   Harrison LH, 2006, CLIN MICROBIOL REV, V19, P142, DOI 10.1128/CMR.19.1.142-164.2006
   Hatipoglu M, 2014, AM J EMERG MED, V32, P470, DOI 10.1016/j.ajem.2014.01.014
   Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595
   Jolley Keith A, 2012, BMC BIOINFORMATICS, V11, P595
   Kaddar M, 2013, VACCINE, V31, pB81, DOI 10.1016/j.vaccine.2012.11.085
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   Manchanda V, 2006, Indian J Med Microbiol, V24, P7
   OLIVARES R, 1993, PATHOL BIOL, V41, P164
   Safadi MAP, 2014, EMERG INFECT DIS, V20, P806, DOI 10.3201/eid2005.130948
   PELTOLA H, 1982, LANCET, V2, P595
   Popovic T, 2001, J CLIN MICROBIOL, V39, P75, DOI 10.1128/JCM.39.1.75-85.2001
   Raghunathan PL, 2006, J INFECT DIS, V193, P607, DOI 10.1086/499822
   Ribeiro GS, 2003, J INFECT DIS, V187, P109, DOI 10.1086/345863
   Rosenstein NE, 2000, PEDIATR CLIN N AM, V47, P337, DOI 10.1016/S0031-3955(05)70210-8
   Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158
   Sáfadi Marco Aurélio Palazzi, 2006, J. Pediatr. (Rio J.), V82, ps35, DOI 10.1590/S0021-75572006000400005
   Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2
   Tamune H, 2014, AM J EMERG MED, V32, P263, DOI 10.1016/j.ajem.2013.11.030
   Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8
   Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7
   v1 Brasil, 2013, AN SIT SAUD 40 AN PR, P536
   WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195
NR 35
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD JAN
PY 2018
VL 20
IS 1
BP 19
EP 24
DI 10.1016/j.micinf.2017.09.010
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FW3XO
UT WOS:000425246400004
PM 28962886
OA Bronze
DA 2020-11-30
ER

PT J
AU Lazzarini, TA
   Goncalves, CCM
   Benites, WM
   da Silva, LF
   Tsuha, DH
   Ko, AI
   Rohrbaugh, R
   Andrews, JR
   Croda, J
AF Lazzarini, Thomas Adriano
   Maymone Goncalves, Crhistinne Cavalheiro
   Benites, Walter Martins
   da Silva, Liliane Ferreira
   Tsuha, Daniel Henrique
   Ko, Albert Icksang
   Rohrbaugh, Robert
   Andrews, Jason Randolph
   Croda, Julio
TI Suicide in Brazilian indigenous communities: clustering of cases in
   children and adolescents by household
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Suicide; Child; Adolescent; Health of Indigenous Peoples; Mental Health;
   Health Vulnerability; Cohort Studies
ID RISK-FACTORS; PREVENTION; PEOPLE; QUEENSLAND; TRENDS; YOUTH
AB OBJECTIVE: To estimate age and sex-specific suicide rates, compare suicide rates between indigenous communities, and quantify the frequency of intrafamilial suicide clustering.
   METHODS: We performed a retrospective cohort study involving 14,666 indigenous individuals in reservations in Dourados, state of Mato Grosso do Sul, Brazil, from 2003 through 2013 using national and local census.
   RESULTS: The overall suicide rate was 73.4 per 100,000 person-years. Adolescent males aged 15-19 and girls aged 10-14 had the highest rates for each sex at 289.3 (95%CI 187.5-391.2) and 85.3 (95%CI 34.9-135.7), respectively. Comparing the largest reservations, Bororo had a higher suicide rate than Jaguapiru (RR = 4.83, 95%CI 2.85-8.16) and had significantly lower socioeconomic indicators including income and access to electricity. Nine of 19 suicides among children under 15 occurred in household clusters. Compared with adult suicides, a greater proportion of child (OR = 5.12, 95%CI 1.89-13.86, p = 0.001) and adolescent (OR = 3.48, 95%CI 1.29-9.44, p = 0.017) suicides occurred within household clusters.
   CONCLUSIONS: High rates of suicide occur among children and adolescents in these indigenous reservations, particularly in poor communities. Nearly half of child suicides occur within household clusters. These findings underscore the need for broad public health interventions and focused mental health interventions in households following a suicide.
C1 [Lazzarini, Thomas Adriano; Ko, Albert Icksang; Rohrbaugh, Robert] Yale Univ, Sch Med, New Haven, CT USA.
   [Maymone Goncalves, Crhistinne Cavalheiro; Croda, Julio] Univ Fed Mato Grosso do Sul, Fac Med, Campo Grande, MS, Brazil.
   [Benites, Walter Martins; da Silva, Liliane Ferreira] Dist Sanit Especial Indigena, Polo Base Dourados, Dourados, MS, Brazil.
   [Tsuha, Daniel Henrique] Univ Fed Mato Grosso do Sul, Fac Comp, Campo Grande, MS, Brazil.
   [Ko, Albert Icksang] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Andrews, Jason Randolph] Stanford Univ, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA.
   [Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil.
RP Croda, J (corresponding author), Rua Gabriel Abrao,92 Jardim Nacoes, BR-79074460 Campo Grande, MS, Brazil.
EM Julio.croda@fiocruz.br
RI Ko, Albert Icksang/P-2343-2015; Croda, Julio/I-5172-2013; Goncalves,
   Crhistinne/AAF-7367-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Croda,
   Julio/0000-0002-6665-6825; Lazzarini, Thomas/0000-0003-1855-2957
FU Bertram Roberts Memorial Fund; Wilbur Downs International Health Student
   Travel Fellowship
FX Bertram Roberts Memorial Fund and the Wilbur Downs International Health
   Student Travel Fellowship.
CR Allen J, 2009, INT J CIRCUMPOL HEAL, V68, P274, DOI 10.3402/ijch.v68i3.18328
   ALTMAN DG, 1991, PRACTICAL STAT MED R, P266
   [Anonymous], 2017, BRAZIL MINIMUM MONTH
   Beautrais AL, 1996, J AM ACAD CHILD PSY, V35, P1174, DOI 10.1097/00004583-199609000-00015
   Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P420, DOI 10.1046/j.1440-1614.2000.00691.x
   Berzuini VLP, 2008, THESIS
   Capp K, 2001, AUST NZ J PUBL HEAL, V25, P315, DOI 10.1111/j.1467-842X.2001.tb00586.x
   Clifford AC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-463
   Coloma C., 2007, Morbidity and Mortality Weekly Report, V56, P7
   Coloma Carlos, 2006, Arch Suicide Res, V10, P191, DOI 10.1080/13811110600662505
   De Leo D, 2011, AUST NZ J PSYCHIAT, V45, P532, DOI 10.3109/00048674.2011.570310
   Hunter Ernest, 2002, Emerg Med (Fremantle), V14, P14, DOI 10.1046/j.1442-2026.2002.00281.x
   Kral MJ, 2012, CULT MED PSYCHIAT, V36, P306, DOI 10.1007/s11013-012-9253-3
   Lafromboise TD, 2008, SUICIDE LIFE-THREAT, V38, P343, DOI 10.1521/suli.2008.38.3.343
   Law CK, 2014, SOC PSYCH PSYCH EPID, V49, P1919, DOI 10.1007/s00127-014-0905-1
   Leenaars AA, 2006, ARCH SUICIDE RES, V10, P305, DOI 10.1080/13811110600790710
   Lemstra M, 2009, CAN J PSYCHIAT, V54, P589, DOI 10.1177/070674370905400903
   LEWIS SA, 1988, J ABNORM CHILD PSYCH, V16, P459, DOI 10.1007/BF00914175
   Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064
   Marin-Leon L, 2012, REV PANAM SALUD PUBL, V32, P351, DOI 10.1590/S1020-49892012001100005
   May PA, 2005, AM J PUBLIC HEALTH, V95, P1238, DOI 10.2105/AJPH.2004.040410
   Muehlenkamp JJ, 2009, PROF PSYCHOL-RES PR, V40, P134, DOI 10.1037/a0013253
   Mullany B, 2009, AM J PUBLIC HEALTH, V99, P1840, DOI 10.2105/AJPH.2008.154880
   Orellana JD, 2016, REV BRAS PSIQUIATR, V38, P222, DOI 10.1590/1516-4446-2015-1720
   Orellana Jesem Douglas Yamall, 2013, Rev. bras. epidemiol., V16, P658, DOI 10.1590/S1415-790X2013000300010
   de Souza MLP, 2012, REV BRAS PSIQUIATR, V34, P489, DOI 10.1016/j.rbp.2012.04.008
   de Souza MLP, 2012, REV BRAS PSIQUIATR, V34, P34, DOI 10.1590/S1516-44462012000100007
   Vick FO, 2011, THESIS
   WHO (World Health Organ.), 2014, PREV SUIC GLOB IMP
   World Heal Organization, 2008, MENT HLTH SUIC RAT P
NR 30
TC 3
Z9 4
U1 0
U2 3
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PY 2018
VL 52
AR 56
DI 10.11606/S1518-8787.2018052000541
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GH2QJ
UT WOS:000433246300002
PM 29791676
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Minter, A
   Diggle, PJ
   Costa, F
   Childs, J
   Ko, AI
   Begon, M
AF Minter, A.
   Diggle, P. J.
   Costa, F.
   Childs, J.
   Ko, A. I.
   Begon, M.
TI Evidence of multiple intraspecific transmission routes for Leptospira
   acquisition in Norway rats (Rattus norvegicus)
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Age-prevalence; intraspecific transmission; leptospirosis; Norway rats
ID DISEASE TRANSMISSION; ZOONOTIC DISEASE; SEOUL VIRUS; INFECTION;
   ENVIRONMENT; INTERROGANS; WILDLIFE; EPIDEMIC
AB Infectious diseases frequently have multiple potential routes of intraspecific transmission of pathogens within wildlife and other populations. For pathogens causing zoonotic diseases, knowing whether these transmission routes occur in the wild and their relative importance, is critical for understanding maintenance, improving control measures and ultimately preventing human disease. The Norway rat (Rattus norvegicus) is the primary reservoir of leptospirosis in the urban slums of Salvador, Brazil. There is biological evidence for potentially three different transmission routes of leptospire infection occurring in the rodent population. Using newly obtained prevalence data from rodents trapped at an urban slum field site, we present changes in cumulative risk of infection in relation to age-dependent transmission routes to infer which intra-specific transmission routes occur in the wild. We found that a significant proportion of animals leave the nest with infection and that the risk of infection increases throughout the lifetime of Norway rats. We did not observe a significant effect of sexual maturity on the risk of infection. In conclusion, our results suggest that vertical and environmental transmission of leptospirosis both occur in wild populations of Norway rats.
C1 [Minter, A.; Begon, M.] Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 7ZB, Merseyside, England.
   [Diggle, P. J.] Univ Lancaster, Lancaster Univ Med Sch, CHICAS, Lancaster, England.
   [Costa, F.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Costa, F.; Ko, A. I.] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Childs, J.; Ko, A. I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Begon, M (corresponding author), Univ Liverpool, Inst Integrat Biol, Crown St, Liverpool L69 7ZB, Merseyside, England.
EM mbegon@liv.ac.uk
RI Costa, Federico/G-1838-2015; Ko, Albert Icksang/P-2343-2015
OI Costa, Federico/0000-0001-6951-2336; Ko, Albert
   Icksang/0000-0001-9023-2339; Diggle, Peter/0000-0003-3521-5020; ,
   Amanda/0000-0003-1171-5688
FU Oswaldo Cruz Foundation; Secretariat of Health Surveillance, Brazilian
   Ministry of Health; Wellcome TrustWellcome Trust [102330/Z/13/Z];
   NSF-NIH grant from Ecology and Evolution of Infection Diseases (EEID)
   program [1 R01 TW009504]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [5 R01 AI052473, 5 U01
   AI088752, 1 R25 TW009338, 1 R01 AI121207, F31 AI114245]; Research and
   Policy for Infectious Disease Dynamics (RAPIDD) program of the Science
   and Technology Directorate (US Department of Homeland Security); FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R01TW009504, R01TW009504,
   R25TW009338, R01TW009504, R25TW009338, R01TW009504, R25TW009338] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01AI088752, U01AI088752, R01AI052473,
   R01AI121207, R01AI052473, R01AI121207, R01AI052473, U01AI088752,
   F31AI114245, R01AI052473, U01AI088752, R01AI052473, R01AI052473,
   U01AI088752, R01AI121207, R01AI052473, R01AI052473, U01AI088752,
   R01AI052473, R01AI052473, R01AI052473, R01AI121207, F31AI114245] Funding
   Source: NIH RePORTER
FX We would like to thank Elsio Wunder and Lin Zhan for the laboratory
   analysis of the samples. We would also like to thank the field team
   coordinators for the data collection: Gabriel G. Perda, Soledad Serrano,
   Daiana De Oliveira and Arsinoe C. Pertile. This work was supported by
   the Oswaldo Cruz Foundation and Secretariat of Health Surveillance,
   Brazilian Ministry of Health; the Wellcome Trust (102330/Z/13/Z); and a
   NSF-NIH grant from the Ecology and Evolution of Infection Diseases
   (EEID) program (1 R01 TW009504), NIH grants (5 R01 AI052473, 5 U01
   AI088752, 1 R25 TW009338, 1 R01 AI121207, F31 AI114245) and by the
   Research and Policy for Infectious Disease Dynamics (RAPIDD) program of
   the Science and Technology Directorate (US Department of Homeland
   Security).
CR Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   BOLIN CA, 1988, J INFECT DIS, V158, P246, DOI 10.1093/infdis/158.1.246
   BOLLES RC, 1960, J COMP PHYSIOL PSYCH, V53, P306, DOI 10.1037/h0045421
   Borremans B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004882
   Burthe SJ, 2010, OECOLOGIA, V162, P653, DOI 10.1007/s00442-009-1495-6
   Caley P, 2004, J APPL ECOL, V41, P94, DOI 10.1111/j.1365-2664.2004.00867.x
   Caley P, 2001, J APPL ECOL, V38, P1362, DOI 10.1046/j.0021-8901.2001.00676.x
   Calhoun JB, 1962, US PUBLIC HLTH SERVI, V1008
   Childs JE, 2007, PREV VET MED, V78, P246, DOI 10.1016/j.prevetmed.2006.10.014
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   De Oliveira D, 2016, EPIDEMIOL INFECT, V144, P2420, DOI 10.1017/S0950268816000637
   Ellis WA, 2015, CURR TOP MICROBIOL, V387, P99, DOI 10.1007/978-3-662-45059-8_6
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4
   FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755
   Galef B.G. Jr, 1981, P211
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   GLASS GE, 1988, EPIDEMIOL INFECT, V101, P459, DOI 10.1017/S0950268800054418
   GLASS GE, 1988, J MAMMAL, V69, P587, DOI 10.2307/1381350
   Heisey DM, 2006, ECOLOGY, V87, P2356, DOI 10.1890/0012-9658(2006)87[2356:TFOGFM]2.0.CO;2
   Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270
   Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310
   ISKJAER C, 1989, J MAMMAL, V70, P662, DOI 10.2307/1381447
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kosmidis I., 2007, BRGLM BIAS REDUCTION
   LAHIRI M. N., 1941, INDIAN JOUR MED RES, V29, P685
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Long GH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001224
   McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9
   Panti-May JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152511
   Pepin KM, 2017, ECOL LETT, V20, P275, DOI 10.1111/ele.12732
   R Core Team, 2017, STAT R LANG ENV COMP
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Roczek A, 2008, J MED MICROBIOL, V57, P658, DOI 10.1099/jmm.0.47677-0
   SHAKED Y, 1993, CLIN INFECT DIS, V17, P241, DOI 10.1093/clinids/17.2.241
   THIELS E, 1988, PHYSIOL BEHAV, V42, P507, DOI 10.1016/0031-9384(88)90152-7
NR 40
TC 8
Z9 8
U1 1
U2 10
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD DEC
PY 2017
VL 145
IS 16
BP 3438
EP 3448
DI 10.1017/S0950268817002539
PG 11
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA FQ2QQ
UT WOS:000418201900012
PM 29173242
OA Other Gold, Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Freitas, BD
   Zin, A
   Ko, A
   Maia, M
   Ventura, CV
   Belfort, R
AF Freitas, Bruno de Paula
   Zin, Andrea
   Ko, Albert
   Maia, Mauricio
   Ventura, Camila V.
   Belfort, Rubens, Jr.
TI Anterior-Segment Ocular Findings and Microphthalmia in Congenital Zika
   Syndrome
SO OPHTHALMOLOGY
LA English
DT Editorial Material
ID VIRUS
C1 [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [Freitas, Bruno de Paula; Maia, Mauricio; Ventura, Camila V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Sao Paulo, Brazil.
   [Freitas, Bruno de Paula; Maia, Mauricio; Ventura, Camila V.; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,1st Floor, BR-04023062 Sao Paulo, Brazil.
   [Zin, Andrea] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Clin Res Unit, Rio De Janeiro, Brazil.
   [Ko, Albert] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ventura, Camila V.] Altino Ventura Fdn, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Rua Botucatu 821,1st Floor, BR-04023062 Sao Paulo, Brazil.
EM prof.belfort@clinicabelfort.com.br
RI Maia, Mauricio/I-5892-2015; Ko, Albert Icksang/P-2343-2015; Ventura,
   Camila V/N-2654-2018
OI Maia, Mauricio/0000-0002-7034-8091; Ko, Albert
   Icksang/0000-0001-9023-2339; Ventura, Camila V/0000-0002-2927-4684
CR Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD DEC
PY 2017
VL 124
IS 12
BP 1876
EP 1878
PG 3
WC Ophthalmology
SC Ophthalmology
GA FM9JZ
UT WOS:000415586000031
PM 28676282
DA 2020-11-30
ER

PT J
AU Pereira, TSC
   Souza, F
   Santos, L
   Walker, R
   Pertile, A
   Pedra, G
   Bahiense, T
   da Silva, E
   Reis, M
   Ko, A
   Childs, J
   Begon, M
   Costa, F
AF Carvalho Pereira, Ticiana S.
   Souza, Fabio
   Santos, Luana
   Walker, Ruth
   Pertile, Arsinoe
   Pedra, Gabriel
   Bahiense, Thiago
   da Silva, Eduardo
   Reis, Mitermayer
   Ko, Albert
   Childs, James
   Begon, Michael
   Costa, Federico
TI INFLUENCE OF CO-INFECTION ON CARRIAGE OF HUMAN PATHOGENS IN BROWN RATS
   FROM AN URBAN SLUM SETTING
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Carvalho Pereira, Ticiana S.] Univ Fed Bahia, Inst Biol, Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz,Minist Saude, Salvador, BA, Brazil.
   [Souza, Fabio; Santos, Luana; Walker, Ruth; Pertile, Arsinoe; Reis, Mitermayer] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Pedra, Gabriel; Begon, Michael] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
   [Bahiense, Thiago] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [da Silva, Eduardo] Univ Fed Bahia, Insituto Biol, Salvador, BA, Brazil.
   [Ko, Albert; Childs, James] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 532
BP 167
EP 167
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502055
DA 2020-11-30
ER

PT J
AU Hacker, KP
   Minter, A
   Almeida, C
   Reinalde, R
   Begon, M
   Diggle, PJ
   Childs, JE
   Reis, MG
   Ko, AI
   Costa, F
AF Hacker, Kathryn P.
   Minter, Amanda
   Almeida, Carolina
   Reinalde, Ramon
   Begon, Mike
   Diggle, Peter J.
   Childs, James E.
   Reis, Mitermayer G.
   Ko, Albert I.
   Costa, Federico
TI USE OF TRACKING PLATES TO IDENTIFY HOTSPOTS OF RAT ABUNDANCE IN SLUM
   COMMUNITIES WITH HIGH ENDEMIC TRANSMISSION OF LEPTOSPIROSIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Hacker, Kathryn P.; Childs, James E.; Ko, Albert I.] Yale Univ, New Haven, CT USA.
   [Minter, Amanda; Begon, Mike; Diggle, Peter J.] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
   [Almeida, Carolina; Reinalde, Ramon; Costa, Federico] Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil.
   [Reis, Mitermayer G.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 644
BP 202
EP 202
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502167
DA 2020-11-30
ER

PT J
AU Owers, KA
   Odetunde, J
   de Matos, RB
   Sacramento, G
   Carvalho, M
   Junior, NN
   Costa, F
   Reis, MG
   Begon, M
   Childs, JE
   Hagan, JE
   Diggle, PJ
   Ko, AI
AF Owers, Katharine A.
   Odetunde, Juliana
   de Matos, Rosan B.
   Sacramento, Gielson
   Carvalho, Mayara
   Junior, Nivison N.
   Costa, Federico
   Reis, Mitermayer G.
   Begon, Mike
   Childs, James E.
   Hagan, Jose E.
   Diggle, Peter J.
   Ko, Albert I.
TI FINE-SCALE GPS TRACKING TO QUANTIFY HUMAN MOVEMENT PATTERNS AND EXPOSURE
   TO LEPTOSPIROSIS IN THE URBAN SLUM ENVIRONMENT
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Owers, Katharine A.; Childs, James E.; Hagan, Jose E.; Ko, Albert I.] Yale Sch Publ Hlth, New Haven, CT USA.
   [Odetunde, Juliana] Univ Kentucky, Coll Med, Lexington, KY USA.
   [de Matos, Rosan B.; Sacramento, Gielson; Carvalho, Mayara; Junior, Nivison N.; Reis, Mitermayer G.] Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico] Univ Fed Bahia, Salvador, BA, Brazil.
   [Begon, Mike] Univ Liverpool, Liverpool, Merseyside, England.
   [Diggle, Peter J.] Univ Lancaster, Lancaster, England.
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1292
BP 406
EP 406
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502814
DA 2020-11-30
ER

PT J
AU Riediger, IN
   Stoddard, RA
   Ribeiro, GS
   Nakatani, SM
   Moreira, SDR
   Skraba, I
   Biondo, AW
   Reis, MG
   Hoffmaster, AR
   Vinetz, JM
   Ko, AI
   Wunder, EA
AF Riediger, Irina N.
   Stoddard, Robyn A.
   Ribeiro, Guilherme S.
   Nakatani, Sueli M.
   Moreira, Suzana D. R.
   Skraba, Irene
   Biondo, Alexander W.
   Reis, Mitermayer G.
   Hoffmaster, Alex R.
   Vinetz, Joseph M.
   Ko, Albert I.
   Wunder, Elsio A., Jr.
TI Rapid, actionable diagnosis of urban epidemic leptospirosis using a
   pathogenic Leptospira lipL32-based real-time PCR assay
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; QUANTITATIVE PCR; DENGUE-FEVER; TAQMAN ASSAY;
   SPP.; OPTIMIZATION; CULTURE; TESTS
AB Background
   With a conservatively estimated 1 million cases of leptospirosis worldwide and a 5-10% fatality rate, the rapid diagnosis of leptospirosis leading to effective clinical and public health decision making is of high importance, and yet remains a challenge.
   Methodology
   Based on parallel, population-based studies in two leptospirosis-endemic regions in Brazil, a real-time PCR assay which detects lipL32, a gene specifically present in pathogenic Leptospira, was assessed for the diagnostic effectiveness and accuracy. Patients identified by active hospital-based surveillance in Salvador and Curitiba during large urban leptospirosis epidemics were tested. Real-time PCR reactions were performed with DNA-extracted samples obtained from 127 confirmed and 23 unconfirmed cases suspected of leptospirosis, 122 patients with an acute febrile illness other than leptospirosis, and 60 healthy blood donors.
   Principal findings
   The PCR assay had a limit of detection of 280 Leptospira genomic equivalents/mL. Sensitivity for confirmed cases was 61% for whole blood and 29% for serum samples. Sensitivity was higher (86%) for samples collected within the first 6 days after onset of illness compared to those collected after 7 days (34%). The real-time PCR assay was able to detect leptospiral DNA in blood from 56% of serological non-confirmed cases. The overall specificity of the assay was 99%.
   Conclusions
   These findings indicate that real-time PCR may be a reliable tool for early diagnosis of leptospirosis, which is decisive for clinical management of severe and life-threatening cases and for public health decision making.
C1 [Riediger, Irina N.; Nakatani, Sueli M.; Skraba, Irene] Cent Lab State Parana, Mol Biol Sect, Curitiba, Parana, Brazil.
   [Stoddard, Robyn A.; Hoffmaster, Alex R.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Ribeiro, Guilherme S.; Reis, Mitermayer G.; Ko, Albert I.; Wunder, Elsio A., Jr.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Fed Univ State Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Moreira, Suzana D. R.] Fed Univ State Parana, Hosp Clin, Curitiba, Parana, Brazil.
   [Biondo, Alexander W.] Fed Univ State Parana, Dept Vet Med, Curitiba, Parana, Brazil.
   [Vinetz, Joseph M.] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA.
   [Ko, Albert I.; Wunder, Elsio A., Jr.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Ko, AI; Wunder, EA (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Inst, Salvador, BA, Brazil.; Ko, AI; Wunder, EA (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
EM albert.ko@yale.edu; elsio.wunder@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Ribeiro, Guilherme/B-6624-2008; Wunder,
   Elsio Augusto/C-2733-2013; Reis, Mitermayer/AAO-9742-2020; BIONDO,
   ALEXANDER WELKER W/E-8823-2018
OI Ko, Albert Icksang/0000-0001-9023-2339; Ribeiro,
   Guilherme/0000-0002-6798-2059; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Reis, Mitermayer/0000-0002-3051-9060;
   BIONDO, ALEXANDER WELKER W/0000-0002-4182-5821
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 TW009504, R25
   TW009338, U01 AI088752, R01 AI052473, D43 TW00919]; Coordination for the
   Improvement of Higher Education Personnel (CAPES) from the Brazilian
   Ministry of Education; National Council of Scientific and Technological
   Development (CNPq) from the Brazilian Ministry of Science and
   TechnologyNational Council for Scientific and Technological Development
   (CNPq); FOGARTY INTERNATIONAL CENTERUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL CENTER
   FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Advancing Translational Sciences (NCATS) [UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207] Funding Source: NIH
   RePORTER
FX his study was supported by the National Institutes of Health [R01
   TW009504, R25 TW009338, U01 AI088752, R01 AI052473 and D43 TW00919]; the
   Coordination for the Improvement of Higher Education Personnel (CAPES)
   from the Brazilian Ministry of Education; and the National Council of
   Scientific and Technological Development (CNPq) from the Brazilian
   Ministry of Science and Technology. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035
   Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093
   Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5527
   Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41
   Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10
   Bourhy P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000724
   Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Cumberland P, 1999, AM J TROP MED HYG, V61, P731, DOI 10.4269/ajtmh.1999.61.731
   Galloway RL, 2015, DIAGN MICR INFEC DIS, V82, P199, DOI [10.1016/j.diagmicrobio2015.03.024, 10.1016/j.diagmicrobio.2015.03.024]
   Gonzalez S, 2013, J INFECT DEV COUNTR, V7, P941, DOI 10.3855/jidc.4110
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kositanont U, 2007, DIAGN MICR INFEC DIS, V57, P117, DOI 10.1016/j.diagmicrobio.2006.07.014
   Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007
   Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0
   Limmathurotsakul D, 2012, CLIN INFECT DIS, V55, P322, DOI 10.1093/cid/cis403
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011
   Mishra B, 2013, J GLOB INFECT DIS, V5, P121, DOI 10.4103/0974-777X.116878
   Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003
   Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002
   Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005
   Roczek A, 2008, J MED MICROBIOL, V57, P658, DOI 10.1099/jmm.0.47677-0
   Schreier S, 2013, EXPERT REV CLIN IMMU, V9, P263, DOI [10.1586/ECI.12.110, 10.1586/eci.12.110]
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   Slack A, 2007, DIAGN MICR INFEC DIS, V57, P361, DOI 10.1016/j.diagmicrobio.2006.10.004
   Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95
   Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Stoddard Robyn Anne, 2013, Methods Mol Biol, V943, P257, DOI 10.1007/978-1-60327-353-4_17
   Suppiah J, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0344-x
   Terpstra WJ, 2003, HUM LEPT GUID DIAGN
   Thaipadunpanit J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016236
   Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122
   Waggoner JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112356
   Wuthiekanun V, 2007, J CLIN MICROBIOL, V45, P1363, DOI 10.1128/JCM.02430-06
NR 39
TC 14
Z9 14
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2017
VL 11
IS 9
AR e0005940
DI 10.1371/journal.pntd.0005940
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA FI6YN
UT WOS:000412142800068
PM 28915243
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Plowright, RK
   Parrish, CR
   McCallum, H
   Hudson, PJ
   Ko, AI
   Graham, AL
   Lloyd-Smith, JO
AF Plowright, Raina K.
   Parrish, Colin R.
   McCallum, Hamish
   Hudson, Peter J.
   Ko, Albert I.
   Graham, Andrea L.
   Lloyd-Smith, James O.
TI Pathways to zoonotic spillover
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID ESCHERICHIA-COLI O157; EBOLA-VIRUS TRANSMISSION; INFECTIOUS-DISEASES;
   ECOLOGICAL NICHE; DOSE-RESPONSE; INHALATION ANTHRAX; INFLUENZA-VIRUS;
   HUMAN MONKEYPOX; LARGE OUTBREAK; LEPTOSPIRA
AB Zoonotic spillover, which is the transmission of a pathogen from a vertebrate animal to a human, presents a global public health burden but is a poorly understood phenomenon. Zoonotic spillover requires several factors to align, including the ecological, epidemiological and behavioural determinants of pathogen exposure, and the within-human factors that affect susceptibility to infection. In this Opinion article, we propose a synthetic framework for animal-to-human transmission that integrates the relevant mechanisms. This framework reveals that all zoonotic pathogens must overcome a hierarchical series of barriers to cause spillover infections in humans. Understanding how these barriers are functionally and quantitatively linked, and how they interact in space and time, will substantially improve our ability to predict or prevent spillover events. This work provides a foundation for transdisciplinary investigation of spillover and synthetic theory on zoonotic transmission.
C1 [Plowright, Raina K.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.
   [Parrish, Colin R.] Cornell Univ, Baker Inst Anim Hlth, Coll Vet Med, Ithaca, NY 14853 USA.
   [McCallum, Hamish] Griffith Univ, Griffith Sch Environm, Brisbane, Qld 4111, Australia.
   [Hudson, Peter J.] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16802 USA.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Graham, Andrea L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.
   [Lloyd-Smith, James O.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.
   [Lloyd-Smith, James O.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
RP Plowright, RK (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.
EM raina.plowright@montana.edu
RI McCallum, Hamish/E-1638-2013; Ko, Albert Icksang/P-2343-2015; Hudson,
   Peter/AAB-8080-2020; Graham, Andrea L./A-8808-2010; Graham, Andrea
   L./P-7296-2019
OI McCallum, Hamish/0000-0002-3493-0412; Ko, Albert
   Icksang/0000-0001-9023-2339; Hudson, Peter/0000-0003-0468-3403; Graham,
   Andrea L./0000-0002-6580-2755; Graham, Andrea L./0000-0002-6580-2755
FU Commonwealth of AustraliaAustralian Government; State of New South Wales
   under the National Hendra Virus Research Program, awarded through the
   Rural Industries Research and Development Corporation; State of
   Queensland under the National Hendra Virus Research Program, awarded
   through the Rural Industries Research and Development Corporation; US
   National Institutes of General Medical Sciences IDeA Program
   [P20GM103474, P30GM110732]; P. Thye, the Morris Animal Foundation;
   Montana University System Research Initiative [51040-MUSRI2015-03];
   Defense Advanced Research Projects Agency (DARPA) Young Faculty
   AwardUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA); US Department of Defense Strategic
   Environmental Research and Development Program (SERDP)United States
   Department of Defense [RC-2633]; US National Science Foundation
   (NSF)National Science Foundation (NSF) [OCE-1335657, DEB-1557022]; US
   Department of Defense SERDP [RC-2635]; RAPIDD program of the Science &
   Technology Directorate of the Department of Homeland Security; Fogarty
   International Center (part of the US National Institutes of Health);
   IDEAS (Infectious Disease Evolution Across Scales); US National Science
   FoundationNational Science Foundation (NSF) [DEB-1354890]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, D43TW007120,
   D43TW007120, D43TW007120, D43TW007120, D43TW007120, D43TW007120,
   R01TW009504, D43TW007120, D43TW007120, D43TW007120, R01TW009504,
   D43TW007120, R01TW009504, D43TW007120, D43TW007120, D43TW007120,
   D43TW007120, D43TW007120, D43TW007120] Funding Source: NIH RePORTER;
   NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI121207, R01AI121207, R01AI121207, R01AI121207,
   R01AI121207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [P20GM103474, P20GM103474,
   P20GM103474, P20GM103474, P30GM110732, P30GM110732, P30GM110732,
   P30GM110732, P20GM103474, P30GM110732, P20GM103474, P20GM103474,
   P20GM103474, P30GM110732, P20GM103474, P20GM103474, P20GM103474,
   P30GM110732, P20GM103474, P30GM110732, P20GM103474, P20GM103474,
   P20GM103474, P30GM110732, P20GM103474, P20GM103474, P30GM110732,
   P30GM110732, P30GM110732, P20GM103474, P20GM103474, P20GM103474,
   P20GM103474, P20GM103474, P30GM110732, P30GM110732, P20GM103474,
   P20GM103474, P20GM103474, P30GM110732, P20GM103474, P20GM103474,
   P30GM110732, P20GM103474, P20GM103474, P30GM110732, P30GM110732,
   P30GM110732, P20GM103474, P20GM103474, P20GM103474, P20GM103474,
   P30GM110732, P30GM110732, P30GM110732, P20GM103474, P30GM110732,
   P20GM103474, P20GM103474, P30GM110732, P20GM103474, P20GM103474,
   P30GM110732, P20GM103474] Funding Source: NIH RePORTER; Directorate For
   GeosciencesNational Science Foundation (NSF)NSF - Directorate for
   Geosciences (GEO) [1335657] Funding Source: National Science Foundation
FX The authors thank J. Wood and E. Fleishman for helpful comments and
   conversations. R.K.P. and H.M. are supported by the Commonwealth of
   Australia, the State of New South Wales and the State of Queensland
   under the National Hendra Virus Research Program, awarded through the
   Rural Industries Research and Development Corporation. R.K.P. is
   supported by the US National Institutes of General Medical Sciences IDeA
   Program (grants P20GM103474 and P30GM110732), P. Thye, the Morris Animal
   Foundation, Montana University System Research Initiative (grant
   51040-MUSRI2015-03), a Defense Advanced Research Projects Agency (DARPA)
   Young Faculty Award and the US Department of Defense Strategic
   Environmental Research and Development Program (SERDP; grant RC-2633).
   J.O.L.-S. is supported by the US National Science Foundation (NSF;
   grants OCE-1335657 and DEB-1557022) and the US Department of Defense
   SERDP (grant RC-2635). J.O.L.-S., A.L.G. and P.J.H. are supported by the
   RAPIDD program of the Science & Technology Directorate of the Department
   of Homeland Security, the Fogarty International Center (part of the US
   National Institutes of Health), and by IDEAS (Infectious Disease
   Evolution Across Scales), which is a Research Coordination Network
   (DEB-1354890) funded by the US National Science Foundation.
CR AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877
   Andre-Fontaine G, 2015, CURR MICROBIOL, V71, P136, DOI 10.1007/s00284-015-0836-4
   Anthony SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00598-13
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Besser TE, 2011, POPULATION GENETICS OF BACTERIA: A TRIBUTE TO THOMAS S. WHITTAM, P303
   Bollaerts K, 2008, RISK ANAL, V28, P427, DOI 10.1111/j.1539-6924.2008.01038.x
   BRACHMAN PS, 1966, BACTERIOL REV, V30, P646, DOI 10.1128/MMBR.30.3.646-659.1966
   BRACHMAN PS, 1958, ANN NY ACAD SCI, V70, P574, DOI 10.1111/j.1749-6632.1958.tb35413.x
   Briand S, 2014, NEW ENGL J MED, V371, P1180, DOI 10.1056/NEJMp1409858
   Brierley L, 2016, AM NAT, V187, pE53, DOI 10.1086/684391
   BROCHIER B, 1991, NATURE, V354, P520, DOI 10.1038/354520a0
   Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044
   Cascio A, 2011, CLIN MICROBIOL INFEC, V17, P336, DOI 10.1111/j.1469-0691.2010.03451.x
   Christou L, 2011, CLIN MICROBIOL INFEC, V17, P326, DOI 10.1111/j.1469-0691.2010.03441.x
   Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06
   Cohen M, 2007, APPL BIOSAFETY, V12, P109, DOI DOI 10.1177/153567600701200207
   Coleman ME, 2008, BIOSECUR BIOTERROR, V6, P147, DOI 10.1089/bsp.2007.0066
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105
   Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000
   Dubey JP, 1998, J PARASITOL, V84, P862, DOI 10.2307/3284606
   Ducatez MF, 2008, VACCINE, V26, pD67, DOI 10.1016/j.vaccine.2008.07.064
   Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295
   Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897
   Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333
   French NP, 2002, EPIDEMIOL INFECT, V128, P325, DOI 10.1017/S0950268801006446
   Geoghegan JL, 2016, P NATL ACAD SCI USA, V113, P4170, DOI 10.1073/pnas.1521582113
   Gerba CP, 2005, J ENVIRON QUAL, V34, P42
   Gilbert SF, 2012, Q REV BIOL, V87, P325, DOI 10.1086/668166
   Gingles NA, 2001, INFECT IMMUN, V69, P426, DOI 10.1128/IAI.69.1.426-434.2001
   Gortazar C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004129
   Greene CE., 2013, INFECT DIS DOG CAT
   Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537
   Gurtler RE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002894
   Haas CN, 2014, QUANTITATIVE MICROBIAL RISK ASSESSMENT, 2ND EDITION, P1, DOI 10.1002/9781118910030
   Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607
   Hampson K, 2007, P NATL ACAD SCI USA, V104, P7717, DOI 10.1073/pnas.0609122104
   Hancock DD, 1997, EPIDEMIOL INFECT, V118, P193, DOI 10.1017/S0950268896007212
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   HESS AD, 1970, AM J TROP MED HYG, V19, P327, DOI 10.4269/ajtmh.1970.19.327
   Hjelle B, 2000, J INFECT DIS, V181, P1569, DOI 10.1086/315467
   Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442
   Hudson P., 2002, ECOLOGY WILDLIFE DIS
   Hutin YJF, 2001, EMERG INFECT DIS, V7, P434
   Jezek Z., 1988, MONOGR VIROL, V17, P119
   Johnson CK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14830
   Jones JL, 2010, EXP PARASITOL, V124, P10, DOI 10.1016/j.exppara.2009.03.013
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Judson S, 2015, VIRUSES-BASEL, V7, P511, DOI 10.3390/v7020511
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Kearney M, 2010, PHILOS T R SOC B, V365, P3469, DOI 10.1098/rstb.2010.0034
   Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073
   Kieft R, 2010, P NATL ACAD SCI USA, V107, P16137, DOI 10.1073/pnas.1007074107
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Knight DJW, 2003, LANCET, V361, P1831, DOI 10.1016/S0140-6736(03)12489-0
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a
   Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528
   Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167
   Levine RS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000176
   Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725
   Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617
   Lingappa J, 2004, GENES IMMUN, V5, P197, DOI 10.1038/sj.gene.6364058
   Lipsitch M, 2016, ELIFE, V5, DOI 10.7554/eLife.18491
   Lloyd-Smith JO, 2015, EPIDEMICS-NETH, V10, P35, DOI 10.1016/j.epidem.2014.09.002
   Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345
   Macpherson CNL, 2005, INT J PARASITOL, V35, P1319, DOI 10.1016/j.ijpara.2005.06.004
   Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103
   Miller RH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001678
   Mitscherlich E., 2012, MICROBIAL SURVIVAL E
   Monahan AM, 2008, INFECT IMMUN, V76, P4952, DOI 10.1128/IAI.00511-08
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102
   Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005
   Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08
   Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4
   Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440
   Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180
   Pigott DM, 2015, T ROY SOC TROP MED H, V109, P366, DOI 10.1093/trstmh/trv024
   Plowright RK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004796
   Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124
   Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541
   Prescott J, 2015, EMERG INFECT DIS, V21, P856, DOI 10.3201/eid2105.150041
   Pujol JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000399
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Reymond D, 1996, J CLIN MICROBIOL, V34, P2053, DOI 10.1128/JCM.34.9.2053-2057.1996
   Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6
   Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792
   Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265
   Schmid-Hempel P, 2007, PLOS PATHOG, V3, P1372, DOI 10.1371/journal.ppat.0030147
   Scott ME, 2006, PARASITOLOGY, V132, P669, DOI 10.1017/S0031182005009583
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859
   Smego RA, 1999, EUR J CLIN MICROBIOL, V18, P1, DOI 10.1007/s100960050219
   Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182
   Spencer SEF, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0446
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Temmam S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/ijms150610377
   Teunis PFM, 2008, EPIDEMIOL INFECT, V136, P761, DOI 10.1017/S0950268807008771
   Thoen CO, 2014, ZOONOTIC TUBERCULOSIS: MYCOBACTERIUM BOVIS AND OTHER PATHOGENIC MYCOBACTERIA, 3RD EDITION, P1, DOI 10.1002/9781118474310
   Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724
   Trobaugh DW, 2017, TRENDS MOL MED, V23, P80, DOI 10.1016/j.molmed.2016.11.003
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Tuttle J, 1999, EPIDEMIOL INFECT, V122, P185, DOI 10.1017/S0950268898001976
   Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013
   Webster R., 1997, VIRAL ZOONOSES FOOD, P105
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997
   Yang W, 2014, CHINESE MED J-PEKING, V127, P3335, DOI 10.1097/00029330-201409200-00025
NR 119
TC 139
Z9 140
U1 8
U2 99
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD AUG
PY 2017
VL 15
IS 8
BP 502
EP 510
DI 10.1038/nrmicro.2017.45
PG 9
WC Microbiology
SC Microbiology
GA FA4FV
UT WOS:000405400100010
PM 28555073
OA Green Published, Bronze, Green Accepted
DA 2020-11-30
ER

PT J
AU Robbiani, DF
   Bozzacco, L
   Keeffe, JR
   Khouri, R
   Olsen, PC
   Gazumyan, A
   Schaefer-Babajew, D
   Avila-Rios, S
   Nogueira, L
   Patel, R
   Azzopardi, SA
   Uhl, LFK
   Saeed, M
   Sevilla-Reyes, EE
   Agudelo, M
   Yao, KH
   Golijanin, J
   Gristick, HB
   Lee, YE
   Hurley, A
   Caskey, M
   Pai, J
   Oliveira, T
   Wunder, EA
   Sacramento, G
   Nery, N
   Orge, C
   Costa, F
   Reis, MG
   Thomas, NM
   Eisenreich, T
   Weinberger, DM
   de Almeida, ARP
   West, AP
   Rice, CM
   Bjorkman, PJ
   Reyes-Teran, G
   Ko, AI
   MacDonald, MR
   Nussenzweig, MC
AF Robbiani, Davide F.
   Bozzacco, Leonia
   Keeffe, Jennifer R.
   Khouri, Ricardo
   Olsen, Priscilla C.
   Gazumyan, Anna
   Schaefer-Babajew, Dennis
   Avila-Rios, Santiago
   Nogueira, Lilian
   Patel, Roshni
   Azzopardi, Stephanie A.
   Uhl, Lion F. K.
   Saeed, Mohsan
   Sevilla-Reyes, Edgar E.
   Agudelo, Marianna
   Yao, Kai-Hui
   Golijanin, Jovana
   Gristick, Harry B.
   Lee, Yu E.
   Hurley, Arlene
   Caskey, Marina
   Pai, Joy
   Oliveira, Thiago
   Wunder, Elsio A., Jr.
   Sacramento, Gielson
   Nery, Nivison, Jr.
   Orge, Cibele
   Costa, Federico
   Reis, Mitermayer G.
   Thomas, Neena M.
   Eisenreich, Thomas
   Weinberger, Daniel M.
   de Almeida, Antonio R. P.
   West, Anthony P., Jr.
   Rice, Charles M.
   Bjorkman, Pamela J.
   Reyes-Teran, Gustavo
   Ko, Albert I.
   MacDonald, Margaret R.
   Nussenzweig, Michel C.
TI Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil
   and Mexico
SO CELL
LA English
DT Article
ID DENGUE VIRUS; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; MEDIATED
   NEUTRALIZATION; CROSS-REACTIVITY; DOMAIN-III; HIV-1; ENHANCEMENT; BROAD;
   GLYCOPROTEIN
AB Antibodies to Zika virus (ZIKV) can be protective. To examine the antibody response in individuals who develop high titers of anti-ZIKV antibodies, we screened cohorts in Brazil and Mexico for ZIKV envelope domain III (ZEDIII) binding and neutralization. We find that serologic reactivity to dengue 1 virus (DENV1) EDIII before ZIKV exposure is associated with increased ZIKV neutralizing titers after exposure. Antibody cloning shows that donors with high ZIKV neutralizing antibody titers have expanded clones of memory B cells that express the same immunoglobulin VH3-23/VK1-5 genes. These recurring antibodies cross-react with DENV1, but not other flaviviruses, neutralize both DENV1 and ZIKV, and protect mice against ZIKV challenge. Structural analyses reveal the mechanism of recognition of the ZEDIII lateral ridge by VH3-23/VK1-5 antibodies. Serologic testing shows that antibodies to this region correlate with serumneutralizing activity to ZIKV. Thus, high neutralizing responses to ZIKV are associated with pre-existing reactivity to DENV1 in humans.
C1 [Robbiani, Davide F.; Olsen, Priscilla C.; Gazumyan, Anna; Schaefer-Babajew, Dennis; Nogueira, Lilian; Patel, Roshni; Uhl, Lion F. K.; Agudelo, Marianna; Yao, Kai-Hui; Golijanin, Jovana; Hurley, Arlene; Caskey, Marina; Pai, Joy; Oliveira, Thiago; Thomas, Neena M.; Eisenreich, Thomas; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.
   [Bozzacco, Leonia; Azzopardi, Stephanie A.; Saeed, Mohsan; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.
   [Keeffe, Jennifer R.; Gristick, Harry B.; Lee, Yu E.; West, Anthony P., Jr.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Khouri, Ricardo; Wunder, Elsio A., Jr.; Sacramento, Gielson; Nery, Nivison, Jr.; Orge, Cibele; Costa, Federico; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz MS, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Avila-Rios, Santiago; Sevilla-Reyes, Edgar E.; Reyes-Teran, Gustavo] Natl Inst Resp Dis, Mexico City 14080, DF, Mexico.
   [Wunder, Elsio A., Jr.; Costa, Federico; Reis, Mitermayer G.; Weinberger, Daniel M.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Costa, Federico; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Fac Med Bahia, BR-40296710 Salvador, BA, Brazil.
   [Costa, Federico; Reis, Mitermayer G.; de Almeida, Antonio R. P.] Univ Fed Bahia, Inst Saude Colet, BR-40296710 Salvador, BA, Brazil.
   [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
RP Robbiani, DF; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; MacDonald, MR (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
EM drobbiani@rockefeller.edu; macdonm@rockefeller.edu;
   nussen@rockefeller.edu
RI Nussenzweig, Michel/AAE-7292-2019; Wunder, Elsio Augusto/C-2733-2013;
   Robbiani, Davide F./AAF-7662-2019; Olsen, Priscilla C/I-8994-2012;
   Khouri, Ricardo/M-3184-2018; Costa, Federico/G-1838-2015; Avila-Rios,
   Santiago/AAB-4383-2020; Reis, Mitermayer/AAO-9742-2020; Ko, Albert
   Icksang/P-2343-2015; Oliveira, Thiago/B-7073-2014
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Robbiani, Davide
   F./0000-0001-7379-3484; Olsen, Priscilla C/0000-0002-8795-037X; Khouri,
   Ricardo/0000-0001-5664-4436; Costa, Federico/0000-0001-6951-2336; Reis,
   Mitermayer/0000-0002-3051-9060; Ko, Albert Icksang/0000-0001-9023-2339;
   Caskey, Marina/0000-0003-1727-8693; Uhl, Lion/0000-0003-1729-9857; Rocha
   Nery Junior, Nivison Ruy/0000-0002-8164-0602; Schaefer-Babajew,
   Dennis/0000-0002-5380-2950; Oliveira, Thiago/0000-0002-2654-0879
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI111825, UL1TR001866, R01AI037526,
   UM1AI100663, R01AI121207, R01TW009504, R25TW009338, U01AI088752,
   R01AI124690, U19AI057229]; Molecular Observatory at Caltech - Gordon and
   Betty Moore Foundation; Robertson Therapeutic Development Fund; Pew
   Latin American Fellows Program in the Biomedical Sciences;
   Studienstiftung des deutschen Volkes; Austrian Marshall Plan Foundation;
   Red INMUNOCANEI-Conacyt; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR001863, UL1TR001866, UL1TR001866, UL1TR001863, UL1TR001863,
   UL1TR001866, UL1TR001863, UL1TR001866, UL1TR001866, UL1TR001866,
   UL1TR001866, UL1TR001866, UL1TR001863, UL1TR001866, UL1TR001863,
   UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI037526, R01AI037526, UM1AI100663, U19AI111825, R01AI037526,
   UM1AI100663, UM1AI100663, UM1AI100663, R01AI037526, U01AI088752,
   UM1AI100663, U19AI111825, UM1AI100663, UM1AI100663, R01AI037526,
   UM1AI100663, UM1AI100663, UM1AI100663, U19AI111825, U19AI111825,
   R01AI121207, U19AI111825, UM1AI100663, UM1AI100663, UM1AI100663,
   U01AI088752, R01AI121207, U19AI111825, T32AI070084, R37AI037526,
   R01AI037526, UM1AI100663, UM1AI100663, U19AI111825, R01AI037526,
   R01AI124690, U19AI111825, U19AI111825, UM1AI100663, U19AI111825,
   UM1AI100663, U19AI111825, R01AI124690, R01AI124690, U19AI111825,
   UM1AI100663, T32AI070084, U19AI111825, T32AI070084, U19AI111825,
   U19AI111825, UM1AI100663, U19AI111825, UM1AI100663, R01AI124690,
   UM1AI100663, U19AI111825, U19AI111825, R01AI037526, R21AI112602,
   U01AI088752, T32AI070084, U19AI111825, U19AI111825, U19AI111825,
   UM1AI100663, U19AI111825, R01AI121207, U19AI111825, UM1AI100663,
   R37AI037526, U19AI111825, U19AI111825, U19AI111825, UM1AI100663,
   UM1AI100663, UM1AI100663, UM1AI100663, UM1AI100663, U19AI111825,
   U19AI111825, UM1AI100663, UM1AI100663, U19AI111825, R37AI037526,
   R37AI037526, R21AI112602, UM1AI100663, U19AI111825, U19AI111825,
   UM1AI100663, UM1AI100663, R01AI037526, R01AI037526, UM1AI100663,
   UM1AI100663, R01AI037526, UM1AI100663, U19AI111825, U19AI111825,
   UM1AI100663, UM1AI100663, UM1AI100663, R01AI037526, R01AI037526,
   R37AI037526, R01AI037526, U19AI111825, R37AI037526, R01AI121207,
   U19AI111825, R01AI037526, U19AI111825, UM1AI100663, U19AI111825,
   U19AI111825, U19AI111825, U01AI088752, U19AI111825, U19AI111825,
   UM1AI100663, U19AI111825, R01AI124690, R01AI037526, U19AI111825,
   R01AI121207, U19AI111825, UM1AI100663, UM1AI100663, UM1AI100663,
   UM1AI100663, UM1AI100663, U19AI111825, UM1AI100663, UM1AI100663,
   UM1AI100663, U19AI111825, UM1AI100663, R01AI037526, UM1AI100663,
   UM1AI100663, UM1AI100663, U19AI111825, UM1AI100663, UM1AI100663,
   R01AI037526, R37AI037526, UM1AI100663, UM1AI100663, U01AI088752,
   U19AI111825, U01AI088752, UM1AI100663, R01AI037526] Funding Source: NIH
   RePORTER
FX We would especially like to thank the members of the Santa Maria
   Mixtequilla and Pau da Lima communities who agreed to participate in
   this study, as well as the Fiocruz community research team and staff of
   Hospital Geral Roberto Santos for their assistance with the clinical
   protocols. We thank members of the Nussenzweig and Rice labs for helpful
   discussions and suggestions. A particular thank you to Lotta von
   Boehmer, Christian Mayer, Yotam Bar-On, Irina Shimeliovich, and Julio
   Cetrulo Lorenzi for sharing expertise, protocols, and reagents. We thank
   Ted Pierson for plasmids pWNVII-Rep-REN-IB and pZIKV/HPF/CprME, Aaron
   Brault (CDC) for ZIKV PRVABC59, Bob Tesh for DENV1 PUO-359, Matt Evans
   for ZIKV MR766 cDNA, and Greg Ebel, James Weger, and Brian Geiss for
   ZIKV PRVABC59 cDNA. We are grateful to Laura Kramer (NYSDOH) and Robert
   Lanciotti (CDC) for PRNT advice and protocols, Kimberly Dowd for RVP
   advice, and Muhammad Arshad for cloning assistance. We thank Barbara
   Johnson, Ann Powers, Christin Goodman, Claire Huang, Brandy Russell
   (CDC), and Claudia Duarte dos Santos for sharing ZIKV information early
   on. Moreover, we are thankful to Mary Ellen Castillo for facilitating
   virus work in the cell culture core, Alison Ashbrook for help with PRNT
   assays, Natalia Frias-Staheli for generation of the DENV1 stock, Corrine
   Quirk for assistance with mouse colonies, Tiffany Luong, Alisa Voll, and
   the Caltech Protein Expression Center for cloning, expression, and
   purification of proteins for crystallography, and Christopher Barnes and
   Beth Stadtmueller for help with crystallographic methods. This work was
   supported by NIH pilot awards U19AI111825 (to D.F.R.) and UL1TR001866
   (to D.F.R. and L.B.), grants R01AI037526, UM1AI100663, U19AI111825, and
   UL1TR001866 (to M.C.N.), grants R01AI121207, R01TW009504, R25TW009338,
   and U01AI088752 (to A.I.K.), grants R01AI124690 (to C.M.R.) and
   U19AI057229 (CCHI Opportunity Fund Project to C.M.R. and M.R.M.), donors
   to the Zika Fund at Rockefeller University and anonymous donors (to
   C.M.R.), and the Molecular Observatory at Caltech supported by the
   Gordon and Betty Moore Foundation (P.J.B.). Operations at the Stanford
   Synchrotron Radiation Lightsource are supported by the US Department of
   Energy and the NIH. Support was also provided by the Robertson
   Therapeutic Development Fund (to D.F.R. and M.C.N.). P.C.O. is supported
   by the Pew Latin American Fellows Program in the Biomedical Sciences,
   D.S.-B. by Studienstiftung des deutschen Volkes, L.F.K.U. by the
   Austrian Marshall Plan Foundation, and E.E.S.-R. is partly supported by
   Red INMUNOCANEI-Conacyt. M.C.N. is an HHMI Investigator. In connection
   with this work, D.F.R. and M.C.N. have a provisional patent application
   with the U.S. Patent and Trademark Office (62/483,001). The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of any of the funding agencies or
   individuals.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L., 2016, EURO SURVEILL, V21
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chapgier A, 2006, PLOS GENET, V2, P1193, DOI 10.1371/journal.pgen.0020131
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/mmbr.00055-16, 10.1128/MMBR.00055-16]
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Jones TA, 2004, ACTA CRYSTALLOGR D, V60, P2115, DOI 10.1107/S0907444904023509
   Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rubelt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049774
   SABIN AB, 1950, BACTERIOL REV, V14, P225
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227
   Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942
   von Boehmer L, 2016, NAT PROTOC, V11, P1908, DOI 10.1038/nprot.2016.102
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   West AP, 2013, P NATL ACAD SCI USA, V110, P10598, DOI 10.1073/pnas.1309215110
   West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352
   Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382
   Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819
NR 73
TC 123
Z9 125
U1 0
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 4
PY 2017
VL 169
IS 4
BP 597
EP 609
DI 10.1016/j.cell.2017.04.024
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA ET8PD
UT WOS:000400560900007
PM 28475892
OA Bronze, Green Accepted
DA 2020-11-30
ER

PT J
AU Richardson, JL
   Burak, MK
   Hernandez, C
   Shirvell, JM
   Mariani, C
   Carvalho-Pereira, TSA
   Pertile, AC
   Panti-May, JA
   Pedra, GG
   Serrano, S
   Taylor, J
   Carvalho, M
   Rodrigues, G
   Costa, F
   Childs, JE
   Ko, AI
   Caccone, A
AF Richardson, Jonathan L.
   Burak, Mary K.
   Hernandez, Christian
   Shirvell, James M.
   Mariani, Carol
   Carvalho-Pereira, Ticiana S. A.
   Pertile, Arsinoe C.
   Panti-May, Jesus A.
   Pedra, Gabriel G.
   Serrano, Soledad
   Taylor, Josh
   Carvalho, Mayara
   Rodrigues, Gorete
   Costa, Federico
   Childs, James E.
   Ko, Albert I.
   Caccone, Adalgisa
TI Using fine-scale spatial genetics of Norway rats to improve control
   efforts and reduce leptospirosis risk in urban slum environments
SO EVOLUTIONARY APPLICATIONS
LA English
DT Article
DE epidemiology; favela; individual-based sampling; intervention; landscape
   genetics; population genetics; public health; reservoir host; spatial
   scale; urban ecology; vector control
ID RATTUS-NORVEGICUS; POPULATION-GENETICS; ERADICATION UNITS;
   MARK-RECAPTURE; NULL ALLELES; LANDSCAPE; URBANIZATION; TRANSMISSION;
   MOVEMENTS; INFERENCE
AB The Norway rat (Rattus norvegicus) is a key pest species globally and responsible for seasonal outbreaks of the zoonotic bacterial disease leptospirosis in the tropics. The city of Salvador, Brazil, has seen recent and dramatic increases in human population residing in slums, where conditions foster high rat density and increasing leptospirosis infection rates. Intervention campaigns have been used to drastically reduce rat numbers. In planning these interventions, it is important to define the eradication units - the spatial scale at which rats constitute continuous populations and from where rats are likely recolonizing, post-intervention. To provide this information, we applied spatial genetic analyses to 706 rats collected across Salvador and genotyped at 16 microsatellite loci. We performed spatially explicit analyses and estimated migration levels to identify distinct genetic units and landscape features associated with genetic divergence at different spatial scales, ranging from valleys within a slum community to city-wide analyses. Clear genetic breaks exist between rats not only across Salvador but also between valleys of slums separated by < 100 m-well within the dispersal capacity of rats. The genetic data indicate that valleys may be considered separate units and identified high-traffic roads as strong impediments to rat movement. Migration data suggest that most (71-90%) movement is contained within valleys, with no clear source population contributing to migrant rats. We use these data to recommend eradication units and discuss the importance of carrying out individual-based analyses at different spatial scales in urban landscapes.
C1 [Richardson, Jonathan L.; Burak, Mary K.] Providence Coll, Dept Biol, Providence, RI 02918 USA.
   [Hernandez, Christian; Shirvell, James M.; Mariani, Carol; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.
   [Carvalho-Pereira, Ticiana S. A.; Pertile, Arsinoe C.; Panti-May, Jesus A.; Pedra, Gabriel G.; Serrano, Soledad; Taylor, Josh; Carvalho, Mayara; Ko, Albert I.] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Rodrigues, Gorete] Secretaria Municipal Saude, Minist Saude, Ctr Controle Zoonoses, Salvador, BA, Brazil.
   [Costa, Federico] Univ Fed Bahia, UFBA, Inst Saude Colet, Salvador, BA, Brazil.
   [Childs, James E.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Richardson, JL (corresponding author), Providence Coll, Dept Biol, Providence, RI 02918 USA.
EM jrichardson@providence.edu
RI Ko, Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015; Panti-May,
   Jesus Alonso/U-2798-2019
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336; Panti-May, Jesus
   Alonso/0000-0003-1669-5727; Carvalho Pereira,
   Ticiana/0000-0003-2370-2198
FU Oswaldo Cruz Foundation; Secretariat of Health Surveillance; Brazilian
   Ministry of Health; Wellcome TrustWellcome Trust [102330/Z/13/Z];
   NSF-NIHNational Science Foundation (NSF)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [5 R01
   AI052473, 5 U01 AI088752, 1 R25 TW009338, 1 R01 AI121207, F31 AI114245,
   R01 AI052473, U01 AI088752, R01 TW009504, R25 TW009338]; Ecology and
   Evolution of Infection Diseases (EEID) [1 R01 TW009504]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R01TW009504, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R01TW009504, R25TW009338, R25TW009338,
   R01TW009504, R25TW009338, R25TW009338, R01TW009504, R25TW009338] Funding
   Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI121207, R01AI052473,
   R01AI052473, U01AI088752, R01AI121207, F31AI114245, U01AI088752,
   F31AI114245, R01AI121207, R01AI052473, U01AI088752, R01AI052473,
   R01AI121207, U01AI088752, R01AI052473, R01AI121207, R01AI052473,
   R01AI052473, U01AI088752] Funding Source: NIH RePORTER
FX Oswaldo Cruz Foundation; Secretariat of Health Surveillance; Brazilian
   Ministry of Health; Wellcome Trust, Grant/Award Number: 102330/Z/13/Z;
   NSF-NIH, Grant/Award Number: 5 R01 AI052473, 5 U01 AI088752, 1 R25
   TW009338, 1 R01 AI121207, F31 AI114245, R01 AI052473, U01 AI088752, R01
   TW009504 and R25 TW009338; Ecology and Evolution of Infection Diseases
   (EEID), Grant/Award Number: 1 R01 TW009504.
CR Abdelkrim J, 2005, CONSERV BIOL, V19, P1509, DOI 10.1111/j.1523-1739.2005.00206.x
   Abdelkrim J, 2007, CONSERV BIOL, V21, P719, DOI 10.1111/j.1523-1739.2007.00696.x
   Adams AL, 2014, BIOL INVASIONS, V16, P1481, DOI 10.1007/s10530-013-0586-9
   Angelone S, 2011, ECOGRAPHY, V34, P714, DOI 10.1111/j.1600-0587.2010.06494.x
   Antoniou M, 2010, VECTOR-BORNE ZOONOT, V10, P867, DOI 10.1089/vbz.2009.0123
   Blair RB, 2001, BIOTIC HOMOGENIZATION, P33
   BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0
   Capizzi D, 2014, MAMMAL REV, V44, P148, DOI 10.1111/mam.12019
   Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191
   Costa F, 2016, J HERED, V107, P181, DOI 10.1093/jhered/esv098
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Cushman SA, 2010, LANDSCAPE ECOL, V25, P967, DOI 10.1007/s10980-010-9467-0
   DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387
   de Masi E, 2009, INT J ENVIRON HEAL R, V19, P291, DOI 10.1080/09603120802592723
   Donihue CM, 2015, AMBIO, V44, P194, DOI 10.1007/s13280-014-0547-2
   Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4
   FENN MGP, 1987, J ZOOL, V213, P745, DOI 10.1111/j.1469-7998.1987.tb03741.x
   Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x
   Fraser CI, 2015, BIOL INVASIONS, V17, P1, DOI 10.1007/s10530-014-0714-1
   Galpern P, 2014, METHODS ECOL EVOL, V5, P1116, DOI 10.1111/2041-210X.12240
   Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x
   Geslin B, 2016, ECOL EVOL, V6, P6599, DOI 10.1002/ece3.2374
   Glass G., 1989, COMP ECOLOGY SOCIAL
   Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627
   Gratz N. G., 1994, P85
   Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x
   Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136
   Hacker KP, 2016, URBAN ECOSYST, V19, P561, DOI 10.1007/s11252-015-0519-8
   Hacker KP, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-45
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x
   Harris S. E., 2016, BIORXIV
   Harris SE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069247, 10.1371/journal.pone.0074938]
   Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195
   HOLM S, 1979, SCAND J STAT, V6, P65
   Hulme-Beaman A, 2016, TRENDS ECOL EVOL, V31, P633, DOI 10.1016/j.tree.2016.05.001
   Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34
   Jombart T., 2016, ADEGENET R PACKAGE E
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455
   Keller D, 2013, MOL ECOL, V22, P2467, DOI 10.1111/mec.12265
   Klaassen CHW, 2012, MOL ECOL, V21, P57, DOI 10.1111/j.1365-294X.2011.05364.x
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Krausman P. R., 2008, SUBURBAN EXURBAN INF
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   Legendre P, 2015, METHODS ECOL EVOL, V6, P1239, DOI 10.1111/2041-210X.12425
   Long J.L., 2003, INTRO MAMMALS WORLD
   Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x
   Luximon N, 2014, MOL ECOL RESOUR, V14, P745, DOI 10.1111/1755-0998.12224
   Lyytimaki J, 2008, ENV SCI, V5, P161, DOI DOI 10.1080/15693430802055524
   MACDONALD DW, 1995, J ZOOL, V236, P349, DOI 10.1111/j.1469-7998.1995.tb04502.x
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025
   McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2
   Moreira IM, 2008, SALVADOR METROPOLITA, P228
   Munshi-South J, 2012, MOL ECOL, V21, P1360, DOI 10.1111/j.1365-294X.2012.05476.x
   Noel S, 2007, CONSERV GENET, V8, P599, DOI 10.1007/s10592-006-9202-1
   Oksanen J., 2016, VEGAN COMMUNITY ECOL
   Oyler-McCance SJ, 2013, CONSERV GENET, V14, P275, DOI 10.1007/s10592-012-0415-1
   Park S.D.E., 2001, EXCEL MICROSATELLITE
   Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190
   Peakall R, 2006, J ZOOL, V268, P207, DOI 10.1111/j.1469-7998.2005.00011.x
   Peres-Neto P., 2015, SPATIAL PATTERN DETE
   Pickett ST, 2008, URBAN ECOL, P99
   Piertney SB, 2016, J APPL ECOL, V53, P332, DOI 10.1111/1365-2664.12589
   Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002
   Pritchard JK, 2000, GENETICS, V155, P945
   Prunier JG, 2013, MOL ECOL, V22, P5516, DOI 10.1111/mec.12499
   R Development Core Team, 2015, R LANG ENV STAT COMP
   Ragionieri L, 2013, BIOL INVASIONS, V15, P2731, DOI 10.1007/s10530-013-0487-y
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Richardson JL, 2016, MOL ECOL, V25, P849, DOI 10.1111/mec.13527
   Richardson JL, 2014, TRENDS ECOL EVOL, V29, P165, DOI 10.1016/j.tree.2014.01.002
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Robertson BC, 2004, J APPL ECOL, V41, P1042, DOI 10.1111/j.0021-8901.2004.00984.x
   Russell JC, 2010, BIOL INVASIONS, V12, P1747, DOI 10.1007/s10530-009-9586-1
   Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105
   Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7
   SELANDER RK, 1975, EVOLUTION, V29, P385, DOI 10.1111/j.1558-5646.1975.tb00829.x
   TAYLOR KD, 1978, J APPL ECOL, V15, P663, DOI 10.2307/2402767
   TAYLOR KD, 1978, MAMMALIA, V42, P63, DOI 10.1515/mamm.1978.42.1.63
   Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z
   Un-Habitat, 2004, MANAG ENV QUAL INT J, V15, P337, DOI DOI 10.1108/MEQ.2004.15.3.337.3
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
   Veale AJ, 2013, MOL ECOL, V22, P5071, DOI 10.1111/mec.12453
   Wagner HH, 2005, ECOLOGY, V86, P1975, DOI 10.1890/04-0914
   Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x
   Wilson DJ, 2007, NEW ZEAL J ECOL, V31, P47
   Wilson GA, 2003, GENETICS, V163, P1177
   Wood BC, 2002, BIODIVERS CONSERV, V11, P1451, DOI 10.1023/A:1016223907962
NR 94
TC 26
Z9 27
U1 1
U2 37
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1752-4571
J9 EVOL APPL
JI Evol. Appl.
PD APR
PY 2017
VL 10
IS 4
BP 323
EP 337
DI 10.1111/eva.12449
PG 15
WC Evolutionary Biology
SC Evolutionary Biology
GA EU6YJ
UT WOS:000401181600002
PM 28352293
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Martin, FS
   Mechaly, AE
   Larrieux, N
   Wunder, EA
   Ko, AI
   Picardeau, M
   Trajtenberg, F
   Buschiazzo, A
AF Martin, Fabiana San
   Mechaly, Ariel E.
   Larrieux, Nicole
   Wunder, Elsio A., Jr.
   Ko, Albert I.
   Picardeau, Mathieu
   Trajtenberg, Felipe
   Buschiazzo, Alejandro
TI Crystallization of FcpA from Leptospira, a novel flagellar protein that
   is essential for pathogenesis
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
DE spirochetes; motility; flagella; SAD phasing; Leptospira interrogans;
   Leptospira biflexa; FcpA; leptospirosis
ID SPIROCHETE; MOTILITY; INTERROGANS; VIRULENCE; SHEATH
AB The protein FcpA is a unique component of the flagellar filament of spirochete bacteria belonging to the genus Leptospira. Although it plays an essential role in translational motility and pathogenicity, no structures of FcpA homologues are currently available in the PDB. Its three-dimensional structure will unveil the novel motility mechanisms that render pathogenic Leptospira particularly efficient at invading and disseminating within their hosts, causing leptospirosis in humans and animals. FcpA from L. interrogans was purified and crystallized, but despite laborious attempts no useful X ray diffraction data could be obtained. This challenge was solved by expressing a close orthologue from the related saprophytic species L. biflexa. Three different crystal forms were obtained: a primitive and a centred monoclinic form, as well as a hexagonal variant. All forms diffracted X-rays to suitable resolutions for crystallographic analyses, with the hexagonal type typically reaching the highest limits of 2.0 angstrom and better. A variation of the quick-soaking procedure resulted in an iodide derivative that was instrumental for single-wavelength anomalous diffraction methods.
C1 [Martin, Fabiana San; Mechaly, Ariel E.; Larrieux, Nicole; Trajtenberg, Felipe; Buschiazzo, Alejandro] Inst Pasteur Montevideo, Lab Mol & Struct Microbiol, Montevideo 11400, Uruguay.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol, New Haven, CT 06520 USA.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Brazilian Minist Hlth, Fdn Oswaldo Cruz, Goncalo Moniz Res Ctr, BR-40296 Salvador, BA, Brazil.
   [Picardeau, Mathieu] Inst Pasteur, Dept Microbiol, Unit Biol Spirochetes, 25-28 Rue Dr Roux, F-75015 Paris, France.
   [Buschiazzo, Alejandro] Inst Pasteur, Dept Microbiol, 25-28 Rue Dr Roux, F-75015 Paris, France.
RP Buschiazzo, A (corresponding author), Inst Pasteur Montevideo, Lab Mol & Struct Microbiol, Montevideo 11400, Uruguay.
EM alebus@pasteur.edu.uy
RI Ko, Albert Icksang/P-2343-2015; Buschiazzo, Alejandro/W-1095-2018;
   Wunder, Elsio Augusto/C-2733-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Buschiazzo,
   Alejandro/0000-0002-2509-6526; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Trajtenberg, Felipe/0000-0003-0427-5549;
   Mechaly, Ariel/0000-0002-5305-7495
FU Agencia Nacional de Investigacion e Innovacion [FCE_3_2016_1_126797];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1 R01 AI121207, 5 U01
   AI088752, 1 R01 TW009504]; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI088752, R01AI121207, R01AI121207, U01AI088752, R01AI121207,
   R01AI121207, U01AI088752, U01AI088752, U01AI088752, U01AI088752] Funding
   Source: NIH RePORTER
FX Funding for this research was provided by: Agencia Nacional de
   Investigacion e Innovacion (award No. FCE_3_2016_1_126797); National
   Institutes of Health (award Nos. 1 R01 AI121207, 5 U01 AI088752, 1 R01
   TW009504).
CR Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403
   GOLDSTEIN SF, 1988, CELL MOTIL CYTOSKEL, V9, P101, DOI 10.1002/cm.970090202
   GOLDSTEIN SF, 1990, P NATL ACAD SCI USA, V87, P4895, DOI 10.1073/pnas.87.13.4895
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504
   Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122
   Trajtenberg F, 2014, MBIO, V5, DOI 10.1128/mBio.02105-14
   van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008
   Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403
NR 17
TC 4
Z9 4
U1 0
U2 2
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD MAR
PY 2017
VL 73
BP 123
EP 129
DI 10.1107/S2053230X17002096
PN 3
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA EO8CY
UT WOS:000396917800002
PM 28291747
OA Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Vinhaes, ES
   Santos, LA
   Dias, L
   Andrade, NA
   Bezerra, VH
   de Carvalho, AT
   de Moraes, L
   Henriques, DF
   Azar, SR
   Vasilakis, N
   Ko, AI
   Andrade, BB
   Siqueira, IC
   Khouri, R
   Boaventura, VS
AF Vinhaes, Eriko S.
   Santos, Luciane A.
   Dias, Lislane
   Andrade, Nilvano A.
   Bezerra, Victor H.
   de Carvalho, Anderson T.
   de Moraes, Laise
   Henriques, Daniele F.
   Azar, Sasha R.
   Vasilakis, Nikos
   Ko, Albert I.
   Andrade, Bruno B.
   Siqueira, Isadora C.
   Khouri, Ricardo
   Boaventura, Viviane S.
TI Transient Hearing Loss in Adults Associated With Zika Virus Infection
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; sensorineural hearing loss; tinnitus; dizziness
ID BRAZIL
AB In 2015, during the outbreak of Zika virus (ZIKV) in Brazil, we identified 3 cases of acute hearing loss after exanthematous illness. Serology yielded finding compatible with ZIKV as the cause of a confirmed (n = 1) and a probable (n = 2) flavivirus infection, indicating an association between ZIKV infection and transient hearing loss.
C1 [Vinhaes, Eriko S.; Dias, Lislane; Andrade, Nilvano A.; Bezerra, Victor H.; de Carvalho, Anderson T.; Boaventura, Viviane S.] Hosp Santa Izabel, Salvador, BA, Brazil.
   [Santos, Luciane A.; de Moraes, Laise; Ko, Albert I.; Andrade, Bruno B.; Siqueira, Isadora C.; Khouri, Ricardo; Boaventura, Viviane S.] Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz MS, Salvador, BA, Brazil.
   [Henriques, Daniele F.] World Hlth Org, Inst Evandro Chagas, Collaborating Ctr Reference & Res Arbovirus, Fundacao Nacl Sa,Minist Saude, Belem, Para, Brazil.
   [Azar, Sasha R.; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Pathol, Galveston, TX USA.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Andrade, Bruno B.] Jose Silveira Fdn, Multinat Org Network Sponsoring Translat & Epidem, Salvador, BA, Brazil.
   [Khouri, Ricardo] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Clin & Epidemiol Virol, Leuven, Belgium.
   [Boaventura, Viviane S.] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
RP Boaventura, VS (corresponding author), Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM viviane.boaventura@bahia.fiocruz.br
RI Khouri, Ricardo/M-3184-2018; Andrade, Bruno/AAI-2248-2020; Vasilakis,
   Nikos/ABE-7318-2020; de Moraes, Laise Eduarda Paixao/N-4475-2017; de
   Siqueira, Isadora Cristina/R-9953-2016; Ko, Albert Icksang/P-2343-2015
OI Khouri, Ricardo/0000-0001-5664-4436; de Moraes, Laise Eduarda
   Paixao/0000-0001-9095-5860; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Ko, Albert Icksang/0000-0001-9023-2339;
   Andrade, Bruno/0000-0001-6833-3811
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1 R01 AI121207, R24
   AI120942]; "Programa Ciencias sem fronteiras," Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico of Brazil; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R24AI120942, R01AI121207, R01AI121207, R24AI120942, R01AI121207,
   R24AI120942, R01AI121207, R24AI120942, R24AI120942, R01AI121207] Funding
   Source: NIH RePORTER
FX This work was supported by the National Institutes of Health (grant
   numbers 1 R01 AI121207 and R24 AI120942). R. K. and L. A. S. were
   supported by "Programa Ciencias sem fronteiras," Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico of Brazil.
CR Casetta I, 2011, J NEUROL, V258, P1880, DOI 10.1007/s00415-011-6011-3
   Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361
   Ribeiro BNF, 2015, INT J SURG CASE REP, V8, P38, DOI 10.1016/j.ijscr.2014.10.057
   Greco A, 2011, AUTOIMMUN REV, V10, P756, DOI 10.1016/j.autrev.2011.05.005
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7
   Taki M, 2009, AURIS NASUS LARYNX, V36, P345, DOI 10.1016/j.anl.2008.05.016
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 12
TC 15
Z9 15
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR 1
PY 2017
VL 64
IS 5
BP 675
EP 677
DI 10.1093/cid/ciw770
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EP3TA
UT WOS:000397303400020
PM 27927858
OA Green Published, Other Gold
DA 2020-11-30
ER

PT J
AU Bourdillon, PM
   Goncalves, CCM
   Pelissari, DM
   Arakaki-Sanchez, D
   Ko, AI
   Croda, J
   Andrews, JR
AF Bourdillon, Paul M.
   Goncalves, Crhistinne C. M.
   Pelissari, Daniele Maria
   Arakaki-Sanchez, Denise
   Ko, Albert I.
   Croda, Julio
   Andrews, Jason R.
TI Increase in Tuberculosis Cases among Prisoners, Brazil, 2009-2014(1)
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID LATENT TUBERCULOSIS; TRANSMISSION; IMPACT; HIV
AB During 2009-2014, incarceration rates in Brazil rose 34%, and tuberculosis (TB) cases among prisoners rose 28.8%. The proportion of national TB cases that occurred among prisoners increased from 6.2% to 8.4% overall and from 19.3% to 25.6% among men 20-29 years of age.
C1 [Bourdillon, Paul M.; Ko, Albert I.] Yale Univ, New Haven, CT USA.
   [Goncalves, Crhistinne C. M.; Croda, Julio] Fed Univ Grande Dourados, Dourados, Brazil.
   [Pelissari, Daniele Maria] Univ Sao Paulo, Sao Paulo, Brazil.
   [Pelissari, Daniele Maria; Arakaki-Sanchez, Denise] Minist Hlth Brazil, Brasilia, DF, Brazil.
   [Ko, Albert I.; Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, Brazil.
   [Ko, Albert I.; Croda, Julio] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Andrews, Jason R.] Stanford Univ, Stanford, CA 94305 USA.
RP Andrews, JR (corresponding author), Stanford Univ, Div Infect Dis & Geog Med, 300 Pasteur Dr,Lane 141, Stanford, CA 94305 USA.
EM jandr@stanford.edu
RI Croda, Julio/I-5172-2013; Goncalves, Crhistinne/AAF-7367-2020; Ko,
   Albert Icksang/P-2343-2015
OI Croda, Julio/0000-0002-6665-6825; Ko, Albert
   Icksang/0000-0001-9023-2339; Pelissari, Daniele
   Maria/0000-0002-0760-1875
FU Wilbur G. Downs Fellowship; Yale School of Medicine Office of Student
   Research; Global Health Equity Scholars Program [NIH 1R25 TW009338];
   Infectious Diseases Society of America Medical Scholars Program; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338] Funding
   Source: NIH RePORTER
FX This project was supported by the Wilbur G. Downs Fellowship, the Yale
   School of Medicine Office of Student Research, the Global Health Equity
   Scholars Program (NIH 1R25 TW009338), and the Infectious Diseases
   Society of America Medical Scholars Program.
CR Barbour V, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000383
   Basu S, 2011, AM J TROP MED HYG, V84, P30, DOI 10.4269/ajtmh.2011.10-0472
   Dana M, 2009, GUIDELINES CONTROL T
   Sgarbi RVE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139487
   Estevan AO, 2013, REV SOC BRAS MED TRO, V46, P515, DOI 10.1590/0037-8682-1441-2013
   Galea G, 2014, PRISONS AND HEALTH
   Legrand J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002100
   Nogueira PA, 2012, REV SAUDE PUBL, V46, P119, DOI 10.1590/S0034-89102011005000080
   Pistarin Berra Jose Antonio, 2006, Revista do Instituto Adolfo Lutz, V65, P133
   Macedo LR, 2013, INT J TUBERC LUNG D, V17, P1427, DOI 10.5588/ijtld.12.0918
   Sacchi FPC, 2015, EMERG INFECT DIS, V21, P452, DOI 10.3201/eid2103.140896
   Sanchez A, 2012, EPIDEMIOL INFECT, V140, P1853, DOI 10.1017/S0950268811002536
   Carbone ADS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0764-8
   Strazza L, 2004, BRAZ J MED BIOL RES, V37, P771, DOI 10.1590/S0100-879X2004000500020
   Urrego J, 2015, AM J TROP MED HYG, V93, P739, DOI 10.4269/ajtmh.15-0166
   Whately de Moura T, 2015, LEVANTAMENTO NACL IN
NR 16
TC 18
Z9 18
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAR
PY 2017
VL 23
IS 3
BP 496
EP 499
DI 10.3201/eid2303.161006
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EL7WB
UT WOS:000394830900017
PM 28221118
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Freitas, BDP
   Ko, AI
   Khouri, R
   Mayoral, M
   Henriques, DF
   Maia, M
   Belfort, R
AF Freitas, Bruno De Paula
   Ko, Albert I.
   Khouri, Ricardo
   Mayoral, Monica
   Henriques, Daniele Freitas
   Maia, Mauricio
   Belfort, Rubens, Jr.
TI Glaucoma and Congenital Zika Syndrome
SO OPHTHALMOLOGY
LA English
DT Editorial Material
ID VIRUS-INFECTION
C1 [Freitas, Bruno De Paula; Mayoral, Monica] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [Freitas, Bruno De Paula; Maia, Mauricio; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Paulista Med Sch, Vis Inst, Dept Ophthalmol, Sao Paulo, SP, Brazil.
   [Ko, Albert I.; Khouri, Ricardo] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Henriques, Daniele Freitas] Minist Hlth, Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Ananindeua, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Paulista Med Sch, Dept Ophthalmol, Rua Botucatu,821, BR-04023062 Sao Paulo, SP, Brazil.
EM prof.belfort@clinicabelfort.com.br
RI Ko, Albert Icksang/P-2343-2015; Maia, Mauricio/I-5892-2015; Khouri,
   Ricardo/M-3184-2018
OI Ko, Albert Icksang/0000-0001-9023-2339; Maia,
   Mauricio/0000-0002-7034-8091; Khouri, Ricardo/0000-0001-5664-4436
CR Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMA0PHTHALM0L.2016.0267]
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 5
TC 22
Z9 22
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD MAR
PY 2017
VL 124
IS 3
BP 407
EP 408
PG 2
WC Ophthalmology
SC Ophthalmology
GA EQ1SB
UT WOS:000397848800040
PM 27914834
DA 2020-11-30
ER

PT J
AU Andrews, JR
   Vaidya, K
   Tamrakar, D
   Hamond, C
   Bern, C
   Bogoch, II
   Ko, AI
   Wunder, EA
AF Andrews, Jason R.
   Vaidya, Krista
   Tamrakar, Dipesh
   Hamond, Camila
   Bern, Caryn
   Bogoch, Isaac I.
   Ko, Albert I.
   Wunder, Elsio A.
TI UNRECOGNIZED BURDEN OF LEPTOSPIROSIS IN RURAL NEPAL: EVIDENCE FROM A
   SERO-EPIDEMIOLOGIC SURVEY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Andrews, Jason R.] Stanford Univ, Sch Med, Stanford, CA USA.
   [Vaidya, Krista; Tamrakar, Dipesh] Kathmandu Univ Hosp, Dhulikhel Hosp, Dhulikhel, Nepal.
   [Hamond, Camila; Ko, Albert I.; Wunder, Elsio A.] Yale Sch Publ Hlth, New Haven, CT USA.
   [Bern, Caryn] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Bogoch, Isaac I.] Univ Toronto, Toronto, ON, Canada.
RI Bogoch, Isaac/AAS-9631-2020; Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 473
BP 146
EP 147
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202472
DA 2020-11-30
ER

PT J
AU Dhewantara, PW
   Mamun, AA
   Zhang, WY
   Guo, DH
   Hu, WB
   Costa, F
   Ko, A
   Soares-Magalhaes, RJ
AF Dhewantara, Pandji W.
   Mamun, Abdullah A.
   Zhang, Wen-Yi
   Guo, Danhuai
   Hu, Wenbiao
   Costa, Federico
   Ko, Albert
   Soares-Magalhaes, Ricardo J.
TI THE CHANGING EPIDEMIOLOGY OF LEPTOSPIROSIS IN MAINLAND CHINA AND ITS
   IMPACT ON ANNUAL DISEASE BURDEN ESTIMATES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Dhewantara, Pandji W.; Soares-Magalhaes, Ricardo J.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.
   [Mamun, Abdullah A.] Univ Queensland, Inst Social Sci Res, Brisbane, Qld, Australia.
   [Zhang, Wen-Yi] Acad Mil Med Sci, Inst Dis Control & Prevent, Ctr Dis Surveillance & Res, Beijing, Peoples R China.
   [Guo, Danhuai] Chinese Acad Sci, Sci Data Ctr, Comp Network Informat Ctr, Beijing, Peoples R China.
   [Hu, Wenbiao] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.
   [Costa, Federico] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   [Ko, Albert] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RI Ko, Albert Icksang/P-2343-2015; Guo, Dan/S-8823-2019; Dhewantara, Pandji
   Wibawa/O-7852-2015; Guo, Danhuai/AAE-9112-2020; Mamun, Abdullah
   A/A-4673-2011
OI Ko, Albert Icksang/0000-0001-9023-2339; Dhewantara, Pandji
   Wibawa/0000-0002-9461-0648; Mamun, Abdullah A/0000-0002-1535-8086
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1157
BP 360
EP 360
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215203525
DA 2020-11-30
ER

PT J
AU Owers, KA
   Hinjoy, S
   Childs, JE
   Herbreteau, V
   Diggle, PJ
   Ko, AI
AF Owers, Katharine A.
   Hinjoy, Soawapak
   Childs, James E.
   Herbreteau, Vincent
   Diggle, Peter J.
   Ko, Albert I.
TI TIMING AND SPATIAL HETEROGENEITY OF LEPTOSPIROSIS TRANSMISSION IN
   NORTHEAST THAILAND
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Owers, Katharine A.; Childs, James E.; Ko, Albert I.] Yale Sch Publ Hlth, New Haven, CT USA.
   [Hinjoy, Soawapak] Minist Publ Hlth, Bur Epidemiol, Dept Dis Control, Nonthaburi, Thailand.
   [Herbreteau, Vincent] UAG, IRD, UR, ESPACE DEV,UM2, St Pierre, Reunion, France.
   [Diggle, Peter J.] Univ Lancaster, Div Med, Lancaster, England.
RI Herbreteau, Vincent/L-4411-2013; Ko, Albert Icksang/P-2343-2015
OI Herbreteau, Vincent/0000-0003-1762-6336; Ko, Albert
   Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1983
BP 618
EP 618
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204699
DA 2020-11-30
ER

PT J
AU Correa, ME
   Croda, J
   de Castro, ARCM
   de Oliveira, SMDL
   Pompilio, MA
   de Souza, RO
   Queiroz, JHFD
   da Silva, KE
   Ko, AI
   Simionatto, S
AF Correa, Maisa Estopa
   Croda, Julio
   Coimbra Motta de Castro, Ana Rita
   do Valle Leone de Oliveira, Sandra Maria
   Pompilio, Mauricio Antonio
   de Souza, Ronaldo Omizolo
   Ferreira de Sa Queiroz, Julio Henrique
   da Silva, Kesia Esther
   Ko, Albert I.
   Simionatto, Simone
TI High Prevalence of Treponema pallidum Infection in Brazilian Prisoners
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID SEXUALLY-TRANSMITTED INFECTIONS; SYPHILIS; HIV; DISEASES; SEX
AB The number of new syphilis cases in Brazil has risen alarmingly in recent years. However, there is limited data regarding syphilis prevalence in the Brazilian prison population. To facilitate the development of effective interventions, a cross-sectional study was undertaken to determine the prevalence of Treponema pallidum infection, active syphilis, and associated risk factors among Brazilian prisoners. We administered a questionnaire to a population-based sample of prisoners from 12 prisons in Central-West Brazil and collected sera for syphilis testing, from January to December 2013. Univariable and multivariable regression analyses were performed to assess associations with active syphilis. We recruited 3,363 prisoners (men: 84.6%; women: 15.4%). The overall lifetime and active syphilis prevalences were 10.5% (9.4% among men; 17% among women, P < 0.001) and 3.8% (2% among men; 9% among women, P < 0.001), respectively. The variables associated with active syphilis in men prisoners were homosexual preference, history of sexually transmitted infections, and human immunodeficiency virus status. Among women, the factors were sex with intravenous drug users, genital ulcer disease, and previous incarceration. Despite the high prevalence of active syphilis, 88.5% reported unawareness of their serological status and 67% reported unprotected sexual practices. Women had the highest rates of infection, including them in a high-risk group for the development of syphilis during pregnancy. Thus, implementing screening programs to enable continuous measures of control and prevention of T. pallidum infection in the prison environment, mainly in women institutions, is important to prevent severe forms of this disease and congenital infections.
C1 [Correa, Maisa Estopa; Croda, Julio; de Souza, Ronaldo Omizolo; Ferreira de Sa Queiroz, Julio Henrique; da Silva, Kesia Esther; Simionatto, Simone] UFGD, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil.
   [Croda, Julio; Coimbra Motta de Castro, Ana Rita; do Valle Leone de Oliveira, Sandra Maria] Fundacao Oswaldo Cruz FIOCRUZ, Campo Grande, MS, Brazil.
   [Coimbra Motta de Castro, Ana Rita] Univ Fed Mato Grosso do Sul, Lab Imunol Clin, Campo Grande, MS, Brazil.
   [do Valle Leone de Oliveira, Sandra Maria; Pompilio, Mauricio Antonio] Univ Fed Mato Grosso do Sul, Fac Med FAMED, Campo Grande, MS, Brazil.
   [Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Simionatto, Simone] Cidade Univ, Dourados, MS, Brazil.
RP Simionatto, S (corresponding author), UFGD, Lab Pesquisa Ciencias Saude, Dourados, MS, Brazil.
EM ysacorrea@gmail.com; juliocroda@gmail.com; arcm.castro@hotmail.com;
   sandrinhaleone@gmail.com; mapompilio@yahoo.com.br;
   ronaldo_omizolo@hotmail.com; juliohenriquefsq@hotmail.com;
   kesia_esther@hotmail.com; albert.ko@yale.edu;
   simonesimionatto@ufgd.edu.br
RI Croda, Julio/I-5172-2013; de Oliveira, Sandra Maria do Valle
   Leone/A-1074-2013; Ko, Albert Icksang/P-2343-2015; Simionatto,
   Simone/AAG-7509-2020
OI Croda, Julio/0000-0002-6665-6825; de Oliveira, Sandra Maria do Valle
   Leone/0000-0002-8960-6716; Ko, Albert Icksang/0000-0001-9023-2339;
   Simionatto, Simone/0000-0003-2367-0915
FU Support Foundation for the Development of Education, Science and
   Technology in the State of Mato Grosso do Sul (FUNDECT)Fundect [0068/13,
   0233/2014, 092/2015]; Ministry of Education (PROEXT); FUNDECTFundect; 
   [SVS/MS-20/2013]
FX This work was partially supported by the Support Foundation for the
   Development of Education, Science and Technology in the State of Mato
   Grosso do Sul (FUNDECT grants 0068/13, 0233/2014 and 092/2015) the
   Ministry of Education (PROEXT 2013-2014) and Secretary of Health
   Surveillance (SVS/MS-20/2013). Maisa Estopa Correa received a
   scholarship from FUNDECT and Kesia Esther da Silva from CAPES.
CR Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-33
   Arora P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044094
   Azbel L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059643
   Bautista-Arredondo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131718
   Brasil, 2015, SIST NAC POL PUBL DR
   Brasil, 2014, LEV NAC INF PEN DEZ
   Brasil Conselho Nacional de Justica, 2014, NOV DIAGN PESS PRES
   Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001
   Callegari FM, 2014, AIDS BEHAV, V18, pS104, DOI 10.1007/s10461-013-0533-x
   de Albuquerque ACC, 2014, CIENC SAUDE COLETIVA, V19, P2125, DOI 10.1590/1413-81232014197.08602013
   Marques NMD, 2011, BRAZ J INFECT DIS, V15, P272, DOI 10.1590/S1413-86702011000300016
   Sgarbi RVE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139487
   Fazel S, 2011, LANCET, V377, P956, DOI 10.1016/S0140-6736(10)61053-7
   Feng TJ, 2008, SEX TRANSM DIS, V35, P1022, DOI 10.1097/OLQ.0b013e31818600f4
   Fernandez-Luqueno F., 2014, SEX TRANSM INFECT, P1
   Gottlieb SL, 2014, VACCINE, V32, P1527, DOI 10.1016/j.vaccine.2013.07.087
   Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173
   Karp G, 2009, EUR J INTERN MED, V20, P9, DOI 10.1016/j.ejim.2008.04.002
   Kazi AM, 2010, INT J INFECT DIS, V14, pE60, DOI 10.1016/j.ijid.2009.11.012
   Ministerio da Saude, 2008, PREV FREQ REL DOENC
   Muga R, 1997, INT J STD AIDS, V8, P225, DOI 10.1258/0956462971919967
   Parvez F, 2013, SEX TRANSM INFECT, V89, P280, DOI 10.1136/sextrans-2012-050977
   Sagnelli E, 2012, EUR REV MED PHARMACO, V16, P2142
   Schuelter-Trevisol F, 2013, REV SOC BRAS MED TRO, V46, P493, DOI 10.1590/0037-8682-1364-2013
   Solomon L, 2004, J URBAN HEALTH, V81, P25, DOI 10.1093/jurban/jth085
   Verneuil L, 2009, EUR J CLIN MICROBIOL, V28, P409, DOI 10.1007/s10096-008-0642-z
   WHO, 2014, PRIS HLTH
   World Health Organization, 2014, EL MOTH TO CHILD TRA
   World Health Organization, 2012, GLOB INC PREV SEL CU
   Young H, 1998, J CLIN MICROBIOL, V36, P913, DOI 10.1128/JCM.36.4.913-917.1998
NR 30
TC 8
Z9 9
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 4
BP 1078
EP 1084
DI 10.4269/ajtmh.17-0098
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5QM
UT WOS:000423208300016
PM 28820706
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Emont, JP
   Ko, AI
   Homasi-Paelate, A
   Ituaso-Conway, N
   Nilles, EJ
AF Emont, Jordan P.
   Ko, Albert I.
   Homasi-Paelate, Avanoa
   Ituaso-Conway, Nese
   Nilles, Eric J.
TI Epidemiological Investigation of a Diarrhea Outbreak in the South
   Pacific Island Nation of Tuvalu during a Severe La Nina-Associated
   Drought Emergency in 2011
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID WATER; OSCILLATION; IMPACTS; CLIMATE
AB The association between heavy rainfall and an increased risk of diarrhea has been well established but less is known about the effect of drought on diarrhea transmission. In 2011, the Pacific island nation of Tuvalu experienced a concurrent severe La Nina-associated drought and large diarrhea outbreak. We conducted a field investigation in Tuvalu to identify factors that contributed to epidemic transmission in the context of a drought emergency. Peak case numbers coincided with the nadir of recorded monthly rainfall, the lowest recorded since 1930. Independent factors associated with increased risk of diarrhea were households with water tank levels below 20% (odds ratio [OR] = 2.31; 95% confidence interval = 1.16-4.60) and decreased handwashing frequency (OR = 3.00 [1.486.08]). The resolution of the outbreak occurred after implementation of a hygiene promotion campaign, despite persistent drought and limited water access. These findings are potentially important given projections that future climate change will cause more frequent and severe droughts.
C1 [Emont, Jordan P.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Homasi-Paelate, Avanoa; Ituaso-Conway, Nese] Tuvalu Minist Hlth, Funafuti, Tuvalu.
   [Nilles, Eric J.] World Hlth Org, Div Pacific Tech Support Emerging Dis Surveillanc, Reg Off Western Pacific, Suva, Fiji.
RP Nilles, EJ (corresponding author), World Hlth Org, Div Pacific Tech Support Emerging Dis Surveillanc, Reg Off Western Pacific, Suva, Fiji.
EM ericnilles@gmail.com
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Nilles, Eric/0000-0001-7044-5257
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1 R01 TW009504];
   Stolwijk Fellowship; Yale Global Health Initiative; Coca-Cola World Fund
   at Yale University; FOGARTY INTERNATIONAL CENTERUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER
FX We would like to thank the support of the National Institutes of Health
   (1 R01 TW009504); the Stolwijk Fellowship, Yale Global Health
   Initiative; and the Coca-Cola World Fund at Yale University.
CR Ahmed W, 2012, APPL ENVIRON MICROB, V78, P219, DOI 10.1128/AEM.06554-11
   Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141
   Bhavnani D, 2014, AM J TROP MED HYG, V90, P705, DOI 10.4269/ajtmh.13-0371
   BURR ML, 1978, PUBLIC HEALTH, V92, P86, DOI 10.1016/S0033-3506(78)80034-1
   Climate Prediction Center, 2015, ENSO DIAGN DISC
   Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246
   Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81
   DILLEY M, 1995, DISASTERS, V19, P181, DOI 10.1111/j.1467-7717.1995.tb00338.x
   Evans CA, 2006, WATER RES, V40, P37, DOI 10.1016/j.watres.2005.10.034
   Gergis JL, 2009, CLIMATIC CHANGE, V92, P343, DOI 10.1007/s10584-008-9476-z
   Government of Australia, 2014, CLIM VAR EXTR CHANG
   Government of Tuvalu, 2010, SECR PAC REG ENV PRO
   Government of Tuvalu, 2011, TOK CENS POP DWELL
   Kool JL, 2012, GLOB PUBLIC HEALTH, V7, P670, DOI 10.1080/17441692.2012.699536
   Mimura N., 2007, CLIMATE CHANGE 2007, V16, P687
   Moors E, 2013, SCI TOTAL ENVIRON, V468, pS139, DOI 10.1016/j.scitotenv.2013.07.021
   ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2
   Stanke C, 2013, PLOS CURR
   TAUXE RV, 1988, EPIDEMIOL INFECT, V100, P279, DOI 10.1017/S0950268800067418
   THACKER SB, 1980, LANCET, V1, P471
   The SPHERE Project, 2011, 1 SPHERE
   United Nations Office for the Coordination of Humanitarian Affairs, 2011, SIT UPD TUV DROUGHT
   United Nations Office for the Coordination of Humanitarian Affairs, 2011, TUV TOK COOK ISL DRO
   WHO, 2004, GUID DRINK WAT QUAL
   World Health Organization, 2011, PAC PUBL HLTH SURV N
NR 25
TC 8
Z9 8
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 96
IS 3
BP 576
EP 582
DI 10.4269/ajtmh.16-0812
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EV4VO
UT WOS:000401761600010
PM 28138046
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Santos, ND
   Sousa, E
   Reis, MG
   Ko, AI
   Costa, F
AF Santos, Norlan de Jesus
   Sousa, Erica
   Reis, Mitermayer G.
   Ko, Albert I.
   Costa, Federico
TI Rat infestation associated with environmental deficiencies in an urban
   slum community with high risk of leptospirosis transmission
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Rodentia; Leptospirosis; Poverty Areas
ID NEW-ZEALAND; NORVEGICUS; BRAZIL; INTERROGANS; EPIDEMIOLOGY; POPULATION;
   ARGENTINA; INFECTION; COMMENSAL; GENETICS
AB We analyzed environmental factors that provide food, water and harborage to rodents and the risk of household rodent infestation in a slum community with a high risk of leptospirosis transmission. Detailed environmental surveys were performed in 221 households. Multivariate regression models evaluated the association between rodent infestation and socioeconomic status and environmental attributes obtained from Geographical Information System surveys. The general household infestation rate was 45.9%. Rattus norvegicus signs were the most prevalent, present in 74% of the infested households. The risk for rodent infestation was associated with environmental factors supporting harborage for rats, such as dilapidated fences/ walls (OR: 8.95; 95% CI: 2.42-33.12) and households built on an earthen slope (OR: 4.68; 95% CI: 2.239.81). An increase of 1 meter from the nearest sewer was associated with a 3% (95% CI: 1%-5%) decrease in the risk of rodent infestation. A lack of sanitation where poor people live provides factors for rat infestation and could the target of educational interventions.
C1 [Santos, Norlan de Jesus] Univ Fed Bahia, Escola Med Vet, Rua Barao de Jeremoabo S-N,Campus de Ondina, BR-40170115 Salvador, BA, Brazil.
   [Sousa, Erica; Reis, Mitermayer G.; Ko, Albert I.; Costa, Federico] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
RP Santos, ND (corresponding author), Univ Fed Bahia, Escola Med Vet, Rua Barao de Jeremoabo S-N,Campus de Ondina, BR-40170115 Salvador, BA, Brazil.
EM norlansantos@hotmail.com
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015; Costa,
   Federico/G-1838-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; Costa, Federico/0000-0001-6951-2336
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq) [300861/1996, 554788/2006]; US National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI052473, TW00919];
   Capes (Coordination for the Improvement of Higher Education Personnel,
   Brazilian Ministry of Education)
FX The authors wish to thank the Zoonosis Control Center in Salvador, Bahia
   State, for their assistance in conducting the study; Ananda Nascimento
   and Ana Claudia da Silva Batista for database management; and Amelia
   Kasper for advice during the preparation of the manuscript. Thanks to
   the Brazilian National Research Council (grants 300861/1996,
   554788/2006), the US National Institutes of Health (grants AI052473 and
   TW00919) and Capes (Coordination for the Improvement of Higher Education
   Personnel, Brazilian Ministry of Education).
CR [Anonymous], 2006, INT PEST MAN COND UR
   Bajomi D, P 12 VERT PEST C
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Castillo E, 2003, INT BIODETER BIODEGR, V52, P135, DOI 10.1016/S0964-8305(03)00033-7
   Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017
   Channon D, 2006, EPIDEMIOL INFECT, V134, P41, DOI 10.1017/S0950268805004607
   Childs JE, 1998, AM J EPIDEMIOL, V148, P78, DOI 10.1093/oxfordjournals.aje.a009563
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   Cristaldi M, 1995, 5 INT C ROD SPAT BIO, P185
   de Masi E, 2009, INT J ENVIRON HEAL R, V19, P1, DOI 10.1080/09603120802126670
   Easterbrook JD, 2005, VECTOR-BORNE ZOONOT, V5, P296, DOI 10.1089/vbz.2005.5.296
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Fernandez MS, 2007, ECOHEALTH, V4, P271, DOI 10.1007/s10393-007-0122-4
   Fundacao Nacional de Saude, 2002, MAN CONTR ROED
   HATHAWAY SC, 1981, J HYG-CAMBRIDGE, V87, P427, DOI 10.1017/S0022172400069679
   Hin LY, 1999, STAT MED, V18, P1101, DOI 10.1002/(SICI)1097-0258(19990515)18:9<1101::AID-SIM99>3.0.CO;2-Q
   Instituto Brasileiro de Geografia e Estatistica, 2007, RES AM CENS DEM
   Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455
   King CM, 2011, J ZOOL, V285, P172, DOI 10.1111/j.1469-7998.2011.00827.x
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Langton SD, 2001, J APPL ECOL, V38, P699, DOI 10.1046/j.1365-2664.2001.00631.x
   LORE R, 1978, J COMP PHYSIOL PSYCH, V92, P888, DOI 10.1037/h0077535
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Meyer A., 2003, AUSTR CTR INT AGR RE, V96, P446
   OLASEHA IO, 1994, J ROY SOC HEALTH, V114, P300, DOI 10.1177/146642409411400604
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Porter FH, 2015, J MAMMAL, V96, P317, DOI 10.1093/jmammal/gyv033
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Secretaria de Vigilincia Sanitaria Ministerio da Saude, 2007, SIST INF AGR NOT
   Traweger D, 2005, J PEST SCI, V78, P17, DOI 10.1007/s10340-004-0062-5
   VILLAFANA F, 2000, B MALARIOL SALUD AMB, V11, P3
NR 33
TC 8
Z9 8
U1 0
U2 3
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PY 2017
VL 33
IS 2
AR e00132115
DI 10.1590/0102-311X00132115
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EP4AM
UT WOS:000397322900006
PM 28300969
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Walker, R
   Carvalho-Pereira, T
   Serrano, S
   Pedra, G
   Hacker, K
   Taylor, J
   Minter, A
   Pertile, A
   Panti-May, A
   Carvalho, M
   Souza, FN
   Nery, N
   Rodrigues, G
   Bahiense, T
   Reis, MG
   Ko, AI
   Childs, JE
   Begon, M
   Costa, F
AF Walker, R.
   Carvalho-Pereira, T.
   Serrano, S.
   Pedra, G.
   Hacker, K.
   Taylor, J.
   Minter, A.
   Pertile, A.
   Panti-May, A.
   Carvalho, M.
   Souza, F. N.
   Nery, N., Jr.
   Rodrigues, G.
   Bahiense, T.
   Reis, M. G.
   Ko, A. I.
   Childs, J. E.
   Begon, M.
   Costa, F.
TI Factors affecting carriage and intensity of infection of Calodium
   hepaticum within Norway rats (Rattus norvegicus) from an urban slum
   environment in Salvador, Brazil
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Brazil; Calodium hepaticum; infection intensity; prevalence; Rattus
   norvegicus
ID CAPILLARIA-HEPATICA; PREVALENCE; BALTIMORE; NEMATODA; RODENTS; AREA
AB Urban slum environments in the tropics are conducive to the proliferation and the spread of rodent-borne zoonotic pathogens to humans. Calodium hepaticum (Brancroft, 1893) is a zoonotic nematode known to infect a variety of mammalian hosts, including humans. Norway rats (Rattus norvegicus) are considered the most important mammalian host of C. hepaticum and are therefore a potentially useful species to inform estimates of the risk to humans living in urban slum environments. There is a lack of studies systematically evaluating the role of demographic and environmental factors that influence both carriage and intensity of infection of C. hepaticum in rodents from urban slum areas within tropical regions. Carriage and the intensity of infection of C. hepaticum were studied in 402 Norway rats over a 2-year period in an urban slum in Salvador, Brazil. Overall, prevalence in Norway rats was 83% (337/402). Independent risk factors for C. hepaticum carriage in R. norvegicus were age and valley of capture. Of those infected the proportion with gross liver involvement (i.e. >75% of the liver affected, a proxy for a high level intensity of infection), was low (8%, 26/337). Sixty soil samples were collected from ten locations to estimate levels of environmental contamination and provide information on the potential risk to humans of contracting C. hepaticum from the environment. Sixty percent (6/10) of the sites were contaminated with C. hepaticum. High carriage levels of C. hepaticum within Norway rats and sub-standard living conditions within slum areas may increase the risk to humans of exposure to the infective eggs of C. hepaticum. This study supports the need for further studies to assess whether humans are becoming infected within this community and whether C. hepaticum is posing a significant risk to human health.
C1 [Walker, R.; Carvalho-Pereira, T.; Serrano, S.; Pedra, G.; Hacker, K.; Taylor, J.; Pertile, A.; Panti-May, A.; Carvalho, M.; Souza, F. N.; Nery, N., Jr.; Reis, M. G.; Ko, A. I.; Costa, F.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Walker, R.; Carvalho-Pereira, T.; Pedra, G.; Taylor, J.; Minter, A.; Begon, M.; Costa, F.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.
   [Hacker, K.; Reis, M. G.; Ko, A. I.; Childs, J. E.; Costa, F.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Rodrigues, G.] Minist Saude, Ctr Controle Zoonoses, Secretaria Municipal Saude, Salvador, BA, Brazil.
   [Costa, F.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Carvalho-Pereira, T.; Pertile, A.] Univ Fed Bahia, Univ Fed Bahia, Inst Biol, Salvador, BA, Brazil.
   [Bahiense, T.] Univ Fed Bahia, Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
RP Costa, F (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.; Costa, F (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
EM fcosta@gmail.com
RI Panti-May, Jesus Alonso/U-2798-2019; Costa, Federico/G-1838-2015; Reis,
   Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Panti-May, Jesus Alonso/0000-0003-1669-5727; Costa,
   Federico/0000-0001-6951-2336; Reis, Mitermayer/0000-0002-3051-9060; Ko,
   Albert Icksang/0000-0001-9023-2339; Carvalho Pereira,
   Ticiana/0000-0003-2370-2198; Hacker, Kathryn/0000-0001-5267-1699; NEVES,
   FABIO/0000-0002-3542-8918; , Amanda/0000-0003-1171-5688; Rocha Nery
   Junior, Nivison Ruy/0000-0002-8164-0602
FU Oswaldo Cruz Foundation; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [F31 AI114245, R01 AI052473, U01 AI088752, R01 TW009504, R25
   TW009338]; Wellcome TrustWellcome Trust [102330/Z/13/Z]; Secretariat of
   Health Surveillance, Brazilian Ministry of Health; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW009504, R25TW009338, R25TW009338, R01TW009504, R25TW009338,
   R01TW009504, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R01TW009504,
   R25TW009338, R25TW009338, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, U01AI088752, U01AI088752, R01AI052473, F31AI114245,
   U01AI088752, R01AI052473, R01AI052473, R01AI052473, F31AI114245,
   R01AI052473, U01AI088752, U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473] Funding Source: NIH
   RePORTER
FX This work was supported by the Oswaldo Cruz Foundation and Secretariat
   of Health Surveillance, Brazilian Ministry of Health, the National
   Institutes of Health (grants F31 AI114245, R01 AI052473, U01 AI088752,
   R01 TW009504 and R25 TW009338) and by the Wellcome Trust
   (102330/Z/13/Z).
CR Burthe SJ, 2010, OECOLOGIA, V162, P653, DOI 10.1007/s00442-009-1495-6
   CHILDS JE, 1988, CAN J ZOOL, V66, P2769, DOI 10.1139/z88-404
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   FARHANGAZAD A, 1977, J PARASITOL, V63, P117, DOI 10.2307/3280114
   Fuehrer HP, 2014, PARASITOL RES, V113, P641, DOI 10.1007/s00436-013-3692-9
   Fuehrer HP, 2011, PARASITOL RES, V109, P969, DOI 10.1007/s00436-011-2494-1
   Galvao V. A., 1976, Revista da Sociedade Brasileira de Medicina Tropical, V10, P333, DOI 10.1590/S0037-86821976000600004
   da Rocha EJG, 2015, REV INST MED TROP SP, V57, P39, DOI 10.1590/S0036-46652015000100006
   Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x
   Simoes RO, 2014, REV INST MED TROP SP, V56, P455, DOI 10.1590/S0036-46652014000500016
   Sudhakar NR, 2013, VET WORLD, V6, P87, DOI 10.5455/vetworld.2013.87-90
NR 11
TC 6
Z9 6
U1 0
U2 7
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JAN
PY 2017
VL 145
IS 2
BP 334
EP 338
DI 10.1017/S0950268816002259
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EK2LF
UT WOS:000393758100015
PM 27780498
OA Green Accepted, Bronze
DA 2020-11-30
ER

PT J
AU Lessa-Aquino, C
   Lindow, JC
   Randall, A
   Wunder, E
   Pablo, J
   Nakajima, R
   Jasinskas, A
   Cruz, JS
   Damlao, AO
   Nery, N
   Ribeiro, GS
   Costa, F
   Hagan, JE
   Reis, MG
   Ko, AI
   Medeiros, MA
   Felgner, PL
AF Lessa-Aquino, Carolina
   Lindow, Janet C.
   Randall, Arlo
   Wunder, Elsio
   Pablo, Jozelyn
   Nakajima, Rie
   Jasinskas, Algis
   Cruz, Jaqueline S.
   Damlao, Alcineia O.
   Nery, Nivison
   Ribeiro, Guilherme S.
   Costa, Federico
   Hagan, Jose E.
   Reis, Mitermayer Galvao
   Ko, Albert I.
   Medeiros, Marco Alberto
   Felgner, Philip L.
TI Distinct antibody responses of patients with mild and severe
   leptospirosis determined by whole proteome microarray analysis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID INTERROGANS SEROVAR COPENHAGENI; IMMUNOGLOBULIN-LIKE PROTEIN; HUMORAL
   IMMUNE-RESPONSE; GUINEA-PIGS; MONOCLONAL-ANTIBODIES; PROTECTIVE
   IMMUNITY; ANTIGEN DISCOVERY; LETHAL INFECTION; DIAGNOSIS; PATHOGEN
AB Background
   Leptospirosis is an important zoonotic disease worldwide. Humans usually present a mild non-specific febrile illness, but a proportion of them develop more severe outcomes, such as multi-organ failure, lung hemorrhage and death. Such complications are thought to depend on several factors, including the host immunity. Protective immunity is associated with humoral immune response, but little is known about the immune response mounted during naturally-acquired Leptospira infection.
   Methods and principal findings
   Here, we used protein microarray chip to profile the antibody responses of patients with severe and mild leptospirosis against the complete Leptospira interrogans serovar Copenhageni predicted ORFeome. We discovered a limited number of immunodominant antigens, with 36 antigens specific to patients, of which 11 were potential serodiagnostic antigens, identified at acute phase, and 33 were potential subunit vaccine targets, detected after recovery. Moreover, we found distinct antibody profiles in patients with different clinical outcomes: in the severe group, overall IgM responses do not change and IgG responses increase over time, while both IgM and IgG responses remain stable in the mild patient group. Analyses of individual patients' responses showed that > 74% of patients in the severe group had significant IgG increases over time compared to 29% of patients in the mild group. Additionally, 90% of IgM responses did not change over time in the mild group, compared to similar to 51% in the severe group.
   Conclusions
   In the present study, we detected antibody profiles associated with disease severity and speculate that patients with mild disease were protected from severe outcomes due to preexisting antibodies, while patients with severe leptospirosis demonstrated an antibody profile typical of first exposure. Our findings represent a significant advance in the understanding of the humoral immune response to Leptospira infection, and we have identified new targets for the development of subunit vaccines and diagnostic tests.
C1 [Lessa-Aquino, Carolina; Medeiros, Marco Alberto] Brazilian Minist Hlth, Biomanguinhos, FIOCRUZ, Rio De Janeiro, RJ, Brazil.
   [Lindow, Janet C.; Wunder, Elsio; Cruz, Jaqueline S.; Damlao, Alcineia O.; Nery, Nivison; Costa, Federico; Reis, Mitermayer Galvao; Ko, Albert I.] Brazilian Minist Hlth, Goncalo Moniz Res Inst, FIOCRUZ, Salvador, BA, Brazil.
   [Lindow, Janet C.; Wunder, Elsio; Hagan, Jose E.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Randall, Arlo] Antigen Discovery Inc, Irvine, CA USA.
   [Pablo, Jozelyn; Nakajima, Rie; Jasinskas, Algis; Felgner, Philip L.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA.
   [Ribeiro, Guilherme S.; Costa, Federico] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
RP Felgner, PL (corresponding author), Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA.
EM pfelgner@uci.edu
RI Wunder, Elsio Augusto/C-2733-2013; Ko, Albert Icksang/P-2343-2015;
   Hagan, Jose/N-6719-2019; Reis, Mitermayer/AAO-9742-2020; Costa,
   Federico/G-1838-2015; Ribeiro, Guilherme/B-6624-2008
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Ko, Albert
   Icksang/0000-0001-9023-2339; Hagan, Jose/0000-0002-1837-6319; Reis,
   Mitermayer/0000-0002-3051-9060; Costa, Federico/0000-0001-6951-2336;
   Ribeiro, Guilherme/0000-0002-6798-2059; Lindow,
   Janet/0000-0003-3235-3698; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U01AI088752]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW009504, R01TW009504, R01TW009504, R01TW009504, R01TW009504]
   Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, U01AI088752, R01AI052473, R01AI052473, R01AI121207,
   R01AI121207, R01AI121207, R01AI121207, R01AI121207, R01AI052473,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, U01AI088752, U01AI088752, R01AI052473,
   U01AI088752, R01AI052473] Funding Source: NIH RePORTER
FX Funding was provided by NIH grant U01AI088752 (AIK). The funders had no
   role in studydesign, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR ADLER B, 1980, PATHOLOGY, V12, P529, DOI 10.3109/00313028009086806
   ADLER B, 1976, INFECT IMMUN, V14, P703, DOI 10.1128/IAI.14.3.703-708.1976
   ADLER B, 1977, INFECT IMMUN, V17, P67, DOI 10.1128/IAI.17.1.67-72.1977
   Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Challa S, 2011, VACCINE, V29, P4431, DOI 10.1016/j.vaccine.2011.04.041
   CHAPMAN AJ, 1991, EPIDEMIOL INFECT, V107, P143, DOI 10.1017/S0950268800048779
   Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102
   De Brito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071743
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   Dent AE, 2015, J INFECT DIS, V212, P1429, DOI 10.1093/infdis/jiv224
   Driguez P, 2016, J INFECT DIS, V213, P122, DOI 10.1093/infdis/jiv356
   Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849
   Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102
   Felgner J, 2015, PARASITOLOGY, V142, P827, DOI 10.1017/S0031182014001978
   Fraga TR, 2011, SCAND J IMMUNOL, V73, P408, DOI 10.1111/j.1365-3083.2010.02505.x
   Gupta S, 2016, PROTEOMICS, V16, P1297, DOI 10.1002/pmic.201500429
   Haab BB, 2001, GENOME BIOL, V2
   Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   JOST BH, 1986, J MED MICROBIOL, V22, P269, DOI 10.1099/00222615-22-3-269
   Kim Seoung Bum, 2008, Stat Anal Data Min, V1, P57, DOI 10.1002/sam.10005
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Landry ML, 2016, CLIN VACCINE IMMUNOL, V23, P540, DOI 10.1128/CVI.00211-16
   Lessa-Aquino C, 2015, J PROTEOME RES, V14, P549, DOI 10.1021/pr500718t
   Lessa-Aquino C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002499
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Liang L, 2015, CURR OPIN INFECT DIS, V28, P438, DOI 10.1097/QCO.0000000000000193
   Liang L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01043
   Liang L, 2012, CHEM BIODIVERS, V9, P977, DOI 10.1002/cbdv.201100360
   MacBeath G, 2000, SCIENCE, V289, P1760
   Maneewatch S, 2008, HYBRIDOMA, V27, P453, DOI 10.1089/hyb.2008.0056
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Nabity SA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001878
   Nakajima R, 2016, J CLIN MICROBIOL
   Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729
   Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0
   Pichichero ME, 2012, HUM VACC IMMUNOTHER, V8, P799, DOI 10.4161/hv.19820
   SCHOONE GJ, 1989, J GEN MICROBIOL, V135, P73
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Sonrier C, 2000, VACCINE, V19, P86, DOI 10.1016/S0264-410X(00)00129-8
   Srikram A, 2011, J INFECT DIS, V203, P870, DOI 10.1093/infdis/jiq127
   Sun AH, 2011, BIOMED ENVIRON SCI, V24, P291, DOI 10.3967/0895-3988.2011.03.013
   Tan XL, 2012, CLIN VACCINE IMMUNOL, V19, P418, DOI 10.1128/CVI.05521-11
NR 49
TC 10
Z9 10
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2017
VL 11
IS 1
AR e0005349
DI 10.1371/journal.pntd.0005349
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EK8CR
UT WOS:000394152000087
PM 28141801
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU do Rosario, MS
   de Jesus, PAP
   Vasilakis, N
   Farias, DS
   Novaes, MAC
   Rodrigues, SG
   Martins, LC
   Vasconcelos, PFD
   Ko, AI
   Alcantara, LCJ
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Pereira de Jesus, Pedro Antonio
   Vasilakis, Nikos
   Farias, Daniel Santana
   Caires Novaes, Marco Antonio
   Rodrigues, Sueli Guerreiro
   Martins, Livia Caricio
   da Costa Vasconcelos, Pedro Fernando
   Ko, Albert Icksang
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Case Report: Guillain-Barre Syndrome after Zika Virus Infection in
   Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DENGUE; OUTBREAK; BAHIA
AB Zika virus (ZIKV) is an emerging flavivirus, which has caused a widespread outbreak in the Americas. Shortly after its introduction in 2015, a cluster of cases with Guillain Barre syndrome was detected in Brazil. Herein, we describe two cases from the city of Salvador, who developed ascending paresis after an acute exanthematous illness. The patients were admitted to the intensive care unit with tetraparesis and cranial nerve palsy, which resolved after intravenous administration of human immunoglobulin. Serological evaluation detected IgM-specific ZIKV antibodies. In regions of Zika virus transmission, health-care workers must be aware of the potential severe neurological complications associated with ZIKV infection and be prepared to provide prompt diagnosis, treatment, and supportive care.
C1 [do Rosario, Mateus Santana; Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Secretaria Estadual Saude Bahia, Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Biodefense & Emerging Infect Dis, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Caires Novaes, Marco Antonio] Fundacao Monte Tabor, Hosp Salo Rafael, Salvador, BA, Brazil.
   [Rodrigues, Sueli Guerreiro; Martins, Livia Caricio; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas SVS MS, Secao Arbovirol & Febres Hemorrag, Ananindeua, Brazil.
   [Ko, Albert Icksang] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas, Salvador, BA, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Caires Novaes, Marco Antonio] Hosp Sao Rafael, Fundacao Monte Tabor, Salvador, BA, Brazil.
   [Martins, Livia Caricio; da Costa Vasconcelos, Pedro Fernando] Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Belem, Para, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Gongalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Vasconcelos,
   Pedro/AAH-3142-2019; Ko, Albert Icksang/P-2343-2015; Vasilakis,
   Nikos/ABE-7318-2020
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Ko, Albert
   Icksang/0000-0001-9023-2339; Alcantara, Luiz/0000-0002-6769-9931; Jesus,
   Pedro Antonio/0000-0003-1211-2272; do Rosario,
   Mateus/0000-0001-7404-6392
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24AI120942]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW009504, R01TW009504, R01TW009504, R01TW009504, R01TW009504]
   Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R24AI120942, R24AI120942, R01AI121207, R24AI120942, R01AI121207,
   R01AI121207, R01AI121207, R01AI121207, R24AI120942, R24AI120942,
   R24AI120942] Funding Source: NIH RePORTER
FX We are grateful to Marcia Weber for the laboratorial technical
   assistance, Fernanda Washington de M. Lima and Daniel Moura for
   assistance in the serological diagnosis, and the physicians and nurses
   involved in the patient's clinical treatment. We also thank Bruno B.
   Andrade for the critical review of the manuscript. This work was
   supported in part by the NIH grant R24AI120942 to Nikos Vasilakis.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos GS, 2015, JPN J INFECT DIS, V68, P45, DOI 10.7883/yoken.JJID.2014.063
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   DVIS/CIEVS, 2015, INF EP DOENC EX MAT
   Garg RK, 2015, NEUROL INDIA, V63, P497, DOI 10.4103/0028-3886.161990
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   PAHO/WHO, 2016, EP UPD NEUR SYNDR CO
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 52
Z9 52
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2016
VL 95
IS 5
BP 1157
EP 1160
DI 10.4269/ajtmh.16-0306
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VC
UT WOS:000400206600035
PM 27645785
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Lindow, JC
   Wunder, EA
   Popper, SJ
   Min, JN
   Mannam, P
   Srivastava, A
   Yao, Y
   Hacker, KP
   Raddassi, K
   Lee, PJ
   Montgomery, RR
   Shaw, AC
   Hagan, JE
   Araujo, GC
   Nery, N
   Relman, DA
   Kim, CC
   Reis, MG
   Ko, AI
AF Lindow, Janet C.
   Wunder, Elsio A., Jr.
   Popper, Stephen J.
   Min, Jin-na
   Mannam, Praveen
   Srivastava, Anup
   Yao, Yi
   Hacker, Kathryn P.
   Raddassi, Khadir
   Lee, Patty J.
   Montgomery, Ruth R.
   Shaw, Albert C.
   Hagan, Jose E.
   Araujo, Guilherme C.
   Nery, Nivison, Jr.
   Relman, David A.
   Kim, Charles C.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Cathelicidin Insufficiency in Patients with Fatal Leptospirosis
SO PLOS PATHOGENS
LA English
DT Article
ID BACTERIAL RNA; ENVIRONMENT; IDENTIFICATION; INFLAMMATION; RECOGNITION;
   INTERROGANS; RESISTANCE; ANTIBODIES; SIGNATURES; PEPTIDES
AB Leptospirosis causes significant morbidity and mortality worldwide; however, the role of the host immune response in disease progression and high case fatality (> 10-50%) is poorly understood. We conducted a multi-parameter investigation of patients with acute leptospirosis to identify mechanisms associated with case fatality. Whole blood transcriptional profiling of 16 hospitalized Brazilian patients with acute leptospirosis (13 survivors, 3 deceased) revealed fatal cases had lower expression of the antimicrobial peptide, cathelicidin, and chemokines, but more abundant pro-inflammatory cytokine receptors. In contrast, survivors generated strong adaptive immune signatures, including transcripts relevant to antigen presentation and immunoglobulin production. In an independent cohort (23 survivors, 22 deceased), fatal cases had higher bacterial loads (P = 0.0004) and lower anti-Leptospira antibody titers (P = 0.02) at the time of hospitalization, independent of the duration of illness. Low serum cathelicidin and RANTES levels during acute illness were independent risk factors for higher bacterial loads (P = 0.005) and death (P = 0.04), respectively. To investigate the mechanism of cathelicidin in patients surviving acute disease, we administered LL-37, the active peptide of cathelicidin, in a hamster model of lethal leptospirosis and found it significantly decreased bacterial loads and increased survival. Our findings indicate that the host immune response plays a central role in severe leptospirosis disease progression. While drawn from a limited study size, significant conclusions include that poor clinical outcomes are associated with high systemic bacterial loads, and a decreased antibody response. Furthermore, our data identified a key role for the antimicrobial peptide, cathelicidin, in mounting an effective bactericidal response against the pathogen, which represents a valuable new therapeutic approach for leptospirosis.
C1 [Lindow, Janet C.; Wunder, Elsio A., Jr.; Hacker, Kathryn P.; Hagan, Jose E.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Lindow, Janet C.; Wunder, Elsio A., Jr.; Hagan, Jose E.; Araujo, Guilherme C.; Nery, Nivison, Jr.; Reis, Mitermayer G.; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Popper, Stephen J.; Relman, David A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.
   [Min, Jin-na; Mannam, Praveen; Srivastava, Anup; Lee, Patty J.] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT USA.
   [Yao, Yi; Montgomery, Ruth R.] Yale Sch Med, Dept Internal Med, Rheumatol Sect, New Haven, CT USA.
   [Yao, Yi; Montgomery, Ruth R.] Yale Sch Med, Dept Neurol, New Haven, CT USA.
   [Raddassi, Khadir] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT USA.
   [Shaw, Albert C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.
   [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA.
   [Kim, Charles C.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA USA.
   [Srivastava, Anup] Univ Arizona, Dept Med, Div Translat & Regenerat Med, Tucson, AZ USA.
   [Yao, Yi] Henry Ford Hlth Syst, Dept Dermatol, Henry Ford Immunol Program, Detroit, MI USA.
   [Kim, Charles C.] Verily, Mountain View, CA USA.
RP Lindow, JC (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Lindow, JC (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
EM jlindow@alum.mit.edu; albert.ko@yale.edu
RI Reis, Mitermayer/AAO-9742-2020; Hagan, Jose/N-6719-2019; Ko, Albert
   Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013
OI Reis, Mitermayer/0000-0002-3051-9060; Hagan, Jose/0000-0002-1837-6319;
   Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Relman, David/0000-0001-8331-1354; Rocha
   Nery Junior, Nivison Ruy/0000-0002-8164-0602; Montgomery,
   Ruth/0000-0002-8661-4454; Lindow, Janet/0000-0003-3235-3698; Lee,
   Patty/0000-0001-9906-1628; Hacker, Kathryn/0000-0001-5267-1699; Kim,
   Charles/0000-0001-6474-8227
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI088752, R01AI052473, R01 AI121207, F31AI114245-02, U19 AI109761];
   Fogarty International CenterUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504]; American Society for Tropical
   Medicine and Hygiene Gorgas Memorial Institute Research Award; Fogarty
   International Center, Global Health Fellows and Scholars Research
   Training Grant [R25 TW009338]; Minsterio da Ciencia, Tecnologia, e
   Inovacao Ciencias Sem Fronteiras Bolsa; National Institute on
   AgingUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [K24 AG042489]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R01TW009504,
   R25TW009338, R01TW009504, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R01TW009504, R25TW009338, R25TW009338, R01TW009504,
   R01TW009504] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U19AI109761, R01AI121207, U19AI109761, U19AI109761, U19AI109761,
   U19AI109761, U01AI088752, U19AI109761, R01AI121207, U19AI109761,
   U01AI088752, U19AI109761, U19AI109761, U19AI109761, U19AI109761,
   U19AI109761, U19AI109761, U01AI088752, U19AI109761, U19AI109761,
   U19AI109761, U19AI109761, U19AI109761, U01AI088752, U19AI109761,
   U19AI109761, U19AI109761, U19AI109761, U19AI109761, U19AI109761,
   R01AI121207, U19AI109761, R01AI121207, U19AI109761, U19AI109761,
   U19AI109761, U19AI109761, R01AI121207, U01AI088752, U19AI109761,
   U19AI109761, U19AI109761, U19AI109761, U19AI109761, U19AI109761,
   U19AI109761, U01AI088752, U19AI109761, U19AI109761, U19AI109761,
   U19AI109761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON
   AGINGUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342] Funding Source: NIH RePORTER
FX Funding was provided by National Institute of Allergy and Infectious
   Diseases grants U01AI088752 (AIK), R01AI052473 (AIK), and R01 AI121207
   (AIK) (https://www.niaid.nih.gov/); Fogarty International Center grant
   R01TW009504 (AIK), (http://www.fic.nih.gov/Pages/Default.aspx); American
   Society for Tropical Medicine and Hygiene Gorgas Memorial Institute
   Research Award (JCL); Fogarty International Center, Global Health
   Fellows and Scholars Research Training Grant R25 TW009338 (JCL)
   (http://www.astmh.org/); Minsterio da Ciencia, Tecnologia, e Inovacao
   Ciencias Sem Fronteiras Bolsa (JCL)
   (http://cnpq.br/apresentacao-bolsas-e-auxilios); National Institute of
   Allergy and Infectious Diseases grant F31AI114245-02 (KPH)
   (https://www.niaid.nih.gov/); National Institute of Allergy and
   Infectious Diseases U19 AI109761 (DAR) (https://www.niaid.nih.gov/); and
   National Institute on Aging K24 AG042489 (ACS)
   (https://www.nia.nih.gov/). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ABDULKADER Regina C.R.M., 2002, Rev. Inst. Med. trop. S. Paulo, V44, P79, DOI 10.1590/S0036-46652002000200005
   Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137
   ADLER B, 1977, INFECT IMMUN, V17, P67, DOI 10.1128/IAI.17.1.67-72.1977
   ADLER B, 1978, J MED MICROBIOL, V11, P387, DOI 10.1099/00222615-11-4-387
   Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101
   Annika Linde GHL, 2013, J CLIN CELL IMMUNOLO, VS13, P003
   [Anonymous], 2016, INTR INJ LL37 MEL
   [Anonymous], 2007, LEPT CAS NOT REC
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193
   Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147
   Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111
   Cedola M, 2015, ACTA TROP, V146, P73, DOI 10.1016/j.actatropica.2015.03.007
   Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Craig SB, 2009, ANN TROP MED PARASIT, V103, P333, DOI 10.1179/136485909X435058
   Dolinay T, 2012, AM J RESP CRIT CARE, V185, P1225, DOI 10.1164/rccm.201201-0003OC
   Eberle F, 2009, EUR J IMMUNOL, V39, P2537, DOI 10.1002/eji.200838978
   Eigenbrod T, 2015, J IMMUNOL, V195, P1092, DOI 10.4049/jimmunol.1403173
   Esteves LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108534
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Fialho RN, 2009, HUM IMMUNOL, V70, P915, DOI 10.1016/j.humimm.2009.08.007
   Goeijenbier M, 2015, J INFECT
   Goncalves-de-Albuquerque CF, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/317950
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Grobmyer SR, 2000, J CLIN IMMUNOL, V20, P212, DOI 10.1023/A:1006641630904
   Gronberg A, 2014, WOUND REPAIR REGEN, V22, P613, DOI 10.1111/wrr.12211
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552
   Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Isogai E, 2004, J APPL RES, V4, p180 
   JOST BH, 1986, J MED MICROBIOL, V22, P269, DOI 10.1099/00222615-22-3-269
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kobayashi Y, 2001, J Infect Chemother, V7, P59, DOI 10.1007/s101560100011
   Kornblit B, 2013, IMMUNOBIOLOGY, V218, P1227, DOI 10.1016/j.imbio.2013.04.010
   Kruger A, 2015, EMBO REP, V16, P1656, DOI 10.15252/embr.201540861
   Kyriakidis I, 2011, CYTOKINE, V54, P117, DOI 10.1016/j.cyto.2011.01.014
   Lingappa J, 2004, GENES IMMUN, V5, P197, DOI 10.1038/sj.gene.6364058
   Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158
   Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733
   Maneewatch S, 2008, HYBRIDOMA, V27, P453, DOI 10.1089/hyb.2008.0056
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Mikulski M, 2014, EUROPEAN J CLIN MICR
   Molnarfi N, 2015, AUTOIMMUN REV, V14, P293, DOI 10.1016/j.autrev.2014.11.013
   Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014
   Panaphut Thanachai, 2002, International Journal of Infectious Diseases, V6, P52, DOI 10.1016/S1201-9712(02)90137-2
   Parikh CR, 2005, J AM SOC NEPHROL, V16, P3046, DOI 10.1681/ASN.2005030236
   Parnell GP, 2013, SHOCK, V40, P166, DOI 10.1097/SHK.0b013e31829ee604
   Popper SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r261
   Prakash M, 2013, CELL SIGNAL, V25, P1567, DOI 10.1016/j.cellsig.2013.03.016
   Qian F, 2015, CLIN VACCINE IMMUNOL, V22, P6, DOI 10.1128/CVI.00508-14
   Reis EAG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002457
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Sambri V, 2002, J ANTIMICROB CHEMOTH, V50, P895, DOI 10.1093/jac/dkf220
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13
   Srikram A, 2011, J INFECT DIS, V203, P870, DOI 10.1093/infdis/jiq127
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Stromstedt AA, 2009, ANTIMICROB AGENTS CH, V53, P593, DOI 10.1128/AAC.00477-08
   Tajiki MH, 1996, CLIN INFECT DIS, V23, P1177, DOI 10.1093/clinids/23.5.1177
   TAJIKI MH, 1997, BRAZ J INFECT DIS, V1, P138
   Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Vieira Silvia R R, 2002, Braz J Infect Dis, V6, P135, DOI 10.1590/S1413-86702002000300006
   Wunder EA, 2016, INFECT IMMUN, V84, P2105, DOI 10.1128/IAI.00094-16
NR 73
TC 15
Z9 15
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD NOV
PY 2016
VL 12
IS 11
AR e1005943
DI 10.1371/journal.ppat.1005943
PG 21
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EI0VO
UT WOS:000392193200010
PM 27812211
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Paiao, DSG
   Lemos, EF
   Carbone, ADS
   Sgarbi, RVE
   Laranjeira, A
   da Silva, FM
   Brandao, LM
   dos Santos, LS
   Martins, VS
   Simionatto, S
   Motta-Castro, ARC
   Pompilio, MA
   Urrego, J
   Ko, AI
   Andrews, JR
   Croda, J
AF Guimaraes Paiao, Dayse Sanchez
   Lemos, Everton Ferreira
   Santos Carbone, Andrea da Silva
   Enne Sgarbi, Renata Viebrantz
   Laranjeira Junior, Alexandre
   da Silva, Fellipe Matos
   Brandao, Leticia Marques
   dos Santos, Luciana Squarizi
   Martins, Vaneli Silva
   Simionatto, Simone
   Coimbra Motta-Castro, Ana Rita
   Pompilio, Mauricio Antonio
   Urrego, Juliana
   Ko, Albert Icksang
   Andrews, Jason Randolph
   Croda, Julio
TI Impact of mass-screening on tuberculosis incidence in a prospective
   cohort of Brazilian prisoners
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Tuberculosis; LTBI; Mass screening; Prisons; Case finding; Brazil;
   Cohort
ID PULMONARY TUBERCULOSIS; LATENT TUBERCULOSIS; PREVALENCE; COMMUNITY;
   TRANSMISSION; INFECTION; INMATES
AB Background: Globally, prison inmates are a high-risk population for tuberculosis (TB), but the specific drivers of disease and impact of mass screening interventions are poorly understood.
   Methods: We performed a prospective cohort study to characterize the incidence and risk factors for tuberculosis infection and disease in 12 Brazilian prisons, and to investigate the effect of mass screening on subsequent disease risk. After recruiting a stratified random sample of inmates, we administered a questionnaire to ascertain symptoms and potential risk factors for tuberculosis; performed tuberculin skin testing (TST); collected sera for HIV testing; and obtained two sputum samples for smear microscopy and culture, from participants reporting a cough of any duration. We repeated the questionnaire and all tests for inmates who remained incarcerated after 1 year. TST conversion was defined as TST >= 10 mm and an induration increase of at least 6 mm in an individual with a baseline TST <10 mm. Cox proportional hazard models were performed to identify risk factors associated with active TB. To evaluate the impact of screening on subsequent risk of disease, we compared TB notifications over one year among individuals randomized to screening for active TB with those not randomized to screening.
   Results: Among 3,771 inmates recruited, 3,380 (89.6 %) were enrolled in the study, and 1,422 remained incarcerated after one year. Among 1,350 inmates (94.9 %) with paired TSTs at baseline and one-year follow-up, 25. 7 % (272/1060) converted to positive. Among those incarcerated for the year, 10 (0.7 %) had TB at baseline and 25 (1.8 %) were diagnosed with TB over the subsequent year. Cases identified through active screening were less likely to be smearpositive than passively detected cases (10.0 % vs 50.9 %; p < 0.01), suggesting early case detection. However, there was no reduction in subsequent disease among individuals actively screened versus those not screened (1.3 % vs 1.7 %; p = 0.88). Drug use during the year (AHR 3.22; 95 % CI 1.05-9.89) and knows somebody with TB were (AHR 2.86; 95 % CI 1.01-8.10) associated with active TB during one year of follow up
   Conclusions: Mass screening in twelve Brazilian prisons did not reduce risk of subsequent disease in twelve Brazilian prisons, likely due to an extremely high force of infection. New approaches are needed to control TB in this high-transmission setting.
C1 [Guimaraes Paiao, Dayse Sanchez; Santos Carbone, Andrea da Silva; Enne Sgarbi, Renata Viebrantz; Laranjeira Junior, Alexandre; da Silva, Fellipe Matos; Brandao, Leticia Marques; dos Santos, Luciana Squarizi; Martins, Vaneli Silva; Croda, Julio] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil.
   [Lemos, Everton Ferreira; Pompilio, Mauricio Antonio] Univ Fed Mato Grosso do Sul, Sch Med, Campo Grande, Brazil.
   [Simionatto, Simone] Fed Univ Grande Dourados, Fac Ambiental & Biol Sci, Dourados, Brazil.
   [Coimbra Motta-Castro, Ana Rita] Univ Fed Mato Grosso do Sul, Dept Biochem Pharm, Campo Grande, Brazil.
   [Coimbra Motta-Castro, Ana Rita; Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, Brazil.
   [Urrego, Juliana; Ko, Albert Icksang] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert Icksang] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Andrews, Jason Randolph] Stanford Sch Med, Div Infect Dis & Geog Med, Palo Alto, CA USA.
RP Croda, J (corresponding author), Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil.; Croda, J (corresponding author), Fundacao Oswaldo Cruz, Campo Grande, Brazil.
EM juliocroda@gmail.com
RI Simionatto, Simone/AAG-7509-2020; Lemos, Everton EFL
   Ferreira/J-5831-2015; Ko, Albert Icksang/P-2343-2015; motta-castro, ana
   rita c/O-2075-2017; Croda, Julio/I-5172-2013
OI Simionatto, Simone/0000-0003-2367-0915; Lemos, Everton EFL
   Ferreira/0000-0001-6652-9191; Ko, Albert Icksang/0000-0001-9023-2339;
   Croda, Julio/0000-0002-6665-6825; Andrews, Jason/0000-0002-5967-251X;
   Motta-Castro, Ana Rita/0000-0003-3070-1337
FU Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do
   Estado do Mato Grosso do Sul (FUNDECT)Fundect [0059/2013]; Ministry of
   Education (PROEXT); Brazilian National Research Council (Ciencias sem
   Fronteiras Program); Fogarty Global Health Equity Scholars Program [NIH
   1 R25 TW009338]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI121207, R01AI121207,
   R01AI121207, R01AI121207] Funding Source: NIH RePORTER
FX This study was funded and sponsored by Fundacao de Apoio ao
   Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado do Mato Grosso
   do Sul (FUNDECT, grant no. 0059/2013), the Ministry of Education
   (PROEXT), the Brazilian National Research Council (Ciencias sem
   Fronteiras Program) and the Fogarty Global Health Equity Scholars
   Program (NIH 1 R25 TW009338). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adane K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149453
   Adesokan H K, 2014, Afr J Med Med Sci, V43, P45
   Aerts A, 2000, INT J TUBERC LUNG D, V4, P1104
   Aguilera XP, 2016, INT J TUBERC LUNG D, V20, P63, DOI 10.5588/ijtld.15.0056
   Alavi SM, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.18872
   [Anonymous], 2000, TUB CONTR PRIS
   Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381
   Bourdillon P, 2015, INT J TUBERC LUNG D, V19, pS436
   Chan PC, 2012, INT J TUBERC LUNG D, V16, P633, DOI 10.5588/ijtld.11.0504
   COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P827
   COMSTOCK GW, 1961, PUBLIC HEALTH REP, V76, P19, DOI 10.2307/4591052
   Croda MG, 2012, T ROY SOC TROP MED H, V106, P223, DOI 10.1016/j.trstmh.2012.01.005
   Dara M, 2015, INT J INFECT DIS, V32, P111, DOI 10.1016/j.ijid.2014.12.029
   Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469
   Getahun H, 2015, GUIDELINES MANAGEMEN
   Johnstone-Robertson S, 2011, SAMJ S AFR MED J, V101, P809
   Kuhleis D, 2012, MEM I OSWALDO CRUZ, V107, P909, DOI 10.1590/S0074-02762012000700012
   MacIntyre CR, 1997, CLIN INFECT DIS, V24, P1060, DOI 10.1086/513632
   Sanchez A, 2005, INT J TUBERC LUNG D, V9, P633
   Sanchez A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-983
   Carbone ADS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0764-8
   Telisinghe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087262
   Urrego J, 2015, AM J TROP MED HYG, V93, P739, DOI 10.4269/ajtmh.15-0166
   Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC
   Yuhara LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071201
NR 25
TC 10
Z9 10
U1 0
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD OCT 3
PY 2016
VL 16
AR 533
DI 10.1186/s12879-016-1868-5
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DX6JW
UT WOS:000384490900002
PM 27716170
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Landry, ML
   Ko, AI
   Kramer, LD
   Vasilakis, N
AF Landry, Marie Louise
   Ko, Albert I.
   Kramer, Laura D.
   Vasilakis, Nikolaos
TI Zika Virus: From Obscurity to Potentially Devastating International
   Threat
SO CLINICAL CHEMISTRY
LA English
DT Editorial Material
C1 [Landry, Marie Louise] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA.
   [Landry, Marie Louise] Yale Univ, Sch Med, Dept Med Infect Dis, New Haven, CT 06510 USA.
   [Landry, Marie Louise] Yale New Haven Med Ctr, Clin Virol Lab, 20 York St, New Haven, CT 06504 USA.
   [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ko, Albert I.] Yale Univ, Sch Med, Med Infect Dis, New Haven, CT USA.
   [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Arbovirus Lab, New York State Dept Hlth,Wadsworth Ctr, Albany, NY 12222 USA.
   [Kramer, Laura D.] SUNY Albany, Sch Publ Hlth, Biomed Sci, Albany, NY 12222 USA.
   [Vasilakis, Nikolaos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikolaos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikolaos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Ko, AI (corresponding author), Yale Univ, Sch Med, POB 208035, New Haven, CT 06520 USA.
EM marie.landry@yale.edu
RI Vasilakis, Nikos/ABE-7318-2020; Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI121207] Funding Source: Medline;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207, R01AI121207]
   Funding Source: NIH RePORTER
NR 0
TC 0
Z9 0
U1 0
U2 62
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD SEP
PY 2016
VL 62
IS 9
BP 1175
EP 1180
DI 10.1373/clinchem.2016.261917
PG 6
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA DU7VH
UT WOS:000382422200003
PM 27551005
OA Green Accepted, Bronze
DA 2020-11-30
ER

PT J
AU Lewnard, JA
   Gonsalves, G
   Ko, AI
AF Lewnard, Joseph A.
   Gonsalves, Gregg
   Ko, Albert I.
TI Low Risk of International Zika Virus Spread due to the 2016 Olympics in
   Brazil
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
ID RIO-DE-JANEIRO; GAMES
C1 Global Hlth Justice Partnership, Yale Sch Publ Hlth, New Haven, CT USA.
   Yale Univ, Yale Law Sch, New Haven, CT USA.
   Minist Saude, Salvador, BA, Brazil.
   [Lewnard, Joseph A.; Ko, Albert I.] Yale Sch Publ Hlth, 60 Coll St,Suite 710, New Haven, CT 06520 USA.
   [Gonsalves, Gregg] Yale Global Hlth Justice Partnership, POB 208215, New Haven, CT 06520 USA.
RP Lewnard, JA (corresponding author), Yale Sch Publ Hlth, 60 Coll St,Suite 710, New Haven, CT 06520 USA.
EM joseph.lewnard@yale.edu
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207, R01AI121207]
   Funding Source: NIH RePORTER; FIC NIH HHSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01 TW009504] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI121207] Funding Source:
   Medline
CR Attaran A, COMMUNICATION
   Centers for Disease Control and Prevention, 2015, ZIK VIR DIS US 2015
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Eberhardt KA, 2016, TRAVEL MED INFECT DI, V14, P212, DOI 10.1016/j.tmaid.2016.05.014
   Lessler J, 2016, B WORLD HEALTH ORGAN, P1
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   Ministerio de Saude (MS), 2015, B EPIDEMIOL, V46, P1
   Secretaria de Vigilancia em Saude-Ministerio da Saude, PROT VIG RESP OC MIC
   Secretaria Nacional de Politicas de Turismo, 2015, AN EST TUR 2015
NR 9
TC 11
Z9 11
U1 0
U2 19
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD AUG 16
PY 2016
VL 165
IS 4
BP 286
EP +
DI 10.7326/M16-1628
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DT1UI
UT WOS:000381267200019
PM 27454521
OA Green Accepted
DA 2020-11-30
ER

PT J
AU Riediger, IN
   Hoffmaster, AR
   Casanovas-Massana, A
   Biondo, AW
   Ko, AI
   Stoddard, RA
AF Riediger, Irina N.
   Hoffmaster, Alex R.
   Casanovas-Massana, Arnau
   Biondo, Alexander W.
   Ko, Albert I.
   Stoddard, Robyn A.
TI An Optimized Method for Quantification of Pathogenic Leptospira in
   Environmental Water Samples
SO PLOS ONE
LA English
DT Article
ID EXTRACTION KITS; OUTBREAK; DNA; HOUSEHOLD; INFECTION; TRANSMISSION;
   PARTICIPANTS; COMMUNITIES; INTERROGANS; RECOVERY
AB Leptospirosis is a zoonotic disease usually acquired by contact with water contaminated with urine of infected animals. However, few molecular methods have been used to monitor or quantify pathogenic Leptospira in environmental water samples. Here we optimized a DNA extraction method for the quantification of leptospires using a previously described Taqman-based qPCR method targeting lipL32, a gene unique to and highly conserved in pathogenic Leptospira. QIAamp DNA mini, MO BIO PowerWater DNA and PowerSoil DNA Isolation kits were evaluated to extract DNA from sewage, pond, river and ultrapure water samples spiked with leptospires. Performance of each kit varied with sample type. Sample processing methods were further evaluated and optimized using the PowerSoil DNA kit due to its performance on turbid water samples and reproducibility. Centrifugation speeds, water volumes and use of Escherichia coli as a carrier were compared to improve DNA recovery. All matrices showed a strong linearity in a range of concentrations from 10(6) to 10 degrees leptospires/mL and lower limits of detection ranging from < 1 cell/ml for river water to 36 cells/mL for ultrapure water with E. coli as a carrier. In conclusion, we optimized a method to quantify pathogenic Leptospira in environmental waters (river, pond and sewage) which consists of the concentration of 40 mL samples by centrifugation at 15,000xg for 20 minutes at 4 degrees C, followed by DNA extraction with the PowerSoil DNA Isolation kit. Although the method described herein needs to be validated in environmental studies, it potentially provides the opportunity for effective, timely and sensitive assessment of environmental leptospiral burden.
C1 [Riediger, Irina N.] Cent Lab State Parana, Curitiba, Parana, Brazil.
   [Hoffmaster, Alex R.; Stoddard, Robyn A.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
   [Casanovas-Massana, Arnau; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Biondo, Alexander W.] Fed Univ State Parana, Dept Vet Med, Curitiba, Parana, Brazil.
   [Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
RP Riediger, IN (corresponding author), Cent Lab State Parana, Curitiba, Parana, Brazil.; Casanovas-Massana, A (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
EM iriediger@yahoo.com.br; arnau.casanovas@yale.edu
RI BIONDO, ALEXANDER WELKER W/E-8823-2018; Ko, Albert Icksang/P-2343-2015;
   Casanovas-Massana, Arnau/H-5806-2019
OI BIONDO, ALEXANDER WELKER W/0000-0002-4182-5821; Ko, Albert
   Icksang/0000-0001-9023-2339; Casanovas-Massana,
   Arnau/0000-0002-3301-6143
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI052473, U01 AI088752, R25 TW009338, R01 TW009504, R01 AI121207];
   CAPES (Brazilian Ministry of Education)CAPES [BEX 066509-6]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207, R01AI121207]
   Funding Source: NIH RePORTER
FX This work was supported by funding from the National Institute of
   Allergy and Infectious Diseases (www.niaid.nih.gov) (award numbers R01
   AI052473, U01 AI088752, R25 TW009338, R01 TW009504 and R01 AI121207 to
   AIK). INR was supported by a sandwich Ph.D. scholarship (BEX 066509-6)
   from CAPES (Brazilian Ministry of Education). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agampodi SB, 2014, EPIDEMIOL INFECT, V142, P843, DOI 10.1017/S0950268813001465
   Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   Behets J, 2007, J MICROBIOL METH, V68, P137, DOI 10.1016/j.mimet.2006.07.002
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bonot S, 2010, APPL MICROBIOL BIOT, V87, P2303, DOI 10.1007/s00253-010-2686-0
   Cosson JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002902
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   Dauphin LA, 2009, J MICROBIOL METH, V76, P30, DOI 10.1016/j.mimet.2008.09.004
   Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Elvang AM, 2001, ENVIRON MICROBIOL, V3, P32, DOI 10.1046/j.1462-2920.2001.00156.x
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Goarant C, 2009, TROP MED INT HEALTH, V14, P926, DOI 10.1111/j.1365-3156.2009.02310.x
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lloyd KG, 2010, FEMS MICROBIOL ECOL, V72, P143, DOI 10.1111/j.1574-6941.2009.00827.x
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Mayer-Scholl A, 2014, INT J ENV RES PUB HE, V11, P7562, DOI 10.3390/ijerph110807562
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Monahan AM, 2009, J APPL MICROBIOL, V107, P707, DOI 10.1111/j.1365-2672.2009.04220.x
   Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615
   Munoz-Zanzi C, 2014, INT J ENV RES PUB HE, V11, P6666, DOI 10.3390/ijerph110706666
   Munoz-Zanzi C, 2014, AM J TROP MED HYG, V90, P497, DOI 10.4269/ajtmh.13-0334
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Rawlins J, 2014, INT J ENV RES PUB HE, V11, P7953, DOI 10.3390/ijerph110807953
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Sejvar J, 2003, EMERG INFECT DIS, V9, P702
   Smith JKG, 2013, EPIDEMIOL INFECT, V141, P585, DOI 10.1017/S0950268812001021
   Stern EJ, 2010, CLIN INFECT DIS, V50, P843, DOI 10.1086/650578
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Tangkanakul W., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P281
   Vein J, 2012, CAN J MICROBIOL, V58, P828, DOI [10.1139/W2012-060, 10.1139/w2012-060]
   Viau EJ, 2011, J WATER HEALTH, V9, P637, DOI 10.2166/wh.2011.064
   Weinberger D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002798
   Whitehouse CA, 2007, MOL CELL PROBE, V21, P92, DOI 10.1016/j.mcp.2006.08.003
   Wuthiekanun V, 2007, J CLIN MICROBIOL, V45, P1363, DOI 10.1128/JCM.02430-06
NR 41
TC 9
Z9 9
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 3
PY 2016
VL 11
IS 8
AR e0160523
DI 10.1371/journal.pone.0160523
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DT3GA
UT WOS:000381367800084
PM 27487084
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU De Oliveira, D
   Figueira, CP
   Zhan, L
   Pertile, AC
   Pedra, GG
   Gusmao, IM
   Wunder, EA
   Rodrigues, G
   Ramos, EAG
   Ko, AI
   Childs, JE
   Reis, MG
   Costa, F
AF De Oliveira, D.
   Figueira, C. P.
   Zhan, L.
   Pertile, A. C.
   Pedra, G. G.
   Gusmao, I. M.
   Wunder, E. A., Jr.
   Rodrigues, G.
   Ramos, E. A. G.
   Ko, A. I.
   Childs, J. E.
   Reis, M. G.
   Costa, F.
TI Leptospira in breast tissue and milk of urban Norway rats (Rattus
   norvegicus)
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Breastfeeding; immunofluorescence; immunohistochemistry; Rattus
   norvegicus; scanning electronic microscopy; vertical transmission
ID INTERROGANS; INFECTION; DISEASE; BRAZIL; RISK; ICTEROHAEMORRHAGIAE;
   EPIDEMIC; MASTITIS; CARRIER; MODEL
AB Leptospirosis is a zoonosis caused by bacteria of the genus Leptospira. The disease is globally distributed and a major public health concern. The Norway rat (Rattus norvegicus) is the main reservoir of the pathogen in urban slums of developing and developed countries. The potential routes of intra-specific leptospire transmission in rats are largely unknown. Herein, we identified pathogenic Leptospira spp. in breast tissue and milk of naturally infected rats. We examined kidney, breast tissue and milk from 24 lactating rats for the presence of leptospires using immunofluorescence, immunohistochemistry, polymerase chain reaction (PCR) and scanning electronic microscopy. All 24 rats had evidence for Leptospira in the kidneys, indicating chronic carriage. The majority of kidney-positive rats had detectable leptospires in milk (18, 75%) and breast tissue (16, 67%), as evidenced by immunofluorescence assay and immunohistochemistry. Four (17%) milk samples and two (8%) breast tissue samples were positive by quantitative real-time PCR. Scanning electron microscopy confirmed the presence of leptospires in breast tissue. No major pathological changes in breast tissue were found. This study, for the first time, identified leptospires in the milk and breast tissue of wild Norway rats, suggesting the possibility of milk-borne transmission of leptospirosis to neonates.
C1 [De Oliveira, D.; Figueira, C. P.; Pertile, A. C.; Pedra, G. G.; Gusmao, I. M.; Ramos, E. A. G.; Ko, A. I.; Reis, M. G.; Costa, F.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Zhan, L.; Wunder, E. A., Jr.; Ko, A. I.; Childs, J. E.; Reis, M. G.; Costa, F.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Rodrigues, G.] Minist Saude, Secretaria Municipal Saude, Ctr Controle Zoonoses, Salvador, BA, Brazil.
   [Reis, M. G.] Univ Fed Bahia, UFBA, Fac Med, Salvador, BA, Brazil.
   [Costa, F.] Univ Fed Bahia, UFBA, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil.
RP Costa, F (corresponding author), Univ Fed Bahia, UFBA, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil.
EM federico.costa@ufba.br
RI Wunder, Elsio Augusto/C-2733-2013; Reis, Mitermayer/AAO-9742-2020; Ko,
   Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Reis,
   Mitermayer/0000-0002-3051-9060; Ko, Albert Icksang/0000-0001-9023-2339;
   Costa, Federico/0000-0001-6951-2336
FU Oswaldo Cruz Foundation, Brazilian Ministry of Health; Secretariat of
   Health Surveillance, Brazilian Ministry of Health; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI052473, U01 AI088752, R01
   TW009504, R25 TW009338, R01 AI121207]; Wellcome TrustWellcome Trust
   [102330/Z/13/Z]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R25TW009338, R01TW009504,
   R25TW009338, R01TW009504, R01TW009504, R25TW009338, R25TW009338,
   R01TW009504, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R01TW009504,
   R25TW009338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI121207, R01AI052473,
   R01AI052473, R01AI121207, R01AI052473, R01AI121207, R01AI052473,
   U01AI088752, R01AI052473, U01AI088752, U01AI088752, R01AI052473,
   U01AI088752, R01AI052473, R01AI052473, R01AI052473, R01AI121207,
   R01AI052473, R01AI052473, R01AI121207, U01AI088752, U01AI088752] Funding
   Source: NIH RePORTER
FX The authors thank the staff of Zoonosis Control Centre, Salvador for
   their assistance in conducting the study. We also to thank Mayara
   Carvalho for her assistance with database processing and Kathryn Hacker
   for review of the grammar. This work could not have been accomplished
   without the joint collaborative effort of the resident associations,
   community leaders and residents, which constitute the Urban Health
   Council of Pau da Lima. We thank the Global Leptospirosis Environmental
   Action Network (GLEAN). We also thank the Histotecnologia platforms and
   electron microscopy of the Goncalo Moniz Research Center
   (FIOCRUZ-CPqGM-Bahia). This work was supported by the Oswaldo Cruz
   Foundation and Secretariat of Health Surveillance, Brazilian Ministry of
   Health, the National Institutes of Health (grants R01 AI052473, U01
   AI088752, R01 TW009504, R25 TW009338 and R01 AI121207) and by the
   Wellcome Trust (102330/Z/13/Z).
CR Agudelo-Florez P, 2013, BIOMEDICA, V33, P82, DOI 10.7705/biomedica.v33i0.686
   Allan KJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003899
   Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   BIRNBAUM S, 1972, AM J EPIDEMIOL, V96, P313, DOI 10.1093/oxfordjournals.aje.a121461
   BOLIN CA, 1988, J INFECT DIS, V158, P246, DOI 10.1093/infdis/158.1.246
   Calhoun J.B., 1963, ECOLOGY SOCIOLOGY NO
   Chagas-Junior AD, 2009, J MED MICROBIOL, V58, P1632, DOI 10.1099/jmm.0.014050-0
   CHUNG H L, 1963, Chin Med J, V82, P777
   Costa F., 2014, PLOS NEGLECT TROP D, V8, P1
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   COX PJ, 1981, J COMP PATHOL, V91, P153, DOI 10.1016/0021-9975(81)90055-4
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746
   ELLIS WA, 1976, VET REC, V99, P368, DOI 10.1136/vr.99.19.368
   Faine S, 1984, MIKROBIOLOGIE HYGIEN, V257, P548
   Faine S., 2000, LEPTOSPIRA LEPTOSPIR
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, P1
   Galef JGB, ECOLOGY WEANING PARE
   Hamond C, 2013, J EQUINE VET SCI, V33, P1157, DOI 10.1016/j.jevs.2013.03.185
   HARRISON NA, 1988, POSTGRAD MED J, V64, P163, DOI 10.1136/pgmj.64.748.163
   HIGGINS RJ, 1980, VET REC, V107, P307, DOI 10.1136/vr.107.13.307
   Himsworth CG, 2014, PLOS ONE, V9, P1
   Holt J, 2006, ACTA TROP, V99, P218, DOI 10.1016/j.actatropica.2006.08.003
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   LAHIRI M. N., 1941, INDIAN JOUR MED RES, V29, P685
   Lau CL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001669
   LEONVIZCAINO L, 1987, COMP IMMUNOL MICROB, V10, P149, DOI 10.1016/0147-9571(87)90009-9
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08
   Muslich LT, 2015, COMP IMMUNOL MICROB, V38, P47, DOI 10.1016/j.cimid.2014.11.001
   POONACHA KB, 1993, VET PATHOL, V30, P362, DOI 10.1177/030098589303000405
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Ristow P, 2008, MICROBIOL-SGM, V154, P1309, DOI 10.1099/mic.0.2007/014746-0
   Roczek A, 2008, J MED MICROBIOL, V57, P658, DOI 10.1099/jmm.0.47677-0
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   SCHNURRENBERGER PR, 1970, AM J EPIDEMIOL, V92, P223, DOI 10.1093/oxfordjournals.aje.a121202
   SHAKED Y, 1993, CLIN INFECT DIS, V17, P241, DOI 10.1093/clinids/17.2.241
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   THIELS E, 1988, PHYSIOL BEHAV, V42, P507, DOI 10.1016/0031-9384(88)90152-7
   THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39
   Ward TG, 1940, AM J TROP MED HYG, V1, P727
NR 44
TC 14
Z9 15
U1 0
U2 11
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD AUG
PY 2016
VL 144
IS 11
BP 2420
EP 2429
DI 10.1017/S0950268816000637
PG 10
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DR3EK
UT WOS:000379785200022
PM 27019024
OA Bronze, Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Lindow, J
   Montgomery, R
   Reis, E
   Tsay, A
   Wunder, E
   Araojo, G
   Nery, N
   Mohanty, S
   Shaw, A
   Reis, M
   Ko, A
AF Lindow, J.
   Montgomery, R.
   Reis, E.
   Tsay, A.
   Wunder, E.
   Araojo, G.
   Nery, N.
   Mohanty, S.
   Shaw, A.
   Reis, M.
   Ko, A.
TI Elevated neutrophil TLR activation during acute severe leptospirosis
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT International Congress of Immunology (ICI)
CY AUG 21-26, 2016
CL Melbourne, AUSTRALIA
C1 [Lindow, J.; Montgomery, R.; Tsay, A.; Wunder, E.; Mohanty, S.; Shaw, A.; Ko, A.] Yale Univ, Sch Med, New Haven, CT USA.
   [Lindow, J.; Reis, E.; Wunder, E.; Araojo, G.; Nery, N.; Reis, M.; Ko, A.] Fiocruz MS, Salvador, BA, Brazil.
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD AUG
PY 2016
VL 46
SU 1
SI SI
MA 593
BP 644
EP 644
PG 1
WC Immunology
SC Immunology
GA DW4KA
UT WOS:000383610401484
DA 2020-11-30
ER

PT J
AU Lindow, J
   Wunder, E
   Popper, S
   Min, JN
   Mannam, P
   Srivastava, A
   Yao, Y
   Hacker, K
   Raddassi, K
   Lee, P
   Montgomery, R
   Shaw, A
   Hagan, J
   Araujo, G
   Nery, N
   Relman, D
   Kim, C
   Reis, M
   Ko, A
AF Lindow, J.
   Wunder, E.
   Popper, S.
   Min, J. -N
   Mannam, P.
   Srivastava, A.
   Yao, Y.
   Hacker, K.
   Raddassi, K.
   Lee, P.
   Montgomery, R.
   Shaw, A.
   Hagan, J.
   Araujo, G.
   Nery, N.
   Relman, D.
   Kim, C.
   Reis, M.
   Ko, A.
TI Cathelicidin insufficiency in patients with fatal leptospirosis
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT International Congress of Immunology (ICI)
CY AUG 21-26, 2016
CL Melbourne, AUSTRALIA
C1 [Lindow, J.; Wunder, E.; Hacker, K.; Araujo, G.; Nery, N.; Reis, M.; Ko, A.] Fiocruz MS, Salvador, BA, Brazil.
   [Lindow, J.; Wunder, E.; Min, J. -N; Mannam, P.; Srivastava, A.; Yao, Y.; Hacker, K.; Raddassi, K.; Lee, P.; Montgomery, R.; Shaw, A.; Ko, A.] Yale Univ, Sch Med, New Haven, CT USA.
   [Popper, S.; Relman, D.] Stanford Univ, Stanford, CA 94305 USA.
   [Hagan, J.] Ctr Dis Controle & Prevent, Atlanta, GA USA.
   [Kim, C.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD AUG
PY 2016
VL 46
SU 1
SI SI
MA 819
BP 765
EP 766
PG 2
WC Immunology
SC Immunology
GA DW4KA
UT WOS:000383610401732
DA 2020-11-30
ER

PT J
AU Wunder, EA
   Figueira, CP
   Benaroudj, N
   Hu, B
   Tong, BA
   Trajtenberg, F
   Liu, J
   Reis, MG
   Charon, NW
   Buschiazzo, A
   Picardeau, M
   Ko, AI
AF Wunder, Elsio A., Jr.
   Figueira, Claudio P.
   Benaroudj, Nadia
   Hu, Bo
   Tong, Brian A.
   Trajtenberg, Felipe
   Liu, Jun
   Reis, Mitermayer G.
   Charon, Nyles W.
   Buschiazzo, Alejandro
   Picardeau, Mathieu
   Ko, Albert I.
TI A novel flagellar sheath protein, FcpA, determines filament coiling,
   translational motility and virulence for the Leptospira spirochete
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID PERIPLASMIC FLAGELLUM; SEQUENCE-ANALYSIS; AXIAL FILAMENT; FLAA; GENE;
   INTERROGANS; PATHOGEN; INACTIVATION; INVOLVEMENT; MUTAGENESIS
AB Leptospira are unique among bacteria based on their helical cell morphology with hook-shaped ends and the presence of periplasmic flagella (PF) with pronounced spontaneous supercoiling. The factors that provoke such supercoiling, as well as the role that PF coiling plays in generating the characteristic hookend cell morphology and motility, have not been elucidated. We have now identified an abundant protein from the pathogen L. interrogans, exposed on the PF surface, and named it Flagellar-coiling protein A (FcpA). The gene encoding FcpA is highly conserved among Leptospira and was not found in other bacteria. fcpA(-) mutants, obtained from clinical isolates or by allelic exchange, had relatively straight, smaller-diameter PF, and were not able to produce translational motility. These mutants lost their ability to cause disease in the standard hamster model of leptospirosis. Complementation of fcpA restored the wild-type morphology, motility and virulence phenotypes. In summary, we identified a novel Leptospira 36-kDa protein, the main component of the spirochete's PF sheath, and a key determinant of the flagella's coiled structure. FcpA is essential for bacterial translational motility and to enable the spirochete to penetrate the host, traverse tissue barriers, disseminate to cause systemic infection and reach target organs.
C1 [Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Wunder, Elsio A., Jr.; Figueira, Claudio P.; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz, Brazilian Minist Hlth, Goncalo Moniz Res Ctr, BR-40296710 Salvador, BA, Brazil.
   [Benaroudj, Nadia; Picardeau, Mathieu] Inst Pasteur, Unit Biol Spirochetes, F-75724 Paris 15, France.
   [Hu, Bo; Tong, Brian A.; Liu, Jun] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA.
   [Buschiazzo, Alejandro] Inst Pasteur Montevideo, Lab Mol & Struct Microbiol, Montevideo 11400, Uruguay.
   [Trajtenberg, Felipe; Charon, Nyles W.] West Virginia Univ, Dept Microbiol & Immunol, Morgantown, WV 26506 USA.
   [Buschiazzo, Alejandro] Inst Pasteur, Dept Struct Biol & Chem, F-75724 Paris 15, France.
RP Wunder, EA (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.; Wunder, EA (corresponding author), Fundacao Oswaldo Cruz, Brazilian Minist Hlth, Goncalo Moniz Res Ctr, BR-40296710 Salvador, BA, Brazil.
EM elsio.wunder@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020;
   Buschiazzo, Alejandro/W-1095-2018; Wunder, Elsio Augusto/C-2733-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Buschiazzo,
   Alejandro/0000-0002-2509-6526; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Trajtenberg, Felipe/0000-0003-0427-5549
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U01 AI0038752, R01
   AI052473, R01 TW009504, D43 TW000919, R01 DE0234431, R01 AI29743, R01
   AI087946]; Brazilian National Research Council (CNPq)National Council
   for Scientific and Technological Development (CNPq); French Ministry of
   ResearchMinistry of Research, France [ANR-08-MIE-018]; Welch
   FoundationThe Welch Foundation [AU-1714]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW009504, D43TW000919, D43TW000919, R01TW009504, D43TW000919,
   D43TW000919, R01TW009504, D43TW000919, R01TW009504, D43TW000919,
   D43TW000919, R01TW009504, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI087946, R01AI087946, R01AI087946, R01AI052473, R01AI087946,
   R01AI029743, R01AI087946, R01AI029743, U01AI088752, R01AI052473,
   R01AI121207, R01AI121207, R01AI087946, R01AI052473, R01AI121207,
   R01AI052473, R01AI029743, R01AI121207, R01AI121207, R01AI052473,
   R01AI052473, U01AI088752, R01AI029743, R01AI029743, R01AI087946,
   R01AI087946, U01AI088752, R01AI029743, R01AI029743, R01AI052473,
   R01AI029743, R01AI029743, R01AI087946, R01AI052473, R01AI029743,
   R01AI029743, R01AI029743, R01AI052473, R01AI029743, U01AI088752,
   R01AI087946, R01AI052473, U01AI088752, U01AI088752, R01AI029743,
   R01AI052473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL
   & CRANIOFACIAL RESEARCHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Dental & Craniofacial Research (NIDCR) [R01DE023431] Funding Source:
   NIH RePORTER
FX We thank Gisele R. Santos and Drs. Leyla Slamti, Kristel Lourdault and
   Vimla Bisht for their technical assistance. We also thank Dr. David
   Haake for providing polyclonal antibodies (alpha-FlaA1) and for his
   helpful discussions, Drs. Joe Vinetz and Derrick Fouts for their
   collaboration in sequencing the genomes of leptospiral strains, and Dr.
   Justin Radolf for his suggestions and advice throughout the study. This
   work was supported by grants from the National Institutes of Health (U01
   AI0038752, R01 AI052473, R01 TW009504, D43 TW000919, R01 DE0234431, R01
   AI29743 and R01 AI087946), Brazilian National Research Council (CNPq),
   French Ministry of Research (ANR-08-MIE-018) and the Welch Foundation
   (AU-1714). The authors declare no conflict of interest.
CR Berg H. C., 1978, 28TH S SOC GEN MICR, P285
   Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bolin CA, 2001, AM J VET RES, V62, P995, DOI 10.2460/ajvr.2001.62.995
   BRAHAMSHA B, 1989, J BACTERIOL, V171, P1692, DOI 10.1128/jb.171.3.1692-1697.1989
   BROMLEY DB, 1979, J BACTERIOL, V137, P1406, DOI 10.1128/JB.137.3.1406-1412.1979
   CHARON NW, 1991, J BACTERIOL, V173, P4820, DOI 10.1128/jb.173.15.4820-4826.1991
   Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359
   Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145
   COCKAYNE A, 1987, J GEN MICROBIOL, V133, P1397
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102
   FAINE S, 1964, J BACTERIOL, V88, P1493, DOI 10.1128/JB.88.5.1493-1496.1964
   Figueira CP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-129
   Ge YG, 1998, J BACTERIOL, V180, P2418, DOI 10.1128/JB.180.9.2418-2425.1998
   GOLDSTEIN SF, 1988, CELL MOTIL CYTOSKEL, V9, P101, DOI 10.1002/cm.970090202
   GOLDSTEIN SF, 1990, P NATL ACAD SCI USA, V87, P4895, DOI 10.1073/pnas.87.13.4895
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   ISAACS RD, 1989, INFECT IMMUN, V57, P3403, DOI 10.1128/IAI.57.11.3403-3411.1989
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Kan WX, 2007, BIOPHYS J, V93, P54, DOI 10.1529/biophysj.106.103143
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12
   Li CH, 2000, J MOL MICROB BIOTECH, V2, P345
   Li CH, 2000, J BACTERIOL, V182, P6698, DOI 10.1128/JB.182.23.6698-6706.2000
   Li C, 2008, J BACTERIOL, V190, P5607, DOI 10.1128/JB.00319-08
   Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253
   Limberger RJ, 2004, J MOL MICROB BIOTECH, V7, P30, DOI 10.1159/000077867
   Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020
   Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11
   Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110
   Macnab R. M., 1996, ESCHERICHIA COLI SAL, P123
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797
   Motaleb MA, 2004, J BACTERIOL, V186, P3703, DOI 10.1128/JB.186.12.3703-3711.2004
   Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08
   Nakamura S, 2014, BIOPHYS J, V106, P47, DOI 10.1016/j.bpj.2013.11.1118
   Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003
   NAUMAN RK, 1969, J BACTERIOL, V98, P264, DOI 10.1128/JB.98.1.264-280.1969
   Noguchi H, 1917, J EXP MED, V25, P755, DOI 10.1084/jem.25.5.755
   Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x
   Picardeau M, 2008, APPL ENVIRON MICROB, V74, P319, DOI 10.1128/AEM.02172-07
   Picardeau M, 2015, CURR TOP MICROBIOL, V387, P43, DOI 10.1007/978-3-662-45059-8_4
   Raddi G, 2012, J BACTERIOL, V194, P1299, DOI 10.1128/JB.06474-11
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07
   SIMPSON CF, 1964, J INFECT DIS, V114, P69, DOI 10.1093/infdis/114.1.69
   Stimson AM, 1907, PUBLIC HEALTH REP, V22, P541, DOI 10.2307/4559008
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   TRUEBA GA, 1992, J BACTERIOL, V174, P4761, DOI 10.1128/JB.174.14.4761-4768.1992
   Wolgemuth CW, 2006, J MOL MICROB BIOTECH, V11, P221, DOI 10.1159/000094056
   Yang J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.268101
NR 56
TC 28
Z9 28
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD AUG
PY 2016
VL 101
IS 3
BP 457
EP 470
DI 10.1111/mmi.13403
PG 14
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA DU9MQ
UT WOS:000382542200007
PM 27113476
OA Green Accepted
DA 2020-11-30
ER

PT J
AU Wunder, EA
   Figueira, CP
   Santos, GR
   Lourdault, K
   Matthias, MA
   Vinetz, JM
   Ramos, E
   Haake, DA
   Picardeau, M
   dos Reis, MG
   Ko, AI
AF Wunder, Elsio A., Jr.
   Figueira, Claudio P.
   Santos, Gisele R.
   Lourdault, Kristel
   Matthias, Michael A.
   Vinetz, Joseph M.
   Ramos, Eduardo
   Haake, David A.
   Picardeau, Mathieu
   dos Reis, Mitermayer G.
   Ko, Albert I.
TI Real-Time PCR Reveals Rapid Dissemination of Leptospira interrogans
   after Intraperitoneal and Conjunctival Inoculation of Hamsters
SO INFECTION AND IMMUNITY
LA English
DT Article
ID RENAL COLONIZATION; INFECTION; VIRULENCE; PATHOGEN; ICTEROHAEMORRHAGIAE;
   DISEASE; GROWTH; MODEL; EPIDEMIC; POMONA
AB The pathogen Leptospira interrogans is a highly motile spirochete that causes acute and fulminant infections in humans and other accidental hosts. Hematogenous dissemination is important for infection by the pathogen but remains poorly understood because few animal model studies have used sensitive tools to quantify the bacteria. We evaluated the kinetics of leptospiral infection in Golden Syrian hamsters by a sensitive quantitative real-time PCR (TaqMan) with lipl32 as the target gene. The dissemination and bacterial burden were measured after intraperitoneal infection with a high dose (10(8)) or low dose (2.5 x 10(2)) of leptospires. We also examined the conjunctival challenge route to mimic the natural history of infection. Quantification of leptospires in perfused animals revealed that pathogens were detected in all organs of intraperitoneally infected hamsters, including the eye and brain, within 1 h after inoculation of 10(8) virulent L. interrogans bacteria. Peaks of 10(5) to 10(8) leptospires per gram or per milliliter were achieved in blood and all tissues between day 4 and day 8 after intraperitoneal inoculation of high- and low-dose challenges, respectively, coinciding with macroscopic and histological changes. The conjunctival route resulted in a delay in the time to peak organ burden in comparison to intraperitoneal infection, indicating that although infection could be established, penetration efficiency was low across this epithelial barrier. Surprisingly, infection with a large inoculum of high-passage-number attenuated L. interrogans strains resulted in dissemination to all organs in the first 4 days postinfection, albeit with a lower burden, followed by clearance from the blood and organs 7 days postinfection and survival of all animals. These results demonstrate that leptospiral dissemination and tissue invasion occur. In contrast, development of a critical level of tissue burden and pathology are dependent on the virulence of the infecting strain.
C1 [Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis Div, New Haven, CT USA.
   [Wunder, Elsio A., Jr.; Figueira, Claudio P.; Santos, Gisele R.; Ramos, Eduardo; dos Reis, Mitermayer G.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Lourdault, Kristel; Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, Paris, France.
   [Lourdault, Kristel; Haake, David A.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90024 USA.
   [Matthias, Michael A.; Vinetz, Joseph M.] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA.
RP Wunder, EA (corresponding author), Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis Div, New Haven, CT USA.; Wunder, EA (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
EM elsio.wunder@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511; lourdault, kristel/0000-0003-2875-5918
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI034431, R01 AI052473, U01
   AI0088752, R25 TW009338, R01 TW009504, D43 TW00919]; CNPq/BrazilNational
   Council for Scientific and Technological Development (CNPq); FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, R25TW009338, R25TW009338, R25TW009338,
   D43TW000919, R25TW009338, R25TW009338, R01TW009504, R25TW009338,
   D43TW000919, R25TW009338, D43TW000919, R25TW009338, D43TW000919,
   R01TW009504, R25TW009338, R25TW009338, D43TW000919, D43TW000919,
   R25TW009338, D43TW000919, R01TW009504, R01TW009504, R25TW009338,
   R01TW009504] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863, UL1TR001863,
   UL1TR001863, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [K24AI068903, R01AI034431, R01AI121207, R01AI034431, K24AI068903,
   R01AI052473, K24AI068903, U01AI088752, R01AI052473, R01AI052473,
   R01AI034431, U01AI088752, R01AI121207, R01AI034431, R01AI034431,
   U01AI088752, R01AI034431, R01AI052473, R01AI034431, R01AI052473,
   R01AI052473, R01AI034431, R01AI034431, U01AI088752, R01AI034431,
   R01AI052473, R01AI052473, R01AI034431, R01AI052473, K24AI068903,
   R01AI121207, U01AI088752, R01AI052473, U01AI088752, K24AI068903,
   R01AI034431, K24AI068903, R01AI121207, R01AI034431, K24AI068903,
   K24AI068903, R01AI052473, K24AI068903, K24AI068903] Funding Source: NIH
   RePORTER; Veterans AffairsUS Department of Veterans Affairs
   [I01BX002003, I01BX002003, I01BX002003, I01BX002003, I01BX002003,
   I01BX002003] Funding Source: NIH RePORTER
FX This work, including the efforts of David A. Haake, was funded by NIH
   (R01 AI034431). This work, including the efforts of Albert Ko, was
   funded by NIH (R01 AI052473). This work, including the efforts of Albert
   Ko, was funded by NIH (U01 AI0088752). This work, including the efforts
   of Albert Ko, was funded by NIH (R25 TW009338). This work, including the
   efforts of Albert Ko, was funded by NIH (R01 TW009504). This work,
   including the efforts of Albert Ko, was funded by NIH (D43 TW00919).
   This work, including the efforts of Elsio Augusto Wunder, was funded by
   CNPq/Brazil (PhD Fellowship).
CR ADLER B, 1976, INFECT IMMUN, V14, P703, DOI 10.1128/IAI.14.3.703-708.1976
   Adler B, 2015, CURR TOP MICROBIOL, V387, P1, DOI 10.1007/978-3-662-45059-8_1
   Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035
   Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012
   Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bolin CA, 2001, AM J VET RES, V62, P995, DOI 10.2460/ajvr.2001.62.995
   Bourhy P, 2014, INT J SYST EVOL MICR, V64, P4061, DOI 10.1099/ijs.0.066597-0
   Brown PD, 2003, RES MICROBIOL, V154, P581, DOI 10.1016/S0923-2508(03)00166-9
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Coutinho ML, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003307
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P39
   Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102
   FAINE S, 1957, BRIT J EXP PATHOL, V38, P8
   FAINE S, 1957, BRIT J EXP PATHOL, V38, P1
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   GREEN JH, 1964, AM J VET RES, V25, P264
   GULATI OP, 1980, EXPERIENTIA, V36, P984, DOI 10.1007/BF01953835
   HAAKE DA, 2006, CURR PROTOC MICROBIO, pCH12
   Hochedez P, 2015, EMERG INFECT DIS, V21, P2221, DOI 10.3201/eid2112.141099
   Inada R, 1916, J EXP MED, V23, P377, DOI 10.1084/jem.23.3.377
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11
   Lourdault K, 2009, J MED MICROBIOL, V58, P648, DOI 10.1099/jmm.0.008169-0
   Marinho M, 2009, AM J TROP MED HYG, V80, P832, DOI 10.4269/ajtmh.2009.80.832
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011
   Ratet G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003359
   Romero EC, 1998, J CLIN MICROBIOL, V36, P1453, DOI 10.1128/JCM.36.5.1453-1455.1998
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Stoddard Robyn Anne, 2013, Methods Mol Biol, V943, P257, DOI 10.1007/978-1-60327-353-4_17
   THOMPSON JC, 1989, J COMP PATHOL, V101, P201, DOI 10.1016/0021-9975(89)90066-2
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Truccolo J, 2002, ANTIMICROB AGENTS CH, V46, P848, DOI 10.1128/AAC.46.3.848-853.2002
   Truccolo J, 2001, FEMS MICROBIOL LETT, V204, P317, DOI 10.1111/j.1574-6968.2001.tb10904.x
   VANDENINGH TSGAM, 1986, VET MICROBIOL, V12, P367, DOI 10.1016/0378-1135(86)90086-6
NR 43
TC 31
Z9 30
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD JUL
PY 2016
VL 84
IS 7
BP 2105
EP 2115
DI 10.1128/IAI.00094-16
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DP5IO
UT WOS:000378529700018
PM 27141082
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Weaver, SC
   Costa, F
   Garcia-Blanco, MA
   Ko, AI
   Ribeiro, GS
   Saade, G
   Shi, PY
   Vasilakis, N
AF Weaver, Scott C.
   Costa, Federico
   Garcia-Blanco, Mariano A.
   Ko, Albert I.
   Ribeiro, Guilherme S.
   Saade, George
   Shi, Pei-Yong
   Vasilakis, Nikos
TI Zika virus: History, emergence, biology, and prospects for control
SO ANTIVIRAL RESEARCH
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; AEDES-AEGYPTI; POTENTIAL VECTOR; DENGUE VIRUS;
   YELLOW-FEVER; HOST FACTORS; PUERTO-RICO; INFECTION; MOSQUITOS; BRAZIL
AB Zika virus (ZIKV), a previously obscure flavivirus closely related to dengue, West Nile, Japanese encephalitis and yellow fever viruses, has emerged explosively since 2007 to cause a series of epidemics in Micronesia, the South Pacific, and most recently the Americas. After its putative evolution in sub-Saharan Africa, ZIKV spread in the distant past to Asia and has probably emerged on multiple occasions into urban transmission cycles involving Aedes (Stegomyia) spp. mosquitoes and human amplification hosts, accompanied by a relatively mild dengue-like illness. The unprecedented numbers of people infected during recent outbreaks in the South Pacific and the Americas may have resulted in enough ZIKV infections to notice relatively rare congenital microcephaly and Guillain-Barre syndromes. Another hypothesis is that phenotypic changes in Asian lineage ZIKV strains led to these disease outcomes. Here, we review potential strategies to control the ongoing outbreak through vector-centric approaches as well as the prospects for the development of vaccines and therapeutics. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Microbiol & Immunol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Costa, Federico; Ko, Albert I.; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Garcia-Blanco, Mariano A.; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Saade, George] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Ko, Albert Icksang/P-2343-2015; Ribeiro, Guilherme/B-6624-2008; Costa,
   Federico/G-1838-2015; Vasilakis, Nikos/ABE-7318-2020; Weaver, Scott
   C/D-6490-2011
OI Ko, Albert Icksang/0000-0001-9023-2339; Ribeiro,
   Guilherme/0000-0002-6798-2059; Costa, Federico/0000-0001-6951-2336;
   Weaver, Scott C/0000-0001-8016-8556; Garcia-Blanco,
   Mariano/0000-0001-8538-1997
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI120942, AI093491, AI121207];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI093491, R24AI120942, R24AI120942, R01AI121207, R01AI121207,
   R01AI093491, R01AI121207, R01AI093491, R24AI120942, R24AI120942,
   R01AI121207, R01AI121207, R01AI093491, R24AI120942, R24AI120942] Funding
   Source: NIH RePORTER
FX The authors' research on Zika virus is supported by NIH grants AI120942
   and AI093491 to SCW, and AI121207 to AIK.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Atkinson B, 2016, EMERG INFEC IN PRESS
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrows NJ, 2014, METHODS MOL BIOL, V1138, P285, DOI 10.1007/978-1-4939-0348-1_18
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V. M., 2016, LANCET
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Committee S. P., 2016, AM J OBSTET GYNECOL
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Cornet M., 1979, ORSTOM ENTOMOL MED P, V17, P149
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   de Paula Freitas B., 2016, JAMA OPHTHALMOL BRAZ
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria N. R., 2016, SCI ONLINE
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Garcia-Blanco MA, 2015, RNA, V21, P525, DOI 10.1261/rna.050138.115
   Garg RK, 2015, NEUROL INDIA, V63, P497, DOI 10.4103/0028-3886.161990
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler D J, 1987, P R Health Sci J, V6, P107
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanley KA, 2013, INFECT GENET EVOL
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Horwood P, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/WPSAR.2013.4.2.003, 10.5365/wpsar.2013.4.2.003]
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marrs C, 2016, AM J PERINATOL
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McGee CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023247
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen E., 2016, INT J INFECT DIS IJI
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Simon O, 2016, J CLIN VIROL, V77, P29, DOI 10.1016/j.jcv.2016.01.016
   Tang H, 2016, CELL STEM CELL
   Taucher C, 2010, J VIROL, V84, P599, DOI 10.1128/JVI.01063-09
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 78
TC 341
Z9 349
U1 8
U2 295
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2016
VL 130
BP 69
EP 80
DI 10.1016/j.antiviral.2016.03.010
PG 12
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA DM2ZW
UT WOS:000376217600009
PM 26996139
OA Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Hacker, KP
   Minter, A
   Begon, M
   Diggle, PJ
   Serrano, S
   Reis, MG
   Childs, JE
   Ko, AI
   Costa, F
AF Hacker, Kathryn P.
   Minter, Amanda
   Begon, Mike
   Diggle, Peter J.
   Serrano, Soledad
   Reis, Mitermayer G.
   Childs, James E.
   Ko, Albert I.
   Costa, Federico
TI A comparative assessment of track plates to quantify fine scale
   variations in the relative abundance of Norway rats in urban slums
SO URBAN ECOSYSTEMS
LA English
DT Article
DE Indirect abundance; Rattus norvegicus; Track plates; Urban slum;
   Zero-inflated; Zoonotic diseases
ID RATTUS-NORVEGICUS; LEPTOSPIRA-INTERROGANS; RODENT POPULATIONS; SMALL
   MAMMALS; BRAZIL; ENVIRONMENT; EPIDEMIC; ECOLOGY; FIELD; RISK
AB Norway rats (Rattus norvegicus) living in urban environments are a critical public health and economic problem, particularly in urban slums where residents are at a higher risk for rat borne diseases, yet convenient methods to quantitatively assess population sizes are lacking. We evaluated track plates as a method to determine rat distribution and relative abundance in a complex urban slum environment by correlating the presence and intensity of rat-specific marks on track plates with findings from rat infestation surveys and trapping of rats to population exhaustion. To integrate the zero-inflated track plate data we developed a two-component mixture model with one binary and one censored continuous component. Track plate mark-intensity was highly correlated with signs of rodent infestation (all coefficients between 0.61 and 0.79 and all p-values < 0.05). Moreover, the mean level of pre-trapping rat-mark intensity on plates was significantly associated with the number of rats captured subsequently (Odds ratio1.38; 95 % CI 1.19-1.61) and declined significantly following trapping (Odds ratio 0.86; 95 % CI 0.78-0.95). Track plates provided robust proxy measurements of rat abundance and distribution and detected rat presence even when populations appeared 'trapped out'. Tracking plates are relatively easy and inexpensive methods that can be used to intensively sample settings such as urban slums, where traditional trapping or mark-recapture studies are impossible to implement, and therefore the results can inform and assess the impact of targeted urban rodent control campaigns.
C1 [Hacker, Kathryn P.; Diggle, Peter J.; Childs, James E.; Ko, Albert I.; Costa, Federico] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06511 USA.
   [Minter, Amanda; Begon, Mike; Diggle, Peter J.; Costa, Federico] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.
   [Serrano, Soledad] Univ Fed Bahia, Inst Biol, UFBA, BR-40110040 Salvador, BA, Brazil.
   [Reis, Mitermayer G.; Ko, Albert I.; Costa, Federico] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Reis, Mitermayer G.; Ko, Albert I.; Costa, Federico] Univ Fed Bahia, Inst Saude Colet, UFBA, BR-40110040 Salvador, BA, Brazil.
RP Costa, F (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06511 USA.; Costa, F (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.; Costa, F (corresponding author), Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.; Costa, F (corresponding author), Univ Fed Bahia, Inst Saude Colet, UFBA, BR-40110040 Salvador, BA, Brazil.
EM federico.costa@ufba.br
RI Costa, Federico/G-1838-2015; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020
OI Costa, Federico/0000-0001-6951-2336; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060; ,
   Amanda/0000-0003-1171-5688; Hacker, Kathryn/0000-0001-5267-1699; Diggle,
   Peter/0000-0003-3521-5020
FU Oswaldo Cruz Foundation; Secretariat of Health Surveillance, Brazilian
   Ministry of Health; Yale Institute for Biospheric Studies Doctoral
   Dissertation Improvement program; Fulbright Fellowship program; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [F31 AI114245, R01
   AI052473, U01 AI088752, R01 TW009504, R25 TW009338]; Wellcome
   TrustWellcome Trust [102330/Z/ 13/Z]; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [R25TW009338,
   R01TW009504, R25TW009338, R01TW009504, R01TW009504, R25TW009338,
   R25TW009338, R01TW009504, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R01TW009504, R25TW009338] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI121207, R01AI121207,
   F31AI114245, F31AI114245, U01AI088752, R01AI052473, R01AI121207,
   U01AI088752, U01AI088752, R01AI121207, R01AI052473, U01AI088752,
   R01AI052473, R01AI052473, R01AI052473, U01AI088752, U01AI088752,
   R01AI052473, R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX We would like to thank team member from Oswaldo Cruz Foundation, Iohama
   Paim, Arsinoe Pertile as well as the Zoonosis Control Center Luciano
   Souza Lima, Lucineide Xavier, and Sheila Cova who participated in the
   data collection for the study. We would also like to thank Nivison Nery
   Jr. for their assistance with database processing and management and
   Steven Belmain for his advice in designing the study. This work could
   not be accomplished without the joint collaborative effort of the
   resident associations, community leaders and residents, which constitute
   the Urban Health Council of Pau da Lima. We would like to thank the
   Global Leptospirosis Environmental Action Network (GLEAN). This work was
   supported by the Oswaldo Cruz Foundation and Secretariat of Health
   Surveillance, Brazilian Ministry of Health, the Yale Institute for
   Biospheric Studies Doctoral Dissertation Improvement program, the
   Fulbright Fellowship program, the National Institutes of Health (grants
   F31 AI114245, R01 AI052473, U01 AI088752, R01 TW009504, and R25
   TW009338) and by the Wellcome Trust [102330/Z/ 13/Z].
CR Allen LR, 2014, ENV SCI POLLUT RES I, DOI 10.1007/s11356-014-3567-3
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Borchers D. L., 2002, ESTIMATING ANIMAL AB
   Brazil, 2005, EP SURV INF DIS
   BROWN LE, 1969, OECOLOGIA, V2, P198, DOI 10.1007/BF00379159
   Cavia R, 2009, LANDSCAPE URBAN PLAN, V90, P11, DOI 10.1016/j.landurbplan.2008.10.017
   CDC, 2006, INT PEST MAN COND UR, V50
   CHILDS JE, 1995, AM J TROP MED HYG, V52, P393, DOI 10.4269/ajtmh.1995.52.393
   Conceicao KS, 2013, BIOMETRICAL J, V55, P661, DOI 10.1002/bimj.201100175
   Connors MJ, 2005, J MAMMAL, V86, P991, DOI 10.1644/1545-1542(2005)86[991:UOTPTQ]2.0.CO;2
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   DAVIS DE, 1953, Q REV BIOL, V28, P373, DOI 10.1086/399860
   DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387
   Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305
   de Masi E, 2009, INT J ENVIRON HEAL R, V19, P291, DOI 10.1080/09603120802592723
   DICKMAN CR, 1986, J ZOOL, V210, P631
   Drennan JE, 1998, J MAMMAL, V79, P352, DOI 10.2307/1382872
   Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x
   EMLEN JT, 1949, ECOLOGY, V30, P430, DOI 10.2307/1932446
   Engeman RM, 2000, PROC VERTEBR PEST C, P183
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x
   GLASS GE, 1988, J MAMMAL, V69, P587, DOI 10.2307/1381350
   Glass GE, 1997, AM J TROP MED HYG, V56, P359, DOI 10.4269/ajtmh.1997.56.359
   Glennon MJ, 2002, J MAMMAL, V83, P734, DOI 10.1644/1545-1542(2002)083<0734:AAFTFE>2.0.CO;2
   Villafane IEG, 2013, MAMMALIA, V77, P187, DOI 10.1515/mammalia-2012-0075
   Himsworth CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091654
   Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270
   Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195
   Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Krojgaard LH, 2009, EPIDEMIOL INFECT, V137, P1586, DOI 10.1017/S0950268809002647
   Lambert D, 1992, AM STAT ASS AM SOC Q, V34, P1, DOI DOI 10.2307/1269547
   Lambropoulos AS, 1999, J ENVIRON HEALTH, V61, P12
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lord R D, 1983, Bull Pan Am Health Organ, V17, P259
   LORD RD, 1971, AM J TROP MED HYG, V20, P338, DOI 10.4269/ajtmh.1971.20.338
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Maskey M, 2006, Indian J Med Microbiol, V24, P337
   McKelvey KS, 2001, CAN J ZOOL, V79, P1754, DOI 10.1139/cjz-79-10-1754
   Mills JN, 1998, EMERG INFECT DIS, V4, P529, DOI 10.3201/eid0404.980403
   Mills JN, 1995, METHODS TRAPPING SAM
   Nams VO, 2003, J MAMMAL, V84, P1374, DOI 10.1644/BEH-001
   Porter FH, 2015, J MAMMAL, V96, P317, DOI 10.1093/jmammal/gyv033
   Promkerd P, 2008, INTEGR ZOOL, V3, P11, DOI 10.1111/j.1749-4877.2008.00069.x
   QUY RJ, 1993, WILDLIFE SOC B, V21, P122
   Quy RJ, 1994, PRED OUTC ROD TRIALS, V16, P133
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Riley LW, 2007, BMC INT HLTH HUMAN R, V7
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   SHEPPE W, 1967, AM MIDL NAT, V78, P471, DOI 10.2307/2485244
   SHEPPE W, 1965, ECOLOGY, V46, P630, DOI 10.2307/1935002
   Sherpherd DS, 1984, VERT PEST C U NEBR L
   SMITH L, 1963, PUBLIC HEALTH REP, V78, P807, DOI 10.2307/4591943
   TAYLOR CA, 1988, CALIF FISH GAME, V74, P4
   Welsh AH, 1996, ECOL MODEL, V88, P297, DOI 10.1016/0304-3800(95)00113-1
   Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1
   Whisson DA, 2005, WILDLIFE RES, V32, P239, DOI 10.1071/WR03128
NR 61
TC 11
Z9 12
U1 1
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1083-8155
EI 1573-1642
J9 URBAN ECOSYST
JI Urban Ecosyst.
PD JUN
PY 2016
VL 19
IS 2
BP 561
EP 575
DI 10.1007/s11252-015-0519-8
PG 15
WC Biodiversity Conservation; Ecology; Environmental Sciences; Urban
   Studies
SC Biodiversity & Conservation; Environmental Sciences & Ecology; Urban
   Studies
GA DV1HF
UT WOS:000382671000003
PM 27453682
OA Green Accepted
DA 2020-11-30
ER

PT J
AU Jones, FK
   Ko, AI
   Becha, C
   Joshua, C
   Musto, J
   Thomas, S
   Ronsse, A
   Kirkwood, CD
   Sio, A
   Aumua, A
   Nilles, EJ
AF Jones, Forrest K.
   Ko, Albert I.
   Becha, Chris
   Joshua, Cynthia
   Musto, Jennie
   Thomas, Sarah
   Ronsse, AxeIle
   Kirkwood, Carl D.
   Sio, Alison
   Aumua, Audrey
   Nilles, Eric J.
TI Increased Rotavirus Prevalence in Diarrheal Outbreak Precipitated by
   Localized Flooding, Solomon Islands, 2014
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB Flooding on 1 of the Solomon Islands precipitated a nationwide epidemic of diarrhea that spread to regions unaffected by flooding and caused >6,000 cases and 27 deaths. Rotavirus was identified in 38% of case-patients tested in the city with the most flooding. Outbreak potential related to weather reinforces the need for global rotavirus vaccination.
C1 [Jones, Forrest K.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Becha, Chris; Joshua, Cynthia; Sio, Alison] Solomon Isl Minist Hlth & Med Serv, Honiara, Solomon Islands.
   [Joshua, Cynthia; Musto, Jennie; Aumua, Audrey] World Hlth Org, Honiara, Fiji.
   [Musto, Jennie; Ronsse, AxeIle; Nilles, Eric J.] World Hlth Org, Suva, Fiji.
   [Thomas, Sarah; Kirkwood, Carl D.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.
   [Kirkwood, Carl D.] La Trobe Univ, Melbourne, Vic, Australia.
RP Nilles, EJ (corresponding author), World Hlth Org, Div Pacific Tech Support, Emerging Dis Surveillance & Response, POB 113, Suva, Fiji.
EM nillese@who.int
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Nilles, Eric/0000-0001-7044-5257
FU Wilbur G. Downs Fellowship; Coca-Cola World Fund at Yale University;
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 TW009504];
   Victorian Government's Operational Infrastructure Support Program;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207, R01AI121207]
   Funding Source: NIH RePORTER
FX Support for the study was provided by the Wilbur G. Downs Fellowship,
   the Coca-Cola World Fund at Yale University, and National Institutes of
   Health (R01 TW009504). We would like to thank Lavoni Tavoto, Adrian
   Simbe, the National Referral Hospital Laboratory, the Solomon Islands
   Red Cross, and Medecins Sans Frontieres for providing assistance with
   data collection and analysis. We also thank Virginia Pitzer, Jordan
   Emont, Aref Senno, Georgiana Green, and Soledad Colombe for their
   valuable insights on study design, analysis and revision and Losalini
   Vakasavuwaqa for administrative support.; The research at MCRI was
   supported by the Victorian Government's Operational Infrastructure
   Support Program. C.D. Kirkwood is director of Australian Rotavirus
   Surveillance Program and WHO Rotavirus Regional Reference laboratory and
   Collaborating Centre for Health (Rotavirus).
CR [Anonymous], 2013, Wkly Epidemiol Rec, V88, P49
   Bilve A, 2014, B WORLD HEALTH ORGAN, V92, P844, DOI 10.2471/BLT.13.133512
   Black RE, 1984, POPUL DEV REV, V10, P141, DOI 10.2307/2807959
   Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653
   Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452
   Cowley D, 2013, EMERG INFECT DIS, V19, P1324, DOI [10.3201/eid1908.121653, 10.3201/eid.1908.121653]
   Kim J, 2014, ANN LAB MED, V34, P216, DOI 10.3343/alm.2014.34.3.216
   Kool JL, 2012, GLOB PUBLIC HEALTH, V7, P670, DOI 10.1080/17441692.2012.699536
   National Oceanic and Atmospheric Administration, GLOB SURF SUMM DAY G
   Office for the Coordination of Humanitarian Affairs Regional Office for the Pacific, 2014, 4 UN OFF COORD HUM A
   Pachauri R.K., 2014, CLIMATE CHANGE 2014
   Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779
   WHO, 2012, OUTBR SURV RESP HUM
NR 13
TC 14
Z9 14
U1 0
U2 4
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2016
VL 22
IS 5
BP 875
EP 879
DI 10.3201/eid2205.151743
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DK2DZ
UT WOS:000374726100016
PM 27088272
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Castiblanco-Valencia, MM
   Fraga, TR
   Breda, LCD
   Vasconcellos, SA
   Figueira, CP
   Picardeau, M
   Wunder, E
   Ko, AI
   Barbosa, AS
   Isaac, L
AF Castiblanco-Valencia, Monica M.
   Fraga, Tatiana R.
   Breda, Leandro C. D.
   Vasconcellos, Silvio A.
   Figueira, Claudio P.
   Picardeau, Mathieu
   Wunder, Elsio
   Ko, Albert I.
   Barbosa, Angela S.
   Isaac, Lourdes
TI Acquisition of negative complement regulators by the saprophyte
   Leptospira biflexa expressing LigA or LigB confers enhanced survival in
   human serum
SO IMMUNOLOGY LETTERS
LA English
DT Article
DE Leptospira; Complement; Immune evasion; Lig proteins; Factor H; C4BP
ID IMMUNOGLOBULIN-LIKE PROTEIN; PATHOGENIC LEPTOSPIRA; FACTOR-H;
   ANTILEPTOSPIRAL ACTIVITY; PROTECTIVE IMMUNITY; BINDING-PROTEIN; C3B
   INACTIVATOR; INTERROGANS; FIBRONECTIN; INFECTION
AB Leptospiral immunoglobulin-like (Lig) proteins are surface exposed molecules present in pathogenic but not in saprophytic Leptospira species. We have previously shown that Lig proteins interact with the soluble complement regulators Factor H (FH), FH like-1 (FHL-1), FH related-1 (FHR-1) and C4b Binding Protein (C4BP). In this study, we used the saprophyte L. biflexa serovar Patoc as a surrogate host to address the specific role of LigA and LigB proteins in leptospiral complement evasion. L biflexa expressing LigA or LigB was able to acquire FH and C4BP. Bound complement regulators retained their cofactor activities of Fl in the proteolytic cleavage of C3b and C4b. Moreover, heterologous expression of ligA and ligB genes in the saprophyte L. biflexa enhanced bacterial survival in human serum. Complement deposition on lig-transformed L biflexa was assessed by flow cytometry analysis. With regard to MAC deposition, L. biflexa expressing LigA or LigB presented an intermediate profile: MAC deposition levels were greater than those found in the pathogenic L. interrogans, but lower than those observed for L. biflexa wildtype. In conclusion, Lig proteins contribute to in vitro control of complement activation on the leptospiral surface, promoting an increased bacterial survival in human serum. (C) 2016 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.
C1 [Castiblanco-Valencia, Monica M.; Fraga, Tatiana R.; Breda, Leandro C. D.; Isaac, Lourdes] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.
   [Vasconcellos, Silvio A.] Univ Sao Paulo, Fac Vet Med, Sao Paulo, Brazil.
   [Figueira, Claudio P.; Ko, Albert I.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Picardeau, Mathieu] Inst Pasteur, Biol Spirochetes Unit, Paris, France.
   [Wunder, Elsio; Ko, Albert I.] Yale Univ, EUA, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Barbosa, Angela S.] Butantan Inst, Bacteriol Lab, Sao Paulo, Brazil.
RP Isaac, L (corresponding author), Av Prof Lineu Prestes 1730, BR-05508900 Sao Paulo, SP, Brazil.
EM louisaac@icb.usp.br
RI Wunder, Elsio Augusto/C-2733-2013; Barbosa, Angela S/I-3518-2013; Breda,
   Leandro C D/C-1552-2018; Breda, Leandro/A-8458-2015; Ko, Albert
   Icksang/P-2343-2015; FRAGA, TATIANA RODRIGUES/ABD-8152-2020
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Barbosa, Angela
   S/0000-0002-6458-9489; Breda, Leandro C D/0000-0001-9556-1676; Breda,
   Leandro/0000-0001-9556-1676; Ko, Albert Icksang/0000-0001-9023-2339;
   Isaac, Lourdes/0000-0002-7746-8942; Rodrigues Fraga,
   Tatiana/0000-0002-5896-5994
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/50043-0,
   2015/09972-0]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01AI088752, R01AI121207, R01AI121207,
   U01AI088752, R01AI121207, U01AI088752, U01AI088752, R01AI121207,
   R01AI121207, U01AI088752, U01AI088752] Funding Source: NIH RePORTER
FX The authors do not have a commercial or other association that might
   pose a conflict of interest. This work was supported by the
   Grants2010/50043-0 and 2015/09972-0 from Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo (FAPESP).
CR Barbosa AS, 2010, INFECT IMMUN, V78, P3207, DOI 10.1128/IAI.00279-10
   Barbosa AS, 2009, INFECT IMMUN, V77, P1137, DOI 10.1128/IAI.01310-08
   Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   da Silva LB, 2015, INFECT IMMUN, V83, P888, DOI 10.1128/IAI.02844-14
   Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029
   Figueira CP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-129
   Fraga TR, 2011, SCAND J IMMUNOL, V73, P408, DOI 10.1111/j.1365-3083.2010.02505.x
   Fraga TR, 2014, J INFECT DIS, V209, P876, DOI 10.1093/infdis/jit569
   GIGLI I, 1979, P NATL ACAD SCI USA, V76, P6596, DOI 10.1073/pnas.76.12.6596
   Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x
   JOHNSON RC, 1965, J BACTERIOL, V89, P1625, DOI 10.1128/JB.89.6.1625-1626.1965
   JOHNSON RC, 1967, J BACTERIOL, V93, P513, DOI 10.1128/JB.93.2.513-519.1967
   Lin XP, 2008, J VET SCI, V9, P133
   Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200
   Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196
   Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301
   Lin YP, 2009, BIOCHEM BIOPH RES CO, V389, P57, DOI 10.1016/j.bbrc.2009.08.089
   Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369
   Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06
   McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012
   Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257
   Pappas CJ, 2015, APPL ENVIRON MICROB, V81, P7888, DOI 10.1128/AEM.02202-15
   Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   SCHARFSTEIN J, 1978, J EXP MED, V148, P207, DOI 10.1084/jem.148.1.207
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188
   Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006
   WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268
   WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147
NR 38
TC 12
Z9 11
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2478
EI 1879-0542
J9 IMMUNOL LETT
JI Immunol. Lett.
PD MAY
PY 2016
VL 173
BP 61
EP 68
DI 10.1016/j.imlet.2016.03.005
PG 8
WC Immunology
SC Immunology
GA DL6GN
UT WOS:000375737800008
PM 26976804
OA Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Freitas, BD
   Dias, JRD
   Prazeres, J
   Sacramento, GA
   Ko, AI
   Maia, M
   Belfort, R
AF Freitas, Bruno de Paula
   de Oliveira Dias, Joao Rafael
   Prazeres, Juliana
   Sacramento, Gielson Almeida
   Ko, Albert Icksang
   Maia, Mauricio
   Belfort, Rubens, Jr.
TI Ocular Findings in Infants With Microcephaly Associated With Presumed
   Zika Virus Congenital Infection in Salvador, Brazil
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID FRENCH-POLYNESIA; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION;
   DECEMBER 2013; DENGUE; PREGNANCY; OUTBREAK; OUTCOMES; FEVER
AB IMPORTANCE The Zika virus (ZIKV) has rapidly reached epidemic proportions, especially in northeastern Brazil, and has rapidly spread to other parts of the Americas. A recent increase in the prevalence of microcephaly in newborn infants and vision-threatening findings in these infants is likely associated with the rapid spread of ZIKV.
   OBJECTIVE To evaluate the ocular findings in infants with microcephaly associated with presumed intrauterine ZIKV infection in Salvador, Bahia, Brazil.
   DESIGN, SETTING, AND PARTICIPANTS Case series at a tertiary hospital. Twenty-nine infants with microcephaly (defined by a cephalic circumference of <= 32 cm) with a presumed diagnosis of congenital ZIKV were recruited through an active search and referrals from other hospitals and health unities. The study was conducted between December 1 and December 21, 2015.
   INTERVENTIONS All infants and mothers underwent systemic and ophthalmic examinations from December 1 through December 21, 2015, in the Roberto Santos General Hospital, Salvador, Brazil. Anterior segment and retinal, choroidal, and optic nerve abnormalities were documented using a wide-field digital imaging system. The differential diagnosis included toxoplasmosis, rubella, cytomegalovirus, herpes simplex virus, syphilis, and human immunodeficiency virus, which were ruled out through serologic and clinical examinations.
   MAIN OUTCOMES AND MEASURES Ocular abnormalities associated with ZIKV.
   RESULTS Twenty-three of 29 mothers (79.3%) reported suspected ZIKV infection signs and symptoms during pregnancy, 18 in the first trimester, 4 in the second trimester, and 1 in the third trimester. Of the 29 infants (58 eyes) examined (18 [62.1%] female), ocular abnormalities were present in 17 eyes (29.3%) of 10 children (34.5%). Bilateral findings were found in 7 of 10 patients presenting with ocular lesions, the most common of which were focal pigment mottling of the retina and chorioretinal atrophy in 11 of the 17 eyes with abnormalities (64.7%), followed by optic nerve abnormalities in 8 eyes (47.1%), bilateral iris coloboma in 1 patient (2 eyes [11.8%]), and lens subluxation in 1 eye (5.9%).
   CONCLUSIONS AND RELEVANCE Congenital infection due to presumed ZIKV exposure is associated with vision-threatening findings, which include bilateral macular and perimacular lesions as well as optic nerve abnormalities in most cases.
C1 [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
   [de Oliveira Dias, Joao Rafael; Prazeres, Juliana; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 822, BR-04023062 Sao Paulo, Brazil.
   [Sacramento, Gielson Almeida; Ko, Albert Icksang] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert Icksang] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 822, BR-04023062 Sao Paulo, Brazil.
EM clinbelf@uol.com.br
RI Maia, Mauricio/I-5892-2015; Ko, Albert Icksang/P-2343-2015; de Oliveira
   Dias, Joao/J-6735-2016
OI Maia, Mauricio/0000-0002-7034-8091; Ko, Albert
   Icksang/0000-0001-9023-2339; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Federal University of Sao Paulo (Paulista Medical School);
   Vision Institute (IPEPO); FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R01TW009504, R01TW009504,
   R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207] Funding Source: NIH
   RePORTER
FX Hospital Geral Roberto Santos provided the site and materials for
   ophthalmologic examination. Federal University of Sao Paulo (Paulista
   Medical School), Vision Institute (IPEPO), and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) provided funds for
   travel expenses as well as the materials necessary for the ocular
   examinations.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Centro de Operacoes de Emergencias em Saude Publica sobre Microcefalias, MON CAS MICR BRAS
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kelly JC, 2016, MEDSCAPE
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministerio da Saude, MICR 3174 CAS SAO IN
   Ministerio da Saude, NOT MED PER CEF DIAG
   Ministerio da Saude, MIN SAUD CONF REL EN
   Ministerio da Saude Secretaria de Vigilancia em Saude, PROT VIG RESP OC MIC
   Ministerio de Saude (MS), 2015, B EPIDEMIOL, V46, P1
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Stewart RD, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/351872
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   World Health Organization (WHO), EP AL NEUR SYNDR CON
   General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14, DOI 10.1001/jama.2013.281053
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 35
TC 136
Z9 140
U1 0
U2 97
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD MAY
PY 2016
VL 134
IS 5
BP 529
EP 535
DI 10.1001/jamaophthalmol.2016.0267
PG 7
WC Ophthalmology
SC Ophthalmology
GA DL7CB
UT WOS:000375796100014
PM 26865554
OA Green Published, Green Accepted, Bronze
DA 2020-11-30
ER

PT J
AU Alfaro-Murillo, JA
   Parpia, AS
   Fitzpatrick, MC
   Tamagnan, JA
   Medlock, J
   Ndeffo-Mbah, ML
   Fish, D
   Avila-Aguero, ML
   Marin, R
   Ko, AI
   Galvani, AP
AF Alfaro-Murillo, Jorge A.
   Parpia, Alyssa S.
   Fitzpatrick, Meagan C.
   Tamagnan, Jules A.
   Medlock, Jan
   Ndeffo-Mbah, Martial L.
   Fish, Durland
   Avila-Aguero, Maria L.
   Marin, Rodrigo
   Ko, Albert I.
   Galvani, Alison P.
TI A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID OUTBREAK
AB Background
   As Zika virus continues to spread, decisions regarding resource allocations to control the outbreak underscore the need for a tool to weigh policies according to their cost and the health burden they could avert. For example, to combat the current Zika outbreak the US President requested the allocation of $1.8 billion from Congress in February 2016.
   Methodology/Principal Findings
   Illustrated through an interactive tool, we evaluated how the number of Zika cases averted, the period during pregnancy in which Zika infection poses a risk of microcephaly, and probabilities of microcephaly and Guillain-Barre Syndrome (GBS) impact the cost at which an intervention is cost-effective. From Northeast Brazilian microcephaly incidence data, we estimated the probability of microcephaly in infants born to Zika-infected women (0.49% to 2.10%). We also estimated the probability of GBS arising from Zika infections in Brazil (0.02% to 0.06%) and Colombia (0.08%). We calculated that each microcephaly and GBS case incurs the loss of 29.95 DALYs and 1.25 DALYs per case, as well as direct medical costs for Latin America and the Caribbean of $91,102 and $28,818, respectively. We demonstrated the utility of our cost-effectiveness tool with examples evaluating funding commitments by Costa Rica and Brazil, the US presidential proposal, and the novel approach of genetically modified mosquitoes. Our analyses indicate that the commitments and the proposal are likely to be cost-effective, whereas the cost-effectiveness of genetically modified mosquitoes depends on the country of implementation.
   Conclusions/Significance
   Current estimates from our tool suggest that the health burden from microcephaly and GBS warrants substantial expenditures focused on Zika virus control. Our results justify the funding committed in Costa Rica and Brazil and many aspects of the budget outlined in the US president's proposal. As data continue to be collected, new parameter estimates can be customized in real-time within our user-friendly tool to provide updated estimates on cost-effectiveness of interventions and inform policy decisions in country-specific settings.
C1 [Alfaro-Murillo, Jorge A.; Parpia, Alyssa S.; Fitzpatrick, Meagan C.; Tamagnan, Jules A.; Ndeffo-Mbah, Martial L.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA.
   [Alfaro-Murillo, Jorge A.; Parpia, Alyssa S.; Fitzpatrick, Meagan C.; Ndeffo-Mbah, Martial L.; Fish, Durland; Ko, Albert I.; Galvani, Alison P.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Medlock, Jan] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.
   [Avila-Aguero, Maria L.] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Pediat Infect Dis Dept, San Jose, Costa Rica.
   [Marin, Rodrigo] Minist Salud, Programa Control Vectores, San Jose, Costa Rica.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [Galvani, Alison P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
RP Galvani, AP (corresponding author), Yale Univ, Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06520 USA.; Galvani, AP (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.; Galvani, AP (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
EM alison.galvani@yale.edu
RI Avila-Aguero, Maria L./AAK-5086-2020; Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Fitzpatrick,
   Meagan/0000-0002-5248-2668; Ndeffo Mbah, Martial/0000-0003-4158-7613
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIH U01 GM087719, U01
   GM105627]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI121207, R01AI121207, R01AI121207, R01AI121207,
   R01AI121207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [U01GM105627, U01GM105627,
   U01GM087719, U01GM087719, U01GM087719, U01GM105627, U01GM105627,
   U01GM087719, U01GM087719, U01GM087719, U01GM105627, U01GM087719,
   U01GM087719, U01GM087719, U01GM087719, U01GM087719] Funding Source: NIH
   RePORTER
FX This research was supported by the National Institutes of Health (NIH
   U01 GM087719 and U01 GM105627). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 2016, COUNTRIES TERRITORIE
   Boadle A., 2016, BRAZILS BNDES PROVID
   Brasil P, 2016, N ENGL J MED MASS ME
   Cao-Lormeau V. M., 2016, LANCET
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, ZIKA VIRUS IN THE UN
   Centers for Disease Control and Prevention, 2016, TRANSCRIPT FOR CDC T
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P57
   de Paula Freitas B, 2016, JAMA OPHTHALMOL
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, N ENGL J MED
   Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1
   Instituto Brasileiro de Geografia e Estatistica, 2014, ESTIMATIVAS DA POPUL
   Instituto Nacional de Salud, 2016, CONTEO CASOS ZIKA MU
   Ministerio da Saude Brasil, 2016, PREVENCAO E COMBATE
   Ministerio de Salud, 2016, ANALISIS DE SITUACIO
   National Birth Defects Prevention Network, 2013, STATE BIRTH DEFECTS
   Nembhard WN, 2001, TERATOLOGY, V64, P267, DOI 10.1002/tera.1073
   Notimerica, 2015, MAS DE 10 MILLONES D
   Rasmussen SA, 2016, N ENGL J MED
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Secretaria de Vigilancia em Saude, 2015, REPORT NO VERSAO 1 2
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   STANAWAY JD, 2013, LANCET INFECT DIS
   Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09
   The White House Office of the Press Secretary, 2016, THE WHITE HOUSE OFFI
   The World Bank, 2014, PURCHASING POWER PAR
   UN Population Division, 2015, 2015 REVISION OF WOR
   United States Department of Labor: Bureau of Labor Statistics, 2016, DATABASES TABLES CAL
   WHO, 2016, MICROCEPHALY PANAMA
   World Development Indicators, 2013, BIRTH RATE CRUDE PER
   World Health Organization, 2010, CHOOSING INTERVENTIO
   World Health Organization, 2016, EMERGENCIES PREPARED
   World Health Organization, 2016, EMERGENCIES ZIKA VIR
   World Health Organization, 2016, WHO DIRECTOR GENERAL
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 39
TC 30
Z9 30
U1 0
U2 51
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2016
VL 10
IS 5
AR e0004743
DI 10.1371/journal.pntd.0004743
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DO4QY
UT WOS:000377769300070
PM 27205899
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Panti-May, JA
   Carvalho-Pereira, TSA
   Serrano, S
   Pedra, GG
   Taylor, J
   Penile, AC
   Minter, A
   Airam, V
   Carvalho, M
   Junior, NN
   Rodrigues, G
   Reis, MG
   Ko, AI
   Childs, JE
   Begon, M
   Costa, F
AF Panti-May, Jesus A.
   Carvalho-Pereira, Ticiana S. A.
   Serrano, Soledad
   Pedra, Gabriel G.
   Taylor, Josh
   Penile, Arsinoe C.
   Minter, Amanda
   Airam, Vladimir
   Carvalho, Mayara
   Junior, Nivison N.
   Rodrigues, Gorete
   Reis, Mitermayer G.
   Ko, Albert I.
   Childs, James E.
   Begon, Mike
   Costa, Federico
TI A Two-Year Ecological Study of Norway Rats (Rattus norvegicus) in a
   Brazilian Urban Slum
SO PLOS ONE
LA English
DT Article
ID BARTONELLA SPP.; INFESTATION; POPULATION; LEPTOSPIROSIS; TRANSMISSION;
   ENVIRONMENT; BALTIMORE; RISK
AB The Norway or brown rat (Rattus norvegicus) is among the most ubiquitous of rodents. However, the lack of studies describing Norway rat populations from tropical areas have limited our understanding regarding their demography and seasonal dynamics. In this study, we describe seasonal pattern in the abundance, reproductive parameters, and morphometrics of Norway rat populations in Salvador, Brazil. Rodents were trapped over four seasonal trapping periods (2013-2014) from three valleys. A total of 802 Norway rats were trapped over the course of the study over 7653 trap-nights. Norway rat abundance was high, but there was no significant differences between seasons. The reproductive parameters (e. g. frequency of pregnant and lactating females) did not show statistical differences between seasons. Female rats collected in the rainy season were heavier and older than females from the dry season. Salvador rats had a high incidence of pregnancy and birth rate (estimated birth rate of 79 young per year) compared to previous studies. The information generated is critical for the understanding of the ecology of Norway rat, the main reservoir of Leptospira in Salvador. However, future studies examining the effect of rodent control programs aimed at reducing populations, and determining rates of recovery, will further clarify our understanding of population dynamics.
C1 [Panti-May, Jesus A.; Carvalho-Pereira, Ticiana S. A.; Serrano, Soledad; Pedra, Gabriel G.; Taylor, Josh; Penile, Arsinoe C.; Airam, Vladimir; Carvalho, Mayara; Junior, Nivison N.; Reis, Mitermayer G.; Ko, Albert I.; Costa, Federico] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Taylor, Josh; Minter, Amanda; Begon, Mike; Costa, Federico] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.
   [Rodrigues, Gorete] Minist Saude, Ctr Controle Zoonoses, Secretaria Municipal Saude, Salvador, BA, Brazil.
   [Reis, Mitermayer G.; Ko, Albert I.; Childs, James E.; Costa, Federico] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
RP Costa, F (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.; Costa, F (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.; Costa, F (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.; Costa, F (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
EM fcosta2001@gmail.com
RI Ko, Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015; Panti-May,
   Jesus Alonso/U-2798-2019; Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336; Panti-May, Jesus
   Alonso/0000-0003-1669-5727; Reis, Mitermayer/0000-0002-3051-9060;
   Carvalho Pereira, Ticiana/0000-0003-2370-2198; ,
   Amanda/0000-0003-1171-5688
FU Oswaldo Cruz Foundation; Secretariat of Health Surveillance, Brazilian
   Ministry of Health; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [F31 AI114245, R01 AI052473, U01 AI088752, R01 TW009504, R25
   TW009338]; Wellcome TrustWellcome Trust [102330/Z/13/Z]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R01TW009504, R25TW009338,
   R25TW009338, R25TW009338, R01TW009504, R25TW009338, R01TW009504,
   R25TW009338, R25TW009338, R01TW009504, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R01TW009504, R25TW009338] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01AI088752, U01AI088752, U01AI088752,
   R01AI121207, F31AI114245, R01AI052473, R01AI052473, U01AI088752,
   U01AI088752, R01AI121207, U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI121207, R01AI052473,
   R01AI052473, R01AI052473, R01AI121207, R01AI121207, R01AI052473,
   F31AI114245] Funding Source: NIH RePORTER
FX This work was supported by the Oswaldo Cruz Foundation and Secretariat
   of Health Surveillance, Brazilian Ministry of Health, the National
   Institutes of Health (grants F31 AI114245, R01 AI052473, U01 AI088752,
   R01 TW009504 and R25 TW009338) and by the Wellcome Trust
   (102330/Z/13/Z). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359
   [Anonymous], 1907, J HYG-CAMBRIDGE, V7, P724
   Berdoy Manuel, 2007, P380
   Bergallo HG, 1999, J MAMMAL, V80, P472, DOI 10.2307/1383294
   BISHOP JA, 1976, J ANIM ECOL, V45, P623, DOI 10.2307/3572
   BLANCHARD DC, 1984, BEHAV PROCESS, V9, P31, DOI 10.1016/0376-6357(84)90006-8
   Burthe SJ, 2010, OECOLOGIA, V162, P653, DOI 10.1007/s00442-009-1495-6
   Buxton PA, 1936, J ANIM ECOL, V5, P53, DOI 10.2307/1091
   Calhoun J.B, 1962, ECOLOGY SOCIOLOGY NO
   CALHOUN JB, 1952, J MAMMAL, V33, P139, DOI 10.2307/1375923
   Cavia R, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P147
   Channon D, 2006, EPIDEMIOL INFECT, V134, P41, DOI 10.1017/S0950268805004607
   Childs JE, 1998, AM J EPIDEMIOL, V148, P78, DOI 10.1093/oxfordjournals.aje.a009563
   Costa F, 2016, J HERED, P1
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   DAVIS DE, 1951, ECOLOGY, V32, P469, DOI 10.2307/1931724
   DAVIS DE, 1949, J MAMMAL, V30, P125, DOI 10.2307/1375259
   DAVIS DE, 1951, ECOLOGY, V32, P462, DOI 10.2307/1931722
   DAVIS DE, 1948, ECOLOGY, V29, P437, DOI 10.2307/1932636
   DAVIS DE, 1948, PHYSIOL ZOOL, V21, P272, DOI 10.1086/physzool.21.3.30152004
   DAVIS DE, 1951, PHYSIOL ZOOL, V24, P9, DOI 10.1086/physzool.24.1.30152099
   Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746
   EMLEN JT, 1948, PHYSIOL ZOOL, V21, P59, DOI 10.1086/physzool.21.1.30151981
   FARHANGAZAD A, 1977, J PARASITOL, V63, P117, DOI 10.2307/3280114
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Glass G.E., 1989, Occasional Papers of the Museum of Natural History University of Kansas, VNo. 130, P1
   GLASS GE, 1988, J MAMMAL, V69, P587, DOI 10.2307/1381350
   Villafane IEG, 2013, MAMMALIA, V77, P187, DOI 10.1515/mammalia-2012-0075
   Herbreteau V, 2011, PROTOCOLS FIELD LAB
   Himsworth CG, 2015, VECTOR-BORNE ZOONOT, V15, P21, DOI 10.1089/vbz.2014.1657
   Himsworth CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091654
   Langton SD, 2001, J APPL ECOL, V38, P699, DOI 10.1046/j.1365-2664.2001.00631.x
   Lantz DE, 1917, FARMERS B USDA
   Leary S, 2013, AVMA GUIDELINES EUTH
   Masi E, 2010, J PEST SCI, V83, P228, DOI 10.1007/s10340-010-0290-9
   McDonald J.H., 2014, HDB BIOL STAT
   McGuire B, 2006, AM MIDL NAT, V155, P221, DOI 10.1674/0003-0031(2006)155[0221:GEOARP]2.0.CO;2
   Miller N, 1911, AM NAT, V45, P623, DOI 10.1086/279243
   Mills JN, 1995, METHODS TRAPPING SAM
   ORGAIN H, 1953, ECOLOGY, V34, P467, DOI 10.2307/1929719
   Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x
   PERRY JS, 1945, P ZOOL SOC LOND, V115, P19
   Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002
   Porter FH, 2015, J MAMMAL, V96, P317, DOI 10.1093/jmammal/gyv033
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1
   Vadell MV, 2014, WILDLIFE RES, V41, P172, DOI 10.1071/WR14005
   World Health Organization, 1992, WHO M ROD EC POP DYN
   Zar J., 1996, BIOSTATISTICAL ANAL
NR 52
TC 24
Z9 27
U1 1
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 25
PY 2016
VL 11
IS 3
AR e0152511
DI 10.1371/journal.pone.0152511
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH3TE
UT WOS:000372708900071
PM 27015422
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Oliveira, CR
   Costa, GSR
   Paploski, IAD
   Kikuti, M
   Kasper, AM
   Silva, MMO
   Tavares, AS
   Cruz, JS
   Queiroz, TL
   Lima, HCAV
   Calcagno, J
   Reis, MG
   Weinberger, DM
   Shapiro, ED
   Ko, AI
   Ribeiro, GS
AF Oliveira, Carlos R.
   Costa, Gisela S. R.
   Paploski, Igor A. D.
   Kikuti, Mariana
   Kasper, Amelia M.
   Silva, Monaise M. O.
   Tavares, Aline S.
   Cruz, Jaqueline S.
   Queiroz, Tassia L.
   Lima, Helena C. A. V.
   Calcagno, Juan
   Reis, Mitermayer G.
   Weinberger, Daniel M.
   Shapiro, Eugene D.
   Ko, Albert I.
   Ribeiro, Guilherme S.
TI Influenza-like illness in an urban community of Salvador, Brazil:
   incidence, seasonality and risk factors
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Influenza-like Illness; Tropics; Brazil; Incidence; Seasonality
ID WINTER SCHOOL BREAKS; RESPIRATORY-INFECTIONS; HOSPITALIZED-PATIENTS;
   CASE DEFINITIONS; SURVEILLANCE; VIRUSES; BURDEN; MORTALITY; CHILDREN;
   IMPACT
AB Background: Our understanding of the epidemiology of influenza is limited in tropical regions, which in turn has hampered identifying optimal region-specific policy to diminish disease burden. Influenza-like illness (ILI) is a clinical diagnosis that can be used as a surrogate for influenza. This study aimed to define the incidence and seasonality of ILI and to assess its association with climatic variables and school calendar in an urban community in the tropical region of Salvador, Brazil.
   Methods: Between 2009 and 2013, we conducted enhanced community-based surveillance for acute febrile illnesses (AFI) among patients >= 5 years of age in a slum community emergency unit in Salvador, Brazil. ILI was defined as a measured temperature of >= 37.8 degrees C or reported fever in a patient with cough or sore throat for <= 7 days, and negative test results for dengue and leptospirosis. Seasonality was analyzed with a harmonic regression model. Negative binomial regression models were used to correlate ILI incidence with rainfall, temperature, relative humidity and the number of days per month that schools were in session while controlling for seasonality.
   Results: There were 2,651 (45.6 % of 5,817 AFI patients) ILI cases with a mean annual incidence of 60 cases/1,000 population (95 % CI 58-62). Risk of ILI was highest among 5-9 year olds with an annual incidence of 105 cases/1,000 population in 2009. ILI had a clear seasonal pattern with peaks between the 35-40th week of the year. ILI peaks were higher and earlier in 5-9 year olds compared with >19 year olds. No association was seen between ILI and precipitation, relative humidity or temperature. There was a significant association between the incidence of ILI in children 5-9 years of age and number of scheduled school days per month.
   Conclusions: We identified a significant burden of ILI with distinct seasonality in the Brazilian tropics and highest rates among young school-age children. Seasonal peaks of ILI in children 5-9 years of age were positively associated with the number of school days, indicating that children may play a role in the timing of seasonal influenza transmission.
C1 [Oliveira, Carlos R.; Shapiro, Eugene D.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.
   [Costa, Gisela S. R.; Paploski, Igor A. D.; Kikuti, Mariana; Kasper, Amelia M.; Silva, Monaise M. O.; Tavares, Aline S.; Cruz, Jaqueline S.; Lima, Helena C. A. V.; Calcagno, Juan; Reis, Mitermayer G.; Ko, Albert I.; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Paploski, Igor A. D.; Kikuti, Mariana; Queiroz, Tassia L.; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Reis, Mitermayer G.; Weinberger, Daniel M.; Shapiro, Eugene D.; Ko, Albert I.; Ribeiro, Guilherme S.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Reis, Mitermayer G.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Shapiro, Eugene D.] Yale Univ, Sch Med, Dept Invest Med, New Haven, CT USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Ribeiro, Guilherme/B-6624-2008; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020; Paploski, Igor AD/D-7015-2014; Kikuti,
   Mariana/G-2313-2017
OI Ribeiro, Guilherme/0000-0002-6798-2059; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060;
   Paploski, Igor AD/0000-0002-3689-2042; Kikuti,
   Mariana/0000-0001-8119-7236; Oliveira, Carlos R./0000-0003-1897-6581;
   Weinberger, Daniel/0000-0003-1178-8086
FU National Council for Scientific and Technological Development -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [550160/2010-8]; Bahia Foundation for Research Support - FAPESB
   [PNX0010/2011, PPP0055/2011, JCB0020/2013]; Federal University of Bahia
   - UFBA [PROPI 2011, PROPI 2013, PRODOC 2013]; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI052473, U01 AI088752, R25
   TW009338, R01 TW009504, R56 AI110449, D43 TW00919]; Oswaldo Cruz
   Foundation; Coordination for the Improvement of Higher Education
   Personnel - CAPES, Brazilian Ministry of EducationCAPES; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, R01TW009504,
   R25TW009338, R25TW009338, R25TW009338, D43TW000919, R25TW009338,
   D43TW000919, D43TW000919, R25TW009338, D43TW000919, R25TW009338,
   D43TW000919, R01TW009504, D43TW000919, D43TW000919, D43TW000919,
   R25TW009338, D43TW000919, R01TW009504, R25TW009338, R01TW009504,
   D43TW000919, R01TW009504, R25TW009338, D43TW000919, R25TW009338,
   R25TW009338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, T32AI007210,
   T32AI007210, R01AI121207, T32AI007210, T32AI007210, R56AI110449,
   T32AI007210, U01AI088752, R01AI121207, T32AI007210, T32AI007210,
   T32AI007210, R01AI052473, T32AI007210, T32AI007210, R01AI052473,
   T32AI007210, T32AI007210, U01AI088752, T32AI007210, R01AI052473,
   U01AI088752, T32AI007210, T32AI007210, R01AI121207, T32AI007210,
   R01AI052473, T32AI007210, T32AI007210, T32AI007210, T32AI007210,
   U01AI088752, T32AI007210, R01AI052473, R01AI052473, T32AI007210,
   R01AI052473, R01AI121207, R01AI052473, T32AI007210, T32AI007210,
   T32AI007210, T32AI007210, R01AI052473, U01AI088752, T32AI007210,
   T32AI007210, R01AI052473, T32AI007210, T32AI007210, T32AI007210,
   R01AI121207, T32AI007210, U01AI088752] Funding Source: NIH RePORTER
FX This work was supported by the National Council for Scientific and
   Technological Development - CNPq (grants: 550160/2010-8; scholarship to:
   MK, IADP, MMOS, MGR GSR); the Bahia Foundation for Research Support -
   FAPESB (grants: PNX0010/2011, PPP0055/2011, and JCB0020/2013); the
   Federal University of Bahia - UFBA (grants: PROPI 2011, PROPI 2013, and
   PRODOC 2013); the National Institutes of Health (grants: R01 AI052473,
   U01 AI088752, R25 TW009338, R01 TW009504, R56 AI110449, and D43
   TW00919); the Oswaldo Cruz Foundation (scholarship to: AMK, MMOS, AST,
   JSC, HCAVL); and the Coordination for the Improvement of Higher
   Education Personnel - CAPES, Brazilian Ministry of Education
   (scholarship to: MK, TLQ). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012
   Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be
   Barr I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037568
   Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445
   Brammer L, 2013, MMWR-MORBID MORTAL W, V62, P473
   Campos EC, 2012, CAD SAUDE PUBLICA, V28, P878, DOI 10.1590/S0102-311X2012000500007
   Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8
   Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810
   Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905
   Chowell G, 2014, EMERG INFECT DIS, V20, P1203, DOI 10.3201/eid2007.130967
   Christiansen CF, 2012, CLIN MICROBIOL INFEC, V18, P963, DOI 10.1111/j.1469-0691.2012.03966.x
   Freitas FTD, 2013, BRAZ J INFECT DIS, V17, P62, DOI 10.1016/j.bjid.2012.09.001
   DEARRUDA E, 1991, J INFECT DIS, V164, P252, DOI 10.1093/infdis/164.2.252
   Dosseh A, 2000, AM J TROP MED HYG, V62, P639, DOI 10.4269/ajtmh.2000.62.639
   Fowlkes A, 2014, J INFECT DIS, V209, P1715, DOI 10.1093/infdis/jit806
   Garza RC, 2013, EMERG INFECT DIS, V19, P938, DOI 10.3201/eid1906.120916
   Guo RN, 2011, PUBLIC HEALTH, V125, P389, DOI 10.1016/j.puhe.2011.03.004
   Gupta V, 2013, INFLUENZA OTHER RESP, V7, P321, DOI 10.1111/j.1750-2659.2012.00401.x
   Hirve S, 2012, B WORLD HEALTH ORGAN, V90, P804, DOI 10.2471/BLT.12.108837
   Imai C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24413
   Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008096
   Lofgren ET, 2010, INFLUENZA OTHER RESP, V4, P205, DOI 10.1111/j.1750-2659.2010.00137.x
   Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13
   Mardy S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-168
   Merrill RM, 2013, INTRO EPIDEMIOLOGY
   Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180
   Murray EL, 2013, EPIDEMIOL INFECT, V141, P212, DOI 10.1017/S095026881200043X
   Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Shei A, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-10
   Silva RD, 2014, MEM I OSWALDO CRUZ, V109, P229, DOI 10.1590/0074-0276140273
   Straliotto Selir M., 2002, Rev. Soc. Bras. Med. Trop., V35, P283, DOI 10.1590/S0037-86822002000400002
   Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194
   Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053
   Yokota RTC, 2011, EMERG INFECT DIS, V17, P1467, DOI 10.3201/eid1708.101233
NR 38
TC 7
Z9 7
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAR 15
PY 2016
VL 16
AR 125
DI 10.1186/s12879-016-1456-8
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA DG5VH
UT WOS:000372146800001
PM 26975185
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Costa, F
   Richardson, JL
   Dion, K
   Mariani, C
   Pertile, AC
   Burak, MK
   Childs, JE
   Ko, AI
   Caccone, A
AF Costa, Federico
   Richardson, Jonathan L.
   Dion, Kirstin
   Mariani, Carol
   Pertile, Arsinoe C.
   Burak, Mary K.
   Childs, James E.
   Ko, Albert I.
   Caccone, Adalgisa
TI Multiple Paternity in the Norway Rat, Rattus norvegicus, from Urban
   Slums in Salvador, Brazil
SO JOURNAL OF HEREDITY
LA English
DT Article
DE brown rat; genetics; mating behavior; microsatellite; multiple
   paternity; polyandry; Rattus norvegicus; urban slums
ID MULTILOCUS GENOTYPE DATA; SIBSHIP INFERENCE; RELATEDNESS; ENVIRONMENT;
   COLONIZATION; TRANSMISSION; POPULATIONS; PARENTAGE; INVASION; BEHAVIOR
AB The Norway rat, Rattus norvegicus, is one of the most important pest species globally and the main reservoir of leptospires causing human leptospirosis in the urban slums of tropical regions. Rodent control is a frequent strategy in those settings to prevent the disease but rapid growth from residual populations and immigration limit the long-term effectiveness of interventions. To characterize the breeding ecology of R. norvegicus and provide needed information for the level of genetic mixing, which can help identify inter-connected eradication units, we estimated the occurrence of multiple paternity, distances between mothers and sires, and inbreeding in rats from urban slum habitat in Salvador, Brazil. We genotyped 9 pregnant females, their 66 offspring, and 371 males at 16 microsatellite loci. Multiple paternity was observed in 22% (2/9) of the study litters. Of the 12 sires that contributed to the 9 litters, we identified 5 (42%) of those sires among our genotyped males. Related males were captured in close proximity to pregnant females (the mean inter-parent trapping distance per litter was 70 m, +/- 58 m SD). Levels of relatedness between mother-sire pairs were higher than expected and significantly higher than relatedness between all females and non-sire males. Our findings indicate multiple paternity is common, inbreeding is apparent, and that mother-sire dyads occur in close proximity within the study area. This information is relevant to improve the spatial definition of the eradication units that may enhance the effectiveness of rodent management programs aimed at preventing human leptospirosis. High levels of inbreeding may also be a sign that eradication efforts are successful.
C1 [Costa, Federico; Pertile, Arsinoe C.] Minist Saude, Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Richardson, Jonathan L.; Burak, Mary K.] Providence Coll, 1 Cunningham Sq, Providence, RI 02918 USA.
   [Costa, Federico] Univ Fed Bahia, UFBA, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil.
   [Costa, Federico; Childs, James E.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06511 USA.
   [Costa, Federico] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.
   [Dion, Kirstin; Mariani, Carol; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, 21 Sachem St, New Haven, CT 06520 USA.
RP Costa, F (corresponding author), Minist Saude, Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.; Costa, F (corresponding author), Univ Fed Bahia, UFBA, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil.; Costa, F (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, 60 Coll St, New Haven, CT 06511 USA.; Costa, F (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England.
EM federico.costa@ufba.br
RI Costa, Federico/G-1838-2015; Ko, Albert Icksang/P-2343-2015
OI Costa, Federico/0000-0001-6951-2336; Ko, Albert
   Icksang/0000-0001-9023-2339
FU Oswaldo Cruz Foundation and Secretariat of Health Surveillance,
   Brazilian Ministry of Health; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [F31 AI114245, R01 AI052473, U01 AI088752, R01 TW009504, R25
   TW009338]; Wellcome TrustWellcome Trust [102330/Z/13/Z]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R25TW009338, R25TW009338,
   R01TW009504, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R01TW009504, R01TW009504, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R01TW009504] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI121207, R01AI121207, R01AI052473,
   F31AI114245, U01AI088752, U01AI088752, U01AI088752, F31AI114245,
   R01AI052473, U01AI088752, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI121207, R01AI052473, U01AI088752,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, R01AI121207,
   R01AI121207] Funding Source: NIH RePORTER
FX Oswaldo Cruz Foundation and Secretariat of Health Surveillance,
   Brazilian Ministry of Health; National Institutes of Health (F31
   AI114245, R01 AI052473, U01 AI088752, R01 TW009504, R25 TW009338);
   Wellcome Trust (102330/Z/13/Z).
CR Abdelkrim J, 2005, CONSERV BIOL, V19, P1509, DOI 10.1111/j.1523-1739.2005.00206.x
   Abdelkrim J, 2005, MOL ECOL, V14, P2923, DOI 10.1111/j.1365-294X.2005.02604.x
   Baker CS, 2013, J HERED, V104, P1, DOI 10.1093/jhered/ess137
   Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x
   Breed WG, 2000, J MAMMAL, V81, P758, DOI 10.1644/1545-1542(2000)081&lt;0758:BMTMAS&gt;2.3.CO;2
   Burton C, 2003, J MAMMAL, V84, P1100, DOI 10.1644/BRG-029
   Calhoun J.B, 1962, ECOLOGY SOCIOLOGY NO
   Capizzi D, 2014, MAMMAL REV, V44, P148, DOI 10.1111/mam.12019
   Christensen LS, 2011, VET MICROBIOL, V149, P64, DOI 10.1016/j.vetmic.2010.10.016
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324
   Dean MD, 2006, MOL ECOL, V15, P4141, DOI 10.1111/j.1365-294X.2006.03068.x
   EMLEN JT, 1948, ECOLOGY, V29, P133, DOI 10.2307/1932809
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Fundacao Nacional de Saude, 2002, MAN CONTR ROED
   Glass GE, 1989, OCCASIONAL PAPERS MU, P130
   Glass GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005794
   Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195
   Instituto Brasileiro De Geografia E Estatistica, 2007, CONT POP 2007 TAB 1
   Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x
   Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455
   Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x
   Kennis J, 2008, MAMMALIA, V72, P150, DOI 10.1515/MAMM.2008.025
   King C, 2014, NEW ZEAL J ECOL, V38, P76
   Kirkpatrick M, 2000, AM NAT, V155, P154, DOI 10.1086/303312
   Lovell JL, 2007, PHYSIOL BEHAV, V90, P537, DOI 10.1016/j.physbeh.2006.11.002
   Macdonald D. W., 1999, Ecologically-based management of rodent pests., P49
   Miller SD, 2010, NEW ZEAL J ECOL, V34, P360
   Moore JA, 2008, CONSERV GENET, V9, P1243, DOI 10.1007/s10592-007-9452-6
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Porter FH, 2015, J MAMMAL, V96, P317, DOI 10.1093/jmammal/gyv033
   QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.1111/j.1558-5646.1989.tb04226.x, 10.2307/2409206]
   Russell JC, 2009, BIOL INVASIONS, V11, P1557, DOI 10.1007/s10530-008-9406-z
   Susilawati TN, 2014, SE ASIAN J TROP MED, V45, P719
   Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122
   Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214
   Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963
   Zewail-Foote M, 2009, PHYSIOL BEHAV, V96, P98, DOI 10.1016/j.physbeh.2008.09.007
NR 41
TC 10
Z9 11
U1 0
U2 23
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1503
EI 1465-7333
J9 J HERED
JI J. Hered.
PD MAR
PY 2016
VL 107
IS 2
BP 181
EP 186
DI 10.1093/jhered/esv098
PG 6
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA DD6VY
UT WOS:000370063900010
PM 26733693
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Menezes, APD
   Azevedo, J
   Leite, MC
   Campos, LC
   Cunha, M
   Carvalho, MDS
   Reis, MG
   Ko, AI
   Weinberger, DM
   Ribeiro, G
   Reis, JN
AF Menezes, Ana Paula de O.
   Azevedo, Jailton
   Leite, Mariela C.
   Campos, Leila C.
   Cunha, Marcelo
   Carvalho, Maria da Gloria S.
   Reis, Mitermayer G.
   Ko, Albert I.
   Weinberger, Daniel M.
   Ribeiro, Guilherme
   Reis, Joice N.
TI Nasopharyngeal carriage of Streptococcus pneumoniae among children in an
   urban setting in Brazil prior to PCV10 introduction
SO VACCINE
LA English
DT Article
DE Children; Nasopharyngeal carriage; Streptococcus pneumoniae; Serotypes;
   PCV10-vaccine
ID PNEUMOCOCCAL CONJUGATE VACCINE; ATTENDING DAY-CARE; SEROTYPE
   DISTRIBUTION; DISEASE; COLONIZATION; REPLACEMENT; POPULATION
AB Information on pneumococcal carriage in the pre-vaccine period is essential to predict and assess the impact of PCV in settings where disease surveillance is particularly difficult. Therefore, we present data on pneumococcal carriage before the introduction of the 10-valent-pneumococcal conjugate vaccine (PCV10) in Brazil. We conducted a prospective study on a cohort of 203 children aged <5 years old, randomly selected in an urban community located in the periphery of the city of Salvador, Brazil and followed them from January/2008 to January/2009. Nasopharyngeal swabs were collected from each child at four times. In total, 721 swabs were collected, yielding a pneumococcal carriage prevalence of 55% (n=398). In multivariate analyses, the variables associated with carriage were having contact with three or more children <2 years old (OR, 2.00; 95% CI 1.33-2.89) and living in a house with an average of 3 residents per room (OR, 1.77; 95% CI 1.05-3.10). Also, white participants were more likely to be protected from colonization (OR, 0.52; 95% CI 0.29-0.93), and prevalence of carriage varied over time, with lower prevalence occurring from February to June (OR, 0.53; 95% CI 0.37-0.78) compared to July to January. Contact with children under 2 years of age and living in crowded housing also were associated with colonization by highly invasive serotypes, although this relationship was not significant. The most prevalent vaccine serotypes were 6A/B (25.4%), 19F (10.1%) and 14 (9.0%), while the most prevalent non-vaccine serotypes were 16F (4.8%), 15B/C (4.5%) and 6C/D (3.5%). Overall, 38.4% (153/398) of the isolates were non-susceptible to penicillin, and of those, 73.8% (113/153) were non-susceptible to trimethoprim/sulfamethoxazole. Colonization rate by PCV10 serotypes was 52.2%. Routine PCV10 vaccination can lead to significant changes in pneumococcal serotypes found in NP colonization, indicating a need for continued monitoring, especially in crowded settings, as occurs in Brazil's slums. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Menezes, Ana Paula de O.; Azevedo, Jailton; Campos, Leila C.; Reis, Mitermayer G.; Ko, Albert I.; Ribeiro, Guilherme; Reis, Joice N.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Leite, Mariela C.; Reis, Joice N.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
   [Cunha, Marcelo] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Carvalho, Maria da Gloria S.] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA USA.
   [Ko, Albert I.; Weinberger, Daniel M.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ribeiro, Guilherme] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
RP Reis, JN (corresponding author), Univ Fed Bahia, Fac Farm, Dept Anal Clin & Toxicol, BR-40170115 Salvador, BA, Brazil.
EM joice@ufba.br
RI Reis, Joice N/H-9227-2013; Ribeiro, Guilherme/B-6624-2008; Ko, Albert
   Icksang/P-2343-2015; da Gloria da Costa Carvalho, Maria/H-1644-2012;
   Reis, Mitermayer/AAO-9742-2020
OI Ribeiro, Guilherme/0000-0002-6798-2059; Ko, Albert
   Icksang/0000-0001-9023-2339; da Gloria da Costa Carvalho,
   Maria/0000-0001-5890-8095; Reis, Mitermayer/0000-0002-3051-9060;
   Azevedo, Jailton/0000-0002-0801-8673; Weinberger,
   Daniel/0000-0003-1178-8086
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq) [482755/2010-5]; Research Support
   Foundation of the State of Bahia (FAPESB) [1431040054051]; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [TW007303]; Global
   Health Equity Scholars training program [TW009338]; Bill and Melinda
   Gates FoundationBill & Melinda Gates Foundation [OPP1114733]; Yale
   Program on Aging [P30AG021342]; NIH/NIAIDUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R56
   AI110449]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW007303, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R01TW007303, R25TW009338, R25TW009338,
   R01TW007303, R01TW007303, R25TW009338, R25TW009338, R01TW007303,
   R25TW009338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R56AI110449] Funding Source:
   NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute on Aging (NIA) [P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342, P30AG021342, P30AG021342, P30AG021342, P30AG021342,
   P30AG021342] Funding Source: NIH RePORTER
FX This work was supported by grants from the Brazilian National Research
   Council (482755/2010-5), the Research Support Foundation of the State of
   Bahia (FAPESB: 1431040054051) and the National Institutes of Health
   (TW007303). DMW is supported by the Global Health Equity Scholars
   training program (TW009338), the Bill and Melinda Gates Foundation
   (OPP1114733), the Yale Program on Aging (P30AG021342), and NIH/NIAID
   (R56 AI110449).
CR Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787
   Andrade ALS, 2010, J INFECTION, V61, P314, DOI 10.1016/j.jinf.2010.07.003
   Berezin EN, 2007, PEDIATR INFECT DIS J, V26, P643, DOI 10.1097/INF.0b013e3180616d0f
   Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7
   Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820
   Burnham KP, 2002, MODEL SELECTION MULT
   Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09
   Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI
   Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049
   Ercibengoa M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-69
   Neves FPG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-318
   Hare KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070478
   Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626
   Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688
   Hsu KK, 2014, EPIDEMIOL INFECT, V142, P379, DOI 10.1017/S0950268813000794
   Huang SS, 2004, AM J EPIDEMIOL, V159, P645, DOI 10.1093/aje/kwh088
   Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012
   [IBGE Estatistica IBdGe], 2010, SUBN AGGL 1 RES, P1
   Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010
   LEFEVRE JC, 1993, J CLIN MICROBIOL, V31, P2724, DOI 10.1128/JCM.31.10.2724-2728.1993
   Menezes APD, 2013, J CLIN MICROBIOL, V51, P2470, DOI 10.1128/JCM.00743-13
   Menezes APD, 2011, VACCINE, V29, P1139, DOI 10.1016/j.vaccine.2010.12.021
   Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1
   Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593
   Pimenta FC, 2011, J MED MICROBIOL, V60, P1455, DOI 10.1099/jmm.0.031450-0
   Reis JN, 2002, J CLIN MICROBIOL, V40, P275, DOI 10.1128/JCM.40.1.275-277.2002
   Reis JN, 2008, J INFECTION, V57, P204, DOI 10.1016/j.jinf.2008.06.017
   Reis R. B., 2008, NEGLECTED TROPICAL D, V2, P1
   Rivera-Olivero IA, 2011, EUR J CLIN MICROBIOL, V30, P1489, DOI 10.1007/s10096-011-1247-5
   Rodrigues F, 2012, VACCINE, V30, P3951, DOI 10.1016/j.vaccine.2012.03.058
   Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7
   Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005
   Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710
   Turner P, 2012, CLIN MICROBIOL INFEC, V18, P970, DOI 10.1111/j.1469-0691.2011.03711.x
   Valente C, 2013, PEDIATR INFECT DIS J, V32, P703, DOI 10.1097/INF.0b013e31828692be
   Volonakis K, 2006, INT J ANTIMICROB AG, V28, P297, DOI 10.1016/j.ijantimicag.2006.07.002
   Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721
   Weinberger DM, 2013, J INFECT DIS, V208, P1274, DOI 10.1093/infdis/jit375
   Zhang QB, 2004, PEDIATR INFECT DIS J, V23, P307, DOI 10.1097/00006454-200404000-00006
NR 39
TC 7
Z9 7
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD FEB 3
PY 2016
VL 34
IS 6
BP 791
EP 797
DI 10.1016/j.vaccine.2015.12.042
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA DD7ML
UT WOS:000370108500012
PM 26742946
OA Green Accepted, Bronze
DA 2020-11-30
ER

PT J
AU Silva, MMO
   Rodrigues, MS
   Paploski, IAD
   Kikuti, M
   Kasper, AM
   Cruz, JS
   Queiroz, TL
   Tavares, AS
   Santana, PM
   Araujo, JMG
   Ko, AI
   Reis, MG
   Ribeiro, GS
AF Silva, Monaise M. O.
   Rodrigues, Moreno S.
   Paploski, Igor A. D.
   Kikuti, Mariana
   Kasper, Amelia M.
   Cruz, Jaqueline S.
   Queiroz, Tassia L.
   Tavares, Aline S.
   Santana, Perla M.
   Araujo, Joselio M. G.
   Ko, Albert I.
   Reis, Mitermayer Galvao
   Ribeiro, Guilherme S.
TI Accuracy of Dengue Reporting by National Surveillance System, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID CAMBODIA; BURDEN
C1 [Silva, Monaise M. O.; Rodrigues, Moreno S.; Paploski, Igor A. D.; Kikuti, Mariana; Kasper, Amelia M.; Cruz, Jaqueline S.; Queiroz, Tassia L.; Tavares, Aline S.; Santana, Perla M.; Ko, Albert I.; Reis, Mitermayer Galvao; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Silva, Monaise M. O.; Paploski, Igor A. D.; Kikuti, Mariana; Queiroz, Tassia L.; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Ko, Albert I.; Reis, Mitermayer Galvao; Ribeiro, Guilherme S.] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Reis, Mitermayer Galvao] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Rodrigues, Moreno/ABD-9852-2020; Ko, Albert Icksang/P-2343-2015; Araujo,
   Joselio M G/B-5502-2013; Reis, Mitermayer/AAO-9742-2020; Ribeiro,
   Guilherme/B-6624-2008; Kikuti, Mariana/G-2313-2017; Paploski, Igor
   AD/D-7015-2014
OI Rodrigues, Moreno/0000-0002-1594-2311; Ko, Albert
   Icksang/0000-0001-9023-2339; Araujo, Joselio M G/0000-0003-3548-2786;
   Reis, Mitermayer/0000-0002-3051-9060; Ribeiro,
   Guilherme/0000-0002-6798-2059; Kikuti, Mariana/0000-0001-8119-7236;
   Paploski, Igor AD/0000-0002-3689-2042
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R01TW009504, D43TW000919,
   D43TW000919, R25TW009338, D43TW000919, R01TW009504, D43TW000919,
   R25TW009338, D43TW000919, R25TW009338, D43TW000919, R25TW009338,
   D43TW000919, R01TW009504, D43TW000919, R25TW009338, R25TW009338,
   R01TW009504, R25TW009338, R25TW009338, D43TW000919, R25TW009338,
   D43TW000919, R25TW009338, D43TW000919, R25TW009338, R25TW009338,
   R01TW009504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI121207, R01AI052473,
   R01AI121207, R01AI052473, U01AI088752, U01AI088752, U01AI088752,
   R01AI121207, R01AI121207, R01AI121207, R01AI052473, R01AI052473,
   U01AI088752, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, U01AI088752, R01AI052473, R01AI052473] Funding
   Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01 TW009504, D43 TW00919, R25 TW009338, D43
   TW000919] Funding Source: Medline; NIAID NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R01
   AI121207, U01 AI088752, R01 AI052473] Funding Source: Medline
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   Ministerio da Saude do Brasil, 2014, ASS NOV CLASS CAS DE
   Ministerio da Saude do Brasil, 2012, DENG NOT REG SIST IN
   Standish K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000633
   Vong S, 2012, EPIDEMIOL INFECT, V140, P491, DOI 10.1017/S0950268811001191
   Wang CC, 2009, T ROY SOC TROP MED H, V103, P871, DOI 10.1016/j.trstmh.2009.04.024
   WHO, 2012, GLOB STRAT DENG PREV
   Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996
NR 10
TC 38
Z9 39
U1 0
U2 24
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2016
VL 22
IS 2
BP 336
EP 339
DI 10.3201/eid2202.150495
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DC1HX
UT WOS:000368968500034
PM 26812472
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Fouts, DE
   Matthias, MA
   Adhikarla, H
   Adler, B
   Amorim-Santos, L
   Berg, DE
   Bulach, D
   Buschiazzo, A
   Chang, YF
   Galloway, RL
   Haake, DA
   Haft, DH
   Hartskeerl, R
   Ko, AI
   Levett, PN
   Matsunaga, J
   Mechaly, AE
   Monk, JM
   Nascimento, ALT
   Nelson, KE
   Palsson, B
   Peacock, SJ
   Picardeau, M
   Ricaldi, JN
   Thaipandungpanit, J
   Wunder, EA
   Yang, XF
   Zhang, JJ
   Vinetz, JM
AF Fouts, Derrick E.
   Matthias, Michael A.
   Adhikarla, Haritha
   Adler, Ben
   Amorim-Santos, Luciane
   Berg, Douglas E.
   Bulach, Dieter
   Buschiazzo, Alejandro
   Chang, Yung-Fu
   Galloway, Renee L.
   Haake, David A.
   Haft, Daniel H.
   Hartskeerl, Rudy
   Ko, Albert I.
   Levett, Paul N.
   Matsunaga, James
   Mechaly, Ariel E.
   Monk, Jonathan M.
   Nascimento, Ana L. T.
   Nelson, Karen E.
   Palsson, Bernhard
   Peacock, Sharon J.
   Picardeau, Mathieu
   Ricaldi, Jessica N.
   Thaipandungpanit, Janjira
   Wunder, Elsio A., Jr.
   Yang, X. Frank
   Zhang, Jun-Jie
   Vinetz, Joseph M.
TI What Makes a Bacterial Species Pathogenic?: Comparative Genomic Analysis
   of the Genus Leptospira
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID FAINEI SEROVAR HURSTBRIDGE; OUTER-MEMBRANE PROTEINS; LPS BIOSYNTHETIC
   LOCI; DNA-DNA HYBRIDIZATION; L-GLUTAMATE OXIDASE; ESCHERICHIA-COLI;
   INTERROGANS BINDS; SP NOV.; METALLOPROTEASE AUREOLYSIN; FAMILY
   LEPTOSPIRACEAE
AB Leptospirosis, caused by spirochetes of the genus Leptospira, is a globally widespread, neglected and emerging zoonotic disease. While whole genome analysis of individual pathogenic, intermediately pathogenic and saprophytic Leptospira species has been reported, comprehensive cross-species genomic comparison of all known species of infectious and non-infectious Leptospira, with the goal of identifying genes related to pathogenesis and mammalian host adaptation, remains a key gap in the field. Infectious Leptospira, comprised of pathogenic and intermediately pathogenic Leptospira, evolutionarily diverged from non-infectious, saprophytic Leptospira, as demonstrated by the following computational biology analyses: 1) the definitive taxonomy and evolutionary relatedness among all known Leptospira species; 2) genomically-predicted metabolic reconstructions that indicate novel adaptation of infectious Leptospira to mammals, including sialic acid biosynthesis, pathogen-specific porphyrin metabolism and the first-time demonstration of cobalamin (B12) autotrophy as a bacterial virulence factor; 3) CRISPR/Cas systems demonstrated only to be present in pathogenic Leptospira, suggesting a potential mechanism for this clade's refractoriness to gene targeting; 4) finding Leptospira pathogen-specific specialized protein secretion systems; 5) novel virulence-related genes/gene families such as the Virulence Modifying (VM) (PF07598 paralogs) proteins and pathogen-specific adhesins; 6) discovery of novel, pathogen-specific protein modification and secretion mechanisms including unique lipoprotein signal peptide motifs, Sec-independent twin arginine protein secretion motifs, and the absence of certain canonical signal recognition particle proteins from all Leptospira; and 7) and demonstration of infectious Leptospira-specific signal-responsive gene expression, motility and chemotaxis systems. By identifying large scale changes in infectious (pathogenic and intermediately pathogenic) vs. non-infectious Leptospira, this work provides new insights into the evolution of a genus of bacterial pathogens. This work will be a comprehensive roadmap for understanding leptospirosis pathogenesis. More generally, it provides new insights into mechanisms by which bacterial pathogens adapt to mammalian hosts.
C1 [Fouts, Derrick E.; Haft, Daniel H.; Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA.
   [Matthias, Michael A.; Berg, Douglas E.; Vinetz, Joseph M.] Univ Calif San Diego, Sch Med, Div Infect Dis, Dept Med, La Jolla, CA 92093 USA.
   [Adhikarla, Haritha; Amorim-Santos, Luciane; Ko, Albert I.; Wunder, Elsio A., Jr.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Adler, Ben] Monash Univ, Dept Microbiol, Australian Res Council, Ctr Excellence Struct & Funct Microbial Gen, Clayton, Vic 3168, Australia.
   [Amorim-Santos, Luciane; Ko, Albert I.; Wunder, Elsio A., Jr.] Fundacao Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Bulach, Dieter] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic, Australia.
   [Buschiazzo, Alejandro; Mechaly, Ariel E.] Inst Pasteur, Lab Mol & Struct Microbiol, Montevideo, Uruguay.
   [Buschiazzo, Alejandro] Inst Pasteur, Dept Struct Biol & Chem, Paris, France.
   [Chang, Yung-Fu] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.
   [Galloway, Renee L.] Ctr Dis Control & Prevent, BSPB, DHCPP, NCEZID,OID,CDC,DHHS, Atlanta, GA USA.
   [Haake, David A.; Matsunaga, James] VA Greater Angeles Healthcare Syst, Los Angeles, CA USA.
   [Haake, David A.; Matsunaga, James] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Hartskeerl, Rudy] Royal Trop Inst KIT, WHO FAO OIE, Amsterdam, Netherlands.
   [Hartskeerl, Rudy] Royal Trop Inst KIT, Natl Collaborating Ctr Reference & Res Leptospiro, KIT Biomed Res, Amsterdam, Netherlands.
   [Levett, Paul N.] Govt Saskatchewan, Dis Control Lab Regina, Saskatoon, SK, Canada.
   [Monk, Jonathan M.; Palsson, Bernhard] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Nascimento, Ana L. T.] Inst Butantan, Ctr Biotecnol, Sao Paulo, SP, Brazil.
   [Nascimento, Ana L. T.] Univ Sao Paulo, Programa Interunidades Biotecnol, Inst Ciencias Biomed, Sao Paulo, SP, Brazil.
   [Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.
   [Picardeau, Mathieu] Inst Pasteur, Biol Spirochetes Unit, Natl Reference Ctr, Paris, France.
   [Picardeau, Mathieu] WHO Collaborating Ctr Leptospirosis, Paris, France.
   [Ricaldi, Jessica N.; Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Fac Med Alberto Hurtado, Lima, Peru.
   [Thaipandungpanit, Janjira] Mahidol Univ, Fac Trop Med, Bangkok, Thailand.
   [Yang, X. Frank; Zhang, Jun-Jie] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.
   [Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Inst Med Alexander von Humboldt, Lima, Peru.
RP Fouts, DE (corresponding author), J Craig Venter Inst, Rockville, MD USA.; Fouts, DE; Vinetz, JM (corresponding author), Univ Calif San Diego, Sch Med, Div Infect Dis, Dept Med, La Jolla, CA 92093 USA.; Vinetz, JM (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Fac Med Alberto Hurtado, Lima, Peru.; Vinetz, JM (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Alexander von Humboldt, Lima, Peru.
EM dfouts@jcvi.org; jvinetz@ucsd.edu
RI Ko, Albert Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013;
   Levett, Paul/H-7349-2019; Buschiazzo, Alejandro/W-1095-2018; Bulach,
   Dieter M/D-5793-2011; zhang, junjie/P-2376-2015; Peacock, Sharon
   J/ABE-6331-2020; Nascimento, Ana L. T. O./M-8663-2019
OI Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Buschiazzo, Alejandro/0000-0002-2509-6526;
   Bulach, Dieter M/0000-0001-9823-6078; zhang, junjie/0000-0002-5108-2072;
   Nascimento, Ana L. T. O./0000-0003-4851-0870; Monk, Jonathan
   M./0000-0002-3895-8949; Ricaldi, Jessica/0000-0003-0330-0554;
   Thaipadungpanit, Janjira/0000-0002-6184-3381; Mechaly,
   Ariel/0000-0002-5305-7495
FU federal funds from National Institute of Allergy and Infectious
   Diseases, National Institutes of Health, Department of Health and Human
   Services [HHSN272200900007C]; U.S. Public Health ServiceUnited States
   Public Health Service [U19AI115658, R01AI108276, D43TW007120,
   K24AI068903, R21AI115273, R01AI052473, R25TW009338, U01AI088752,
   R01TW009504, R01AI121207]; ANII (Uruguay) [FSA_1_2013_1_12557,
   ALI_1_2014_1_4982]; FOGARTY INTERNATIONAL CENTERUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW009504, D43TW007120,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   D43TW007120, D43TW007120, R25TW009338, D43TW007120, R25TW009338,
   D43TW007120, R25TW009338, D43TW007120, R25TW009338, R25TW009338,
   D43TW007120, D43TW007120, D43TW007120, D43TW007120, D43TW007120,
   R01TW009504, D43TW007120, D43TW007120, D43TW007120, D43TW007120,
   R25TW009338, R25TW009338, R01TW009504, D43TW007120, R01TW009504,
   R01TW009504, R25TW009338] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI088752, K24AI068903, R01AI052473, R01AI108276, R01AI034431,
   K24AI068903, U19AI115658, R01AI052473, K24AI068903, R01AI034431,
   U19AI115658, K24AI068903, R01AI034431, R01AI034431, U19AI115658,
   U19AI115658, U19AI115658, U19AI115658, R01AI052473, U19AI115658,
   R01AI052473, R01AI121207, U19AI115658, R21AI115273, U01AI088752,
   R01AI052473, R01AI108276, U19AI115658, R01AI052473, R01AI052473,
   R01AI108276, U01AI088752, R01AI034431, R01AI052473, K24AI068903,
   U19AI115658, R01AI108276, U01AI088752, R01AI034431, K24AI068903,
   R01AI034431, U01AI088752, U19AI115658, U19AI115658, U19AI115658,
   R01AI034431, U19AI115658, R01AI034431, U19AI115658, U19AI115658,
   R01AI034431, R01AI108276, R01AI052473, R01AI108276, U19AI115658,
   R01AI121207, U19AI115658, U19AI115658, R01AI034431, R01AI121207,
   U19AI115658, U19AI115658, K24AI068903, U19AI115658, R01AI052473,
   R01AI121207, K24AI068903, U19AI115658, U01AI088752, R01AI034431,
   K24AI068903, U19AI115658, R01AI121207, R21AI115273, U19AI115658,
   K24AI068903, R01AI034431, R01AI052473] Funding Source: NIH RePORTER;
   Veterans AffairsUS Department of Veterans Affairs [I01BX002003,
   I01BX002003, I01BX002003, I01BX002003, I01BX002003, I01BX002003] Funding
   Source: NIH RePORTER
FX This project has been funded in whole or part with federal funds from
   the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services under
   Contract Number HHSN272200900007C. This work was also supported in part
   by the following U.S. Public Health Service grants: U19AI115658 (JMV),
   R01AI108276 (JMV), D43TW007120 (JMV), K24AI068903 (JMV), R21AI115273
   (MAM), R01AI052473 (AIK), U01AI088752 (AIK), R25TW009338 (AIK),
   R01TW009504 (AIK), and R01AI121207 (AIK). In addition, support to the A.
   Buschiazzo team was provided in part by grants FSA_1_2013_1_12557 and
   ALI_1_2014_1_4982 from ANII (Uruguay). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1
   Adekoya OA, 2009, CHEM BIOL DRUG DES, V73, P7, DOI 10.1111/j.1747-0285.2008.00757.x
   Adler B, 2015, CURR TOP MICROBIOL, V387, P251, DOI 10.1007/978-3-662-45059-8_10
   Adler B, 2015, CURR TOP MICROBIOL, V387, P1, DOI 10.1007/978-3-662-45059-8_1
   Agampodi SB, 2013, AM J TROP MED HYG, V88, P184, DOI 10.4269/ajtmh.2012.12-0526
   Ahmed A, 2011, J BACTERIOL PARASITO, pS5
   Ahmed A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001374
   Ahmed A, 2015, METHODS MOL BIOL, V1247, P349, DOI 10.1007/978-1-4939-2004-4_25
   Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28
   Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607
   Ashford DA, 2000, AM J TROP MED HYG, V63, P249, DOI 10.4269/ajtmh.2000.63.249
   Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120
   Auch AF, 2010, STAND GENOMIC SCI, V2, P142, DOI 10.4056/sigs.541628
   AUSTIN FE, 1981, INFECT IMMUN, V33, P372, DOI 10.1128/IAI.33.2.372-379.1981
   Barbosa AS, 2010, INFECT IMMUN, V78, P3207, DOI 10.1128/IAI.00279-10
   Barbosa AS, 2009, INFECT IMMUN, V77, P1137, DOI 10.1128/IAI.01310-08
   Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   BOHMER A, 1989, EUR J BIOCHEM, V182, P327, DOI 10.1111/j.1432-1033.1989.tb14834.x
   Boonsilp S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001954
   Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643
   Bourhy P, 2005, J BACTERIOL, V187, P3931, DOI 10.1128/JB.187.12.3931-3940.2005
   Bourhy P, 2007, INFECT IMMUN, V75, P677, DOI 10.1128/IAI.01067-06
   Bourhy P, 2014, INT J SYST EVOL MICR, V64, P4061, DOI 10.1099/ijs.0.066597-0
   Bourhy P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002114
   Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839
   Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129
   Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7
   Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   Bulach DM, 2000, J MOL MICROB BIOTECH, V2, P375
   Bulach DM, 2000, INFECT IMMUN, V68, P3793, DOI 10.1128/IAI.68.7.3793-3798.2000
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348
   Castiblanco-Valencia MM, 2012, J INFECT DIS, V205, P995, DOI 10.1093/infdis/jir875
   Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0
   Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009
   Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614
   Chang YF, 2007, VACCINE, V25, P8190, DOI 10.1016/j.vaccine.2007.09.020
   Chappel RJ, 1998, EPIDEMIOL INFECT, V121, P473, DOI 10.1017/S095026889800137X
   Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145
   Chen YS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-294
   Chiani Y, 2016, INFECT GENET EVOL, V37, P245, DOI 10.1016/j.meegid.2015.11.033
   Chou LF, 2012, GENE, V511, P364, DOI 10.1016/j.gene.2012.09.074
   Choy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041566
   Choy HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016879
   Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08
   Davidsen T, 2010, NUCLEIC ACIDS RES, V38, pD340, DOI 10.1093/nar/gkp912
   Davie JJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-70
   de la Pena-Moctezuma A, 1999, FEMS MICROBIOL LETT, V177, P319, DOI 10.1111/j.1574-6968.1999.tb13749.x
   de la Pena-Moctezuma A, 2001, FEMS IMMUNOL MED MIC, V31, P73, DOI 10.1111/j.1574-695X.2001.tb01589.x
   Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478
   Dikken H, 1978, METHOD MICROBIOL, P259, DOI DOI 10.1016/S0580-9517(08)70493-8
   Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884
   Domingos R, 2015, MICROBIOLOGY
   Domingos RF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-50
   Drozd M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026336
   Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189
   Ebrahim A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-74
   Evangelista K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002672
   Evangelista KV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003215
   Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102
   Faine M, 1999, LEPTOSPIRA LEPTOSPIR
   FAINE S., 1994, LEPTOSPIRA LEPTOSPIR
   Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2
   Felsenstein J., 2009, PHYLIP PHYLOGENY INF
   Felsenstein J, 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X
   Fernandes LGV, 2014, MICROBIOL-SGM, V160, P149, DOI 10.1099/mic.0.072074-0
   Fernandes LGV, 2012, INFECT IMMUN, V80, P3679, DOI 10.1128/IAI.00474-12
   Figueira CP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-129
   Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367
   Fondi M, 2015, MICROBIOL RES, V171, P52, DOI 10.1016/j.micres.2015.01.003
   Fondi M, 2015, METHODS MOL BIOL, V1231, P233, DOI 10.1007/978-1-4939-1720-4_15
   Fong C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-170
   Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015
   Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141
   Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732
   Fouts DE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks757
   Fraga TR, 2014, J INFECT DIS, V209, P876, DOI 10.1093/infdis/jit569
   Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551
   Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375
   Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612
   Gonnet P, 2004, PROTEOMICS, V4, P1597, DOI 10.1002/pmic.200300749
   Gordienko EN, 2013, J BACTERIOL, V195, P2786, DOI 10.1128/JB.02285-12
   Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Gurobi Optimization I, 2014, GUR OPT REF MAN 2014
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998
   Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234
   Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060
   Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291
   Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47
   Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672
   Ho TD, 2012, CURR OPIN MICROBIOL, V15, P182, DOI 10.1016/j.mib.2012.01.001
   Hochedez P, 2013, EUROSURVEILLANCE, V18, P14
   Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103
   Hu Y, 2004, MYCOBACTERIUM TUBERC, P415
   Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498
   Islam MS, 2014, FEMS MICROBIOL LETT, V356, P39, DOI 10.1111/1574-6968.12495
   Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1
   Janwitthayanan W, 2013, MICROBIOL RES, V168, P268, DOI 10.1016/j.micres.2012.12.005
   JONES CJ, 1989, J BACTERIOL, V171, P3890, DOI 10.1128/jb.171.7.3890-3900.1989
   Kassegne K, 2014, J INFECT DIS, V209, P1105, DOI 10.1093/infdis/jit659
   Keener JP, 2010, J THEOR BIOL, V263, P481, DOI 10.1016/j.jtbi.2009.12.015
   KEENLEYSIDE WJ, 1994, MOL MICROBIOL, V11, P437, DOI 10.1111/j.1365-2958.1994.tb00325.x
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kumar VS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000308
   Laarman AJ, 2011, J IMMUNOL, V186, P6445, DOI 10.4049/jimmunol.1002948
   Lambert A, 2012, APPL ENVIRON MICROB, V78, P8467, DOI 10.1128/AEM.02288-12
   Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12
   Lehmann JS, 2014, PATHOGENS, V3, P280, DOI 10.3390/pathogens3020280
   Lehmann JS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002468
   Levett PN, 2015, CURR TOP MICROBIOL, V387, P11, DOI 10.1007/978-3-662-45059-8_2
   Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Levett PN, 2014, INT J SYST IN PRESS, V64
   Li SJ, 2010, INNATE IMMUN-LONDON, V16, P80, DOI 10.1177/1753425909105580
   Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253
   Longhi MT, 2009, J MED MICROBIOL, V58, P1275, DOI 10.1099/jmm.0.011916-0
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06
   Matthias MA, 2005, AM J TROP MED HYG, V73, P964, DOI 10.4269/ajtmh.2005.73.964
   Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213
   McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012
   McNally DJ, 2008, CHEMMEDCHEM, V3, P55, DOI 10.1002/cmdc.200700170
   Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60
   Mendes RS, 2011, INFECT IMMUN, V79, P4657, DOI 10.1128/IAI.05583-11
   Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003
   Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870
   Monk JM, 2013, P NATL ACAD SCI USA, V110, P20338, DOI 10.1073/pnas.1307797110
   MUNOA FJ, 1991, J BIOL CHEM, V266, P17667
   MURACHI T, 1987, BIOTECHNOL APPL BIOC, V9, P303, DOI 10.1111/j.1470-8744.1987.tb00479.x
   Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022
   Nalam K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012637
   Nally JE, 2005, PROTEOMICS, V5, P144, DOI 10.1002/pmic.200400880
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605
   Nickerson NN, 2008, MOL MICROBIOL, V69, P1530, DOI 10.1111/j.1365-2958.2008.06384.x
   Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76
   Oliveira R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002396
   Oliveira R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021962
   Oliveira TR, 2010, MICROBES INFECT, V12, P207, DOI 10.1016/j.micinf.2009.12.004
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Paetzel M, 2002, J BIOL CHEM, V277, P9512, DOI 10.1074/jbc.M110983200
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   Pallen MJ, 2005, TRENDS MICROBIOL, V13, P143, DOI 10.1016/j.tim.2005.02.008
   Park J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-545
   Perolat P, 1998, INT J SYST BACTERIOL, V48, P851, DOI 10.1099/00207713-48-3-851
   Petersen AM, 2001, J MED MICROBIOL, V50, P96, DOI 10.1099/0022-1317-50-1-96
   Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607
   Pinne M, 2012, J BACTERIOL, V194, P6074, DOI 10.1128/JB.01119-12
   Potempa M, 2012, BIOL CHEM, V393, P873, DOI 10.1515/hsz-2012-0174
   Qin JH, 2008, INFECT IMMUN, V76, P2411, DOI 10.1128/IAI.01730-07
   Que-Gewirth NLS, 2004, J BIOL CHEM, V279, P25420, DOI 10.1074/jbc.M400598200
   Raddi G, 2012, J BACTERIOL, V194, P1299, DOI 10.1128/JB.06474-11
   Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414
   RAMADASS P, 1992, INT J SYST BACTERIOL, V42, P215, DOI 10.1099/00207713-42-2-215
   RAMADASS P, 1990, INT J SYST BACTERIOL, V40, P231, DOI 10.1099/00207713-40-3-231
   Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Ricaldi JN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001853
   Ricaldi JN, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-161
   Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106
   Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097
   Rohwer F, 2003, CELL, V113, P141, DOI 10.1016/S0092-8674(03)00276-9
   Romero EC, 2011, J CLIN MICROBIOL, V49, P3940, DOI 10.1128/JCM.01119-11
   Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x
   Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137
   Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000
   SAINTGIRONS I, 1990, RES MICROBIOL, V141, P1131, DOI 10.1016/0923-2508(90)90086-6
   Saito M, 2013, INT J SYST EVOL MICR, V63, P2457, DOI 10.1099/ijs.0.047233-0
   Santos SR, 2004, ENVIRON MICROBIOL, V6, P754, DOI 10.1111/j.1462-2920.2004.00617.x
   Schoenhofen IC, 2009, GLYCOBIOLOGY, V19, P715, DOI 10.1093/glycob/cwp039
   Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0
   SHENBERG E, 1967, J BACTERIOL, V93, P1598, DOI 10.1128/JB.93.5.1598-1606.1967
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067
   Siqueira GH, 2013, AM J TROP MED HYG, V89, P1103, DOI 10.4269/ajtmh.13-0205
   Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108
   Souza NM, 2012, MICROB PATHOGENESIS, V53, P125, DOI 10.1016/j.micpath.2012.06.001
   STALHEIM OH, 1964, J BACTERIOL, V88, P48, DOI 10.1128/JB.88.1.48-54.1964
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102
   Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006
   Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0
   Toma C, 2011, CELL MICROBIOL, V13, P1783, DOI 10.1111/j.1462-5822.2011.01660.x
   Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006
   Vernikos G, 2015, CURR OPIN MICROBIOL, V23, P148, DOI 10.1016/j.mib.2014.11.016
   Vieira ML, 2014, FEMS MICROBIOL LETT, V352, P129, DOI 10.1111/1574-6968.12349
   Vieira ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/758513
   Vieira ML, 2010, J INFECTION, V60, P52, DOI 10.1016/j.jinf.2009.10.047
   Viriyakosol S, 2005, INFECT IMMU IN PRESS
   Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354
   Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101
   Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8
   Woodson JD, 2004, P NATL ACAD SCI USA, V101, P3591, DOI 10.1073/pnas.0305939101
   Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100
   YASUDA PH, 1987, INT J SYST BACTERIOL, V37, P407, DOI 10.1099/00207713-37-4-407
   Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618
   Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225
NR 214
TC 115
Z9 120
U1 1
U2 36
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2016
VL 10
IS 2
AR e0004403
DI 10.1371/journal.pntd.0004403
PG 57
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DH1TH
UT WOS:000372567300024
PM 26890609
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Sarno, M
   Sacramento, GA
   Khouri, R
   do Rosario, MS
   Costa, F
   Archanjo, G
   Santos, LA
   Nery, N
   Vasilakis, N
   Ko, AI
   de Almeida, ARP
AF Sarno, Manoel
   Sacramento, Gielson A.
   Khouri, Ricardo
   do Rosario, Mateus S.
   Costa, Federico
   Archanjo, Gracinda
   Santos, Luciane A.
   Nery, Nivison, Jr.
   Vasilakis, Nikos
   Ko, Albert I.
   de Almeida, Antonio R. P.
TI Zika Virus Infection and Stillbirths: A Case of Hydrops Fetalis,
   Hydranencephaly and Fetal Demise
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID OUTBREAK; BRAZIL
AB Background
   The rapid spread of Zika virus in the Americas and current outbreak of microcephaly in Brazil has raised attention to the possible deleterious effects that the virus may have on fetuses.
   Methodology/Principal Findings
   We report a case of a 20-year-old pregnant woman who was referred to our service after a large Zika virus outbreak in the city of Salvador, Brazil with an ultrasound examination that showed intrauterine growth retardation of the fetus at the 18th gestational week. Ultrasound examinations in the 2nd and 3rd trimesters demonstrated severe microcephaly, hydranencephaly, intracranial calcifications and destructive lesions of posterior fossa, in addition to hydrothorax, ascites and subcutaneous edema. An induced labor was performed at the 32nd gestational week due to fetal demise and delivered a female fetus. ZIKV-specific real-time polymerase chain reaction amplification products were obtained from extracts of cerebral cortex, medulla oblongata and cerebrospinal and amniotic fluid, while extracts of heart, lung, liver, vitreous body of the eye and placenta did not yield detectable products.
   Conclusions/Significance
   This case report provides evidence that in addition to microcephaly, there may be a link between Zika virus infection and hydrops fetalis and fetal demise. Given the recent spread of the virus, systematic investigation of spontaneous abortions and stillbirths may be warranted to evaluate the risk that ZIKV infection imparts on these outcomes.
C1 [Sarno, Manoel; do Rosario, Mateus S.; Archanjo, Gracinda; de Almeida, Antonio R. P.] Hosp Geral Roberto Santos, Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Sarno, Manoel; Costa, Federico; de Almeida, Antonio R. P.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Sarno, Manoel; Costa, Federico; de Almeida, Antonio R. P.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Sacramento, Gielson A.; Khouri, Ricardo; Costa, Federico; Santos, Luciane A.; Nery, Nivison, Jr.; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Ko, AI (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.; Ko, AI (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
EM albert.ko@yale.edu
RI Vasilakis, Nikos/ABE-7318-2020; Ko, Albert Icksang/P-2343-2015; Costa,
   Federico/G-1838-2015; Khouri, Ricardo/M-3184-2018; Pinto,
   Marcelo/G-7503-2012
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336; Khouri, Ricardo/0000-0001-5664-4436;
   Pinto, Marcelo/0000-0003-3462-7277; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602; do Rosario, Mateus/0000-0001-7404-6392
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI121207, R01AI121207, R01AI121207, R01AI121207] Funding Source: NIH
   RePORTER; FIC NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01 TW009504] Funding Source: Medline; NIAID
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI121207] Funding Source: Medline
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Brazil Ministry of Health, 2016, 11 BRAZ MIN HLTH
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci A, 2016, ZIKA VIRUS AM YET AN
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, N ENGL J MED
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 11
TC 209
Z9 215
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2016
VL 10
IS 2
AR e0004517
DI 10.1371/journal.pntd.0004517
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DH1TH
UT WOS:000372567300081
PM 26914330
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Lewnard, JA
   Antillon, M
   Gonsalves, G
   Miller, AM
   Ko, AI
   Pitzer, VE
AF Lewnard, Joseph A.
   Antillon, Marina
   Gonsalves, Gregg
   Miller, Alice M.
   Ko, Albert I.
   Pitzer, Virginia E.
TI Strategies to Prevent Cholera Introduction during International
   Personnel Deployments: A Computational Modeling Analysis Based on the
   2010 Haiti Outbreak
SO PLOS MEDICINE
LA English
DT Article
ID VIBRIO-CHOLERAE; DOUBLE-BLIND; PROTECTIVE EFFICACY; HOUSEHOLD CONTACTS;
   EPIDEMIC CHOLERA; RURAL BANGLADESH; B-SUBUNIT; EL-TOR; TETRACYCLINE;
   HYPERINFECTIVITY
AB Background
   Introduction of Vibrio cholerae to Haiti during the deployment of United Nations (UN) peacekeepers in 2010 resulted in one of the largest cholera epidemics of the modern era. Following the outbreak, a UN-commissioned independent panel recommended three predeployment intervention strategies to minimize the risk of cholera introduction in future peacekeeping operations: screening for V. cholerae carriage, administering prophylactic antimicrobial chemotherapies, or immunizing with oral cholera vaccines. However, uncertainty regarding the effectiveness of these approaches has forestalled their implementation by the UN. We assessed how the interventions would have impacted the likelihood of the Haiti cholera epidemic.
   Methods and Findings
   We developed a stochastic model for cholera importation and transmission, fitted to reported cases during the first weeks of the 2010 outbreak in Haiti. Using this model, we estimated that diagnostic screening reduces the probability of cases occurring by 82% (95% credible interval: 75%, 85%); however, false-positive test outcomes may hamper this approach. Antimicrobial chemoprophylaxis at time of departure and oral cholera vaccination reduce the probability of cases by 50% (41%, 57%) and by up to 61% (58%, 63%), respectively. Chemoprophylaxis beginning 1 wk before departure confers a 91% (78%, 96%) reduction independently, and up to a 98% reduction (94%, 99%) if coupled with vaccination. These results are not sensitive to assumptions about the background cholera incidence rate in the endemic troop-sending country. Further research is needed to (1) validate the sensitivity and specificity of rapid test approaches for detecting asymptomatic carriage, (2) compare prophylactic efficacy across antimicrobial regimens, and (3) quantify the impact of oral cholera vaccine on transmission from asymptomatic carriers.
   Conclusions
   Screening, chemoprophylaxis, and vaccination are all effective strategies to prevent cholera introduction during large-scale personnel deployments such as that precipitating the 2010 Haiti outbreak. Antimicrobial chemoprophylaxis was estimated to provide the greatest protection at the lowest cost among the approaches recently evaluated by the UN.
C1 [Lewnard, Joseph A.; Antillon, Marina; Gonsalves, Gregg; Ko, Albert I.; Pitzer, Virginia E.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Antillon, Marina; Gonsalves, Gregg; Miller, Alice M.; Ko, Albert I.] Yale Univ, Global Hlth Justice Partnership, New Haven, CT USA.
   [Gonsalves, Gregg; Miller, Alice M.] Yale Univ, Sch Law, New Haven, CT 06520 USA.
   [Miller, Alice M.] Yale Univ, Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT 06520 USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
RP Lewnard, JA (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
EM joseph.lewnard@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Ibrahim, Essam H./G-1960-2018
OI Ko, Albert Icksang/0000-0001-9023-2339; Ibrahim, Essam
   H./0000-0003-0130-2257; Pitzer, Virginia/0000-0003-1015-2289; Antillon,
   Marina/0000-0002-0235-6030
FU Bill and Melinda Gates FoundationBill & Melinda Gates Foundation
   [OPP1091919]; US National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01-AI112970, R01-TW009504, R01-AI052473]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW009504, R01TW009504, R01TW009504, R01TW009504, R01TW009504]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI121207, R01AI052473,
   R01AI052473, R01AI121207, R01AI112970, R01AI112970, R01AI121207,
   R01AI052473, R01AI052473, R01AI112970, R01AI052473, R01AI121207,
   R01AI052473, R01AI052473, R01AI052473, R01AI112970, R01AI112970,
   R01AI052473, R01AI052473, R01AI052473, R01AI121207] Funding Source: NIH
   RePORTER
FX The authors received support from the Bill and Melinda Gates Foundation
   (OPP1091919) and the US National Institutes of Health (R01-AI112970,
   R01-TW009504, R01-AI052473). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alam A, 2005, INFECT IMMUN, V73, P6674, DOI 10.1128/IAI.73.10.6674-6679.2005
   Alam NH, 2003, GUT, V52, P1419, DOI 10.1136/gut.52.10.1419
   Ali A, 2011, EMERG INFECT DIS, V17, P699, DOI 10.3201/eid1704.101973
   Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427
   Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1586
   [Anonymous], 2014, INT DRUG PRIC IND GU
   [Anonymous], 2012, HAIT 2009 POP DAT SE
   Azman AS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001867
   Azman AS, 2013, J INFECTION, V66, P432, DOI 10.1016/j.jinf.2012.11.013
   BART KJ, 1970, J INFECT DIS, V121, pS17, DOI 10.1093/infdis/121.Supplement.S17
   Barzilay EJ, 2013, NEW ENGL J MED, V368, P599, DOI 10.1056/NEJMoa1204927
   Bhuiyan NA, 2003, J CLIN MICROBIOL, V41, P3939, DOI 10.1128/JCM.41.8.3939-3941.2003
   BLACK RE, 1987, INFECT IMMUN, V55, P1116, DOI 10.1128/IAI.55.5.1116-1120.1987
   CASH RA, 1974, J INFECT DIS, V129, P45, DOI 10.1093/infdis/129.1.45
   Chakraborty S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00320
   Chao DL, 2014, CURR TOP MICROBIOL, V379, P195, DOI 10.1007/82_2013_307
   Chao DL, 2011, P NATL ACAD SCI USA, V108, P7081, DOI 10.1073/pnas.1102149108
   Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928
   Chretien JP, 2007, B WORLD HEALTH ORGAN, V85, P174, DOI 10.2471/BLT.06.037101
   CLEMENTS ML, 1982, J INFECT DIS, V145, P465, DOI 10.1093/infdis/145.4.465
   de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105
   Dick MH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001845
   Dowell SF, 2011, EMERG INFECT DIS, V17, P1299, DOI 10.3201/eid1707.110625
   Dutta D, 1996, J ANTIMICROB CHEMOTH, V37, P575, DOI 10.1093/jac/37.3.575
   ECHEVARRIA J, 1995, CLIN INFECT DIS, V20, P1480, DOI 10.1093/clinids/20.6.1480
   Ernst S, 2011, EMERG INFECT DIS, V17, P2155, DOI 10.3201/eid1711.110815
   Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145
   Faruque ASG, 2007, J HEALTH POPUL NUTR, V25, P241
   Gaudart J, 2013, PLOS NEGLECT TROP D, V7
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050
   Grad YH, 2012, EPIDEMIOLOGY, V23, P523, DOI 10.1097/EDE.0b013e3182572581
   Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X
   Harris JR, 2009, TROP MED INT HEALTH, V14, P1117, DOI 10.1111/j.1365-3156.2009.02335.x
   Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007
   Hossain MS, 2002, J HEALTH POPUL NUTR, V20, P18
   Houston S, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001822
   HUGHES JM, 1982, B WORLD HEALTH ORGAN, V60, P395
   Ivers LC, 2012, AM J TROP MED HYG, V86, P36, DOI 10.4269/ajtmh.2012.11-0435
   Jackson BR, 2013, AM J TROP MED HYG, V89, P654, DOI 10.4269/ajtmh.13-0208
   Jenson D, 2011, EMERG INFECT DIS, V17, P2130, DOI 10.3201/eid1711.110958
   Katz LS, 2013, MBIO, V4, DOI 10.1128/mBio.00398-13
   Lantagne D, 2014, CURR TOP MICROBIOL, V379, P145, DOI 10.1007/82_2013_331
   Leibovici-Weissman Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008625.pub2
   LEVINE MM, 1988, LANCET, V2, P468, DOI 10.1016/S0140-6736(88)90120-1
   LINDENBA.J, 1967, B WORLD HEALTH ORGAN, V36, P871
   McCormack WM, 1967, B WORLD HEALTH ORGAN, V38, P787
   Medrano Rojas P, ASSISTANT SECRETARY
   Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778
   Ministere de la sante publique et de la population, RAPP CHOL 01 MARS 20
   Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771
   Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674
   Orata FD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003967
   Patra FC, 1999, SCAND J INFECT DIS, V31, P151, DOI 10.1080/003655499750006191
   Piarroux R, 2011, EMERG INFECT DIS, V17, P1161, DOI 10.3201/eid1707.110059
   RABBANI GH, 1989, ANTIMICROB AGENTS CH, V33, P1447, DOI 10.1128/AAC.33.9.1447
   RENDTORFF RC, 1967, DIS COLON RECTUM, V10, P222, DOI 10.1007/BF02617184
   Reveiz L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027060
   Reyburn R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000952
   Sack DA, 1998, INFECT IMMUN, V66, P1968, DOI 10.1128/IAI.66.5.1968-1972.1998
   Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493
   SANCHEZ JL, 1994, LANCET, V344, P1273, DOI 10.1016/S0140-6736(94)90755-2
   Shin S, 2011, CLIN INFECT DIS, V52, P1343, DOI 10.1093/cid/cir141
   Steffen R, 1999, EMERG INFECT DIS, V5, P485, DOI 10.3201/eid0503.990331
   TAMAYO JF, 1965, B WORLD HEALTH ORGAN, V33, P645
   United Nations Peacekeeping, TROOP POL CONTR
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779
   Weil AA, 2009, CLIN INFECT DIS, V49, P1473, DOI 10.1086/644779
   WOODWARD WE, 1972, AM J EPIDEMIOL, V96, P342, DOI 10.1093/oxfordjournals.aje.a121465
NR 71
TC 17
Z9 17
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD JAN
PY 2016
VL 13
IS 1
AR e1001947
DI 10.1371/journal.pmed.1001947
PG 23
WC Medicine, General & Internal
SC General & Internal Medicine
GA DC7AL
UT WOS:000369370600014
PM 26812236
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Hagan, JE
   Moraga, P
   Costa, F
   Capian, N
   Ribeiro, GS
   Wunder, EA
   Felzemburgh, RDM
   Reis, RB
   Nery, N
   Santana, FS
   Fraga, D
   dos Santos, BL
   Santos, AC
   Queiroz, A
   Tassinari, W
   Carvalho, MS
   Reis, MG
   Diggle, PJ
   Ko, AI
AF Hagan, Jose E.
   Moraga, Paula
   Costa, Federico
   Capian, Nicolas
   Ribeiro, Guilherme S.
   Wunder, Elsio A., Jr.
   Felzemburgh, Ridalva D. M.
   Reis, Renato B.
   Nery, Nivison
   Santana, Francisco S.
   Fraga, Deborah
   dos Santos, Balbino L.
   Santos, Andreia C.
   Queiroz, Adriano
   Tassinari, Wagner
   Carvalho, Marilia S.
   Reis, Mitermayer G.
   Diggle, Peter J.
   Ko, Albert I.
TI Spatiotemporal Determinants of Urban Leptospirosis Transmission:
   Four-Year Prospective Cohort Study of Slum Residents in Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RATS RATTUS-NORVEGICUS; ENVIRONMENT; EPIDEMIC; OUTBREAK; INTERROGANS;
   INFECTION; GENETICS; SALVADOR; DISEASE; DENGUE
AB Background
   Rat-borne leptospirosis is an emerging zoonotic disease in urban slum settlements for which there are no adequate control measures. The challenge in elucidating risk factors and informing approaches for prevention is the complex and heterogeneous environment within slums, which vary at fine spatial scales and influence transmission of the bacterial agent.
   Methodology/Principal Findings
   We performed a prospective study of 2,003 slum residents in the city of Salvador, Brazil during a four-year period (2003-2007) and used a spatiotemporal modelling approach to delineate the dynamics of leptospiral transmission. Household interviews and Geographical Information System surveys were performed annually to evaluate risk exposures and environmental transmission sources. We completed annual serosurveys to ascertain leptospiral infection based on serological evidence. Among the 1,730 (86%) individuals who completed at least one year of follow-up, the infection rate was 35.4 (95% CI, 30.7-40.6) per 1,000 annual follow-up events. Male gender, illiteracy, and age were independently associated with infection risk. Environmental risk factors included rat infestation (OR 1.46, 95% CI, 1.00-2.16), contact with mud (OR 1.57, 95% CI 1.17-2.17) and lower household elevation (OR 0.92 per 10m increase in elevation, 95% CI 0.82-1.04). The spatial distribution of infection risk was highly heterogeneous and varied across small scales. Fixed effects in the spatiotemporal model accounted for the majority of the spatial variation in risk, but there was a significant residual component that was best explained by the spatial random effect. Although infection risk varied between years, the spatial distribution of risk associated with fixed and random effects did not vary temporally. Specific "hot-spots" consistently had higher transmission risk during study years.
   Conclusions/Significance
   The risk for leptospiral infection in urban slums is determined in large part by structural features, both social and environmental. Our findings indicate that topographic factors such as household elevation and inadequate drainage increase risk by promoting contact with mud and suggest that the soil-water interface serves as the environmental reservoir for spillover transmission. The use of a spatiotemporal approach allowed the identification of geographic outliers with unexplained risk patterns. This approach, in addition to guiding targeted community-based interventions and identifying new hypotheses, may have general applicability towards addressing environmentally-transmitted diseases that have emerged in complex urban slum settings.
C1 [Hagan, Jose E.; Costa, Federico; Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Moraga, Paula; Capian, Nicolas; Diggle, Peter J.] Univ Lancaster, Div Med, Lancaster, England.
   [Costa, Federico; Ribeiro, Guilherme S.; Felzemburgh, Ridalva D. M.; Reis, Renato B.; Nery, Nivison; Santana, Francisco S.; Fraga, Deborah; dos Santos, Balbino L.; Santos, Andreia C.; Queiroz, Adriano; Reis, Mitermayer G.; Ko, Albert I.] Minist Saude, Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Tassinari, Wagner; Carvalho, Marilia S.] Minist Saude, Fdn Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
RP Ko, AI (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.; Ko, AI (corresponding author), Minist Saude, Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
EM albert.ko@yale.edu
RI Wunder, Elsio Augusto/C-2733-2013; Costa, Federico/G-1838-2015; Queiroz,
   Adriano/AAQ-1164-2020; CARVALHO, MARILIA/AAD-8283-2020; Hagan,
   Jose/N-6719-2019; Ko, Albert Icksang/P-2343-2015; Ribeiro,
   Guilherme/B-6624-2008; CARVALHO, MARILIA S/C-3425-2013; Reis,
   Mitermayer/AAO-9742-2020
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Costa,
   Federico/0000-0001-6951-2336; Queiroz, Adriano/0000-0003-0080-6509;
   CARVALHO, MARILIA/0000-0002-9566-0284; Hagan, Jose/0000-0002-1837-6319;
   Ko, Albert Icksang/0000-0001-9023-2339; Ribeiro,
   Guilherme/0000-0002-6798-2059; Reis, Mitermayer/0000-0002-3051-9060;
   /0000-0001-5266-0201; Santos, Balbino Lino dos/0000-0002-6430-229X;
   Diggle, Peter/0000-0003-3521-5020; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602
FU Oswaldo Cruz Foundation; Secretariat of Health Surveillance, Brazilian
   Ministry of Health; CAPES (Coordination for the Improvement of Higher
   Education Personnel)CAPES; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 AI052473, U01 AI088752, R01 TW009504, R24 TW007988, R25
   TW009338, D43 TW00919]; Wellcome TrustWellcome Trust [102330/Z/13/Z];
   Brazilian Ministry of Education; Medical Research CouncilMedical
   Research Council UK (MRC) [G0902153] Funding Source: researchfish;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R24TW007988, R25TW009338,
   R01TW009504, R24TW007988, R24TW007988, R25TW009338, R25TW009338,
   R25TW009338, R24TW007988, D43TW000919, D43TW000919, R01TW009504,
   R24TW007988, R24TW007988, R01TW009504, R25TW009338, R25TW009338,
   D43TW000919, R25TW009338, R01TW009504, D43TW000919, R25TW009338,
   R25TW009338, D43TW000919, R25TW009338, D43TW000919, R01TW009504,
   D43TW000919, R25TW009338, R24TW007988, R25TW009338, R24TW007988,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U01AI088752, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, R01AI121207, R01AI052473, R01AI052473,
   U01AI088752, U01AI088752, R01AI121207, R01AI121207, R01AI121207,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, U01AI088752,
   R01AI052473, R01AI121207, R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the Oswaldo Cruz Foundation and Secretariat
   of Health Surveillance, Brazilian Ministry of Health; CAPES
   (Coordination for the Improvement of Higher Education Personnel),
   Brazilian Ministry of Education; the National Institutes of Health
   (grants R01 AI052473, U01 AI088752, R01 TW009504, R24 TW007988, R25
   TW009338 and D43 TW00919) and by the Wellcome Trust [102330/Z/13/Z]. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Agampodi SB, 2011, AM J TROP MED HYG, V85, P471, DOI 10.4269/ajtmh.2011.11-0276
   AKAIKE H, 1978, ANN I STAT MATH, V30, P9, DOI 10.1007/BF02480194
   Bacallao J, 2014, INT J ENV RES PUB HE, V11, P8301, DOI 10.3390/ijerph110808301
   Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59
   Barcellos C, 2000, INT J ENVIRON HEAL R, V10, P301, DOI 10.1080/0960312002001500
   Barros FC, 2001, INT J EPIDEMIOL, V30, P1001, DOI 10.1093/ije/30.5.1001
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Costa F, PLOS NEGL T IN PRESS
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   De A, 2002, INDIAN J MED MICROBI, V20, P153
   de Araujo WN, 2013, AM J TROP MED HYG, V88, P359, DOI 10.4269/ajtmh.2012.12-0245
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02
   HELLSTROM JS, 1978, RES VET SCI, V25, P29, DOI 10.1016/S0034-5288(18)33003-0
   Instituto Brasileiro de Geografia e Estadistica [Brazilian Institute of Geography and Statistics], 2010, POP RES TOT URB TOT
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455
   Karande Sunil, 2002, Indian Journal of Pediatrics, V69, P855, DOI 10.1007/BF02723705
   Kaur I R, 2003, J Assoc Physicians India, V51, P249
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Maskey M, 2006, Indian J Med Microbiol, V24, P337
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Porter FH, 2015, J MAMMAL, V96, P317, DOI 10.1093/jmammal/gyv033
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Torgerson PR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004122
   Travassos Claudia, 2004, Cad. Saúde Pública, V20, P660, DOI 10.1590/S0102-311X2004000300003
   Wood S. N., 2006, INTRO R
NR 41
TC 65
Z9 66
U1 1
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2016
VL 10
IS 1
AR e0004275
DI 10.1371/journal.pntd.0004275
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DH1SR
UT WOS:000372565700011
PM 26771379
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Sgarbi, RVE
   Carbone, ADS
   Paiao, DSG
   Lemos, EF
   Simionatto, S
   Puga, MAM
   Motta-Castro, ARC
   Pompilio, MA
   Urrego, J
   Ko, AI
   Andrews, JR
   Croda, J
AF Enne Sgarbi, Renata Viebrantz
   Santos Carbone, Andrea da Silva
   Guimaraes Paiao, Dayse Sanchez
   Lemos, Everton Ferreira
   Simionatto, Simone
   Moreira Puga, Marco Antonio
   Coimbra Motta-Castro, Ana Rita
   Pompilio, Mauricio Antonio
   Urrego, Juliana
   Ko, Albert I.
   Andrews, Jason R.
   Croda, Julio
TI A Cross-Sectional Survey of HIV Testing and Prevalence in Twelve
   Brazilian Correctional Facilities
SO PLOS ONE
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTING DRUG-USE; SAO-PAULO;
   RISK-FACTORS; SEROPREVALENCE; PRISONERS; HEPATITIS; SYPHILIS; INMATES;
   STATE
AB Background
   Prior studies have reported higher HIV prevalence among prisoners than the general population in Brazil, but data have been derived from single prisons. The aim of this study was to evaluate HIV testing practices, prevalence and linkage to care among inmates in a network of 12 prisons.
   Methods
   We administered a questionnaire to a population-based sample of inmates from 12 prisons in Central-West Brazil and collected sera for HIV and syphilis testing from January to December 2013. We evaluated factors associated with HIV testing and infection using multivariable logistic regression models. Six months after HIV testing, we assessed whether each HIV-infected prisoner was engaged in clinical care and whether they had started anti-retroviral therapy.
   Results
   We recruited 3,362 inmates, of whom 2,843 (85%) were men from 8 prisons, and 519 (15%) were women from 4 prisons. Forty-five percent of participants reported never having been tested for HIV previously. In multivariable analysis, the variables associated with previous HIV testing were lack of a stable partner (adjusted odds ratio [AOR]: 1.38; 95% CI: 1.18-1.60), completed more than four years of schooling (AOR 1.40; 95% CI: 1.20-1.64), history of previous incarceration (AOR: 1.68; 95% CI: 1.43-1.98), history of mental illness (AOR 1.52; 95% CI: 1.31-1.78) and previous surgery (AOR 1.31; 95% CI: 1.12-1.52). Fifty-four (1.6%) of all participants tested positive for HIV; this included 44 (1.54%) men and 10 (1.92%) women. Among male inmates, HIV infection was associated with homosexuality (AOR 6.20, 95% CI: 1.73-22.22), self-report of mental illness (AOR 2.18, 95% CI: 1.13-4.18), history of sexually transmitted infections (AOR 3.28, 95% CI: 1.64-6.56), and syphilis sero-positivity (AOR 2.54, 95% CI: 1.20-5.39). Among HIV-infected individuals, 34 (63%) were unaware of their HIV status; only 23 of these 34 (68%) newly diagnosed participants could be reached at six month follow-up, and 21 of 23 (91%) were engaged in HIV care.
   Conclusions
   HIV testing rates among prison inmates are low, and the majority of HIV-infected inmates were unaware of their HIV diagnosis. Incarceration can be an opportunity for diagnosis and treatment of HIV among vulnerable populations who have poor access to health services, but further work is needed on transitional HIV care for released inmates.
C1 [Enne Sgarbi, Renata Viebrantz; Santos Carbone, Andrea da Silva; Guimaraes Paiao, Dayse Sanchez] Fed Univ Grande Dourados, Univ Hosp, Dourados, Brazil.
   [Lemos, Everton Ferreira; Croda, Julio] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil.
   [Simionatto, Simone] Fed Univ Grande Dourados, Fac Ambiental & Biol Sci, Dourados, Brazil.
   [Moreira Puga, Marco Antonio; Coimbra Motta-Castro, Ana Rita] Univ Fed Mato Grosso do Sul, Dept Biochem Pharm, Campo Grande, Brazil.
   [Coimbra Motta-Castro, Ana Rita] Fundacao Oswaldo Cruz, Campo Grande, Brazil.
   [Pompilio, Mauricio Antonio] Univ Fed Mato Grosso do Sul, Fac Med, Campo Grande, Brazil.
   [Urrego, Juliana; Ko, Albert I.] Yale Univ, Dept Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Andrews, Jason R.] Stanford Univ, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA.
RP Croda, J (corresponding author), Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil.
EM juliocroda@ufgd.edu.br
RI Lemos, Everton EFL Ferreira/J-5831-2015; motta-castro, ana rita
   c/O-2075-2017; Ko, Albert Icksang/P-2343-2015; Simionatto,
   Simone/AAG-7509-2020; Croda, Julio/I-5172-2013
OI Lemos, Everton EFL Ferreira/0000-0001-6652-9191; Ko, Albert
   Icksang/0000-0001-9023-2339; Simionatto, Simone/0000-0003-2367-0915;
   Croda, Julio/0000-0002-6665-6825; Andrews, Jason/0000-0002-5967-251X;
   Motta-Castro, Ana Rita/0000-0003-3070-1337
FU Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do
   Estado do Mato Grosso do Sul (FUNDECT)Fundect [0067/2012]; Ministry of
   Education (PROEXT), Secretary of Health Surveillance [SVS/MS-20/2013];
   Brazilian National Research Council (Ciencias sem Fronteiras Program);
   Fogarty Global Health Equity Scholars Program [NIH 1 R25 TW009338];
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338] Funding
   Source: NIH RePORTER
FX This work received support from the following sources: Fundacao de Apoio
   ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado do Mato
   Grosso do Sul (FUNDECT, 0067/2012, http://fundect.ledes.net/) and the
   Ministry of Education (PROEXT 2014,
   http://portal.mec.gov.br/index.php?option=com_content&view=article&id=12
   243:proextapresentacao&catid=235:proext-programa-de-extensao-universitar
   ia-&Itemid=487), Secretary of Health Surveillance (SVS/MS-20/2013). AIK
   received support from the Brazilian National Research Council (Ciencias
   sem Fronteiras Program, http://www.cienciasemfronteiras.gov.br/web/csf),
   and AIK and JRA received support from Fogarty Global Health Equity
   Scholars Program (NIH 1 R25 TW009338, http://ghes.berkeley.edu/).
CR [Anonymous], 2009, HIV TEST COUNS PRIS
   BRASIL, 2013, B EP HIV AIDS, V01
   BRASIL, 2005, PLAN NAC SAUD SIST P
   BRASIL. Ministerio da Saude, 2012, POL BRAS ENFR AIDS R
   Burattini MN, 2000, REV SAUDE PUBL, V34, P431, DOI 10.1590/S0034-89102000000500001
   Burattini MN, 2005, INT J STD AIDS, V16, P836, DOI 10.1258/095646205774988136
   Catalan-Soares B C, 2000, Rev Soc Bras Med Trop, V33, P27, DOI 10.1590/S0037-86822000000100004
   de Albuquerque ACC, 2014, CIENC SAUDE COLETIVA, V19, P2125, DOI 10.1590/1413-81232014197.08602013
   Coelho HC, 2007, CAD SAUDE PUBLICA, V23, P2197, DOI 10.1590/S0102-311X2007000900027
   de Almeida MC, 2014, AIDS BEHAV, V18, P2387, DOI 10.1007/s10461-014-0812-1
   DEPEN Ministerio da Justica. Secretaria Nacional de Justica. Departamento Penitenciario Nacional, 2012, SIST INT INF PEN INF
   de Lemos LMD, 2013, AIDS CARE, V25, P691, DOI 10.1080/09540121.2013.764389
   El Maerrawi I, 2015, INT J STD AIDS, V26, P120, DOI 10.1177/0956462414531242
   Francisco RBL, 2009, INFECCAO PELO VIRUS
   GABE Cristina, 2008, RBAC, V40, P87
   Gough E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-777
   Haghdoost AA, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-32
   Jurgens R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-26
   Jurgens R, 2009, LANCET INFECT DIS, V9, P57, DOI 10.1016/S1473-3099(08)70305-0
   MacGowan R, 2009, SEX TRANSM DIS, V36, pS9, DOI 10.1097/OLQ.0b013e318148b6b1
   Marins JR, 2000, AIDS BEHAV, V4
   Maruschak LM, 2012, 238877 NCJ US DEP JU
   Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2
   Osti NM, 1999, MEM I OSWALDO CRUZ, V94, P479, DOI 10.1590/S0074-02761999000400009
   Pistarin Berra Jose Antonio, 2006, Revista do Instituto Adolfo Lutz, V65, P133
   Poulin C, 2007, CAN MED ASSOC J, V177, P252, DOI 10.1503/cmaj.060760
   Reis CB, 2011, CIENC SAUDE COLETIVA, V16, P3331, DOI 10.1590/S1413-81232011000800032
   Rodriguez-Diaz CE, 2014, J INT ASS PROVID AID
   Semaille C, 2013, EURO SURVEILL, V18
   Spaulding A, 2002, CLIN INFECT DIS, V35, P305, DOI 10.1086/341418
   Strazza L, 2004, BRAZ J MED BIOL RES, V37, P771, DOI 10.1590/S0100-879X2004000500020
   UNODC, 2013, WORLD DRUG REP
   Walmsley R., 2013, WORLD PRISON POPULAT
   WHO UNODC UNAIDS, 2007, EFF INT ADDR HIV PRI
   World Health Organization United Nations Office on Drugs and Crime & Joint United Nations Programme on HIV/AIDS, 2013, HIV PREV TREATM CAR
NR 35
TC 19
Z9 19
U1 1
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 14
PY 2015
VL 10
IS 10
AR e0139487
DI 10.1371/journal.pone.0139487
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CU0CK
UT WOS:000363183100049
PM 26466312
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Urrego, J
   Ko, AI
   Carbone, ADS
   Paiao, DSG
   Sgarbi, RVE
   Yeckel, CW
   Andrews, JR
   Crodat, J
AF Urrego, Juliana
   Ko, Albert I.
   Santos Carbone, Andrea da Silva
   Guimaraes Paiao, Dayse Sanchez
   Enne Sgarbi, Renata Viebrantz
   Yeckel, Catherine W.
   Andrews, Jason R.
   Crodat, Julio
TI The Impact of Ventilation and Early Diagnosis on Tuberculosis
   Transmission in Brazilian Prisons
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID LATENT TUBERCULOSIS; AIRBORNE INFECTION; TB TRANSMISSION; RISK; AIR;
   VARIABILITY; IRRADIATION; PEOPLE; ROOM
AB Prisoners have among the highest incidence of tuberculosis (TB) globally. However, the contribution of the prison environment on transmission is not well understood and structural characteristics have received little attention as effective epidemiological interventions in TB control. We evaluated architectural characteristics and estimated ventilation rates in 141 cells in three prisons in central west Brazil using steady-state exhaled carbon dioxide (CO2) levels. We used a modified Wells-Riley equation to estimate the probability of infection for inmates sharing a cell with an infectious case and projected the impact of interventions, including early diagnosis and improved ventilation. Overall, prison cells were densely populated (mean 2.1 m(2) per occupant) and poorly ventilated, with only three cells meeting World Health Organization (WHO) standards for per-person ventilation (60 L/s) applied in infection control settings. In the absence of interventions, projected mean risk of infection was 78.0% during a 6-month period. Decreasing time-to-diagnosis by 25% reduced transmission risk by 8.3%. Improving ventilation to WHO standards decreased transmission by 38.2%, whereas optimizing cross-ventilation reduced transmission by 64.4%. Prison environments promote high infection risk over short-time intervals. In this context, enhanced diagnostics have a limited impact on reducing transmission. Improving natural ventilation may be required to effectively control TB in prisons.
C1 Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   Minist Saude, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   Fundacao Univ Fed Grande Dourados, Hosp Univ Dourados, Dourados, Brazil.
   Stanford Univ, Sch Med, Stanford, CA 94305 USA.
   Fundacao Univ Fed Grande Dourados, Fac Ciencias Saude, Dourados, Brazil.
   Minist Saude, Fundacao Oswaldo Cruz, Campo Grande, Brazil.
RP Andrews, JR (corresponding author), Stanford Univ, Sch Med, Div Infect Dis & Geog Med, 300 Pasteur Dr,L141, Stanford, CA 94305 USA.
EM jandr@stanford.edu
RI Croda, Julio/I-5172-2013; Ko, Albert Icksang/P-2343-2015
OI Croda, Julio/0000-0002-6665-6825; Ko, Albert
   Icksang/0000-0001-9023-2339; Andrews, Jason/0000-0002-5967-251X
FU Foundation for the Development of Teaching, Science, and Technology of
   the State of Mato Grosso do SulFundect [0067/12, 0059/13]; Secretariat
   of Health Surveillance, Brazilian Ministry of Health [20/2013]; Ciencias
   sem Fronteiras Program of the Brazilian National Research Council;
   Fogarty Global Health Equity Scholars Program (NIH) [1 R25 TW009338];
   Jan A. J. Stolwijk Fellowship at the Yale School of Public Health;
   National Institute of Allergy and Infectious DiseaseUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [K01 AI104411]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [K01AI104411, K01AI104411,
   K01AI104411, K01AI104411, K01AI104411] Funding Source: NIH RePORTER
FX This work was supported by Foundation for the Development of Teaching,
   Science, and Technology of the State of Mato Grosso do Sul (0067/12 and
   0059/13); Secretariat of Health Surveillance, Brazilian Ministry of
   Health (20/2013); Ciencias sem Fronteiras Program of the Brazilian
   National Research Council; Fogarty Global Health Equity Scholars Program
   (NIH 1 R25 TW009338); Jan A. J. Stolwijk Fellowship at the Yale School
   of Public Health (to J.U.); and National Institute of Allergy and
   Infectious Disease (K01 AI104411 to J.R.A.). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Andrews JR, 2013, AM J EPIDEMIOL, V177, P556, DOI 10.1093/aje/kws331
   Basu S, 2011, AM J TROP MED HYG, V84, P30, DOI 10.4269/ajtmh.2011.10-0472
   Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381
   Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0
   Brazilian Ministry of Justice, 2012, STAT REP AN PRIS SYS
   Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002
   de Oliveira SMDL, 2011, J BRAS PNEUMOL, V37, P646, DOI 10.1590/S1806-37132011000500012
   Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068
   Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043
   Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188
   Estevan AO, 2013, REV SOC BRAS MED TRO, V46, P515, DOI 10.1590/0037-8682-1441-2013
   Fournet N, 2006, PUBLIC HEALTH, V120, P976, DOI 10.1016/j.puhe.2006.06.004
   International Centre for Prison Studies, 2013, WORLD PRIS BRIEF BRA
   Johnstone-Robertson S, 2011, SAMJ S AFR MED J, V101, P809
   Ko GP, 2001, RISK ANAL, V21, P657, DOI 10.1111/0272-4332.214142
   Kuhleis D, 2012, MEM I OSWALDO CRUZ, V107, P909, DOI 10.1590/S0074-02762012000700012
   Lygizos M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-300
   Middelkoop K, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-221
   Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9
   Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
   NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302
   Nogueira PA, 2012, REV SAUDE PUBL, V46, P119, DOI 10.1590/S0034-89102011005000080
   Persily A., 1997, ASHRAE T, V103, P1
   Pinna GD, 2006, AM J PHYSIOL-HEART C, V290, pH424, DOI 10.1152/ajpheart.00438.2005
   Qian H, 2010, BUILD ENVIRON, V45, P559, DOI 10.1016/j.buildenv.2009.07.011
   RILEY RL, 1962, AM REV RESPIR DIS, V85, P511
   Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x
   Sanchez A, 2009, INT J TUBERC LUNG D, V13, P1247
   Sanchez A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-983
   Carbone ADS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0764-8
   Spengler JD, 2000, ANNU REV ENERG ENV, V25, P567, DOI 10.1146/annurev.energy.25.1.567
   Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020
   SULTAN L, 1960, AM REV RESPIR DIS, V82, P358
   Turiel I, 1982, ASHRAE T, V88, P12
   Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9
   WHO, 2009, WHO POL TB INF CONTR
   Winetsky DE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001348
   World Health Organization (WHO), 2009, NAT VENT INF CONTR H
NR 38
TC 20
Z9 20
U1 0
U2 11
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2015
VL 93
IS 4
BP 739
EP 746
DI 10.4269/ajtmh.15-0166
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA CS8BX
UT WOS:000362311800014
PM 26195459
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Torgerson, PR
   Hagan, JE
   Costa, F
   Calcagno, J
   Kane, M
   Martinez-Silveira, MS
   Goris, MGA
   Stein, C
   Ko, AI
   Abela-Ridder, B
AF Torgerson, Paul R.
   Hagan, Jose E.
   Costa, Federico
   Calcagno, Juan
   Kane, Michael
   Martinez-Silveira, Martha S.
   Goris, Marga G. A.
   Stein, Claudia
   Ko, Albert I.
   Abela-Ridder, Bernadette
TI Global Burden of Leptospirosis: Estimated in Terms of Disability
   Adjusted Life Years
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID FEBRILE ILLNESS; CONGENITAL TOXOPLASMOSIS; NORTHERN TANZANIA; DISEASE;
   BRAZIL; ETIOLOGY; THAILAND; INJURY; DALYS
AB Background
   Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis can cause life-threatening disease, there is no global burden of disease estimate in terms of Disability Adjusted Life Years (DALYs) available.
   Methodology/Principal Findings
   We utilised the results of a parallel publication that reported global estimates of morbidity and mortality due to leptospirosis. We estimated Years of Life Lost (YLLs) from age and gender stratified mortality rates. Years of Life with Disability (YLDs) were developed from a simple disease model indicating likely sequelae. DALYs were estimated from the sum of YLLs and YLDs. The study suggested that globally approximately 2.90 million DALYs are lost per annum (UIs 1.25-4.54 million) from the approximately annual 1.03 million cases reported previously. Males are predominantly affected with an estimated 2.33 million DALYs (UIs 0.98-3.69) or approximately 80% of the total burden. For comparison, this is over 70% of the global burden of cholera estimated by GBD 2010. Tropical regions of South and South-east Asia, Western Pacific, Central and South America, and Africa had the highest estimated leptospirosis disease burden.
   Conclusions/Significance
   Leptospirosis imparts a significant health burden worldwide, which approach or exceed those encountered for a number of other zoonotic and neglected tropical diseases. The study findings indicate that highest burden estimates occur in resource-poor tropical countries, which include regions of Africa where the burden of leptospirosis has been under-appreciated and possibly misallocated to other febrile illnesses such as malaria.
C1 [Torgerson, Paul R.] Univ Zurich, Epidemiol Sect, Vetsuisse Fac, Zurich, Switzerland.
   [Hagan, Jose E.; Costa, Federico; Calcagno, Juan; Martinez-Silveira, Martha S.; Ko, Albert I.] Fundacao Oswaldo Cruz, Minist Saude, Salvador, BA, Brazil.
   [Hagan, Jose E.; Costa, Federico; Ko, Albert I.] Yale Univ, Dept Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT USA.
   [Costa, Federico] Fed Univ Bahia UFBA, Inst Collect Hlth, Salvador, BA, Brazil.
   [Kane, Michael] Yale Univ, Ctr Analyt Sci, Sch Publ Hlth, New Haven, CT USA.
   [Goris, Marga G. A.] KIT Biomed Res, Royal Trop Inst, WHO FAO OIE, Amsterdam, Netherlands.
   [Goris, Marga G. A.] KIT Biomed Res, Royal Trop Inst, Natl Leptospirosis Reference Ctr, Amsterdam, Netherlands.
   [Stein, Claudia] WHO, Reg Off Europe, Div Informat Evidence Res & Innovat DIR, DK-2100 Copenhagen, Denmark.
   [Abela-Ridder, Bernadette] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland.
RP Torgerson, PR (corresponding author), Univ Zurich, Epidemiol Sect, Vetsuisse Fac, Zurich, Switzerland.
EM abelab@who.int
RI Martinez-Silveira, Martha Silvia/O-7270-2014; Torgerson, Paul
   R/M-4447-2013; Ko, Albert Icksang/P-2343-2015; Torgerson, Paul
   R/A-7510-2010; Hagan, Jose/N-6719-2019; Costa, Federico/G-1838-2015
OI Martinez-Silveira, Martha Silvia/0000-0002-1004-1784; Torgerson, Paul
   R/0000-0003-4277-9983; Ko, Albert Icksang/0000-0001-9023-2339;
   Torgerson, Paul R/0000-0003-4277-9983; Hagan, Jose/0000-0002-1837-6319;
   Costa, Federico/0000-0001-6951-2336
FU World Health OrganizationWorld Health Organization; Brazilian Ministry
   of Education; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI052473, U01 AI088752, D43 TW00919, R25 TW009338, T32 AI007172, R24
   TW007988]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R25TW009338, D43TW000919,
   R25TW009338, R01TW009504, R24TW007988, R24TW007988, R25TW009338,
   R25TW009338, R25TW009338, D43TW000919, R01TW009504, R24TW007988,
   R24TW007988, R25TW009338, D43TW000919, D43TW000919, D43TW000919,
   R24TW007988, R25TW009338, R01TW009504, R01TW009504, R24TW007988,
   R25TW009338, R25TW009338, R25TW009338, D43TW000919, D43TW000919,
   R01TW009504, R25TW009338, R24TW007988, D43TW000919, R25TW009338,
   D43TW000919, D43TW000919, R25TW009338, R24TW007988, D43TW000919] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI052473, T32AI007172, T32AI007172,
   T32AI007172, T32AI007172, R01AI121207, T32AI007172, T32AI007172,
   T32AI007172, R01AI121207, T32AI007172, T32AI007172, T32AI007172,
   T32AI007172, T32AI007172, R01AI052473, T32AI007172, T32AI007172,
   T32AI007172, T32AI007172, R01AI052473, R01AI052473, T32AI007172,
   R01AI052473, R01AI052473, T32AI007172, T32AI007172, T32AI007172,
   R01AI052473, T32AI007172, R01AI052473, R01AI052473, T32AI007172,
   T32AI007172, U01AI088752, T32AI007172, T32AI007172, R01AI121207,
   R01AI052473, T32AI007172, T32AI007172, T32AI007172, T32AI007172,
   U01AI088752, U01AI088752, R01AI052473, T32AI007172, U01AI088752,
   T32AI007172, U01AI088752, T32AI007172, T32AI007172, T32AI007172,
   U01AI088752, R01AI121207] Funding Source: NIH RePORTER
FX This work was supported by the World Health Organization, Brazilian
   Ministry of Education and National Institutes of Health (R01 AI052473,
   U01 AI088752, D43 TW00919, R25 TW009338, T32 AI007172, R24 TW007988).
   The World Health Organization approved the final manuscript before
   publication and thus their permission was required before the decision
   to publish. Two of the co-authors are also employees of the WHO. Thus
   the WHO did have an input into the the study design, analysis,
   preparation of the manuscript and decision to publish. Other funders
   played no role in these areas.
CR Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Biggs HM, 2011, AM J TROP MED HYG, V85, P275, DOI 10.4269/ajtmh.2011.11-0176
   Carles G., 1995, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V24, P418
   Clement J, 1999, LANCET, V354, P2003, DOI 10.1016/S0140-6736(05)76782-9
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324
   Goris MGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076549
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003709
   Ismail TF, 2006, AM J TROP MED HYG, V75, P1085, DOI 10.4269/ajtmh.2006.75.1085
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kortbeek LM, 2009, MEM I OSWALDO CRUZ, V104, P370, DOI 10.1590/S0074-02762009000200034
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Manock SR, 2009, AM J TROP MED HYG, V81, P146, DOI 10.4269/ajtmh.2009.81.146
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6
   MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429
   Pappachan Joseph M, 2007, Indian J Med Sci, V61, P441
   Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011
   Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8
   SHAKED Y, 1993, CLIN INFECT DIS, V17, P241, DOI 10.1093/clinids/17.2.241
   Souza Verena Maria Mendes de, 2011, Rev. Saúde Pública, V45, P1001, DOI 10.1590/s0034-89102011005000070
   Stein C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000161
   Suttinont C, 2006, ANN TROP MED PARASIT, V100, P363, DOI 10.1179/136485906X112158
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   WHO, 2011, 2 M LEPT BURD EP REF, P37
   Wuthiekanun V, 2007, EMERG INFECT DIS, V13, P124, DOI 10.3201/eid1301.060718
NR 29
TC 100
Z9 104
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2015
VL 9
IS 10
AR e0004122
DI 10.1371/journal.pntd.0004122
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CV7NC
UT WOS:000364459600029
PM 26431366
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Costa, F
   Hagan, JE
   Calcagno, J
   Kane, M
   Torgerson, P
   Martinez-Silveira, MS
   Stein, C
   Abela-Ridder, B
   Ko, AI
AF Costa, Federico
   Hagan, Jose E.
   Calcagno, Juan
   Kane, Michael
   Torgerson, Paul
   Martinez-Silveira, Martha S.
   Stein, Claudia
   Abela-Ridder, Bernadette
   Ko, Albert I.
TI Global Morbidity and Mortality of Leptospirosis: A Systematic Review
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID ACUTE FEBRILE ILLNESS; PULMONARY INVOLVEMENT; URBAN EPIDEMIC;
   CLIMATE-CHANGE; NON-MALARIA; OUTBREAK; TRANSMISSION; INFECTION;
   COMMUNITY; ENVIRONMENT
AB Background
   Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as an important cause of pulmonary haemorrhage syndrome, the lack of global estimates for morbidity and mortality has contributed to its neglected disease status.
   Methodology/Principal Findings
   We conducted a systematic review of published morbidity and mortality studies and databases to extract information on disease incidence and case fatality ratios. Linear regression and Monte Carlo modelling were used to obtain age and gender-adjusted estimates of disease morbidity for countries and Global Burden of Disease (GBD) and WHO regions. We estimated mortality using models that incorporated age and gender-adjusted disease morbidity and case fatality ratios. The review identified 80 studies on disease incidence from 34 countries that met quality criteria. In certain regions, such as Africa, few quality assured studies were identified. The regression model, which incorporated country-specific variables of population structure, life expectancy at birth, distance from the equator, tropical island, and urbanization, accounted for a significant proportion (R-2 = 0.60) of the variation in observed disease incidence. We estimate that there were annually 1.03 million cases (95% CI 434,000-1,750,000) and 58,900 deaths (95% CI 23,800-95,900) due to leptospirosis worldwide. A large proportion of cases (48%, 95% CI 40-61%) and deaths (42%, 95% CI 34-53%) were estimated to occur in adult males with age of 20-49 years. Highest estimates of disease morbidity and mortality were observed in GBD regions of South and Southeast Asia, Oceania, Caribbean, Andean, Central, and Tropical Latin America, and East Sub-Saharan Africa.
   Conclusions
   / Significance Leptospirosis is among the leading zoonotic causes of morbidity worldwide and accounts for numbers of deaths, which approach or exceed those for other causes of haemorrhagic fever. Highest morbidity and mortality were estimated to occur in resource-poor countries, which include regions where the burden of leptospirosis has been underappreciated.
C1 [Costa, Federico; Hagan, Jose E.; Calcagno, Juan; Martinez-Silveira, Martha S.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   [Costa, Federico] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Costa, Federico; Hagan, Jose E.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Kane, Michael] Yale Univ, Sch Publ Hlth, Ctr Analyt Sci, New Haven, CT USA.
   [Torgerson, Paul] Univ Zurich, Vetsuisse Fac, Epidemiol Sect, Zurich, Switzerland.
   [Stein, Claudia] UN City, Reg Off Europe, WHO, Div Informat Evidence Res & Innovat, Copenhagen O, Denmark.
   [Abela-Ridder, Bernadette] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland.
RP Costa, F (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
EM albert.ko@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Martinez-Silveira, Martha
   Silvia/O-7270-2014; Hagan, Jose/N-6719-2019; Costa,
   Federico/G-1838-2015; Torgerson, Paul R/A-7510-2010; Torgerson, Paul
   R/M-4447-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Martinez-Silveira, Martha
   Silvia/0000-0002-1004-1784; Hagan, Jose/0000-0002-1837-6319; Costa,
   Federico/0000-0001-6951-2336; Torgerson, Paul R/0000-0003-4277-9983;
   Torgerson, Paul R/0000-0003-4277-9983
FU World Health OrganizationWorld Health Organization; Brazilian Ministry
   of Education; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI052473, U01 AI088752, D43 TW00919, R25 TW009338, T32 AI007172, R24
   TW007988]; Wellcome TrustWellcome Trust [102330/Z/13/Z]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, R01TW009504,
   R24TW007988, R24TW007988, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, R01TW009504,
   R25TW009338, R25TW009338, R24TW007988, D43TW000919, R01TW009504,
   R24TW007988, R24TW007988, R25TW009338, R01TW009504, D43TW000919,
   R25TW009338, D43TW000919, R25TW009338, R01TW009504, R25TW009338,
   R24TW007988, R25TW009338, R25TW009338, D43TW000919, R25TW009338,
   R24TW007988, R25TW009338, R24TW007988, R25TW009338] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [T32AI007172, R01AI121207, T32AI007172, T32AI007172,
   T32AI007172, T32AI007172, T32AI007172, T32AI007172, T32AI007172,
   T32AI007172, R01AI052473, U01AI088752, T32AI007172, U01AI088752,
   T32AI007172, T32AI007172, T32AI007172, T32AI007172, R01AI052473,
   R01AI052473, U01AI088752, R01AI052473, T32AI007172, R01AI052473,
   T32AI007172, T32AI007172, T32AI007172, U01AI088752, T32AI007172,
   R01AI052473, R01AI052473, T32AI007172, T32AI007172, T32AI007172,
   R01AI052473, T32AI007172, R01AI052473, T32AI007172, T32AI007172,
   T32AI007172, U01AI088752, T32AI007172, R01AI052473, R01AI121207,
   T32AI007172, T32AI007172, U01AI088752, R01AI121207, T32AI007172,
   T32AI007172, R01AI052473, T32AI007172, T32AI007172, R01AI121207,
   T32AI007172] Funding Source: NIH RePORTER
FX This work was supported by the World Health Organization, Brazilian
   Ministry of Education, National Institutes of Health (R01 AI052473, U01
   AI088752, D43 TW00919, R25 TW009338, T32 AI007172, R24 TW007988) and
   Wellcome Trust (102330/Z/13/Z). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abela-Ridder B, 2010, INT J ANTIMICROB AG, V36, pS5, DOI 10.1016/j.ijantimicag.2010.06.012
   Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Agampodi SB, 2014, EPIDEMIOL INFECT, V142, P843, DOI 10.1017/S0950268813001465
   Agampodi S, 2009, LANCET INFECT DIS, V9, P524, DOI 10.1016/S1473-3099(09)70211-7
   Agampodi SB, 2011, AM J TROP MED HYG, V85, P471, DOI 10.4269/ajtmh.2011.11-0276
   Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biggs HM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002589
   Biggs HM, 2011, AM J TROP MED HYG, V85, P275, DOI 10.4269/ajtmh.2011.11-0176
   Bovet P, 1999, INT J EPIDEMIOL, V28, P583, DOI 10.1093/ije/28.3.583
   Bruce MG, 2005, ACTA TROP, V96, P36, DOI 10.1016/j.actatropica.2005.07.001
   Charron DF, 2012, ECOHEALTH, V9, P256, DOI 10.1007/s10393-012-0791-5
   Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324
   de Vries SG, 2014, INT J INFECT DIS, V28, P47, DOI 10.1016/j.ijid.2014.06.013
   DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756
   Division UNP, 2010, 2010 POPULATION ESTI
   Epstein PR, 1999, SCIENCE, V285, P347, DOI 10.1126/science.285.5426.347
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Gasem MH, 2009, EMERG INFECT DIS, V15, P975, DOI 10.3201/eid1506.081405
   Goris MGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076549
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Halliday JEB, 2013, AM J TROP MED HYG, V89, P1095, DOI 10.4269/ajtmh.13-0415
   Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003709
   Hood GM, 2010, POP TOOLS POPTOOLS
   Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865
   Ismail TF, 2006, AM J TROP MED HYG, V75, P1085, DOI 10.4269/ajtmh.2006.75.1085
   Katz AR, 2002, AM J TROP MED HYG, V66, P61, DOI 10.4269/ajtmh.2002.66.61
   Kendall EA, 2010, AM J TROP MED HYG, V82, P1127, DOI 10.4269/ajtmh.2010.09-0574
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Lacerda HG, 2008, T ROY SOC TROP MED H, V102, P1233, DOI 10.1016/j.trstmh.2008.05.010
   Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Lau C, 2010, TRAVEL MED INFECT DI, V8, P33, DOI 10.1016/j.tmaid.2009.12.002
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   (LERG) WHOLERG, 2009, INFORMAL CONSULTATIO
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Mayxay M, 2013, LANCET, V1, P46
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   MOCH RW, 1975, J TROP MED HYG, V78, P38
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535]
   Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615
   Mudur G, 2005, BRIT MED J, V331, P307, DOI 10.1136/bmj.331.7512.307-a
   Mueller TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095868
   Musso D, 2013, J MICROBIOL IMMUNOL, V46, P245, DOI 10.1016/j.jmii.2013.03.001
   Papa A, 2009, EMERG INFECT DIS, V15, P834, DOI [10.3201/eid1505080270, 10.3201/eid1505.080270]
   Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Picardeau M, 2014, DIAGN MICR INFEC DIS, V78, P1, DOI 10.1016/j.diagmicrobio.2013.09.012
   Punjabi NH, 2012, AM J TROP MED HYG, V86, P46, DOI 10.4269/ajtmh.2012.10-0497
   Rathinam S R, 2002, Curr Opin Ophthalmol, V13, P381, DOI 10.1097/00055735-200212000-00007
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Reller ME, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002941
   Ricaldi JN, 2013, CURR OPIN INFECT DIS, V26, P399, DOI 10.1097/QCO.0000000000000001
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   Sejvar J, 2003, EMERG INFECT DIS, V9, P702
   Sethi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000579
   South A, 2012, RWORIDMAP MAPPING GL
   Suttinont C, 2006, ANN TROP MED PARASIT, V100, P363, DOI 10.1179/136485906X112158
   Team RC, 2012, R A LANGUAGE AND ENV
   United Nations Human Settlements Programme, 2003, THE CHALLENGE OF THE, P310
   World Health Organization, 2003, LIST MEMB STAT WHO R, P182
   World Health Organization, 2010, REPORT OF THE WHO ST
   World Health Organization. International Leptospirosis Society, 2003, HUMAN LEPTOSPIROSIS
   World Health Organization Leptospirosis Epidemiology Reference Group (LERG), 2010, REPORT OF THE FIRST
   World Health Organization Leptospirosis Epidemiology Reference Group (LERG), 2011, REPORT OF THE SECOND
   Wuthiekanun V, 2007, EMERG INFECT DIS, V13, P124, DOI 10.3201/eid1301.060718
   Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8
NR 77
TC 443
Z9 459
U1 5
U2 76
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2015
VL 9
IS 9
AR e0003898
DI 10.1371/journal.pntd.0003898
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CT7YI
UT WOS:000363031200005
PM 26379143
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU dos Santos, MS
   Azevedo, J
   Menezes, APD
   Cordeiro, SM
   Escobar, EC
   Lima, JB
   Campos, LC
   Carvalho, MDS
   Reis, MG
   Ko, AI
   Reis, JN
AF dos Santos, Milena Soares
   Azevedo, Jailton
   Menezes, Ana Paula de Oliveria
   Cordeiro, Soraia Machado
   Escobar, Eliane Cunegundes
   Lima, Josilene Borges
   Campos, Leila Carvalho
   Carvalho, Maria da Gloria S.
   Reis, Mitermayer G.
   Ko, Albert I.
   Reis, Joice Neves
TI Temporal trends and clonal diversity of penicillin non-susceptible
   pneumococci from meningitis cases from 1996 to 2012, in Salvador, Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Streptococcus pneumoniae; Antibiotic resistance; Genotype; Surveillance
ID INVASIVE STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; UNITED-STATES;
   ANTIMICROBIAL SUSCEPTIBILITY; ADULT PATIENTS; SEROTYPE; RESISTANCE;
   DISEASE; PREVALENCE; EPIDEMIOLOGY
AB Background: Hospital-based surveillance for pneumococcal meningitis has been conducted since January 1996 in the city of Salvador, Brazil. The purpose of this study was to describe the temporal evolution of Penicillin Non-Susceptible Streptococcus pneumoniae (PNSSP) in regards to serotype distributions and clonal diversity recovered from meningitis cases over 17 years.
   Methods: Broth microdilution was used to identify pneumococcal isolates that were PNSSP (Minimum Inhibitory Concentration > 0.12 mu g/ml). The annual incidence rate of meningitis cases was calculated. Serotyping was defined using multiplex polymerase chain reaction assays and quellung reaction. Genetic diversity of PNSSP isolates was assessed using both pulsed-field gel electrophoresis (PFGE) and Multilocus Sequence Typing (MLST) analyses.
   Results: A total of 854cerebrospinal fluid (CSF) culture pneumococcal isolates were tested by broth microdilution method and serotyped. A total of 173 (20.3 %) were penicillin non-susceptible (PNSSP) (Minimum Inhibitory concentration >= 0.12 mu g/ml). The annual incidence of meningitis cases declined from 1.65/100,000 population (1996) to 0.2/100,000 population in 2012 and the rate due to PNSSP declined 82 % over the 17-years of surveillance. PNSSP isolates were restricted to 13 serotypes, being the most common ones serotypes14 (45.1 %; 78/173), 23 F (19.1 %; 33/173), 6B (14.4 %; 25/173), 19 F (9.2 %; 16/173) and 19A (5.2 %; 9/173). Among the PNSSP isolates, 94 % had serotypes represented in the 10-valent conjugate vaccine (PCV10). The predominant serotype 14 clonal groups were identified as PFGE group A/multilocus sequence type 66 (ST66) [35.3 % (61/173)] and PFGE group GK/ST156 [4.6 % (8/173)], the latter one associated with high level resistance to penicillin and ceftriaxone.
   Conclusions: Our results show sustained reductions in pneumococcal meningitis cases in the Metropolitan region of Salvador from 1996 to 2012. This might reflect a beneficial impact of conjugate vaccines. Continued surveillance and further studies need to be conducted to better understanding on PCV10 vaccine impact.
C1 [dos Santos, Milena Soares; Azevedo, Jailton; Menezes, Ana Paula de Oliveria; Escobar, Eliane Cunegundes; Campos, Leila Carvalho; Reis, Mitermayer G.; Ko, Albert I.; Reis, Joice Neves] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Cordeiro, Soraia Machado; Reis, Joice Neves] Univ Fed Bahia, Dept Anal Clin & Toxicol, Fac Farm, BR-40170115 Salvador, BA, Brazil.
   [dos Santos, Milena Soares] Univ Fed Bahia, Inst Multidisciplinar Saude, BR-45029094 Vitoria Da Conquista, BA, Brazil.
   [Menezes, Ana Paula de Oliveria] Univ Estadual Sudoeste Bahia, BR-45206190 Jequie, BA, Brazil.
   [Lima, Josilene Borges] Univ Fed Bahia, Inst Ciencias Saude, BR-40110902 Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Carvalho, Maria da Gloria S.] Ctr Dis Control & Prevent, Streptococcus Lab, Atlanta, GA 30333 USA.
RP Reis, JN (corresponding author), Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
EM joice@ufba.br
RI Reis, Mitermayer/AAO-9742-2020; Reis, Joice N/H-9227-2013; Ko, Albert
   Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; Santos, Milena Soares/0000-0002-1995-140X;
   Azevedo, Jailton/0000-0002-0801-8673
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq) [482755/2010-5]; Bahia State Foundation
   [PP-SUS0001/2009]; PAPESNational Council for Scientific and
   Technological Development (CNPq) [407551/2012-3]; National Institute of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 TW007303, D43 TW00919]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, R01TW007303, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   R01TW007303, R01TW007303, D43TW000919, R01TW007303, R01TW007303,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER
FX This work was supported by grants from the Brazilian National Research
   Council (482755/2010-5), the Bahia State Foundation for the support of
   research (PP-SUS0001/2009), Strategic program to support health research
   - PAPES (#407551/2012-3), and the National Institute of Health (R01
   TW007303,D43 TW00919).
CR Alvares JR, 2011, BRAZ J INFECT DIS, V15, P22, DOI 10.1590/S1413-86702011000100005
   Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012
   Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125
   Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006
   Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052
   Brandileone MCC, 2006, J MED MICROBIOL, V55, P567, DOI 10.1099/jmm.0.46387-0
   Brandileone MCD, 1998, MICROB DRUG RESIST, V4, P209
   Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09
   Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08
   Castaneda Elizabeth, 2009, Pediatr Infect Dis J, V28, pe265, DOI 10.1097/INF.0b013e3181a74b22
   CDC. Centers for Disease Control and Prevention, 2014, PCR DED PNEUM SER
   CLSI, 2011, M100S21 CLSI, V31
   Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8
   Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049
   Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004
   Hackel M, 2013, VACCINE, V31, P4881, DOI 10.1016/j.vaccine.2013.07.054
   Imai S, 2009, CLIN MICROBIOL INFEC, V15, P1039, DOI 10.1111/j.1469-0691.2009.02935.x
   Instituto Brasileiro de Geografia e Estatistica (IBGE), RES CENS POP SALV CI
   Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010
   Jefferies JM, 2010, J CLIN MICROBIOL, V48, P87, DOI 10.1128/JCM.01485-09
   Ko AI, 2000, CLIN INFECT DIS, V30, P78, DOI 10.1086/313619
   Liu ZY, 2012, ANTIMICROB AGENTS CH, V56, P743, DOI 10.1128/AAC.05122-11
   MARQUES HHD, 1988, PEDIATR INFECT DIS J, V7, P433, DOI 10.1097/00006454-198806000-00017
   McEllistrem MC, 2000, J CLIN MICROBIOL, V38, P351
   Menezes APD, 2011, VACCINE, V29, P1139, DOI 10.1016/j.vaccine.2010.12.021
   Ministerio da Saude Brasil, 2010, PROP INTR VAC PNEUM
   Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043
   Parra EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084993
   Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593
   Reinert RR, 2009, CLIN MICROBIOL INFEC, V15, P7, DOI 10.1111/j.1469-0691.2009.02724.x
   Reis JN, 2002, J CLIN MICROBIOL, V40, P275, DOI 10.1128/JCM.40.1.275-277.2002
   Secretaria de Saude do Estado da Bahia (SESAB), B EP
   Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104
   World Health Organization (WHO), 2012, PNEUM VACC 2012
   Yoshioka CRM, 2011, J PEDIAT-BRAZIL, V87, P70, DOI [10.1590/S0021-75572011000100012, 10.2223/JPED.2063]
   Zhao CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082361
NR 36
TC 9
Z9 9
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUL 30
PY 2015
VL 15
AR 302
DI 10.1186/s12879-015-1049-y
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA CN7UJ
UT WOS:000358639200007
PM 26223380
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Kikuti, M
   Cunha, GM
   Paploski, IAD
   Kasper, AM
   Silva, MMO
   Tavares, AS
   Cruz, JS
   Queiroz, TL
   Rodrigues, MS
   Santana, PM
   Lima, HCAV
   Calcagno, J
   Takahashi, D
   Gonalves, AHO
   Araujo, JMG
   Gauthier, K
   Diuk-Wasser, MA
   Kitron, U
   Ko, AI
   Reis, MG
   Ribeiro, GS
AF Kikuti, Mariana
   Cunha, Geraldo M.
   Paploski, Igor A. D.
   Kasper, Amelia M.
   Silva, Monaise M. O.
   Tavares, Aline S.
   Cruz, Jaqueline S.
   Queiroz, Tassia L.
   Rodrigues, Moreno S.
   Santana, Perla M.
   Lima, Helena C. A. V.
   Calcagno, Juan
   Takahashi, Daniele
   Gonalves, Andre H. O.
   Araujo, Joselio M. G.
   Gauthier, Kristine
   Diuk-Wasser, Maria A.
   Kitron, Uriel
   Ko, Albert I.
   Reis, Mitermayer G.
   Ribeiro, Guilherme S.
TI Spatial Distribution of Dengue in a Brazilian Urban Slum Setting: Role
   of Socioeconomic Gradient in Disease Risk
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HEMORRHAGIC-FEVER; SURVEILLANCE; TRANSMISSION; EPIDEMIC; PATTERN; STATE
AB Background
   Few studies of dengue have shown group-level associations between demographic, socioeconomic, or geographic characteristics and the spatial distribution of dengue within small urban areas. This study aimed to examine whether specific characteristics of an urban slum community were associated with the risk of dengue disease.
   Methodology/Principal Findings
   From 01/2009 to 12/2010, we conducted enhanced, community-based surveillance in the only public emergency unit in a slum in Salvador, Brazil to identify acute febrile illness (AFI) patients with laboratory evidence of dengue infection. Patient households were geocoded within census tracts (CTs). Demographic, socioeconomic, and geographical data were obtained from the 2010 national census. Associations between CTs characteristics and the spatial risk of both dengue and non-dengue AFI were assessed by Poisson log-normal and conditional auto-regressive models (CAR). We identified 651 (22.0%) dengue cases among 2,962 AFI patients. Estimated risk of symptomatic dengue was 21.3 and 70.2 cases per 10,000 inhabitants in 2009 and 2010, respectively. All the four dengue serotypes were identified, but DENV2 predominated (DENV1: 8.1%; DENV2: 90.7%; DENV3: 0.4%; DENV4: 0.8%). Multivariable CAR regression analysis showed increased dengue risk in CTs with poorer inhabitants (RR: 1.02 for each percent increase in the frequency of families earning <= 1 times the minimum wage; 95% CI: 1.01-1.04), and decreased risk in CTs located farther from the health unit (RR: 0.87 for each 100 meter increase; 95% CI: 0.80-0.94). The same CTs characteristics were also associated with non-dengue AFI risk.
   Conclusions/Significance
   This study highlights the large burden of symptomatic dengue on individuals living in urban slums in Brazil. Lower neighborhood socioeconomic status was independently associated with increased risk of dengue, indicating that within slum communities with high levels of absolute poverty, factors associated with the social gradient influence dengue transmission. In addition, poor geographic access to health services may be a barrier to identifying both dengue and non-dengue AFI cases. Therefore, further spatial studies should account for this potential source of bias.
C1 [Kikuti, Mariana; Paploski, Igor A. D.; Kasper, Amelia M.; Silva, Monaise M. O.; Tavares, Aline S.; Cruz, Jaqueline S.; Rodrigues, Moreno S.; Santana, Perla M.; Lima, Helena C. A. V.; Calcagno, Juan; Takahashi, Daniele; Gonalves, Andre H. O.; Ko, Albert I.; Reis, Mitermayer G.; Ribeiro, Guilherme S.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Kikuti, Mariana; Paploski, Igor A. D.; Queiroz, Tassia L.; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Coletiva, Salvador, BA, Brazil.
   [Cunha, Geraldo M.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   [Gauthier, Kristine; Diuk-Wasser, Maria A.; Ko, Albert I.; Reis, Mitermayer G.; Ribeiro, Guilherme S.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Kitron, Uriel] Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA.
   [Reis, Mitermayer G.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Ribeiro, Guilherme/B-6624-2008; Rodrigues, Moreno/ABD-9852-2020; Araujo,
   Joselio M G/B-5502-2013; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020; Kikuti, Mariana/G-2313-2017; Paploski, Igor
   AD/D-7015-2014
OI Ribeiro, Guilherme/0000-0002-6798-2059; Rodrigues,
   Moreno/0000-0002-1594-2311; Araujo, Joselio M G/0000-0003-3548-2786; Ko,
   Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Kikuti, Mariana/0000-0001-8119-7236;
   Paploski, Igor AD/0000-0002-3689-2042
FU National Council for Scientific and Technological Development -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [550160/2010-8, 400830/2013-2]; Bahia Foundation for Research Support -
   FAPESB [PNX0010/2011, PPP0055/2011, JCB0020/2013]; Federal University of
   Bahia - UFBA; National Institutes of Health - NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 AI052473, U01 AI088752, R25 TW009338, D43 TW00919]; National
   Institutes of Health - NIH (FICRS-F fellowship)United States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA;
   Oswaldo Cruz Foundation; Coordination for the Improvement of Higher
   Education Personnel - CAPES, Brazilian Ministry of EducationCAPES;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, D43TW000919,
   R25TW009338, D43TW000919, R01TW009504, D43TW000919, D43TW000919,
   R25TW009338, D43TW000919, R25TW009338, R25TW009338, D43TW000919,
   D43TW000919, R01TW009504, R25TW009338, D43TW000919, R01TW009504,
   R25TW009338, R01TW009504, D43TW000919, D43TW000919, R25TW009338,
   D43TW000919, R01TW009504, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, U01AI088752, U01AI088752, R01AI052473,
   U01AI088752, R01AI052473, R01AI052473, U01AI088752, R01AI052473,
   U01AI088752, R01AI052473, R01AI052473, R01AI052473, R01AI052473] Funding
   Source: NIH RePORTER
FX This work was supported by the National Council for Scientific and
   Technological Development - CNPq (grant 550160/2010-8 to MGR, and grant
   400830/2013-2 to GSR; scholarship to: MK, IADP, MMOS); the Bahia
   Foundation for Research Support - FAPESB (grant PNX0010/2011 to MGR, and
   grants PPP0055/2011 and JCB0020/2013 to GSR; scholarship to: AHOG); the
   Federal University of Bahia - UFBA (grants PROPI 2011, PROPI 2013, and
   PRODOC 2013 to GSR); the National Institutes of Health - NIH (grants R01
   AI052473, U01 AI088752, R25 TW009338, and D43 TW00919 to AIK; FICRS-F
   fellowship to: JC); the Oswaldo Cruz Foundation (scholarship to: AMK,
   MMOS, AST, JSC, HCAVL, DT, MGR); and the Coordination for the
   Improvement of Higher Education Personnel - CAPES, Brazilian Ministry of
   Education (scholarship to: MK, TLQ). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abor PA, 2011, INT J SOC ECON, V38, P628, DOI 10.1108/03068291111139258
   Aguilera Sandra Lúcia Vieira Ulinski, 2014, Rev. bras. epidemiol., V17, P654, DOI 10.1590/1809-4503201400030007
   Baade PD, 2013, BMC CANCER, V13
   Banerjee S., 2003, HIERARCHICAL MODELIN
   Barcellos C, 2005, REV SOC BRAS MED TRO, V38, P246, DOI 10.1590/S0037-86822005000300008
   BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   BRASIL, 2009, DIR NAC PREV CONTR E
   BRASIL, 2013, ASS NOV CLASS CAS DE
   BRASIL, 2005, DIAGN RAP MUN VIG EN
   BRASIL, 2013, BRAS DES 2013
   Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012
   Cordeiro R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-355
   Costa JV, 2013, CAD SAUDE PUBLICA, V29, P1522, DOI [10.1590/0102-311X00110912, 10.1590/S0102-311X2013001200005]
   da Costa AIP, 1998, REV SAUDE PUBL, V32, P232, DOI 10.1590/S0034-89101998000300005
   Resendes APD, 2010, REV SAUDE PUBL, V44, P274, DOI 10.1590/s0034-89102010000200007
   da Saude M, 2014, DENG NOT REG SIST IN
   da Saude M, 2009, GUID VIG EP
   da Saude M, 2011, DENG DIAGN MAN CLIN
   De Allegri M, 2011, HEALTH POLICY, V99, P210, DOI 10.1016/j.healthpol.2010.10.010
   de Almeida AS, 2009, REV SAUDE PUBL, V43, P666, DOI 10.1590/s0034-89102009000400013
   Teixeira TRD, 2008, CAD SAUDE PUBLICA, V24, P2160, DOI 10.1590/S0102-311X2008000900022
   Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2
   Duarte HHP, 2006, REV SAUDE PUBL, V40, P134, DOI 10.1590/S0034-89102006000100021
   Environmental Systems Research Institute, 2011, ARCGIS DESKT REL 9
   Espinoza-Gomez F, 2003, SALUD PUBLICA MEXICO, V45, P365, DOI 10.1590/s0036-36342003000500006
   Flauzino RF, 2009, REV SAUDE PUBL, V43
   [Fundacao Instituto Brasileiro de Geografia e Estatistica IBGE], 2010, CENS DEM 2010 RES UN
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Heukelbach J, 2001, TROP MED INT HEALTH, V6, P635, DOI 10.1046/j.1365-3156.2001.00762.x
   IBGE, 2010, GEOC MALH DIG CENS 2
   Indaratna Kaemthong, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P669
   Ir P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010930
   Koyadun Surachart, 2012, Interdiscip Perspect Infect Dis, V2012, P907494, DOI 10.1155/2012/907494
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Laughlin CA, 2012, J INFECT DIS, V206, P1121, DOI 10.1093/infdis/jis351
   Maciel I. J., 2008, Revista de Patologia Tropical, V37, P111
   Mena N, 2011, REV PANAM SALUD PUBL, V29, P234, DOI 10.1590/S1020-49892011000400004
   Mondini Adriano, 2007, Rev. Saúde Pública, V41, P923, DOI 10.1590/S0034-89102007000600006
   Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010
   Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168
   PAHO, 2013, NUMB REP CAS DENG SE
   QGIS Development Team, 2014, QGIS GEOGR INF SYST
   RAHAMAN MM, 1982, AM J PUBLIC HEALTH, V72, P1124, DOI 10.2105/AJPH.72.10.1124
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x
   Runge-Ranzinger S, 2014, TROP MED INT HEALTH, V19, P1116, DOI 10.1111/tmi.12333
   Runge-Ranzinger S, 2008, TROP MED INT HEALTH, V13, P1022, DOI 10.1111/j.1365-3156.2008.02112.x
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Teixeira  M G, 2001, Rev Soc Bras Med Trop, V34, P269
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Thammapalo S, 2008, EPIDEMIOL INFECT, V136, P135, DOI 10.1017/S0950268807008126
   UN-HABITAT, 2011, STAT WORLDS CIT 2010
   UN-HABITAT, 2013, STAT WORLDS CIT 20 1
   UN-HABITAT, 2003, CHALL SLUMS
   Vasconcelos P F, 1999, Rev Soc Bras Med Trop, V32, P171
   Vasconcelos PFC, 1998, REV SAUDE PUBL, V32, P447, DOI 10.1590/S0034-89101998000500007
   WHO, 2012, GLOB STRAT DENG PREV
   WHO, 2014, DENG SEV DENG
NR 70
TC 35
Z9 36
U1 0
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2015
VL 9
IS 7
AR e0003937
DI 10.1371/journal.pntd.0003937
PG 18
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CO3SM
UT WOS:000359079700041
PM 26196686
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Backstedt, BT
   Buyuktanir, O
   Lindow, J
   Wunder, EA
   Reis, MG
   Usmani-Brown, S
   Ledizet, M
   Ko, A
   Pal, U
AF Backstedt, Brian T.
   Buyuktanir, Ozlem
   Lindow, Janet
   Wunder, Elsio A., Jr.
   Reis, Mitermayer G.
   Usmani-Brown, Sahar
   Ledizet, Michel
   Ko, Albert
   Pal, Utpal
TI Efficient Detection of Pathogenic Leptospires Using 16S Ribosomal RNA
SO PLOS ONE
LA English
DT Article
ID MEDIATED ISOTHERMAL AMPLIFICATION; REAL-TIME PCR; INTERROGANS SEROVAR
   COPENHAGENI; POLYMERASE-CHAIN-REACTION; APTIMA COMBO-2 ASSAY;
   GENE-EXPRESSION; BORRELIA-BURGDORFERI; CHLAMYDIA-TRACHOMATIS; NORTHERN
   TANZANIA; QUANTITATIVE PCR
AB Pathogenic Leptospira species cause a prevalent yet neglected zoonotic disease with mild to life-threatening complications in a variety of susceptible animals and humans. Diagnosis of leptospirosis, which primarily relies on antiquated serotyping methods, is particularly challenging due to presentation of non-specific symptoms shared by other febrile illnesses, often leading to misdiagnosis. Initiation of antimicrobial therapy during early infection to prevent more serious complications of disseminated infection is often not performed because of a lack of efficient diagnostic tests. Here we report that specific regions of leptospiral 16S ribosomal RNA molecules constitute a novel and efficient diagnostic target for PCR-based detection of pathogenic Leptospira serovars. Our diagnostic test using spiked human blood was at least 100-fold more sensitive than corresponding leptospiral DNA-based quantitative PCR assays, targeting the same 16S nucleotide sequence in the RNA and DNA molecules. The sensitivity and specificity of our RNA assay against laboratory-confirmed human leptospirosis clinical samples were 64% and 100%, respectively, which was superior then an established parallel DNA detection assay. Remarkably, we discovered that 16S transcripts remain appreciably stable ex vivo, including untreated and stored human blood samples, further highlighting their use for clinical detection of L. interrogans. Together, these studies underscore a novel utility of RNA targets, specifically 16S rRNA, for development of PCR-based modalities for diagnosis of human leptospirosis, and also may serve as paradigm for detection of additional bacterial pathogens for which early diagnosis is warranted.
C1 [Backstedt, Brian T.; Buyuktanir, Ozlem; Pal, Utpal] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.
   [Backstedt, Brian T.; Buyuktanir, Ozlem; Pal, Utpal] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.
   [Lindow, Janet; Wunder, Elsio A., Jr.; Ko, Albert] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Lindow, Janet; Reis, Mitermayer G.; Ko, Albert] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Usmani-Brown, Sahar; Ledizet, Michel] L2 Diagnost, New Haven, CT USA.
RP Pal, U (corresponding author), Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.
EM upal@umd.edu
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020; Pal,
   Utpal/I-5265-2015; YAS, Ozlem BUYUKTANIR/AAP-2720-2020; Wunder, Elsio
   Augusto/C-2733-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; YAS, Ozlem
   BUYUKTANIR/0000-0002-7641-7350; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Lindow, Janet/0000-0003-3235-3698
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [AI114064-01, AI052473, TW009504, AI088752, 1R43AI114064-01]; ASTMH
   Gorgas Memorial Institute Research Award; Fiocruz-CNPq Ciencias Sem
   Fronteiras; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW009504, R25TW009338,
   R01TW009504, R25TW009338, R25TW009338, R01TW009504, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R01TW009504, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R01TW009504,
   R25TW009338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, U01AI088752,
   U01AI088752, R01AI052473, R01AI052473, U01AI088752, R01AI052473,
   U01AI088752, R01AI052473, R41AI114064, R01AI052473, R01AI052473,
   U01AI088752, U01AI088752, R01AI052473, R01AI052473, R01AI052473,
   R41AI114064, R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by funding from the National Institute of
   Allergy and Infectious Diseases (Award Number AI114064-01 to AK, ML, and
   UP as well as AI052473, TW009504, and AI088752 to AK, and
   1R43AI114064-01 to L2 Diagnostics (AK, ML, UP co-PIs). JL is supported
   by 2014 ASTMH Gorgas Memorial Institute Research Award, 2014 Global
   Health Equity Scholars Fellowship and Fiocruz-CNPq Ciencias Sem
   Fronteiras. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. L2
   Diagnostics provided support in the form of salaries for authors SUB and
   ML as well as AK and UP through subcontracts with Yale University and
   the University of Maryland, but did not have any additional role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Agampodi SB, 2012, CLIN INFECT DIS, V54, P1249, DOI 10.1093/cid/cis035
   Ahmed A, 2014, INT J ENV RES PUB HE, V11, P4953, DOI 10.3390/ijerph110504953
   Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093
   Arikawa E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-328
   Beissner M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001756
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Biggs HM, 2013, VECTOR-BORNE ZOONOT, V13, P572, DOI 10.1089/vbz.2012.1205
   Biggs HM, 2011, AM J TROP MED HYG, V85, P275, DOI 10.4269/ajtmh.2011.11-0176
   BOLIN CA, 1991, AM J VET RES, V52, P1639
   Boonsilp S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-338
   Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10
   Bruce MG, 2005, ACTA TROP, V96, P36, DOI 10.1016/j.actatropica.2005.07.001
   Bugrysheva JV, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-17
   Cao YG, 2011, VACCINE, V29, P7379, DOI 10.1016/j.vaccine.2011.07.070
   Cheng A, 2014, AM J CLIN PATHOL, V141, P397, DOI 10.1309/AJCPFQ25SQVZAWHZ
   Chong S, 2003, J CLIN MICROBIOL, V41, P778, DOI 10.1128/JCM.41.2.778-782.2003
   Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004
   CORWIN A, 1990, INT J EPIDEMIOL, V19, P743, DOI 10.1093/ije/19.3.743
   Coutinho ML, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003307
   Curtis KA, 2014, J CLIN MICROBIOL, V52, P2674, DOI 10.1128/JCM.00935-14
   Dufour B, 2008, REV SCI TECH OIE, V27, P529, DOI 10.20506/rst.27.2.1817
   Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Ferreira AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112312
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   GALE NB, 1966, AM J TROP MED HYG, V15, P64, DOI 10.4269/ajtmh.1966.15.64
   Goarant C, 2009, TROP MED INT HEALTH, V14, P926, DOI 10.1111/j.1365-3156.2009.02310.x
   Goarant C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002289
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   HELLSTROM JS, 1978, RES VET SCI, V25, P29, DOI 10.1016/S0034-5288(18)33003-0
   Imai M, 2007, J VIROL METHODS, V141, P173, DOI 10.1016/j.jviromet.2006.12.004
   JACKSON LA, 1993, PEDIATR INFECT DIS J, V12, P48, DOI 10.1097/00006454-199301000-00011
   Jayawardena S, 2007, EMERG INFECT DIS, V13, P899, DOI 10.3201/eid1306.061572
   Jiang LJ, 2012, J MICROBIOL BIOTECHN, V22, P1301, DOI 10.4014/jmb.1202.02032
   Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081525
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Karande S, 2005, J TROP PEDIATRICS, V51, P174, DOI 10.1093/tropej/fmh100
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Koizumi N, 2005, J Postgrad Med, V51, P210
   Lacerda HG, 2008, T ROY SOC TROP MED H, V102, P1233, DOI 10.1016/j.trstmh.2008.05.010
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   Leshem E, 2010, AM J TROP MED HYG, V82, P459, DOI 10.4269/ajtmh.2010.09-0239
   Lessa-Aquino C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002499
   Lettieri C, 2004, MIL MED, V169, P687, DOI 10.7205/MILMED.169.9.687
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lourdault K, 2014, INFECT IMMUN, V82, P893, DOI 10.1128/IAI.01533-13
   Lowe P, 2006, J CLIN MICROBIOL, V44, P2619, DOI 10.1128/JCM.00476-06
   Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733
   Maquart M, 2014, J VIROL METHODS, V195, P92, DOI 10.1016/j.jviromet.2013.10.001
   Matsui M, 2012, APPL ENVIRON MICROB, V78, P6372, DOI 10.1128/AEM.00911-12
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615
   Musso D, 2013, J MICROBIOL IMMUNOL, V46, P245, DOI 10.1016/j.jmii.2013.03.001
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Natarajaseenivasan K, 2012, SAUDI J BIOL SCI, V19, P151, DOI 10.1016/j.sjbs.2011.11.005
   Noubade R, 2002, Indian J Med Microbiol, V20, P33
   Pan L, 2011, J CLIN MICROBIOL, V49, P4117, DOI 10.1128/JCM.01085-11
   Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004
   Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252
   Paulino LC, 2002, ELECTROPHORESIS, V23, P520, DOI 10.1002/1522-2683(200202)23:4<520::AID-ELPS520>3.0.CO;2-R
   Perez J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-325
   Picardeau M, 2014, DIAGN MICR INFEC DIS, V78, P1, DOI 10.1016/j.diagmicrobio.2013.09.012
   Promnares K, 2009, MOL MICROBIOL, V74, P112, DOI 10.1111/j.1365-2958.2009.06853.x
   Raz A, 2012, MOL MICROBIOL, V84, P631, DOI 10.1111/j.1365-2958.2012.08047.x
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Reller ME, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002941
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Ricaldi JN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001853
   Sethi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000579
   Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95
   Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13
   Sonthayanon P, 2011, AM J TROP MED HYG, V84, P614, DOI 10.4269/ajtmh.2011.10-0473
   Stern EJ, 2010, CLIN INFECT DIS, V50, P843, DOI 10.1086/650578
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Storck CH, 2008, EPIDEMIOL INFECT, V136, P1407, DOI 10.1017/S0950268807000052
   THIERMANN AB, 1980, INT J ZOONOSES, V7, P62
   Trueba G, 2004, INT MICROBIOL, V7, P35
   Tucunduva de Faria M, 2007, J COMP PATHOL, V137, P231, DOI 10.1016/j.jcpa.2007.08.001
   VANCREVEL R, 1994, CLIN INFECT DIS, V19, P132, DOI 10.1093/clinids/19.1.132
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   Waggoner JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112356
   Yang XL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000326
   Zhang GD, 2011, APPL ENVIRON MICROB, V77, P6495, DOI 10.1128/AEM.00520-11
   Zhu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080028
   Zuerner RL, 2011, CLIN VACCINE IMMUNOL, V18, P684, DOI 10.1128/CVI.00288-10
NR 88
TC 16
Z9 16
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 19
PY 2015
VL 10
IS 6
AR e0128913
DI 10.1371/journal.pone.0128913
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CL3FE
UT WOS:000356835000033
PM 26091292
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Unger, A
   Felzemburgh, RDM
   Snyder, RE
   Ribeiro, GS
   Mohr, S
   Costa, VBA
   Melendez, AXTO
   Reis, RB
   Santana, FS
   Riley, LW
   Reis, MG
   Ko, AI
AF Unger, Alon
   Felzemburgh, Ridalva D. M.
   Snyder, Robert E.
   Ribeiro, Guilherme S.
   Mohr, Sharif
   Costa, Vinicius B. A.
   Melendez, Astrid X. T. O.
   Reis, Renato B.
   Santana, Francisco S.
   Riley, Lee W.
   Reis, Mitermayer G.
   Ko, Albert I.
CA Pau da Lima Urban Hlth Team
TI Hypertension in a Brazilian Urban Slum Population
SO JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
LA English
DT Article
DE Hypertension; Non-communicable disease; Urban slum; Prevalence; Brazil
ID RISK-FACTORS; GLOBAL BURDEN; NONCOMMUNICABLE DISEASES;
   CARDIOVASCULAR-DISEASES; BLOOD-PRESSURE; PREVALENCE; HEALTH; NAIROBI;
   IMPACT; KENYA
AB Low- and middle-income countries account for the majority of hypertension disease burden. However, little is known about the distribution of this illness within subpopulations of these countries, particularly among those who live in urban informal settlements. A cross-sectional hypertension survey was conducted in 2003 among 5649 adult residents of a slum settlement in the city of Salvador, Brazil. Hypertension was defined as either an elevated arterial systolic (a parts per thousand yen140 mmHg) or diastolic (a parts per thousand yen90 mmHg) blood pressure. Sex-specific multivariable models of systolic blood pressure were constructed to identify factors associated with elevated blood pressure. The prevalence of hypertension in the population 18 years and older was 21 % (1162/5649). Men had 1.2 times the risk of hypertension compared with women (95 % confidence intervals (CI), 1.05, 1.36). Increasing age and lack of any schooling, particularly for women, were also significantly associated with elevated blood pressure (p < 0.05). There was also a direct association between men who were black and an elevated blood pressure. Among those who were hypertensive, 65.5 % were aware of their condition, and only 36.3 % of those aware were actively using anti-hypertensive medications. Men were less likely to be aware of their diagnosis or to use medications (p < 0.01 for both) than women. The prevalence of hypertension in this slum community was lower than reported frequencies in the non-slum population of Brazil and Salvador, yet both disease awareness and treatment frequency were low. Further research on hypertension and other chronic non-communicable diseases in slum populations is urgently needed to guide prevention and treatment efforts in this growing population.
C1 [Unger, Alon] Univ Calif San Francisco, Div Hosp Med, 533 Parnassus Ave,Suite U127A,Box 0131, San Francisco, CA 94143 USA.
   [Unger, Alon; Felzemburgh, Ridalva D. M.; Ribeiro, Guilherme S.; Mohr, Sharif; Costa, Vinicius B. A.; Melendez, Astrid X. T. O.; Reis, Renato B.; Santana, Francisco S.; Reis, Mitermayer G.] Fundacao Oswaldo Cruz FIOCRUZ, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Snyder, Robert E.; Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Snyder, Robert E.; Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Unger, A (corresponding author), Univ Calif San Francisco, Div Hosp Med, 533 Parnassus Ave,Suite U127A,Box 0131, San Francisco, CA 94143 USA.
EM alon.unger@ucsf.edu
RI Ribeiro, Guilherme/B-6624-2008; Reis, Mitermayer/AAO-9742-2020; Ko,
   Albert Icksang/P-2343-2015; Snyder, Robert E./AAD-4433-2020
OI Ribeiro, Guilherme/0000-0002-6798-2059; Reis,
   Mitermayer/0000-0002-3051-9060; Ko, Albert Icksang/0000-0001-9023-2339;
   Snyder, Robert E./0000-0001-9743-0872
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq) [300.861/96-6]; Oswaldo Cruz Foundation
   [0250.250.102]; US National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01
   AI052473, U01 AI088752, D43 TW00919, R25 TW009338]; Fogarty
   International Center/Ellison Medical Foundation Fellowship in Global
   Health and Clinical Research [TW00018]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW000018, R25TW009338, R25TW009338, D43TW000018, D43TW000018,
   R25TW009338, D43TW000919, R25TW009338, D43TW000018, D43TW000018,
   R25TW009338, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   R25TW009338, R25TW009338, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000919, D43TW000018, D43TW000018, R25TW009338,
   D43TW000919, R01TW009504, R25TW009338, D43TW000018, D43TW000919,
   D43TW000018, R01TW009504, D43TW000018, D43TW000018, D43TW000018,
   R25TW009338, D43TW000018, D43TW000018, D43TW000018, D43TW000919,
   R25TW009338, D43TW000018, D43TW000919, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000919, D43TW000919, D43TW000919,
   D43TW000018, D43TW000018, R25TW009338, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, R25TW009338, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000919, R01TW009504, D43TW000919,
   D43TW000018, D43TW000018, R01TW009504, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   R01TW009504, D43TW000018, D43TW000018, D43TW000018] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI052473, U01AI088752, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   U01AI088752, R01AI052473, U01AI088752, R01AI052473, R01AI052473,
   U01AI088752, R01AI052473, U01AI088752] Funding Source: NIH RePORTER
FX This work was supported by the Brazilian National Research Council
   (grant 300.861/96-6), Oswaldo Cruz Foundation (grant 0250.250.102), and
   the US National Institutes of Health (grants R01 AI052473, U01 AI088752,
   D43 TW00919, R25 TW009338). A Unger was supported by a Fogarty
   International Center/Ellison Medical Foundation Fellowship in Global
   Health and Clinical Research (grant TW00018).
CR Anand K, 2007, NATL MED J INDIA, V20, P115
   Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146
   Awad M, 2014, CARDIOVASC J AFR, V25, DOI 10.5830/CVJA-2014-058
   Ayah R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-371
   Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240
   Brasil. Ministerio da Saude, 2012, VIG BRAS 2012 VIG FA
   Miquilin IDC, 2013, CAD SAUDE PUBLICA, V29, P1392
   Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2
   Daniel OJ, 2013, J URBAN HEALTH, V90, P1016, DOI 10.1007/s11524-013-9795-x
   Moreira JPD, 2011, CIENC SAUDE COLETIVA, V16, P3781, DOI 10.1590/S1413-81232011001000014
   Moraes Suzana Alves de, 2014, Rev. bras. epidemiol., V17, P323, DOI 10.1590/1809-4503201400020004ENG
   Doumas M, 2013, CURR HYPERTENS REP, V15, P321, DOI 10.1007/s11906-013-0359-y
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Fuentes R, 2000, J HYPERTENS, V18, P521, DOI 10.1097/00004872-200018050-00003
   Gao Y, 2013, PLOS ONE, DOI [10.1371/journal.pone.0065938.g001, DOI 10.1371/JOURNAL.PONE.0065938.G001]
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Guimaraes AC, 2002, J HUM HYPERTENS, V16, pS7, DOI 10.1038/sj.jhh.1001332
   Hacker KP, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-45
   Heitzinger K, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-19
   Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5
   Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2010, CENS DEM AGL SUBN PR
   James PA, 2014, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2013.284427, DOI 10.1001/JAMA.2013.284427.2013]
   Joshi MD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1177
   Kanungo S, 2010, B WORLD HEALTH ORGAN, V88, P667, DOI 10.2471/BLT.09.073742
   Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003
   Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3
   Lanas F, 2007, CIRCULATION, V115, P1067, DOI 10.1161/CIRCULATIONAHA.106.633552
   Lessa Ines, 2004, Ciênc. saúde coletiva, V9, P931, DOI 10.1590/S1413-81232004000400014
   Lessa Ínes, 2006, Arq. Bras. Cardiol., V87, P747, DOI 10.1590/S0066-782X2006001900011
   Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8
   Marins VMR, 2007, J BIOSOC SCI, V39, P221, DOI 10.1017/S0021932006001246
   Mendis S, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0486-3
   Mendoza-Sassi R, 2003, REV SAUDE PUBL, V37, P372, DOI [10.1590/S0034-89102003000300017, 10.1590/s0034-89102003000300017]
   Ministerio da Saude, 2008, VIG BRAS 2007 VIG FA
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Nwankwo Tatiana, 2013, NCHS Data Brief, P1
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878
   Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Ribeiro GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037855
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9
   Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7
   Shei A, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-10
   SITTHIAMORN C, 1989, INT J EPIDEMIOL, V18, P89, DOI 10.1093/ije/18.1.89
   Snyder RE, 2014, J URBAN HEALTH, V91, P432, DOI 10.1007/s11524-013-9848-1
   Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2
   Tailakh A, 2014, NURS HEALTH SCI, V16, P126, DOI 10.1111/nhs.12060
   Thakur RP, 2013, ANN MED HEALTH SCI R, V3, P19, DOI 10.4103/2141-9248.109466
   Tibazarwa KB, 2014, CAN J CARDIOL, V30, P527, DOI 10.1016/j.cjca.2014.02.020
   UN-HABITAT, 2003, CHALL SLUMS GLOB REP
   Unger A, 2007, PLOS MED, V4, P1561, DOI 10.1371/journal.pmed.0040295
   United Nations Human Settlements Programme (UN-HABITAT), 2012, STAT WORLDS CIT 2012
   van de Vijver SJM, 2013, J HYPERTENS, V31, P1018, DOI 10.1097/HJH.0b013e32835e3a56
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   World Health Organization, 2008, FACT SHEET
   World Health Organization, 2013, GLOB BRIEF HYP SIL K
   Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487
NR 60
TC 10
Z9 10
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1099-3460
EI 1468-2869
J9 J URBAN HEALTH
JI J. Urban Health
PD JUN
PY 2015
VL 92
IS 3
BP 446
EP 459
DI 10.1007/s11524-015-9956-1
PG 14
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA CJ6SR
UT WOS:000355624400004
PM 25920334
OA Green Published
DA 2020-11-30
ER

PT J
AU Costa, F
   Wunder, EA
   De Oliveira, D
   Bisht, V
   Rodrigues, G
   Reis, MG
   Ko, AI
   Begon, M
   Childs, JE
AF Costa, Federico
   Wunder, Elsio A., Jr.
   De Oliveira, Daiana
   Bisht, Vimla
   Rodrigues, Gorete
   Reis, Mitermayer G.
   Ko, Albert I.
   Begon, Mike
   Childs, James E.
TI Patterns in Leptospira Shedding in Norway Rats (Rattus norvegicus) from
   Brazilian Slum Communities at High Risk of Disease Transmission
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SPIROCHAETA ICTEROHAEMORRHAGIAE; WEILS-DISEASE; SEOUL VIRUS; INNER-CITY;
   INTERROGANS; INFECTION; MODEL; ENVIRONMENT; POPULATION; GENETICS
AB Background We address some critical but unknown parameters of individuals and populations of Norway rats (Rattus norvegicus) that influence leptospiral infection, maintenance and spirochetal loads shed in urine, which contaminates the environment ultimately leading to human infection.
   Methodology/Principal Findings Our study, conducted in Salvador, Brazil, established the average load of leptospires in positive kidneys to be 5.9 x 10(6) per mL (range 3.1-8.2 x10(6)) genome equivalents (GEq), similar to the 6.1 x 10(6) per ml (range 2.2-9.4 x10(6)) average obtained from paired urines, with a significant positive correlation (R-2=0.78) between the two. Based on bivariate and multivariate modeling, we found with both kidney and urine samples that leptospiral loads increased with the age of rats (based on the index of body length to mass), MAT titer and the presence of wounding/scars, and varied with site of capture. Some associations were modified by sex but trends were apparent. Combining with data on the demographic properties and prevalence of leptospiral carriage in rat populations in Salvador, we estimated that daily leptospiral loads shed in the urine of a population of 82 individuals exceeded 9.1 x 10(10) leptospires.
   Conclusions/Significance These factors directly influence the risk of leptospiral acquisition among humans and provide essential epidemiological information linking properties of rat populations with risk of human infection.
C1 [Costa, Federico; De Oliveira, Daiana; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [Costa, Federico] Univ Fed Bahia UFBA, Inst Saude Colet, Salvador, BA, Brazil.
   [Costa, Federico; Wunder, Elsio A., Jr.; Bisht, Vimla; Reis, Mitermayer G.; Ko, Albert I.; Childs, James E.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Costa, Federico; Begon, Mike] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.
   [Rodrigues, Gorete] Minist Saude, Ctr Controle Zoonoses, Secretaria Municipal Saude, Salvador, BA, Brazil.
RP Costa, F (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
EM fcosta2001@gmail.com
RI Ko, Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015; Wunder,
   Elsio Augusto/C-2733-2013; Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336; Wunder, Elsio Augusto/0000-0002-5239-8511;
   Reis, Mitermayer/0000-0002-3051-9060
FU Oswaldo Cruz Foundation; Secretariat of Health Surveillance; Brazilian
   Ministry of Health; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [F31 AI114245, R01 AI052473, U01 AI088752, R01 TW009504, R25
   TW009338]; Wellcome TrustWellcome Trust [102330/Z/13/Z]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009338, R25TW009338, R25TW009338,
   R01TW009504, R25TW009338, R01TW009504, R01TW009504, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R01TW009504, R25TW009338, R01TW009504, R25TW009338, R25TW009338] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01AI088752, U01AI088752, U01AI088752,
   F31AI114245, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, R01AI052473, R01AI052473, F31AI114245,
   U01AI088752, U01AI088752, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the Oswaldo Cruz Foundation and Secretariat
   of Health Surveillance, Brazilian Ministry of Health, the National
   Institutes of Health (grants F31 AI114245, R01 AI052473, U01 AI088752,
   R01 TW009504 and R25 TW009338) and by the Wellcome Trust
   (102330/Z/13/Z). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359
   Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012
   Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59
   Barcellos C, 2000, INT J ENVIRON HEAL R, V10, P301, DOI 10.1080/0960312002001500
   BOLLES RC, 1960, J COMP PHYSIOL PSYCH, V53, P306, DOI 10.1037/h0045421
   CHANG SL, 1948, J INFECT DIS, V82, P256, DOI 10.1093/infdis/82.3.256
   Costa F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003338
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   Courcoul A, 2011, J THEOR BIOL, V284, P130, DOI 10.1016/j.jtbi.2011.06.017
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   DEMERS RY, 1983, J FAM PRACTICE, V17, P1007
   Desvars A, 2013, ACTA TROP, V125, P258, DOI 10.1016/j.actatropica.2012.11.011
   Donaldson HH, 1924, RAT DATA REFERENCE T
   Durski KN, 2014, INT J ENV RES PUB HE, V11, P6000, DOI 10.3390/ijerph110606000
   Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746
   Faine S., 1982, GUIDELINES CONTROL L
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   GLASS GE, 1988, J MAMMAL, V69, P587, DOI 10.2307/1381350
   GOLLOP JH, 1993, WESTERN J MED, V159, P76
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Hagan JE, 2013, P 8 INT LEPT SOC SCI, P66
   Health Surveillance Secretary BMoH, 2007, LEPT CAS NOT REC
   Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270
   Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310
   Holt J, 2006, ACTA TROP, V99, P218, DOI 10.1016/j.actatropica.2006.08.003
   Ido M, 1917, JEXPLMED, V24, P341
   Inoue T, 2010, CLIN NEPHROL, V73, P76
   ISKJAER C, 1989, J MAMMAL, V70, P662, DOI 10.2307/1381447
   Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Koizumi N, 2009, J MED MICROBIOL, V58, P1227, DOI 10.1099/jmm.0.011528-0
   Krojgaard LH, 2009, EPIDEMIOL INFECT, V137, P1586, DOI 10.1017/S0950268809002647
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   LIDICKER WZ, 1973, ECOL MONOGR, V43, P271, DOI 10.2307/1942343
   Lourdault K, 2009, J MED MICROBIOL, V58, P648, DOI 10.1099/jmm.0.008169-0
   LUZZI GA, 1987, J INFECTION, V15, P57, DOI 10.1016/S0163-4453(87)91451-4
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103
   Monahan AM, 2008, INFECT IMMUN, V76, P4952, DOI 10.1128/IAI.00511-08
   Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Noguchi H, 1918, J EXP MED, V27, P609, DOI 10.1084/jem.27.5.609
   Noguchi H, 1918, J EXP MED, V27, P575, DOI 10.1084/jem.27.5.575
   Porter FH, 2015, J MAMMAL, V96, P317, DOI 10.1093/jmammal/gyv033
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Ricaldi JN, 2013, CURR OPIN INFECT DIS, V26, P399, DOI 10.1097/QCO.0000000000000001
   Roczek A, 2008, J MED MICROBIOL, V57, P658, DOI 10.1099/jmm.0.47677-0
   Royston P, 1992, STAT COMPUT, V2, P117, DOI DOI 10.1007/BF01891203
   Scialfa E, 2010, REV ARGENT MICROBIOL, V42, P126, DOI 10.1590/S0325-75412010000200012
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545
   Spichler AS, 2008, AM J TROP MED HYG, V79, P911, DOI 10.4269/ajtmh.2008.79.911
   STERLING CR, 1981, VET PATHOL, V18, P628, DOI 10.1177/030098588101800508
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39
   Tucunduva de Faria M, 2007, J COMP PATHOL, V137, P231, DOI 10.1016/j.jcpa.2007.08.001
   Vanasco NB, 2003, PREV VET MED, V60, P227, DOI 10.1016/S0167-5877(03)00144-2
   Villanueva SYAM, 2010, AM J TROP MED HYG, V82, P889, DOI 10.4269/ajtmh.2010.09-0711
   WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1
NR 60
TC 58
Z9 58
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2015
VL 9
IS 6
AR e0003819
DI 10.1371/journal.pntd.0003819
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA CM0VX
UT WOS:000357398100026
PM 26047009
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Porter, FH
   Costa, F
   Rodrigues, G
   Farias, H
   Cunha, M
   Glass, GE
   Reis, MG
   Ko, AI
   Childs, JE
AF Porter, Fleur H.
   Costa, Federico
   Rodrigues, Gorete
   Farias, Helena
   Cunha, Marcelo
   Glass, Gregory E.
   Reis, Mitermayer G.
   Ko, Albert I.
   Childs, James E.
TI Morphometric and demographic differences between tropical and temperate
   Norway rats (Rattus norvegicus)
SO JOURNAL OF MAMMALOGY
LA English
DT Article
DE Bergmann's rule; invasive species; Norway rat; rodent control; urban
   ecology
ID BODY-SIZE; LEPTOSPIRA-INTERROGANS; BERGMANNS RULE; URBAN; POPULATIONS;
   ECOLOGY; AGE
AB Rattus norvegicus (Norway rat) is one of the most abundant and geographically widespread mammals. Ecological studies focusing on urban Norway rat populations are restricted to temperate regions, and data describing populations from tropical cities are lacking. We compared the morphometrics and demographic characteristics of rats captured in urban low-income settlements in Salvador, Brazil, to a season, environmental area of capture, and sex-matched sample from Baltimore, Maryland. Norway rats of both sexes were significantly smaller in Salvador, although the threshold mass marking sexual maturity was equivalent for both cities. Pregnancy rates were comparable (similar to 50%); however, juveniles were commonly trapped in Salvador (20%) while they were rarely trapped in Baltimore during winter months (2%). These findings suggest that tropical and temperate rats differ with respect to body metrics, while size at sexual maturity is similar. Further studies conducted over different seasons are required before any firm conclusions are reached; however, this study provides preliminary support for Bergmann's rule that species at higher absolute latitude are larger than the same species sampled at lower latitudes.
C1 [Porter, Fleur H.; Costa, Federico; Ko, Albert I.; Childs, James E.] Yale Univ, Sch Publ Hlth, LEPH, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Costa, Federico; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Salvador, BA, Brazil.
   [Cunha, Marcelo] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Rio De Janeiro, Brazil.
   [Rodrigues, Gorete; Farias, Helena] Ctr Controle Zoonoses, Secretaria Municipal Saude, Salvador, BA, Brazil.
   [Glass, Gregory E.] Johns Hopkins Bloomberg Sch Publ Hlth, Div Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
RP Childs, JE (corresponding author), Yale Univ, Sch Publ Hlth, LEPH, Dept Epidemiol Microbial Dis, 60 Coll St,Room 606, New Haven, CT 06510 USA.
EM james.childs@yale.edu
RI Reis, Mitermayer/AAO-9742-2020; Costa, Federico/G-1838-2015; Ko, Albert
   Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Costa,
   Federico/0000-0001-6951-2336; Ko, Albert Icksang/0000-0001-9023-2339
FU Yale Institute for Biospheric Studies; William Prusoff Foundation;
   Overlook International Foundation; Yale Center for Latin American and
   Iberian Studies; Johns Hopkins Bloomberg School of Public Health Animal
   Care and Use Committee [RA06H302];  [NIAID U01 AI088752];  [NIAID R01
   AI052473];  [FIC D43 TW00919];  [FIC R01 TW009504];  [R25 TW009338]; 
   [NSF EF0525751]
FX We thank everyone at the Centro de Control de Zoonoses, Salvador (CCZ)
   and everyone at FIOCRUZ who assisted with field work and data collection
   in Salvador, especially I. de Almeida Barbosa Bispo, I. Guimaraes, and
   M. Medrado who assisted with project logistics. We thank K. Hacker and
   G. Ghizzi who collaborated with the data analyses. We also thank 2
   anonymous reviewers for their critical and constructive reviews. Rat
   collections in Salvador were conducted in accordance with Municipal
   Health Code 5504/99, which grants the Centro de Controle de Zoonoses
   authority to capture and euthanize rats. Rat collections in Baltimore
   were approved by the Johns Hopkins Bloomberg School of Public Health
   Animal Care and Use Committee (RA06H302). Support was provided by grants
   NIAID U01 AI088752, NIAID R01 AI052473, FIC D43 TW00919, FIC R01
   TW009504, R25 TW009338, and NSF EF0525751. Support for rat collections
   in Salvador was provided by the Yale Institute for Biospheric Studies,
   the William Prusoff Foundation, the Overlook International Foundation,
   and the Yale Center for Latin American and Iberian Studies.
CR Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400
   Bergmann Carl, 1847, GOTTINGER STUDIEN, V3, P595
   BISHOP JA, 1976, J ANIM ECOL, V45, P623, DOI 10.2307/3572
   Buckle A, 1994, RODENT PESTS THEIR C
   CALHOUN JB, 1962, PUBLIC HLTH SERVICE, V1008
   CHILDS JE, 1986, J MAMMAL, V67, P196, DOI 10.2307/1381025
   CHITTY D, 1946, J MAMMAL, V27, P63, DOI 10.2307/1375143
   CHITTY D, 1949, ECOLOGY, V30, P536, DOI 10.2307/1932457
   Clauss M, 2013, OIKOS, V122, P1465, DOI 10.1111/j.1600-0706.2013.00463.x
   Costa F., 2014, VECTOR-BORNE ZOONOT, V14, P13
   DAVIS DE, 1948, J WILDLIFE MANAGE, V12, P162, DOI 10.2307/3796411
   DAVIS DE, 1953, Q REV BIOL, V28, P373, DOI 10.1086/399860
   DAVIS DE, 1948, ANAT REC, V101, P691
   DAVIS DE, 1948, PHYSIOL ZOOL, V21, P272, DOI 10.1086/physzool.21.3.30152004
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   Ellis BA, 1999, J INFECT DIS, V180, P220, DOI 10.1086/314824
   FARHANG-AZAD A, 1979, Annals of Zoology (Agra), V15, P1
   Freckleton RP, 2003, AM NAT, V161, P821, DOI 10.1086/374346
   Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x
   Glass G.E., 1989, Occasional Papers of the Museum of Natural History University of Kansas, VNo. 130, P1
   GLASS GE, 1988, J MAMMAL, V69, P587, DOI 10.2307/1381350
   Glass GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005794
   Villafane IEG, 2013, MAMMALIA, V77, P187, DOI 10.1515/mammalia-2012-0075
   Gratz N.G., 1988, P101
   Himsworth CG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002270
   ISKJAER C, 1989, J MAMMAL, V70, P662, DOI 10.2307/1381447
   KATARANOVSKI D, 1991, ACTA VET-BEOGRAD, V41, P247
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   LEDUC JW, 1986, B WORLD HEALTH ORGAN, V64, P139
   Madsen T, 1999, AUST J ECOL, V24, P80, DOI 10.1046/j.1442-9993.1999.00948.x
   Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837
   Millien V, 2006, PLOS BIOL, V4, P1863, DOI 10.1371/journal.pbio.0040321
   Mills JN, 1995, METHODS TRAPPING SAM
   Pratt H. D., 1991, VECTOR BORNE DIS CON, V3013-G, P1
   PYE T, 1980, J ZOOL, V192, P237
   Reis R. B., 2008, NEGLECTED TROPICAL D, V2, P1
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   SAS, 2008, SAS STAT 9 2 US GUID
   SCHEIN MW, 1953, AM J TROP MED HYG, V2, P1117, DOI 10.4269/ajtmh.1953.2.1117
   Schiller E. L., 1956, Journal of Mammalogy, V37, P181, DOI 10.2307/1376676
   Singleton G. R., 1999, Ecologically-based management of rodent pests., P17
   TAYLOR KD, 1978, J APPL ECOL, V15, P663, DOI 10.2307/2402767
   Yom-Tov Y, 1999, J BIOGEOGR, V26, P947, DOI 10.1046/j.1365-2699.1999.00338.x
   Yom-Tov Y, 2011, BIOL REV, V86, P531, DOI 10.1111/j.1469-185X.2010.00168.x
NR 45
TC 8
Z9 10
U1 0
U2 20
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2372
EI 1545-1542
J9 J MAMMAL
JI J. Mammal.
PD APR
PY 2015
VL 96
IS 2
BP 317
EP 323
DI 10.1093/jmammal/gyv033
PG 7
WC Zoology
SC Zoology
GA CH7XG
UT WOS:000354249300007
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Sacchi, FPC
   Praca, RM
   Tatara, MB
   Simonsen, V
   Ferrazoli, L
   Croda, MG
   Suffys, PN
   Ko, AI
   Andrews, JR
   Croda, J
AF Sacchi, Flavia P. C.
   Praca, Renata M.
   Tatara, Mariana B.
   Simonsen, Vera
   Ferrazoli, Lucilaine
   Croda, Mariana G.
   Suffys, Philip N.
   Ko, Albert I.
   Andrews, Jason R.
   Croda, Julio
TI Prisons as Reservoir for Community Transmission of Tuberculosis, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MYCOBACTERIUM-TUBERCULOSIS; EPIDEMIOLOGY; DYNAMICS
AB We conducted a population-based study of tuberculosis (TB) cases in Dourados, Brazil, to assess the relationship between incarceration and TB in the general population. Incarceration was associated with TB in an urban population; 54% of Mycobacterium tuberculosis strains were related to strains from persons in prisons. TB control in prisons is critical for reducing disease prevalence.
C1 [Sacchi, Flavia P. C.; Praca, Renata M.; Tatara, Mariana B.; Croda, Mariana G.; Croda, Julio] Fundacao Univ Fed Grande Dourados, BR-79804970 Dourados, MS, Brazil.
   [Simonsen, Vera; Ferrazoli, Lucilaine] Adolfo Lutz Inst, Sao Paulo, Brazil.
   [Suffys, Philip N.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Andrews, Jason R.] Stanford Univ, Sch Med, Stanford, CA 94305 USA.
RP Croda, J (corresponding author), Fundacao Univ Fed Grande Dourados, Fac Ciencias Saude, Rodovia Dourados,Itaum Km 12, BR-79804970 Dourados, MS, Brazil.
EM juliocroda@ufgd.edu.br
RI Ferrazoli, Lucilaine LF/H-6959-2012; Ko, Albert Icksang/P-2343-2015;
   Croda, Julio/I-5172-2013; suffys, philip/E-3009-2013
OI Ferrazoli, Lucilaine LF/0000-0002-5389-7056; Ko, Albert
   Icksang/0000-0001-9023-2339; Croda, Julio/0000-0002-6665-6825; Croda,
   Mariana/0000-0003-1436-9717
FU National Council for Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico)National Council
   for Scientific and Technological Development (CNPq) [471429/2011-2,
   404237/2012-6]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338] Funding Source: NIH RePORTER
FX This work was supported by the National Council for Scientific and
   Technological Development (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) [471429/2011-2 and 404237/2012-6].
CR Basu S, 2011, AM J TROP MED HYG, V84, P30, DOI 10.4269/ajtmh.2011.10-0472
   Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381
   Behr MA, 1998, AM J RESP CRIT CARE, V158, P465, DOI 10.1164/ajrccm.158.2.9801062
   Diel R, 2002, J CLIN MICROBIOL, V40, P532, DOI 10.1128/JCM.40.2.532-539.2002
   Estevan AO, 2013, REV SOC BRAS MED TRO, V46, P515, DOI 10.1590/0037-8682-1441-2013
   Johnstone-Robertson S, 2011, SAMJ S AFR MED J, V101, P809
   Jones TF, 1999, ANN INTERN MED, V131, P557, DOI 10.7326/0003-4819-131-8-199910190-00002
   Kuhleis D, 2012, MEM I OSWALDO CRUZ, V107, P909, DOI 10.1590/S0074-02762012000700012
   Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005
   Lemos ACM, 2009, J BRAS PNEUMOL, V35, P63, DOI 10.1590/S1806-37132009000100009
   Reyes H, 1997, BRIT MED J, V315, P1447, DOI 10.1136/bmj.315.7120.1447
   Sanchez A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-983
   VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993
   Warren RM, 2002, J CLIN MICROBIOL, V40, P1705, DOI 10.1128/JCM.40.5.1705-1708.2002
   Wilkinson D, 1997, TROP MED INT HEALTH, V2, P747, DOI 10.1046/j.1365-3156.1997.d01-386.x
NR 15
TC 39
Z9 42
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAR
PY 2015
VL 21
IS 3
BP 452
EP 455
DI 10.3201/eid2103.140896
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CC3SI
UT WOS:000350269300009
PM 25642998
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Carbone, ADS
   Paiao, DSG
   Sgarbi, RVE
   Lemos, EF
   Cazanti, RF
   Ota, MM
   Laranjeira, A
   Bampi, JVB
   Elias, VPF
   Simionatto, S
   Motta-Castro, ARC
   Pompilio, MA
   de Oliveira, SMD
   Ko, AI
   Andrews, JR
   Croda, J
AF Santos Carbone, Andrea da Silva
   Guimaraes Paiao, Dayse Sanchez
   Enne Sgarbi, Renata Viebrantz
   Lemos, Everton Ferreira
   Cazanti, Renato Fernando
   Ota, Marcos Massaki
   Laranjeira Junior, Alexandre
   Bortolotto Bampi, Jose Victor
   Fayad Elias, Vanessa Perreira
   Simionatto, Simone
   Coimbra Motta-Castro, Ana Rita
   Pompilio, Mauricio Antonio
   do Valle de Oliveira, Sandra Maria
   Ko, Albert I.
   Andrews, Jason R.
   Croda, Julio
TI Active and latent tuberculosis in Brazilian correctional facilities: a
   cross-sectional study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Tuberculosis; Prisoners; TST; Infection; Active case detection;
   Screening cross-sectional study; Brazil; Epidemiology
ID PRISON; PREVALENCE; INMATES; INFECTION; TB
AB Background: Tuberculosis (TB) rates among prisoners are more than 20 times that of the general population in Brazil, yet there are limited data available to facilitate the development of effective interventions in this high-transmission setting. We aimed to assess risk factors for TB infection and evaluate the yield of mass screening for active disease among inmates.
   Methods: We administered a questionnaire and tuberculin skin test (TST) to a population-based sample of inmates from 12 prisons in Central-West Brazil and collected sera for HIV testing and two sputum samples for smear microscopy and culture from participants reporting a cough of any duration. Hierarchical Poisson regression models were used to evaluate factors associated with latent tuberculosis infection (LTBI).
   Results: We recruited 3,380 inmates, of which 2,861 (84.6%) were males from 8 prisons, and 519 (15.4%) were females from 4 prisons. Among the 1,020 (30%) subjects who reported a cough, we obtained sputum from 691 (68%) and identified 31 cases of active TB for a point prevalence of 917 (95% CI, 623-1302) per 100,000 prisoners. Evaluation of the two sputum smear samples failed to identify 74% of the TB cases, and 29% of the cases reported less than 2 weeks of symptoms. Obtaining a second culture identified an additional 7 (24%) cases. The prevalences of LTBI were 22.5% and 11.7% for male and female prisoners, respectively and duration of incarceration (in years) was associated with LTBI in male and female in the multivariable model (1.04, 95% CI, 1.01-1.07 and 1.34, 95% CI, 1.06-1.70, respectively). The prevalence of LTBI is 8.6% among newly incarcerated inmates, among whom LTBI prevalence significantly increased by 5% with each year of incarceration.
   Conclusions: Although the overall LTBI prevalence among inmates in Central-West Brazil is low, tuberculosis incidence is high (> 1,800/100,00), likely due to the high force of infection among a largely susceptible inmate population. Efforts to reduce transmission in prisons may require mass screening for active TB, utilizing sputum culture in case-detection protocols.
C1 [Santos Carbone, Andrea da Silva; Guimaraes Paiao, Dayse Sanchez; Enne Sgarbi, Renata Viebrantz] Fed Univ Grande Dourados, Univ Hosp, Dourados, Brazil.
   [Lemos, Everton Ferreira; Cazanti, Renato Fernando; Ota, Marcos Massaki; Laranjeira Junior, Alexandre; Bortolotto Bampi, Jose Victor; Fayad Elias, Vanessa Perreira; Croda, Julio] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil.
   [Simionatto, Simone] Fed Univ Grande Dourados, Fac Ambiental & Biol Sci, Dourados, Brazil.
   [Coimbra Motta-Castro, Ana Rita] Univ Fed Mato Grosso do Sul, Dept Biochem Pharm, Campo Grande, MS, Brazil.
   [Coimbra Motta-Castro, Ana Rita; Croda, Julio] Fundacao Oswaldo Cruz, Campo Grande, Brazil.
   [Pompilio, Mauricio Antonio] Univ Fed Mato Grosso do Sul, Fac Med, Campo Grande, MS, Brazil.
   [do Valle de Oliveira, Sandra Maria] Univ Fed Mato Grosso do Sul, Univ Hosp, Campo Grande, MS, Brazil.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Andrews, Jason R.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
RP Croda, J (corresponding author), Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil.
EM juliocroda@ufgd.edu.br
RI motta-castro, ana rita c/O-2075-2017; Simionatto, Simone/AAG-7509-2020;
   Croda, Julio/I-5172-2013; de Oliveira, Sandra Maria do Valle
   Leone/A-1074-2013; Lemos, Everton EFL Ferreira/J-5831-2015; Ko, Albert
   Icksang/P-2343-2015
OI Simionatto, Simone/0000-0003-2367-0915; Croda,
   Julio/0000-0002-6665-6825; de Oliveira, Sandra Maria do Valle
   Leone/0000-0002-8960-6716; Lemos, Everton EFL
   Ferreira/0000-0001-6652-9191; Ko, Albert Icksang/0000-0001-9023-2339;
   Andrews, Jason/0000-0002-5967-251X; Motta-Castro, Ana
   Rita/0000-0003-3070-1337
FU Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do
   Estado do Mato Grosso do Sul (FUNDECT)Fundect [0067/2012]; Ministry of
   Education (PROEXT); Brazilian National Research Council (Ciencias sem
   Fronteiras Program); Fogarty Global Health Equity Scholars Program (NIH)
   [1 R25 TW009338]; FOGARTY INTERNATIONAL CENTERUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338] Funding Source: NIH RePORTER
FX The authors are grateful to the State Agency of the Administration of
   Prisons for their full support during the study period. We thank the
   prisoner participants, without whom this study could not have been
   performed. Our appreciation also extends to the staff of the UFGD TB
   study group for their support during the study, including Junio Pereira
   Pardins, Vinicius Neonato de Oliveira, Guilherme de Freitas Bezerra, and
   Sylka Rebelato Toppan. We would also like to extend our gratitude to
   Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do
   Estado do Mato Grosso do Sul (FUNDECT, 0067/2012), the Ministry of
   Education (PROEXT), the Brazilian National Research Council (Ciencias
   sem Fronteiras Program) and the Fogarty Global Health Equity Scholars
   Program (NIH 1 R25 TW009338).
CR Abrahao RMCM, 2006, INT J TUBERC LUNG D, V10, P203
   Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381
   Bone A., 2000, TUBERCULOSIS CONTROL
   [Brasil Ministerio da Saude SdVeS], 2011, MAN REC CONTR TUB BR
   Dara M, 2009, WHO GUIDELINES CONTR
   David H, 1989, METHODES LABORATOIRE, P39
   Estevan AO, 2013, REV SOC BRAS MED TRO, V46, P515, DOI 10.1590/0037-8682-1441-2013
   Fournet N, 2006, PUBLIC HEALTH, V120, P976, DOI 10.1016/j.puhe.2006.06.004
   KUDOH S, 1974, B WORLD HEALTH ORGAN, V51, P71
   Kuhleis D, 2012, MEM I OSWALDO CRUZ, V107, P909, DOI 10.1590/S0074-02762012000700012
   Margolis B, 2013, INT J TUBERC LUNG D, V17, P1538, DOI 10.5588/ijtld.13.0193
   Lemos ACM, 2009, J BRAS PNEUMOL, V35, P63, DOI 10.1590/S1806-37132009000100009
   Moreira TR, 2010, REV BRASILEIRA PESQU, V12, P26
   Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17
   Nogueira Péricles Alves, 2009, Rev. bras. epidemiol., V12, P30, DOI 10.1590/S1415-790X2009000100004
   Nogueira PA, 2012, REV SAUDE PUBL, V46, P119, DOI 10.1590/S0034-89102011005000080
   Sacchi FPC, 2014, INCARCERATION ASS TU
   Salem JI, 1990, J PNEUMOL, V16, P133
   Sanchez A, 2005, INT J TUBERC LUNG D, V9, P633
   Sanchez A, 2009, INT J TUBERC LUNG D, V13, P1247
   Stuckler D, 2008, P NATL ACAD SCI USA, V105, P13280, DOI 10.1073/pnas.0801200105
   White MC, 2012, PUBLIC HEALTH, V126, P752, DOI 10.1016/j.puhe.2012.04.009
   *WHO, 2007, STAT PAP PRIS TUB
NR 23
TC 38
Z9 38
U1 0
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 22
PY 2015
VL 15
AR 24
DI 10.1186/s12879-015-0764-8
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA AZ7JR
UT WOS:000348396000001
PM 25608746
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Lessa-Aquino, C
   Wunder, EA
   Lindow, JC
   Rodrigues, CB
   Pablo, J
   Nakajima, R
   Jasinskas, A
   Liang, L
   Reis, MG
   Ko, AI
   Medeiros, MA
   Felgner, PL
AF Lessa-Aquino, Carolina
   Wunder, Elsio A., Jr.
   Lindow, Janet C.
   Rodrigues, Camila B.
   Pablo, Jozelyn
   Nakajima, Rie
   Jasinskas, Algis
   Liang, Li
   Reis, Mitermayer G.
   Ko, Albert I.
   Medeiros, Marco A.
   Felgner, Philip L.
TI Proteomic Features Predict Seroreactivity against Leptospiral Antigens
   in Leptospirosis Patients
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
ID HUMORAL IMMUNE-RESPONSE; PROTEIN MICROARRAY; IDENTIFICATION; INFECTION;
   VACCINE; INTERROGANS
AB With increasing efficiency, accuracy, and speed we can access complete genome sequences from thousands of infectious microorganisms; however, the ability to predict antigenic targets of the immune system based on amino acid sequence alone is still needed. Here we use a Leptospira interrogans microarray expressing 91% (3359) of all leptospiral predicted ORFs (3667) and make an empirical accounting of all antibody reactive antigens recognized in sera from naturally infected humans; 191 antigens elicited an IgM or IgG response, representing 5% of the whole proteome. We classified the reactive antigens into 26 annotated COGs (clusters of orthologous groups), 26 JCVI Mainrole annotations, and 11 computationally predicted proteomic features. Altogether, 14 significantly enriched categories were identified, which are associated with immune recognition including mass spectrometry evidence of in vitro expression and in vivo mRNA up-regulation. Together, this group of 14 enriched categories accounts for just 25% of the leptospiral proteome but contains 50% of the immunoreactive antigens. These findings are consistent with our previous studies of other Gram-negative bacteria. This genome-wide approach provides an empirical basis to predict and classify antibody reactive antigens based on structural, physical-chemical, and functional proteomic features and a framework for understanding the breadth and specificity of the immune response to L. interrogans.
C1 [Lessa-Aquino, Carolina; Rodrigues, Camila B.; Medeiros, Marco A.] Brazilian Minist Hlth, FIOCRUZ, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Lessa-Aquino, Carolina; Rodrigues, Camila B.; Pablo, Jozelyn; Nakajima, Rie; Jasinskas, Algis; Liang, Li; Felgner, Philip L.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92697 USA.
   [Wunder, Elsio A., Jr.; Lindow, Janet C.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Wunder, Elsio A., Jr.; Lindow, Janet C.; Reis, Mitermayer G.; Ko, Albert I.] Brazilian Minist Hlth, Goncalo Moniz Res Inst, FIOCRUZ, BR-40296710 Salvador, BA, Brazil.
RP Felgner, PL (corresponding author), Univ Calif Irvine, Dept Med, Div Infect Dis, 3221 McGaugh Hall, Irvine, CA 92697 USA.
EM pfelgner@uci.edu
RI Wunder, Elsio Augusto/C-2733-2013; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060;
   Lindow, Janet/0000-0003-3235-3698
FU [R01AI052473];  [R01TW009504];  [U01AI088752]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW009504, R01TW009504, R01TW009504, R01TW009504, R01TW009504]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, U01AI088752,
   U01AI088752, U01AI088752, U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473] Funding
   Source: NIH RePORTER
FX We acknowledge the institutions involved in this study and the Molecular
   and Cellular Biology Postgraduation Program of Oswaldo Cruz Institute,
   Fiocruz. Funding support: R01AI052473 - Natural History of
   Leptospirosis, R01TW009504 - Ecoepidemiology of Leptospirosis,
   U01AI088752 - Disease Determinants of Urban Leptospirosis.
CR ADLER B, 1980, PATHOLOGY, V12, P529, DOI 10.3109/00313028009086806
   Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08
   Barry AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008326
   Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004
   CHAPMAN AJ, 1991, EPIDEMIOL INFECT, V107, P143, DOI 10.1017/S0950268800048779
   Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   Donati C, 2013, ANN NY ACAD SCI, V1285, P115, DOI 10.1111/nyas.12046
   Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985
   Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106
   Fraga TR, 2011, SCAND J IMMUNOL, V73, P408, DOI 10.1111/j.1365-3083.2010.02505.x
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Lessa-Aquino C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002499
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Liang L, 2012, CHEM BIODIVERS, V9, P977, DOI 10.1002/cbdv.201100360
   Liang L, 2011, J PROTEOME RES, V10, P4813, DOI 10.1021/pr200619r
   Magnan CN, 2010, BIOINFORMATICS, V26, P2936, DOI 10.1093/bioinformatics/btq551
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Maneewatch S, 2008, HYBRIDOMA, V27, P453, DOI 10.1089/hyb.2008.0056
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Noguchi H, 1920, J EXP MED, V31, P135, DOI 10.1084/jem.31.2.135
   Pinne M, 2012, J BACTERIOL, V194, P6074, DOI 10.1128/JB.01119-12
   Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816
   Tan XL, 2012, CLIN VACCINE IMMUNOL, V19, P418, DOI 10.1128/CVI.05521-11
   Vigil A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006304
   Vigil A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011447
   Vigil A, 2010, PROTEOMICS, V10, P2259, DOI 10.1002/pmic.201000064
NR 31
TC 9
Z9 9
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD JAN
PY 2015
VL 14
IS 1
BP 549
EP 556
DI 10.1021/pr500718t
PG 8
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA AY3UA
UT WOS:000347506600048
PM 25358092
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Thome, S
   Lessa-Aquino, C
   Ko, AI
   Lilenbaum, W
   Medeiros, MA
AF Thome, Sabrina
   Lessa-Aquino, Carolina
   Ko, Albert Icksang
   Lilenbaum, Walter
   Medeiros, Marco Alberto
TI Identification of immunodominant antigens in canine leptospirosis by
   Multi-Antigen Print ImmunoAssay (MAPIA)
SO BMC VETERINARY RESEARCH
LA English
DT Article
DE Leptospirosis; Dogs; MAPIA; LipL32; Lig proteins
ID DIAGNOSIS; PROTEINS; SERODIAGNOSIS; ANTIBODIES; ASSAY
AB Background: The microscopic agglutination test (MAT), the standard method for serological diagnosis of leptospirosis, may present limitations regarding its sensitivity. Current studies suggest that Leptospira immunoglobulin-like (Lig) proteins and LipL32 are of particular interest as serodiagnostic markers since they are present only in pathogenic species of the Leptospira genus. The purpose of this study was to identify leptospiral immunodominant proteins that are recognized by canine sera from diseased dogs.
   Results: A total of 109 dogs were studied, including seroreactive dogs (MAT >= 800) and dogs with no seroreactivity detectable by MAT. Eight recombinant fragments (31-70 kDa) of pathogenic Leptospira were tested for their use as diagnostic markers for canine leptospirosis using the Multi-antigen Print Immunoassay (MAPIA) platform: LigB [582-947aa] from L. interrogans serovar Pomona, L. interrogans serovar Copenhageni and L. kirschneri serovar Gryppotyphosa, LigB [131-649aa] from L. interrogans serovar Copenhageni, L. interrogans serovar Canicola and L. kirschneri serovar Gryppotyphosa, LigA [625-1224aa] L. interrogans serovar Copenhageni and LipL32 from L. interrogans serovar Copenhageni. The data were analyzed and ROC curves were generated. Altogether, LigB [131-649aa] L. interrogans Canicola, LigB [131-649aa] L. kirschneri Gryppotyphosa and LipL32 L. interrogans Copenhageni showed best accuracy (AUC = 0.826 to 0.869), with 70% specificity and sensitivity ranging from 89% to 95%.
   Conclusions: These results reinforce their potential as diagnostic candidates for the development of new methods for the serological diagnosis of canine leptospirosis.
C1 [Thome, Sabrina; Lilenbaum, Walter] Univ Fed Fluminense, Dept Microbiol & Parasitol, Lab Vet Bacteriol, Niteroi, RJ, Brazil.
   [Lessa-Aquino, Carolina; Medeiros, Marco Alberto] Fiocruz MS, BioManguinhos, Lab Recombinant Technol, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Ko, Albert Icksang] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.
RP Medeiros, MA (corresponding author), Fiocruz MS, BioManguinhos, Lab Recombinant Technol, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM medeiros@bio.fiocruz.br
RI Ko, Albert Icksang/P-2343-2015; Truu, Jaak/H-1323-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Truu, Jaak/0000-0003-1818-6678
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Ministry of Science and Technology, Brazil; Bio-Manguinhos and
   Oswaldo Cruz Foundation; Brazilian Ministry of Health; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI052473, U01
   AI088752, R01 TW009504, D43TW00919]; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW000919,
   R01TW009504, R01TW009504, D43TW000919, D43TW000919, D43TW000919,
   R01TW009504, R01TW009504, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, R01TW009504, D43TW000919, D43TW000919] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, R01AI052473, R01AI052473] Funding Source: NIH
   RePORTER
FX This study was funded by National Council for Scientific and
   Technological Development (CNPq), Ministry of Science and Technology,
   Brazil, Bio-Manguinhos and Oswaldo Cruz Foundation, Brazilian Ministry
   of Health and the National Institutes of Health (R01 AI052473, U01
   AI088752, R01 TW009504, D43TW00919). The authors would like to thank
   LATED - Bio-Manguinhos (FIOCRUZ), Ana Paula Loureiro, Ariel Director and
   Gabriel Martins - LABV - UFF and all veterinarians who participated
   directly or indirectly in this study. WL and MAM are CNPq.
CR Abdoel TH, 2011, VET MICROBIOL, V150, P211, DOI 10.1016/j.vetmic.2011.01.015
   Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   [Anonymous], 2012, MANUAL DIAGNOSTIC TE
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002
   Dellagostin OA, 2011, HUM VACCINES, V7, P1215, DOI 10.4161/hv.7.11.17944
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Hamond C, 2012, VET REC, V171, DOI 10.1136/vr.e5022
   Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07
   Juvet F, 2011, VET REC, V168, DOI 10.1136/vr.d740
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   La-ard A, 2011, SE ASIAN J TROP MED, V42, P128
   Lavinsky MO, 2012, PREV VET MED, V106, P79, DOI 10.1016/j.prevetmed.2012.03.015
   Lessa-Aquino C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002499
   Lottersberger J, 2009, LETT APPL MICROBIOL, V49, P641, DOI 10.1111/j.1472-765X.2009.02723.x
   Lyashchenko KP, 2000, J IMMUNOL METHODS, V242, P91, DOI 10.1016/S0022-1759(00)00241-6
   Martins G, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-237
   McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012
   Nabity SA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001878
   Pinne M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051025
   Sykes JE, 2011, J VET INTERN MED, V25, P1, DOI 10.1111/j.1939-1676.2010.0654.x
   Ye CL, 2014, CLIN VACCINE IMMUNOL, V21, P478, DOI 10.1128/CVI.00649-13
NR 23
TC 2
Z9 2
U1 0
U2 27
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1746-6148
J9 BMC VET RES
JI BMC Vet. Res.
PD DEC 3
PY 2014
VL 10
AR 288
DI 10.1186/s12917-014-0288-2
PG 9
WC Veterinary Sciences
SC Veterinary Sciences
GA AX6IO
UT WOS:000347026300001
PM 25466383
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Costa, F
   Ribeiro, GS
   Felzemburgh, RDM
   Santos, N
   Reis, RB
   Santos, AC
   Fraga, DBM
   Araujo, WN
   Santana, C
   Childs, JE
   Reis, MG
   Ko, AI
AF Costa, Federico
   Ribeiro, Guilherme S.
   Felzemburgh, Ridalva D. M.
   Santos, Norlan
   Reis, Renato Barbosa
   Santos, Andreia C.
   Mothe Fraga, Deborah Bittencourt
   Araujo, Wildo N.
   Santana, Carlos
   Childs, James E.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Influence of Household Rat Infestation on Leptospira Transmission in the
   Urban Slum Environment
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RODENT INFESTATION; INTERROGANS; NORVEGICUS; INFECTION; SALVADOR; RISK;
   OUTBREAK; GENETICS
AB Background: The Norway rat (Rattus norvegicus) is the principal reservoir for leptospirosis in many urban settings. Few studies have identified markers for rat infestation in slum environments while none have evaluated the association between household rat infestation and Leptospira infection in humans or the use of infestation markers as a predictive model to stratify risk for leptospirosis.
   Methodology/Principal Findings: We enrolled a cohort of 2,003 urban slum residents from Salvador, Brazil in 2004, and followed the cohort during four annual serosurveys to identify serologic evidence for Leptospira infection. In 2007, we performed rodent infestation and environmental surveys of 80 case households, in which resided at least one individual with Leptospira infection, and 109 control households. In the case-control study, signs of rodent infestation were identified in 78% and 42% of the households, respectively. Regression modeling identified the presence of R. norvegicus feces (OR, 4.95; 95% CI, 2.13-11.47), rodent burrows (2.80; 1.06-7.36), access to water (2.79; 1.28-6.09), and un-plastered walls (2.71; 1.21-6.04) as independent risk factors associated with Leptospira infection in a household. We developed a predictive model for infection, based on assigning scores to each of the rodent infestation risk factors. Receiver operating characteristic curve analysis found that the prediction score produced a good/excellent fit based on an area under the curve of 0.78 (0.71-0.84).
   Conclusions/Significance: Our study found that a high proportion of slum households were infested with R. norvegicus and that rat infestation was significantly associated with the risk of Leptospira infection, indicating that high level transmission occurs among slum households. We developed an easily applicable prediction score based on rat infestation markers, which identified households with highest infection risk. The use of the prediction score in community-based screening may therefore be an effective risk stratification strategy for targeting control measures in slum settings of high leptospirosis transmission.
C1 [Costa, Federico; Ribeiro, Guilherme S.; Reis, Renato Barbosa; Santos, Andreia C.; Mothe Fraga, Deborah Bittencourt; Reis, Mitermayer G.; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Costa, Federico; Childs, James E.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Costa, Federico; Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Felzemburgh, Ridalva D. M.; Santos, Norlan; Mothe Fraga, Deborah Bittencourt] Univ Fed Bahia, Salvador, BA, Brazil.
   [Araujo, Wildo N.] Univ Brasilia, Ceilandia, DF, Brazil.
   [Santana, Carlos] Brazil Minist Hlth, Zoonosis Control Ctr, Salvador, BA, Brazil.
RP Costa, F (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
EM fcosta@pqvisitante.bahia.fiocruz.br
RI Ko, Albert Icksang/P-2343-2015; Araujo, Wildo Navegantes/AAD-9163-2020;
   Costa, Federico/G-1838-2015; Ribeiro, Guilherme/B-6624-2008; Reis,
   Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Araujo, Wildo
   Navegantes/0000-0002-6856-4094; Costa, Federico/0000-0001-6951-2336;
   Ribeiro, Guilherme/0000-0002-6798-2059; Reis,
   Mitermayer/0000-0002-3051-9060
FU Secretariat of Health Surveillance; Oswaldo Cruz Foundation; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI052473, U01
   AI088752, R01 TW009504, R24 TW007988, R25 TW009338, D43 TW00919];
   Wellcome TrustWellcome Trust [102330/Z/13/Z]; CAPES (Coordination for
   the Improvement of Higher Education Personnel/Ministry of
   Education/Brazil)CAPES; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R01TW009504, R24TW007988, R25TW009338,
   R01TW009504, D43TW000919, R25TW009338, D43TW000919, R25TW009338,
   R24TW007988, D43TW000919, R24TW007988, D43TW000919, R24TW007988,
   R24TW007988, D43TW000919, R24TW007988, R01TW009504, R01TW009504,
   R01TW009504, R25TW009338, D43TW000919, R24TW007988, R25TW009338,
   R25TW009338, R25TW009338, D43TW000919, D43TW000919, D43TW000919,
   R24TW007988, D43TW000919, R25TW009338, D43TW000919, R25TW009338] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, U01AI088752, R01AI052473, U01AI088752,
   U01AI088752, U01AI088752, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473] Funding Source: NIH
   RePORTER
FX This work was supported by the Secretariat of Health Surveillance, the
   Oswaldo Cruz Foundation and the National Institutes of Health (grants
   R01 AI052473, U01 AI088752, R01 TW009504, R24 TW007988, R25 TW009338 and
   D43 TW00919), by the Wellcome Trust [102330/Z/13/Z] and CAPES
   (Coordination for the Improvement of Higher Education Personnel/Ministry
   of Education/Brazil). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Bonner PC, 2007, AM J TROP MED HYG, V77, P169, DOI 10.4269/ajtmh.2007.77.169
   Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221
   Brazil, 2005, GUIA VIG EP, P816
   Brazil, 2002, MAN CONTR ROED
   CARTER ME, 1980, NEW ZEAL VET J, V28, P45, DOI 10.1080/00480169.1980.34688
   CDC, 2006, INT PEST MAN COND UR
   Channon D, 2006, EPIDEMIOL INFECT, V134, P41, DOI 10.1017/S0950268805004607
   CHILDS JE, 1995, AM J TROP MED HYG, V52, P393, DOI 10.4269/ajtmh.1995.52.393
   CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   Costa F, 2012, REV PANAM SALUD PUBL, V32, P169, DOI 10.1590/S1020-49892012000900001
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   de Masi E, 2009, INT J ENVIRON HEAL R, V19, P1, DOI 10.1080/09603120802126670
   Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Hacker KP, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-45
   HATHAWAY SC, 1981, J HYG-CAMBRIDGE, V87, P427, DOI 10.1017/S0022172400069679
   [IBGE Estatistica IBdGe], 2010, SUBN AGGL 1 RES, P1
   Jackson W.B., 1982, P1077
   Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455
   Karande Sunil, 2002, Indian Journal of Pediatrics, V69, P855, DOI 10.1007/BF02723705
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Langton SD, 2001, J APPL ECOL, V38, P699, DOI 10.1046/j.1365-2664.2001.00631.x
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Nowak RM, 1991, WALKERS MAMMALS WORL
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   SAS, 2004, SAS OR 9 1 2 US GUID
   THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39
   UN-Habitat, 2010, STAT WORLDS CIT 2010
   Vittinghoff E, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b138825
NR 41
TC 36
Z9 36
U1 0
U2 16
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2014
VL 8
IS 12
AR e3338
DI 10.1371/journal.pntd.0003338
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AX1IM
UT WOS:000346701000022
PM 25474580
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Valencia, MMC
   Breda, LCD
   Albuquerque, JA
   Vasconcellos, SA
   Figueira, CP
   Croda, J
   Ko, A
   Barbosa, AS
   Isaac, L
AF Castiblanco Valencia, Monica M.
   Dantas Breda, Leandro Carvalho
   Albuquerque, Jose Antonio
   Vasconcellos, Silvio Arruda
   Figueira, Claudio Pereira
   Croda, Julio
   Ko, Albert
   Barbosa, Angela S.
   Isaac, Lourdes
TI Expression of ligA or ligB by non-pathogenic Leptospira biflexa
   increases bacterial survival in human serum by acquisition of factor H
   and C4BP
SO MOLECULAR IMMUNOLOGY
LA English
DT Meeting Abstract
CT 25th International Complement Workshop
CY SEP 14-18, 2014
CL Rio de Janeiro, BRAZIL
C1 [Castiblanco Valencia, Monica M.; Dantas Breda, Leandro Carvalho; Albuquerque, Jose Antonio; Isaac, Lourdes] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, BR-05508 Sao Paulo, Brazil.
   [Vasconcellos, Silvio Arruda] Univ Sao Paulo, Fac Vet Med, BR-05508 Sao Paulo, Brazil.
   [Figueira, Claudio Pereira; Croda, Julio; Ko, Albert] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Ko, Albert] Yale Univ, Sch Med, New Haven, CT USA.
   [Ko, Albert] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Barbosa, Angela S.] Butantan Inst, Bacteriol Lab, Sao Paulo, Brazil.
RI Barbosa, Angela S/I-3518-2013; Croda, Julio/I-5172-2013; Ko, Albert
   Icksang/P-2343-2015
OI Barbosa, Angela S/0000-0002-6458-9489; Croda, Julio/0000-0002-6665-6825;
   Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD OCT
PY 2014
VL 61
IS 2
SI SI
MA 151
BP 269
EP 269
PG 1
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA AP7NZ
UT WOS:000342265300170
DA 2020-11-30
ER

PT J
AU Evangelista, KV
   Hahn, B
   Wunder, EA
   Ko, AI
   Haake, DA
   Coburn, J
AF Evangelista, Karen V.
   Hahn, Beth
   Wunder, Elsio A., Jr.
   Ko, Albert I.
   Haake, David A.
   Coburn, Jenifer
TI Identification of Cell-Binding Adhesins of Leptospira interrogans
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID OUTER-MEMBRANE PROTEINS; PATHOGENIC LEPTOSPIRA; EXTRACELLULAR-MATRIX;
   BORRELIA-BURGDORFERI; PHAGE DISPLAY; TREPONEMA-PALLIDUM;
   YERSINIA-PSEUDOTUBERCULOSIS; ENDOTHELIAL-CELLS; INVASIN PROTEIN;
   CULTURED-CELLS
AB Leptospirosis is a globally distributed bacterial infectious disease caused by pathogenic members of the genus Leptospira. Infection can lead to illness ranging from mild and non-specific to severe, with jaundice, kidney and liver dysfunction, and widespread endothelial damage. The adhesion of pathogenic Leptospira species (spp.), the causative agent of leptospirosis, to host tissue components is necessary for infection and pathogenesis. While it is well-established that extracellular matrix (ECM) components play a role in the interaction of the pathogen with host molecules, we have shown that pathogenic Leptospira interrogans binds to host cells more efficiently than to ECM components. Using in vitro phage display to select for phage clones that bind to EA. hy926 endothelial cells, we identified the putative lipoproteins LIC10508 and LIC13411, and the conserved hypothetical proteins LIC12341 and LIC11574, as candidate L. interrogans sv. Copenhageni st. Fiocruz L1-130 adhesins. Recombinant LIC11574, but not its L. biflexa homologue LBF1629, exhibited dose-dependent binding to both endothelial and epithelial cells. In addition, LIC11574 and LIC13411 bind to VE-cadherin, an endothelial cell receptor for L. interrogans. Extraction of bacteria with the non-ionic detergent Triton X-114 resulted in partitioning of the candidate adhesins to the detergent fraction, a likely indication that these proteins are outer membrane localized. All candidate adhesins were recognized by sera obtained from leptospirosis patients but not by sera from healthy individuals as assessed by western blot. This work has identified bacterial adhesins that are potentially involved in L. interrogans infection of the mammalian host, and through cadherin binding, may contribute to dissemination and vascular damage. Our findings may be of value in leptospirosis control and prevention, with the bacterial adhesins potentially serving as targets for development of diagnostics, therapeutics, and vaccines.
C1 [Evangelista, Karen V.; Coburn, Jenifer] Med Coll Wisconsin, Grad Program Microbiol Immunol & Mol Genet, Milwaukee, WI 53226 USA.
   [Hahn, Beth; Coburn, Jenifer] Med Coll Wisconsin, Dept Med, Div Infect Dis, Milwaukee, WI 53226 USA.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Haake, David A.] VA Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA.
   [Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
   [Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA.
   [Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
RP Evangelista, KV (corresponding author), VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
EM jcoburn@mcw.edu
RI Wunder, Elsio Augusto/C-2733-2013; Ko, Albert Icksang/P-2343-2015
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Ko, Albert
   Icksang/0000-0001-9023-2339
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21 AI077560, R56
   AI087835,, R21 AI093509, R01 AI 034431, R01 AI 052473, R01 TW009504, U01
   AI088752]; Veterans Affairs Merit Review awardUS Department of Veterans
   Affairs; FOGARTY INTERNATIONAL CENTERUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI034431, R01AI034431, R01AI034431, R01AI112920,
   U01AI088752, R01AI034431, R01AI034431, U01AI088752, R01AI052473,
   R01AI052473, R01AI034431, R01AI034431, U01AI088752, R01AI052473,
   R01AI034431, R21AI093509, R21AI093509, R01AI034431, R01AI052473,
   R21AI077560, R01AI112920, R01AI052473, R01AI034431, R21AI077560,
   R01AI052473, R01AI052473, R01AI034431, R01AI112920, U01AI088752,
   R56AI087835, R01AI052473, R01AI112920, R01AI034431, R01AI034431,
   R01AI052473, U01AI088752, R01AI052473, U01AI088752] Funding Source: NIH
   RePORTER; Veterans AffairsUS Department of Veterans Affairs
   [I01BX002003, I01BX002003, I01BX002003, I01BX002003, I01BX002003]
   Funding Source: NIH RePORTER
FX This work was supported by National Institutes of Health grants R21
   AI077560, R56 AI087835, and R21 AI093509 to JC, R01 AI 034431 to DAH,
   R01 AI 052473, R01 TW009504, and U01 AI088752 to AIK, and by a Veterans
   Affairs Merit Review award to DAH. None of the funders had any role in
   the design or analysis of experiments, the preparation of the
   manuscript, or the decision to publish.
CR ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748
   ADLER B, 1977, INFECT IMMUN, V17, P67, DOI 10.1128/IAI.17.1.67-72.1977
   Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Antonara S, 2007, MOL MICROBIOL, V66, P262, DOI 10.1111/j.1365-2958.2007.05924.x
   BALLARD SA, 1986, J MED MICROBIOL, V21, P59, DOI 10.1099/00222615-21-1-59
   Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06
   Barcellos C, 2000, INT J ENVIRON HEAL R, V10, P301, DOI 10.1080/0960312002001500
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   BLANCO DR, 1991, MOL MICROBIOL, V5, P2405, DOI 10.1111/j.1365-2958.1991.tb02086.x
   Breiner DD, 2009, INFECT IMMUN, V77, P5528, DOI 10.1128/IAI.00546-09
   Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004
   Ching ATC, 2012, BIOCHEM BIOPH RES CO, V427, P774, DOI 10.1016/j.bbrc.2012.09.137
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   Cinco M, 2006, NEW MICROBIOL, V29, P193
   CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0
   Coburn J, 1999, MOL MICROBIOL, V34, P926, DOI 10.1046/j.1365-2958.1999.01654.x
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004
   Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003
   Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002
   CUNNINGHAM TM, 1988, J BACTERIOL, V170, P5789, DOI 10.1128/jb.170.12.5789-5796.1988
   Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897
   Dejana E, 2013, PROG MOL BIOL TRANSL, V116, P119, DOI 10.1016/B978-0-12-394311-8.00006-6
   Dong HY, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-223
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   EDGELL CJS, 1990, IN VITRO CELL DEV B, V26, P1167
   Evangelista K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002672
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Fernandes LGV, 2012, INFECT IMMUN, V80, P3679, DOI 10.1128/IAI.00474-12
   Figueira CP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-129
   Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004
   Gomez RM, 2008, MICROB PATHOGENESIS, V45, P315, DOI 10.1016/j.micpath.2008.08.004
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993
   Haake DA, 2010, MOL MICROBIOL, V77, P805, DOI 10.1111/j.1365-2958.2010.07262.x
   Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291
   Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x
   ISBERG RR, 1988, P NATL ACAD SCI USA, V85, P6682, DOI 10.1073/pnas.85.18.6682
   ITO T, 1987, JPN J VET SCI, V49, P875
   ITO T, 1987, VET MICROBIOL, V15, P89, DOI 10.1016/0378-1135(87)90133-7
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kupek E, 2000, Braz J Infect Dis, V4, P131
   LEONG JM, 1990, EMBO J, V9, P1979, DOI 10.1002/j.1460-2075.1990.tb08326.x
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lin XP, 2008, J VET SCI, V9, P133
   Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196
   Lin YP, 2009, BIOCHEM BIOPH RES CO, V389, P57, DOI 10.1016/j.bbrc.2009.08.089
   Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531
   Martinez-Lopez DG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000918
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2007, MICROBIOL-SGM, V153, P3390, DOI 10.1099/mic.0.2007/007948-0
   Merien F, 1998, FEMS MICROBIOL LETT, V169, P95, DOI 10.1111/j.1574-6968.1998.tb13304.x
   Merien F, 1997, INFECT IMMUN, V65, P729, DOI 10.1128/IAI.65.2.729-738.1997
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Oliveira R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002396
   Oliveira TR, 2010, MICROBES INFECT, V12, P207, DOI 10.1016/j.micinf.2009.12.004
   Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729
   Pinne M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051025
   Pinne M, 2012, J BACTERIOL, V194, P6074, DOI 10.1128/JB.01119-12
   Pinne M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006071
   RADOLF JD, 1995, INFECT IMMUN, V63, P4244, DOI 10.1128/IAI.63.11.4244-4252.1995
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   SADZIENE A, 1991, J CLIN INVEST, V88, P82, DOI 10.1172/JCI115308
   Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   SKARE JT, 1995, J CLIN INVEST, V96, P2380, DOI 10.1172/JCI118295
   Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188
   THOMAS DD, 1990, INFECT IMMUN, V58, P581, DOI 10.1128/IAI.58.3.581-585.1990
   TSUCHIMOTO M, 1984, ZBL BAKT-INT J MED M, V258, P268, DOI 10.1016/S0176-6724(84)80044-9
   VINH T, 1984, J MED MICROBIOL, V18, P73, DOI 10.1099/00222615-18-1-73
   Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618
   Zhang XY, 2005, ACTA BIOCH BIOPH SIN, V37, P649, DOI 10.1111/j.1745-7270.2005.00094.x
NR 75
TC 16
Z9 16
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2014
VL 8
IS 10
AR e3215
DI 10.1371/journal.pntd.0003215
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AS9WJ
UT WOS:000344589000033
PM 25275630
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Lewnard, JA
   Jirmanus, L
   Nery, N
   Machado, PR
   Glesby, MJ
   Ko, AI
   Carvalho, EM
   Schriefer, A
   Weinberger, DM
AF Lewnard, Joseph A.
   Jirmanus, Lara
   Nery Junior, Nivison
   Machado, Paulo R.
   Glesby, Marshall J.
   Ko, Albert I.
   Carvalho, Edgar M.
   Schriefer, Albert
   Weinberger, Daniel M.
TI Forecasting Temporal Dynamics of Cutaneous Leishmaniasis in Northeast
   Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RIO-DE-JANEIRO; VIANNIA BRAZILIENSIS; CLIMATE-CHANGE; VISCERAL
   LEISHMANIASIS; STATE; HEALTH; REGION; TRANSMISSION; PSYCHODIDAE;
   INFECTION
AB Introduction: Cutaneous leishmaniasis (CL) is a vector-borne disease of increasing importance in northeastern Brazil. It is known that sandflies, which spread the causative parasites, have weather-dependent population dynamics. Routinely-gathered weather data may be useful for anticipating disease risk and planning interventions.
   Methodology/Principal Findings: We fit time series models using meteorological covariates to predict CL cases in a rural region of Bahia, Brazil from 1994 to 2004. We used the models to forecast CL cases for the period 2005 to 2008. Models accounting for meteorological predictors reduced mean squared error in one, two, and three month-ahead forecasts by up to 16% relative to forecasts from a null model accounting only for temporal autocorrelation.
   Significance: These outcomes suggest CL risk in northeastern Brazil might be partially dependent on weather. Responses to forecasted CL epidemics may include bolstering clinical capacity and disease surveillance in at-risk areas. Ecological mechanisms by which weather influences CL risk merit future research attention as public health intervention targets.
C1 [Lewnard, Joseph A.; Ko, Albert I.; Weinberger, Daniel M.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Jirmanus, Lara; Machado, Paulo R.; Carvalho, Edgar M.; Schriefer, Albert] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.
   [Jirmanus, Lara] Brigham & Womens Hosp, Ctr Womens Hlth & Gender Biol, Boston, MA 02115 USA.
   [Nery Junior, Nivison; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Glesby, Marshall J.] Weill Cornell Med Coll, Div Infect Dis, New York, NY USA.
RP Lewnard, JA (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
EM joseph.lewnard@yale.edu
RI Ko, Albert Icksang/P-2343-2015; Schriefer, Albert/AAP-2765-2020;
   MACHADO, PAULO ROBERTO LIMA/AAP-2642-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Schriefer,
   Albert/0000-0002-5496-6789; MACHADO, PAULO ROBERTO
   LIMA/0000-0003-1894-6171; Rocha Nery Junior, Nivison
   Ruy/0000-0002-8164-0602; Weinberger, Daniel/0000-0003-1178-8086;
   Jirmanus, Lara/0000-0002-5245-8254
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01TW009504,
   R25TW009338, AI30639-20]; Yale School of Public Health predoctoral
   fellowship; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW009504, R25TW009338,
   R25TW009338, R01TW009504, R25TW009338, R25TW009338, R01TW009504,
   R01TW009504, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   R25TW009338, R25TW009338, R25TW009338, R25TW009338, R01TW009504,
   R25TW009338] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING
   TRANSLATIONAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS) [UL1TR000142, UL1TR000142,
   UL1TR000142, UL1TR000142, UL1TR000142] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER
FX AIK, DMW, and EMC were supported by grants from the National Institutes
   of Health (R01TW009504, R25TW009338, and AI30639-20, respectively:
   http://report.nih.gov/). JAL was supported by a Yale School of Public
   Health predoctoral fellowship. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Almeida AS, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-13
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003
   Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041
   Atkinson S, 2005, HEALTH PROMOT INT, V20, P167, DOI 10.1093/heapro/dah605
   Bacon KM, 2013, VACCINE, V31, P480, DOI 10.1016/j.vaccine.2012.11.032
   Barbosa DS, 2014, ACTA TROP, V131, P56, DOI 10.1016/j.actatropica.2013.12.002
   Box G.E.P., 1994, TIME SERIES ANAL FOR
   Brandao SP, 2003, T ROY SOC TROP MED H, V97, P291, DOI 10.1016/S0035-9203(03)90146-5
   Brandao SP, 1999, T ROY SOC TROP MED H, V93, P488, DOI 10.1016/S0035-9203(99)90346-2
   Brandao SP, 2011, J VECTOR ECOL, V36, pS71, DOI 10.1111/j.1948-7134.2011.00114.x
   Brockwell P.J., 2006, TIME SERIES THEORY M
   Broutet N., 1994, Cahiers d'Etudes et de Recherches Francophones/Sante, V4, P87
   Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644
   Campbell-Lendrum D, 2001, MEM I OSWALDO CRUZ, V96, P159, DOI 10.1590/S0074-02762001000200004
   Cardenas R, 2006, AM J TROP MED HYG, V75, P273, DOI 10.4269/ajtmh.2006.75.273
   Chaves LF, 2009, ANN TROP MED PARASIT, V103, P221, DOI 10.1179/136485909X398267
   Chaves LF, 2004, ACTA TROP, V92, P245, DOI 10.1016/j.actatropica.2004.08.004
   Chaves LF, 2007, TRENDS PARASITOL, V23, P311, DOI 10.1016/j.pt.2007.05.003
   Chaves LF, 2006, PLOS MED, V3, P1320, DOI 10.1371/journal.pmed.0030295
   Chaves LF, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000033
   Chaves LF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000176
   Costa J M, 1998, Rev Soc Bras Med Trop, V31, P279, DOI 10.1590/S0037-86821998000300005
   Costa J M, 1988, Rev Soc Bras Med Trop, V21, P145, DOI 10.1590/S0037-86821988000300009
   Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007
   de Castro EA, 2005, ACTA TROP, V93, P141, DOI 10.1016/j.actatropica.2004.10.004
   Guerra JAD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000980
   Donalisio MR, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/642910
   Ferreira AL, 2001, MEM I OSWALDO CRUZ, V96, P1061, DOI 10.1590/S0074-02762001000800006
   Franke CR, 2002, EMERG INFECT DIS, V8, P914, DOI 10.3201/eid0809.010523
   Franke CR, 2002, T ROY SOC TROP MED H, V96, P236, DOI 10.1016/S0035-9203(02)90087-8
   Ximenes MDFD, 2006, J MED ENTOMOL, V43, P990
   Fuller DO, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014011
   Gilbert JA, 2014, EPIDEMICS-NETH, V6, P37, DOI 10.1016/j.epidem.2013.11.002
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   GOMES AD, 1990, REV I MED TROP, V32, P105
   Guimaraes LH, 2009, T ROY SOC TROP MED H, V103, P712, DOI 10.1016/j.trstmh.2009.04.019
   HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663
   Jirmanus L, 2012, AM J TROP MED HYG, V86, P426, DOI 10.4269/ajtmh.2012.11-0378
   Juarez RIN, 2001, INT J CLIMATOL, V21, P1803, DOI 10.1002/joc.639
   Karagiannis-Voules DA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002213
   LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207
   Machado PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000912
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
   Meneses CRV, 2002, J VECTOR ECOL, V27, P207
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Oliveira CCG, 2004, ACTA TROP, V90, P155, DOI 10.1016/j.actatropica.2003.11.011
   Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8
   PRIESTLEY MB, 1973, J R STAT SOC B, V35, P153
   Queiroz A, 2012, J CLIN MICROBIOL, V50, P4028, DOI 10.1128/JCM.02064-12
   Rocha LD, 2007, AM J TROP MED HYG, V76, P559, DOI 10.4269/ajtmh.2007.76.559
   Salomon OD, 2004, J MED ENTOMOL, V41, P33, DOI 10.1603/0022-2585-41.1.33
   Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x
   Schriefer A, 2009, EMERG INFECT DIS, V15, P871, DOI 10.3201/eid1506.080406
   Scope A, 2003, J AM ACAD DERMATOL, V49, P672, DOI 10.1067/S0190-9622(03)01576-7
   SOUSA AD, 1995, AM J TROP MED HYG, V53, P380
   Souza NA, 2002, MEM I OSWALDO CRUZ, V97, P759, DOI 10.1590/S0074-02762002000600001
   Soyiri IN, 2013, ENVIRON HEALTH PREV, V18, P1, DOI 10.1007/s12199-012-0294-6
   Stige LC, 2007, P NATL ACAD SCI USA, V104, P16188, DOI 10.1073/pnas.0706813104
   Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214
   Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9
   Thornton SJ, 2010, DRUG DEV IND PHARM, V36, P1312, DOI 10.3109/03639041003796648
   Trujillo AV, 2013, MEM I OSWALDO CRUZ, V108, P463, DOI 10.1590/S0074-0276108042013011
   Weinberger D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002798
   Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336
NR 65
TC 10
Z9 10
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2014
VL 8
IS 10
AR e3283
DI 10.1371/journal.pntd.0003283
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AS9WJ
UT WOS:000344589000079
PM 25356734
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Witchell, TD
   Eshghi, A
   Nally, JE
   Hof, R
   Boulanger, MJ
   Wunder, EA
   Ko, AI
   Haake, DA
   Cameron, CE
AF Witchell, Timothy D.
   Eshghi, Azad
   Nally, Jarlath E.
   Hof, Rebecca
   Boulanger, Martin J.
   Wunder, Elsio A., Jr.
   Ko, Albert I.
   Haake, David A.
   Cameron, Caroline E.
TI Post-translational Modification of LipL32 during Leptospira interrogans
   Infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID OUTER-MEMBRANE; PATHOGENIC LEPTOSPIRA; RICKETTSIA-PROWAZEKII; PROTEOMIC
   ANALYSIS; CALCIUM-BINDING; PLASMA FIBRONECTIN; MASS-SPECTROMETRY;
   SURFACE PROTEIN; ANTIGEN; LIPOPROTEIN
AB Background: Leptospirosis, a re-emerging disease of global importance caused by pathogenic Leptospira spp., is considered the world's most widespread zoonotic disease. Rats serve as asymptomatic carriers of pathogenic Leptospira and are critical for disease spread. In such reservoir hosts, leptospires colonize the kidney, are shed in the urine, persist in fresh water and gain access to a new mammalian host through breaches in the skin.
   Methodology/Principal Findings: Previous studies have provided evidence for post-translational modification (PTM) of leptospiral proteins. In the current study, we used proteomic analyses to determine the presence of PTMs on the highly abundant leptospiral protein, LipL32, from rat urine-isolated L. interrogans serovar Copenhageni compared to in vitro-grown organisms. We observed either acetylation or tri-methylation of lysine residues within multiple LipL32 peptides, including peptides corresponding to regions of LipL32 previously identified as epitopes. Intriguingly, the PTMs were unique to the LipL32 peptides originating from in vivo relative to in vitro grown leptospires. The identity of each modified lysine residue was confirmed by fragmentation pattern analysis of the peptide mass spectra. A synthetic peptide containing an identified tri-methylated lysine, which corresponds to a previously identified LipL32 epitope, demonstrated significantly reduced immunoreactivity with serum collected from leptospirosis patients compared to the peptide version lacking the tri-methylation. Further, a subset of the identified PTMs are in close proximity to the established calcium-binding and putative collagen-binding sites that have been identified within LipL32.
   Conclusions/Significance: The exclusive detection of PTMs on lysine residues within LipL32 from in vivo-isolated L. interrogans implies that infection-generated modification of leptospiral proteins may have a biologically relevant function during the course of infection. Although definitive determination of the role of these PTMs must await further investigations, the reduced immune recognition of a modified LipL32 epitope suggests the intriguing possibility that LipL32 modification represents a novel mechanism of immune evasion within Leptospira.
C1 [Witchell, Timothy D.; Eshghi, Azad; Hof, Rebecca; Boulanger, Martin J.; Cameron, Caroline E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.
   [Nally, Jarlath E.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Haake, David A.] Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA.
   [Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
RP Witchell, TD (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.
EM caroc@uvic.ca
RI Ko, Albert Icksang/P-2343-2015; Eshghi, Azad/AAW-2290-2020; Wunder,
   Elsio Augusto/C-2733-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Eshghi, Azad/0000-0002-8641-273X
FU Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of CanadaCGIAR [327186];
   Canada Research Chair ProgramCanada Research Chairs; Michael Smith
   Foundation for Health Research Scholar Program; Science Foundation
   IrelandScience Foundation Ireland [05/YI/B696]; Research Stimulus Fund
   (Department of Agriculture, Food & Marine, Ireland) [06/363]; Veterans
   Affairs Merit Review awardUS Department of Veterans Affairs; Public
   Health Service from the National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-034431]; Natural History of
   Leptospirosis [R01AI052473]; Ecoepidemiology of Leptospirosis
   [R01TW009504]; Disease Determinants of Urban Leptospirosis
   [U01AI088752]; Natural Sciences and Engineering Research Council
   (NSERC)Natural Sciences and Engineering Research Council of Canada;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, R01TW009504, R01TW009504,
   R01TW009504, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI034431, U01AI088752, R01AI034431, R01AI034431, U01AI088752,
   R01AI052473, R01AI052473, R21AI034431, R01AI034431, R01AI052473,
   U01AI088752, R01AI034431, R01AI034431, R01AI052473, R01AI052473,
   R29AI034431, R01AI052473, R01AI034431, R01AI034431, R29AI034431,
   U01AI088752, R01AI034431, R01AI034431, R29AI034431, R01AI052473,
   R01AI052473, R01AI034431, R01AI052473, R29AI034431, U01AI088752,
   R01AI052473, U01AI088752, R01AI052473, R01AI034431, R29AI034431,
   R01AI034431] Funding Source: NIH RePORTER; Veterans AffairsUS Department
   of Veterans Affairs [I01BX002003, I01BX002003, I01BX002003, I01BX002003,
   I01BX002003] Funding Source: NIH RePORTER
FX This research was supported by a Discovery Grant from the Natural
   Sciences and Engineering Research Council of Canada (327186; CEC), the
   Canada Research Chair Program (CEC) and the Michael Smith Foundation for
   Health Research Scholar Program (CEC). This research was also funded in
   part by Science Foundation Ireland award 05/YI/B696 (JEN), The Research
   Stimulus Fund (06/363 Department of Agriculture, Food & Marine, Ireland;
   JEN), Veterans Affairs Merit Review award (DAH), Public Health Service
   grant AI-034431 from the National Institute of Allergy and Infectious
   Diseases (DAH), and grants R01AI052473 (Natural History of
   Leptospirosis; AIK and EAW), R01TW009504 (Ecoepidemiology of
   Leptospirosis; AIK and EAW) and U01AI088752 (Disease Determinants of
   Urban Leptospirosis; AIK and EAW). MJB is supported by an operating
   grant from the Natural Sciences and Engineering Research Council (NSERC)
   and by the Canada Research Chair program. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abeykoon A, 2014, J BIOL CHEM, V289, P7691, DOI 10.1074/jbc.M113.535567
   Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Cameron CE, 2005, INFECT IMMUN, V73, P7485, DOI 10.1128/IAI.73.11.7485-7494.2005
   Cao XJ, 2010, CELL RES, V20, P197, DOI 10.1038/cr.2009.127
   Chao CC, 2008, CLIN VACCINE IMMUNOL, V15, P684, DOI 10.1128/CVI.00281-07
   Chao CC, 2007, BBA-PROTEINS PROTEOM, V1774, P373, DOI 10.1016/j.bbapap.2007.01.001
   Doyle HA, 2012, CURR OPIN IMMUNOL, V24, P112, DOI 10.1016/j.coi.2011.12.003
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Engelhard VH, 2006, CURR OPIN IMMUNOL, V18, P92, DOI 10.1016/j.coi.2005.11.015
   Eshghi A, 2012, MICROBIOL-SGM, V158, P622, DOI 10.1099/mic.0.054767-0
   Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Ganoza CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000612
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002
   Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x
   Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07
   Hauk P, 2012, J BIOL CHEM, V287, P4826, DOI 10.1074/jbc.M111.277210
   Hauk P, 2009, J MOL BIOL, V390, P722, DOI 10.1016/j.jmb.2009.05.034
   Ido Y, 1917, J EXP MED, V26, P341, DOI 10.1084/jem.26.3.341
   Izurieta Ricardo, 2008, J Emerg Trauma Shock, V1, P21, DOI 10.4103/0974-2700.40573
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lo YY, 2013, J BIOL CHEM, V288, P12335, DOI 10.1074/jbc.M112.418699
   Lottersberger J, 2009, LETT APPL MICROBIOL, V49, P641, DOI 10.1111/j.1472-765X.2009.02723.x
   Lucas DSD, 2014, VET MICROBIOL, V169, P163, DOI 10.1016/j.vetmic.2013.12.016
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Matthiesen R, 2005, J PROTEOME RES, V4, P2338, DOI 10.1021/pr050264q
   Monahan AM, 2008, INFECT IMMUN, V76, P4952, DOI 10.1128/IAI.00511-08
   Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08
   Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06
   Nally JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026046
   Nally JE, 2005, PROTEOMICS, V5, P144, DOI 10.1002/pmic.200400880
   Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7
   Pinne M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051025
   Plank R, 2000, MICROBES INFECT, V2, P1265, DOI 10.1016/S1286-4579(00)01280-6
   Pustelny C, 2013, ENVIRON MICROBIOL, V15, P597, DOI 10.1111/1462-2920.12040
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   RODIONOV AV, 1991, ACTA VIROL, V35, P557
   Seixas FK, 2007, VACCINE, V26, P88, DOI 10.1016/j.vaccine.2007.10.052
   Silva João José Pereira da, 2002, Rev. Soc. Bras. Med. Trop., V35, P395, DOI 10.1590/S0037-86822002000400017
   Tucunduva de Faria M, 2007, J COMP PATHOL, V137, P231, DOI 10.1016/j.jcpa.2007.08.001
   Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320
   UN-Habitat, 2003, CHALL SLUMS GLOB REP
   Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038
   Zhang JZ, 2006, VACCINE, V24, P2317, DOI 10.1016/j.vaccine.2005.11.044
   Zhang KL, 2004, PROTEOMICS, V4, P1, DOI 10.1002/pmic.200300503
NR 53
TC 22
Z9 21
U1 1
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2014
VL 8
IS 10
AR e3280
DI 10.1371/journal.pntd.0003280
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AS9WJ
UT WOS:000344589000078
PM 25356675
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Reller, ME
   Wunder, EA
   Miles, JJ
   Flom, JE
   Mayorga, O
   Woods, CW
   Ko, AI
   Dumler, JS
   Matute, AJ
AF Reller, Megan E.
   Wunder, Elsio A., Jr.
   Miles, Jeremy J.
   Flom, Judith E.
   Mayorga, Orlando
   Woods, Christopher W.
   Ko, Albert I.
   Dumler, J. Stephen
   Matute, Armando J.
TI Unsuspected Leptospirosis Is a Cause of Acute Febrile Illness in
   Nicaragua
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PULMONARY HEMORRHAGE; URBAN EPIDEMIC; RISK-FACTORS; OUTBREAK; INFECTION;
   BRAZIL
AB Background: Epidemic severe leptospirosis was recognized in Nicaragua in 1995, but unrecognized epidemic and endemic disease remains unstudied.
   Methodology/Principal Findings: To determine the burden of and risk factors associated with symptomatic leptospirosis in Nicaragua, we prospectively studied patients presenting with fever at a large teaching hospital. Epidemiologic and clinical features were systematically recorded, and paired sera tested by IgM-ELISA to identify patients with probable and possible acute leptospirosis. Microscopic Agglutination Test and PCR were used to confirm acute leptospirosis. Among 704 patients with paired sera tested by MAT, 44 had acute leptospirosis. Patients with acute leptospirosis were more likely to present during rainy months and to report rural residence and fresh water exposure. The sensitivity of clinical impression and acute-phase IgM detected by ELISA were poor.
   Conclusions/Significance: Leptospirosis is a common (6.3%) but unrecognized cause of acute febrile illness in Nicaragua. Rapid point-of-care tests to support early diagnosis and treatment as well as tests to support population-based studies to delineate the epidemiology, incidence, and clinical spectrum of leptospirosis, both ideally pathogen-based, are needed.
C1 [Reller, Megan E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Med Microbiol, Baltimore, MD 21205 USA.
   [Reller, Megan E.; Woods, Christopher W.] Hubert Yeargan Ctr Global Hlth, Durham, NC USA.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Sch Med, New Haven, CT USA.
   [Miles, Jeremy J.] Duke Univ, Sch Med, Durham, NC USA.
   [Flom, Judith E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Mayorga, Orlando; Matute, Armando J.] Univ Nacl Autonoma Nicaragua, Hosp Escuela Oscar Danilo Rosales Arguello, Leon, Nicaragua.
   [Woods, Christopher W.] Duke Univ, Sch Med, Dept Med, Div Infect Dis, Durham, NC 27706 USA.
   [Dumler, J. Stephen] Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
RP Reller, ME (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Div Med Microbiol, Baltimore, MD 21205 USA.
EM mreller1@jhmi.edu
RI Ko, Albert Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511
FU Johns Hopkins Center for Global Health Junior Faculty Grant; Clinician
   Scientist Career Development Award from Johns Hopkins School of
   Medicine; National Institute of Allergy and Infectious Diseases,
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [K23AIO83931];  [R01 AI052473];
   [U01 AI088752];  [R01 TW009504]; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [R01TW009504,
   R01TW009504, R01TW009504, R01TW009504, R01TW009504] Funding Source: NIH
   RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Advancing Translational
   Sciences (NCATS) [UL1TR000142, UL1TR000142, UL1TR000142, UL1TR000142,
   UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U01AI088752, R01AI052473,
   R01AI052473, U01AI088752, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, U01AI088752, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, U01AI088752] Funding
   Source: NIH RePORTER
FX Patient enrollment was supported by the Hubert-Yeargan Center for Global
   Health. MER and testing for leptospirosis by ELISA was supported by a
   Johns Hopkins Center for Global Health Junior Faculty Grant, a Clinician
   Scientist Career Development Award from Johns Hopkins School of
   Medicine, and the National Institute of Allergy and Infectious Diseases,
   National Institutes of Health (K23AIO83931). Testing by MAT and PCR were
   supported by R01 AI052473, U01 AI088752, and R01 TW009504. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Ashford DA, 2000, AM J TROP MED HYG, V63, P249, DOI 10.4269/ajtmh.2000.63.249
   Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009
   CLARK LG, 1966, AM J TROP MED HYG, V15, P735, DOI 10.4269/ajtmh.1966.15.735
   Cumberland P, 2001, EUR J EPIDEMIOL, V17, P601, DOI 10.1023/A:1015509105668
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Kaufmann Arnold F., 1995, P621
   Keenan J, 2010, AM J TROP MED HYG, V83, P633, DOI 10.4269/ajtmh.2010.09-0609
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Lacerda HG, 2008, T ROY SOC TROP MED H, V102, P1233, DOI 10.1016/j.trstmh.2008.05.010
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   MACKENZIE RB, 1966, AM J TROP MED HYG, V15, P57, DOI 10.4269/ajtmh.1966.15.57
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   MUNOZ F, 1995, JAMA-J AM MED ASSOC, V274, P1668
   Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Reller ME, 2011, EMERG INFECT DIS, V17, P1678, DOI [10.3201/eid1709.100915, 10.3201/eid1709.100915.]
   Ressner RA, 2008, ANTIMICROB AGENTS CH, V52, P2750, DOI 10.1128/AAC.00044-08
   Russell KL, 2003, AM J TROP MED HYG, V69, P53, DOI 10.4269/ajtmh.2003.69.53
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   Sehgal S C, 2006, Indian J Med Microbiol, V24, P310
   Spichler A, 2011, INT J INFECT DIS, V15, pE486, DOI 10.1016/j.ijid.2011.03.020
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8
NR 28
TC 20
Z9 21
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2014
VL 8
IS 7
AR e2941
DI 10.1371/journal.pntd.0002941
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AN4IQ
UT WOS:000340551500013
PM 25058149
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Eshghi, A
   Becam, J
   Lambert, A
   Sismeiro, O
   Dillies, MA
   Jagla, B
   Wunder, EA
   Ko, AI
   Coppee, JY
   Goarant, C
   Picardeau, M
AF Eshghi, Azad
   Becam, Jerome
   Lambert, Ambroise
   Sismeiro, Odile
   Dillies, Marie-Agnes
   Jagla, Bernd
   Wunder, Elsio A., Jr.
   Ko, Albert I.
   Coppee, Jean-Yves
   Goarant, Cyrille
   Picardeau, Mathieu
TI A Putative Regulatory Genetic Locus Modulates Virulence in the Pathogen
   Leptospira interrogans
SO INFECTION AND IMMUNITY
LA English
DT Article
ID PIG INFECTION MODEL; OUTER-MEMBRANE; LISTERIA-MONOCYTOGENES; SEROVAR
   LAI; STRESS CONDITIONS; BINDING PROTEINS; ANIMAL-MODELS; SIGMA-FACTOR;
   EXPRESSION; GENOME
AB Limited research has been conducted on the role of transcriptional regulators in relation to virulence in Leptospira interrogans, the etiological agent of leptospirosis. Here, we identify an L. interrogans locus that encodes a sensor protein, an anti-sigma factor antagonist, and two genes encoding proteins of unknown function. Transposon insertion into the gene encoding the sensor protein led to dampened transcription of the other 3 genes in this locus. This lb139 insertion mutant (the lb139(-) mutant) displayed attenuated virulence in the hamster model of infection and reduced motility in vitro. Whole-transcriptome analyses using RNA sequencing revealed the downregulation of 115 genes and the upregulation of 28 genes, with an overrepresentation of gene products functioning in motility and signal transduction and numerous gene products with unknown functions, predicted to be localized to the extracellular space. Another significant finding encompassed suppressed expression of the majority of the genes previously demonstrated to be upregulated at physiological osmolarity, including the sphingomyelinase C precursor Sph2 and LigB. We provide insight into a possible requirement for transcriptional regulation as it relates to leptospiral virulence and suggest various biological processes that are affected due to the loss of native expression of this genetic locus.
C1 [Eshghi, Azad; Lambert, Ambroise; Picardeau, Mathieu] Inst Pasteur, Biol Spirochetes Unit, Paris, France.
   [Becam, Jerome; Goarant, Cyrille] Assoc Pasteur Int Network, Inst Pasteur Nouvelle Caledonie, Noumea, New Caledonia.
   [Sismeiro, Odile; Dillies, Marie-Agnes; Jagla, Bernd; Coppee, Jean-Yves] Inst Pasteur, Dept Genomes & Genet, Paris, France.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Picardeau, M (corresponding author), Inst Pasteur, Biol Spirochetes Unit, Paris, France.
EM mpicard@pasteur.fr
RI Goarant, Cyrille/D-4267-2018; Wunder, Elsio Augusto/C-2733-2013; Eshghi,
   Azad/AAW-2290-2020; Ko, Albert Icksang/P-2343-2015; Lambert,
   Ambroise/P-3792-2016
OI Goarant, Cyrille/0000-0002-0690-9464; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Ko, Albert Icksang/0000-0001-9023-2339;
   Eshghi, Azad/0000-0002-8641-273X; Lambert, Ambroise/0000-0002-3909-2948
FU Institut Pasteur; French Ministry of ResearchMinistry of Research,
   France [ANR-08-MIE-018]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U01 AI088752, R01 AI052473]; France Genomique; NATIONAL INSTITUTE
   OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01AI052473,
   U01AI088752, R01AI052473, R01AI052473, U01AI088752, U01AI088752,
   R01AI052473, U01AI088752, U01AI088752, R01AI052473, U01AI088752,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the Institut Pasteur, France Genomique
   (https://www.france-genomique.org/spip/), the French Ministry of
   Research (ANR-08-MIE-018), and the National Institutes of Health (U01
   AI088752, R01 AI052473).
CR Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Bauby H, 2003, MICROBIOL-SGM, V149, P689, DOI 10.1099/mic.0.26065-0
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005
   Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x
   Chagas AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032712
   Chaturongakul S, 2004, APPL ENVIRON MICROB, V70, P5349, DOI 10.1128/AEM.70.9.5349-5356.2004
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Eshghi A, 2012, INFECT IMMUN, V80, P3892, DOI 10.1128/IAI.00466-12
   Figueira CP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-129
   Fouet A, 2000, J BACTERIOL, V182, P5036, DOI 10.1128/JB.182.18.5036-5045.2000
   Garner MR, 2006, INFECT IMMUN, V74, P876, DOI 10.1128/IAI.74.2.876-886.2006
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Goerke C, 2005, INFECT IMMUN, V73, P3415, DOI 10.1128/IAI.73.6.3415-3421.2005
   Humphreys S, 1999, INFECT IMMUN, V67, P1560
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Jonsson IM, 2004, INFECT IMMUN, V72, P6106, DOI 10.1128/IAI.72.10.6106-6111.2004
   Kassegne K, 2014, J INFECT DIS, V209, P1105, DOI 10.1093/infdis/jit659
   King AM, 2014, INFECT IMMUN, V82, P1123, DOI 10.1128/IAI.01546-13
   King AM, 2013, INFECT IMMUN, V81, P2768, DOI 10.1128/IAI.00531-13
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Liao SM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-253
   Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06
   Lo M, 2010, INFECT IMMUN, V78, P4850, DOI 10.1128/IAI.00435-10
   Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11
   Lourdault K, 2009, J MED MICROBIOL, V58, P648, DOI 10.1099/jmm.0.008169-0
   Matsui M, 2012, APPL ENVIRON MICROB, V78, P6372, DOI 10.1128/AEM.00911-12
   Matsunaga J, 2007, MICROBIOL-SGM, V153, P3390, DOI 10.1099/mic.0.2007/007948-0
   Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06
   Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011
   Murray GL, 2010, MOL MICROBIOL, V78, P701, DOI 10.1111/j.1365-2958.2010.07360.x
   Murray GL, 2009, MICROBES INFECT, V11, P311, DOI 10.1016/j.micinf.2008.11.014
   Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08
   Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08
   Patarakul K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-31
   Picardeau M, 2008, APPL ENVIRON MICROB, V74, P319, DOI 10.1128/AEM.02172-07
   Pinne M, 2012, J BACTERIOL, V194, P6074, DOI 10.1128/JB.01119-12
   Qin JH, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-51
   Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097
   Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178
   Viratyosin W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-181
   Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998
   Wilks M, 2013, PCR DETECTION MICROB, V943, P257
   Xue F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000857
   Zhang KK, 2013, INFECT IMMUN, V81, P3872, DOI 10.1128/IAI.01195-12
   Zhang Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-20
NR 49
TC 20
Z9 20
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD JUN
PY 2014
VL 82
IS 6
BP 2542
EP 2552
DI 10.1128/IAI.01803-14
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA AH8HN
UT WOS:000336378100039
PM 24686063
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Felzemburgh, RDM
   Ribeiro, GS
   Costa, F
   Reis, RB
   Hagan, JE
   Melendez, AXTO
   Fraga, D
   Santana, FS
   Mohr, S
   dos Santos, BL
   Silva, AQ
   Santos, AC
   Ravines, RR
   Tassinari, WS
   Carvalho, MS
   Reis, MG
   Ko, AI
AF Felzemburgh, Ridalva D. M.
   Ribeiro, Guilherme S.
   Costa, Federico
   Reis, Renato B.
   Hagan, Jose E.
   Melendez, Astrid X. T. O.
   Fraga, Deborah
   Santana, Francisco S.
   Mohr, Sharif
   dos Santos, Balbino L.
   Silva, Adriano Q.
   Santos, Andreia C.
   Ravines, Romy R.
   Tassinari, Wagner S.
   Carvalho, Marilia S.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Prospective Study of Leptospirosis Transmission in an Urban Slum
   Community: Role of Poor Environment in Repeated Exposures to the
   Leptospira Agent
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RISK-FACTORS; INFECTION; INTERROGANS; OUTBREAK; ANTIBODIES; RESIDENTS;
   BARBADOS; RATS
AB Background: Leptospirosis has emerged as an urban health problem as slum settlements have rapidly spread worldwide and created conditions for rat-borne transmission. Prospective studies have not been performed to determine the disease burden, identify risk factors for infection and provide information needed to guide interventions in these marginalized communities.
   Methodology/Principal Findings: We enrolled and followed a cohort of 2,003 residents from a slum community in the city of Salvador, Brazil. Baseline and one-year serosurveys were performed to identify primary and secondary Leptospira infections, defined as respectively, seroconversion and four-fold rise in microscopic agglutination titers. We used multinomial logistic regression models to evaluate risk exposures for acquiring primary and secondary infection. A total of 51 Leptospira infections were identified among 1,585 (79%) participants who completed the one-year follow-up protocol. The crude infection rate was 37.8 per 1,000 person-years. The secondary infection rate was 2.3 times higher than that of primary infection rate (71.7 and 31.1 infections per 1,000 person-years, respectively). Male gender (OR 2.88; 95% CI 1.40-5.91) and lower per capita household income (OR 0.54; 95% CI, 0.30-0.98 for an increase of $1 per person per day) were independent risk factors for primary infection. In contrast, the 15-34 year age group (OR 10.82, 95% CI 1.38-85.08), and proximity of residence to an open sewer (OR 0.95; 0.91-0.99 for an increase of 1 m distance) were significant risk factors for secondary infection.
   Conclusions/Significance: This study found that slum residents had high risk (>3% per year) for acquiring a Leptospira infection. Re-infection is a frequent event and occurs in regions of slum settlements that are in proximity to open sewers. Effective prevention of leptospirosis will therefore require interventions that address the infrastructure deficiencies that contribute to repeated exposures among slum inhabitants.
C1 [Felzemburgh, Ridalva D. M.; Ribeiro, Guilherme S.; Costa, Federico; Reis, Renato B.; Hagan, Jose E.; Melendez, Astrid X. T. O.; Fraga, Deborah; Santana, Francisco S.; Mohr, Sharif; dos Santos, Balbino L.; Silva, Adriano Q.; Santos, Andreia C.; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Felzemburgh, Ridalva D. M.] Univ Fed Bahia, Escola Enfermagem, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Costa, Federico; Hagan, Jose E.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Santana, Francisco S.] Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Ravines, Romy R.; Tassinari, Wagner S.; Carvalho, Marilia S.] Fundacao Oswaldo Cruz, Minist Saude, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Tassinari, Wagner S.] Univ Fed Rural Rio de Janeiro, Rio De Janeiro, Brazil.
RP Felzemburgh, RDM (corresponding author), Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
EM albert.ko@yale.edu
RI CARVALHO, MARILIA/AAD-8283-2020; Costa, Federico/G-1838-2015; Ribeiro,
   Guilherme/B-6624-2008; Queiroz, Adriano/AAQ-1164-2020; Ko, Albert
   Icksang/P-2343-2015; Hagan, Jose/N-6719-2019; Reis,
   Mitermayer/AAO-9742-2020
OI CARVALHO, MARILIA/0000-0002-9566-0284; Costa,
   Federico/0000-0001-6951-2336; Ribeiro, Guilherme/0000-0002-6798-2059;
   Queiroz, Adriano/0000-0003-0080-6509; Ko, Albert
   Icksang/0000-0001-9023-2339; Hagan, Jose/0000-0002-1837-6319; Reis,
   Mitermayer/0000-0002-3051-9060; Santos, Balbino Lino
   dos/0000-0002-6430-229X
FU Oswaldo Cruz Foundation; Secretariat of Health Surveillance, Brazilian
   Ministry of Health; CAPES (Coordination for the Improvement of Higher
   Education Personnel), Brazilian Ministry of EducationCAPES; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI052473, U01
   AI088752, R01 TW009504, R24 TW007988, R25 TW009338, D43 TW00919];
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R24TW007988, R01TW009504, R24TW007988,
   D43TW000919, R25TW009338, R25TW009338, R24TW007988, R25TW009338,
   R24TW007988, R25TW009338, R24TW007988, R25TW009338, D43TW000919,
   R24TW007988, R25TW009338, R25TW009338, R01TW009504, R01TW009504,
   D43TW000919, R25TW009338, R24TW007988, D43TW000919, R25TW009338,
   R25TW009338, R25TW009338, D43TW000919, R25TW009338, D43TW000919,
   D43TW000919, D43TW000919, R01TW009504, D43TW000919, D43TW000919,
   R25TW009338, R01TW009504, R24TW007988, D43TW000919] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI052473, R01AI052473, U01AI088752, U01AI088752,
   U01AI088752, U01AI088752, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, R01AI052473, R01AI052473, U01AI088752,
   R01AI052473, R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the Oswaldo Cruz Foundation and Secretariat
   of Health Surveillance, Brazilian Ministry of Health; CAPES
   (Coordination for the Improvement of Higher Education Personnel),
   Brazilian Ministry of Education; and the National Institutes of Health
   (grants R01 AI052473, U01 AI088752, R01 TW009504, R24 TW007988, R25
   TW009338 and D43 TW00919). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   Ashford DA, 2000, AM J TROP MED HYG, V63, P249, DOI 10.4269/ajtmh.2000.63.249
   Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59
   Barcellos C, 2000, INT J ENVIRON HEAL R, V10, P301, DOI 10.1080/0960312002001500
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Caldas EM, 1978, REV INST MED TROP SP, V20, P90
   CHILDS JE, 1992, AM J PUBLIC HEALTH, V82, P597, DOI 10.2105/AJPH.82.4.597
   Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378
   Cumberland P, 2001, EUR J EPIDEMIOL, V17, P601, DOI 10.1023/A:1015509105668
   Daher E, 1999, AM J TROP MED HYG, V61, P630, DOI 10.4269/ajtmh.1999.61.630
   de Araujo WN, 2013, AM J TROP MED HYG, V88, P359, DOI 10.4269/ajtmh.2012.12-0245
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   Dias JP, 2007, REV SOC BRAS MED TRO, V40, P499, DOI 10.1590/S0037-86822007000500002
   Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102
   EVERARD COR, 1990, ANN TROP MED PARASIT, V84, P255, DOI 10.1080/00034983.1990.11812465
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Goris MGA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002290
   Gouveia EL, 2008, EMERG INFECT DIS, V14
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Health Surveillance Secretary BMoH, 2007, LEPT CAS NOT REC BRA
   [IBGE Estatistica IBdGe], 2010, SUBN AGGL 1 RES, P1
   Jansen A, 2007, CLIN INFECT DIS, V44, pE69, DOI 10.1086/513431
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kupek E, 2000, Braz J Infect Dis, V4, P131
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   LUPIDI R, 1991, J CLIN MICROBIOL, V29, P805, DOI 10.1128/JCM.29.4.805-809.1991
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Marmot M, 2001, NEW ENGL J MED, V345, P134, DOI 10.1056/NEJM200107123450210
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Maskey M, 2006, Indian J Med Microbiol, V24, P337
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Oliveira DSC, 2009, ANN TROP MED PARASIT, V103, P149, DOI 10.1179/136485909X398221
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   Smith JKG, 2013, EPIDEMIOL INFECT, V141, P585, DOI 10.1017/S0950268812001021
   Souza V, 2010, CAD SAUDE COL, V18, P115
   UN-Habitat, 2010, STAT WORLDS CIT 2010
   United Nations Human Settlements Programme, 2003, CHALL SLUMS GLOB REP
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Vijayachari P, 2004, EPIDEMIOL INFECT, V132, P1115, DOI 10.1017/S0950268804002948
NR 47
TC 76
Z9 78
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2014
VL 8
IS 5
AR e2927
DI 10.1371/journal.pntd.0002927
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AJ5OS
UT WOS:000337735100077
PM 24875389
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Araujo, AM
   Reis, EAG
   Athanazio, DA
   Ribeiro, GS
   Hagan, JE
   Araujo, GC
   Damiao, AO
   Couto, NS
   Ko, AI
   Noronha-Dutra, A
   Reis, MG
AF Araujo, Alan M.
   Reis, Eliana A. G.
   Athanazio, Daniel A.
   Ribeiro, Guilherme S.
   Hagan, Jose E.
   Araujo, Guilherme C.
   Damiao, Alcineia O.
   Couto, Nicolli S.
   Ko, Albert I.
   Noronha-Dutra, Alberto
   Reis, Mitermayer G.
TI Oxidative Stress Markers Correlate with Renal Dysfunction and
   Thrombocytopenia in Severe Leptospirosis
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID NITRIC-OXIDE; ANTIOXIDANT; SEPSIS; THERAPY; OXYGEN; BLOOD
AB Leptospirosis is a zoonotic disease that causes severe manifestations such as Weil's disease and pulmonary hemorrhage syndrome. The aim of this study was to evaluate whether reactive oxygen species (ROS) production and antioxidant reduced glutathione (GSH) levels are related to complications in patients hospitalized with leptospirosis. The ROS production and GSH levels were measured in blood samples of 12 patients and nine healthy controls using chemiluminescence and absorbance assays. We found that ROS production was higher and GSH levels were lower in leptospirosis patients compared with healthy individuals. Among patients, GSH depletion was correlated with thrombocytopenia and elevated serum creatinine, whereas a strong positive correlation was observed between ROS production and elevated serum potassium. Additional investigation of the biological significance of ROS production and GSH levels is warranted as they may guide the development of novel adjuvant therapies for leptospirosis targeting oxidative stress.
C1 [Araujo, Alan M.; Reis, Eliana A. G.; Araujo, Guilherme C.; Damiao, Alcineia O.; Couto, Nicolli S.; Reis, Mitermayer G.] Fundacao Oswaldo Cruz, Lab Pathol & Mol Biol, BR-40296710 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, BR-40110040 Salvador, BA, Brazil.
   Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Athanazio, Daniel A.] Fed Univ Bahia Brazil, Fac Med, BR-40025010 Salvador, BA, Brazil.
   [Hagan, Jose E.; Ko, Albert I.] Yale Univ, New Haven, CT USA.
   [Hagan, Jose E.; Ko, Albert I.; Noronha-Dutra, Alberto] Fundacao Oswaldo Cruz, BR-40296710 Salvador, BA, Brazil.
RP Reis, MG (corresponding author), Fundacao Oswaldo Cruz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM amoreiradearaujo@gmail.com; eagreis@gmail.com; daa@ufba.br;
   gsribeiro@ufba.br; jose.hagan@gmail.com; guyaraujo@gmail.com;
   alcidamiao@gmail.com; nicolli.sorice@gmail.com; albert.ko@yale.edu;
   dutra.alberto@gmail.com; miter@bahia.fiocruz.br
RI Ribeiro, Guilherme/B-6624-2008; Athanazio, Daniel/P-6622-2014; Hagan,
   Jose/N-6719-2019; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020
OI Ribeiro, Guilherme/0000-0002-6798-2059; Hagan, Jose/0000-0002-1837-6319;
   Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; de Araujo, Alan/0000-0003-2656-4077
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [558714/2008-0]; Program of Nucleus of Excellency; Brazilian Research
   Council [020/2009]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [U01 AI088752, R01 AI052473, R01 TW009504, D43 TW00919]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, R01TW009504,
   D43TW000919, R01TW009504, D43TW000919, R01TW009504, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, R01TW009504,
   R01TW009504, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI088752, R01AI052473, R01AI052473, U01AI088752, U01AI088752,
   R01AI052473, R01AI052473, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, U01AI088752, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by CNPq grant no. 558714/2008-0; Program of
   Nucleus of Excellency; Brazilian Research Council no. 020/2009; National
   Institutes of Health (U01 AI088752, R01 AI052473, R01 TW009504, and D43
   TW00919).
CR Borrelli E, 1996, CRIT CARE MED, V24, P392, DOI 10.1097/00003246-199603000-00006
   Campos R, 2012, AM J PHYSIOL-LUNG C, V302, P1640, DOI 10.1152/ajplung.00097.2011
   Cerqueira TB, 2008, BRAZ J INFECT DIS, V12, P248, DOI 10.1590/S1413-86702008000300016
   Chuang CC, 2006, CRIT CARE, V10, DOI 10.1186/cc4826
   Cowley HC, 1996, CRIT CARE MED, V24, P1179, DOI 10.1097/00003246-199607000-00019
   CROSS CE, 1990, J LAB CLIN MED, V115, P396
   Erdogan HM, 2008, VET RES COMMUN, V32, P333, DOI 10.1007/s11259-008-9036-z
   Galley HF, 1996, CRIT CARE MED, V24, P1649, DOI 10.1097/00003246-199610000-00008
   GOODE HF, 1995, CRIT CARE MED, V23, P646, DOI 10.1097/00003246-199504000-00011
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Maciel EAP, 2006, ACTA TROP, V100, P256, DOI 10.1016/j.actatropica.2006.11.006
   Mashimo M, 2006, HELICOBACTER, V11, P266, DOI 10.1111/j.1523-5378.2006.00410.x
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Medeiros FD, 2010, ACTA TROP, V115, P155, DOI 10.1016/j.actatropica.2010.02.016
   Mishra V, 2007, CLIN LAB, V53, P199
   NORONHADUTRA AA, 1993, FEBS LETT, V321, P59, DOI 10.1016/0014-5793(93)80621-Z
   Rinaldi S, 2009, CURR DRUG TARGETS, V10, P872, DOI 10.2174/138945009789108774
   Siriwanij T, 2005, NEPHROLOGY, V10, P1, DOI 10.1111/j.1440-1797.2005.00332.x
   Spichler A, 2007, AM J TROP MED HYG, V77, P1111, DOI 10.4269/ajtmh.2007.77.1111
   Victor Victor M., 2009, Infectious Disorders - Drug Targets, V9, P376
   Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004
   World Health Organization, 2003, HUM LEPT GUID DIAGN
   Yang CW, 2000, J AM SOC NEPHROL, V11, P2017
   Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119
   Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62
NR 27
TC 15
Z9 15
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD APR
PY 2014
VL 90
IS 4
BP 719
EP 723
DI 10.4269/ajtmh.13-0667
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA AE6HS
UT WOS:000334091800024
PM 24493675
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Shei, A
   Costa, F
   Reis, MG
   Ko, AI
AF Shei, Amie
   Costa, Federico
   Reis, Mitermayer G.
   Ko, Albert I.
TI The impact of Brazil's Bolsa Familia conditional cash transfer program
   on children's health care utilization and health outcomes
SO BMC INTERNATIONAL HEALTH AND HUMAN RIGHTS
LA English
DT Article
ID MIDDLE-INCOME COUNTRIES; PROPENSITY SCORE; INFANT-MORTALITY;
   INTERVENTIONS; NUTRITION
AB Background: Conditional cash transfer (CCT) programs provide poor families with cash conditional on investments in health and education. Brazil's Bolsa Familia program began in 2003 and is currently the largest CCT program in the world. This community-based study examines the impact of Bolsa Familia on child health in a slum community in a large urban center.
   Methods: In 2010, detailed household surveys were conducted with randomly selected Bolsa Familia beneficiaries and non-beneficiaries in a Brazilian slum community of approximately 14,000 inhabitants in a large urban center. 567 families (with 1,266 children) were interviewed. Propensity score methods were used to control for differences between beneficiary and non-beneficiary children to estimate program impacts on health care utilization and health outcomes.
   Results: Bolsa Familia has increased the odds of children's visits to the health post for preventive services. In children under age seven, Bolsa Familia was associated with increased odds for growth monitoring (OR = 3.1; 95% CI 1.9-5.1), vaccinations (OR = 2.8; 95% CI 1.4-5.4), and checkups (OR = 1.6; 95% CI 0.98-2.5), and with the number of growth monitoring visits (beta = 0.6; p = 0.049) and checkups (beta = 0.2; p = 0.068). There were positive spillover effects on older siblings (ages 7-17) no longer required to meet the health conditionalities. Bolsa Familia increased their odds for growth monitoring (OR = 2.5; 95% CI 1.3-4.9) and checkups (OR = 1.7; 95% CI 0.9-3.2) and improved psychosocial health (beta = 2.6; p = 0.007).
   Conclusions: Bolsa Familia has improved health care utilization, especially for services related to the health conditionalites, and there were positive spillover effects on older siblings. The findings of this study are promising, but they also suggest that further improvements in health may depend on the quality of health care services provided, the scope of services linked to the health conditionalities, and coordination with other social safety net programs.
C1 [Shei, Amie] Anal Grp Inc, Boston, MA 02199 USA.
   [Costa, Federico; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz, BR-40296 Salvador, BA, Brazil.
   [Costa, Federico; Reis, Mitermayer G.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Reis, Mitermayer G.] Univ Fed Bahia, Bahia Sch Med, BR-40025 Salvador, BA, Brazil.
   [Reis, Mitermayer G.] Bahiana Sch Med & Publ Hlth, BR-40285 Salvador, BA, Brazil.
RP Shei, A (corresponding author), Anal Grp Inc, 111 Huntington Ave,10th Floor, Boston, MA 02199 USA.
EM ashei@analysisgroup.com
RI Reis, Mitermayer/AAO-9742-2020; Costa, Federico/G-1838-2015; Ko, Albert
   Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Costa,
   Federico/0000-0001-6951-2336; Ko, Albert Icksang/0000-0001-9023-2339
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01 TW009504, D43 TW00919, R25 TW009338] Funding Source: Medline; NIAID
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01 AI088752, R01 AI052473] Funding Source:
   Medline; FOGARTY INTERNATIONAL CENTERUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, R25TW009338, R25TW009338,
   R01TW009504, R25TW009338, D43TW000919, R01TW009504, R25TW009338,
   R25TW009338, R25TW009338, D43TW000919, D43TW000919, D43TW000919,
   R25TW009338, D43TW000919, R25TW009338, D43TW000919, R25TW009338,
   R01TW009504, R25TW009338, R01TW009504, D43TW000919, R25TW009338,
   R25TW009338, R01TW009504, D43TW000919, R25TW009338, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, U01AI088752, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, U01AI088752,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, R01AI052473] Funding
   Source: NIH RePORTER
CR American Association for Public Opinion Research, 2009, STAND DEF FIN DISP C
   Attanasio O, 2005, SHORT TERM IMPACT CO
   Oliveira FDC, 2011, CIENC SAUDE COLETIVA, V16, P3307, DOI 10.1590/S1413-81232011000800030
   Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023
   De Brauw A, 2012, SSRN ELECTION J 2012
   de Lima Flavia Emilia Leite, 2011, Rev Bras Epidemiol, V14, P198, DOI 10.1590/S1415-790X2011000200002
   De Oliveira AMHC, 2007, FIRST RESULTS PRELIM, P392
   Diaz JJ, 2006, J HUM RESOUR, V41, P319, DOI 10.3368/jhr.XLI.2.319
   Fernald Lia C H, 2008, Prev Chronic Dis, V5, pA81
   Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7
   Fiszbein Ariel, 2009, CONDITIONAL CASH TRA
   Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109
   Gertler P., 2000, IMPACT PROGRESA HLTH
   Guanais FC, 2013, AM J PUBLIC HEALTH, V103, P2000, DOI 10.2105/AJPH.2013.301452
   Haddad M. A., 2008, J INT DEV, V20, P654
   Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900
   Lignani JD, 2011, PUBLIC HEALTH NUTR, V14, P785, DOI 10.1017/S136898001000279X
   Linden A, 2011, J EVAL CLIN PRACT, V17, P1231, DOI 10.1111/j.1365-2753.2010.01504.x
   Lindert K., 2007, NUTS BOLTS BRAZILS B
   Maluccio J, 2005, IMPACT EVALUATION CO
   Ministerio do Desenvolvimento Social e Combate a Fome, 2011, BOLS FAM COMPL 8 AN
   Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6
   Norredam M, 2009, J GEN INTERN MED, V24, P438, DOI 10.1007/s11606-009-1034-5
   O'Donnell O, 2007, CAD SAUDE PUBLICA, V23, P2820, DOI 10.1590/S0102-311X2007001200003
   Ozer EJ, 2009, PEDIATRICS, V123, pE630, DOI 10.1542/peds.2008-2882
   Paes-Sousa R, 2011, B WORLD HEALTH ORGAN, V89, P496, DOI 10.2471/BLT.10.084202
   Piperata BA, 2011, AM J PHYS ANTHROPOL, V146, P1, DOI 10.1002/ajpa.21459
   Piperata BA, 2011, AM J HUM BIOL, V23, P458, DOI 10.1002/ajhb.21147
   Ranganathan M, 2012, PREV MED, V55, pS95, DOI 10.1016/j.ypmed.2011.11.015
   Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41
   Saris-Baglama RN, 2007, SF10TM HLTH SURVEY C
   Shei A, 2013, HEALTH AFFAIR, V32, P1274, DOI 10.1377/hlthaff.2012.0827
   Soares F. V, 2006, CASH TRANSFER PROGRA
NR 38
TC 37
Z9 39
U1 1
U2 34
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1472-698X
J9 BMC INT HEALTH HUM R
JI BMC Int. Health Hum. Rights.
PD APR 1
PY 2014
VL 14
AR 10
DI 10.1186/1472-698X-14-10
PG 9
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA AG1KD
UT WOS:000335173000002
PM 24690131
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Weinberger, D
   Baroux, N
   Grangeon, JP
   Ko, AI
   Goarant, C
AF Weinberger, Daniel
   Baroux, Noemie
   Grangeon, Jean-Paul
   Ko, Albert I.
   Goarant, Cyrille
TI El Nino Southern Oscillation and Leptospirosis Outbreaks in New
   Caledonia
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RISK-FACTORS; PACIFIC; TRANSMISSION; TEMPERATURE
AB Author Summary
   The El Nino Southern Oscillation is a major ocean - atmosphere phenomenon that strongly contributes to the timing and intensity of rainfall in the tropical Pacific islands and beyond. As a consequence, it also has a major effect on the number of cases of leptospirosis. By incorporating oceanographic parameters in models, we have been able to predict leptospirosis outbreaks in New Caledonia 4 months in advance. We discuss that this forecasting delay might be used to implement timely interventions prior to the occurrence of outbreaks. Possible interventions include controlling rodent reservoir populations before population growth and maintaining sewage networks or river banks. The major impact of El Nino on the climate of Pacific Islands Countries and Territories suggests that other countries might be able to build similar predictive models.
   Leptospirosis is an important cause of seasonal outbreaks in New Caledonia and the tropics. Using time series derived from high-quality laboratory-based surveillance from 2000-2012, we evaluated whether climatic factors, including El Nino Southern Oscillation (ENSO) and meteorological conditions allow for the prediction of leptospirosis outbreaks in New Caledonia. We found that La Nina periods are associated with high rainfall, and both of these factors were in turn, temporally associated with outbreaks of leptospirosis. The sea surface temperature in El Nino Box 4 allowed forecasting of leptospirosis outbreaks four months into the future, a time lag allowing public health authorities to increase preparedness. To our knowledge, our observations in New Caledonia are the first demonstration that ENSO has a strong association with leptospirosis. This association should be tested in other regions in the South Pacific, Asia or Latin America where ENSO may drive climate variability and the risk for leptospirosis outbreaks.
C1 [Weinberger, Daniel; Ko, Albert I.] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.
   [Baroux, Noemie; Goarant, Cyrille] Inst Pasteur, Inst Pasteur Int Network, Noumea, New Caledonia.
   [Grangeon, Jean-Paul] Direct Affaires Sanit & Sociales Nouvelle Caledon, Noumea, New Caledonia.
   [Ko, Albert I.] Yale Univ, Sch Med, New Haven, CT USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
RP Weinberger, D (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.
EM cgoarant@pasteur.nc
RI Goarant, Cyrille/D-4267-2018; Ko, Albert Icksang/P-2343-2015
OI Goarant, Cyrille/0000-0002-0690-9464; Ko, Albert
   Icksang/0000-0001-9023-2339
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 TW009504, U01
   AI088752, R01 AI052473]; French Ministere de l'Enseignement Superieur et
   de la Recherche; Institut Pasteur
FX This work was supported by grants from the National Institutes of Health
   (R01 TW009504, U01 AI088752, R01 AI052473), from the French Ministere de
   l'Enseignement Superieur et de la Recherche and from Institut Pasteur.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Abela-Ridder B, 2013, PRINC MAH AW C 2013
   Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Barbero R, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016577
   Berlioz-Arthaud A, 2007, Bull Soc Pathol Exot, V100, P133
   Bouree P, 1999, B SOC PATHOL EXOT, V92, P51
   Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10
   Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653
   Chadsuthi S, 2012, ASIAN PAC J TROP MED, V5, P539, DOI 10.1016/S1995-7645(12)60095-9
   Clyde MA, 1999, BAYESIAN STATISTICS 6, P157
   Coelho MSZS, 2012, INT J BIOMETEOROL, V56, P233, DOI 10.1007/s00484-011-0419-4
   DASS-NC, 2012, SIT SAN NOUV CAL, P320
   Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377
   Freckleton RP, 2011, BEHAV ECOL SOCIOBIOL, V65, P91, DOI 10.1007/s00265-010-1045-6
   Gaynor K, 2007, AM J TROP MED HYG, V76, P882, DOI 10.4269/ajtmh.2007.76.882
   Goarant C, 2009, TROP MED INT HEALTH, V14, P926, DOI 10.1111/j.1365-3156.2009.02310.x
   Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x
   Jansen A, 2005, EMERG INFECT DIS, V11, P1048, DOI 10.3201/eid1107.041172
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kousky VE, 2007, WEATHER FORECAST, V22, P353, DOI 10.1175/WAF987.1
   Kovats RS, 2000, B WORLD HEALTH ORGAN, V78, P1127
   Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011
   MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219
   Merien F, 1996, AM J TROP MED HYG, V55, P174, DOI 10.4269/ajtmh.1996.55.174
   Merien F, 2005, REV FRANCAISE LAB, V374, P1
   Nicet JB, 2000, MON WEATHER REV, V128, P3001, DOI 10.1175/1520-0493(2000)128<3001:ERPCIN>2.0.CO;2
   Perez J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001361
   Perrocheau A, 1997, EUR J EPIDEMIOL, V13, P161, DOI 10.1023/A:1007300514760
   Raftery A.E., 2013, BMA BAYESIAN MODEL A
   RASMUSSON EM, 1982, MON WEATHER REV, V110, P354, DOI 10.1175/1520-0493(1982)110<0354:VITSST>2.0.CO;2
   ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P2161, DOI 10.1175/1520-0493(1987)115<2161:AEOTTS>2.0.CO;2
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   Storck CH, 2008, EPIDEMIOL INFECT, V136, P1407, DOI 10.1017/S0950268807000052
   Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6
   Team RDevelopment Core, 2005, R LANG ENV STAT COMP
   Vanasco NB, 2008, ACTA TROP, V107, P255, DOI 10.1016/j.actatropica.2008.06.007
   Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147
   Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X
   Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336
   World Health Organization, 2003, HUM LEPT GUID DIAGN
   Xiao H, 2013, EPIDEMIOL INFECT, V141, P1867, DOI 10.1017/S0950268812002555
NR 47
TC 31
Z9 32
U1 2
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2014
VL 8
IS 4
DI 10.1371/journal.pntd.0002798
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AG3TK
UT WOS:000335342400033
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Hagan, JE
   Dias, JS
   Villasboas-Bisneto, JC
   Falcao, MB
   Ko, AI
   Ribeiro, GS
AF Hagan, Jose Edward
   Dias, Jesangeli Sousa
   Villasboas-Bisneto, Jose Caetano
   Falcao, Melissa Barreto
   Ko, Albert Icksang
   Ribeiro, Guilherme Sousa
TI Puerperal brain cryptococcoma in an HIV-negative woman successfully
   treated with fluconazole: a case report
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Cryptococcus; Immune reconstitution inflammatory syndrome; Treatment
ID NEOFORMANS; PREGNANCY; VARIETY; DISEASE; CANCER; HOST
AB Cryptococcus spp. cerebral abscesses are uncommon in immunocompetent subjects. The recommended induction treatment is the administration of amphotericin B plus flucytosine combined with resection for lesions >= 3cm. In this paper, we describe an HIV-negative woman diagnosed with a large cryptococcoma in the immediate postpartum period. The lesion was not resected, and due to amphotericin B intolerance, she received an extended course of fluconazole monotherapy. There was no disease recurrence during the 4 years of follow-up. The abrupt onset of her symptoms following delivery suggests that she developed a postpartum immune reconstitution syndrome. This case also demonstrates that in specific situations fluconazole monotherapy can be attempted in immunocompetent patients with cryptococcoma.
C1 [Hagan, Jose Edward; Ko, Albert Icksang] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Hagan, Jose Edward; Villasboas-Bisneto, Jose Caetano; Ko, Albert Icksang; Ribeiro, Guilherme Sousa] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Dias, Jesangeli Sousa; Falcao, Melissa Barreto] Hosp Couto Maia, Secretaria Saude Estado Bahia, Salvador, BA, Brazil.
   [Dias, Jesangeli Sousa] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
   [Ribeiro, Guilherme Sousa] Univ Fed Bahia, Inst Saude Coletiva, Salvador, BA, Brazil.
RP Ribeiro, GS (corresponding author), Univ Fed Bahia, Inst Saude Coletiva, Rua Basilio da Gama S-N,Campus Univ Canela, BR-40110040 Salvador, BA, Brazil.
EM gsribeiro@ufba.br
RI Ko, Albert Icksang/P-2343-2015; Ribeiro, Guilherme/B-6624-2008; Hagan,
   Jose/N-6719-2019
OI Ko, Albert Icksang/0000-0001-9023-2339; Ribeiro,
   Guilherme/0000-0002-6798-2059; Hagan, Jose/0000-0002-1837-6319;
   Villasboas Bisneto, Jose Caetano/0000-0002-2907-0809
FU National Institutes of Health through the Fogarty International Clinical
   Research Scholars and Fellows Program at Vanderbilt University [R24
   TW007988]; American Relief and Recovery Act; NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI052473]; FICUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43 TW00919]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW000919, R24TW007988, D43TW000919, D43TW000919, D43TW000919,
   R24TW007988, D43TW000919, D43TW000919, R24TW007988, D43TW000919,
   D43TW000919, D43TW000919, R24TW007988, D43TW000919, R24TW007988,
   R24TW007988, R24TW007988, R24TW007988, D43TW000919] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the National Institutes of Health through the
   Fogarty International Clinical Research Scholars and Fellows Program at
   Vanderbilt University (R24 TW007988) and the American Relief and
   Recovery Act, and through grants, NIAID R01 AI052473 and FIC D43
   TW00919.
CR Costa MLB, 2009, REV INST MED TROP SP, V51, P289, DOI 10.1590/S0036-46652009000500010
   Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992
   DeBess E., 2010, Morbidity and Mortality Weekly Report, V59, P865
   Huang CJ, 2005, J THORAC IMAG, V20, P115, DOI 10.1097/01.rti.0000154073.21571.77
   Kagan E, 2010, AM J MED SCI, V340, P173, DOI 10.1097/MAJ.0b013e3181e52c95
   Li Q, 2010, ACTA NEUROCHIR, V152, P129, DOI 10.1007/s00701-009-0311-8
   MITCHELL DH, 1995, CLIN INFECT DIS, V20, P611, DOI 10.1093/clinids/20.3.611
   Nishikawa MM, 2003, J CLIN MICROBIOL, V41, P73, DOI 10.1128/JCM.41.1.73-77.2003
   Nucci A, 1999, ARQ NEURO-PSIQUIAT, V57, P678, DOI 10.1590/S0004-282X1999000400023
   Pereira Carlos Alberto Pires, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P367, DOI 10.1590/S0036-46651993000400011
   Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858
   Singh N, 2007, CLIN INFECT DIS, V45, P1192, DOI 10.1086/522182
   Yamaguchi H, 1996, EUR J CLIN MICROBIOL, V15, P787, DOI 10.1007/BF01701520
NR 13
TC 5
Z9 5
U1 0
U2 2
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAR-APR
PY 2014
VL 47
IS 2
BP 254
EP 256
DI 10.1590/0037-8682-0215-2013
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AI1SF
UT WOS:000336631700024
PM 24861306
OA DOAJ Gold, Green Accepted
DA 2020-11-30
ER

PT J
AU Costa, F
   Porter, FH
   Rodrigues, G
   Farias, H
   de Faria, MT
   Wunder, EA
   Osikowicz, LM
   Kosoy, MY
   Reis, MG
   Ko, AI
   Childs, JE
AF Costa, Federico
   Porter, Fleur Helena
   Rodrigues, Gorete
   Farias, Helena
   de Faria, Marcus Tucunduva
   Wunder, Elsio A.
   Osikowicz, Lynn M.
   Kosoy, Michael Y.
   Reis, Mitermayer Galvao
   Ko, Albert I.
   Childs, James E.
TI Infections by Leptospira interrogans, Seoul Virus, and Bartonella spp.
   Among Norway Rats (Rattus norvegicus) from the Urban Slum Environment in
   Brazil
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Leptospira interrogans; Seoul virus; Bartonella spp; Norway rats (Rattus
   norvegicus); Brazil
ID HANTAVIRUS INFECTION; RODENTS; POPULATION; BALTIMORE; ZOONOSES; MARYLAND
AB Norway rats (Rattus norvegicus) are reservoir hosts for zoonotic pathogens that cause significant morbidity and mortality in humans. Studies evaluating the prevalence of zoonotic pathogens in tropical Norway rat populations are rare, and data on co-infection with multiple pathogens are nonexistent. Herein, we describe the prevalence of leptospiral carriage, Seoul virus (SEOV), and Bartonella spp. infection independently, in addition to the rates of co-infection among urban, slum-dwelling Norway rats in Salvador, Brazil, trapped during the rainy season from June to August of 2010. These data were complemented with previously unpublished Leptospira and SEOV prevalence information collected in 1998. Immunofluorescence staining of kidney impressions was used to identify Leptospira interrogans in 2010, whereas isolation was used in 1998, and western blotting was used to detect SEOV antibodies in 2010, whereas enzyme-linked immunosorbent assay (ELISA) was used in 1998: in 2010, Bartonella spp. were isolated from a subsample of rats. The most common pathogen in both years was Leptospira spp. (83%, n=142 in 1998, 63%, n=84 in 2010). SEOV was detected in 18% of individuals in both 1998 and 2010 (n=78 in 1998; n=73 in 2010), and two species of Bartonella were isolated from 5 of 26 rats (19%) tested in 2010. The prevalence of all agents increased significantly with rat mass/age. Acquisition of Leptospira spp. occurred at a younger mass/age than SEOV and Bartonella spp. infection, suggesting differences in the transmission dynamics of these pathogens. These data indicate that Norway rats in Salvador serve as reservoir hosts for all three of these zoonotic pathogens and that the high prevalence of leptospiral carriage in Salvador rats poses a high degree of risk to human health.
C1 [Costa, Federico; Reis, Mitermayer Galvao] Minist Saude, Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, BR-40296710 Salvador, BA, Brazil.
   [Costa, Federico; Porter, Fleur Helena; Wunder, Elsio A.; Ko, Albert I.] Yale Univ, Div Epidemiol Microbial Dis, Sch Publ Hlth, New Haven, CT USA.
   [Rodrigues, Gorete; Farias, Helena] Minist Saude, Ctr Controle Zoonoses, Secretaria Municipal Saude, Salvador, BA, Brazil.
   [de Faria, Marcus Tucunduva] Embrapa Amazonia Orienta, Belem, Para, Brazil.
   [Osikowicz, Lynn M.; Kosoy, Michael Y.] Ctr Dis Control & Prevent, DVBID, Ft Collins, CO USA.
   [Childs, James E.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.
   [Childs, James E.] Yale Univ, Sch Med, Ctr Ecoepidemiol, New Haven, CT USA.
RP Costa, F (corresponding author), Minist Saude, Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020; Costa,
   Federico/G-1838-2015; Wunder, Elsio Augusto/C-2733-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Costa, Federico/0000-0001-6951-2336;
   Wunder, Elsio Augusto/0000-0002-5239-8511
FU Secretariat of Health Surveillance; Oswaldo Cruz Foundation; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI052473, U01
   AI088752, R01 TW009504, R24 TW007988, R25 TW009338, D43 TW00919]; CAPES
   (Coordination for the Improvement of Higher Education Personnel/Ministry
   of Education/Brazil)CAPES; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R25TW009338, R25TW009338,
   R25TW009338, D43TW000919, R25TW009338, D43TW000919, D43TW000919,
   R24TW007988, R01TW009504, R25TW009338, R24TW007988, D43TW000919,
   R01TW009504, R24TW007988, D43TW000919, D43TW000919, R25TW009338,
   R25TW009338, R24TW007988, R25TW009338, R24TW007988, D43TW000919,
   R01TW009504, R25TW009338, R25TW009338, R25TW009338, R01TW009504,
   R24TW007988, R25TW009338, R24TW007988, R01TW009504, D43TW000919,
   R25TW009338, D43TW000919, D43TW000919, R24TW007988, D43TW000919] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, U01AI088752, R01AI052473, R01AI052473,
   U01AI088752, R01AI052473, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, U01AI088752] Funding Source: NIH
   RePORTER
FX We would like to thank the staff of Centro de Controle de Zoonoses from
   Salvador for their assistance in conducting the study and Julia Schoen
   for assisting with database management; Ying Bai for the Bartonella spp.
   sequencing; and Kate Hacker for her critical advice during the
   preparation of the manuscript. This work was supported by the
   Secretariat of Health Surveillance, the Oswaldo Cruz Foundation and the
   National Institutes of Health (grants R01 AI052473, U01 AI088752, R01
   TW009504, R24 TW007988, R25 TW009338 and D43 TW00919) and CAPES
   (Coordination for the Improvement of Higher Education Personnel/Ministry
   of Education/Brazil).
CR Andrade ZA, 1954, B FUNDACAO GONCALO M, V3, P1
   Antoniou M, 2010, VECTOR-BORNE ZOONOT, V10, P867, DOI 10.1089/vbz.2009.0123
   Bai Y, 2009, AM J TROP MED HYG, V81, P811, DOI 10.4269/ajtmh.2009.09-0294
   Battersby SA, 2002, J ENV HLTH RES, V1, P4
   Chagas-Junior AD, 2009, J MED MICROBIOL, V58, P1632, DOI 10.1099/jmm.0.014050-0
   CHILDS J E, 1988, Bulletin of the Society for Vector Ecology, V13, P113
   Childs JE, 1998, AM J EPIDEMIOL, V148, P78, DOI 10.1093/oxfordjournals.aje.a009563
   Chow Ling, 2005, Journal of Microbiology Immunology and Infection, V38, P343
   Clement J, 1997, EMERG INFECT DIS, V3, P205, DOI 10.3201/eid0302.970218
   Clement J, 1999, LANCET, V354, P2003, DOI 10.1016/S0140-6736(05)76782-9
   CLEMENT J, 1994, LANCET, V344, P131, DOI 10.1016/S0140-6736(94)91319-6
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   dos Santos ED, 2005, EPIDEMIOL SERV SAUDE, V14, P15
   Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746
   Easterbrook JD, 2005, VECTOR-BORNE ZOONOT, V5, P296, DOI 10.1089/vbz.2005.5.296
   FELDMANN H, 1993, VIRUS RES, V30, P351, DOI 10.1016/0168-1702(93)90101-R
   GLASS GE, 1988, EPIDEMIOL INFECT, V101, P459, DOI 10.1017/S0950268800054418
   Glass GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005794
   Gouveia EL, 2008, EMERG INFECT DIS, V14
   Gratz N. G., 1994, P85
   Gundi VAKB, 2012, EMERG INFECT DIS, V18, P631, DOI 10.3201/eid1804.110816
   Gundi VAKB, 2009, INT J SYST EVOL MICR, V59, P2956, DOI 10.1099/ijs.0.002865-0
   Health Surveillance Secretary, 2007, LEPT CAS NOT REC
   Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310
   Hjelle B, 1997, J CLIN MICROBIOL, V35, P600, DOI 10.1128/JCM.35.3.600-608.1997
   Instituto Brasileiro de Geografia e Estatistica, 2007, CONT POP 2007 TAB 1
   Iversson LB, 1992, REV ASSOC MED BRAS, V40, P85
   Katz G, 2001, VECTOR-BORNE ZOONOT, V1, P181, DOI 10.1089/153036601753552549
   KAWAMATA J, 1987, LAB ANIM SCI, V37, P431
   Klein SL, 2002, J MAMMAL, V83, P478, DOI 10.1644/1545-1542(2002)083&lt;0478:EAPFAW&gt;2.0.CO;2
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kosoy M, 2004, VECTOR-BORNE ZOONOT, V4, P285, DOI 10.1089/vbz.2004.4.285
   Kosoy M, 2010, AM J TROP MED HYG, V82, P1140, DOI 10.4269/ajtmh.2010.09-0778
   Kosoy MY, 1997, AM J TROP MED HYG, V57, P578, DOI 10.4269/ajtmh.1997.57.578
   Lamas C, 2008, MEM I OSWALDO CRUZ, V103, P221, DOI 10.1590/S0074-02762008000300001
   Lamas C, 2010, INT J INFECT DIS, V14, pE373, DOI 10.1016/j.ijid.2010.02.450
   LEDUC JW, 1986, B WORLD HEALTH ORGAN, V64, P139
   LEDUC JW, 1985, AM J TROP MED HYG, V34, P810, DOI 10.4269/ajtmh.1985.34.810
   Macdonald DW, 1999, ACIAR MONOGRAPH, V59
   Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213
   Meyer A., 2003, AUSTR CTR INT AGR RE, V96, P446
   Mills James N., 1999, ACIAR Monograph Series, V59, P134
   Mills JN, 1995, METHODS TRAPPING SAM
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180
   Porter FH, DEMOGRAPHIC DI UNPUB
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Sanfeliu I, 2011, VECTOR-BORNE ZOONOT, V11, P697, DOI 10.1089/vbz.2010.0165
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Taylor PJ, 2008, INTEGR ZOOL, V3, P38, DOI 10.1111/j.1749-4877.2008.00072.x
   UN-HABITAT, 2003, SLUMS WORLD FAC URB
   Vanasco NB, 2003, PREV VET MED, V60, P227, DOI 10.1016/S0167-5877(03)00144-2
   Webster JP, 1995, MAMMALIA, V59, P645
NR 54
TC 62
Z9 64
U1 1
U2 22
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD JAN 1
PY 2014
VL 14
IS 1
BP 33
EP 40
DI 10.1089/vbz.2013.1378
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 284ZE
UT WOS:000329360400004
PM 24359425
OA Green Published
DA 2020-11-30
ER

PT J
AU Nogueira, SV
   Backstedt, BT
   Smith, AA
   Qin, JH
   Wunder, EA
   Ko, A
   Pal, U
AF Nogueira, Sarah Veloso
   Backstedt, Brian T.
   Smith, Alexis A.
   Qin, Jin-Hong
   Wunder, Elsio A., Jr.
   Ko, Albert
   Pal, Utpal
TI Leptospira interrogans Enolase Is Secreted Extracellularly and Interacts
   with Plasminogen
SO PLOS ONE
LA English
DT Article
ID OUTER-MEMBRANE PROTEINS; BACTERIAL-CELL SURFACE; BORRELIA-BURGDORFERI;
   ALPHA-ENOLASE; BINDS PLASMINOGEN; IDENTIFICATION; INFECTION;
   PATHOGENESIS; INSIGHTS; RECEPTOR
AB Leptospira interrogans is the agent for leptospirosis, an important zoonosis in humans and animals across the globe. Surface proteins of invading pathogens, such as L. interrogans, are thought to be responsible for successful microbial persistence in vivo via interaction with specific host components. In particular, a number of invasive infectious agents exploit host proteolytic pathways, such as one involving plasminogen (Pg), which aid in efficient pathogen dissemination within the host. Here we show that L. interrogans serovar Lai binds host Pg and that the leptospiral gene product LA1951, annotated as enolase, is involved in this interaction. Interestingly, unlike in related pathogenic Spirochetes, such as Borrelia burgdorferi, LA1951 is not readily detectable in the L. interrogans outer membrane. We show that the antigen is indeed secreted extracellularly; however, it can reassociate with the pathogen surface, where it displays Pg-binding and measurable enzymatic activity. Hamsters infected with L. interrogans also develop readily detectable antibody responses against enolase. Taken together, our results suggest that the L. interrogans enolase has evolved to play a role in pathogen interaction with host molecules, which may contribute to the pathogenesis of leptospirosis.
C1 [Nogueira, Sarah Veloso; Backstedt, Brian T.; Smith, Alexis A.; Qin, Jin-Hong; Pal, Utpal] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.
   [Nogueira, Sarah Veloso; Backstedt, Brian T.; Smith, Alexis A.; Qin, Jin-Hong; Pal, Utpal] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.
   [Wunder, Elsio A., Jr.; Ko, Albert] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
RP Pal, U (corresponding author), Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.
EM upal@umd.edu
RI Pal, Utpal/I-5265-2015; Wunder, Elsio Augusto/C-2733-2013; Ko, Albert
   Icksang/P-2343-2015
OI Wunder, Elsio Augusto/0000-0002-5239-8511; Ko, Albert
   Icksang/0000-0001-9023-2339
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI080615, AI088752,
   AI052473]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI080615, R01AI080615, R01AI080615, R01AI080615,
   R01AI052473, R01AI052473, R01AI080615, R01AI052473, R01AI080615,
   R01AI080615, R56AI080615, U01AI088752, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, R01AI052473,
   R01AI080615, R01AI052473, U01AI088752, U01AI088752, U01AI088752,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX This study was supported by funding from National Institutes of Health
   (AI080615, AI088752 and AI052473). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adler B, 2011, VET MICROBIOL, V153, P73, DOI 10.1016/j.vetmic.2011.02.055
   Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017
   Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06
   Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x
   Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Chang YF, 2007, VACCINE, V25, P8190, DOI 10.1016/j.vaccine.2007.09.020
   Chhatwal GS, 2002, TRENDS MICROBIOL, V10, P205, DOI 10.1016/S0966-842X(02)02351-X
   Cinco M, 2010, NEW MICROBIOL, V33, P283
   COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995
   Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6
   Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x
   Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005
   Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004
   Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002
   Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029
   Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000
   Floden AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027502
   Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224
   Grassmann AA, 2012, CLIN VACCINE IMMUNOL, V19, P740, DOI 10.1128/CVI.05720-11
   Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942
   Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kornblatt MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028481
   Lee SH, 2002, INFECT IMMUN, V70, P315, DOI 10.1128/IAI.70.1.315-322.2002
   Levett PN, 2001, CLIN DIAGN LAB IMMUN, V8, P349, DOI 10.1128/CDLI.8.2.349-351.2001
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lopez-Villar E, 2006, PROTEOMICS, V6, pS107, DOI 10.1002/pmic.200500479
   Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1016/S0378-1097(00)00044-6
   MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034
   Mundodi V, 2008, INFECT IMMUN, V76, P523, DOI 10.1128/IAI.01352-07
   Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08
   Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Nogueira SV, 2012, INFECT IMMUN, V80, P82, DOI 10.1128/IAI.05671-11
   Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10
   Pal U, 2008, J EXP MED, V205, P133, DOI 10.1084/jem.20070962
   Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729
   Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002
   Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503
   Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910
   PLOW EF, 1995, FASEB J, V9, P939
   Promnares K, 2009, MOL MICROBIOL, V74, P112, DOI 10.1111/j.1365-2958.2009.06853.x
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x
   Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097
   Siqueira GH, 2013, AM J TROP MED HYG
   Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780
   Toledo A, 2012, INFECT IMMUN, V80, P359, DOI 10.1128/IAI.05836-11
   VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405
   Velineni S, 2006, Indian J Med Microbiol, V24, P339
   Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09
   Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259
   Vieira Monica L, 2009, Open Microbiol J, V3, P69, DOI 10.2174/1874285800903010069
   Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09
   Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11
   Yang XL, 2011, J PROTEOME RES, V10, P4556, DOI 10.1021/pr200395b
   Zeng L, 2013, OMICS, DOI [10.1089/omi.2013.0043, DOI 10.1089/0MI.2013.0043.PUBMED:23895271]
NR 63
TC 24
Z9 23
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 18
PY 2013
VL 8
IS 10
AR e78150
DI 10.1371/journal.pone.0078150
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 239MM
UT WOS:000326029300144
PM 24205133
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Kajdacsi, B
   Costa, F
   Hyseni, C
   Porter, F
   Brown, J
   Rodrigues, G
   Farias, H
   Reis, MG
   Childs, JE
   Ko, AI
   Caccone, A
AF Kajdacsi, Brittney
   Costa, Federico
   Hyseni, Chaz
   Porter, Fleur
   Brown, Julia
   Rodrigues, Gorete
   Farias, Helena
   Reis, Mitermayer G.
   Childs, James E.
   Ko, Albert I.
   Caccone, Adalgisa
TI Urban population genetics of slum-dwelling rats (Rattus norvegicus) in
   Salvador, Brazil
SO MOLECULAR ECOLOGY
LA English
DT Article
DE population genetics; Rattus norvegicus; rodent control; urban ecology
ID GLOSSINA-FUSCIPES-FUSCIPES; LEPTOSPIRA-INTERROGANS; UGANDA IMPLICATIONS;
   COMPUTER-PROGRAM; BIASED DISPERSAL; NORWAY RATS; ERADICATION; SIZE;
   CITY; DIFFERENTIATION
AB Throughout the developing world, urban centres with sprawling slum settlements are rapidly expanding and invading previously forested ecosystems. Slum communities are characterized by untended refuse, open sewers and overgrown vegetation, which promote rodent infestation. Norway rats (Rattus norvegicus) are reservoirs for epidemic transmission of many zoonotic pathogens of public health importance. Understanding the population ecology of R.norvegicus is essential to formulate effective rodent control strategies, as this knowledge aids estimation of the temporal stability and spatial connectivity of populations. We screened for genetic variation, characterized the population genetic structure and evaluated the extent and patterns of gene flow in the urban landscape using 17 microsatellite loci in 146 rats from nine sites in the city of Salvador, Brazil. These sites were divided between three neighbourhoods within the city spaced an average of 2.7km apart. Surprisingly, we detected very little relatedness among animals trapped at the same site and found high levels of genetic diversity, as well as structuring across small geographical distances. Most F-ST comparisons among sites were statistically significant, including sites <400m apart. Bayesian analyses grouped the samples in three genetic clusters, each associated with distinct sampling sites from different neighbourhoods or valleys within neighbourhoods. These data indicate the existence of complex genetic structure in R.norvegicus in Salvador, linked to the heterogeneous urban landscape. Future rodent control measures need to take into account the spatial and temporal linkage of rat populations in Salvador, as revealed by genetic data, to develop informed eradication strategies.
C1 [Kajdacsi, Brittney; Hyseni, Chaz; Brown, Julia; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
   [Costa, Federico; Porter, Fleur; Childs, James E.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.
   [Costa, Federico; Reis, Mitermayer G.; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Gocalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Rodrigues, Gorete; Farias, Helena] Minist Saude, Secretaria Municipal Saude, Ctr Controle Zoonoses, BR-41720010 Salvador, BA, Brazil.
RP Kajdacsi, B (corresponding author), Fordham Univ, Dept Biol Sci, Louis Calder Ctr, Biol Field Stn, 53 Whippoorwill Rd, Armonk, NY 10504 USA.
EM brittney.kajdacsi@aya.yale.edu
RI Reis, Mitermayer/AAO-9742-2020; Costa, Federico/G-1838-2015; Ko, Albert
   Icksang/P-2343-2015; Hyseni, Chaz/I-7633-2018
OI Reis, Mitermayer/0000-0002-3051-9060; Costa,
   Federico/0000-0001-6951-2336; Ko, Albert Icksang/0000-0001-9023-2339;
   Hyseni, Chaz/0000-0003-2567-8013
FU Secretariat of Health Surveillance and Oswaldo Cruz Foundation,
   Brazilian Ministry of Health; CAPES (Coordination for the Improvement of
   Higher Education Personnel), Brazilian Ministry of EducationCAPES;
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 TW009504, U01
   AI088752, R01 AI052473, R24 TW007988, D43 TW00919]; Yale Institute for
   Biospheric Studies, Molecular Systematics and Conservation Genetics
   Center and Wilbur Downs Fellowship Program; Graduate Center, City
   University of New York (CUNY); FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R24TW007988, R01TW009504,
   R24TW007988, R24TW007988, R01TW009504, D43TW000919, R01TW009504,
   D43TW000919, D43TW000919, R24TW007988, D43TW000919, R24TW007988,
   D43TW000919, D43TW000919, R24TW007988, D43TW000919, R24TW007988,
   R24TW007988, D43TW000919, D43TW000919, R01TW009504, R01TW009504,
   D43TW000919, D43TW000919] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI088752, R01AI052473, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, U01AI088752, U01AI088752, U01AI088752,
   R01AI052473, U01AI088752, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX We thank the staff of the Centro de Controle de Zoonoses (CCZ) in
   Salvador for their assistance in conducting the study. This work was
   supported by the Secretariat of Health Surveillance and Oswaldo Cruz
   Foundation, Brazilian Ministry of Health; CAPES (Coordination for the
   Improvement of Higher Education Personnel), Brazilian Ministry of
   Education; National Institutes of Health (grants R01 TW009504, U01
   AI088752, R01 AI052473, R24 TW007988 and D43 TW00919); and Yale
   Institute for Biospheric Studies, Molecular Systematics and Conservation
   Genetics Center and Wilbur Downs Fellowship Program. We thank Danielle
   Edwards, Sarah Federman and Ryan Garrick for their assistance during
   data collection and analysis, as well as The Yale Institute for
   Biospheric Studies, Molecular Systematics and Conservation Genetics
   Center for use of laboratory facilities. Brittney Kajdacsi was supported
   by a Science Scholarship from The Graduate Center, City University of
   New York (CUNY) during the writing of this manuscript.
CR Abdelkrim J, 2005, CONSERV BIOL, V19, P1509, DOI 10.1111/j.1523-1739.2005.00206.x
   Abdelkrim J, 2010, CONSERV GENET, V11, P1953, DOI 10.1007/s10592-010-0085-9
   Abdelkrim J, 2009, BIOL INVASIONS, V11, P473, DOI 10.1007/s10530-008-9263-9
   Abdelkrim J, 2007, CONSERV BIOL, V21, P719, DOI 10.1111/j.1523-1739.2007.00696.x
   Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892
   Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x
   Beadell JS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000636
   Brazilian Institute of Geography and Statistics, 1971, BRAZ MIN HLTH EST PO
   Brazilian Institute of Geography and Statistics, 2011, SUMM 2010 DEM CENS
   Brouat C, 2007, MOL ECOL, V16, P2985, DOI 10.1111/j.1365-294X.2007.03353.x
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Calhoun J.B, 1962, ECOLOGY SOCIOLOGY NO
   Calmet C, 2001, BIODIVERS CONSERV, V10, P911, DOI 10.1023/A:1016636512734
   Chanteau S, 1998, ARCH I PASTEUR MADAG, V64, P12
   CHESSER RK, 1991, GENETICS, V129, P573
   CHESSER RK, 1991, GENETICS, V127, P437
   CHILDS J E, 1991, Bulletin of the Society for Vector Ecology, V16, P245
   Civen R, 2008, CLIN INFECT DIS, V46, P913, DOI 10.1086/527443
   COTTAM C, 1948, J MAMMAL, V29, P299, DOI 10.1093/jmammal/29.3.299
   DAVIS DE, 1951, ECOLOGY, V32, P462, DOI 10.2307/1931722
   DAVIS DE, 1951, AM J PUBLIC HEALTH, V41, P158
   DAVIS DE, 1953, Q REV BIOL, V28, P373, DOI 10.1086/399860
   DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   Dechet AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039672
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   FARHANG-AZAD A, 1979, Annals of Zoology (Agra), V15, P1
   Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019
   FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455
   Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x
   GAZEY WJ, 1986, ECOLOGY, V67, P941, DOI 10.2307/1939816
   Gilabert A, 2007, CAN J ZOOL, V85, P965, DOI 10.1139/Z07-083
   Gileva EA, 2006, RUSS J ECOL+, V37, P271, DOI 10.1134/S1067413606040096
   Glass G.E., 1989, Occasional Papers of the Museum of Natural History University of Kansas, VNo. 130, P1
   Glass GE, 2005, MARYLAND VECTOR BORN, V5, P296
   Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x
   Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627
   Heiberg AC, 2012, WILDLIFE RES, V39, P202, DOI 10.1071/WR11149
   Himsworth CG, 2013, VECTOR-BORNE ZOONOT, V13, P349, DOI 10.1089/vbz.2012.1195
   Hinson ER, 2006, BRAIN BEHAV IMMUN, V20, P182, DOI 10.1016/j.bbi.2005.06.003
   HOLM S, 1979, SCAND J STAT, V6, P65
   Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x
   Hyseni C, 2012, PARASITE VECTOR, V5, P1, DOI 10.1186/1756-3305-5-222
   ISKJAER C, 1989, J MAMMAL, V70, P662, DOI 10.2307/1381447
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a
   Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x
   Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kosoy M, 2010, AM J TROP MED HYG, V82, P1140, DOI 10.4269/ajtmh.2010.09-0778
   Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7
   Macdonald David W., 1999, ACIAR Monograph Series, V59, P49
   MACDONALD DW, 1995, J ZOOL, V236, P349, DOI 10.1111/j.1469-7998.1995.tb04502.x
   Matocq MD, 2000, EVOLUTION, V54, P1423
   Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213
   Mccoy KD, 2008, PARASITE, V15, P444, DOI 10.1051/parasite/2008153444
   Mills JN, 1995, METHODS TRAPPING SAM
   Moreira IM, 2008, SALVADOR METROPOLITA, P228
   Nkogwe Comfort, 2011, Veterinary Medicine International, V2011, P1, DOI 10.4061/2011/686923
   ORGAIN H, 1953, ECOLOGY, V34, P467, DOI 10.2307/1929719
   Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   PEREIRA MM, 1988, T ROY SOC TROP MED H, V82, P768, DOI 10.1016/0035-9203(88)90231-3
   Petit E, 2006, CONSERV BIOL, V20, P1062, DOI 10.1111/j.1523-1739.2006.00417.x
   Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074
   Pound N, 2004, ANIM BEHAV, V68, P819, DOI 10.1016/j.anbehav.2004.02.004
   Pritchard JK, 2000, GENETICS, V155, P945
   Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Robertson BC, 2004, J APPL ECOL, V41, P1042, DOI 10.1111/j.0021-8901.2004.00984.x
   Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x
   Russell JC, 2010, ANIM BEHAV, V79, P159, DOI 10.1016/j.anbehav.2009.10.020
   Russell JC, 2009, BIOL INVASIONS, V11, P1557, DOI 10.1007/s10530-008-9406-z
   Russell JC, 2009, BIOL CONSERV, V142, P1404, DOI 10.1016/j.biocon.2009.01.032
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Singleton GR, 1999, ECOLOGICALLY BASED M, P49
   Slotman MA, 2007, MOL ECOL NOTES, V7, P168, DOI 10.1111/j.1471-8286.2006.01533.x
   Solano P, 2010, TRENDS PARASITOL, V26, P255, DOI 10.1016/j.pt.2010.02.006
   TAYLOR KD, 1978, J APPL ECOL, V15, P663, DOI 10.2307/2402767
   TAYLOR KD, 1978, MAMMALIA, V42, P63, DOI 10.1515/mamm.1978.42.1.63
   Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z
   UN-HABITAT World Health Organization, 2010, HIDD CIT UNM OV HLTH
   Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x
   WEBSTER JP, 1995, PARASITOLOGY, V111, P247, DOI 10.1017/S0031182000081804
NR 87
TC 35
Z9 38
U1 1
U2 105
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0962-1083
EI 1365-294X
J9 MOL ECOL
JI Mol. Ecol.
PD OCT
PY 2013
VL 22
IS 20
BP 5056
EP 5070
DI 10.1111/mec.12455
PG 15
WC Biochemistry & Molecular Biology; Ecology; Evolutionary Biology
SC Biochemistry & Molecular Biology; Environmental Sciences & Ecology;
   Evolutionary Biology
GA 233EW
UT WOS:000325550000002
PM 24118116
OA Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Lessa-Aquino, C
   Rodrigues, CB
   Pablo, J
   Sasaki, R
   Jasinskas, A
   Liang, L
   Wunder, EA
   Ribeiro, GS
   Vigil, A
   Galler, R
   Molina, D
   Liang, XW
   Reis, MG
   Ko, AI
   Medeiros, MA
   Felgner, PL
AF Lessa-Aquino, Carolina
   Rodrigues, Camila Borges
   Pablo, Jozelyn
   Sasaki, Rie
   Jasinskas, Algis
   Liang, Li
   Wunder, Elsio A., Jr.
   Ribeiro, Guilherme S.
   Vigil, Adam
   Galler, Ricardo
   Molina, Douglas
   Liang, Xiaowu
   Reis, Mitermayer G.
   Ko, Albert I.
   Medeiros, Marco Alberto
   Felgner, Philip L.
TI Identification of Seroreactive Proteins of Leptospira interrogans
   Serovar Copenhageni Using a High-Density Protein Microarray Approach
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID IMMUNOGLOBULIN-LIKE PROTEINS; HUMORAL IMMUNE-RESPONSE; INFECTION;
   DIAGNOSIS; VACCINE; PATHOGENESIS; ENVIRONMENT; BIOLOGY; LIGA
AB Background: Leptospirosis is a widespread zoonotic disease worldwide. The lack of an adequate laboratory test is a major barrier for diagnosis, especially during the early stages of illness, when antibiotic therapy is most effective. Therefore, there is a critical need for an efficient diagnostic test for this life threatening disease.
   Methodology: In order to identify new targets that could be used as diagnostic makers for leptopirosis, we constructed a protein microarray chip comprising 61% of Leptospira interrogans proteome and investigated the IgG response from 274 individuals, including 80 acute-phase, 80 convalescent-phase patients and 114 healthy control subjects from regions with endemic, high endemic, and no endemic transmission of leptospirosis. A nitrocellulose line blot assay was performed to validate the accuracy of the protein microarray results.
   Principal findings: We found 16 antigens that can discriminate between acute cases and healthy individuals from a region with high endemic transmission of leptospirosis, and 18 antigens that distinguish convalescent cases. Some of the antigens identified in this study, such as LipL32, the non-identical domains of the Lig proteins, GroEL, and Loa22 are already known to be recognized by sera from human patients, thus serving as proof-of-concept for the serodiagnostic antigen discovery approach. Several novel antigens were identified, including the hypothetical protein LIC10215 which showed good sensitivity and specificity rates for both acute- and convalescent-phase patients.
   Conclusions: Our study is the first large-scale evaluation of immunodominant antigens associated with naturally acquired leptospiral infection, and novel as well as known serodiagnostic leptospiral antigens that are recognized by antibodies in the sera of leptospirosis cases were identified. The novel antigens identified here may have potential use in both the development of new tests and the improvement of currently available assays for diagnosing this neglected tropical disease. Further research is needed to assess the utility of these antigens in more deployable diagnostic platforms.
C1 [Lessa-Aquino, Carolina; Rodrigues, Camila Borges; Galler, Ricardo; Medeiros, Marco Alberto] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   [Lessa-Aquino, Carolina; Rodrigues, Camila Borges; Pablo, Jozelyn; Sasaki, Rie; Jasinskas, Algis; Liang, Li; Vigil, Adam; Felgner, Philip L.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA.
   [Pablo, Jozelyn; Molina, Douglas; Liang, Xiaowu] Antigen Discovery Inc, Irvine, CA USA.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Yale Univ, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ribeiro, Guilherme S.; Reis, Mitermayer G.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Inst, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Galler, Ricardo] Brazilian Minist Hlth, Inst Oswaldo Cruz, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
RP Lessa-Aquino, C (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
EM pfelgner@uci.edu
RI Ribeiro, Guilherme/B-6624-2008; Reis, Mitermayer/AAO-9742-2020; Ko,
   Albert Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013
OI Ribeiro, Guilherme/0000-0002-6798-2059; Reis,
   Mitermayer/0000-0002-3051-9060; Ko, Albert Icksang/0000-0001-9023-2339;
   Wunder, Elsio Augusto/0000-0002-5239-8511
FU NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI052473, U01 AI088752, R44 AI072856];
   FICUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW00919]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U01AI088752, U01AI088752, U01AI088752, U01AI088752,
   U01AI088752, U01AI088752] Funding Source: NIH RePORTER
FX The study was funded by the following grants: NIAID R01 AI052473, NIAID
   U01 AI088752, FIC D43 TW00919 and NIAID R44 AI072856. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Baldi P., 2001, BIOINFORMATICS MACHI
   Baldi P., 2002, DNA MICROARRAYS GENE
   Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08
   Barry AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008326
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Brasil Ministerio da Saude, 2012, IND DAD BAS SAUD BRA
   Chalayon P, 2011, T ROY SOC TROP MED H, V105, P289, DOI 10.1016/j.trstmh.2011.01.008
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   Evangelista KV, 2010, FUTURE MICROBIOL, V5, P1413, DOI 10.2217/FMB.10.102
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Kim Seoung Bum, 2008, Stat Anal Data Min, V1, P57, DOI 10.1002/sam.10005
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Liang L, 2012, CHEM BIODIVERS, V9, P977, DOI 10.1002/cbdv.201100360
   Liang L, 2011, J PROTEOME RES, V10, P4813, DOI 10.1021/pr200619r
   Magnan CN, 2010, BIOINFORMATICS, V26, P2936, DOI 10.1093/bioinformatics/btq551
   Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   MCCLAIN JBL, 1984, ANN INTERN MED, V100, P696, DOI 10.7326/0003-4819-100-5-696
   Nabity SA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001878
   Palaniappan RUM, 2007, CURR OPIN INFECT DIS, V20, P284, DOI 10.1097/QCO.0b013e32814a5729
   Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0
   Pinne M, 2012, J BACTERIOL, V194, P6074, DOI 10.1128/JB.01119-12
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Srimanote P, 2008, J MICROBIOL METH, V72, P73, DOI 10.1016/j.mimet.2007.10.012
   Sun AH, 2011, BIOMED ENVIRON SCI, V24, P291, DOI 10.3967/0895-3988.2011.03.013
   Tan XL, 2012, CLIN VACCINE IMMUNOL, V19, P418, DOI 10.1128/CVI.05521-11
   Trieu A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007948
   Vigil A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011447
   WATT G, 1988, LANCET, V1, P433
   World Health Organization, 2003, HUM LEPT GUID DIAGN
NR 41
TC 25
Z9 26
U1 1
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2013
VL 7
IS 10
AR e2499
DI 10.1371/journal.pntd.0002499
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 299DW
UT WOS:000330376500035
PM 24147173
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Reis, EAG
   Hagan, JE
   Ribeiro, GS
   Teixeira-Carvalho, A
   Martins, OA
   Montgomery, RR
   Shaw, AC
   Ko, AI
   Reis, MG
AF Reis, Eliana A. G.
   Hagan, Jose E.
   Ribeiro, Guilherme S.
   Teixeira-Carvalho, Andrea
   Martins-Filho, Olindo A.
   Montgomery, Ruth R.
   Shaw, Albert C.
   Ko, Albert I.
   Reis, Mitermayer G.
TI Cytokine Response Signatures in Disease Progression and Development of
   Severe Clinical Outcomes for Leptospirosis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID URBAN LEPTOSPIROSIS; LUNG INJURY; INTERLEUKIN-10; MARKERS; SEPSIS;
   BRAZIL; IL-10
AB Background: The role of the immune response in influencing leptospirosis clinical outcomes is not yet well understood. We hypothesized that acute-phase serum cytokine responses may play a role in disease progression, risk for death, and severe pulmonary hemorrhage syndrome (SPHS).
   Methodology/Principal Findings: We performed a case-control study design to compare cytokine profiles in patients with mild and severe forms of leptospirosis. Among patients hospitalized with severe disease, we compared those with fatal and nonfatal outcomes. During active outpatient and hospital-based surveillance we prospectively enrolled 172 patients, 23 with mild disease (outpatient) and 149 with severe leptospirosis (hospitalized). Circulating concentrations of pro-and anti-inflammatory cytokines at the time of patient presentation were measured using a multiplex bead array assay. Concentrations of IL-1 beta, IL-2, IL-4, IL-6, IL-8, IL-10, IL-17A, and TNF-alpha were significantly higher (P<0.05) in severe disease compared to mild disease. Among severe patients, levels of IL-6 (P<0.001), IL-8 (P = 0.0049) and IL-10 (P<0.001), were higher in fatal compared to non-fatal cases. High levels of IL-6 and IL-10 were independently associated (P<0.05) with case fatality after adjustment for age and days of symptoms. IL-6 levels were higher (P = 0.0519) among fatal cases who developed SPHS than among who did not.
   Conclusion/Significance: This study shows that severe cases of leptospirosis are differentiated from mild disease by a "cytokine storm" process, and that IL-6 and IL-10 may play an immunopathogenic role in the development of life-threatening outcomes in human leptospirosis.
C1 [Reis, Eliana A. G.; Hagan, Jose E.; Ribeiro, Guilherme S.; Ko, Albert I.; Reis, Mitermayer G.] Fundacao Oswaldo Cruz, Lab Pathol & Mol Biol, Salvador, BA, Brazil.
   [Hagan, Jose E.; Ko, Albert I.; Reis, Mitermayer G.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Teixeira-Carvalho, Andrea; Martins-Filho, Olindo A.] Fundacao Oswaldo Cruz, Rene Rachou Inst, Belo Horizonte, MG, Brazil.
   [Montgomery, Ruth R.; Shaw, Albert C.] Yale Univ, Sch Med, Yale Dept Internal Med, New Haven, CT USA.
RP Hagan, JE (corresponding author), Fundacao Oswaldo Cruz, Lab Pathol & Mol Biol, Salvador, BA, Brazil.
EM miter@bahia.fiocruz.br
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015; Ribeiro,
   Guilherme/B-6624-2008; Hagan, Jose/N-6719-2019
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; Ribeiro, Guilherme/0000-0002-6798-2059;
   Hagan, Jose/0000-0002-1837-6319; Montgomery, Ruth/0000-0002-8661-4454
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U01 A1088752, R25
   TW009338, R01 AI052473, D43 TW00919]; Brazilian National Council for
   Scientific Research (CNPq)National Council for Scientific and
   Technological Development (CNPq) [558714/2008-0]; Program of Nucleus of
   Excellence grant [020/2009]; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R25TW009338, D43TW000919,
   R25TW009338, D43TW000919, R25TW009338, D43TW000919, D43TW000919,
   D43TW000919, R25TW009338, R25TW009338, R25TW009338, R25TW009338,
   D43TW000919, R25TW009338, D43TW000919, R25TW009338, R25TW009338,
   D43TW000919, R25TW009338, R25TW009338, D43TW000919, D43TW000919,
   D43TW000919, R25TW009338] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, U01AI088752,
   U01AI088752, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   U01AI088752, R01AI052473, U01AI088752, U01AI088752, U01AI088752,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE ON AGINGUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) [K24AG042489, K24AG042489, K24AG042489, K24AG042489,
   K24AG042489, K24AG042489, K24AG042489] Funding Source: NIH RePORTER
FX This work was supported by National Institutes of Health (www.nih.gov)
   grant #U01 A1088752, R25 TW009338, R01 AI052473, D43 TW00919, and
   Brazilian National Council for Scientific Research (CNPq) (www.cnpq.br)
   grant #558714/2008-0 and Program of Nucleus of Excellence grant
   #020/2009. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Ahuja N, 2012, AM J PHYSIOL-RENAL, V303, pF864, DOI 10.1152/ajprenal.00025.2012
   BONFIELD TL, 1995, AM J RESP CELL MOL, V13, P257, DOI 10.1165/ajrcmb.13.3.7544594
   Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783
   CASSATELLA MA, 1994, J EXP MED, V179, P1695, DOI 10.1084/jem.179.5.1695
   ESTAVOYER JM, 1991, REV INFECT DIS, V13, P1245
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Instituto Brasileiro de Geografia e Estatistica, 2010, SINT IND SOC AN COND, P232
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kyriakidis I, 2011, CYTOKINE, V54, P117, DOI 10.1016/j.cyto.2011.01.014
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lowanitchapat A, 2010, COMP IMMUNOL MICROB, V33, P423, DOI 10.1016/j.cimid.2009.05.001
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McBride AJA, 2007, CLIN VACCINE IMMUNOL, V14, P1245, DOI 10.1128/CVI.00217-07
   MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165
   Parsons PE, 2005, CRIT CARE MED, V33, P1, DOI 10.1097/01.CCM.0000149854.61192.DC
   Restrepo BN, 2008, AM J TROP MED HYG, V79, P673, DOI 10.4269/ajtmh.2008.79.673
   Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274
   Standiford TJ, 2000, CURR PHARM DESIGN, V6, P633, DOI 10.2174/1381612003400533
   Stowe RP, 2010, J GERONTOL A-BIOL, V65, P429, DOI 10.1093/gerona/glp198
   Tajiki H, 1996, CLIN INFECT DIS, V23, P1177, DOI DOI 10.1093/CLINIDS/23.5.1177
   TAJIKI MH, 1997, BRAZ J INFECT DIS, V1, P138
   Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004
   Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453
   Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042266
   WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558
   Yang CW, 2007, KIDNEY INT, V72, P918, DOI 10.1038/sj.ki.5002393
NR 32
TC 38
Z9 39
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2013
VL 7
IS 9
AR e2457
DI 10.1371/journal.pntd.0002457
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 224WA
UT WOS:000324920800056
PM 24069500
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Peterson, K
   Ribeiro, GD
   dos Reis, MG
   Paploski, IAD
   Ko, A
   Salles-Costa, R
   Perez-Escamilla, R
AF Peterson, Krysta
   Ribeiro, Guilherme de Sousa
   dos Reis, Mitermayer Galvao
   Paploski, Igor A. D.
   Ko, Albert
   Salles-Costa, Rosana
   Perez-Escamilla, Rafael
TI Household Food Insecurity and Obesity Risk in an Urban Slum in Brazil
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Joint Annual Meeting of the ASPET/BPS at Experimental Biology (EB)
CY APR 20-24, 2013
CL Boston, MA
SP ASPET, British Pharmacol Soc (BPS)
C1 [Peterson, Krysta; Ko, Albert; Perez-Escamilla, Rafael] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Ribeiro, Guilherme de Sousa] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [dos Reis, Mitermayer Galvao; Paploski, Igor A. D.] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Salles-Costa, Rosana] Univ Fed Rio de Janeiro, Nutr Inst Josue de Castro, Rio De Janeiro, Brazil.
RI Paploski, Igor AD/D-7015-2014; Ko, Albert Icksang/P-2343-2015; Costa,
   Rosana/K-2016-2014; Ribeiro, Guilherme/B-6624-2008
OI Paploski, Igor AD/0000-0002-3689-2042; Ko, Albert
   Icksang/0000-0001-9023-2339; Ribeiro, Guilherme/0000-0002-6798-2059
NR 0
TC 1
Z9 1
U1 0
U2 5
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2013
VL 27
MA 243.6
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 157GG
UT WOS:000319883500519
DA 2020-11-30
ER

PT J
AU Sacchi, FPC
   Croda, MG
   Estevan, AO
   Ko, AI
   Croda, J
AF Correia Sacchi, Flavia Patussi
   Croda, Mariana Garcia
   Estevan, Anderson Oliveira
   Ko, Albert I.
   Croda, Julio
TI Sugar cane manufacturing is associated with tuberculosis in an
   indigenous population in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Risk factors; Indigenous; TB; Sugar cane; Epidemiology; Case-control
   study
ID ALCOHOLISM
AB Background: Tuberculosis (TB) remains one of the leading causes of morbidity and mortality among indigenous peoples in Brazil, and identifying the risk factors for TB in this population secondary to specific epidemiological conditions is essential for recommending interventions aimed at disease control.
   Methods: This case-control study was conducted with an indigenous population between June 2009 and August 2011 in Dourados, Brazil. Tuberculosis cases reported to the national disease surveillance programme were paired with two control cases matched by age and geographic location.
   Results: There were 63 cases included in this study, and the annual incidence of TB in the indigenous communities examined was 222 (95% CI, 148-321) per 100 000 inhabitants. The multivariate analysis demonstrated that the variables associated with TB infection included male gender (OR 2.6; 95% CI 1.3-5.3), not owning a home (OR 3.4; 95% CI 1.2-10.1), illiteracy (OR 2.4; 95% CI 1.1-5.0), TB contact (OR 2.4; 95% CI 1.2-4.8) and work performed in a sugar cane factory (OR 6.8; 95% CI 1.2-36.9).
   Conclusion: There is a potential relationship between exposure to sugar cane manufacturing processes and tuberculosis infection among indigenous populations.
C1 [Correia Sacchi, Flavia Patussi; Croda, Mariana Garcia] Fed Univ Grande Dourados, Univ Hosp, BR-79804970 Dourados, MS, Brazil.
   [Correia Sacchi, Flavia Patussi; Estevan, Anderson Oliveira; Croda, Julio] Fed Univ Grande Dourados, Fac Hlth Sci, BR-79804970 Dourados, MS, Brazil.
   [Ko, Albert I.] Brazilian Minist Hlth, Goncalo Moniz Inst, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis Div, New Haven, CT USA.
RP Croda, J (corresponding author), Fed Univ Grande Dourados, Fac Hlth Sci, Rodovia Dourados Itaurn Km 12, BR-79804970 Dourados, MS, Brazil.
EM juliocroda@ufgd.edu.br
RI Ko, Albert Icksang/P-2343-2015; Croda, Julio/I-5172-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Croda,
   Julio/0000-0002-6665-6825; Croda, Mariana/0000-0003-1436-9717
FU Foundation for the Support of Teaching, Science, and Technology
   Development of Mato Grosso do Sul (Fundacao de Apoio ao Desenvolvimento
   do Ensino, Ciencia e Tecnologia do Estado do Mato Grosso do Sul)
   [07/2009]; National Council for Scientific and Technological Development
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq)
   [559094/2009-4]
FX This work was supported by the Foundation for the Support of Teaching,
   Science, and Technology Development of Mato Grosso do Sul (Fundacao de
   Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado do
   Mato Grosso do Sul) [07/2009] and by the National Council for Scientific
   and Technological Development (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) [559094/2009-4].
CR Allen AG, 2004, ATMOS ENVIRON, V38, P5025, DOI 10.1016/j.atmosenv.2004.06.019
   Amarante JM, 2000, B PNEUMOL SANIT, V8, P123
   Amre DK, 1999, OCCUP ENVIRON MED, V56, P548, DOI 10.1136/oem.56.8.548
   [Anonymous], 2011, BRAZ EC CLASS CRIT
   Arbex Marcos Abdo, 2004, J. bras. pneumol., V30, P158, DOI 10.1590/S1806-37132004000200015
   Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P959, DOI 10.1590/S1806-37132008001100012
   Basta Paulo Cesar, 2004, Rev. Soc. Bras. Med. Trop., V37, P338, DOI 10.1590/S0037-86822004000400010
   Basta Paulo Cesar, 2006, Cad. Saúde Pública, V22, P245, DOI 10.1590/S0102-311X2006000200002
   Basta RC, 2006, INT J TUBERC LUNG D, V10, P1354
   Buchillet D, 1998, CAD SAUDE PUBLICA, V14, P181, DOI DOI 10.1590/S0102-311X1998000100026
   Croda MG, 2012, T ROY SOC TROP MED H, V106, P223, DOI 10.1016/j.trstmh.2012.01.005
   Dalcolmo Margareth Pretti, 2007, Rev. Saúde Pública, V41, P34, DOI [10.1590/s0034-89102007000800006, 10.1590/S0034-89102007000800006]
   de la Haye B, 2012, INT J TUBERC LUNG D, V16, P886, DOI 10.5588/ijtld.11.0624
   EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905
   Goetsch U, 2012, INFECTION, V40, P389, DOI 10.1007/s15010-011-0238-x
   Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494
   Marques Ana Maria Campos, 2003, Cad. Saúde Pública, V19, P1405, DOI 10.1590/S0102-311X2003000500019
   Martinelli LA, 2008, ECOL APPL, V18, P885, DOI 10.1890/07-1813.1
   MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121
   Menezes AMB, 1998, REV BRAS EPIDEMIOL, V1, P11
   Ministerio da Saude. Secretaria de Vigileincia em Saude. Departamento de Vigiloncia Epidemiologica, 2011, GUID TUB CONTR BRAZ
   Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17
   Pakasi TA, 2009, INT J TUBERC LUNG D, V13, P755
   Ribeiro Helena, 2008, Rev. Saúde Pública, V42, P370, DOI [10.1590/S0034-89102008005000009, 10.1590/s0034-89102008005000009]
   Sanchez A, 2009, INT J TUBERC LUNG D, V13, P1247
   Severo N. P. F., 2005, Revista de Ciencias Farmaceuticas Basica e Aplicada, V26, P83
   SINAN MS, 2011, NAT NOT DIS SURV SYS
   Tocque K, 1999, EUR RESPIR J, V13, P541, DOI 10.1183/09031936.99.13354199
   WHO, 2008, GLOB FUND FIGHT AIDS
   World Health Organization, 2011, GLOB TUB CONTR
NR 30
TC 13
Z9 14
U1 1
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR
PY 2013
VL 107
IS 3
BP 152
EP 157
DI 10.1093/trstmh/trs089
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 102GI
UT WOS:000315832500003
PM 23306443
OA Green Published
DA 2020-11-30
ER

PT J
AU de Araujo, WN
   Finkmoore, B
   Ribeiro, GS
   Reis, RB
   Felzemburgh, RDM
   Hagan, JE
   Reis, MG
   Ko, AI
   Costa, F
AF de Araujo, Wildo Navegantes
   Finkmoore, Brooke
   Ribeiro, Guilherme S.
   Reis, Renato B.
   Felzemburgh, Ridalva D. M.
   Hagan, Jose E.
   Reis, Mitermayer G.
   Ko, Albert I.
   Costa, Federico
TI Knowledge, Attitudes, and Practices Related to Leptospirosis among Urban
   Slum Residents in Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID RISK-FACTORS
AB Leptospirosis disproportionately affects residents of urban slums. To understand the knowledge, attitudes, and practices regarding leptospirosis, we conducted a cross-sectional study among residents of an urban slum community in Salvador, Brazil. Of the 257 residents who were interviewed, 225 (90%) were aware of leptospirosis and more than two-thirds of respondents correctly identified the modes of disease transmission and ways to reduce exposure. However, study participants who performed risk activities such as cleaning open sewers had limited access to protective clothing such as boots (33%) or gloves (35%). Almost all respondents performed at least one activity to prevent household rat infestation, which often included use of an illegal poison. Our findings support the need for interventions targeted at the individual and household levels to reduce risk of leptospirosis until large-scale structural interventions are available to residents of urban slum communities.
C1 Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   Minist Hlth, Secretariat Surveillance Hlth, Field Epidemiol Training Program, Brasilia, DF, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Hagan, Jose E.; Ko, Albert I.] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
RP Costa, F (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM wildo.araujo@saude.gov.br; brooke.finkmoore@gmail.com;
   gsribeiro@ufba.br; rbarbosa@aluno.bahia.fiocruz.br; ridalva@gmail.com;
   jose.hagan@yale.edu; miter@bahia.fiocruz.br; albert.ko@yale.edu;
   fcosta@pqvisitante.bahia.fiocruz.br
RI Costa, Federico/G-1838-2015; Hagan, Jose/N-6719-2019; Araujo, Wildo
   Navegantes/AAD-9163-2020; Ribeiro, Guilherme/B-6624-2008; Ko, Albert
   Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020
OI Costa, Federico/0000-0001-6951-2336; Hagan, Jose/0000-0002-1837-6319;
   Araujo, Wildo Navegantes/0000-0002-6856-4094; Ribeiro,
   Guilherme/0000-0002-6798-2059; Ko, Albert Icksang/0000-0001-9023-2339;
   Reis, Mitermayer/0000-0002-3051-9060
FU Secretariat of Health Surveillance; Oswaldo Cruz Foundation; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U01 AI088752, R01
   AI052473, R25 TW009338, D43 TW00919]; Office of the DirectorNational
   Science Foundation (NSF)NSF - Office of the Director (OD); Fogarty
   International CenterUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC); Office of AIDS ResearchUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA; National Cancer Center; National Eye InstituteUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI); National Heart, Blood, and Lung
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI); National Institute of Dental and Craniofacial
   ResearchUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Dental &
   Craniofacial Research (NIDCR); National Institute On Drug AbuseUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute on Drug Abuse (NIDA); National
   Institute of Mental HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Mental Health (NIMH); National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); National Institutes of Health Office of
   Women's Health and Research through the Fogarty International Clinical
   Research Scholars and Fellows Program at Vanderbilt University [R24
   TW007988]; American Relief and Recovery Act; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R24TW007988, D43TW000919, R25TW009338, D43TW000919, R25TW009338,
   R01TW009504, D43TW000919, D43TW000919, R25TW009338, D43TW000919,
   R25TW009338, D43TW000919, R24TW007988, D43TW000919, R25TW009338,
   R25TW009338, R25TW009338, R24TW007988, R25TW009338, R24TW007988,
   D43TW000919, R25TW009338, R24TW007988, R24TW007988, R01TW009504,
   R01TW009504, R01TW009504, R24TW007988, R25TW009338, R01TW009504,
   R25TW009338, R25TW009338, R24TW007988, D43TW000919, D43TW000919,
   D43TW000919, R25TW009338] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, U01AI088752, R01AI052473, U01AI088752, U01AI088752,
   R01AI052473, U01AI088752, R01AI052473, R01AI052473, U01AI088752,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the Secretariat of Health Surveillance, the
   Oswaldo Cruz Foundation, and the National Institutes of Health (grants
   U01 AI088752, R01 AI052473, R25 TW009338 and D43 TW00919, Office of the
   Director, Fogarty International Center, Office of AIDS Research,
   National Cancer Center, National Eye Institute, National Heart, Blood,
   and Lung Institute, National Institute of Dental and Craniofacial
   Research, National Institute On Drug Abuse, National Institute of Mental
   Health, National Institute of Allergy and Infectious Diseases, and
   National Institutes of Health Office of Women's Health and Research
   through the Fogarty International Clinical Research Scholars and Fellows
   Program at Vanderbilt University [R24 TW007988], and the American Relief
   and Recovery Act).
CR Agampodi SB, 2010, INT J PREVENTIVE MED, V1, P158
   BENNETT RM, 1991, VET REC, V129, P118, DOI 10.1136/vr.129.6.118
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Brazilian Institute of Geography and Statistics, 2010, RES POP TOT URB TOT, P1
   Faine SB, 1993, LEPTOSPIRA LEPTOSPIR, P368
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Kaliyaperumal K., 2004, AECS ILLUMINATION, V4, P7
   Karande Sunil, 2002, Indian Journal of Pediatrics, V69, P855, DOI 10.1007/BF02723705
   Keenan J, 2010, AM J TROP MED HYG, V83, P633, DOI 10.4269/ajtmh.2010.09-0609
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Kyobutungi Catherine, 2008, Popul Health Metr, V6, P1, DOI 10.1186/1478-7954-6-1
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213
   Nwafor-Okoli C, 2010, INT J INFECT DIS, V14, pE390, DOI 10.1016/j.ijid.2010.02.488
   Philipp R, 1992, Br J Sports Med, V26, P223
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Steneroden KK, 2011, ZOONOSES PUBLIC HLTH, V58, P449, DOI 10.1111/j.1863-2378.2011.01389.x
   Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527, DOI 10.1097/00001432-200110000-00005
   Wiwanitkit Viroj, 2006, Rural Remote Health, V6, P526
NR 21
TC 22
Z9 23
U1 0
U2 16
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD FEB
PY 2013
VL 88
IS 2
BP 359
EP 363
DI 10.4269/ajtmh.2012.12-0245
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 082ZG
UT WOS:000314431900026
PM 23269657
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Wu, HM
   Cordeiro, SM
   Harcourt, BH
   Carvalho, MDS
   Azevedo, J
   Oliveira, TQ
   Leite, MC
   Salgado, K
   Reis, MG
   Plikaytis, BD
   Clark, TA
   Mayer, LW
   Ko, AI
   Martin, SW
   Reis, JN
AF Wu, Henry M.
   Cordeiro, Soraia M.
   Harcourt, Brian H.
   Carvalho, Maria da Gloria S.
   Azevedo, Jailton
   Oliveira, Tainara Q.
   Leite, Mariela C.
   Salgado, Katia
   Reis, Mitermayer G.
   Plikaytis, Brian D.
   Clark, Thomas A.
   Mayer, Leonard W.
   Ko, Albert I.
   Martin, Stacey W.
   Reis, Joice N.
TI Accuracy of real-time PCR, Gram stain and culture for Streptococcus
   pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis
   diagnosis
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Bacterial meningitis; Diagnostic test evaluation; Real-time PCR;
   Streptococcus pneumoniae Neisseria meningitidis; Haemophilus influenzae
ID POLYMERASE-CHAIN-REACTION; BACTERIAL-MENINGITIS; MENINGOCOCCAL
   MENINGITIS; CEREBROSPINAL-FLUID; DISEASE; AMPLIFICATION; EPIDEMIOLOGY;
   FEATURES; ADULTS; TESTS
AB Background: Although cerebrospinal fluid (CSF) culture is the diagnostic reference standard for bacterial meningitis, its sensitivity is limited, particularly when antibiotics were previously administered. CSF Gram staining and real-time PCR are theoretically less affected by antibiotics; however, it is difficult to evaluate these tests with an imperfect reference standard.
   Methods and findings: CSF from patients with suspected meningitis from Salvador, Brazil were tested with culture, Gram stain, and real-time PCR using S. pneumoniae, N. meningitidis, and H. influenzae specific primers and probes. An antibiotic detection disk bioassay was used to test for the presence of antibiotic activity in CSF. The diagnostic accuracy of tests were evaluated using multiple methods, including direct evaluation of Gram stain and real-time PCR against CSF culture, evaluation of real-time PCR against a composite reference standard, and latent class analysis modeling to evaluate all three tests simultaneously.
   Results: Among 451 CSF specimens, 80 (17.7%) had culture isolation of one of the three pathogens (40 S. pneumoniae, 36 N. meningitidis, and 4 H. influenzae), and 113 (25.1%) were real-time PCR positive (51 S. pneumoniae, 57 N. meningitidis, and 5 H. influenzae). Compared to culture, real-time PCR sensitivity and specificity were 95.0% and 90.0%, respectively. In a latent class analysis model, the sensitivity and specificity estimates were: culture, 81.3% and 99.7%; Gram stain, 98.2% and 98.7%; and real-time PCR, 95.7% and 94.3%, respectively. Gram stain and real-time PCR sensitivity did not change significantly when there was antibiotic activity in the CSF.
   Conclusion: Real-time PCR and Gram stain were highly accurate in diagnosing meningitis caused by S. pneumoniae, N. meningitidis, and H. influenzae, though there were few cases of H. influenzae. Furthermore, real-time PCR and Gram staining were less affected by antibiotic presence and might be useful when antibiotics were previously administered. Gram staining, which is inexpensive and commonly available, should be encouraged in all clinical settings.
C1 [Wu, Henry M.; Harcourt, Brian H.; Carvalho, Maria da Gloria S.; Plikaytis, Brian D.; Clark, Thomas A.; Mayer, Leonard W.; Martin, Stacey W.] CDC, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Cordeiro, Soraia M.; Azevedo, Jailton; Salgado, Katia; Reis, Mitermayer G.; Ko, Albert I.; Reis, Joice N.] Fundacao Oswaldo Cruz, BR-40296710 Salvador, BA, Brazil.
   [Oliveira, Tainara Q.; Leite, Mariela C.; Reis, Joice N.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA.
RP Wu, HM (corresponding author), 550 Peachtree St NE,MOT 7, Atlanta, GA 30308 USA.
EM hmwu@emory.edu
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020; Reis,
   Joice N/H-9227-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Azevedo, Jailton/0000-0002-0801-8673
CR Andersen J, 1997, J INFECTION, V34, P227, DOI 10.1016/S0163-4453(97)94255-9
   Baughman AL, 2008, CLIN VACCINE IMMUNOL, V15, P106, DOI 10.1128/CVI.00223-07
   BOHR V, 1983, J INFECTION, V7, P193, DOI 10.1016/S0163-4453(83)96980-3
   Bronska E, 2006, CLIN MICROBIOL INFEC, V12, P137, DOI 10.1111/j.1469-0691.2005.01327.x
   Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09
   BRYAN JP, 1990, REV INFECT DIS, V12, P128
   Bryant PA, 2004, J CLIN MICROBIOL, V42, P2919, DOI 10.1128/JCM.42.7.2919-2925.2004
   Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06
   Cordeiro SM, 2007, T ROY SOC TROP MED H, V101, P1147, DOI 10.1016/j.trstmh.2007.06.012
   Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001
   DALTON HP, 1968, AM J CLIN PATHOL, V49, P410
   DeBiasi RL, 1999, ARCH NEUROL-CHICAGO, V56, P1215, DOI 10.1001/archneur.56.10.1215
   GEISELER PJ, 1980, REV INFECT DIS, V2, P725
   Gray SJ, 2006, J MED MICROBIOL, V55, P887, DOI 10.1099/jmm.0.46288-0
   Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17
   KARANDANIS D, 1976, SOUTHERN MED J, V69, P449, DOI 10.1097/00007611-197604000-00021
   Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050
   Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004
   NI HL, 1992, LANCET, V340, P1432, DOI 10.1016/0140-6736(92)92622-M
   Nigrovic LE, 2008, PEDIATRICS, V122, P726, DOI 10.1542/peds.2007-3275
   Richardson DC, 2003, J CLIN MICROBIOL, V41, P3851, DOI 10.1128/JCM.41.8.3851-3853.2003
   Sacchi CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020675
   Saravolatz LD, 2003, CLIN INFECT DIS, V36, P40, DOI 10.1086/345438
   Schuurman T, 2004, J CLIN MICROBIOL, V42, P734, DOI 10.1128/JCM.42.2.734-740.2004
   Tunkel A. R., 2001, BACTERIAL MENINGITIS
   van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845
   Wang X, 2009, 109 ASM GEN M PENNS
   Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004
   Werno AM, 2008, CLIN INFECT DIS, V46, P926, DOI 10.1086/528798
NR 29
TC 57
Z9 60
U1 0
U2 42
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 22
PY 2013
VL 13
AR 26
DI 10.1186/1471-2334-13-26
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA 080IE
UT WOS:000314234200001
PM 23339355
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Nabity, SA
   Ribeiro, GS
   Aquino, CL
   Takahashi, D
   Damiao, AO
   Goncalves, AHO
   Miranda, DB
   Greenwald, R
   Esfandiari, J
   Lyashchenko, KP
   Reis, MG
   Medeiros, MA
   Ko, AI
AF Nabity, Scott A.
   Ribeiro, Guilherme S.
   Aquino, Carolina Lessa
   Takahashi, Daniele
   Damiao, Alcineia Oliveira
   Goncalves, Andre H. O.
   Miranda-Filho, Democrito B.
   Greenwald, Rena
   Esfandiari, Javan
   Lyashchenko, Konstantin P.
   Reis, Mitermayer G.
   Medeiros, Marco A.
   Ko, Albert I.
TI Accuracy of a Dual Path Platform (DPP) Assay for the Rapid Point-of-Care
   Diagnosis of Human Leptospirosis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AGGLUTINATION-TEST; URBAN EPIDEMIC; DIPSTICK ASSAY; PROTEINS; LIGA;
   INTERROGANS; EXPRESSION; INFECTION; TESTS; IGM
AB Background: Diagnosis of leptospirosis by the gold standard serologic assay, the microscopic agglutination test (MAT), requires paired sera and is not widely available. We developed a rapid assay using immunodominant Leptospira immunoglobulin-like (Lig) proteins in a Dual Path Platform (DPP). This study aimed to evaluate the assay's diagnostic performance in the setting of urban transmission.
   Methodology: We determined test sensitivity using 446 acute and convalescent sera from MAT-confirmed case-patients with severe or mild leptospirosis in Brazil. We assessed test specificity using 677 sera from the following groups: healthy residents of a Brazilian slum with endemic transmission, febrile outpatients from the same slum, healthy blood donors, and patients with dengue, hepatitis A, and syphilis. Three operators independently interpreted visual results without knowing specimen status.
   Results: The overall sensitivity for paired sera was 100% and 73% for severe and mild disease, respectively. In the acute phase, the assay achieved a sensitivity of 85% and 64% for severe and mild leptospirosis, respectively. Within seven days of illness onset, the assay achieved a sensitivity of 77% for severe disease and 60% for mild leptospirosis. Sensitivity of the DPP assay was similar to that for IgM-ELISA and increased with both duration of symptoms (chi-square regression P = 0.002) and agglutinating titer (Spearman rho = 0.24, P < 0.001). Specificity was >= 93% for dengue, hepatitis A, syphilis, febrile outpatients, and blood donors, while it was 86% for healthy slum residents. Inter-operator agreement ranged from very good to excellent (kappa: 0.82-0.94) and test-to-test reproducibility was also high (kappa: 0.89).
   Conclusions: The DPP assay performed acceptably well for diagnosis of severe acute clinical leptospirosis and can be easily implemented in hospitals and health posts where leptospirosis is a major public health problem. However, test accuracy may need improvement for mild disease and early stage leptospirosis, particularly in regions with high transmission.
C1 [Nabity, Scott A.] Duke Univ, Sch Med, Durham, NC 27710 USA.
   [Nabity, Scott A.; Ribeiro, Guilherme S.; Takahashi, Daniele; Damiao, Alcineia Oliveira; Goncalves, Andre H. O.; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Aquino, Carolina Lessa; Medeiros, Marco A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Miranda-Filho, Democrito B.] Univ Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Greenwald, Rena; Esfandiari, Javan; Lyashchenko, Konstantin P.] Chembio Diagnost Syst, Medford, NY USA.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Ko, Albert I.] Yale Univ, Sch Med, New Haven, CT USA.
RP Nabity, SA (corresponding author), Duke Univ, Sch Med, Durham, NC 27710 USA.
EM gsribeiro@ufba.br
RI Ribeiro, Guilherme/B-6624-2008; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020
OI Ribeiro, Guilherme/0000-0002-6798-2059; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R44 AI072856, U01
   AI088752, R01 AI052473, D43 TW00919]; NIAID SBIR [R44 A1072856];
   American Relief and Recovery Act; National Council for Scientific and
   Technological Development, Brazilian Ministry of Science and Technology
   (CNPq/MCT)National Council for Scientific and Technological Development
   (CNPq); Department of Science and Technology, Secretariat of Science
   Technology and Strategic Inputs, Brazilian Ministry of Health (DECIT/MS)
   [554788/2006-3]; Oswaldo Cruz Foundation, Brazilian Ministry of Health
   (Bio-Manguinhos and Goncalo Moniz Research Center); NIH Office of the
   DirectorUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; NIH Fogarty International CenterUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC); NIH Office of
   AIDS Research; NIH National Cancer Center; NIH National Eye
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI); NIH
   National Heart, Blood, and Lung InstituteUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI); NIH National Institute of
   Dental & Craniofacial ResearchUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Dental & Craniofacial Research (NIDCR); NIH National Institute On
   Drug AbuseUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Drug Abuse
   (NIDA); NIH National Institute of Mental HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Mental Health (NIMH); NIH National Institute of
   Allergy and Infectious Diseases Health; NIH Office of Women's Health and
   Research through the International Clinical Research Scholars and
   Fellows Program at Vanderbilt University [R24 TW007988]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, R01TW009504, D43TW000919,
   R24TW007988, D43TW000919, D43TW000919, D43TW000919, R24TW007988,
   D43TW000919, R01TW009504, D43TW000919, R24TW007988, D43TW000919,
   D43TW000919, R24TW007988, R24TW007988, R24TW007988, R24TW007988,
   R01TW009504, R01TW009504, R24TW007988, R01TW009504, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, U01AI088752,
   U01AI088752, R44AI072856, U01AI088752, R01AI052473, R01AI052473,
   R44AI072856, R01AI052473, U01AI088752, U01AI088752, U01AI088752,
   R01AI052473, R44AI072856, R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the following grants: (1) National Institutes
   of Health R44 AI072856; (2) NIH U01 AI088752; (3) NIH R01 AI052473; (4)
   NIH D43 TW00919; (5) NIAID SBIR R44 A1072856; and (6) NIH Office of the
   Director, Fogarty International Center, Office of AIDS Research,
   National Cancer Center, National Eye Institute, National Heart, Blood,
   and Lung Institute, National Institute of Dental & Craniofacial
   Research, National Institute On Drug Abuse, National Institute of Mental
   Health, National Institute of Allergy and Infectious Diseases Health,
   and NIH Office of Women's Health and Research through the International
   Clinical Research Scholars and Fellows Program at Vanderbilt University
   (R24 TW007988) and the American Relief and Recovery Act. Additional
   support was provided by the National Council for Scientific and
   Technological Development, Brazilian Ministry of Science and Technology
   (CNPq/MCT); the Department of Science and Technology, Secretariat of
   Science Technology and Strategic Inputs, Brazilian Ministry of Health
   (DECIT/MS) (554788/2006-3); and the Oswaldo Cruz Foundation, Brazilian
   Ministry of Health (Bio-Manguinhos and Goncalo Moniz Research Center
   Letters of Agreement 01/1999, 01/2000, 04/2002, 02/2003, 08/2005,
   03/2006, 03/2007, 03/2008, 03/2009, 03/2010, 03/2011, and 03/2012). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR ABDULKADER Regina C.R.M., 2002, Rev. Inst. Med. trop. S. Paulo, V44, P79, DOI 10.1590/S0036-46652002000200005
   ADLER B, 1978, J MED MICROBIOL, V11, P387, DOI 10.1099/00222615-11-4-387
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   ARIMITSU Y, 1994, B WORLD HEALTH ORGAN, V72, P395
   Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003
   Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010
   Brandao AP, 1998, J CLIN MICROBIOL, V36, P3138
   Brasil Ministerio da Sau de, 2010, IND DAD BAS SAUD BRA
   Castro AR, 2010, J CLIN MICROBIOL, V48, P4615, DOI 10.1128/JCM.00624-10
   CDC, 1995, MMWR-MORBID MORTAL W, V43, P1
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   Choy HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016879
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005
   Dias JP, 2007, REV SOC BRAS MED TRO, V40, P499, DOI 10.1590/S0037-86822007000500002
   Effler PV, 2002, J CLIN MICROBIOL, V40, P1464, DOI 10.1128/JCM.40.4.1464-1469.2002
   Ellis T, 2008, VECTOR-BORNE ZOONOT, V8, P541, DOI 10.1089/vbz.2007.0241
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Figueira CP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-129
   Finsterer Josef, 2005, J Infect, V51, pE67, DOI 10.1016/j.jinf.2004.08.019
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Hull-Jackson C, 2006, J CLIN MICROBIOL, V44, P1853, DOI 10.1128/JCM.44.5.1853-1855.2006
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Limmathurotsakul D, 2012, CLIN INFECT DIS OFFI
   Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2007, MICROBIOL-SGM, V153, P3390, DOI 10.1099/mic.0.2007/007948-0
   McBride AJA, 2007, CLIN VACCINE IMMUNOL, V14, P1245, DOI 10.1128/CVI.00217-07
   McBride AJA, 2007, ACTA TROP, V102, P206, DOI 10.1016/j.actatropica.2007.05.002
   McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012
   MCCLAIN JBL, 1984, ANN INTERN MED, V100, P696, DOI 10.7326/0003-4819-100-5-696
   Ooteman MC, 2006, J MICROBIOL METH, V65, P247, DOI 10.1016/j.mimet.2005.07.015
   Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011
   Paster BJ, 2000, J MOL MICROB BIOTECH, V2, P341
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Smits HL, 2000, TROP MED INT HEALTH, V5, P124, DOI 10.1046/j.1365-3156.2000.00525.x
   Smits HL, 2001, CLIN DIAGN LAB IMMUN, V8, P166, DOI 10.1128/CDLI.8.1.166-169.2001
   TERPSTRA WJ, 1985, J GEN MICROBIOL, V131, P377
   Thaipadunpanit J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016236
   Torrie J.H., 1997, PRINCIPLES PROCEDURE
   WATT G, 1988, LANCET, V1, P433
   Winslow WE, 1997, J CLIN MICROBIOL, V35, P1938, DOI 10.1128/JCM.35.8.1938-1942.1997
   World Health Organization, 2003, HUM LEPT GUID DIAGN
   Yersin C, 1999, TROP MED INT HEALTH, V4, P38, DOI 10.1046/j.1365-3156.1999.00352.x
NR 50
TC 20
Z9 20
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2012
VL 6
IS 11
AR e1878
DI 10.1371/journal.pntd.0001878
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 048CX
UT WOS:000311888900009
PM 23133686
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Angel, MO
   Ristow, P
   Ko, AI
   Di-Lorenzo, C
AF Olivera Angel, Martha
   Ristow, Paula
   Ko, Albert I.
   Di-Lorenzo, Cecilia
TI Serological trail of Brucella infection in an urban slum population in
   Brazil
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE serology; Brucella abortus; Brucella canis; zoonosis; urban slum
ID RISK OCCUPATIONAL GROUPS; CANIS ANTIBODIES; DOGS; SEROPREVALENCE;
   MUNICIPALITY; ABORTUS; STATE
AB Introduction: Brucellosis is a re-emerging zoonosis with new cases reported each year in many Latin American countries, but it is mostly under-recognized. This study presents a serological investigation of infection with Brucella abortus and Brucella canis in a poor urban community in the city of Salvador, Brazil.
   Methodology: Human sera (n = 180) were randomly selected from 3,171 samples taken from healthy individuals during 2003-2004 and tested with C-ELISA for B. abortus and I-ELISA for B. canis.
   Results: Thirteen percent (24/180) of the individuals were positive for B. abortus and 4.6 % (8/174) were positive for B. canis. Among the variables studied only age (older than 45 years) appeared to be a risk factor for the detection of Brucella antibodies.
   Conclusion: These results indicate the presence of Brucella infection in this settlement and highlight the need to understand the epidemiology of infection under these circumstances to establish the necessary measures for surveillance and control.
C1 [Olivera Angel, Martha] Univ Antioquia, Grp Invest Vericel, Fac Ciencias Agr, Medellin, Colombia.
   [Ristow, Paula] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Saude, Salvador, Brazil.
   [Ristow, Paula] Univ Fed Bahia, Inst Biol, Salvador, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Di-Lorenzo, Cecilia] Univ La Plata, Fac Ciencias Vet, Lab Inmunol Vet, Buenos Aires, DF, Argentina.
RP Angel, MO (corresponding author), Univ Antioquia, Grp Invest Vericel, Fac Ciencias Agr, Carrera 75 65-87, Medellin, Colombia.
EM syngamia@gmail.com
RI Ko, Albert Icksang/P-2343-2015; Ristow, Paula/AAP-6522-2020; Ristow,
   Paula/D-1276-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Ristow,
   Paula/0000-0001-8494-361X
FU Oswaldo Cruz Foundation; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [D43 TW00919, R01 AI052473, U01 AI088752]; Universidad de
   Antioquia; Universidad de la PlataNational University of La Plata;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW009504, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, R01TW009504, R01TW009504, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   R01TW009504, R01TW009504, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI088752, R01AI052473, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, R01AI052473,
   U01AI088752, R01AI052473, U01AI088752, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX We are grateful to Dr. Nidia Lucero at INEI-ANLIS and Malbran Institute
   for processing the ELISA samples. We thank Federico Costa for performing
   the risk analysis. This work was supported in part by the Oswaldo Cruz
   Foundation and National Institutes of Health (grants D43 TW00919, R01
   AI052473 and U01 AI088752), Universidad de Antioquia, and Universidad de
   la Plata.
CR Almeida AC, 2004, ARQ BRAS MED VET ZOO, V56, P275, DOI 10.1590/S0102-09352004000200021
   Azevedo SS, 2003, PESQUI VET BRASIL, V23, P156, DOI 10.1590/S0100-736X2003000400003
   Bricker BJ, 2000, J CLIN MICROBIOL, V38, P1258, DOI 10.1128/JCM.38.3.1258-1262.2000
   Cavalcanti L, 2007, REV BRAS SAUDE PROD, V7, P176
   Chanto G, 2007, REV BIOL TROP, V55, P385
   De Massis F, 2005, Clin Microbiol Infect, V11, P632, DOI 10.1111/j.1469-0691.2005.01204.x
   Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4
   HOFF GL, 1975, AM J TROP MED HYG, V24, P157, DOI 10.4269/ajtmh.1975.24.157
   Iowa State University, 2011, CAN BRUC BRUC CAN
   LEWIS GE, 1973, AM J PUBLIC HEALTH, V63, P204, DOI 10.2105/AJPH.63.3.204
   Lucero NE, 2010, EPIDEMIOL INFECT, V138, P280, DOI 10.1017/S0950268809990525
   Lucero NE, 1999, J CLIN MICROBIOL, V37, P3245, DOI 10.1128/JCM.37.10.3245-3248.1999
   Lucero NE, 2008, MANUAL PROCEDIMIENTO
   Makita K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014188
   Mantur B G, 2007, Indian J Med Microbiol, V25, P188
   Mendoza-Nunez M, 2008, AM J TROP MED HYG, V78, P595, DOI 10.4269/ajtmh.2008.78.595
   Ministerio da Saude do Brazil. Organizacao Pan-Americana da Saude/Brazil, 2001, DOENC REL TRAB MAN P
   MONROE PW, 1975, J CLIN MICROBIOL, V2, P382
   Nomura A, 2010, EMERG INFECT DIS, V16, P1183, DOI 10.3201/eid1607.090209
   OIE, 2009, TERR AN HLTH COD BRU
   Olivera M, 2009, COLOMB MEDICA, V40, P218
   Padilla Poester F, 2011, BRUC 2011 INT C RES
   Pappas G, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/j.ijantimicag.2010.06.013
   Poester FP, 2002, VET MICROBIOL, V90, P55, DOI 10.1016/S0378-1135(02)00245-6
   Ramos TRR, 2008, BRAZ J INFECT DIS, V12, P133, DOI 10.1590/S1413-86702008000200007
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Reyes J, 2010, REV COLOMB CIENC PEC, V23, P35
   Swai ES, 2009, ZOONOSES PUBLIC HLTH, V56, P183, DOI 10.1111/j.1863-2378.2008.01175.x
   Tenorio T. G. S., 2008, Arqivos do Instituto Biologico Sao Paulo, V75, P415
NR 29
TC 10
Z9 13
U1 0
U2 2
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD SEP
PY 2012
VL 6
IS 9
BP 675
EP 679
DI 10.3855/jidc.2347
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA 092IP
UT WOS:000315114300006
PM 23000868
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Costa, F
   Martinez-Silveira, MS
   Hagan, JE
   Hartskeerl, RA
   dos Reis, MG
   Ko, AI
AF Costa, Federico
   Martinez-Silveira, Martha Silvia
   Hagan, Jose E.
   Hartskeerl, Rudy A.
   dos Reis, Mitermayer Galvao
   Ko, Albert Icksang
TI Surveillance for leptospirosis in the Americas, 1996-2005: a review of
   data from ministries of health
SO REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC
   HEALTH
LA English
DT Article
DE Leptospirosis; epidemiologic surveillance; disease notification; review;
   Americas
ID DIAGNOSIS; DISEASE; NOV.
AB Objective. To characterize current leptospirosis reporting practices in the Americas.
   Methods. Information was collected from the official websites of national ministries of health from the Americas region and two international organizations; personal communications; and three international morbidity databases. For all sources other than the morbidity databases, the review was limited to official reports citing clinically suspected and laboratory confirmed leptospirosis cases or deaths during the period 1996-2005.
   Results. A total of 73 out of 1 644 reports met the selection criteria and were included in the analysis. Published leptospirosis data were available from half of the countries/sovereign territories (24 out of 48), and 18 of them had mandatory notification policies for leptospirosis. The sum of the median number of leptospirosis cases notified annually by the 24 countries/territories was 4 713.5, but just three countries (Brazil, Costa Rica, and Cuba) accounted for 83.1% (3 920 cases) of the notifications. Eight (16.7%) countries reported deaths due to leptospirosis. The sum of the median number of deaths reported annually for the eight countries was 380, but 349 (91.8%) were reported by Brazil.
   Conclusions. Notification practices in the Americas for leptospirosis are limited. Therefore, the numbers of cases and deaths reported are not representative for the region. The lack of leptospirosis data for many countries/territories may reflect weaknesses in certain aspects of national surveillance systems, including mandatory reporting policies, clinical laboratory infrastructure for performing case confirmation, and capacity to collect reported cases. Improved surveillance of leptospirosis cases and deaths in the Americas is needed to allow monitoring of regional epidemiological patterns and to estimate the burden of this important disease.
C1 [Costa, Federico; Martinez-Silveira, Martha Silvia; dos Reis, Mitermayer Galvao] Fundacao Oswaldo Cruz Fiocruz, Minist Saude, Ctr Pesquisas Goncalo Moniz CPqGM, LPBM, Salvador, BA, Brazil.
   [Hagan, Jose E.; Ko, Albert Icksang] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, LEPH, New Haven, CT USA.
   [Hartskeerl, Rudy A.] WHO FAO OIE, Amsterdam, Netherlands.
   [Hartskeerl, Rudy A.] Royal Trop Inst KIT, Dept Biomed Res, Natl Collaborating Ctr Reference & Res Leptospiro, Amsterdam, Netherlands.
RP Costa, F (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Minist Saude, Ctr Pesquisas Goncalo Moniz CPqGM, LPBM, Salvador, BA, Brazil.
EM fcosta2001@gmail.com
RI Hagan, Jose/N-6719-2019; Costa, Federico/G-1838-2015; Martinez-Silveira,
   Martha Silvia/O-7270-2014; Ko, Albert Icksang/P-2343-2015
OI Hagan, Jose/0000-0002-1837-6319; Costa, Federico/0000-0001-6951-2336;
   Martinez-Silveira, Martha Silvia/0000-0002-1004-1784; Ko, Albert
   Icksang/0000-0001-9023-2339
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R24 TW007988, D43 TW000919, R01 TW009504, D43 TW00919] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI052473, U01 AI088752]
   Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [D43TW000919, D43TW000919,
   R24TW007988, R01TW009504, R24TW007988, D43TW000919, D43TW000919,
   R01TW009504, D43TW000919, D43TW000919, D43TW000919, R01TW009504,
   R24TW007988, R24TW007988, R24TW007988, D43TW000919, R24TW007988,
   D43TW000919, R24TW007988, R01TW009504, D43TW000919, R24TW007988,
   D43TW000919, R01TW009504] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, U01AI088752, U01AI088752, U01AI088752,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, U01AI088752,
   U01AI088752, U01AI088752] Funding Source: NIH RePORTER
CR 47. Secretaria de Salud Direccion General de Epidemiologa (MX), 2004, VIGIL EPIDEMIOL MEXI
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839
   Caribbean Epidemiology Centre, 2006, CAREC SURVEILL REP, V26, P8
   Caribbean Epidemiology Centre, 2006, CAREC SURVEILL REP, V26, P1
   Cumberland P, 1999, AM J TROP MED HYG, V61, P731, DOI 10.4269/ajtmh.1999.61.731
   Direccion Nacional de Estadcstica (CU), 2006, EST SAL SER TIEMP MO
   Dupont H, 1997, CLIN INFECT DIS, V25, P720, DOI 10.1086/513767
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300
   Institut Pasteur (FR), 2002, RAPP ACT CTR REF LEP
   Institut Pasteur (FR), 1996, CONTR SURV LEPT FRAN
   Institut Pasteur (FR), 2005, CONTR SURV LEPT FRAN
   Institut Pasteur (FR), 2000, CONTR SURV LEPT FRAN
   Institut Pasteur (FR), 2001, RAPP ACT CTR REF LEP
   Institut Pasteur (FR), 1997, CONTR SURV LEPT FRAN
   Institut Pasteur (FR), 2004, CONTR SURV LEPT FRAN
   Institut Pasteur (FR), 1998, CONTR SURV LEPT FRAN
   Institut Pasteur (FR), 1999, CONTR SURV LEPT FRAN
   Institut Pasteur (FR), 2003, CONTR SURV LEPT FRAN
   International Leptospirosis Society, 2002, ILS WORLDW SURV 1998
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002
   Levett PN, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000120
   Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lhomme V, 1996, MED MALADIES INFECT, V26, P94, DOI 10.1016/S0399-077X(96)80161-2
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McBride AJA, 2007, CLIN VACCINE IMMUNOL, V14, P1245, DOI 10.1128/CVI.00217-07
   *MIN CHILDR FAM DE, 2003, BRIT COL ANN REP EAR, P7
   Ministerio da Saude (BR), 2006, SER HIST CAS OB DOEN
   Ministerio de Salud (CR), 2006, MEM AN 2005 4 AN GES, P75
   Ministerio de Salud Departamento de Epidemiologia (CL), 2006, B ELECT MENSUAL VIGI
   Ministerio de Salud Departamento de Epidemiologia (CL), 2003, B ELECT MENSUAL VIGI
   Ministerio de Salud Departamento de Vigilancia de Factores Protectores y de Riesgo a la Salud y Enfermedades (PA), 2001, B EPIDEMIOL PANAMA, V25, P1
   Ministerio de Salud Departamento de Vigilancia de Factores Protectores y de Riesgo a la Salud y Enfermedades (PA), 2002, B EPIDEMIOL PANAMA
   Ministerio de Salud Departamento de Vigilancia de Factores Protectores y de Riesgo a la Salud y Enfermedades (PA), 2000, B EPIDEMIOL PANAMA, V24, P1
   Ministerio de Salud Direccion de Epidemiologia y Analisis Estrategico Direccion de Vigilancia Epidemiologica (VE), 2005, B EPIDEMIOL SEM VENE, V54, P1
   Ministerio de Salud Direccion de Epidemiologia y Analisis Estrategico Direccion de Vigilancia Epidemiologica (VE), 2006, B EPIDEMIOL SEM VENE, V55, P1
   Ministerio de Salud Direccion Vigilancia de la Salud Unidad de Informacion Estadistica (CR), 2006, MAN VIG CONTR LEISHM, P1
   Ministerio de Salud (NI), 2003, B EPIDEMIOL NICARAGU, P1
   Ministerio de Salud (NI), 2005, B EPIDEMIOL NICARAGU, P1
   Ministerio de Salud (NI), 2006, B EPIDEMIOL NICARAGU, P1
   Ministerio de Salud (NI), 2004, B EPIDEMIOL NICARAGU, P1
   Ministerio de Salud Oficina General de Epidemiologia (PE), 2005, B EPIDEMIOL PERU, V14, P1
   Ministerio de Salud Publica Departamento de Epidemiologia Vigilancia en Salud Publica (UY), 2006, ENF NOT OBL CAS NOT, V52
   Ministerio de Salud Publica Direccion General del Sistema Integral de Atencion en Salud (GT), 2004, B EPIDEMIOL GUATEMAL, V7, P1
   Ministerio de Salud Publica (EC), 2005, FORM EP 2 ENF EV NOT
   Ministerio de Salud Publica (EC), 2007, VIGILANCIA EPIDEMIOL
   Ministerio de Salud Publica (GT), 2006, SEMANA EPIDEMIOL GUA, V8, P1
   Ministerio de Salud Publica (GT), 2005, SEMANA EPIDEMIOL GUA, V7, P1
   Ministerio de Salud Sistema Nacional de Vigilancia de la Salud (CR), 2003, B EPIDEMIOL COSTA RI, V3, P1
   Ministerio de Salud Sistema Nacional de Vigilancia en Salud Publica Oficina de Epidemiologia (CO), 2000, SEMANA EPIDEMIOL COL, P1
   Ministerio de Salud y de Ambiente de la Nacion (AR), 2004, B EPIDEMIOL PERIOD A, V2, P13
   Ministerio de Salud y de Ambiente de la Nacion (AR), 2005, B EPIDEMIOL PERIOD A, V4, P13
   Ministerio de Salud y de Ambiente de la Nacion Direccion de Epidemiologia Centro de Informacion (AR), 2007, COMMUNICATION
   Ministerio de Salud y Deportes (BO), 2001, B SEM VIGIL BOLIVIA
   Ministry of Health Government Statistics Department (LC), 2004, REP CAS COMM NOT DIS
   Ministry of Health Wellness & the Environment Medical & Health Care Health Promotion (VC), 2007, LEPT ST VINC GREN IN
   Ochoa J E, 2000, Rev Panam Salud Publica, V7, P325
   Organizacion Panamericana de la Salud, 2003, REUN RED VIG ENF EM
   Organizacion Panamericana de la Salud, 2002, REUN CONJ RED VIG EN
   Organizacion Panamericana de la Salud, 2003, B EPIDEMIOL, V24, P6
   Organizacion Panamericana de la Salud; Ministerio de Salud Direccion de Vigilancia Epidemiologica (VE), 1999, VIG CONTR ENF GRAF M
   Pan American Health Organization, 1998, HLTH AM SUR, P470
   Pan American Health Organization. Regional Core Health Data System, 2001, COUNTR HLTH PROF BAR
   Pan American Health Organization. Regional Core Health Data System, 2001, COUNTR HLTH PROF DOM
   Pan American Health Organization. Regional Core Health Data System, 2002, COUNTR HLTH PROF GUA
   Pan American Health Organization. Regional Core Health Data System, 2002, REG COR HLTH DAT SYS
   Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011
   Pila Perez R, 1996, MAPFRE MED, V7, P60
   Ribeiro AF, 2006, B EPIDEMIOL PAUL, V3, P2
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Secretaria de Estado de Salud Publica y Asistencia Social Direccion de Epidemiologa (DO), 2002, AN SIT SAL IND BAS 2
   Secretaria de Estado de Salud Publica y Asistencia Social Direccion General de Epide-miologa (DO), 2003, AN SIT SAL REP DOM 2
   Secretaria de Estado de Salud Publica y Asistencia Social Direccion General de Epidemiologa (DO), 2003, AN SIT SAL IND BAS 2
   Secretaria de Salud Direccion General de Epidemioloa (MX), 2002, VIGIL EPIDEMIOL MEXI
   Secretaria de Salud Direccion General de Epidemiologa (MX), 2003, VIGIL EPIDEMIOL MEXI
   Secretaria de Salud Direccion General de Epidemiologa (MX), 2005, VIGIL EPIDEMIOL MEXI
   . Secretaria de Salud Direccion General de Epidemiologa (MX), 2006, VIGIL EPIDEMIOL MEXI
   Secretaria de Salud Direccion General de Epidemiologa (MX), 2001, VIGIL EPIDEMIOL MEXI
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   Senado y Camara de Diputados de la Nacion Argentina, 1960, B OFICIAL ARGENTINA, V68, P2
   WHO, 2010, ZOON VET PUBL HLTH
   World Health Organization, 2008, WHO KIT LEPTONET DAT
   *WORLD ORG AN HLTH, 2004, HAND, V2
NR 88
TC 19
Z9 26
U1 0
U2 7
PU PAN AMER HEALTH ORGANIZATION
PI WASHINGTON
PA 525 23RD ST NW, WASHINGTON, DC 20037 USA
SN 1020-4989
J9 REV PANAM SALUD PUBL
JI Rev. Panam. Salud Publica
PD SEP
PY 2012
VL 32
IS 3
BP 169
EP 177
DI 10.1590/S1020-49892012000900001
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 045HY
UT WOS:000311687300001
PM 23183556
OA Bronze, Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Ribeiro, GS
   Tartof, SY
   Oliveira, DWS
   Guedes, ACS
   Reis, MG
   Riley, LW
   Ko, AI
AF Ribeiro, Guilherme S.
   Tartof, Sara Y.
   Oliveira, Dalton W. S.
   Guedes, Aldalice C. S.
   Reis, Mitermayer G.
   Riley, Lee W.
   Ko, Albert I.
TI Surgery for Valvular Heart Disease: A Population-Based Study in a
   Brazilian Urban Center
SO PLOS ONE
LA English
DT Article
ID VALVE-REPLACEMENT; MITRAL-VALVE; EPIDEMIOLOGY; PREDICTION; MORTALITY
AB Background: In middle income countries, the burden of rheumatic heart disease (RHD) remains high, but the prevalence of other heart valve diseases may rise as the population life expectancy increases. Here, we compared population-based data on surgical procedures to assess the relative importance of causes of heart valve disease in Salvador, Brazil.
   Methodology/Principal Findings: Medical charts of patients who underwent surgery for valvular heart disease from January 2002-December 2005 were reviewed. Incidence of surgery for valvular heart disease was calculated. Logistic regression was used to identify factors associated with in-hospital death following surgery. The most common etiologies for valvular dysfunction in 491 valvular heart surgery patients were RHD (60.3%), degenerative valve disease (15.3%), and endocarditis (4.5%). Mean annual incidence for surgeries due to any valvular heart diseases, RHD, and degenerative valvular disease were 5.02, 3.03, and 0.77 per 100,000 population, respectively. Incidence of surgery due to RHD was highest in young adults; procedures were predominantly paid by the public health sector. In contrast, the incidence of surgery due to degenerative valvular disease was highest among those older than 60 years of age; procedures were mostly paid by the private sector. The overall in-hospital case-fatality ratio was 11.9%. Independent factors associated with death included increase in age (odds ratio: 1.04 per year of age; 95% confidence interval: 1.02-1.06), endocarditis (6.35; 1.92-21.04), multiple valve operative procedures (4.35; 2.12-8.95), and prior heart valve surgery (2.49; 1.05-5.87).
   Conclusions/Significance: RHD remains the main cause for valvular heart surgery in Salvador, which primarily affects young adults without private health insurance. In contrast, surgery due to degenerative valvular disease primarily impacts the elderly with private health insurance. Strategies to reduce the burden of valvular heart disease will need to address the disparate factors that contribute to RHD as well as degenerative valve disease.
C1 [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.; Oliveira, Dalton W. S.; Guedes, Aldalice C. S.; Reis, Mitermayer G.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Tartof, Sara Y.; Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis Div, New Haven, CT USA.
RP Ribeiro, GS (corresponding author), Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
EM gsribeiro@ufba.br
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015; Ribeiro,
   Guilherme/B-6624-2008
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; Ribeiro, Guilherme/0000-0002-6798-2059
FU Brazilian National Council for Scientific and Technological Development,
   Training and Research in Global Infectious Disease, Fogarty
   International Center, National Institutes of Health [TW006563]; Centers
   for Disease Control and Prevention Grants for Public Health Research
   Dissertation [R36]; FOGARTY INTERNATIONAL CENTERUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW009504, D43TW006563,
   D43TW006563, D43TW006563, D43TW006563, D43TW006563, R01TW009504,
   R01TW009504, R01TW009504, D43TW006563, D43TW006563, D43TW006563,
   R01TW009504, D43TW006563, D43TW006563] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
FX This study was supported by Brazilian National Council for Scientific
   and Technological Development, Training and Research in Global
   Infectious Disease, Fogarty International Center, National Institutes of
   Health (TW006563), and Centers for Disease Control and Prevention Grants
   for Public Health Research Dissertation (R36). The funding sources had
   no involvement in study design, data collection, analysis,
   interpretation, report writing, or publication. The authors had full
   access to all data and accept full responsibility for the content of
   this report.
CR Boudoulas H, 1994, J Heart Valve Dis, V3, P516
   C. de Populacao e Indicadores Sociais, 2008, PROJ POP BRAS SEX ID
   Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X
   Datasus Departamento de Informatica do SUS Secretaria Executiva Ministerio da Saude, 2012, POP RES AN 2 FAIX ET, P2002
   Edwards FH, 2001, J AM COLL CARDIOL, V37, P885, DOI 10.1016/S0735-1097(00)01202-X
   Enriquez-Sarano M, 2009, LANCET, V373, P1382, DOI 10.1016/S0140-6736(09)60692-9
   Enriquez-Sarano R, 1999, J AM COLL CARDIOL, V34, P1129, DOI 10.1016/S0735-1097(99)00314-9
   Iung B, 2011, NAT REV CARDIOL, V8, P162, DOI 10.1038/nrcardio.2010.202
   Jamieson WRE, 1999, ANN THORAC SURG, V67, P943, DOI 10.1016/S0003-4975(99)00175-7
   Kleinert S, 2011, LANCET, V377, P1721, DOI 10.1016/S0140-6736(11)60433-9
   Lisboa LAF, 2010, ARQ BRAS CARDIOL, V94, P174, DOI 10.1590/S0066-782X2010000200006
   Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085
   Monin JL, 2005, J AM COLL CARDIOL, V46, P302, DOI 10.1016/j.jacc.2005.03.064
   Nkomo Vuyisile T, 2006, Lancet, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8
   Nowicki ER, 2004, ANN THORAC SURG, V77, P1966, DOI 10.1016/j.athoracsur.2003.12.035
   OLSON LJ, 1987, MAYO CLIN PROC, V62, P22, DOI 10.1016/S0025-6196(12)61522-5
   Ray S, 2010, CLIN MED, V10, P168
   Rose AG, 1996, CURR OPIN CARDIOL, V11, P98, DOI 10.1097/00001573-199603000-00002
   Soler-Soler J, 2000, HEART, V83, P721, DOI 10.1136/heart.83.6.721
   WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease, 2001, RHEUM FEV RHEUM HEAR
NR 20
TC 17
Z9 22
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2012
VL 7
IS 5
AR e37855
DI 10.1371/journal.pone.0037855
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 959WT
UT WOS:000305349600034
PM 22666401
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Weldon, D
   Ko, A
   Williams, Y
   Wells, E
   White, L
   Hsu, M
   Johnston, G
AF Weldon, D.
   Ko, A.
   Williams, Y.
   Wells, E.
   White, L.
   Hsu, M.
   Johnston, G.
TI Monitoring Alterations in RNA Levels of Living Cells Using a Novel RNA
   Detection Technology.
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
C1 [Weldon, D.; Ko, A.; Williams, Y.; Wells, E.; White, L.; Hsu, M.; Johnston, G.] EMD Millipore, Temecula, CA USA.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PY 2012
VL 23
MA 1733
PG 2
WC Cell Biology
SC Cell Biology
GA V38MX
UT WOS:000209348605101
DA 2020-11-30
ER

PT J
AU Gouveia, EL
   Reis, JN
   Flannery, B
   Cordeiro, SM
   Lima, JBT
   Pinheiro, RM
   Salgado, K
   Mascarenhas, AV
   Carvalho, MG
   Beall, BW
   Reis, MG
   Ko, AI
AF Gouveia, Edilane L.
   Reis, Joice N.
   Flannery, Brendan
   Cordeiro, Soraia M.
   Lima, Josilene B. T.
   Pinheiro, Ricardo M.
   Salgado, Katia
   Mascarenhas, Ana Veronica
   Carvalho, M. Gloria
   Beall, Bernard W.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Clinical outcome of pneumococcal meningitis during the emergence of
   pencillin-resistant Streptococcus pneumoniae: an observational study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
ID ACUTE BACTERIAL-MENINGITIS; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL
   SUSCEPTIBILITY; PENICILLIN SUSCEPTIBILITY; CHILDREN; BRAZIL;
   CHLORAMPHENICOL; DEXAMETHASONE; SURVEILLANCE; INFECTIONS
AB Background: Prior to the availability of generic third-generation cephalosporins, penicillins were widely used for treatment of pneumococcal meningitis in developing countries despite concerns about rising levels of penicillin resistance among pneumococcal isolates. We examined the impact of penicillin resistance on outcomes of pneumococcal meningitis over a ten year period in an infectious diseases hospital in Brazil.
   Methods: Clinical presentation, antimicrobial therapy and outcomes were reviewed for 548 patients with culture-confirmed pneumococcal meningitis from December, 1995, to November, 2005. Pneumococcal isolates from meningitis patients were defined as penicillin-resistant if Minimum Inhibitory Concentrations for penicillin were greater than 0.06 mu g/ml. Proportional hazards regression was used to identify risk factors for fatal outcomes.
   Results: During the ten-year period, ceftriaxone replaced ampicillin as first-line therapy for suspected bacterial meningitis. In hospital case-fatality for pneumococcal meningitis was 37%. Of 548 pneumococcal isolates from meningitis cases, 92 (17%) were resistant to penicillin. After controlling for age and severity of disease at admission, penicillin resistance was associated with higher case-fatality (Hazard Ratio [HR], 1.62; 95% Confidence Interval [CI], 1.08-2.43). Penicillin-resistance remained associated with higher case-fatality when initial therapy included ceftriaxone (HR, 1.68; 95% CI 1.02-2.76).
   Conclusions: Findings support the use of third generation cephalosporin antibiotics for treatment of suspected pneumococcal meningitis even at low prevalence of pneumococcal resistance to penicillins.
C1 [Gouveia, Edilane L.; Reis, Joice N.; Cordeiro, Soraia M.; Lima, Josilene B. T.; Pinheiro, Ricardo M.; Reis, Mitermayer G.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Reis, Joice N.] Univ Fed Bahia, Sch Pharm, Salvador, BA, Brazil.
   [Flannery, Brendan] Pan Amer Hlth Org, Brasilia, DF, Brazil.
   [Salgado, Katia; Mascarenhas, Ana Veronica] Secretary Hlth State Bahia, Hosp Couto Maia, Salvador, BA, Brazil.
   [Carvalho, M. Gloria; Beall, Bernard W.] Ctr Dis Control & Prevent, Streptococcus Lab, Atlanta, GA USA.
   [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.
RP Ko, AI (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
EM albert.ko@yale.edu
RI Reis, Mitermayer/AAO-9742-2020; Reis, Joice N/H-9227-2013; Ko, Albert
   Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339
FU Oswaldo Cruz Foundation/Brazilian Ministry of Health [0250.250.415];
   Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq) [300.861/96-6, 521.132/98-3,
   521.636/96-5, 350.052/95-6, FINEP 4196086200]; Research Support
   Foundation for the State of Bahia (FAPESB) [1431040054051]; National
   Institute of Health, USAUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI-30639, TW-00919,
   TW-00018, TW-00905, TW -007303]; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [R01TW007303,
   D43TW000919, D43TW000919, D43TW000919, R01TW007303, D43TW000919,
   R01TW007303, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, R01TW007303, R01TW007303, D43TW000919, D43TW000919] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639] Funding Source: NIH RePORTER
FX This work was supported by grants from the Oswaldo Cruz
   Foundation/Brazilian Ministry of Health (0250.250.415), the Brazilian
   National Research Council (300.861/96-6, 521.132/98-3, 521.636/96-5,
   350.052/95-6 and FINEP 4196086200), Research Support Foundation for the
   State of Bahia (FAPESB - 1431040054051) and National Institute of
   Health, USA (AI-30639, TW-00919, TW-00018, TW-00905, TW -007303).
CR American Academy of Pediatrics Committee on Infectious Diseases, 1997, PEDIATRICS, V99, P289
   Andes D, 1998, ANTIMICROB AGENTS CH, V42, P2375, DOI 10.1128/AAC.42.9.2375
   Arditi M, 1998, PEDIATRICS, V102, P1087, DOI 10.1542/peds.102.5.1087
   Begg N, 1999, J INFECTION, V39, P1, DOI 10.1016/S0163-4453(99)90095-6
   Brandileone MCC, 2006, J MED MICROBIOL, V55, P567, DOI 10.1099/jmm.0.46387-0
   Brandileone MCC, 2005, J ANTIMICROB CHEMOTH, V56, P437, DOI 10.1093/jac/dki196
   Brouwer MC, 2010, LANCET INFECT DIS, V10, P262, DOI 10.1016/S1473-3099(10)70045-1
   Buckingham SC, 2001, PEDIATR INFECT DIS J, V20, P837, DOI 10.1097/00006454-200109000-00003
   Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6
   Castaneda Elizabeth, 2009, Pediatr Infect Dis J, V28, pe265, DOI 10.1097/INF.0b013e3181a74b22
   Castanheira M, 2003, MICROB DRUG RESIST, V9, P345, DOI 10.1089/107662903322762770
   Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI
   Duke T, 2003, ARCH DIS CHILD, V88, P536, DOI 10.1136/adc.88.6.536
   Fiore AE, 2000, CLIN INFECT DIS, V30, P71, DOI 10.1086/313606
   FRIEDLAND IR, 1992, LANCET, V339, P405, DOI 10.1016/0140-6736(92)90087-J
   FRIEDLAND IR, 1993, LANCET, V342, P240, DOI 10.1016/0140-6736(93)92331-M
   Hortal M, 2001, MICROB DRUG RESIST, V7, P391, DOI 10.1089/10766290152773400
   Agudelo CI, 2009, REV PANAM SALUD PUBL, V25, P305, DOI 10.1590/S1020-49892009000400004
   JORGENSEN JH, 1994, J CLIN MICROBIOL, V32, P159, DOI 10.1128/JCM.32.1.159-163.1994
   Kaplan SL, 1998, CLIN MICROBIOL REV, V11, P628, DOI 10.1128/CMR.11.4.628
   KLUGMAN KP, 1992, LANCET, V340, P437, DOI 10.1016/0140-6736(92)91527-F
   Ko AI, 2000, CLIN INFECT DIS, V30, P78, DOI 10.1086/313619
   LEBEL MH, 1989, PEDIATRICS, V83, P161
   McCracken GH, 2002, LANCET, V360, P183, DOI 10.1016/S0140-6736(02)09499-0
   Molyneux E, 2006, ANN TROP PAEDIATR, V26, P29, DOI 10.1179/146532806X90583
   Mwangi I, 2002, PEDIATR INFECT DIS J, V21, P1042, DOI 10.1097/00006454-200211000-00013
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Peltola H, 2007, CLIN INFECT DIS, V45, P1277, DOI 10.1086/522534
   RADETSKY M, 1992, PEDIATR INFECT DIS J, V11, P694, DOI 10.1097/00006454-199209000-00002
   Reis JN, 2002, J CLIN MICROBIOL, V40, P275, DOI 10.1128/JCM.40.1.275-277.2002
   Secretariat for Health Surveillance, 2004, MEN, V7, P2004
   Sinner SW, 2004, INFECT DIS CLIN N AM, V18, P581, DOI 10.1016/j.idc.2004.04.005
   Weinstein MP, 2009, CLIN INFECT DIS, V48, P1596, DOI 10.1086/598975
   WHO, 2007, WHOCDSEPR20073
   World Health Organization, 1997, M 18 20 JUN 1997 GEN
   Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534
NR 36
TC 20
Z9 21
U1 0
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 21
PY 2011
VL 11
AR 323
DI 10.1186/1471-2334-11-323
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA 889HF
UT WOS:000300063600001
PM 22103652
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Carmona-Gasca, CA
   Lara, LL
   Castillo-Sanchez, LO
   Ramirez-Ortega, JM
   Ko, A
   Palomera, CL
   de la Pena-Moctezuma, A
AF Alfredo Carmona-Gasca, Carlos
   Leon Lara, Lemuel
   Olivia Castillo-Sanchez, Luz
   Manuel Ramirez-Ortega, Jose
   Ko, Albert
   Luna Palomera, Carlos
   de la Pena-Moctezuma, Alejandro
TI Detection of Leptospira santarosai and L. kirschneri in cattle: new
   isolates with potential impact in bovine production and public health
SO VETERINARIA MEXICO
LA English
DT Article
DE LEPTOSPIRA; TARASSOVI; MINI; GRIPPOTYPHOSA; CATTLE; ISOLATION; MLST
ID SEROVAR HARDJO; HARDJOPRAJITNO; EPIDEMIOLOGY; STRAIN; SEJROE; PCR
AB Bovine leptospirosis causes high economic losses in cattle mainly due to reproductive failure, as well as representing public health risk. Since the last century, antibody titers against several Leptospira serovars have been detected by the microscopic agglutination test (MAT) in Mexico. With the exception of very few cases, the presence of serovars causing leptospirosis in cattle and other animal species has not been demonstrated by isolation in Mexico, and in such cases characterization had to be done abroad by complex and slow immunological approaches, by comparison with a number of reference strains. The present study was conducted to perform the molecular characterization of Leptospira isolates by multiple locus sequencing typing (MLST). A hundred and ninety seven sera and kidneys samples were collected immediately after slaughter, from grazing cattle coming from the south-eastern states of Mexico. Anti-Leptospira antibodies were detected by the MAT and kidneys were inoculated into EMJH and Fletcher's specific medium. A seropositivity of 60.4% (119 out of 197), with titers from 1:100 up to 1:3 200 was detected. Four isolates (2.03%), referred as CAL4, CAL6, CAL7 and MOCA45, were characterized by serology, ribotyping and MLST as L. kirschneri serovar Grippotyphosa; L. interrogans serovar Hardjo; L. santarosai serovar Mini and L. santarosai serovar Tarassovi, respectively. With the exception of serovar Hardjo, the three other isolates belong to serovars and species not previously isolated in Mexico. These findings make it necessary to evaluate the potential distribution of such serovars among cattle and their role on animal production and public health.
C1 [Alfredo Carmona-Gasca, Carlos; Olivia Castillo-Sanchez, Luz; Manuel Ramirez-Ortega, Jose; de la Pena-Moctezuma, Alejandro] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Ctr Ensenanza Invest & Extens Prod Anim Altiplano, Grp Invest Leptospira & Leptospirosis, Mexico City 04510, DF, Mexico.
   [Leon Lara, Lemuel] Univ Autonoma Estado Mexico, Fac Med Vet & Zootecnia, Ctr Invest & Estudios Avanzados Salud Anim, Mexico City, DF, Mexico.
   [Ko, Albert] Weill Cornell Med Coll, BR-40295001 Salvador, BA, Brazil.
   [Ko, Albert] Brazilian Minist Hlth, Oswaldo Cruz Fdn, BR-40295001 Salvador, BA, Brazil.
   [Luna Palomera, Carlos] Univ Juarez Autonoma Tabasco, Fac Med Vet & Zootecnia, Villahermosa, Tabasco, Mexico.
RP de la Pena-Moctezuma, A (corresponding author), Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Ctr Ensenanza Invest & Extens Prod Anim Altiplano, Grp Invest Leptospira & Leptospirosis, Mexico City 04510, DF, Mexico.
EM delapema@unam.mx
RI Ko, Albert Icksang/P-2343-2015; Luna-Palomera, Carlos/O-1948-2017
OI Ko, Albert Icksang/0000-0001-9023-2339; Luna-Palomera,
   Carlos/0000-0002-0465-8622
FU Universidad Nacional Autonoma de Mexico MACROPROYECTO; Carlos Alfredo
   Carmona Gasca [165530]; Consejo Nacional de Ciencia y Tecnologia
   (CONACyT)Consejo Nacional de Ciencia y Tecnologia (CONACyT); 
   [UNAM/PAPIIT IN222806];  [IN221409];  [SEP-Conacyt 83123]
FX This work was partially sponsored by the grants: UNAM/PAPIIT IN222806
   and IN221409; SEP-Conacyt 83123 and the Universidad Nacional Autonoma de
   Mexico MACROPROYECTO No. 7. The scholarship No. 165530 for postgraduate
   studies of Carlos Alfredo Carmona Gasca awarded by the Consejo Nacional
   de Ciencia y Tecnologia (CONACyT) is greatly appreciated.
CR Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Ahmed N., 2006, ANN CLIN MICROB ANTI, V23, P5
   Alonso-Andicoberry C., 2001, Investigacion Agraria Produccion y Sanidad Animales, V16, P205
   Alt DP, 2001, J AM VET MED ASSOC, V219, P636, DOI 10.2460/javma.2001.219.636
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   Amatredjo A., 1975, Veterinary Bulletin, V43, P875
   Ayanegui-Alcerreca MA, 2007, NEW ZEAL VET J, V55, P102, DOI 10.1080/00480169.2007.36750
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   BRYAN NS, 1955, MICH STATE U VET, V16, P27
   CHAVEZ TR, 2006, THESIS U NACL AUTONO
   de la Pena-Moctezuma A, 1999, FEMS MICROBIOL LETT, V177, P319, DOI 10.1111/j.1574-6968.1999.tb13749.x
   ELLIS WA, 1994, VET CLIN N AM-FOOD A, V10, P463, DOI 10.1016/S0749-0720(15)30532-6
   ELLIS WA, 1977, BRIT VET J, V133, P108, DOI 10.1016/S0007-1935(17)34212-4
   ELLIS WA, 1986, CURRENT TOPICS VET M, P13
   Feresu SB, 1999, INT J SYST BACTERIOL, V49, P1111, DOI 10.1099/00207713-49-3-1111
   GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691
   HANSON LE, 1976, J DAIRY SCI, V59, P1166, DOI 10.3168/jds.S0022-0302(76)84339-1
   Johnson DW, 1943, BRIT MED J, V1943, P659
   JUNGHERR E., 1944, Journal of the American Veterinary Medical Association, V105, P276
   LUNA AMA, 2005, REV CUBANA MED TROP, V57, P28
   MENA BR, 2006, THESIS U NACL AUTONO
   MICHNA SW, 1969, VET REC, V84, P83, DOI 10.1136/vr.84.4.83
   MIKHIN NA, 1935, SOVYET VET, V10, P23
   Moles Cervantes Luis Pedro, 2002, Rev Cubana Med Trop, V54, P24
   MYERS M, 1985, 30 CTR PAN ZOON ORG
   PEROLAT P, 1994, J CLIN MICROBIOL, V32, P1949, DOI 10.1128/JCM.32.8.1949-1957.1994
   RAMADASS P, 1990, RES VET SCI, V49, P194, DOI 10.1016/S0034-5288(18)31076-2
   ROTH EE, 1960, AM J VET RES, V21, P422
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   SALOMON SA, 1988, INFORM SERVICIO SOCI
   Smith CR, 1997, AUST VET J, V75, P818, DOI 10.1111/j.1751-0813.1997.tb15661.x
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   THIERMANN AB, 1986, AM J VET RES, V47, P61
   THIERMANN AB, 1982, AM J VET RES, V43, P780
   Thornley CN, 2002, EPIDEMIOL INFECT, V128, P29, DOI 10.1017/S0950268801006392
   TORTEN M, 1970, AM J EPIDEMIOL, V91, P52, DOI 10.1093/oxfordjournals.aje.a121112
   Vasconcellos SA, 2001, BRAZ J MICROBIOL, V32, P298
   Vedhagiri K, 2010, BRAZ J MICROBIOL, V41, P150, DOI 10.1590/S1517-838220100001000022
   Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371
   ZAMORA J, 1991, ARCH MED VET, V23, P131
   ZUERNER RL, 1993, J CLIN MICROBIOL, V31, P578, DOI 10.1128/JCM.31.3.578-583.1993
NR 41
TC 9
Z9 9
U1 0
U2 18
PU UNIV NACIONAL AUTONOMA MEXICO FACULTAD MEDICINA VETERINARIA ZOOTECNIA
PI MEXICO
PA CIRCUITO EXTERIOR, CIUDAD UNIVERSITARIA, MEXICO 04510, DF, MEXICO
SN 0301-5092
EI 2448-6760
J9 VET MEXICO
JI Vet. Mexico
PD OCT-DEC
PY 2011
VL 42
IS 4
BP 277
EP 288
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA 856CD
UT WOS:000297613400003
DA 2020-11-30
ER

PT J
AU Carvalho, M
   Claudio, S
   Boaventura, E
   Ribeiro, G
   Quintana, M
   Nobre, A
   Diggle, P
   Reis, M
   Ko, A
AF Carvalho, M.
   Claudio, S.
   Boaventura, E.
   Ribeiro, G.
   Quintana, M.
   Nobre, A.
   Diggle, P.
   Reis, M.
   Ko, A.
TI INFLUENCE OF CLIMATE ON THE INCIDENCE OF URBAN LEPTOSPIROSIS
SO JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
LA English
DT Meeting Abstract
C1 [Carvalho, M.; Claudio, S.; Quintana, M.; Nobre, A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Boaventura, E.; Ribeiro, G.; Reis, M.; Ko, A.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Ko, A.] Yale Univ, New Haven, CT USA.
   [Diggle, P.] Univ Lancaster, Lancaster, England.
RI CARVALHO, MARILIA/AAD-8283-2020; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020; Ribeiro, Guilherme/B-6624-2008
OI CARVALHO, MARILIA/0000-0002-9566-0284; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060;
   Ribeiro, Guilherme/0000-0002-6798-2059
NR 0
TC 0
Z9 0
U1 0
U2 6
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0143-005X
J9 J EPIDEMIOL COMMUN H
JI J. Epidemiol. Community Health
PD AUG
PY 2011
VL 65
SU 1
BP A361
EP A361
DI 10.1136/jech.2011.142976m.33
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 807MG
UT WOS:000293901801593
OA Bronze
DA 2020-11-30
ER

PT J
AU de Melo, CB
   Reis, RB
   Ko, AI
   Barreto, CMN
   Lima, AP
   da Silva, AM
AF de Melo, Clenio Bezerra
   Reis, Renato Barbosa
   Ko, Albert Icsang
   Noia Barreto, Carmelia Maria
   Lima, Andrea Prudente
   da Silva, Angela Maria
TI Geographical distribution of leptospirosis in Aracaju, State of Sergipe
   from 2001 to 2007
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Article
DE Geoprocessing; Geographic Information System; Leptospirosis; Kernel
AB Introduction: Leptospirosis, a disease caused by pathogenic spirochetes of the genus Leptospira, is one of the most widespread zoonoses in the world and is considered an important public health problem. This paper aims to describe the spatial pattern of leptospirosis in the city of Aracaju from 2001 to 2007 in an effort to identify areas at risk for leptospirosis. Methods: We used the ratio of Kernel, which represents the ratio between two surfaces, to visualize the surface of disease risk. The numerator corresponds to the number of cases geocoded to the census tract, and the denominator of the kernel corresponds to the population of these areas. Using this method, the areas with the highest density of cases were delineated and compared visually with socioeconomic factors, such as average income. Results: The spatial pattern was different in periods of rain compared with periods of drought and did not coincide with the areas considered most at risk for the disease. This study revealed the importance of applying spatial analysis techniques in the field of public health. Conclusions: These findings indicate that the kernel is a useful tool for obtaining a comprehensive review of the epidemiology of leptospirosis in Aracaju, which supports the kernel's use by the municipal health departments and by the state.
C1 [de Melo, Clenio Bezerra] Univ Fed Sergipe, Nucleo Pos Grad Med, Aracaju, SE, Brazil.
   [Reis, Renato Barbosa; Ko, Albert Icsang] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Ko, Albert Icsang] Univ Cornnel, Curso Med, Lab Doencas Infecciosas, New York, NY USA.
   [Noia Barreto, Carmelia Maria; Lima, Andrea Prudente] Univ Fed Sergipe, Curso Med, Aracaju, SE, Brazil.
   [da Silva, Angela Maria] Yniv Fed Sergipe, Disciplina Infectol, Aracaju, SE, Brazil.
RP de Melo, CB (corresponding author), Rua Manoel Motta 121, BR-49038340 Aracaju, SE, Brazil.
EM clenioimuno@yahoo.com.br
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01AI088752, U01AI088752, U01AI088752, U01AI088752, U01AI088752,
   U01AI088752] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [U01 AI088752] Funding Source: Medline
CR BARCELLOS C, 2002, CAD SAUDE PUBLICA, V17, pS59
   Carneiro R.M., 2000, DOENCAS INFECCIOSAS, P481
   CARVALHO MS, 1998, SERIE EPIDEMIOLOGICA, V4, P79
   *I BRAS GEOGR EST, CENS DEM 2008
   *I BRAS GEOGR EST, 2004, RES AM CENS DEM 2000
   Instituto Brasileiro de Geografia e Estatistica, CENS DEM 2007
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   TAPERO JW, 2000, LEPTOSPIRA SPECIES L
   TASSINARI WS, 2001, CAD SAUDE PUBLICA, V20, P1721
NR 9
TC 8
Z9 10
U1 0
U2 8
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2011
VL 44
IS 4
BP 475
EP 480
DI 10.1590/S0037-86822011000400015
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 810MA
UT WOS:000294128200015
PM 21860894
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Figueira, CP
   Croda, J
   Choy, HA
   Haake, DA
   Reis, MG
   Ko, AI
   Picardeau, M
AF Figueira, Claudio Pereira
   Croda, Julio
   Choy, Henry A.
   Haake, David A.
   Reis, Mitermayer G.
   Ko, Albert I.
   Picardeau, Mathieu
TI Heterologous expression of pathogen-specific genes ligA and ligB in the
   saprophyte Leptospira biflexa confers enhanced adhesion to cultured
   cells and fibronectin
SO BMC MICROBIOLOGY
LA English
DT Article
ID IMMUNOGLOBULIN-LIKE PROTEIN; TARGETED MUTAGENESIS; PROTECTIVE IMMUNITY;
   ESCHERICHIA-COLI; C-TERMINUS; INTERROGANS; BINDING; CONSTRUCTION;
   LIPOPROTEIN; CHALLENGE
AB Background: In comparison to other bacterial pathogens, our knowledge of the molecular basis of the pathogenesis of leptospirosis is extremely limited. An improved understanding of leptospiral pathogenetic mechanisms requires reliable tools for functional genetic analysis. Leptospiral immunoglobulin-like (Lig) proteins are surface proteins found in pathogenic Leptospira, but not in saprophytes. Here, we describe a system for heterologous expression of the Leptospira interrogans genes ligA and ligB in the saprophyte Leptospira biflexa serovar Patoc.
   Results: The genes encoding LigA and LigB under the control of a constitutive spirochaetal promoter were inserted into the L. biflexa replicative plasmid. We were able to demonstrate expression and surface localization of LigA and LigB in L. biflexa. We found that the expression of the lig genes significantly enhanced the ability of transformed L. biflexa to adhere in vitro to extracellular matrix components and cultured cells, suggesting the involvement of Lig proteins in cell adhesion.
   Conclusions: This work reports a complete description of the system we have developed for heterologous expression of pathogen-specific proteins in the saprophytic L. biflexa. We show that expression of LigA and LigB proteins from the pathogen confers a virulence-associated phenotype on L. biflexa, namely adhesion to eukaryotic cells and fibronectin in vitro. This study indicates that L. biflexa can serve as a surrogate host to characterize the role of key virulence factors of the causative agent of leptospirosis.
C1 [Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, F-75724 Paris 15, France.
   [Figueira, Claudio Pereira; Croda, Julio; Reis, Mitermayer G.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, BR-40295001 Salvador, BA, Brazil.
   [Choy, Henry A.; Haake, David A.] Vet Affairs Greater Los Angeles Hlth Care Syst, Div Infect Dis, Los Angeles, CA 90073 USA.
   [Choy, Henry A.; Haake, David A.] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA.
   [Ko, Albert I.] Yale Univ, Sch Med, Div Epidemiol Microbial Dis, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.
   [Croda, Julio] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, Brazil.
RP Picardeau, M (corresponding author), Inst Pasteur, Unite Biol Spirochetes, 28 Rue Docteur Roux, F-75724 Paris 15, France.
EM mpicard@pasteur.fr
RI Reis, Mitermayer/AAO-9742-2020; Croda, Julio/I-5172-2013; Ko, Albert
   Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Croda, Julio/0000-0002-6665-6825;
   Ko, Albert Icksang/0000-0001-9023-2339
FU Institut Pasteur, Paris, France; French Ministry of ResearchMinistry of
   Research, France [ANR-08-MIE-018]; Oswaldo Cruz Foundation [PDTIS
   RVR05]; Brazilian National Research Council (INCTV)National Council for
   Scientific and Technological Development (CNPq); VA Medical Research
   FundsUS Department of Veterans Affairs; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [D43 TW00919, R01 AI34431, U01
   AI088752]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI052473, R01AI052473, R01AI052473, R01AI034431,
   R01AI034431, R01AI034431, U01AI088752, R01AI052473, R01AI034431,
   R01AI052473, R01AI034431, R01AI034431, R01AI034431, R01AI052473,
   R01AI052473, U01AI088752, R01AI034431, U01AI088752, R01AI052473,
   R01AI034431, R01AI034431, R01AI052473, R01AI034431, R01AI052473,
   R01AI034431, U01AI088752, R01AI034431, R01AI052473, U01AI088752,
   U01AI088752] Funding Source: NIH RePORTER
FX This work was supported by the Institut Pasteur, Paris, France; the
   French Ministry of Research ANR-08-MIE-018, the Fiocruz-Pasteur
   Scientific Cooperation Agreement, Oswaldo Cruz Foundation (PDTIS RVR05),
   Brazilian National Research Council (INCTV), VA Medical Research Funds,
   and the National Institutes of Health (grants D43 TW00919, R01 AI34431
   and U01 AI088752). This research was conducted by C. P. Figueira in
   partial fulfillment of the requirements for a Ph.D. from Goncalo Moniz
   Research Center, Oswaldo Cruz Foundation, Brazil.
CR ANTOINE JC, 1991, INFECT IMMUN, V59, P764, DOI 10.1128/IAI.59.3.764-775.1991
   Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70
   Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06
   Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002
   Bauby H, 2003, MICROBIOL-SGM, V149, P689, DOI 10.1099/mic.0.26065-0
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bono JL, 2000, J BACTERIOL, V182, P2445, DOI 10.1128/JB.182.9.2445-2452.2000
   Bourhy P, 2005, J BACTERIOL, V187, P3931, DOI 10.1128/JB.187.12.3931-3940.2005
   Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005
   Cao XJ, 2010, CELL RES, V20, P197, DOI 10.1038/cr.2009.127
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   Choy HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016879
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029
   Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lin XP, 2008, J VET SCI, V9, P133
   Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200
   Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196
   Lin YP, 2009, BIOCHEM BIOPH RES CO, V389, P57, DOI 10.1016/j.bbrc.2009.08.089
   Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531
   Longhi MT, 2009, J MED MICROBIOL, V58, P1275, DOI 10.1099/jmm.0.011916-0
   LOUVEL H, 2007, GENETIC MANIPULATION
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06
   Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1016/S0378-1097(00)00044-6
   Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08
   Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x
   Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   PEPE JC, 1993, P NATL ACAD SCI USA, V90, P6473, DOI 10.1073/pnas.90.14.6473
   Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607
   Picardeau M, 2008, APPL ENVIRON MICROB, V74, P319, DOI 10.1128/AEM.02172-07
   Poggi D, 2010, APPL ENVIRON MICROB, V76, P4882, DOI 10.1128/AEM.00775-10
   Praetorius J, 2002, EXP CELL RES, V276, P52, DOI 10.1006/excr.2002.5516
   Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000
   SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527
   Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Srimanote P, 2008, J MICROBIOL METH, V72, P73, DOI 10.1016/j.mimet.2007.10.012
   Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188
   THOMAS DD, 1990, INFECT IMMUN, V58, P581, DOI 10.1128/IAI.58.3.581-585.1990
   Vieira ML, 2010, J INFECTION, V60, P52, DOI 10.1016/j.jinf.2009.10.047
   Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008
NR 52
TC 42
Z9 44
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD JUN 9
PY 2011
VL 11
AR 129
DI 10.1186/1471-2180-11-129
PG 9
WC Microbiology
SC Microbiology
GA 790UK
UT WOS:000292614500001
PM 21658265
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Szonyi, B
   Agudelo-Florez, P
   Ramirez, M
   Moreno, N
   Ko, AI
AF Szonyi, Barbara
   Agudelo-Florez, Piedad
   Ramirez, Marcela
   Moreno, Natali
   Ko, Albert I.
TI An outbreak of severe leptospirosis in capuchin (Cebus) monkeys
SO VETERINARY JOURNAL
LA English
DT Article
DE Leptospirosis; Cebus; Capuchin monkey; Outbreak; Rat
ID BRAZIL
AB Naturally acquired acute leptospirosis in monkeys is uncommon. This study reports an outbreak of severe leptospirosis among 52 capuchin (Cebus) monkeys that had been rescued from homes and housed in a wildlife rehabilitation center in Colombia in 2007. Case confirmation consisted of Leptospira isolation followed by a polymerase chain reaction targeting the LipL32 gene. The attack and mortality rates were 71% and 27%, respectively. Sixteen cases were confirmed. Necropsy revealed diffuse jaundice and pulmonary hemorrhage. Multi-locus sequence typing identified the agent to be Leptospira interrogans sequence type 17, indicating rats as the source of infection. An environmental survey confirmed rodent infestation as the cause of the outbreak. The extent of Leptospira transmission between humans and monkeys is unknown. Improper husbandry of non-human primates could create new reservoirs and transmission routes for Leptospira threatening conservation efforts and public health. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Szonyi, Barbara] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.
   [Agudelo-Florez, Piedad; Ramirez, Marcela; Moreno, Natali] Univ CES, Inst Colombiano Med Trop, Sabaneta, Colombia.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
RP Szonyi, B (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.
EM bs77@cornell.edu
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU National Institutes of Health, USAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; Departamento
   Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS,
   ColombiaDepartamento Administrativo de Ciencia, Tecnologia e Innovacion
   Colciencias [325645221265 - 352-2008]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, U01AI088752,
   U01AI088752, R01AI052473, R01AI052473, R01AI052473, U01AI088752,
   R01AI052473, U01AI088752, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, U01AI088752, R01AI052473, U01AI088752, R01AI052473] Funding
   Source: NIH RePORTER
FX This work was supported by the Fogarty International Clinical Research
   Scholars Program: National Institutes of Health, USA and the
   Departamento Administrativo de Ciencia, Tecnologia e Innovacion
   COLCIENCIAS, Colombia (Cod 325645221265 - 352-2008).
CR Agudelo-Florez P, 2009, AM J TROP MED HYG, V81, P906, DOI 10.4269/ajtmh.2009.09-0195
   BAULU J, 1987, J WILDLIFE DIS, V23, P60, DOI 10.7589/0090-3558-23.1.60
   Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000120
   Lilenbaum W, 2005, VET J, V169, P462, DOI 10.1016/j.tvjl.2004.03.015
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   MINETTE HP, 1966, AM J TROP MED HYG, V15, P190, DOI 10.4269/ajtmh.1966.15.190
   PEROLAT P, 1992, AM J TROP MED HYG, V46, P538, DOI 10.4269/ajtmh.1992.46.538
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056
NR 11
TC 26
Z9 27
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-0233
J9 VET J
JI Vet. J.
PD MAY
PY 2011
VL 188
IS 2
BP 237
EP 239
DI 10.1016/j.tvjl.2010.05.002
PG 3
WC Veterinary Sciences
SC Veterinary Sciences
GA 771EG
UT WOS:000291139400024
PM 20554228
OA Green Accepted
DA 2020-11-30
ER

PT J
AU Wilson, ME
   Ko, AI
   Reis, MG
AF Wilson, Mary Elizabeth
   Ko, Albert Icksang
   Reis, Mitermayer G.
TI Collaborative Teaching and Learning: A Model for Building Capacity and
   Partnerships to Address NTDs
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
C1 [Wilson, Mary Elizabeth] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.
   [Ko, Albert Icksang] Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis Div, New Haven, CT USA.
   [Reis, Mitermayer G.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Reis, Mitermayer G.] Univ Fed Bahia, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Reis, Mitermayer G.] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
RP Wilson, ME (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.
EM mary_wilson@harvard.edu
RI Reis, Mitermayer/AAO-9742-2020; Ceron, Jhoni/H-3436-2018; Ko, Albert
   Icksang/P-2343-2015; Ribeiro, Guilherme/B-6624-2008; Segurado, Aluisio
   C/K-2229-2012
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; Ribeiro, Guilherme/0000-0002-6798-2059;
   Segurado, Aluisio C/0000-0002-6311-8036
CR *MIN SAUD, 2008, PROGR NAC CONTR VIG
   *MIN SAUD, 2009, OB LEISHM VISC
   *MIN SAUD, 2010, OB LEPT
   *MIN SAUD, 2008, OB ESQ
   *MIN SAUD, 2008, CAS CONF ESQ
   *MIN SAUD, 2010, CAS CONF LEPT
   *MIN SAUD, 2009, CAS CONF LEISHM VISC
   *MIN SAUD, 2010, OB DENG COM COMPL
   *MIN SAUD, 2008, CAS DENG
   Ministerio da Saude (BR), 2002, PROGR NAC CONTR DENG
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2010, CAS LEISHM TEG AM
   *SECR VIG SAUD, 2009, B INF SECR VIG SAUD
   *SUP CONTR END, 2009, VET DOENC ESQ MANS
NR 13
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1935-2727
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2011
VL 5
IS 3
AR e939
DI 10.1371/journal.pntd.0000939
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 742KI
UT WOS:000288940800002
PM 21468316
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Choy, HA
   Kelley, MM
   Croda, J
   Matsunaga, J
   Babbitt, JT
   Ko, AI
   Picardeau, M
   Haake, DA
AF Choy, Henry A.
   Kelley, Melissa M.
   Croda, Julio
   Matsunaga, James
   Babbitt, Jane T.
   Ko, Albert I.
   Picardeau, Mathieu
   Haake, David A.
TI The Multifunctional LigB Adhesin Binds Homeostatic Proteins with
   Potential Roles in Cutaneous Infection by Pathogenic Leptospira
   interrogans
SO PLOS ONE
LA English
DT Article
ID IMMUNOGLOBULIN-LIKE PROTEINS; STAPHYLOCOCCUS-AUREUS; CLUMPING FACTOR;
   EXTRACELLULAR-MATRIX; MUCOSAL IMMUNOLOGY; CRYSTAL-STRUCTURE;
   HUMAN-FIBRINOGEN; GENE-EXPRESSION; TISSUE-REPAIR; MODEL
AB Leptospirosis is a potentially fatal zoonotic disease in humans and animals caused by pathogenic spirochetes, such as Leptospira interrogans. The mode of transmission is commonly limited to the exposure of mucous membrane or damaged skin to water contaminated by leptospires shed in the urine of carriers, such as rats. Infection occurs during seasonal flooding of impoverished tropical urban habitats with large rat populations, but also during recreational activity in open water, suggesting it is very efficient. LigA and LigB are surface localized proteins in pathogenic Leptospira strains with properties that could facilitate the infection of damaged skin. Their expression is rapidly induced by the increase in osmolarity encountered by leptospires upon transition from water to host. In addition, the immunoglobulin-like repeats of the Lig proteins bind proteins that mediate attachment to host tissue, such as fibronectin, fibrinogen, collagens, laminin, and elastin, some of which are important in cutaneous wound healing and repair. Hemostasis is critical in a fresh injury, where fibrinogen from damaged vasculature mediates coagulation. We show that fibrinogen binding by recombinant LigB inhibits fibrin formation, which could aid leptospiral entry into the circulation, dissemination, and further infection by impairing healing. LigB also binds fibroblast fibronectin and type III collagen, two proteins prevalent in wound repair, thus potentially enhancing leptospiral adhesion to skin openings. LigA or LigB expression by transformation of a nonpathogenic saprophyte, L. biflexa, enhances bacterial adhesion to fibrinogen. Our results suggest that by binding homeostatic proteins found in cutaneous wounds, LigB could facilitate leptospirosis transmission. Both fibronectin and fibrinogen binding have been mapped to an overlapping domain in LigB comprising repeats 9-11, with repeat 11 possibly enhancing binding by a conformational effect. Leptospirosis patient antibodies react with the LigB domain, suggesting applications in diagnosis and vaccines that are currently limited by the strain-specific leptospiral lipopolysaccharide coats.
C1 [Choy, Henry A.; Matsunaga, James; Babbitt, Jane T.; Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
   [Choy, Henry A.; Kelley, Melissa M.; Matsunaga, James; Babbitt, Jane T.] Vet Affairs Greater Los Angeles Healthcare Syst, Res Serv, Los Angeles, CA USA.
   [Croda, Julio; Ko, Albert I.] Brasilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Croda, Julio] Fed Univ Grande Dourados, Fac Hlth Sci, Dourados, MS, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT 06510 USA.
   [Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, Paris, France.
   [Haake, David A.] Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA.
   [Haake, David A.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA.
   [Haake, David A.] Univ Calif Los Angeles, Dept Mol Genet Microbiol & Immunol, Los Angeles, CA USA.
RP Choy, HA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
EM hachoy@ucla.edu
RI Ko, Albert Icksang/P-2343-2015; Croda, Julio/I-5172-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Croda, Julio/0000-0002-6665-6825
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI34431, U01
   AI088752, D43 TW00919, R01 AI052473]; VA Medical Research FundsUS
   Department of Veterans Affairs; Institut Pasteur, Paris, France; French
   Ministry of ResearchMinistry of Research, France [ANR-08-MIE-018];
   Oswaldo Cruz Foundation [PDTIS RVR05]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, R01AI034431,
   R01AI034431, R01AI034431, R01AI052473, R01AI034431, R01AI052473,
   R01AI052473, R01AI034431, R01AI052473, R01AI052473, U01AI088752,
   U01AI088752, U01AI088752, R01AI034431, R01AI052473, R01AI034431,
   R01AI034431, R01AI052473, R01AI052473, R01AI052473, R01AI034431,
   R01AI034431, U01AI088752, U01AI088752, R01AI034431, R01AI052473,
   R01AI034431, R01AI034431, U01AI088752] Funding Source: NIH RePORTER
FX This study was supported by the National Institutes of Health (R01
   AI34431, U01 AI088752, D43 TW00919, and R01 AI052473), VA Medical
   Research Funds (to D. A. H.), the Institut Pasteur, Paris, France, the
   French Ministry of Research (ANR-08-MIE-018), and the Fiocruz-Pasteur
   Scientific Cooperation Agreement, Oswaldo Cruz Foundation (PDTIS RVR05).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Baum CL, 2005, DERMATOL SURG, V31, P674
   BERNSTEIN JM, 1992, RESPIRATION, V59, P3
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bowden MG, 2008, J BIOL CHEM, V283, P638, DOI 10.1074/jbc.M706252200
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200
   Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619
   Eidhin DN, 1998, MOL MICROBIOL, V30, P245
   Ganesh VK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000226
   Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942
   Ham SA, 2010, J CELL MOL MED, V14, P1747, DOI 10.1111/j.1582-4934.2009.00816.x
   Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291
   HAWIGER J, 1982, BIOCHEMISTRY-US, V21, P1407, DOI 10.1021/bi00535a047
   Ito T, 1987, Nihon Juigaku Zasshi, V49, P875
   Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196
   Lin YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011301
   Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369
   Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531
   Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5
   Liu CZ, 2005, THROMB HAEMOSTASIS, V94, P286, DOI 10.1160/TH05-03-0205
   Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06
   Lo M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000560
   Lourdault K, 2009, J MED MICROBIOL, V58, P648, DOI 10.1099/jmm.0.008169-0
   Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012
   McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x
   Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Monahan AM, 2009, J APPL MICROBIOL, V107, P707, DOI 10.1111/j.1365-2672.2009.04220.x
   Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X
   Narita M, 2005, AM J TROP MED HYG, V73, P652, DOI 10.4269/ajtmh.2005.73.652
   Nestle FO, 2007, J CLIN INVEST, V117, P2382, DOI 10.1172/JCI33349
   Perkins S, 2001, J BIOL CHEM, V276, P44721, DOI 10.1074/jbc.M106741200
   QUAGLINO D, 1991, J INVEST DERMATOL, V97, P34
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Spraggon G, 1997, NATURE, V389, P455
   Thibeault SL, 2009, MUCOSAL IMMUNOL, V2, P122, DOI 10.1038/mi.2008.82
   Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531
   Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618
   Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888
NR 51
TC 46
Z9 46
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 9
PY 2011
VL 6
IS 2
AR e16879
DI 10.1371/journal.pone.0016879
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 721NN
UT WOS:000287361700049
PM 21347378
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Silva, N
   Eremeeva, ME
   Rozental, T
   Ribeiro, GS
   Paddock, CD
   Ramos, EAG
   Favacho, ARM
   Reis, MG
   Dasch, GA
   de Lemos, ERS
   Ko, AI
AF Silva, Nanci
   Eremeeva, Marina E.
   Rozental, Tatiana
   Ribeiro, Guilherme S.
   Paddock, Christopher D.
   Ramos, Eduardo Antonio G.
   Favacho, Alexsandra R. M.
   Reis, Mitermayer G.
   Dasch, Gregory A.
   de Lemos, Elba R. S.
   Ko, Albert I.
TI Eschar-associated Spotted Fever Rickettsiosis, Bahia, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID RHIPICEPHALUS-SANGUINEUS TICKS; ENDEMIC AREA; SAO-PAULO; MASSILIAE;
   STATE
AB In Brazil, Brazilian spotted fever was once considered the only tick-borne rickettsial disease. We report eschar-associated rickettsial disease that occurred after a tick bite. The etiologic agent is most related to Rickettsia parkeri, R. africae, and R. sibirica and probably widely distributed from Sao Paulo to Bahia in the Atlantic Forest.
C1 [Ko, Albert I.] Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis Div, New Haven, CT 06520 USA.
   [Silva, Nanci] Med & Publ Hlth Sch Bahia, Salvador, BA, Brazil.
   [Eremeeva, Marina E.; Paddock, Christopher D.; Dasch, Gregory A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Rozental, Tatiana; Favacho, Alexsandra R. M.; de Lemos, Elba R. S.] Inst Oswaldo Cruz, BR-20001 Rio De Janeiro, Brazil.
   [Ribeiro, Guilherme S.; Ramos, Eduardo Antonio G.; Reis, Mitermayer G.; Ko, Albert I.] Inst Oswaldo Cruz, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Salvador, BA, Brazil.
RP Ko, AI (corresponding author), Yale Univ, Sch Publ Hlth, Epidemiol Microbial Dis Div, 60 Coll St,POB 208034, New Haven, CT 06520 USA.
EM albert.ko@yale.edu
RI Reis, Mitermayer/AAO-9742-2020; Rozental, Tatiana/B-6270-2014; Ribeiro,
   Guilherme/B-6624-2008; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Rozental,
   Tatiana/0000-0002-8360-8876; Ribeiro, Guilherme/0000-0002-6798-2059; Ko,
   Albert Icksang/0000-0001-9023-2339; Lemos, Elba/0000-0003-3761-0200;
   Dasch, Gregory/0000-0001-6090-1810; Favacho,
   Alexsandra/0000-0002-4950-2357
CR Angerami RN, 2006, ANN NY ACAD SCI, V1078, P252, DOI 10.1196/annals.1374.044
   Garcia-Garcia JC, 2010, AM J TROP MED HYG, V82, P691, DOI 10.4269/ajtmh.2010.09-0662
   COSTA PSG, 2004, REV BRAS PARASITOL S, V13, P360
   Cragun WC, 2010, ARCH DERMATOL, V146, P641, DOI 10.1001/archdermatol.2010.48
   De Lemos ERS, 2001, AM J TROP MED HYG, V65, P329
   EREMEEVA M, 1995, J CLIN MICROBIOL, V33, P2738, DOI 10.1128/JCM.33.10.2738-2744.1995
   Eremeeva ME, 2006, APPL ENVIRON MICROB, V72, P5569, DOI 10.1128/AEM.00122-06
   Jensenius M, 2003, CLIN INFECT DIS, V36, P1411, DOI 10.1086/375083
   Labruna MB, 2009, ANN NY ACAD SCI, V1166, P156, DOI 10.1111/j.1749-6632.2009.04516.x
   Parola Philippe, 2009, Curr Infect Dis Rep, V11, P40, DOI 10.1007/s11908-009-0007-5
   Piza J, 1932, TIFO EXANTEMATICO SA, P11
   Plank SJ, 1979, REV MED BAHIA, V25, P330
   Sabatini GS, 2010, J MED ENTOMOL, V47, P913, DOI 10.1603/ME10073
   Silveira I, 2007, EMERG INFECT DIS, V13, P1111, DOI 10.3201/eid1307.061397
   Spolidorio MG, 2010, EMERG INFECT DIS, V16, P521, DOI 10.3201/eid1603.091338
   WALKER DH, 1981, J AM ACAD DERMATOL, V4, P571, DOI 10.1016/S0190-9622(81)70059-8
NR 16
TC 83
Z9 87
U1 0
U2 11
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD FEB
PY 2011
VL 17
IS 2
BP 275
EP 278
DI 10.3201/eid1702.100859
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 722MM
UT WOS:000287436400022
PM 21291605
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Menezes, APD
   Campos, LC
   dos Santos, MS
   Azevedo, J
   dos Santos, RCN
   Carvalho, MDS
   Beall, BW
   Martin, SW
   Salgado, K
   Reis, MG
   Ko, AI
   Reis, JN
AF Menezes, Ana Paula de O.
   Campos, Leila C.
   dos Santos, Milena S.
   Azevedo, Jailton
   dos Santos, Renan C. N.
   Carvalho, Maria da Gloria S.
   Beall, Bernard W.
   Martin, Stacey W.
   Salgado, Katia
   Reis, Mitermayer G.
   Ko, Albert I.
   Reis, Joice N.
TI Serotype distribution and antimicrobial resistance of Streptococcus
   pneumoniae prior to introduction of the 10-valent pneumococcal conjugate
   vaccine in Brazil, 2000-2007
SO VACCINE
LA English
DT Article
DE Streptococcus pneumoniae; Vaccine; Antimicrobial resistance; Meningitis;
   Children
ID DETERMINING CAPSULAR SEROTYPES; SEQUENTIAL MULTIPLEX PCR;
   HAEMOPHILUS-INFLUENZAE; UNITED-STATES; DISEASE; MENINGITIS; CHILDREN;
   IMPACT; SUSCEPTIBILITY; EMERGENCE
AB This study describes the serotype distribution and antibiotic resistance patterns among 397 S. pneumoniae meningitis case isolates recovered in Salvador, Brazil, during the period of 2000-2007, before introduction of the 10-valent pneumococcal conjugate vaccine.
   The active hospital-based surveillance showed a decline in the annual incidence rates of pneumococcal meningitis during the period of study, from 1.12 cases to 0.83 cases/100,000 persons for all age groups (P<0.001), with an overall case-fatality rate of 28.6% (113 of 395) for all patients and 41.9% (57 of 136) for those <5 years of age. Serotypes 14 (n = 55; 13.9%), 3 (n = 32; 8.1%), 23F (n = 32; 8.1%), 19F (n = 31; 7.8%). 6B (n = 30; 7.6%), 18C (n = 28; 7.1%), and 6A (n = 20; 5%) were the most prevalent serotypes. In patients <5 years the estimated projected coverage of 7-, 10- and 13-valent conjugate vaccines was 74.3%, 75.7% and 83.1%, respectively. Antimicrobial susceptibility testing revealed that 22.1% (n = 88) of isolates were non-susceptible to penicillin, 56% were non-susceptible to trimethoprim/sulphamethoxazole, and 29.6% were non-susceptible to tetracycline. Nonsusceptibility to penicillin and cefotaxime was detected solely among serotype 14 isolates (n = 4; 1%). This study provides an important baseline to assess the impact of conjugate vaccine implantation on the epidemiology of meningitis due to Streptococcus pneumoniae in Salvador. Brazil. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Menezes, Ana Paula de O.; Campos, Leila C.; dos Santos, Milena S.; Azevedo, Jailton; dos Santos, Renan C. N.; Reis, Mitermayer G.; Ko, Albert I.; Reis, Joice N.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Carvalho, Maria da Gloria S.; Beall, Bernard W.] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA.
   [Martin, Stacey W.] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA 30333 USA.
   [Salgado, Katia] Hosp Couto Maia, BR-40415100 Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.
   [Reis, Joice N.] Univ Fed Bahia, Fac Farm, BR-40170115 Salvador, BA, Brazil.
RP Reis, JN (corresponding author), Fundacao Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, MS,Rua Waldemar Falcao 121, BR-40296710 Salvador, Candeal, Brazil.
EM joice@ufba.br
RI Ko, Albert Icksang/P-2343-2015; Reis, Joice N/H-9227-2013; Reis,
   Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Azevedo, Jailton/0000-0002-0801-8673;
   Santos, Milena Soares/0000-0002-1995-140X
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [491345/2005-4,
   478685/2007-6]; Research Support Foundation for the State of Bahia
   (FAPESB) [1431040054051, PP-SUS0001/2009]; CAPES-PNPDCAPES [1472/2008];
   Fogarty International Center of the National Institute of Health,
   USAUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01 TW007303, D43TW00919]; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R01TW007303, D43TW000919,
   R01TW007303, D43TW000919, D43TW000919, R01TW007303, D43TW000919,
   R01TW007303, D43TW000919, D43TW000919, R01TW007303, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH
   RePORTER
FX Above all, we thank the study patients and their families; and the
   clinical, laboratory and administrative staff of Hospital Couto Maia. We
   are especially grateful to Neide O. Silva. Edilane L. Gouveia and
   Tainara Q. Oliveira for their participation in data collection,
   processing and analysis. This study was supported by grants from the
   Brazilian National Research Council (CNPq - 491345/2005-4 and
   478685/2007-6), Research Support Foundation for the State of Bahia
   (FAPESB - 1431040054051 and PP-SUS0001/2009), CAPES-PNPD (1472/2008) and
   Fogarty International Center of the National Institute of Health, USA
   (R01 TW007303 and D43TW00919).
CR Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004
   Brandileone MCC, 2006, J MED MICROBIOL, V55, P567, DOI 10.1099/jmm.0.46387-0
   Brandileone MCC, 2003, J INFECT DIS, V187, P1206, DOI 10.1086/374396
   Campos LC, 2009, DIAGN MICR INFEC DIS, V65, P112, DOI 10.1016/j.diagmicrobio.2009.06.020
   Castaneda Elizabeth, 2009, Pediatr Infect Dis J, V28, pe265, DOI 10.1097/INF.0b013e3181a74b22
   *CDCP, 2010, PCR DED PNEUM SER
   Clinical and Laboratory Standards Institute, 2007, M100S17 CLIN LAB STA
   Dagan R, 2009, CLIN MICROBIOL INFEC, V15, P16, DOI 10.1111/j.1469-0691.2009.02726.x
   Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0
   Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x
   Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6
   Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608
   Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626
   Hsu KK, 2010, PEDIATR INFECT DIS J, V29, P289, DOI 10.1097/INF.0b013e3181c15471
   Instituto Brasileiro de Geografia e Estatistica, 2002, CENS DEM 2000 RES UN
   Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8
   Klugman KP, 2009, CLIN MICROBIOL INFEC, V15, P989, DOI 10.1111/j.1469-0691.2009.03066.x
   Klugman KP, 2002, J ANTIMICROB CHEMOTH, V50, P1, DOI 10.1093/jac/dkf500
   Ko AI, 2000, CLIN INFECT DIS, V30, P78, DOI 10.1086/313619
   Koeth LM, 2004, INT J ANTIMICROB AG, V23, P356, DOI 10.1016/j.ijantimicag.2003.09.022
   Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5
   Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938
   Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996
   Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660
   O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6
   Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006
   Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca
   Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593
   Prymula R, 2009, EXPERT REV VACCINES, V8, P1479, DOI [10.1586/erv.09.113, 10.1586/ERV.09.113]
   Reis JN, 2002, J CLIN MICROBIOL, V40, P275, DOI 10.1128/JCM.40.1.275-277.2002
   Ruckinger S, 2008, VACCINE, V26, P3984, DOI 10.1016/j.vaccine.2008.04.031
   Saha SK, 2009, CLIN INFECT DIS, V48, pS75, DOI 10.1086/596544
   Scott JAG, 2007, VACCINE, V25, P2398, DOI 10.1016/j.vaccine.2006.09.008
   *SECR SAUD EST BAH, 2008, CAS NOT MEN BAH
   Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823
   *WHO, 2007, WKLY EPIDEMIOL REC, V82, P93
   2008, PNEUMOADIP
NR 37
TC 17
Z9 19
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD FEB 1
PY 2011
VL 29
IS 6
BP 1139
EP 1144
DI 10.1016/j.vaccine.2010.12.021
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 721FU
UT WOS:000287339800006
PM 21182994
OA Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Lima, JBT
   Ribeiro, GS
   Cordeiro, SM
   Gouveia, EL
   Salgado, K
   Spratt, BG
   Godoy, D
   Reis, MG
   Ko, AI
   Reis, JN
AF Lima, Josilene B. T.
   Ribeiro, Guilherme S.
   Cordeiro, Soraia M.
   Gouveia, Edilane L.
   Salgado, Katia
   Spratt, Brian G.
   Godoy, Daniel
   Reis, Mitermayer G.
   Ko, Albert I.
   Reis, Joice N.
TI Poor Clinical Outcome for Meningitis Caused by Haemophilus influenzae
   Serotype A Strains Containing the IS1016-bexA Deletion
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID FIELD GEL-ELECTROPHORESIS; CONJUGATE VACCINE; B VACCINE; A DISEASE;
   IMMUNIZATION; VIRULENCE; CHILDREN; ERA; INFECTIONS; ELIMINATION
AB Since the introduction of Haemophilus influenzae type b (Hib) conjugate vaccines, meningitis caused by serotypes other than Hib has gained in importance. We conducted active hospital-based surveillance for meningitis over an 11-year period in Salvador, Brazil. H. influenzae isolates were serotyped and analyzed by polymerase chain reaction, pulsed-field gel electrophoresis, and DNA sequencing to identify strains with a specific deletion (IS1016) in the bexA gene (IS1016-bexA). We identified 43 meningitis cases caused by non-type b H. influenzae: 28 (65%) were caused by type a (Hia), 9 (21%) were caused by noncapsulated strains, and 3 (7%) each were caused by types e and f. Hia isolates clustered in 2 clonal groups; clonal group A strains (n = 9) had the IS1016-bexA deletion. Among children < 5 years of age, meningitis caused by Hia from clonal group A had higher case-fatality than meningitis caused by clonal group B. Despite small numbers, these results indicate that the presence of the IS1016-bexA deletion is associated with enhanced virulence in non-type b H. influenzae.
C1 [Lima, Josilene B. T.; Ribeiro, Guilherme S.; Cordeiro, Soraia M.; Gouveia, Edilane L.; Reis, Mitermayer G.; Ko, Albert I.; Reis, Joice N.] Univ Fed Bahia, Goncalo Moniz Res Ctr, Oswaldo Cruz Fdn, Brazilian Minist Hlth, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Reis, Joice N.] Univ Fed Bahia, Sch Pharm, Salvador, BA, Brazil.
   [Salgado, Katia] Hosp Couto Maia, Secretary Hlth State Bahia, Salvador, BA, Brazil.
   [Spratt, Brian G.; Godoy, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.
   [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.
RP Reis, JN (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Ministerio Saude, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM joice@ufba.br
RI Ribeiro, Guilherme/B-6624-2008; Reis, Joice N/H-9227-2013; Ko, Albert
   Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020
OI Ribeiro, Guilherme/0000-0002-6798-2059; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq) [491345/2005-4]; Research Support
   Foundation for the State of Bahia [FAPESB- 1431040054051]; National
   Institute of Health, USAUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [D43 TW00919, R01
   TW007303]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW007303, R01TW007303,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, R01TW007303, R01TW007303,
   R01TW007303, D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH
   RePORTER
FX Brazilian National Research Council (491345/2005-4), Research Support
   Foundation for the State of Bahia (FAPESB- 1431040054051), and National
   Institute of Health, USA (D43 TW00919 and R01 TW007303).
CR Adderson EE, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e18
   Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8
   Bajanca P, 2004, J CLIN MICROBIOL, V42, P807, DOI 10.1128/JCM.42.2.807-810.2004
   Bruun B, 2004, J MED MICROBIOL, V53, P1161, DOI 10.1099/jmm.0.45749-0
   Campos J, 2004, J CLIN MICROBIOL, V42, P524, DOI 10.1128/JCM.42.2.524-529.2004
   Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P234
   Cerquetti M, 2003, EMERG INFECT DIS, V9, P258
   CURRAN R, 1994, J MED MICROBIOL, V41, P120, DOI 10.1099/00222615-41-2-120
   Dagan R, 1999, VACCINE, V17, P134, DOI 10.1016/S0264-410X(98)00165-0
   ESKOLA J, 1990, NEW ENGL J MED, V323, P1381, DOI 10.1056/NEJM199011153232004
   FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994
   Farhoudi D, 2005, SCAND J INFECT DIS, V37, P717, DOI 10.1080/00365540510012800
   Forleo-Neto E, 1999, J INFECT DIS, V180, P1153, DOI 10.1086/315018
   Hammitt LL, 2005, PEDIATR INFECT DIS J, V24, P453, DOI 10.1097/01.inf.0000160954.90881.29
   Hviid A, 2004, VACCINE, V22, P378, DOI 10.1016/j.vaccine.2003.08.001
   *I BRAS GEOGR EST, 1996, AN EST BRAS, V56
   Jin Z, 2007, INFECT IMMUN, V75, P2650, DOI 10.1128/IAI.01774-06
   Kapogiannis BG, 2005, CLIN INFECT DIS, V41, pE97, DOI 10.1086/498028
   KROLL JS, 1993, J INFECT DIS, V168, P172, DOI 10.1093/infdis/168.1.172
   KROLL JS, 1994, J INFECT DIS, V169, P676, DOI 10.1093/infdis/169.3.676
   LaClaire LL, 2003, J CLIN MICROBIOL, V41, P393, DOI 10.1128/JCM.41.1.393-396.2003
   Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003
   Millar EV, 2000, AM J PUBLIC HEALTH, V90, P1550, DOI 10.2105/AJPH.90.10.1550
   Millar EV, 2005, CLIN INFECT DIS, V40, P823, DOI 10.1086/428047
   Noel GJ, 1996, INFECT IMMUN, V64, P4769, DOI 10.1128/IAI.64.11.4769-4775.1996
   Ogilvie C, 2001, J INFECT DIS, V184, P144, DOI 10.1086/322001
   Peltola H, 1999, J INFECT DIS, V179, P223, DOI 10.1086/314535
   Perdue DG, 2000, JAMA-J AM MED ASSOC, V283, P3089, DOI 10.1001/jama.283.23.3089
   Ribeiro GS, 2003, J INFECT DIS, V187, P109, DOI 10.1086/345863
   Ribeiro GS, 2007, VACCINE, V25, P4420, DOI 10.1016/j.vaccine.2007.03.024
   Saito M, 1999, J CLIN MICROBIOL, V37, P2142, DOI 10.1128/JCM.37.7.2142-2147.1999
   Satola SW, 2007, J CLIN MICROBIOL, V45, P3230, DOI 10.1128/JCM.00794-07
   Satola SW, 2003, INFECT IMMUN, V71, P3639, DOI 10.1128/IAI.71.6.3639-3644.2003
   Sill ML, 2007, CAN J MICROBIOL, V53, P1191, DOI 10.1139/W07-088
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995
   Tsang RSW, 2006, J CLIN MICROBIOL, V44, P1530, DOI 10.1128/JCM.44.4.1530-1535.2006
   Urwin G, 1996, CLIN INFECT DIS, V22, P1069, DOI 10.1093/clinids/22.6.1069
NR 37
TC 22
Z9 22
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV 15
PY 2010
VL 202
IS 10
BP 1577
EP 1584
DI 10.1086/656778
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 665SY
UT WOS:000283057000017
PM 20932170
OA Green Published, Bronze, Green Accepted
DA 2020-11-30
ER

PT J
AU Ribeiro, GS
   Felzemburgh, RD
   Costa, F
   Reis, RB
   Fraga, DB
   Queiroz, A
   Santos, BL
   Santos, AC
   Wunder, EA
   Tassinari, WS
   Carvalho, MS
   Reis, MG
   Ko, AI
AF Ribeiro, Guilherme S.
   Felzemburgh, Ridalva D.
   Costa, Federico
   Reis, Renato B.
   Fraga, Debora B.
   Queiroz, Adriano
   Santos, Balbino L.
   Santos, Andreia C.
   Wunder, Elsio A.
   Tassinari, Wagner S.
   Carvalho, Marilia S.
   Reis, Mitermayer G.
   Ko, Albert I.
TI PROSPECTIVE COHORT STUDY ON THE BURDEN OF LEPTOSPIROSIS AND ITS
   TRANSMISSION IN THE URBAN SLUM ENVIRONMENT
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Ribeiro, Guilherme S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Felzemburgh, Ridalva D.; Costa, Federico; Reis, Renato B.; Fraga, Debora B.; Queiroz, Adriano; Santos, Balbino L.; Santos, Andreia C.; Wunder, Elsio A.; Reis, Mitermayer G.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Tassinari, Wagner S.; Carvalho, Marilia S.] Brazilian Minist Hlth, Natl Sch Publ Hlth, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.
RI Reis, Mitermayer/AAO-9742-2020; CARVALHO, MARILIA S/C-3425-2013; Wunder,
   Elsio Augusto/C-2733-2013; Queiroz, Adriano/AAQ-1164-2020; CARVALHO,
   MARILIA/AAD-8283-2020; Costa, Federico/G-1838-2015; Ribeiro,
   Guilherme/B-6624-2008; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Queiroz, Adriano/0000-0003-0080-6509;
   CARVALHO, MARILIA/0000-0002-9566-0284; Costa,
   Federico/0000-0001-6951-2336; Ribeiro, Guilherme/0000-0002-6798-2059;
   Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 409
BP 122
EP 123
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819700410
DA 2020-11-30
ER

PT J
AU Costa, F
   Ribeiro, GS
   Santos, N
   Santos, N
   Reis, RB
   Rodrigues, MG
   de Farias, HMC
   Guimaraes, I
   Brant, J
   Reis, MG
   Ko, AI
AF Costa, Federico
   Ribeiro, Guilherme S.
   Santos, Norlan
   Santos, Nilzelene
   Reis, Renato B.
   Rodrigues, Maria Gorete
   de Farias, Helena M. C.
   Guimaraes, Isabel
   Brant, Jonas
   Reis, Mitermayer G.
   Ko, Albert I.
TI ALTERNATIVE COMMUNITY-BASED SCREENING FOR RAT INFESTATION TO IDENTIFY
   HIGH-RISK HOUSEHOLDS FOR LEPTOSIROSIS IN URBAN SLUM SETTLEMENTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Costa, Federico; Santos, Norlan; Santos, Nilzelene; Reis, Renato B.; Reis, Mitermayer G.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.] Inst Collect Hlth, Salvador, BA, Brazil.
   [Rodrigues, Maria Gorete; de Farias, Helena M. C.; Guimaraes, Isabel] Zoonosis Control Ctr, Salvador, BA, Brazil.
   [Brant, Jonas] Brazilian Minist Hlth, Field Epidemiol Training Program, Brasilia, DF, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA.
RI Reis, Mitermayer/AAO-9742-2020; Ribeiro, Guilherme/B-6624-2008; Ko,
   Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ribeiro,
   Guilherme/0000-0002-6798-2059; Ko, Albert Icksang/0000-0001-9023-2339;
   Costa, Federico/0000-0001-6951-2336
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 857
BP 255
EP 256
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819701225
DA 2020-11-30
ER

PT J
AU Calcagno, JI
   Lima, HC
   Goncalves, AH
   Costa, F
   Takahashi, D
   Wunder, EA
   Silva, J
   Reis, MG
   Ko, AI
   Ribeiro, GG
AF Calcagno, Juan I.
   Lima, Helena C.
   Goncalves, Andre H.
   Costa, Federico
   Takahashi, Daniele
   Wunder, Elsio A.
   Silva, Jailton
   Reis, Mitermayer G.
   Ko, Albert I.
   Ribeiro, Guilherme G.
TI MILD AND SEVERE CLINICAL FORMS OF URBAN LEPTOSPIROSIS: ACTIVE
   OUTPATIENT-BASED SURVEILLANCE IN A SLUM COMMUNITY IN BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Calcagno, Juan I.; Lima, Helena C.; Goncalves, Andre H.; Costa, Federico; Takahashi, Daniele; Wunder, Elsio A.; Silva, Jailton; Reis, Mitermayer G.; Ribeiro, Guilherme G.] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT USA.
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020; Ribeiro,
   Guilherme/B-6624-2008
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Ribeiro, Guilherme/0000-0002-6798-2059
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 894
BP 267
EP 268
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819701262
DA 2020-11-30
ER

PT J
AU Ristow, P
   McBride, F
   Wunder, EA
   Medeiros, MA
   Esteves, GS
   Figueira, CP
   McBride, AJ
   Rocha, G
   Chagas, A
   Santos, CS
   Homma, A
   Galler, R
   Reis, MG
   Ko, AI
AF Ristow, Paula
   McBride, Flavia
   Wunder, Elsio A., Jr.
   Medeiros, Marco A.
   Esteves, Gabriela S.
   Figueira, Claudio P.
   McBride, Alan J.
   Rocha, Gisele
   Chagas, Adenizar, Jr.
   Santos, Cleiton S.
   Homma, Akira
   Galler, Ricardo
   Reis, Mitermayer G.
   Ko, Albert I.
TI SUBUNIT LEPTOSPIRAL IMMUNOGLOBULIN-LIKE (LIG) PROTEIN VACCINE PROTECTS
   AGAINST LETHAL CHALLENGE IN THE HAMSTER MODEL OF LEPTOSPIROSIS AND
   PROTECTION IS ANTIBODY MEDIATED
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Ristow, Paula; McBride, Flavia; Wunder, Elsio A., Jr.; Figueira, Claudio P.; McBride, Alan J.; Rocha, Gisele; Chagas, Adenizar, Jr.; Santos, Cleiton S.; Reis, Mitermayer G.] Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Medeiros, Marco A.; Esteves, Gabriela S.; Homma, Akira; Galler, Ricardo] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA.
RI Ristow, Paula/D-1276-2013; Ko, Albert Icksang/P-2343-2015; Wunder, Elsio
   Augusto/C-2733-2013; Reis, Mitermayer/AAO-9742-2020; Ristow,
   Paula/AAP-6522-2020
OI Ristow, Paula/0000-0001-8494-361X; Ko, Albert
   Icksang/0000-0001-9023-2339; Wunder, Elsio Augusto/0000-0002-5239-8511;
   Reis, Mitermayer/0000-0002-3051-9060; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 899
BP 269
EP 269
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819701267
DA 2020-11-30
ER

PT J
AU Reis, EA
   W, ES
   Ribeiro, GS
   Santos, AC
   Damiao, AO
   Andrade, JCS
   Silva, NS
   Ko, AI
   Reis, MG
AF Reis, Eliana A.
   W, Elsio A., Jr.
   Ribeiro, Guilherme S.
   Santos, Andrea C.
   Damiao, Alcineia O.
   Andrade, Jorge Clarencio S.
   Silva, Nilzelene S.
   Ko, Albert I.
   Reis, Mitermayer G.
TI LEPTOSPIROSIS-ASSOCIATED SEVERE PULMONARY HEMORRHAGE SYNDROME IS
   ASSOCIATED WITH ELEVATED IL-10 AND INCREASED CD19+B CELLS AND Gamma
   Delta T CELLS POPULATION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Reis, Eliana A.; W, Elsio A., Jr.; Ribeiro, Guilherme S.; Santos, Andrea C.; Damiao, Alcineia O.; Andrade, Jorge Clarencio S.; Silva, Nilzelene S.; Reis, Mitermayer G.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Ko, Albert I.] Cornell, Ithaca, NY USA.
RI Reis, Mitermayer/AAO-9742-2020; Ribeiro, Guilherme/B-6624-2008; Ko,
   Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ribeiro,
   Guilherme/0000-0002-6798-2059; Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 1031
BP 308
EP 308
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819701398
DA 2020-11-30
ER

PT J
AU Franco-Paredes, C
   Ko, AI
   Aksoy, S
   Hotez, PJ
AF Franco-Paredes, Carlos
   Ko, Albert I.
   Aksoy, Serap
   Hotez, Peter J.
TI A New Clinical Section in PLoS Neglected Tropical Diseases
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Editorial Material
C1 [Franco-Paredes, Carlos] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico.
   [Franco-Paredes, Carlos] Emory Univ, Dept Med, Atlanta, GA 30322 USA.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA.
   [Aksoy, Serap] Yale Univ, Sch Publ Hlth, New Haven, CT USA.
   [Hotez, Peter J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
   [Hotez, Peter J.] Sabin Vaccine Inst, Washington, DC USA.
RP Franco-Paredes, C (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico.
EM cfranco@emory.edu
RI Aksoy, Serap/K-2244-2019; Ko, Albert Icksang/P-2343-2015;
   Franco-Paredes, Carlos/R-4226-2019
OI Aksoy, Serap/0000-0001-9941-143X; Ko, Albert
   Icksang/0000-0001-9023-2339; Hotez, Peter/0000-0001-8770-1042
CR Tellez I, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000772
NR 1
TC 0
Z9 0
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1935-2727
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2010
VL 4
IS 9
AR e760
DI 10.1371/journal.pntd.0000760
PG 2
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 655TB
UT WOS:000282271300001
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Marotto, PCF
   Ko, AI
   Murta-Nascimento, C
   Seguro, AC
   Prado, RR
   Barbosa, MC
   Cleto, SA
   Eluf-Neto, J
AF Marotto, Paulo C. F.
   Ko, Albert I.
   Murta-Nascimento, Cristiane
   Seguro, Antonio C.
   Prado, Rogerio R.
   Barbosa, Marcia C.
   Cleto, Sergio A.
   Eluf-Neto, Jose
TI Early identification of leptospirosis-associated pulmonary hemorrhage
   syndrome by use of a validated prediction model
SO JOURNAL OF INFECTION
LA English
DT Article
DE Leptospirosis; Leptospirosis-associated pulmonary hemorrhage syndrome;
   ROC curve; Predictive model; Brazil
ID MORTALITY; DISEASE
AB Objective: To identify prediction factors for the development of leptospirosis-associated pulmonary hemorrhage syndrome (LPHS).
   Methods: We conducted a prospective cohort study. The study comprised of 203 patients, aged >= 14 years, admitted with complications of the severe form of leptospirosis at the Emilio Ribas Institute of Infectology (Sao Paulo, Brazil) between 1998 and 2004. Laboratory and demographic data were obtained and the severity of illness score and involvement of the lungs and others organs were determined. Logistic regression was performed to identify independent predictors of LPHS. A prospective validation cohort of 97 subjects with severe form of leptospirosis admitted at the same hospital between 2004 and 2006 was used to independently evaluate the predictive value of the model.
   Results: The overall mortality rate was 7.9%. Multivariate logistic regression revealed that five factors were independently associated with the development of LPHS: serum potassium (mmol/L) (OR = 2.6; 95% CI = 1.1-5.9); serum creatinine (mmol/L) (OR = 1.2; 95% CI = 1.1-1.4); respiratory rate (breaths/min) (OR = 1.1; 95% CI = 1.1-1.2); presenting shock (OR = 69.9; 95% CI = 20.1-236.4), and Glasgow Coma Scale Score (GCS) < 15 (OR = 7.7; 95% CI = 1.3-23.0). We used these findings to calculate the risk of LPHS by the use of a spreadsheet. In the validation cohort, the equation classified correctly 92% of patients (Kappa statistic = 0.80).
   Conclusions: We developed and validated a multivariate model for predicting LPHS. This tool should prove useful in identifying LPHS patients, allowing earlier management and thereby reducing mortality. (C) 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
C1 [Marotto, Paulo C. F.] Inst Infectol Emilio Ribas, Unidade Terapia Intens, Div Cient, BR-01246903 Sao Paulo, Brazil.
   [Ko, Albert I.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Ko, Albert I.] Weill Cornell Med Coll, Dept Med, Div Infect Dis, New York, NY USA.
   [Murta-Nascimento, Cristiane] Hosp del Mar, IMAS, Evaluat & Clin Epidemiol Unit, Barcelona, Spain.
   [Murta-Nascimento, Cristiane] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain.
   [Seguro, Antonio C.] Univ Sao Paulo, Lab Basic Sci LIM 12, Dept Nephrol, Sao Paulo, Brazil.
   [Prado, Rogerio R.; Eluf-Neto, Jose] Univ Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil.
RP Marotto, PCF (corresponding author), Inst Infectol Emilio Ribas, Unidade Terapia Intens, Div Cient, Av Dr Arnaldo 165, BR-01246903 Sao Paulo, Brazil.
EM pmarotto@terra.com.br
RI Eluf-Neto, Jose/B-2522-2009; Murta-Nascimento, Cristiane/G-3738-2012;
   Ko, Albert Icksang/P-2343-2015
OI Eluf-Neto, Jose/0000-0001-7504-2115; Murta-Nascimento,
   Cristiane/0000-0001-8686-1079; Ko, Albert Icksang/0000-0001-9023-2339
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI052473, D43
   TW00919]; Secretary of Health, Sao Paulo State, Brazil; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, U01AI088752, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, U01AI088752,
   R01AI052473, R01AI052473, U01AI088752, R01AI052473, U01AI088752,
   U01AI088752, R01AI052473] Funding Source: NIH RePORTER
FX We would like to thank Mr. Carlos C. F. Marotto, Ms. Kesia Santos and
   Ms. Adriana Sanudo for the technical assistance. This work was
   supported, in part, by the National Institutes of Health (grants R01
   AI052473 and D43 TW00919) and the Secretary of Health, Sao Paulo State,
   Brazil.
CR Andrade L, 2008, SEMIN NEPHROL, V28, P383, DOI 10.1016/j.semnephrol.2008.04.008
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   *BRAS MIN SAUD SEC, GUIA VIG EP MIN SAUD
   Craig SB, 2009, ANN TROP MED PARASIT, V103, P333, DOI 10.1179/136485909X435058
   Dolhnikoff M, 2007, CURR OPIN PULM MED, V13, P230, DOI 10.1097/MCP.0b013e3280f9df74
   Doudier B, 2006, CLIN MICROBIOL INFEC, V12, P299, DOI 10.1111/j.1469-0691.2005.01335.x
   Dupont H, 1997, CLIN INFECT DIS, V25, P720, DOI 10.1086/513767
   Esen S, 2004, SWISS MED WKLY, V134, P347
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Niwattayakul K, 2002, RENAL FAILURE, V24, P297, DOI 10.1081/JDI-120005363
   Paganin F, 2007, INTENS CARE MED, V33, P1959, DOI 10.1007/s00134-007-0776-y
   Panaphut Thanachai, 2002, International Journal of Infectious Diseases, V6, P52, DOI 10.1016/S1201-9712(02)90137-2
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   Tattevin P, 2005, LUNG, V183, P283, DOI 10.1007/s00408-004-2541-0
   TREVEJO RT, 1995, J INFECT DIS, V1998, P1457
   Yersin C, 2000, T ROY SOC TROP MED H, V94, P71, DOI 10.1016/S0035-9203(00)90445-0
NR 19
TC 21
Z9 24
U1 0
U2 8
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
J9 J INFECTION
JI J. Infect.
PD MAR
PY 2010
VL 60
IS 3
BP 218
EP 223
DI 10.1016/j.jinf.2009.12.005
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA 559VQ
UT WOS:000274856500004
PM 20026189
OA Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Cerqueira, GM
   McBride, AJA
   Queiroz, A
   Pinto, LS
   Silva, EE
   Hartskeerl, RA
   Reis, MG
   Ko, AI
   Dellagostin, OA
AF Cerqueira, Gustavo M.
   McBride, Alan J. A.
   Queiroz, Adriano
   Pinto, Luciano S.
   Silva, Everton E.
   Hartskeerl, Rudy A.
   Reis, Mitermayer G.
   Ko, Albert I.
   Dellagostin, Odir A.
TI Monitoring Leptospira Strain Collections: The Need for Quality Control
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID SEQUENCE-ANALYSIS; IDENTIFICATION; GENE; IMPACT
AB The purpose of this study was to perform a 16S sequence-based quality control of two Leptospira strain collections. 16S rRNA gene sequencing was used to verify two Leptospira reference collections provided by the World Health Organization and maintained at a reference laboratory for leptospirosis in Brazil. Among the 89 serovars evaluated, four conflicting strains were identified in one of the collections. Although 16S rRNA gene sequencing cannot identify Leptospira beyond the species level, it is suitable for the identification of contamination and quality control of leptospiral reference collections. This study highlights the importance of the availability of high-quality 16S rRNA sequences in public databases. In addition, it emphasizes the need for periodical verifications and quality control of Leptospira reference collections.
C1 [Pinto, Luciano S.; Silva, Everton E.; Dellagostin, Odir A.] Univ Fed Pelotas, Ctr Biotechnol, BR-96010900 Pelotas, RS, Brazil.
   [Reis, Mitermayer G.] Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Hartskeerl, Rudy A.] Royal Trop Inst, Dept Biomed Res, NL-1105 AZ Amsterdam, Netherlands.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Infect Dis, New York, NY 10021 USA.
RP Dellagostin, OA (corresponding author), Univ Fed Pelotas, Ctr Biotechnol, Campus Univ Capao do Leao S-N, BR-96010900 Pelotas, RS, Brazil.
EM cer-queira@butantan.gov.br; alanm@pqvisitante.bahia.fiocruz.br;
   adrianoqs@gmail.com; ls_pinto@hotmail.com; fagonde@yahoo.com.br;
   r.hartskeerl@kit.nl; miter@bahia.fiocruz.br; aik2001@med.cornell.edu;
   odir@ufpel.edu.br
RI Dellagostin, Odir/C-2331-2009; McBride, Alan/D-4106-2012; Queiroz,
   Adriano/AAQ-1164-2020; Cerqueira, Gustavo/B-7180-2015; Ko, Albert
   Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020; da Silva Pinto,
   Luciano/M-9913-2019
OI Dellagostin, Odir/0000-0003-2803-4088; McBride,
   Alan/0000-0001-9682-540X; Queiroz, Adriano/0000-0003-0080-6509;
   Cerqueira, Gustavo/0000-0002-3029-6899; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060; da
   Silva Pinto, Luciano/0000-0001-8656-4031
FU Bio-Manguinhos, Fiocruz [09224-7, PDTIS RVR05]; Brazilian National
   Research CouncilNational Council for Scientific and Technological
   Development (CNPq) [01.06.0298.00, 3773/2005, 420067/2005, 554788/2006];
   Research Support Foundation for the State of Bahia; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [51101 AI052473, 2D43 TW00919]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, U01AI088752, R01AI052473, U01AI088752, R01AI052473,
   U01AI088752, U01AI088752, R01AI052473, U01AI088752, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, U01AI088752,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX G.M.C. was supported by CAPES foundation, Brazilian Ministry of
   Education. This work was supported by Bio-Manguinhos, Fiocruz (09224-7
   and PDTIS RVR05), the Brazilian National Research Council (01.06.0298.00
   3773/2005, 420067/2005, 554788/2006), Research Support Foundation for
   the State of Bahia, and the National Institutes of Health (51101
   AI052473, 2D43 TW00919).
CR Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012
   Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0
   Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009
   Chappel RJ, 2004, J CLIN MICROBIOL, V42, P5484, DOI 10.1128/JCM.42.12.5484-5488.2004
   Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004
   HOOKEY JV, 1993, J GEN MICROBIOL, V139, P2585, DOI 10.1099/00221287-139-11-2585
   Kmety E, 1993, CLASSIFICATION SPECI
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Majed Z, 2005, J CLIN MICROBIOL, V43, P539, DOI 10.1128/JCM.43.2.539-545.2005
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06
   Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322
   Postic D, 2000, RES MICROBIOL, V151, P333, DOI 10.1016/S0923-2508(00)00156-X
   Silva EF, 2007, VET MICROBIOL, V121, P144, DOI 10.1016/j.vetmic.2006.11.010
   Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95
   Slack Andrew T, 2005, Ann Clin Microbiol Antimicrob, V4, P10, DOI 10.1186/1476-0711-4-10
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056
   Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752
   WEISBURG WG, 1991, J BACTERIOL, V173, P7
   World Health Organization, 2003, HUM LEPT GUID DIAGN
NR 25
TC 22
Z9 24
U1 0
U2 6
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JAN
PY 2010
VL 82
IS 1
BP 83
EP 87
DI 10.4269/ajtmh.2010.09-0558
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 540VF
UT WOS:000273367400016
PM 20065000
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU Chagas-Junior, AD
   McBride, AJA
   Athanazio, DA
   Figueira, CP
   Medeiros, MA
   Reis, MG
   Ko, AI
   McBride, FWC
AF Chagas-Junior, Adenizar D.
   McBride, Alan J. A.
   Athanazio, Daniel A.
   Figueira, Claudio P.
   Medeiros, Marco A.
   Reis, Mitermayer G.
   Ko, Albert I.
   McBride, Flavia W. C.
TI An imprint method for detecting leptospires in the hamster model of
   vaccine-mediated immunity for leptospirosis
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID PATHOGENIC LEPTOSPIRA; PROTECTIVE IMMUNITY; PROTEIN-A; CUTANEOUS
   LEISHMANIASIS; LIG GENES; DIAGNOSIS; INTERROGANS; INFECTION; BRAZIL;
   IMMUNOPROTECTION
AB In determining the efficacy of new vaccine candidates for leptospirosis, the primary end point is death and an important secondary end point is sterilizing immunity. However, evaluation of this end point is often hampered by the time-consuming demands and complexity of methods such as culture isolation (CI). In this study, we evaluated the use of an imprint (or touch preparation) method (IM) in detecting the presence of leptospires in tissues of hamsters infected with Leptospira interrogans serovar Copenhageni. In a dissemination study, compared to Cl, the IM led to equal or improved detection of leptospires in kidney, liver, lung and blood samples collected post-infection and overall concordance was good (kappa=0.61). Furthermore, in an evaluation of hamsters immunized with a recombinant leptospiral protein-based vaccine candidate and subsequently challenged, the agreement between the Cl and IM was very good (kappa=0.84). These findings indicate that the IM is a rapid method for the direct observation of Leptospira slop. that can be readily applied to evaluating infection in experimental animals and determining sterilizing immunity when screening potential vaccine candidates.
C1 [Chagas-Junior, Adenizar D.; McBride, Alan J. A.; Athanazio, Daniel A.; Figueira, Claudio P.; Reis, Mitermayer G.; Ko, Albert I.; McBride, Flavia W. C.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Athanazio, Daniel A.; McBride, Flavia W. C.] Univ Fed Bahia, Hlth Sci Inst, Dept Biointeract, Salvador, BA, Brazil.
   [Medeiros, Marco A.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Infect Dis, Ithaca, NY 14853 USA.
RP McBride, FWC (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
EM fmcbride@ufba.br
RI McBride, Alan/D-4106-2012; Reis, Mitermayer/AAO-9742-2020; Athanazio,
   Daniel/P-6622-2014; Ko, Albert Icksang/P-2343-2015
OI McBride, Alan/0000-0001-9682-540X; Reis, Mitermayer/0000-0002-3051-9060;
   Ko, Albert Icksang/0000-0001-9023-2339
FU Bahia State Foundation for Research Support (FAPESB) [5108/2005,
   PES-0092/2008, 54663]; Oswaldo Cruz Foundation; Brazilian National
   Research CouncilNational Council for Scientific and Technological
   Development (CNPq) [554788/2006]; National institutes of Health,
   USAUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 A1052473, D43 TW-00919]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the Bahia State Foundation for Research
   Support (FAPESB), grants 5108/2005, PES-0092/2008 and 54663; the Oswaldo
   Cruz Foundation; the Brazilian National Research Council, grant
   554788/2006; and the National institutes of Health, USA, grants R01
   A1052473 and D43 TW-00919. The authors are grateful to Cleiton Silva
   Santos and Jefferson Alves for technical assistance in the experimental
   procedures.
CR ADLER B, 2009, VET MICROBIOL   0313
   Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012
   Bahamdan KA, 1996, INT J DERMATOL, V35, P558, DOI 10.1111/j.1365-4362.1996.tb03654.x
   BERGER RS, 1987, J AM ACAD DERMATOL, V16, P1096, DOI 10.1016/S0190-9622(87)70142-X
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029
   Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   Jan IS, 2008, J FORMOS MED ASSOC, V107, P443, DOI 10.1016/S0929-6646(08)60151-5
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   KAR K, 1995, CRIT REV MICROBIOL, V21, P123, DOI 10.3109/10408419509113537
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Koizumi N, 2005, J Postgrad Med, V51, P210
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   LANDIS JR, 1977, BIOMETRICS, V33, P174
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   OLSEN I, 1990, ACTA ODONTOL SCAND, V48, P11, DOI 10.3109/00016359009012729
   Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006
   Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002
   PARK SK, 1989, AM J TROP MED HYG, V41, P345, DOI 10.4269/ajtmh.1989.41.345
   ROSCOE M, 2005, JAAPA, V18, P53
   Roscoe Michael, 2005, JAAPA, V18, P47
   Seder RA, 2003, VACCINE BOOK, P51
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   SILVERMAN JF, 1995, CLIN LAB MED, V15, P251, DOI 10.1016/S0272-2712(18)30332-9
   Sonrier C, 2000, VACCINE, V19, P86, DOI 10.1016/S0264-410X(00)00129-8
   Teixeira AC, 2008, REV INST MED TROP SP, V50, P157, DOI 10.1590/S0036-46652008000300005
   Volpini AC, 2006, CLIN MICROBIOL INFEC, V12, P815, DOI 10.1111/j.1469-0691.2006.01422.x
   World Health Organization, 2003, HUM LEPT GUID DIAGN
   Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008
NR 40
TC 14
Z9 14
U1 0
U2 5
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD DEC
PY 2009
VL 58
IS 12
BP 1632
EP 1637
DI 10.1099/jmm.0.014050-0
PG 6
WC Microbiology
SC Microbiology
GA 525ZY
UT WOS:000272258300015
PM 19679685
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU Unger, A
   Felzemburgh, RD
   Costa, VB
   Melendez, AX
   Reis, RB
   Santana, FS
   Mohr, S
   Reis, MG
   Riley, LW
   Ko, AI
AF Unger, Alon
   Felzemburgh, Ridalva D.
   Costa, Vinicius B.
   Melendez, Astrid X.
   Reis, Renato B.
   Santana, Francisco S.
   Mohr, Sharif
   Reis, Mitermayer G.
   Riley, Lee W.
   Ko, Albert I.
TI HYPERTENSION IN AN URBAN SLUM POPULATION: POTENTIAL IMPACT OF SLUM
   HEALTH ON THE FORMAL HEALTH SECTOR
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 18-22, 2009
CL Washington, DC
SP Amer Soc Trop Med & Hyg
C1 [Unger, Alon] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.
   [Unger, Alon] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA.
   [Felzemburgh, Ridalva D.; Costa, Vinicius B.; Melendez, Astrid X.; Reis, Renato B.; Santana, Francisco S.; Mohr, Sharif; Reis, Mitermayer G.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Ko, Albert I.] Cornell Univ, Div Infect Dis, Weill Med Coll, New York, NY 10021 USA.
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2009
VL 81
IS 5
SU S
MA 1136
BP 328
EP 328
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 521WK
UT WOS:000271956701550
DA 2020-11-30
ER

PT J
AU Campos, LC
   Carvalho, MDS
   Beall, BW
   Cordeiro, SM
   Takahashi, D
   Reis, MG
   Ko, AI
   Reis, JN
AF Campos, Leila C.
   Carvalho, Maria da Gloria S.
   Beall, Bernard W.
   Cordeiro, Soraia M.
   Takahashi, Daniele
   Reis, Mitermayer G.
   Ko, Albert I.
   Reis, Joice N.
TI Prevalence of Streptococcus pneumoniae serotype 6C among invasive and
   carriage isolates in metropolitan Salvador, Brazil, from 1996 to 2007
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Streptococcus pneumoniae; Serotype 6C; Epidemiology; Meningitis;
   Carriage
ID FIELD GEL-ELECTROPHORESIS; UNITED-STATES; PNEUMOCOCCAL SEROTYPE; DISEASE
AB The newly described Streptococcus pnemnoniae serotype 6C accounted for 2.3% (16/709) of meningitis cases and 3.2% (3/95) of nasopharyngeal isolates from healthy individuals in Brazil. The strains were multidrug resistant (18.8%) and genetically diverse. Despite low serotype 6C prevalence, Continuous surveillance is necessary to guide vaccine strategies. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Campos, Leila C.; Cordeiro, Soraia M.; Takahashi, Daniele; Reis, Mitermayer G.; Ko, Albert I.; Reis, Joice N.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Campos, Leila C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Carvalho, Maria da Gloria S.; Beall, Bernard W.] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Dept Med, Div Infect Dis, New York, NY 10021 USA.
   [Reis, Joice N.] Univ Fed Bahia, Fac Farm, BR-40170115 Salvador, BA, Brazil.
RP Reis, JN (corresponding author), Fundacao Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM joice@ufba.br
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015; Reis,
   Joice N/H-9227-2013
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; 
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW000919-09, R01 TW007303-01, R01 TW007303-02, D43 TW000919-10, R01
   TW007303-03, D43TW00919, R01 TW007303-05, R01 TW007303, D43 TW000919,
   R01 TW007303-04] Funding Source: Medline; Wellcome TrustWellcome Trust
   Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [D43TW000919, R01TW007303,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   R01TW007303, D43TW000919, R01TW007303, R01TW007303, D43TW000919,
   D43TW000919, R01TW007303, D43TW000919, D43TW000919] Funding Source: NIH
   RePORTER
CR Carvalho MD, 2009, J CLIN MICROBIOL, V47, P554, DOI 10.1128/JCM.01919-08
   [CLSI Wayne PA Clinical and Laboratory Standards Institute], 2007, M100S17 CLSI
   du Plessis M, 2008, INT J ANTIMICROB AG, V32, pS66, DOI 10.1016/j.ijantimicag.2008.06.002
   Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049
   Granat SM, 2007, PEDIATR INFECT DIS J, V26, P319, DOI 10.1097/01.inf.0000257425.24492.11
   Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608
   Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626
   Jacobs MR, 2009, J CLIN MICROBIOL, V47, P64, DOI 10.1128/JCM.01524-08
   Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871
   McEllistrem MC, 2000, J CLIN MICROBIOL, V38, P351
   *MIN SAUD SECR EX, 2008, MAIS SAUD DIR TOD 20
   Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996
   Nunes S, 2009, J CLIN MICROBIOL, V47, P472, DOI 10.1128/JCM.01984-08
   Pai R, 2005, J CLIN MICROBIOL, V43, P5440, DOI 10.1128/JCM.43.11.5440-5444.2005
   Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339
   Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07
   Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06
   Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144
   Reis JN, 2008, J INFECTION, V57, P204, DOI 10.1016/j.jinf.2008.06.017
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995
   *WHO, 2007, WKLY EPIDEMIOL REC, V82, P93
NR 21
TC 23
Z9 24
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD OCT
PY 2009
VL 65
IS 2
BP 112
EP 115
DI 10.1016/j.diagmicrobio.2009.06.020
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA 499XP
UT WOS:000270260400006
PM 19709842
OA Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Ko, AI
   Goarant, C
   Picardeau, M
AF Ko, Albert I.
   Goarant, Cyrille
   Picardeau, Mathieu
TI Leptospira: the dawn of the molecular genetics era for an emerging
   zoonotic pathogen
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID IMMUNOGLOBULIN-LIKE PROTEIN; OUTER-MEMBRANE PROTEINS; INTERROGANS
   SEROVAR ICTEROHAEMORRHAGIAE; POTENTIAL VACCINE CANDIDATES; TYPE-1
   IMMUNE-RESPONSE; TANDEM-REPEAT ANALYSIS; WC1(+) GAMMA-DELTA;
   EXTRACELLULAR-MATRIX; BINDING PROTEIN; GUINEA-PIGS
AB Leptospirosis is a zoonotic disease that has emerged as an important cause of morbidity and mortality among impoverished populations. One hundred years after the discovery of the causative spirochaetal agent, little is understood about Leptospira spp. pathogenesis, which in turn has hampered the development of new intervention strategies to address this neglected disease. However, the recent availability of complete genome sequences for Leptospira spp. and the discovery of genetic tools for their transformation have led to important insights into the biology of these pathogens and their pathogenesis. We discuss the life cycle of the bacterium, the recent advances in our understanding and the implications for the future prevention of leptospirosis.
C1 [Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, F-75724 Paris 15, France.
   [Ko, Albert I.] Cornell Univ, Div Infect Dis, Weill Med Coll, New York, NY 10021 USA.
   [Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, BR-40296170 Salvador, BA, Brazil.
   [Goarant, Cyrille] Inst Pasteur Nouvelle Caledonie, Lab Rech Bacteriol, Noumea 98845, New Caledonia.
RP Picardeau, M (corresponding author), Inst Pasteur, Unite Biol Spirochetes, 28 Rue Docteur Roux, F-75724 Paris 15, France.
EM mathieu.picardeau@pasteur.fr
RI Ko, Albert Icksang/P-2343-2015; Goarant, Cyrille/D-4267-2018
OI Ko, Albert Icksang/0000-0001-9023-2339; Goarant,
   Cyrille/0000-0002-0690-9464
FU Institut Pasteur; Oswaldo Cruz Foundation; Brazilian National Research
   CouncilNational Council for Scientific and Technological Development
   (CNPq) [01.06.0298.00, 3773/2005, 554788/2006]; Research Support
   Foundation for the State of Bahia [54663]; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [2R01 AI052473, 2D43 TW00919]; Institut
   Pasteur and by Agence Nationale de la RechercheFrench National Research
   Agency (ANR) [05-JCJC-0105-01]; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX We thank C. Figueira, E. Wunder, E. Couture, M.-C. Prevost and P. Ristow
   for providing the figures of leptospires and their pathology. We also
   thank L. Riley, G. Baranton, I. Saint Girons, M. Reis and G. Ribeiro for
   their critical advice during the preparation of this manuscript. Some of
   the work described was supported by a cooperative agreement between
   Institut Pasteur and the Oswaldo Cruz Foundation, Brazilian National
   Research Council (grants 01.06.0298.00, 3773/2005 and 554788/2006,
   Instituto Nacional de Ciencia e Tecnologia de Vacinas), by the Research
   Support Foundation for the State of Bahia (54663), by the National
   Institutes of Health (grants 2R01 AI052473 and 2D43 TW00919), by the
   Institut Pasteur and by Agence Nationale de la Recherche (n degrees
   05-JCJC-0105-01).
CR ADLER B, 1977, INFECT IMMUN, V17, P67, DOI 10.1128/IAI.17.1.67-72.1977
   ADLER B, 1978, J MED MICROBIOL, V11, P387, DOI 10.1099/00222615-11-4-387
   Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28
   Andrade L, 2007, AM J PHYSIOL-RENAL, V292, pF586, DOI 10.1152/ajprenal.00102.2006
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Asuthkar S, 2007, INFECT IMMUN, V75, P4582, DOI 10.1128/IAI.00324-07
   Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012
   Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70
   Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06
   Barbosa AS, 2009, INFECT IMMUN, V77, P1137, DOI 10.1128/IAI.01310-08
   BARIL C, 1992, J GEN MICROBIOL, V138, P47, DOI 10.1099/00221287-138-1-47
   Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Blumerman SL, 2007, EUR J IMMUNOL, V37, P1204, DOI 10.1002/eji.200636216
   Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245
   Bourhy P, 2005, J BACTERIOL, V187, P3931, DOI 10.1128/JB.187.12.3931-3940.2005
   Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005
   Bourhy P, 2007, INFECT IMMUN, V75, P677, DOI 10.1128/IAI.01067-06
   Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001
   Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005
   Brown RA, 2003, VACCINE, V21, P4448, DOI 10.1016/S0264-410X(03)00439-0
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   Burth P, 2005, J INFECT DIS, V191, P51, DOI 10.1086/426455
   Chassin C, 2009, J IMMUNOL, V183, P2669, DOI 10.4049/jimmunol.0900506
   Chierakul W, 2008, CLIN INFECT DIS, V46, P254, DOI 10.1086/524664
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   CINCO M, 1983, ZBL BAKT-INT J MED M, V254, P261
   CRODA J, CLIN MICROB IN PRESS
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004
   Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002
   de Fost M, 2003, CLIN DIAGN LAB IMMUN, V10, P332, DOI 10.1128/CDLI.10.2.332-335.2003
   DEBRITO T, 1979, J PATHOL, V128, P177, DOI 10.1002/path.1711280403
   Diament D, 2002, INFECT IMMUN, V70, P1677, DOI 10.1128/IAI.70.4.1677-1683.2002
   ELLIS WA, 1983, ZBL BAKT-INT J MED M, V255, P323, DOI 10.1016/S0174-3031(83)80173-5
   FAINE S, 1957, BRIT J EXP PATHOL, V38, P8
   FAINE S, 1957, BRIT J EXP PATHOL, V38, P1
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029
   Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089
   Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   González A., 2005, Rev. argent. microbiol., V37, P169
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   HAAKE DA, 1994, METHOD ENZYMOL, V236, P447
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993
   HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991
   Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07
   Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07
   Ido Y, 1916, J EXP MED, V24, P471, DOI 10.1084/jem.24.5.471
   Inada R, 1916, J EXP MED, V23, P377, DOI 10.1084/jem.23.3.377
   Isogai E, 1998, J VET MED B, V45, P529, DOI 10.1111/j.1439-0450.1998.tb00824.x
   ITO T, 1987, VET MICROBIOL, V15, P89, DOI 10.1016/0378-1135(87)90133-7
   JOHNSON RC, 1966, J BACTERIOL, V91, P1403, DOI 10.1128/JB.91.4.1403-1409.1966
   JOST BH, 1986, J MED MICROBIOL, V22, P269, DOI 10.1099/00222615-22-3-269
   Klimpel GR, 2003, J IMMUNOL, V171, P1447, DOI 10.4049/jimmunol.171.3.1447
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Koizumi N, 2005, J Postgrad Med, V51, P210
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   Lee SH, 2000, GENE, V254, P19, DOI 10.1016/S0378-1119(00)00293-6
   Lee SH, 2002, INFECT IMMUN, V70, P315, DOI 10.1128/IAI.70.1.315-322.2002
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Li CH, 2000, J MOL MICROB BIOTECH, V2, P345
   Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200
   Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196
   Lingappa J, 2004, GENES IMMUN, V5, P197, DOI 10.1038/sj.gene.6364058
   Liu YY, 2007, MED MICROBIOL IMMUN, V196, P233, DOI 10.1007/s00430-007-0047-0
   Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06
   Lourdault K, 2009, J MED MICROBIOL, V58, P648, DOI 10.1099/jmm.0.008169-0
   Louvel H, 2006, J BACTERIOL, V188, P7893, DOI 10.1128/JB.00711-06
   Louvel H, 2005, J BACTERIOL, V187, P3249, DOI 10.1128/JB.187.9.3249-3254.2005
   LOUVEL H, 2007, CURR PROTOC MICROBIO, V12
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06
   Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012
   Meri T, 2005, MICROB PATHOGENESIS, V39, P139, DOI 10.1016/j.micpath.2005.07.003
   Merien F, 1998, FEMS MICROBIOL LETT, V169, P95, DOI 10.1111/j.1574-6968.1998.tb13304.x
   Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1016/S0378-1097(00)00044-6
   Merien F, 1997, INFECT IMMUN, V65, P729, DOI 10.1128/IAI.65.2.729-738.1997
   MINETTE HP, 1968, AM J TROP MED HYG, V17, P202, DOI 10.4269/ajtmh.1968.17.202
   Mitchison M, 1997, J BACTERIOL, V179, P1262, DOI 10.1128/jb.179.4.1262-1267.1997
   Monahan AM, 2008, INFECT IMMUN, V76, P4952, DOI 10.1128/IAI.00511-08
   Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797
   Murray GL, 2009, MICROBES INFECT, V11, P311, DOI 10.1016/j.micinf.2008.11.014
   Murray GL, 2009, INFECT IMMUN, V77, P952, DOI 10.1128/IAI.01370-08
   Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08
   Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022
   Naiman BM, 2002, INFECT IMMUN, V70, P6147, DOI 10.1128/IAI.70.11.6147-6157.2002
   Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06
   Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005
   Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Nicodemo AC, 1997, AM J TROP MED HYG, V56, P181, DOI 10.4269/ajtmh.1997.56.181
   Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   Panaphut Thanachai, 2002, International Journal of Infectious Diseases, V6, P52, DOI 10.1016/S1201-9712(02)90137-2
   PARK SK, 1989, AM J TROP MED HYG, V41, P345, DOI 10.4269/ajtmh.1989.41.345
   PASTER BJ, 1991, J BACTERIOL, V173, P6101, DOI 10.1128/JB.173.19.6101-6109.1991
   Pereira MM, 2005, AM J TROP MED HYG, V72, P13, DOI 10.4269/ajtmh.2005.72.13
   Pereira MM, 1998, EXP TOXICOL PATHOL, V50, P191, DOI 10.1016/S0940-2993(98)80083-3
   Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x
   Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607
   Picardeau M, 2008, APPL ENVIRON MICROB, V74, P319, DOI 10.1128/AEM.02172-07
   Qin JH, 2008, INFECT IMMUN, V76, P2411, DOI 10.1128/IAI.01730-07
   Que-Gewirth NLS, 2004, J BIOL CHEM, V279, P25420, DOI 10.1074/jbc.M400598200
   Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Ristow P, 2008, MICROBIOL-SGM, V154, P1309, DOI 10.1099/mic.0.2007/014746-0
   Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097
   RUGMAN FP, 1991, J CLIN PATHOL, V44, P517, DOI 10.1136/jcp.44.6.517
   Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000
   SAINTGIRONS I, 1990, RES MICROBIOL, V141, P1131, DOI 10.1016/0923-2508(90)90086-6
   Salaun L, 2006, J CLIN MICROBIOL, V44, P3954, DOI 10.1128/JCM.00336-06
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   SEGURO AC, 1990, NEPHRON, V55, P146, DOI 10.1159/000185943
   Seixas FK, 2007, VACCINE, V26, P88, DOI 10.1016/j.vaccine.2007.10.052
   Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Slack A, 2006, J MED MICROBIOL, V55, P1549, DOI 10.1099/jmm.0.46779-0
   Srimanote P, 2008, J MICROBIOL METH, V72, P73, DOI 10.1016/j.mimet.2007.10.012
   STAMM LV, 1991, APPL ENVIRON MICROB, V57, P183, DOI 10.1128/AEM.57.1.183-189.1991
   STERLING CR, 1981, VET PATHOL, V18, P628, DOI 10.1177/030098588101800508
   Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188
   Tajiki MH, 1996, CLIN INFECT DIS, V23, P1177, DOI 10.1093/clinids/23.5.1177
   Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056
   THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39
   THOMAS DD, 1990, INFECT IMMUN, V58, P581, DOI 10.1128/IAI.58.3.581-585.1990
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Truccolo J, 2001, FEMS MICROBIOL LETT, V204, P317, DOI 10.1111/j.1574-6968.2001.tb10904.x
   Trueba G, 2004, INT MICROBIOL, V7, P35
   Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006
   Verma A, 2008, CLIN VACCINE IMMUNOL, V15, P1019, DOI 10.1128/CVI.00203-07
   Vernel-Pauillac F, 2006, INFECT IMMUN, V74, P4172, DOI 10.1128/IAI.00447-06
   Viratyosin W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-181
   Viriyakosol S, 2006, INFECT IMMUN, V74, P887, DOI 10.1128/IAI.74.2.887-895.2006
   Vivian JP, 2009, J MOL BIOL, V387, P1229, DOI 10.1016/j.jmb.2009.02.038
   Wagenaar JFP, 2007, TROP MED INT HEALTH, V12, P111, DOI 10.1111/j.1365-3156.2006.01792.x
   Weil A, 1886, DTSCH ARCH KLIN MED, V39, P209
   Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354
   Wu MS, 2004, NEPHROL DIAL TRANSPL, V19, P2472, DOI 10.1093/ndt/gfh452
   Xue F, 2009, MICROBES INFECT, V11, P328, DOI 10.1016/j.micinf.2008.12.007
   Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008
   Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119
   Yang GG, 2005, J FORMOS MED ASSOC, V104, P759
   Yang HL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-293
   YELTON DB, 1986, J BACTERIOL, V165, P41, DOI 10.1128/jb.165.1.41-46.1986
   YURI K, 1993, INFECT IMMUN, V61, P2270, DOI 10.1128/IAI.61.5.2270-2272.1993
   Zuerner RL, 2009, J CLIN MICROBIOL, V47, P1202, DOI 10.1128/JCM.01639-08
NR 157
TC 368
Z9 388
U1 1
U2 53
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD OCT
PY 2009
VL 7
IS 10
BP 736
EP 747
DI 10.1038/nrmicro2208
PG 12
WC Microbiology
SC Microbiology
GA 494QU
UT WOS:000269831000018
PM 19756012
OA Green Accepted
DA 2020-11-30
ER

PT J
AU Cerqueira, GM
   McBride, AJA
   Picardeau, M
   Ribeiro, SG
   Moreira, AN
   Morel, V
   Reis, MG
   Ko, AI
   Dellagostin, OA
AF Cerqueira, Gustavo M.
   McBride, Alan J. A.
   Picardeau, Mathieu
   Ribeiro, Samuel G.
   Moreira, Angela N.
   Morel, Viviane
   Reis, Mitermayer G.
   Ko, Albert I.
   Dellagostin, Odir A.
TI Distribution of the leptospiral immunoglobulin-like (lig) genes in
   pathogenic Leptospira species and application of ligB to typing
   leptospiral isolates
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
ID FIELD GEL-ELECTROPHORESIS; ARBITRARILY PRIMED PCR; REAL-TIME PCR;
   PROTECTIVE IMMUNITY; PROTEIN-A; FAMILY LEPTOSPIRACEAE; HAMSTER MODEL; SP
   NOV.; IDENTIFICATION; INTERROGANS
AB The family of leptospiral immunoglobulin-like (lig) genes comprises figA, ligB and ligC. This study used PCR to demonstrate the presence of fig genes among serovars from a collection of leptospiral strains and clinical isolates. Whilst ligA and ligC appeared to be present in a limited number of pathogenic serovars, the ligB gene was distributed ubiquitously among all pathogenic strains. None of the fig genes were detected among intermediate or saprophytic Leptospira species. It was also shown that, similar to the previously characterized secY gene, a short specific PCR fragment of ligB could be used to correctly identify pathogenic Leptospira species. These findings demonstrate that ligB is widely present among pathogenic strains and may be useful for their reliable identification and classification.
C1 [Cerqueira, Gustavo M.; Ribeiro, Samuel G.; Moreira, Angela N.; Dellagostin, Odir A.] Univ Fed Pelotas, Ctr Biotechnol, BR-96010900 Pelotas, RS, Brazil.
   [Cerqueira, Gustavo M.; Picardeau, Mathieu; Morel, Viviane] Inst Pasteur, Unite Biol Spirochetes, F-75015 Paris, France.
   [McBride, Alan J. A.; Reis, Mitermayer G.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Cerqueira, GM (corresponding author), Univ Fed Pelotas, Ctr Biotechnol, POB 354, BR-96010900 Pelotas, RS, Brazil.
EM gcenbiot@ufpel.edu.br
RI Dellagostin, Odir/C-2331-2009; Cerqueira, Gustavo/B-7180-2015; Moreira,
   Angela/D-1278-2019; McBride, Alan/D-4106-2012; Reis,
   Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Dellagostin, Odir/0000-0003-2803-4088; Cerqueira,
   Gustavo/0000-0002-3029-6899; Moreira, Angela/0000-0001-5347-8559;
   McBride, Alan/0000-0001-9682-540X; Reis, Mitermayer/0000-0002-3051-9060;
   Ko, Albert Icksang/0000-0001-9023-2339; Goncalves-Ribeiro,
   Samuel/0000-0002-0261-3965
FU CAPES FoundationCAPES; Brazilian Ministry of Education; Bio-Manguinhos;
   Oswaldo Cruz Foundation [09224-7, PDTIS RVR05]; Brazilian National
   Research CouncilNational Council for Scientific and Technological
   Development (CNPq) [01.06.0298.00, 3773/2005, 420067/2005, 554788/2006,
   473006/2006-5]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01
   AI052473, 2D43 TW00919]; Institut Pasteur; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473] Funding Source: NIH
   RePORTER
FX G. M. C. was supported by the CAPES Foundation, Brazilian Ministry of
   Education. This work was supported by Bio-Manguinhos, Oswaldo Cruz
   Foundation (09224-7 and PDTIS RVR05), the Brazilian National Research
   Council (grants 01.06.0298.00 3773/2005, 420067/2005, 554788/2006,
   473006/2006-5), the National Institutes of Health (5R01 AI052473, 2D43
   TW00919), and the Institut Pasteur.
CR Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839
   Brown PD, 1997, J MED MICROBIOL, V46, P173, DOI 10.1099/00222615-46-2-173
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029
   Faisal SM, 2009, VACCINE, V27, P378, DOI 10.1016/j.vaccine.2008.10.089
   Galloway RL, 2008, AM J TROP MED HYG, V78, P628, DOI 10.4269/ajtmh.2008.78.628
   Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004
   HERRMANN JL, 1992, J CLIN MICROBIOL, V30, P1696, DOI 10.1128/JCM.30.7.1696-1702.1992
   HOOKEY JV, 1993, J GEN MICROBIOL, V139, P2585, DOI 10.1099/00221287-139-11-2585
   Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x
   Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Levett PN, 2003, CLIN INFECT DIS, V36, P447, DOI 10.1086/346208
   Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196
   Majed Z, 2005, J CLIN MICROBIOL, V43, P539, DOI 10.1128/JCM.43.2.539-545.2005
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213
   McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012
   Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006
   Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002
   Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   PEROLAT P, 1994, J CLIN MICROBIOL, V32, P1949, DOI 10.1128/JCM.32.8.1949-1957.1994
   Postic D, 2000, RES MICROBIOL, V151, P333, DOI 10.1016/S0923-2508(00)00156-X
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Salaun L, 2006, J CLIN MICROBIOL, V44, P3954, DOI 10.1128/JCM.00336-06
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Slack AT, 2008, INT J SYST EVOL MICR, V58, P2305, DOI 10.1099/ijs.0.64947-0
   Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95
   Slack Andrew T, 2005, Ann Clin Microbiol Antimicrob, V4, P10, DOI 10.1186/1476-0711-4-10
   Srimanote P, 2008, J MICROBIOL METH, V72, P73, DOI 10.1016/j.mimet.2007.10.012
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752
   Vijayachari P, 2004, J CLIN MICROBIOL, V42, P3575, DOI 10.1128/jcm.42.8.3575-3580.2004
   Wangroongsarb P, 2007, FEMS MICROBIOL LETT, V271, P170, DOI 10.1111/j.1574-6968.2007.00711.x
   Yan WW, 2009, MICROBES INFECT, V11, P230, DOI 10.1016/j.micinf.2008.11.008
   YASUDA PH, 1987, INT J SYST BACTERIOL, V37, P407, DOI 10.1099/00207713-37-4-407
NR 52
TC 36
Z9 38
U1 0
U2 7
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD SEP
PY 2009
VL 58
IS 9
BP 1173
EP 1181
DI 10.1099/jmm.0.009175-0
PG 9
WC Microbiology
SC Microbiology
GA 492RF
UT WOS:000269676200008
PM 19528180
OA Green Published
DA 2020-11-30
ER

PT J
AU Santos, MS
   Ribeiro, GD
   Oliveira, TQ
   Santos, RCN
   Gouveia, E
   Salgado, K
   Takahashi, D
   Fontes, C
   Campos, LC
   Reis, MG
   Ko, AI
   Reis, JN
AF Santos, Milena Soares
   Ribeiro, Guilherme de Sousa
   Oliveira, Tainara Queiroz
   Nery Santos, Renan Cardoso
   Gouveia, Edilane
   Salgado, Katia
   Takahashi, Daniele
   Fontes, Cleuber
   Campos, Leila Carvalho
   Reis, Mitermayer Galvao
   Ko, Albert Icksang
   Reis, Joice Neves
TI Burden of group A streptococcal meningitis in Salvador, Brazil: report
   of 11 years of population-based surveillance
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Streptococcus pyogenes; Group A streptococcus; Meningitis; M typing
ID SHOCK-LIKE SYNDROME; MOLECULAR CHARACTERIZATION; CHANGING EPIDEMIOLOGY;
   PYOGENES MENINGITIS; UNITED-STATES; EMM TYPE; INFECTIONS; DISEASE;
   FEATURES
AB Background: Over recent decades, a resurgence of invasive group A streptococcal (GAS) infections has been observed; GAS remains a rare cause of pyogenic meningitis. We report herein population-based findings of long-term surveillance for GAS meningitis in Salvador, Brazil, and estimate the overall burden of invasive GAS infections.
   Methods: From February 1996 to February 2007 we conducted active surveillance for GAS meningitis in the state reference hospital for infectious diseases in Salvador, Brazil. Data on clinical presentation, laboratory records, and outcome were collected through interviews and chart review. GAS isolates were evaluated for antimicrobial susceptibility and emm type.
   Results: We identified 20 cases of GAS meningitis, which accounted for 0.9% of all culture-proven bacterial meningitis in the study period. The mean annual incidence of GAS meningitis was 0.03 cases per 100 000 population in metropolitan Salvador and peaked in children <1 year of age (0.67 cases per 100 000 population). Among 17 cases with clinical information available, 41% required intensive care unit support and 25% died. Tested isolates were susceptible to penicillin and exhibited large emm type diversity. Based on the incidence of GAS meningitis, we estimate that the annual incidence of GAS infection is 3 cases per 100 000 population in metropolitan Salvador.
   Conclusions: Although rare, GAS is a life-threatening cause of bacterial meningitis. Knowledge of the incidence and emm type variability of the disease is necessary for planning immunization strategies. (C) 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Santos, Milena Soares; Ribeiro, Guilherme de Sousa; Oliveira, Tainara Queiroz; Nery Santos, Renan Cardoso; Gouveia, Edilane; Takahashi, Daniele; Reis, Mitermayer Galvao; Ko, Albert Icksang; Reis, Joice Neves] Fundacao Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, Minist Saude, BR-40296710 Salvador, BA, Brazil.
   [Salgado, Katia] Hosp Couto Maia, Secretaria Saude Estado Bahia, Salvador, BA, Brazil.
   [Fontes, Cleuber; Reis, Joice Neves] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
   [Campos, Leila Carvalho] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Minist Saude, Rio De Janeiro, Brazil.
   [Ko, Albert Icksang] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Reis, JN (corresponding author), Fundacao Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, Minist Saude, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM joice@bahia.flocruz.br
RI Ribeiro, Guilherme/B-6624-2008; Ko, Albert Icksang/P-2343-2015; Reis,
   Joice N/H-9227-2013; Reis, Mitermayer/AAO-9742-2020
OI Ribeiro, Guilherme/0000-0002-6798-2059; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060;
   Santos, Milena Soares/0000-0002-1995-140X
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq) [491345/2005-4]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW007303, R01TW007303, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, R01TW007303, D43TW000919, R01TW007303, D43TW000919,
   D43TW000919, D43TW000919, R01TW007303, D43TW000919, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER
FX Funding: This study was supported by grants from the Brazilian National
   Research Council (491345/2005-4), Research Support Foundation for the
   State of Bahia (FAPESB - 1431040054051), and National Institute of
   Health, USA (D43 TW00919 and R01 TW007303).
CR Abdissa A, 2006, CLIN INFECT DIS, V42, P1362, DOI 10.1086/503422
   Arnoni MV, 2007, BRAZ J INFECT DIS, V11, P375, DOI 10.1590/S1413-86702007000300015
   Baraldes MA, 1999, EUR J CLIN MICROBIOL, V18, P572, DOI 10.1007/s100960050349
   Berner R, 2000, EUR J PEDIATR, V159, P527, DOI 10.1007/s004310051325
   Brugha R, 2002, LANCET, V359, P435, DOI 10.1016/S0140-6736(02)07607-9
   CARAPETIS J, 1995, CLIN INFECT DIS, V21, P1220, DOI 10.1093/clinids/21.5.1220
   Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X
   *CDCP, PROT EMM TYP
   Centers for Disease Control and Prevention, STREPT PYOG EMM SEQ
   CHOW JW, 1992, CLIN INFECT DIS, V14, P418, DOI 10.1093/clinids/14.2.418
   Clinical and Laboratory Standards Institute (CLSI), 2002, M100S12 CLSI, V22
   COLMAN G, 1993, J MED MICROBIOL, V39, P165, DOI 10.1099/00222615-39-3-165
   Descheemaeker P, 2000, J MED MICROBIOL, V49, P467, DOI 10.1099/0022-1317-49-5-467
   Ekelund K, 2005, J CLIN MICROBIOL, V43, P3101, DOI 10.1128/JCM.43.7.3101-3109.2005
   HOGE CW, 1993, JAMA-J AM MED ASSOC, V269, P384, DOI 10.1001/jama.269.3.384
   *IBGE, 2000, ANN EST BRAS, V56
   Ikebe T, 2007, EPIDEMIOL INFECT, V135, P1227, DOI 10.1017/S0950268807007984
   Lamagni TL, 2008, EMERG INFECT DIS, V14, P202, DOI 10.3201/eid1402.070888
   Laupland KB, 2006, CLIN MICROBIOL INFEC, V12, P224, DOI 10.1111/j.1469-0691.2005.01345.x
   O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264
   Perera Nelun, 2005, J Infect, V51, pE1, DOI 10.1016/j.jinf.2004.06.006
   PIMTANOTHAI N, 1999, J MED ASS THAI S1, V85, P5371
   Rivera A, 2006, J MED MICROBIOL, V55, P1115, DOI 10.1099/jmm.0.46481-0
   Rogers S, 2007, J INFECT DIS, V195, P1625, DOI 10.1086/513875
   SCHLECH WF, 1985, JAMA-J AM MED ASSOC, V253, P1749, DOI 10.1001/jama.253.12.1749
   SCHWARTZ B, 1990, LANCET, V336, P1167, DOI 10.1016/0140-6736(90)92777-F
   Smeesters PR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000010
   Sommer R, 1999, CLIN INFECT DIS, V29, P929, DOI 10.1086/520461
   STEER AC, 2007, EPIDEMIOL INFECT, P1
   STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101
   Tanna A, 2006, J MED MICROBIOL, V55, P1419, DOI 10.1099/jmm.0.46465-0
   van de Beek D, 2002, CLIN INFECT DIS, V34, pE32, DOI 10.1086/339941
   PNEUMO ADIP
NR 33
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2009
VL 13
IS 4
BP 456
EP 461
DI 10.1016/j.ijid.2008.09.006
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA 469EL
UT WOS:000267878400012
PM 19019714
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Silva, EF
   Cerqueira, GM
   Seyffert, N
   Seixas, FK
   Hartwig, DD
   Athanazio, DA
   Pinto, LS
   Queiroz, A
   Ko, AI
   Brod, CS
   Dellagostin, OA
AF Silva, Everton F.
   Cerqueira, Gustavo M.
   Seyffert, Nubia
   Seixas, Fabiana K.
   Hartwig, Daiane D.
   Athanazio, Daniel A.
   Pinto, Luciano S.
   Queiroz, Adriano
   Ko, Albert I.
   Brod, Claudiomar S.
   Dellagostin, Odir A.
TI Leptospira noguchii and Human and Animal Leptospirosis, Southern Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Silva, Everton F.] Univ Fed Pelotas, Ctr Biotecnol, BR-96010900 Pelotas, RS, Brazil.
   [Athanazio, Daniel A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Athanazio, Daniel A.; Queiroz, Adriano; Ko, Albert I.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA.
RP Silva, EF (corresponding author), Univ Fed Pelotas, Ctr Biotecnol, Campus Univ,Cx Postal 354, BR-96010900 Pelotas, RS, Brazil.
EM efsilva@ufpel.edu.br
RI Seyffert, Nubia/N-6410-2014; da Silva Pinto, Luciano/M-9913-2019;
   Athanazio, Daniel/P-6622-2014; Queiroz, Adriano/AAQ-1164-2020;
   Cerqueira, Gustavo/B-7180-2015; Seixas, Fabiana Kommling/X-2706-2018;
   Dellagostin, Odir/C-2331-2009; Ko, Albert Icksang/P-2343-2015
OI Seyffert, Nubia/0000-0002-2193-6508; da Silva Pinto,
   Luciano/0000-0001-8656-4031; Queiroz, Adriano/0000-0003-0080-6509;
   Cerqueira, Gustavo/0000-0002-3029-6899; Seixas, Fabiana
   Kommling/0000-0003-4204-2500; Dellagostin, Odir/0000-0003-2803-4088; Ko,
   Albert Icksang/0000-0001-9023-2339
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW000919] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI052473] Funding Source: Medline
CR Barcellos Christovam, 2003, Cad. Saúde Pública, V19, P1283, DOI 10.1590/S0102-311X2003000500007
   Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FRASER DW, 1973, ANN INTERN MED, V79, P786, DOI 10.7326/0003-4819-79-6-786
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Salaun L, 2006, J CLIN MICROBIOL, V44, P3954, DOI 10.1128/JCM.00336-06
   Silva EF, 2007, VET MICROBIOL, V121, P144, DOI 10.1016/j.vetmic.2006.11.010
NR 7
TC 23
Z9 24
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2009
VL 15
IS 4
BP 621
EP 623
DI 10.3201/eid1504.071669
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 425NR
UT WOS:000264644900029
PM 19331754
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Murray, GL
   Srikram, A
   Hoke, DE
   Wunder, EA
   Henry, R
   Lo, M
   Zhang, KK
   Sermswan, RW
   Ko, AI
   Adler, B
AF Murray, Gerald L.
   Srikram, Amporn
   Hoke, David E.
   Wunder, Elsio A., Jr.
   Henry, Rebekah
   Lo, Miranda
   Zhang, Kunkun
   Sermswan, Rasana W.
   Ko, Albert I.
   Adler, Ben
TI Major Surface Protein LipL32 Is Not Required for Either Acute or Chronic
   Infection with Leptospira interrogans
SO INFECTION AND IMMUNITY
LA English
DT Article
ID OUTER-MEMBRANE PROTEINS; MUTAGENESIS; GENE; IDENTIFICATION; LIPOPROTEIN;
   TRANSPOSON; EVOLUTION; HEMOLYSIN
AB Leptospira interrogans is responsible for leptospirosis, a zoonosis of worldwide distribution. LipL32 is the major outer membrane protein of pathogenic leptospires, accounting for up to 75% of total outer membrane protein. In recent times LipL32 has become the focus of intense study because of its surface location, dominance in the host immune response, and conservation among pathogenic species. In this study, an lipL32 mutant was constructed in L. interrogans using transposon mutagenesis. The lipL32 mutant had normal morphology and growth rate compared to the wild type and was equally adherent to extracellular matrix. Protein composition of the cell membranes was found to be largely unaffected by the loss of LipL32, with no obvious compensatory increase in other proteins. Microarray studies found no obvious stress response or upregulation of genes that may compensate for the loss of LipL32 but did suggest an association between LipL32 and the synthesis of heme and vitamin B-12. When hamsters were inoculated by systemic and mucosal routes, the mutant caused acute severe disease manifestations that were indistinguishable from wild-type L. interrogans infection. In the rat model of chronic infection, the LipL32 mutant colonized the renal tubules as efficiently as the wild-type strain. In conclusion, this study showed that LipL32 does not play a role in either the acute or chronic models of infection. Considering the abundance and conservation of LipL32 among all pathogenic Leptospira spp. and its absence in saprophytic Leptospira, this finding is remarkable. The role of this protein in leptospiral biology and pathogenesis thus remains elusive.
C1 [Murray, Gerald L.; Hoke, David E.; Henry, Rebekah; Lo, Miranda; Adler, Ben] Monash Univ, Dept Microbiol, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia.
   [Zhang, Kunkun; Adler, Ben] Monash Univ, Dept Microbiol, Australian Res Council Ctr Excellence Struct & Fu, Clayton, Vic 3800, Australia.
   [Srikram, Amporn] Khon Kaen Univ, Fac Med, Melioidosis Res Ctr, Khon Kaen 40002, Thailand.
   [Sermswan, Rasana W.] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen 40002, Thailand.
   [Wunder, Elsio A., Jr.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, BR-40296 Salvador, BA, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Adler, B (corresponding author), Monash Univ, Dept Microbiol, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia.
EM ben.adler@med.monash.edu.au
RI Ko, Albert Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013
OI Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511; Murray, Gerald/0000-0003-3330-4433; Henry,
   Rebekah/0000-0001-6530-8557
FU National Health and Medical Research Council (NHMRC) AustraliaNational
   Health and Medical Research Council of Australia; Australian Research
   CouncilAustralian Research Council; Brazilian National Research
   CouncilNational Council for Scientific and Technological Development
   (CNPq) [420067/2005]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 AI052473, R01 AI034431, D43 TW00919]; NHMRC Peter Doherty
   FellowshipNational Health and Medical Research Council of Australia;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI034431, R01AI052473,
   R01AI034431, R01AI034431, R01AI034431, R01AI034431, R01AI052473,
   R01AI052473, R01AI034431, R01AI052473, R01AI052473, R01AI034431,
   R01AI052473, R01AI034431, R01AI034431, R01AI052473, R01AI052473,
   R01AI034431, R01AI034431, R01AI034431, R01AI034431] Funding Source: NIH
   RePORTER
FX This work was supported by the National Health and Medical Research
   Council (NHMRC) Australia, Australian Research Council, the Brazilian
   National Research Council (Instituto Milenio 420067/2005), and the
   National Institutes of Health (R01 AI052473, R01 AI034431, and D43
   TW00919). G. L. M. is supported by an NHMRC Peter Doherty Fellowship.
CR Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012
   Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70
   Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06
   Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005
   Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001
   Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005
   Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004
   Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07
   Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07
   Lee SH, 2000, GENE, V254, P19, DOI 10.1016/S0378-1119(00)00293-6
   Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0
   Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06
   Morton DJ, 1999, INFECT IMMUN, V67, P2729, DOI 10.1128/IAI.67.6.2729-2739.1999
   Murray GL, 2008, MICROBES INFECT, V10, P791, DOI 10.1016/j.micinf.2008.04.010
   Murray GL, 2009, MICROBES INFECT, V11, P311, DOI 10.1016/j.micinf.2008.11.014
   Murray GL, 2009, INFECT IMMUN, V77, P810, DOI 10.1128/IAI.01293-08
   Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06
   Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607
   Ristow P, 2008, MICROBIOL-SGM, V154, P1309, DOI 10.1099/mic.0.2007/014746-0
   Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097
   Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200
   Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188
   Xu QL, 2008, MOL MICROBIOL, V69, P15, DOI 10.1111/j.1365-2958.2008.06264.x
NR 33
TC 80
Z9 83
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD MAR
PY 2009
VL 77
IS 3
BP 952
EP 958
DI 10.1128/IAI.01370-08
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 408DZ
UT WOS:000263416700004
PM 19103763
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU McBride, AJA
   Cerqueira, GM
   Suchard, MA
   Moreira, AN
   Zuerner, RL
   Reis, MG
   Haake, DA
   Ko, AI
   Dellagostin, OA
AF McBride, Alan J. A.
   Cerqueira, Gustavo M.
   Suchard, Marc A.
   Moreira, Angela N.
   Zuerner, Richard L.
   Reis, Mitermayer G.
   Haake, David A.
   Ko, Albert I.
   Dellagostin, Odir A.
TI Genetic diversity of the Leptospiral immunoglobulin-like (Lig) genes in
   pathogenic Leptospira spp.
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Leptospirosis; Lig; Pathogenesis; Molecular evolution; Sequence analysis
ID SURFACE-EXPOSED LIPOPROTEIN; OUTER-MEMBRANE PROTEIN; MOLECULAR-CLONING;
   SEQUENCE-ANALYSIS; NUCLEOTIDE-SEQUENCES; MAMMALIAN INFECTION; PROTECTIVE
   IMMUNITY; BINDING PROTEIN; URBAN EPIDEMIC; HAMSTER MODEL
AB Recent serologic, immunoprotection, and pathogenesis studies identified the Lig proteins as key virulence determinants in interactions of leptospiral pathogens with the mammalian host. We examined the sequence variation and recombination patterns of ligA, ligB, and ligC among 10 pathogenic strains from five Leptospira species. All strains were found to have intact ligB genes and genetic drift accounting for most of the ligB genetic diversity observed. The ligA gene was found exclusively in L. interrogans and L. kirschneri strains, and was created from ligB by a two-step partial gene duplication process. The aminoterminal domain of LigB and the LigA paralog were essentially identical (98.5 +/- 0.8% mean identity) in strains with both genes. Like ligB, ligC gene variation also followed phylogenetic patterns, suggesting an early gene duplication event. However, ligC is a pseudogene in several strains, suggesting that LigC is not essential for virulence. Two ligB genes and one ligC gene had mosaic compositions and evidence for recombination events between related Leptospira species was also found for some ligA genes. In conclusion, the results presented here indicate that Lig diversity has important ramifications for the selection of Lig polypeptides for use in diagnosis and as vaccine candidates. This sequence information will aid the identification of highly conserved regions within the Lig proteins and improve upon the performance characteristics of the Lig proteins in diagnostic assays and in subunit vaccine formulations with the potential to confer heterologous protection. (C) 2008 Elsevier B.V. All rights reserved.
C1 [McBride, Alan J. A.; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Cerqueira, Gustavo M.; Moreira, Angela N.; Dellagostin, Odir A.] Univ Fed Pelotas, Ctr Biotecnol, Pelotas, RS, Brazil.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.
   [Suchard, Marc A.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA.
   [Zuerner, Richard L.] USDA ARS, Natl Anim Dis Ctr, Ames, IA 50010 USA.
   [Haake, David A.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Dellagostin, OA (corresponding author), Univ Fed Pelotas, Ctr Biotecnol, Pelotas, RS, Brazil.
EM odir@ufpel.edu.br
RI McBride, Alan/D-4106-2012; Cerqueira, Gustavo/B-7180-2015; Reis,
   Mitermayer/AAO-9742-2020; Moreira, Angela/D-1278-2019; Dellagostin,
   Odir/C-2331-2009; Ko, Albert Icksang/P-2343-2015
OI McBride, Alan/0000-0001-9682-540X; Cerqueira,
   Gustavo/0000-0002-3029-6899; Reis, Mitermayer/0000-0002-3051-9060;
   Moreira, Angela/0000-0001-5347-8559; Dellagostin,
   Odir/0000-0003-2803-4088; Ko, Albert Icksang/0000-0001-9023-2339
FU Bio-Manguinhos; Oswaldo Cruz Foundation; Brazilian Ministry of Health
   [09224-7]; Brazilian National Research CouncilNational Council for
   Scientific and Technological Development (CNPq) [01.06.0298.00
   3773/2005, 420067/2005, 554788/2006, 473006/2006-5]; Public Health
   ServiceUnited States Public Health Service [AI-34431]; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R01
   AI034431]; VA Medical Research FundsUS Department of Veterans Affairs;
   Fogarty International CenterUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43 TW00919]; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; Alfred P. Sloane Research Fellowship;
   John Simon Guggenheim Memorial Fellowship; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI034431, R01AI034431,
   R01AI034431, R29AI034431, R01AI034431, R29AI034431, R01AI034431,
   R29AI034431, R01AI034431, R01AI034431, R01AI034431, R01AI034431,
   R01AI034431, R01AI034431, R01AI034431, R29AI034431, R01AI034431,
   R29AI034431, R21AI034431] Funding Source: NIH RePORTER
FX This work was supported by Bio-Manguinhos, Oswaldo Cruz Foundation,
   Brazilian Ministry of Health (grant 09224-7), Brazilian National
   Research Council (grants 01.06.0298.00 3773/2005, 420067/2005,
   554788/2006 and 473006/2006-5); Public Health Service grants AI-34431
   (to D.A.H.) and R01 AI034431 (to A.I.K.) from the National Institute of
   Allergy and Infectious Diseases, the VA Medical Research Funds(to
   D.A.H.) and grant D43 TW00919 (to A.I.K.) from the Fogarty International
   Center, National Institutes of Health. M.A.S. is supported by an Alfred
   P. Sloane Research Fellowship and a John Simon Guggenheim Memorial
   Fellowship.
CR Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   COLE JR, 1973, APPL MICROBIOL, V25, P976, DOI 10.1128/AEM.25.6.976-980.1973
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005
   Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003
   Drummond A.J., 2007, GENEIOUS V3 5
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Gonzales MJ, 2002, BIOINFORMATICS, V18, P886, DOI 10.1093/bioinformatics/18.6.886
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998
   HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993
   Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942
   Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291
   HOOKEY JV, 1993, J GEN MICROBIOL, V139, P2585, DOI 10.1099/00221287-139-11-2585
   Hsieh WJ, 2005, FEMS MICROBIOL LETT, V243, P339, DOI 10.1016/j.femsle.2004.12.021
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Karande S, 2005, J TROP PEDIATRICS, V51, P174, DOI 10.1093/tropej/fmh100
   Karande S, 2003, ARCH DIS CHILD, V88, P1070, DOI 10.1136/adc.88.12.1070
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   Koizumi N, 2003, FEMS MICROBIOL LETT, V226, P215, DOI 10.1016/S0378-1097(03)00619-0
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   LI WH, 1988, MOL BIOL EVOL, V5, P313
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2006, MICROBIOL-SGM, V152, P3777, DOI 10.1099/mic.0.29162-0
   Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Minin VN, 2005, BIOINFORMATICS, V21, P3034, DOI 10.1093/bioinformatics/bti459
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Nei M., 2000, MOL EVOLUTION PHYLOG
   Ochman H, 2006, SCIENCE, V311, P1730, DOI 10.1126/science.1119966
   Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   Peacock SJ, 2008, T ROY SOC TROP MED H, V102, P5, DOI 10.1016/j.trstmh.2007.06.004
   Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002
   Sambrook J., 2001, MOL CLONING LAB MANU
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996
   Silva EF, 2008, VACCINE, V26, P3892, DOI 10.1016/j.vaccine.2008.04.085
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Srimanote P, 2008, J MICROBIOL METH, V72, P73, DOI 10.1016/j.mimet.2007.10.012
   Suchard MA, 2003, J AM STAT ASSOC, V98, P427, DOI 10.1198/016214503000215
   Suchard MA, 2002, SYST BIOL, V51, P715, DOI 10.1080/10635150290102384
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006
   Yanagihara Y, 2007, COMP IMMUNOL MICROB, V30, P399, DOI 10.1016/j.cimid.2007.05.003
   Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618
NR 67
TC 53
Z9 54
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD MAR
PY 2009
VL 9
IS 2
BP 196
EP 205
DI 10.1016/j.meegid.2008.10.012
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA 417BL
UT WOS:000264049400006
PM 19028604
OA Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Murray, GL
   Morel, V
   Cerqueira, GM
   Croda, J
   Srikram, A
   Henry, R
   Ko, AI
   Dellagostin, OA
   Bulach, DM
   Sermswan, RW
   Adler, B
   Picardeau, M
AF Murray, Gerald L.
   Morel, Viviane
   Cerqueira, Gustavo M.
   Croda, Julio
   Srikram, Amporn
   Henry, Rebekah
   Ko, Albert I.
   Dellagostin, Odir A.
   Bulach, Dieter M.
   Sermswan, Rasana W.
   Adler, Ben
   Picardeau, Mathieu
TI Genome-Wide Transposon Mutagenesis in Pathogenic Leptospira Species
SO INFECTION AND IMMUNITY
LA English
DT Article
ID RANDOM INSERTIONAL MUTAGENESIS; INTERROGANS; BIFLEXA; IRON; VIRULENCE;
   GENE; CONSTRUCTION; INACTIVATION; SUPERFAMILY; INSIGHTS
AB Leptospira interrogans is the most common cause of leptospirosis in humans and animals. Genetic analysis of L. interrogans has been severely hindered by a lack of tools for genetic manipulation. Recently we developed the mariner-based transposon Himar1 to generate the first defined mutants in L. interrogans. In this study, a total of 929 independent transposon mutants were obtained and the location of insertion determined. Of these mutants, 721 were located in the protein coding regions of 551 different genes. While sequence analysis of transposon insertion sites indicated that transposition occurred in an essentially random fashion in the genome, 25 unique transposon mutants were found to exhibit insertions into genes encoding 16S or 23S rRNAs, suggesting these genes are insertional hot spots in the L. interrogans genome. In contrast, loci containing notionally essential genes involved in lipopolysaccharide and heme biosynthesis showed few transposon insertions. The effect of gene disruption on the virulence of a selected set of defined mutants was investigated using the hamster model of leptospirosis. Two attenuated mutants with disruptions in hypothetical genes were identified, thus validating the use of transposon mutagenesis for the identification of novel virulence factors in L. interrogans. This library provides a valuable resource for the study of gene function in L. interrogans. Combined with the genome sequences of L. interrogans, this provides an opportunity to investigate genes that contribute to pathogenesis and will provide a better understanding of the biology of L. interrogans.
C1 [Morel, Viviane; Cerqueira, Gustavo M.; Croda, Julio; Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, F-75724 Paris 15, France.
   [Murray, Gerald L.; Henry, Rebekah; Bulach, Dieter M.; Adler, Ben] Monash Univ, Dept Microbiol, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia.
   [Cerqueira, Gustavo M.; Dellagostin, Odir A.] Univ Fed Pelotas, Ctr Biotechnol, BR-96010900 Pelotas, RS, Brazil.
   [Croda, Julio; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Srikram, Amporn] Khon Kaen Univ, Fac Med, Melioidosis Res Ctr, Khon Kaen 40002, Thailand.
   [Ko, Albert I.] Cornell Univ, Div Int Med & Infect Dis, Weill Med Coll, New York, NY 10021 USA.
   [Sermswan, Rasana W.] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen 40002, Thailand.
   [Adler, Ben] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Dept Microbiol, Clayton, Vic 3800, Australia.
RP Picardeau, M (corresponding author), Inst Pasteur, Unite Biol Spirochetes, 28 Rue Docteur Roux, F-75724 Paris 15, France.
EM ben.adler@med.monash.edu.au; mpicard@pasteur.fr
RI Croda, Julio/I-5172-2013; Ko, Albert Icksang/P-2343-2015; Bulach, Dieter
   M/D-5793-2011; Dellagostin, Odir/C-2331-2009; Cerqueira,
   Gustavo/B-7180-2015
OI Croda, Julio/0000-0002-6665-6825; Ko, Albert
   Icksang/0000-0001-9023-2339; Bulach, Dieter M/0000-0001-9823-6078;
   Dellagostin, Odir/0000-0003-2803-4088; Cerqueira,
   Gustavo/0000-0002-3029-6899; Henry, Rebekah/0000-0001-6530-8557; Murray,
   Gerald/0000-0003-3330-4433
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [2 D43 TW-00919, D43 TW000919] Funding Source: Medline; NIAID NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [2 R01 AI034431, R01 AI052473, R01 AI034431,
   5 R01 AI052473] Funding Source: Medline; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, R01AI034431,
   R01AI034431, R01AI034431, R01AI052473, R01AI034431, R01AI052473,
   R01AI034431, R01AI034431, R01AI034431, R01AI052473, R01AI034431,
   R01AI034431, R01AI034431, R01AI052473, R01AI052473, R01AI052473,
   R01AI034431, R01AI052473, R01AI052473, R01AI052473, R01AI034431,
   R01AI052473, R01AI034431] Funding Source: NIH RePORTER
CR Asuthkar S, 2007, INFECT IMMUN, V75, P4582, DOI 10.1128/IAI.00324-07
   Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   Chiang SL, 2002, GENE, V296, P179, DOI 10.1016/S0378-1119(02)00856-9
   Croda J, 2008, INFECT IMMUN, V76, P5826, DOI 10.1128/IAI.00989-08
   Donahue JP, 2000, MOL MICROBIOL, V37, P1066, DOI 10.1046/j.1365-2958.2000.02036.x
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Etienne G, 2005, MICROBIOL-SGM, V151, P2075, DOI 10.1099/mic.0.27869-0
   Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004
   Harper M, 2004, INFECT IMMUN, V72, P3436, DOI 10.1128/IAI.72.6.3436-3443.2004
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Louvel H, 2006, J BACTERIOL, V188, P7893, DOI 10.1128/JB.00711-06
   Louvel H, 2005, J BACTERIOL, V187, P3249, DOI 10.1128/JB.187.9.3249-3254.2005
   LOUVEL H, 2007, GENETIC MANIPULATION
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Murray GL, 2008, MICROBES INFECT, V10, P791, DOI 10.1016/j.micinf.2008.04.010
   Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x
   Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607
   Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1
   Prod'hom G, 1998, FEMS MICROBIOL LETT, V158, P75, DOI 10.1111/j.1574-6968.1998.tb12803.x
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097
   Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000
   Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188
   Tilly K, 2000, J MOL MICROB BIOTECH, V2, P433
   Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406
NR 30
TC 78
Z9 79
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD FEB
PY 2009
VL 77
IS 2
BP 810
EP 816
DI 10.1128/IAI.01293-08
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 399CF
UT WOS:000262777300028
PM 19047402
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Salomao, R
   Pavanelli, T
   Brunialti, M
   Ko, A
AF Salomao, R.
   Pavanelli, T.
   Brunialti, M.
   Ko, A.
TI CELL SURFACE RECEPTORS EXPRESSION AND PRODUCTION OF INFLAMMATORY
   CYTOKINES BY MONOCYTES OF PATIENTS WITH LEPTOSPIROSIS
SO SHOCK
LA English
DT Meeting Abstract
CT 32nd Annual Conference on Shock
CY JUN 06-09, 2009
CL San Antonio, TX
SP Shock Soc
C1 [Salomao, R.; Pavanelli, T.; Brunialti, M.; Ko, A.] Univ Fed Sao Paulo, Escola Paulista Med, BR-04039032 Sao Paulo, Brazil.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1073-2322
J9 SHOCK
JI Shock
PY 2009
VL 31
BP 77
EP 77
PG 1
WC Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease
SC General & Internal Medicine; Hematology; Surgery; Cardiovascular System
   & Cardiology
GA 463ND
UT WOS:000267438000224
DA 2020-11-30
ER

PT J
AU Croda, J
   Medeiros, MA
   Greenwald, R
   Sun, J
   Mcbride, A
   Peacock, SJ
   Choy, HA
   Haake, DA
   Homma, A
   Reis, MG
   Esfandiari, J
   Lyashchenko, KP
   Ko, AI
AF Croda, Julio
   Medeiros, Marco A.
   Greenwald, Rena
   Sun, Jenny
   Mcbride, Alan
   Peacock, Sharon J.
   Choy, Henry A.
   Haake, David A.
   Homma, Akira
   Reis, Mitermayer G.
   Esfandiari, Javan
   Lyashchenko, Konstantin P.
   Ko, Albert I.
TI IDENTIFICATION OF IMUNODOMINANT REGIONS OF LEPTOSPIRAL
   IMMUNOGLOBUILIN-LIKE PROTEINS FOR USE IN THE DIAGNOSIS OF LEPTOSPIROSIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC 07-11, 2008
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg
C1 [Croda, Julio; Mcbride, Alan; Reis, Mitermayer G.; Ko, Albert I.] Brazilian Minist Hlth, Goncalo Moniz Inst, Oswaldo Cruz Fdn, Salvador, BA, Brazil.
   [Medeiros, Marco A.; Homma, Akira] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   [Greenwald, Rena; Sun, Jenny; Esfandiari, Javan; Lyashchenko, Konstantin P.] Chembio Diagnost Syst Inc, Medford, NY USA.
   [Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.
   [Choy, Henry A.; Haake, David A.] Univ Calif Los Angeles, Dept Med, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90024 USA.
   [Choy, Henry A.; Haake, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Ithaca, NY USA.
RI Peacock, Sharon J/ABE-6331-2020; Croda, Julio/I-5172-2013; Ko, Albert
   Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020
OI Croda, Julio/0000-0002-6665-6825; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2008
VL 79
IS 6
MA 68
BP 20
EP 21
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 382ZT
UT WOS:000261644600069
DA 2020-11-30
ER

PT J
AU Croda, J
   Figueira, CP
   Wunder, EA
   Santos, CS
   Reis, MG
   Ko, AI
   Picardeau, M
AF Croda, Julio
   Figueira, Claudio Pereira
   Wunder, Elsio A., Jr.
   Santos, Cleiton S.
   Reis, Mitermayer G.
   Ko, Albert I.
   Picardeau, Mathieu
TI Targeted Mutagenesis in Pathogenic Leptospira Species: Disruption of the
   LigB Gene Does Not Affect Virulence in Animal Models of Leptospirosis
SO INFECTION AND IMMUNITY
LA English
DT Article
ID IMMUNOGLOBULIN-LIKE PROTEINS; PROTECTIVE IMMUNITY; INTERROGANS;
   INFECTION; FIBRONECTIN; BINDING; MUTANT; INACTIVATION; LIPOPROTEIN;
   INDUCTION
AB The pathogenic mechanisms of Leptospira interrogans, the causal agent of leptospirosis, remain largely unknown. This is mainly due to the lack of tools for genetically manipulating pathogenic Leptospira species. Thus, homologous recombination between introduced DNA and the corresponding chromosomal locus has never been demonstrated for this pathogen. Leptospiral immunoglobulin-like repeat (Lig) proteins were previously identified as putative Leptospira virulence factors. In this study, a ligB mutant was constructed by allelic exchange in L. interrogans; in this mutant a spectinomycin resistance (Spc(r)) gene replaced a portion of the ligB coding sequence. Gene disruption was confirmed by PCR, immunoblot analysis, and immunofluorescence studies. The ligB mutant did not show decrease virulence compared to the wild-type strain in the hamster model of leptospirosis. In addition, inoculation of rats with the ligB mutant induced persistent colonization of the kidneys. Finally, LigB was not required to mediate bacterial adherence to cultured cells. Taken together, our data provide the first evidence of site-directed homologous recombination in pathogenic Leptospira species. Furthermore, our data suggest that LigB does not play a major role in dissemination of the pathogen in the host and in the development of acute disease manifestations or persistent renal colonization.
C1 [Croda, Julio; Figueira, Claudio Pereira; Wunder, Elsio A., Jr.; Santos, Cleiton S.; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Brazilian Minist Hlth, Salvador, BA, Brazil.
   [Croda, Julio] Univ Sao Paulo, Sch Med, Dept Pathol, Lab Pathol Transmissible Dis, Sao Paulo, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
   [Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, Paris, France.
RP Ko, AI (corresponding author), Fundacao Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Reis, Mitermayer/AAO-9742-2020; Croda, Julio/I-5172-2013; Ko, Albert
   Icksang/P-2343-2015; Wunder, Elsio Augusto/C-2733-2013
OI Reis, Mitermayer/0000-0002-3051-9060; Croda, Julio/0000-0002-6665-6825;
   Ko, Albert Icksang/0000-0001-9023-2339; Wunder, Elsio
   Augusto/0000-0002-5239-8511
FU Fiocruz-Pasteur Scientific Cooperation Agreement; Brazilian National
   Research CouncilNational Council for Scientific and Technological
   Development (CNPq) [420067/2005]; French Ministry of Research ANR Jeunes
   ChercheursFrench National Research Agency (ANR)Ministry of Research,
   France [05-JCJC-0105-01]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [5 R01 AI052473, 2 R01 AI034431, 2 D43 TW00919]; Research Support
   Foundation of the State of Sao Paulo.Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2007/00083-2]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI034431, R01AI034431,
   R01AI052473, R01AI052473, R01AI034431, R01AI052473, R01AI052473,
   R01AI034431, R01AI052473, R01AI034431, R01AI052473, R01AI052473,
   R01AI034431, R01AI034431, R01AI034431, R01AI052473, R01AI052473,
   R01AI034431, R01AI034431, R01AI034431, R01AI034431, R01AI034431,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by a Fiocruz-Pasteur Scientific Cooperation
   Agreement, by the Brazilian National Research Council (Instituto Milenio
   420067/2005), by the French Ministry of Research ANR Jeunes Chercheurs
   (no. 05-JCJC-0105-01), and by the National Institutes of Health (grants
   5 R01 AI052473, 2 R01 AI034431, and 2 D43 TW00919). J. Croda received
   scholarship 2007/00083-2 from the Research Support Foundation of the
   State of Sao Paulo.
CR [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012
   Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70
   Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06
   Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002
   Bauby H, 2003, MICROBIOL-SGM, V149, P689, DOI 10.1099/mic.0.26065-0
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005
   Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Guegan R, 2003, MOL MICROBIOL, V49, P745, DOI 10.1046/j.1365-2958.2003.03589.x
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Kameni APT, 2002, J BACTERIOL, V184, P452, DOI 10.1128/JB.184.2.452-458.2002
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lin YP, 2007, BIOCHEM BIOPH RES CO, V362, P443, DOI 10.1016/j.bbrc.2007.07.196
   Louvel H, 2006, J BACTERIOL, V188, P7893, DOI 10.1128/JB.00711-06
   Louvel H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-25
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Mazouni K, 2006, J BACTERIOL, V188, P469, DOI 10.1128/JB.188.2.469-476.2006
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1016/S0378-1097(00)00044-6
   Merien F, 1997, INFECT IMMUN, V65, P729, DOI 10.1128/IAI.65.2.729-738.1997
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x
   Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   PEPE JC, 1993, P NATL ACAD SCI USA, V90, P6473, DOI 10.1073/pnas.90.14.6473
   Picardeau M, 2003, FEMS MICROBIOL LETT, V225, P257, DOI 10.1016/S0378-1097(03)00529-9
   Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x
   Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097
   Saint Girons I, 2000, J BACTERIOL, V182, P5700, DOI 10.1128/JB.182.20.5700-5705.2000
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Srimanote P, 2008, J MICROBIOL METH, V72, P73, DOI 10.1016/j.mimet.2007.10.012
   Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188
NR 46
TC 69
Z9 70
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD DEC
PY 2008
VL 76
IS 12
BP 5826
EP 5833
DI 10.1128/IAI.00989-08
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 373WJ
UT WOS:000261003900042
PM 18809657
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Lacerda, HG
   Monteiro, GR
   Oliveira, CCG
   Suassuna, FB
   Queiroz, JW
   Barbosa, JDA
   Martins, DR
   Reis, MG
   Ko, AI
   Jeronimo, SMB
AF Lacerda, Henio G.
   Monteiro, Gloria R.
   Oliveira, Carlos C. G.
   Suassuna, Fernando B.
   Queiroz, Jose W.
   Barbosa, James D. A.
   Martins, Daniella R.
   Reis, Mitemayer G.
   Ko, Albert I.
   Jeronimo, Selma M. B.
TI Leptospirosis in a subsistence farming community in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Leptospirosis; Disease outbreaks; Surveillance; Prevalence; Rural
   population; Brazil
ID RISK-FACTORS; URBAN EPIDEMIC; BARBADOS; INFECTION; SERODIAGNOSIS;
   ANTIBODIES; OUTBREAK; ILLNESS; SEROVAR; AMAZON
AB Leptospirosis has been reported in rural areas of Brazil. However, there is limited information about the exposure risk or the risk of Leptospira infection for rural-based populations. A cross-sectional study was carried out in order to determine the prevalence and risk factors for prior Leptospira infection in a rural subsistence farming region of the state of Rio Grande do Norte, an area in which outbreaks of leptospirosis have occurred. Among 290 individuals enrolled, 44 (15.2%) had anti-Leptospira IgM antibodies as determined by IgM ELISA. Infection tended to occur with activities related to the rice fields (P=0.08). Our findings indicate that Leptospira infection occurs even in years of tow rainfall, and may have an important impact among poor rural-based subsistence farmers in Brazil. Additional studies are needed to characterize the mode of transmission in this region. (c) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 [Monteiro, Gloria R.; Queiroz, Jose W.; Barbosa, James D. A.; Martins, Daniella R.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59078970 Natal, RN, Brazil.
   [Lacerda, Henio G.; Suassuna, Fernando B.] Univ Fed Rio Grande do Norte, Dept Infect Dis, BR-59078970 Natal, RN, Brazil.
   [Oliveira, Carlos C. G.; Reis, Mitemayer G.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59078970 Natal, RN, Brazil.
   [Ko, Albert I.] Oswoldo Cruz Fdn Brazilian Minister Hlth, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert I.] Cornell Univ, Weil Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, CP 1624, BR-59078970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020; Ko,
   Albert Icksang/P-2343-2015
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Ko, Albert Icksang/0000-0001-9023-2339
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [A1052473, FIC D43 TWO0919]; Consetho
   Nacionat de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
FX This work was funded in part by NIH grants (NIAID R01 A1052473 and FIC
   D43 TWO0919) and Consetho Nacionat de Desenvolvimento Cientifico e
   Tecnologico (CNPq), SMBJ and MGR are CNPq researchers.
CR Aguiar DM, 2007, BRAZ J MICROBIOL, V38, P93, DOI 10.1590/S1517-83822007000100019
   Ashford DA, 2000, AM J TROP MED HYG, V63, P249, DOI 10.4269/ajtmh.2000.63.249
   AZEVEDO E, 1968, REV I ADOLFO LUTZ SA, V28, P85
   Bruce MG, 2005, ACTA TROP, V96, P36, DOI 10.1016/j.actatropica.2005.07.001
   Bunnell JE, 2000, AM J TROP MED HYG, V63, P255, DOI 10.4269/ajtmh.2000.63.255
   CALDAS E. M., 1977, Revista de Medicina, Bahia, V23, P90
   CALDAS E. M., 1979, Revista do Instituto Adolfo Lutz, V39, P85
   Cumberland P, 2001, EUR J EPIDEMIOL, V17, P601, DOI 10.1023/A:1015509105668
   EVERARD COR, 1992, J TROP MED HYG, V95, P13
   EVERARD COR, 1989, EPIDEMIOL INFECT, V103, P143, DOI 10.1017/S0950268800030442
   Everard J. D., 1993, Reviews in Medical Microbiology, V4, P114
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Hartskeerl RA, 1996, VET QUART, V18, pS149
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Kuriakose M, 1997, EUR J EPIDEMIOL, V13, P691, DOI 10.1023/A:1007300729615
   Levett PN, 2000, AM J TROP MED HYG, V62, P112, DOI 10.4269/ajtmh.2000.62.112
   Levett PN, 2003, CLIN INFECT DIS, V36, P447, DOI 10.1086/346208
   LIMA CCC, 1996, REV SOC BRAS MED TRO, V29, P95
   LUPIDI R, 1991, J CLIN MICROBIOL, V29, P805, DOI 10.1128/JCM.29.4.805-809.1991
   MARTINEZ SR, 1993, REV CUBANA MED TROP, V45, P32
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McBride AJA, 2007, ACTA TROP, V102, P206, DOI 10.1016/j.actatropica.2007.05.002
   Ministerio da Saude, 1995, MAN LEPT
   Perrocheau A, 1997, EUR J EPIDEMIOL, V13, P161, DOI 10.1023/A:1007300514760
   Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180
   Russell KL, 2003, AM J TROP MED HYG, V69, P53, DOI 10.4269/ajtmh.2003.69.53
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   *SECR EST SAUD RIO, 1997, REL VIG EP LEPT
   SUASSUNA F, 1985, REV SOC BRAS MED TRO, V19, P116
   Tangkanakul W, 2000, AM J TROP MED HYG, V63, P204, DOI 10.4269/ajtmh.2000.63.204
   World Health Organization, 2003, HUM LEPT GUID DIAGN
NR 34
TC 12
Z9 13
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD DEC
PY 2008
VL 102
IS 12
BP 1233
EP 1238
DI 10.1016/j.trstmh.2008.05.010
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 377XK
UT WOS:000261285500011
PM 18599101
OA Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU de Faria, MT
   Calderwood, MS
   Athanazio, DA
   McBride, AJA
   Hartskeerl, RA
   Pereira, MM
   Ko, AI
   Reis, MG
AF de Faria, Marcos Tucunduva
   Calderwood, Michael S.
   Athanazio, Daniel A.
   McBride, Alan J. A.
   Hartskeerl, Rudy A.
   Pereira, Martha Maria
   Ko, Albert I.
   Reis, Mitermayer G.
TI Carriage of Leptospira interrogans among domestic rats from an urban
   setting highly endemic for leptospirosis in Brazil
SO ACTA TROPICA
LA English
DT Article
DE Leptospira; Leptospirosis; Rats; Poverty areas
ID RIO-DE-JANEIRO; RATTUS-NORVEGICUS; POPULATION; ISLANDS; PCR;
   COPENHAGENI; ANTIBODIES; INFECTION; EPIDEMIC; BARBADOS
AB A survey was conducted to identify reservoirs for urban leptospirosis in the city of Salvador, Brazil. Sampling protocols were performed in the vicinity of households of severe leptospirosis cases identified during active hospital-based surveillance. Among a total of 142 captured Rattus norvegicus (Norwegian brown rat), 80.3% had a positive culture isolate from urine or kidney specimens and 68.1% had a positive serum sample by microscopic agglutination test (MAT) titre of >= 1:100. Monoclonal antibody-based typing of isolates identified that the agent carried by rats was Leptospira interrogans serovar Copenhageni. which was the same serovar isolated from patients during hospital-based surveillance. Leptospira spp. were not isolated from 8 captured Didelphis marsupialis (Opossum), while 5/7 had a positive MAT titre against a saprophytic serogroup. R. rattus were not captured during the survey. The study findings indicate that the brown rat is a major rodent reservoir for leptospirosis in this urban setting. Furthermore, the high carriage rates of L. interrogans serovar Copenhageni in captured rats suggest that there is a significant degree of environmental contamination with this agent in the household environment of high risk areas, which in turn is a cause of transmission during urban epidemics. (C) 2008 Elsevier B.V. All rights reserved.
C1 [de Faria, Marcos Tucunduva; Athanazio, Daniel A.; McBride, Alan J. A.; Ko, Albert I.; Reis, Mitermayer G.] Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, BR-40296710 Salvador, BA, Brazil.
   [Calderwood, Michael S.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.
   [Athanazio, Daniel A.; Reis, Mitermayer G.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Hartskeerl, Rudy A.] Royal Trop Inst, Dept Biomed Res, NL-1105 AZ Amsterdam, Netherlands.
   [Pereira, Martha Maria] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Ithaca, NY 14853 USA.
RP Reis, MG (corresponding author), Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Rua Waldemar Falcao 121 Candeal, BR-40296710 Salvador, BA, Brazil.
EM tucun@cpatu.embrapa.br; miter@bahia.flocruz.br
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020;
   Athanazio, Daniel/P-6622-2014; McBride, Alan/D-4106-2012
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; McBride, Alan/0000-0001-9682-540X
FU Research Support Foundation for the State of Bahia (FABESB); National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI052473, D43
   TW00919]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the Research Support Foundation for the State
   of Bahia (FABESB), and the National Institutes of Health (grants R01
   AI052473 and D43 TW00919).
CR Andrade ZA, 1954, B FUNDACAO GONCALO M, V3, P1
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   CARTER ME, 1980, NEW ZEAL VET J, V28, P45, DOI 10.1080/00480169.1980.34688
   Collares-Pereira M, 2000, FEMS MICROBIOL LETT, V185, P181, DOI 10.1111/j.1574-6968.2000.tb09059.x
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Faine S., 1982, GUIDELINES CONTROL L
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064
   GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691
   HATHAWAY SC, 1980, J HYG-CAMBRIDGE, V87, P427
   Jansen A, 2005, EMERG INFECT DIS, V11, P1048, DOI 10.3201/eid1107.041172
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Levett PN, 1998, W INDIAN MED J, V47, P15
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   PEREIRA MM, 1988, T ROY SOC TROP MED H, V82, P768, DOI 10.1016/0035-9203(88)90231-3
   Pezzella M, 2004, Ann Ig, V16, P721
   Priya CG, 2007, J POSTGRAD MED, V53, P236
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Sehgal SC, 2000, INDIAN J MED RES, V112, P135
   Sharma S, 2003, EPIDEMIOL INFECT, V131, P985, DOI 10.1017/S095026880300880X
   Sunbul M, 2001, SCAND J INFECT DIS, V33, P896, DOI 10.1080/00365540110076796
   TAMAI T, 1988, MICROBIOL IMMUNOL, V32, P887, DOI 10.1111/j.1348-0421.1988.tb01450.x
   Tassinari WS, 2008, TROP MED INT HEALTH, V13, P503, DOI 10.1111/j.1365-3156.2008.02028.x
   TAYLOR KD, 1991, J TROP MED HYG, V94, P102
   THIERMANN AB, 1977, AM J TROP MED HYG, V26, P970, DOI 10.4269/ajtmh.1977.26.970
   VADO-SOLÍS Ignacio, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P335, DOI 10.1590/S0036-46652002000600008
   Vanasco NB, 2003, PREV VET MED, V60, P227, DOI 10.1016/S0167-5877(03)00144-2
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   WEBSTER JP, 1995, EPIDEMIOL INFECT, V114, P195, DOI 10.1017/S0950268800052043
   World Health Organization, 2003, HUM LEPT GUID DIAGN
NR 38
TC 91
Z9 95
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD OCT
PY 2008
VL 108
IS 1
BP 1
EP 5
DI 10.1016/j.actatropica.2008.07.005
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 378UR
UT WOS:000261350200001
PM 18721789
OA Green Accepted
DA 2020-11-30
ER

PT J
AU Vanasco, NB
   Schmeling, MF
   Lottersberger, J
   Costa, F
   Ko, AI
   Tarabla, HD
AF Vanasco, N. B.
   Schmeling, M. F.
   Lottersberger, J.
   Costa, F.
   Ko, A. I.
   Tarabla, H. D.
TI Clinical characteristics and risk factors of human leptospirosis in
   Argentina (1999-2005)
SO ACTA TROPICA
LA English
DT Article
DE Leptospirosis; Epidemiology; Risk factors; Microscopic agglutination
   test; Rural transmission; Argentina
ID SEROVAR ARBOREA; URBAN EPIDEMIC; ISOLATIONS; DISEASE; HARDJO
AB There is scarce data on the burden of leptospirosis and its epidemiological characteristics in Argentina. This study aimed to evaluate distribution of leptospirosis cases and identify risk factors for the disease during national laboratory-based surveillance. From January 1999 to December 2005,812 suspected cases were referred to the national reference laboratory, of which 182 and 463 had respectively, laboratory confirmed and unconfirmed diagnosis of leptospirosis. The diagnosis of leptospirosis was discarded in 167 cases. The most prevalent presumptive infecting serogroup was lcterohaemorrhagie followed by Pomona, Ballum and Canicola. The majority of cases occurred during the worm and rainy months. Confirmed cases were predominantly adults and males, who presented with fever, headache and myalgias. Severe clinical manifestations included jaundice and acute renal insufficiency. Conjunctival suffusion, a hallmark clinical sign of leptospirosis, was found in 55% of confirmed cases, and 43% of the cases with discarded diagnosis (p = 0.036). After multivariate analyses, age >30 years (OR = 2.16; 1.05-4.41), occupation in a rural setting (OR = 3.41; 1.45-8.06), contact with contaminated surface water (OR = 2.17; 1.01 -4.68), and contact with floods (OR=4.49: 1.17-17.25) were significantly associated with leptospirosis. In conclusion, although activities associated with rural occupations remain important risk factors in Argentina, exposures occurring during flooding events have emerged to be the major risk factor for leptospirosis. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Vanasco, N. B.] Inst Nacl Enfermedades Resp INER Dr E Coni, Adm Nacl Lab, RA-3000 Santa Fe, Argentina.
   Inst Salud ANLIS Dr Carlos G Malbran, RA-3000 Santa Fe, Argentina.
   [Vanasco, N. B.; Lottersberger, J.] Fac Bioquim & Ciencias Biol, Santa Fe, Argentina.
   [Costa, F.; Ko, A. I.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Ko, A. I.] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Ithaca, NY 14853 USA.
   [Tarabla, H. D.] INTA, Rafaela, Argentina.
RP Vanasco, NB (corresponding author), Inst Nacl Enfermedades Resp INER Dr E Coni, Adm Nacl Lab, Blas Parera 8260, RA-3000 Santa Fe, Argentina.
EM bibi_vanasco@hotmail.com; jlotters@fbcb.unl.edu.ar
RI Ko, Albert Icksang/P-2343-2015; Costa, Federico/G-1838-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Costa,
   Federico/0000-0001-6951-2336
FU Administracion Nacional de Laboratorios e Institutos cle Salud (ANLIS
FX This work was supported by the Administracion Nacional de Laboratorios e
   Institutos cle Salud (ANLIS), and the cooperative agreement between
   ANLIS and the Fundacao Oswaldo Cruz.
CR *AAVLD, 2002, INF LEPT REP ARG
   *AAVLD, 1994, MAN LEPT
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Cacchione R, 1980, MED VET, V61, P236
   CACCHIONE R A, 1975, Revista de la Asociacion Argentina de Microbiologia, V7, P21
   CACCIAPUOTI B, 1976, B I SIEROTER MILAN, V55, P495
   Faine S., 1982, WHO OFFSET PUBLICATI, V67
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   MYERS DM, 1976, J CLIN MICROBIOL, V3, P548
   MYERS DM, 1975, TROP GEOGR MED, V27, P63
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Slack AT, 2006, EPIDEMIOL INFECT, V134, P1217, DOI 10.1017/S0950268806006352
   Vanasco N. B., 2002, Revista Argentina de Microbiologia, V34, P124
   Vanasco N B, 2000, Rev Panam Salud Publica, V7, P35, DOI 10.1590/S1020-49892000000100006
   Vanasco NB, 2003, PREV VET MED, V60, P227, DOI 10.1016/S0167-5877(03)00144-2
   Vanasco NB, 2000, VET REC, V147, P246, DOI 10.1136/vr.147.9.246
   Vanasco NB, 2004, SALUD CIENCIA, V12, p[26, 31]
   Vanasco NB, 2007, REV PANAM SALUD PUBL, V21, P388, DOI 10.1590/S1020-49892007000500007
   World Health Organization, 2003, HUM LEPT GUID DIAGN
   Yang HY, 2005, J NEPHROL, V18, P45
   Yersin C, 1998, AM J TROP MED HYG, V59, P933, DOI 10.4269/ajtmh.1998.59.933
   Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8
NR 25
TC 64
Z9 71
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD SEP
PY 2008
VL 107
IS 3
BP 255
EP 258
DI 10.1016/j.actatropica.2008.06.007
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 369QA
UT WOS:000260707800007
PM 18671932
OA Green Published
DA 2020-11-30
ER

PT J
AU Reis, JN
   Palma, T
   Ribeiro, GS
   Pinheiro, RM
   Ribeiro, CT
   Cordeiro, SM
   da Silva, HP
   Moschioni, M
   Thompson, TA
   Spratt, B
   Riley, LW
   Barocchi, MA
   Reis, MG
   Ko, AI
AF Reis, Joice Neves
   Palma, Tania
   Ribeiro, Guilherme S.
   Pinheiro, Ricardo M.
   Ribeiro, Cassio Tamara
   Cordeiro, Soraia Machado
   da Silva Filho, H. P.
   Moschioni, Monica
   Thompson, Terry A.
   Spratt, Brian
   Riley, Lee W.
   Barocchi, Michele A.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Transmission of Streptococcus pneumoniae in an urban slum community
SO JOURNAL OF INFECTION
LA English
DT Article
DE Streptococcus pneumoniae; nasopharyngeal carriage; pneumococcal
   conjugate vaccines; antibiotic resistance; urban slums
ID FIELD GEL-ELECTROPHORESIS; DAY-CARE-CENTERS; NASOPHARYNGEAL CARRIAGE;
   INVASIVE-DISEASE; PNEUMOCOCCAL CARRIAGE; SEROTYPE DISTRIBUTION;
   ANTIMICROBIAL SUSCEPTIBILITY; CONJUGATE VACCINE; HEALTHY-CHILDREN;
   YOUNG-CHILDREN
AB Background: Inhabitants of slum settlements represent a significant proportion of the population at risk for pneumococcal disease in developing countries.
   Methods: We conducted a household survey of pneumococcal carriage among residents of a slum community in the city of Salvador, Brazil.
   Results: Among 262 subjects, 95 (36%) were colonized with Streptococcus pneumoniae. Children < 5 years of age (OR, 8.0; 95% CI, 3.5-18.6) and those who attended schools (OR, 2.7, 95% CI, 1.2-6.0) had significantly higher risk of being colonized. Of 94 isolates obtained from colonized individuals, 51 % had serotypes included in the seven-valent pneumococcal conjugate vaccine. Overall, 10% (9 of 94 isolates) were nonsusceptible to penicillin and 28% (27 of 94 isolates) were resistant to cotrimoxazole. BOX-PCR, PFGE and MLST analyses found that 44% of the carriage isolates belonged to 14 distinct clonal groups. Strains of the same clonal group were isolated from multiple members of 9 out of the 39 study households. Nineteen carriage isolates had genotypes that were the same as those identified among 362 strains obtained from active surveillance for meningitis.
   Conclusions: The study's findings indicate that there is significant intra- and inter-household spread of S. pneumoniae in the slum community setting. However, a limited number of clones encountered during carriage among slum residents were found to cause invasive disease. (c) 2008 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
C1 [Reis, Joice Neves; Palma, Tania; Ribeiro, Guilherme S.; Pinheiro, Ricardo M.; Ribeiro, Cassio Tamara; Cordeiro, Soraia Machado; da Silva Filho, H. P.; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, Minist Saude, BR-40296710 Salvador, Candeal, Brazil.
   [Reis, Joice Neves] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
   [Moschioni, Monica; Barocchi, Michele A.] Novartis Vaccines, I-53100 Siena, Italy.
   [Thompson, Terry A.] Ctr Dis Control & Prevent, Streptococcus Lab, Atlanta, GA 30333 USA.
   [Spratt, Brian] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.
   [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Dept Med, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Reis, JN (corresponding author), Fundacao Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, Minist Saude, Rua Waldemar Falcao 121, BR-40296710 Salvador, Candeal, Brazil.
EM joice@bahia.fiocruz.br
RI Ko, Albert Icksang/P-2343-2015; Spratt, Brian G/A-1676-2009; Reis,
   Mitermayer/AAO-9742-2020; Reis, Joice N/H-9227-2013; Filho, Hermes P
   Silva/H-7932-2013; Ribeiro, Guilherme/B-6624-2008
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Ribeiro, Guilherme/0000-0002-6798-2059
FU Oswaldo Cruz Foundation, Brazilian Ministry of Health [0250.250.415];
   Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq) [300.861/96-6, 521.132/98-3, PRONEX
   4196086200]; Research Foundation for the State of Bahia [1431040054051];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [D43 TW00919, R01
   TW007303]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [D43TW000919, R01TW007303,
   R01TW007303, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   R01TW007303, D43TW000919, R01TW007303, D43TW000919, D43TW000919,
   D43TW000919, R01TW007303, D43TW000919, D43TW000919] Funding Source: NIH
   RePORTER
FX We thank the families of the study community whichparticipated in the
   study. We also thank laboratory assistants Cintia Carta, Adriano Queiroz
   and Maviany Mota, for their immensurable help; Richard Facklam for
   advice during laboratory analysis and confirmation of the serotyping
   results. This work was supported by grants from the Oswaldo Cruz
   Foundation, Brazilian Ministry of Health (0250.250.415); the Brazilian
   National Research Council (300.861/96-6, 521.132/98-3 and PRONEX
   4196086200); the Research Foundation for the State of Bahia
   (1431040054051) and the National Institutes of Health (D43 TW00919 and
   R01 TW007303).
CR Bayraktar MR, 2005, INT J ANTIMICROB AG, V26, P241, DOI 10.1016/j.ijantimicag.2005.06.014
   Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7
   Bogaert D, 2006, MICROBIOL-SGM, V152, P377, DOI 10.1099/mic.0.28394-0
   Borer A, 2001, CLIN INFECT DIS, V33, P436, DOI 10.1086/321888
   Brandileone MCD, 1998, MICROB DRUG RESIST, V4, P209
   Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624
   *CLSI, 2002, 12 INF S
   Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009
   de Andrade ALSS, 2003, J CLIN MICROBIOL, V41, P3970, DOI 10.1128/JCM.41.8.3970-3972.2003
   Denno Donna M, 2002, West Afr J Med, V21, P233
   Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049
   Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477
   Feikin DR, 2003, PEDIATR INFECT DIS J, V22, P564, DOI 10.1097/00006454-200306000-00016
   Frazao N, 2005, PEDIATR INFECT DIS J, V24, P243, DOI 10.1097/01.inf.0000154326.77617.3e
   Giebink GS, 2001, NEW ENGL J MED, V345, P1177, DOI 10.1056/NEJMra010462
   Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941
   Hoshino K, 2002, J CLIN MICROBIOL, V40, P4357, DOI 10.1128/JCM.40.11.4357-4359.2002
   Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338
   Huang SS, 2005, CLIN INFECT DIS, V40, P1215, DOI 10.1086/428580
   Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012
   *IBGE, 2000, AN EST BRAS, V56
   Ko AI, 2000, CLIN INFECT DIS, V30, P78, DOI 10.1086/313619
   Laval CB, 2006, CLIN MICROBIOL INFEC, V12, P50, DOI 10.1111/j.1469-0691.2005.01304.x
   LEFEVRE JC, 1993, J CLIN MICROBIOL, V31, P2724, DOI 10.1128/JCM.31.10.2724-2728.1993
   Levine S, 2006, PEDIATR INFECT DIS J, V25, P176, DOI 10.1097/01.inf.0000199303.43096.3c
   Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980
   Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076
   *PROGR UNHS, 2003, CHALL SLUMS GLOB REP, P310
   Reis JN, 2002, J CLIN MICROBIOL, V40, P275, DOI 10.1128/JCM.40.1.275-277.2002
   REIS JN, 2003, 103 GEN M WASH DC AM
   Rey Luís C., 2002, J. Pediatr. (Rio J.), V78, P105, DOI 10.1590/S0021-75572002000200008
   Robinson DA, 2001, J INFECT DIS, V183, P1501, DOI 10.1086/320194
   Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686
   *SECOMP, 2005, MAP POBR AR URB EST
   Shimada J, 2002, J CLIN MICROBIOL, V40, P1851, DOI 10.1128/JCM.40.5.1851-1853.2002
   Singh NK, 2007, VACCINE, V25, P5244, DOI 10.1016/j.vaccine.2007.04.054
   Sinha A, 2007, LANCET, V369, P389, DOI 10.1016/S0140-6736(07)60195-0
   Takala AK, 1996, J INFECT DIS, V173, P128, DOI 10.1093/infdis/173.1.128
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995
   Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823
   *WHO, 2002, REC 1 LIN OUTP TREAT
NR 41
TC 22
Z9 22
U1 0
U2 6
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD SEP
PY 2008
VL 57
IS 3
BP 204
EP 213
DI 10.1016/j.jinf.2008.06.017
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA 357GV
UT WOS:000259835200006
PM 18672297
OA Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Silva, EF
   Santos, CS
   Athanazio, DA
   Seyffert, N
   Seixas, FK
   Cerqueira, GM
   Fagundes, MQ
   Brod, CS
   Reis, MG
   Dellagostin, OA
   Ko, AI
AF Silva, Everton F.
   Santos, Cleiton S.
   Athanazio, Daniel A.
   Seyffert, Nubia
   Seixas, Fabiana K.
   Cerqueira, Gustavo M.
   Fagundes, Michel Q.
   Brod, Claudiomar S.
   Reis, Mitermayer G.
   Dellagostin, Odir A.
   Ko, Albert I.
TI Characterization of virulence of Leptospira isolates in a hamster model
SO VACCINE
LA English
DT Article
DE Leptospira; leptospirosis; lethal dose; isolation; animal model;
   virulence
ID INTERROGANS SEROVAR COPENHAGENI; OUTER-MEMBRANE PROTEINS; PROTECTIVE
   IMMUNITY; PULMONARY LEPTOSPIROSIS; ELECTRON MICROSCOPY; VACCINE
   CANDIDATES; GUINEA-PIG; IMMUNOGLOBULIN; DNA; PATHOGENESIS
AB Effort has been made to identify protective antigens in order to develop a recombinant vaccine against leptospirosis. Several attempts failed to conclusively demonstrate efficacy of vaccine candidates due to the lack of an appropriate model of lethal leptospirosis. The purposes of our study were: (i) to test the virulence of leptospiral isolates from Brazil, which are representative of important serogroups that cause disease in humans and animals; and (ii) to standardize the lethal dose 50% (LD50) for each of the virulent strains using a hamster (Mesocricetus auratus) model. Five of seven Brazilian isolates induced lethality in a hamster model, with inocula lower than 200 leptospires. Histopathological examination of infected animals showed typical lesions found in both natural and experimental leptospirosis. Results described here demonstrated the potential use of Brazilian isolates as highly virulent strains in challenge experiments using hamster as an appropriate animal model for leptospirosis. Furthermore these strains may be useful in heterologous challenge studies which aim to evaluate cross-protective responses induced by sub-unit vaccine candidates. (C) 2008 Elsevier Ltd. All rights reserved
C1 [Silva, Everton F.; Seyffert, Nubia; Seixas, Fabiana K.; Cerqueira, Gustavo M.; Fagundes, Michel Q.; Dellagostin, Odir A.] Univ Fed Pelotas, Ctr Biotecnol, BR-96010900 Pelotas, RS, Brazil.
   [Silva, Everton F.; Santos, Cleiton S.; Athanazio, Daniel A.; Reis, Mitermayer G.; Ko, Albert I.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Brod, Claudiomar S.] Univ Fed Pelotas, Fac Med Vet, Ctr Controle Zoonoses, BR-96010900 Pelotas, RS, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Dellagostin, OA (corresponding author), Univ Fed Pelotas, Ctr Biotecnol, Campus Univ,Caixa Postal 357, BR-96010900 Pelotas, RS, Brazil.
EM odir@ufpel.edu.br
RI Athanazio, Daniel/P-6622-2014; Ko, Albert Icksang/P-2343-2015;
   Cerqueira, Gustavo/B-7180-2015; Seyffert, Nubia/N-6410-2014;
   Dellagostin, Odir/C-2331-2009; Seixas, Fabiana Kommling/X-2706-2018;
   Fagundes, Michel/F-2335-2013; Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Cerqueira,
   Gustavo/0000-0002-3029-6899; Seyffert, Nubia/0000-0002-2193-6508;
   Dellagostin, Odir/0000-0003-2803-4088; Seixas, Fabiana
   Kommling/0000-0003-4204-2500; Reis, Mitermayer/0000-0002-3051-9060
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW000919-11, D43 TW000919, 2 D43 TW-00919] Funding Source: Medline;
   NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [5 R01 AI052473, R01 AI052473-05, R01
   AI052473] Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473] Funding Source: NIH RePORTER
CR AREAN VM, 1962, AM J PATHOL, V40, P393
   AREAN VM, 1962, LAB INVEST, V11, P273
   Athanazio DA, 2008, ACTA TROP, V105, P176, DOI 10.1016/j.actatropica.2007.10.012
   Athanazio DA, 2008, ACTA TROP, V105, P95, DOI 10.1016/j.actatropica.2007.09.004
   Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001
   Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005
   Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   Chang YF, 2007, VACCINE, V25, P8190, DOI 10.1016/j.vaccine.2007.09.020
   Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005
   DEBRITO T, 1966, VIRCHOWS ARCH A, V341, P64
   DEBRITO T, 1967, VIRCHOWS ARCH A, V342, P61
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Faine S., 1982, GUIDELINES CONTROL L
   Faisal SM, 2008, VACCINE, V26, P277, DOI 10.1016/j.vaccine.2007.10.029
   Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005
   Nally JE, 2005, PROTEOMICS, V5, P144, DOI 10.1002/pmic.200400880
   Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006
   Pereira MM, 2005, AM J TROP MED HYG, V72, P13, DOI 10.4269/ajtmh.2005.72.13
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Reed LJ, 1938, AM J HYG, V27, P494, DOI 10.1093/oxfordjournals.aje.a118408
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097
   Romero EC, 1998, J CLIN MICROBIOL, V36, P1453, DOI 10.1128/JCM.36.5.1453-1455.1998
   Seixas FK, 2007, VACCINE, V26, P88, DOI 10.1016/j.vaccine.2007.10.052
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Silva EF, 2007, VET MICROBIOL, V121, P144, DOI 10.1016/j.vetmic.2006.11.010
   Spichler A, 2007, AM J TROP MED HYG, V77, P1111, DOI 10.4269/ajtmh.2007.77.1111
   Thongboonkerd V, 2008, EXPERT REV MOL DIAGN, V8, P53, DOI 10.1586/14737159.8.1.53
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527, DOI 10.1097/00001432-200110000-00005
   World Health Organization, 2003, HUM LEPT GUID DIAGN
NR 46
TC 66
Z9 70
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
J9 VACCINE
JI Vaccine
PD JUL 23
PY 2008
VL 26
IS 31
BP 3892
EP 3896
DI 10.1016/j.vaccine.2008.04.085
PG 5
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 331JR
UT WOS:000258009000015
PM 18547690
OA Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Ringe, B
   Xiao, G
   Sass, DA
   Karam, J
   Shang, S
   Maroney, TP
   Trebelev, AE
   Levison, S
   Fuchs, AC
   Petrucci, R
   Ko, A
   Gonzalez, M
   Reynolds, JC
   Meyers, WC
AF Ringe, B.
   Xiao, G.
   Sass, D. A.
   Karam, J.
   Shang, S.
   Maroney, T. P.
   Trebelev, A. E.
   Levison, S.
   Fuchs, A. C.
   Petrucci, R.
   Ko, A.
   Gonzalez, M.
   Reynolds, J. C.
   Meyers, W. C.
TI Rescue of a living donor with liver transplantation
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Article
DE liver transplantation; living donation; postoperative liver failure
ID HEPATECTOMY; STENOSIS; DEATH
AB Postoperative liver failure is a rare complication after living donor liver resection. This is a case report of a 22-year-old healthy donor who was rescued with liver transplantation 11 days after right hemihepatectomy. Nine months later the patient is alive, and has fully recovered from his multiple organ failure. According to a review of the literature, there are four additional living liver donors, who received a liver transplant. Our own patient is the only survivor, so far. This case demonstrates that even in supposedly healthy living donors postoperative complications cannot be completely prevented. Although liver failure is rare in these patients, timely transplantation may need to be considered as the only life-saving treatment.
C1 [Ringe, B.; Xiao, G.; Meyers, W. C.] Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19104 USA.
   [Sass, D. A.; Reynolds, J. C.] Drexel Univ, Coll Med, Dept Med, Div Gastroenterol & Hepatol, Philadelphia, PA 19104 USA.
   [Karam, J.] Drexel Univ, Coll Med, Dept Trauma, Philadelphia, PA 19104 USA.
   [Shang, S.] Drexel Univ, Coll Med, Dept Diagnost Radiol, Philadelphia, PA 19104 USA.
   [Maroney, T. P.; Trebelev, A. E.] Drexel Univ, Coll Med, Dept Intervent Radiol, Philadelphia, PA 19104 USA.
   [Levison, S.] Drexel Univ, Coll Med, Dept Med, Div Nephrol, Philadelphia, PA 19104 USA.
   [Fuchs, A. C.] Drexel Univ, Coll Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA.
   [Petrucci, R.] Drexel Univ, Coll Med, Dept Psychiat, Philadelphia, PA 19104 USA.
   [Ko, A.] Drexel Univ, Coll Med, Dept Med, Div Pulm Med & Crit Care, Philadelphia, PA 19104 USA.
   [Gonzalez, M.] Drexel Univ, Coll Med, Dept Anesthesiol, Philadelphia, PA 19104 USA.
RP Ringe, B (corresponding author), Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19104 USA.
EM burckhardt.ringe@drexelmed.edu
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
CR Adam P, 2003, LIVER TRANSPLANT, V9, P1231, DOI 10.1016/j.lts.2003.09.018
   Akabayashi A, 2004, TRANSPLANTATION, V77, P634, DOI 10.1097/01.TP.0000115342.98226.7C
   Akamatsu N, 2006, TRANSPL P, V38, P2948, DOI 10.1016/j.transproceed.2006.08.107
   Braun F, 2004, ETHICAL, LEGAL, AND SOCIAL ISSUES IN ORGAN TRANSPLANTATION, P249
   Brown RS, 2003, NEW ENGL J MED, V348, P818, DOI 10.1056/NEJMsa021345
   FUKUZAWA K, 1993, TRANSPLANTATION, V56, P223, DOI 10.1097/00007890-199307000-00043
   Goodman BP, 2008, PHYS MED REH CLIN N, V19, P97, DOI 10.1016/j.pmr.2007.10.012
   JURIM O, 1993, ANN SURG, V218, P10, DOI 10.1097/00000658-199307000-00003
   Kadry Z, 2003, TRANSPLANTATION, V75, P769, DOI 10.1097/01.TP.0000055255.41393.B5
   Malago M, 2003, ANN SURG, V238, P853, DOI 10.1097/01.sla.0000098619.71694.74
   Milkiewicz P, 2002, J GASTROEN HEPATOL, V17, P208, DOI 10.1046/j.1440-1746.2002.02671.x
   Nadalin S, 2007, TRANSPL INT, V20, P312, DOI 10.1111/j.1432-2277.2006.00424.x
   RINGE B, 1993, ANN SURG, V218, P3, DOI 10.1097/00000658-199307000-00002
   Ringe B, 2008, TRANSPLANTATION, V85, P790, DOI 10.1097/TP.0b013e318167345e
   Ringe B, 2007, LIVER TRANSPLANT, V13, pS108
   SINGER PA, 1989, NEW ENGL J MED, V321, P620, DOI 10.1056/NEJM198908313210919
   Strong RW, 1996, TRANSPLANT P, V28, P2366
NR 17
TC 15
Z9 15
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD JUL
PY 2008
VL 8
IS 7
BP 1557
EP 1561
DI 10.1111/j.1600-6143.2008.02261.x
PG 5
WC Surgery; Transplantation
SC Surgery; Transplantation
GA 324WJ
UT WOS:000257549800028
PM 18510644
OA Bronze
DA 2020-11-30
ER

PT J
AU Reis, RB
   Ribeiro, GS
   Felzemburgh, RDM
   Santana, FS
   Mohr, S
   Melendez, AXTO
   Queiroz, A
   Santos, AC
   Ravines, RR
   Tassinari, WS
   Carvalho, MS
   Reis, MG
   Ko, AI
AF Reis, Renato B.
   Ribeiro, Guilherme S.
   Felzemburgh, Ridalva D. M.
   Santana, Francisco S.
   Mohr, Sharif
   Melendez, Astrid X. T. O.
   Queiroz, Adriano
   Santos, Andreia C.
   Ravines, Romy R.
   Tassinari, Wagner S.
   Carvalho, Marilia S.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Impact of Environment and Social Gradient on Leptospira Infection in
   Urban Slums
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HEALTH; BRAZIL; SANITATION; OUTBREAK; DETERMINANTS; INEQUALITIES;
   EPIDEMIC; MEDICINE; CLIMATE; COHORT
AB Background: Leptospirosis has become an urban health problem as slum settlements have expanded worldwide. Efforts to identify interventions for urban leptospirosis have been hampered by the lack of population-based information on Leptospira transmission determinants. The aim of the study was to estimate the prevalence of Leptospira infection and identify risk factors for infection in the urban slum setting.
   Methods and Findings: We performed a community- based survey of 3,171 slum residents from Salvador, Brazil. Leptospira agglutinating antibodies were measured as a marker for prior infection. Poisson regression models evaluated the association between the presence of Leptospira antibodies and environmental attributes obtained from Geographical Information System surveys and indicators of socioeconomic status and exposures for individuals. Overall prevalence of Leptospira antibodies was 15.4% (95% confidence interval [CI], 14.0-16.8). Households of subjects with Leptospira antibodies clustered in squatter areas at the bottom of valleys. The risk of acquiring Leptospira antibodies was associated with household environmental factors such as residence in flood- risk regions with open sewers (prevalence ratio [PR] 1.42, 95% CI 1.14-1.75) and proximity to accumulated refuse (1.43, 1.04-1.88), sighting rats (1.32, 1.10-1.58), and the presence of chickens (1.26, 1.05-1.51). Furthermore, low income and black race (1.25, 1.03-1.50) were independent risk factors. An increase of US$1 per day in per capita household income was associated with an 11% (95% CI 5%-18%) decrease in infection risk.
   Conclusions: Deficiencies in the sanitation infrastructure where slum inhabitants reside were found to be environmental sources of Leptospira transmission. Even after controlling for environmental factors, differences in socioeconomic status contributed to the risk of Leptospira infection, indicating that effective prevention of leptospirosis may need to address the social factors that produce unequal health outcomes among slum residents, in addition to improving sanitation.
C1 [Reis, Renato B.; Ribeiro, Guilherme S.; Felzemburgh, Ridalva D. M.; Santana, Francisco S.; Mohr, Sharif; Melendez, Astrid X. T. O.; Queiroz, Adriano; Santos, Andreia C.; Reis, Mitermayer G.; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Santana, Francisco S.] Secretaria Estadual Saude Bahia, Salvador, BA, Brazil.
   [Ravines, Romy R.; Tassinari, Wagner S.; Carvalho, Marilia S.] Minist Saude, Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Tassinari, Wagner S.] Univ Fed Rural Rio de Janeiro, Rio De Janeiro, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Reis, RB (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI CARVALHO, MARILIA S/C-3425-2013; Reis, Mitermayer/AAO-9742-2020;
   CARVALHO, MARILIA/AAD-8283-2020; Ko, Albert Icksang/P-2343-2015;
   Ribeiro, Guilherme/B-6624-2008; Queiroz, Adriano/AAQ-1164-2020
OI Reis, Mitermayer/0000-0002-3051-9060; CARVALHO,
   MARILIA/0000-0002-9566-0284; Ko, Albert Icksang/0000-0001-9023-2339;
   Ribeiro, Guilherme/0000-0002-6798-2059; Queiroz,
   Adriano/0000-0003-0080-6509
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [NIAID R01
   AI052473, FIC D43 TW00919]; Brazilian National Research CouncilNational
   Council for Scientific and Technological Development (CNPq)
   [300861/1996, 473082/2004, 420067/2005, 305723/2006, 150176/2007];
   Oswaldo Cruz Foundation [0250.250.102]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473] Funding Source: NIH
   RePORTER
FX This work was supported by the US National Institutes of Health (grants
   NIAID R01 AI052473, FIC D43 TW00919), Brazilian National Research
   Council (grants 300861/ 1996, 473082/ 2004, 420067/ 2005, 305723/ 2006,
   150176/ 2007), and Oswaldo Cruz Foundation (grant 0250.250.102). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Ashby D, 2006, STAT MED, V25, P3589, DOI 10.1002/sim.2672
   Barcellos C, 2000, INT J ENVIRON HEAL R, V10, P301, DOI 10.1080/0960312002001500
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Barreto ML, 2007, LANCET, V370, P1622, DOI 10.1016/S0140-6736(07)61638-9
   Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
   Barros FC, 2001, INT J EPIDEMIOL, V30, P1001, DOI 10.1093/ije/30.5.1001
   Bartram J, 2005, LANCET, V365, P810, DOI 10.1016/S0140-6736(05)71007-2
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   *BRAZ MIN HLTH HLT, 2007, CONF CAS MEN DIS BRA
   *BRAZ MIN HLTH HLT, 2007, MEN DIS DEAHTS BRAZI
   *BRAZ MIN HLTH HLT, 2007, LEPT CAS NOT REC
   *BRAZ MIN HLTH HLT, 2007, VISC LEISHM CAS FAT
   *BRAZ MIN HLTH HLT, 2007, VISC LEISHM CAS NOT
   *BRAZ MIN HLTH HLT, 2008, DENG EP REP
   CALDAS EM, 1979, INT J ZOONOSES, V6, P85
   Cumberland P, 2001, EUR J EPIDEMIOL, V17, P601, DOI 10.1023/A:1015509105668
   Dias JP, 2007, REV SOC BRAS MED TRO, V40, P499, DOI 10.1590/S0037-86822007000500002
   Epstein PR, 1999, SCIENCE, V285, P347, DOI 10.1126/science.285.5426.347
   *GAN ASS UN, 2000, UN MILL DECL
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Greenland S, 2000, AM J EPIDEMIOL, V151, P531
   Hin LY, 1999, STAT MED, V18, P1101, DOI 10.1002/(SICI)1097-0258(19990515)18:9<1101::AID-SIM99>3.0.CO;2-Q
   Hutton G, 2007, J WATER HEALTH, V5, P481, DOI 10.2166/wh.2007.009
   *I BRAS GEOGR EST, 2002, CENS DEM 2000 RES UN
   Jackson W.B., 1982, P1077
   Karande Sunil, 2002, Indian Journal of Pediatrics, V69, P855, DOI 10.1007/BF02723705
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   KUPERSTEIN M, 1991, NEURAL NETWORKS, V4, P131, DOI 10.1016/0893-6080(91)90001-L
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   LUPIDI R, 1991, J CLIN MICROBIOL, V29, P805, DOI 10.1128/JCM.29.4.805-809.1991
   Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154
   Marmot M, 2001, NEW ENGL J MED, V345, P134, DOI 10.1056/NEJM200107123450210
   Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   *MIN SAL PUBL ORG, 1998, ORG PAN SAL, P175
   Nowak RM, 1991, WALKERS MAMMALS WORL
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Romero EC, 2006, MEM I OSWALDO CRUZ, V101, P373, DOI 10.1590/S0074-02762006000400005
   Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7
   *SECR COMB POBR DE, 2005, MAP POBR AR URB EST
   Tassinari Wagner de Souza, 2004, Cad. Saúde Pública, V20, P1721, DOI 10.1590/S0102-311X2004000600031
   Travassos Claudia, 2004, Cad. Saúde Pública, V20, P660, DOI 10.1590/S0102-311X2004000300003
   UN-HABITAT, 2003, SLUMS WORLD FACE URB
   United Nations Human Settlements Programme Staff and United Nations Human Settlements Programme, 2003, CHALL SLUMS GLOB REP
   World Health Organization, 2003, HUM LEPT GUID DIAGN
NR 52
TC 207
Z9 212
U1 0
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2008
VL 2
IS 4
AR e228
DI 10.1371/journal.pntd.0000228
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 385IA
UT WOS:000261806700006
PM 18431445
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Tassinari, WS
   Pellegrini, DCP
   Sa, CBP
   Reis, RB
   Ko, AI
   Carvalho, MS
AF Tassinari, Wagner S.
   Pellegrini, Debora C. P.
   Sa, Claudio B. P.
   Reis, Renato B.
   Ko, Albert I.
   Carvalho, Marilia S.
TI Demographic census of Rio de Janeiro Brazil
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE leptospirosis; urban epidemics; geographic information systems; spatial
   epidemiology; generalized linear mixed model
ID HUMAN LEPTOSPIROSIS; URBAN EPIDEMIC; OUTBREAK; DISEASE; HEALTH
AB Objective To analyse the epidemiological profile of 488 cases of leptospirosis in Rio de Janeiro, Brazil between 1997 and 2002, using a variety of methods of spatial epidemiology, to establish alert guidelines in general hospitals, which might be a tool to improve diagnosis and treatment of leptospirosis to reduce lethality rates.
   Methods Scan statistics identified six space-time clusters, which comprised a range of 2 to 28 cases per cluster. Generalized linear mixed models were used to evaluate risk factors for a cluster case which incorporated individual characteristics and spatial information on environmental and climactic factors in a single model frame.
   Results Cluster case events were associated with heavy rainfall (OR 3.71; 95% CI 1.83-7.51). The model did not identify socioeconomic or environmental covariates that significantly influence the risk of developing a cluster rather than non-cluster case.
   Conclusion Clustering of leptospirosis in this urban setting appears to be due to transmission during heavy rainfall.
C1 [Tassinari, Wagner S.] Univ Fed Rural Rio de Janeiro, Dept Math, BR-23890000 Rio de Janeiro, Brazil.
   [Tassinari, Wagner S.; Pellegrini, Debora C. P.; Sa, Claudio B. P.; Carvalho, Marilia S.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [Reis, Renato B.; Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
RP Tassinari, WS (corresponding author), Univ Fed Rural Rio de Janeiro, Dept Math, BR-23890000 Rio de Janeiro, Brazil.
EM tassinari@ufrrj.br
RI Ko, Albert Icksang/P-2343-2015; CARVALHO, MARILIA S/C-3425-2013;
   CARVALHO, MARILIA/AAD-8283-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; CARVALHO,
   MARILIA/0000-0002-9566-0284
CR ABREU MA, 1987, RIO JANEIRO URBAN EV
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Barcellos C, 2000, INT J ENVIRON HEAL R, V10, P301, DOI 10.1080/0960312002001500
   BARCELLOS C, 2001, REPROTS PUBLIC HLTH, V17, P1
   Bharadwaj R, 2002, JPN J INFECT DIS, V55, P194
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Boland M, 2004, EPIDEMIOL INFECT, V132, P195, DOI 10.1017/S0950268803001596
   BRASSEL KE, 1979, GEOGR ANAL, V11, P289
   Camara G., 2000, 2 WORKSH BRAS GEOINF
   DOMM BM, 1960, MEDICINE, V39, P117
   Elliott P., 2000, SPATIAL EPIDEMIOLOGY
   EVERARD COR, 1995, EUR J EPIDEMIOL, V11, P311, DOI 10.1007/BF01719436
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   *FIBGE, 2001, DEM CENS RIO JAN
   *FUNASA, 2005, EP SURV GUID
   *GEOPR LAB, 2001, SISLOC GEOC SYST
   *GEORIO, 2006, RAINF DAT
   Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x
   Intergovernmental Panel on Climate Change [IPCC], 2007, CLIM CHANG 2007 PHYS
   Jansen A, 2005, EMERG INFECT DIS, V11, P1048, DOI 10.3201/eid1107.041172
   Kariv R, 2001, EMERG INFECT DIS, V7, P990, DOI 10.3201/eid0706.010611
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809
   KUPEK E, 2001, BRAZILIAN J INFECTIO, V4, P131
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   MANTEL N, 1967, CANCER RES, V27, P209
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McCulloch CE, 2000, GEN LINEAR MIXED MOD
   Merien F, 1996, AM J TROP MED HYG, V55, P174, DOI 10.4269/ajtmh.1996.55.174
   Mills JN, 1998, EMERG INFECT DIS, V4, P529, DOI 10.3201/eid0404.980403
   Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615
   NAVARRO MBM, 2002, EMERGENTS REEMERGENT
   Okabe A, 2000, SPATIAL TESSELLATION
   R Development Core Team, 2005, R LANG ENV STAT COMP
   ROBERTS L, 2001, ECOSYSTEM CHANGE PUB
   Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002
   SANTOS S, 2006, SPACE APPROACHES PUB
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7
   SKABA DA, 2004, REPORTS PUBLIC HLTH, V20, P1753
   Snedecor G.W., 1982, STAT METHODS
   Snijders T.A.B., 1999, MULTILEVEL ANAL INTR
   Tangkanakul W., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P281
   TASSINARI WS, 2004, REPORTS PUBLIC HLTH, V20, P1721
   United Nations Habitat (UN-Habitat), 2003, CHALL SLUMS GLOB REP, P310
   WATSON JT, 2007, EMERG INFECT DIS, V13
   Wuthiekanun V, 2007, EMERG INFECT DIS, V13, P124, DOI 10.3201/eid1301.060718
   Yersin C, 1998, AM J TROP MED HYG, V59, P933, DOI 10.4269/ajtmh.1998.59.933
NR 49
TC 32
Z9 34
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1360-2276
EI 1365-3156
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD APR
PY 2008
VL 13
IS 4
BP 503
EP 512
DI 10.1111/j.1365-3156.2008.02028.x
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 287YY
UT WOS:000254954600009
PM 18312472
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Gouvela, EL
   Metcalfe, J
   de Carvalho, ALF
   Aires, TSF
   Villasboas-Bisneto, JC
   Queirroz, A
   Santos, AG
   Salgado, K
   Reis, MG
   Ko, AI
AF Gouvela, Edilane L.
   Metcalfe, John
   de Carvalho, Ana Luiza F.
   Aires, Talita S. F.
   Villasboas-Bisneto, Jose Caetano
   Queirroz, Adriano
   Santos, Andreia G.
   Salgado, Katia
   Reis, Mitermayer G.
   Ko, Albert I.
TI Leptospirosis-associated severe pulmonary hemorrhagic syndrome,
   Salvador, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INVOLVEMENT; FEATURES; EPIDEMIC
AB We report the emergence of leptospirosis-associated severe pulmonary hemorrhagic syndrome (SPHS) in slum communities in Salvador, Brazil. Although active surveillance did not identify SPHS before 2003, 47 cases were identified from 2003 through 2005; the case-fatality rate was 74%. By 2005, SPHS caused 55% of the deaths due to leptospirosis.
C1 [Gouvela, Edilane L.; de Carvalho, Ana Luiza F.; Aires, Talita S. F.; Villasboas-Bisneto, Jose Caetano; Queirroz, Adriano; Santos, Andreia G.; Reis, Mitermayer G.; Ko, Albert I.] Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldi Cruz, Minist Saude, BR-40296 Salvador, BA, Brazil.
   [Metcalfe, John] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Salgado, Katia] Hosp Couto Maia, Secretaria Saude Estado Bahia, Salvador, BA, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, New York, NY USA.
RP Ko, AI (corresponding author), Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldi Cruz, Minist Saude, Rua Waldemar Falcao 121, BR-40296 Salvador, BA, Brazil.
EM aik2001@ined.cornell.edu
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; Villasboas Bisneto, Jose
   Caetano/0000-0002-2907-0809; Metcalfe, John/0000-0002-2279-7036
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [5043TW00919, D43 TW000919] Funding Source: Medline; NIAID NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01 AI052473, 5R01AI052473] Funding Source: Medline;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
CR Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Goncalves A J, 1992, Rev Soc Bras Med Trop, V25, P261
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McBride AJA, 2007, CLIN VACCINE IMMUNOL, V14, P1245, DOI 10.1128/CVI.00217-07
   Nicodemo AC, 1997, AM J TROP MED HYG, V56, P181, DOI 10.4269/ajtmh.1997.56.181
   Panaphut Thanachai, 2002, International Journal of Infectious Diseases, V6, P52, DOI 10.1016/S1201-9712(02)90137-2
   PARK SK, 1989, AM J TROP MED HYG, V41, P345, DOI 10.4269/ajtmh.1989.41.345
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   SEHGAL SC, 1995, INDIAN J MED RES, V102, P9
   Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Yersin C, 2000, T ROY SOC TROP MED H, V94, P71, DOI 10.1016/S0035-9203(00)90445-0
NR 15
TC 138
Z9 145
U1 1
U2 10
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAR
PY 2008
VL 14
IS 3
BP 505
EP 508
DI 10.3201/eid1403.071064
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 270BV
UT WOS:000253695800028
PM 18325275
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Codeco, CT
   Lele, S
   Pascual, M
   Bouma, M
   Ko, AI
AF Codeco, Claudia Torres
   Lele, Subhash
   Pascual, Mercedes
   Bouma, Menno
   Ko, Albert I.
TI A stochastic model for ecological systems with strong nonlinear response
   to environmental drivers: application to two water-borne diseases
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE nonlinear; cholera; leptospirosis; seasonality; disease dynamics;
   extrinsic forcing
ID VIBRIO-CHOLERAE; CLIMATE-CHANGE; RAINFALL; NOISE; SHEEP
AB Ecological systems with threshold behaviour show drastic shifts in population abundance or species diversity in response to small variation in critical parameters. Examples of threshold behaviour arise in resource competition theory, epidemiological theory and environmentally driven population dynamics, to name a few. Although expected from theory, thresholds may be difficult to detect in real datasets due to stochasticity, finite population size and confounding effects that soften the observed shifts and introduce variability in the data. Here, we propose a modelling framework for threshold responses to environmental drivers that allows for a flexible treatment of the transition between regimes, including variation in the sharpness of the transition and the variance of the response. The model assumes two underlying stochastic processes whose mixture determines the system's response. For environmentally driven systems, the mixture is a function of an environmental covariate and the response may exhibit strong nonlinearity. When applied to two datasets for water-borne diseases, the model was able to capture the effect of rainfall on the mean number of cases as well as the variance. A quantitative description of this kind of threshold behaviour is of more general application to predict the response of ecosystems and human health to climate change.
C1 [Codeco, Claudia Torres] Fundacao Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Lele, Subhash] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB T6G 2G1, Canada.
   [Pascual, Mercedes] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48104 USA.
   [Bouma, Menno] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England.
   [Ko, Albert I.] Goncalo Muniz Res Ctr, BR-40295001 Brotas Salvador, BA, Brazil.
RP Codeco, CT (corresponding author), Fundacao Oswaldo Cruz, Ave Brasil,4365,Res Oficial, BR-21045900 Rio De Janeiro, Brazil.
EM codeco@fliocruz.br
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW-00919, D43 TW000919] Funding Source: Medline; NIAID NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [AI-052473, R01 AI052473] Funding Source: Medline; PHS
   HHSUnited States Public Health Service [EF 0430 120] Funding Source:
   Medline; FOGARTY INTERNATIONAL CENTERUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
CR ANDERSON R M, 1991
   [Anonymous], 2005, Wkly Epidemiol Rec, V80, P21
   Charron DF, 2004, J TOXICOL ENV HEAL A, V67, P1667, DOI 10.1080/15287390490492313
   Codeco CT, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-1
   Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194
   Efron B., 1993, INTRO BOOTSTRAP
   Ellis Alicia M., 2004, BMC Ecology, V4, P2, DOI 10.1186/1472-6785-4-2
   Engel R, 2001, B MATH BIOL, V63, P1005, DOI 10.1006/bulm.2001.0238
   Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Godambe VP, 1991, ESTIMATING FUNCTIONS
   Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291
   Grover J. P., 1997, RESOURCE COMPETITION
   Grover-Kopec E, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-6
   HUQ A, 1984, APPL ENVIRON MICROB, V48, P420, DOI 10.1128/AEM.48.2.420-424.1984
   Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103
   Jacobson AR, 2004, ECOLOGY, V85, P1598, DOI 10.1890/02-0753
   Karande S, 2003, ARCH DIS CHILD, V88, P1070, DOI 10.1136/adc.88.12.1070
   Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820
   Lele S, 2002, J STAT PLAN INFER, V103, P117, DOI 10.1016/S0378-3758(01)00215-4
   Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004
   Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438
   McLachlan G., 2000, WILEY SER PROB STAT
   MILLER CJ, 1982, LANCET, V1, P1216
   Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7
   Platonov A.E., 2006, VESTN AKAD MED NAUK, V2, P25
   Ruiz-Moreno D, 2007, ECOHEALTH, V4, P52, DOI 10.1007/s10393-006-0079-8
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002
   SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669
   Stenseth NC, 2004, P ROY SOC B-BIOL SCI, V271, P1985, DOI 10.1098/rspb.2004.2794
NR 31
TC 20
Z9 20
U1 1
U2 20
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD FEB 6
PY 2008
VL 5
IS 19
BP 247
EP 252
DI 10.1098/rsif.2007.1135
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 241AC
UT WOS:000251628300009
PM 17698477
OA Green Published
DA 2020-11-30
ER

PT J
AU Athanazio, DA
   Silva, EF
   Santos, CS
   Rocha, GM
   Vannier-Santos, MA
   McBride, AJA
   Ko, AI
   Reis, MG
AF Athanazio, Daniel A.
   Silva, Everton F.
   Santos, Cleiton S.
   Rocha, Gustavo M.
   Vannier-Santos, Marcos A.
   McBride, Alan J. A.
   Ko, Albert I.
   Reis, Mitermayer G.
TI Rattus norvegicus as a model for persistent renal colonization by
   pathogenic Leptospira interrogans
SO ACTA TROPICA
LA English
DT Article
DE leptospirosis; Leptospira; rats; animal disease models
ID SEROVAR ICTEROHAEMORRHAGIAE; ICTERO-HAEMORRHAGIAE; LETHAL INFECTION;
   GUINEA-PIGS; CARRIER; HAMSTER; DISEASE; KIDNEY; RATS; PCR
AB Leptospirosis continues to be a disease with a poorly understood pathogenesis. The experimental rat model is amenable for the investigation of leptospiral dissemination, tropism, persistence of renal colonization and factors related to disease resistance. In this study, Wistar rats were infected intraperitoneally with virulent Leptospira interrogans serovar Copenhageni strain Fiocruz L1-130. The detection of leptospires in tissue samples was based on culture, silver staining and immunofluorescence techniques. An inoculum of 10,000 leptospires induced colonization in 50% of rats and colonization persisted for the 4-month period of the study. Dissemination kinetics revealed that renal colonization took place 7-9 days after infection, with no underlying histopathology. The peak leptospiral load occurred on day 5 post-infection, followed by rapid clearance in all tissues except the kidneys, where dense leptospiral aggregates persisted in the renal tubules. We conclude that the experimental rat model is suitable for studies contributing towards the understanding of the mechanisms of colonization and resistance to severe disease in leptospirosis. (C) 2007 Elsevier B.V. All rights reserved.
C1 [Athanazio, Daniel A.; Silva, Everton F.; Santos, Cleiton S.; Rocha, Gustavo M.; Vannier-Santos, Marcos A.; McBride, Alan J. A.; Ko, Albert I.; Reis, Mitermayer G.] Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Athanazio, Daniel A.; Reis, Mitermayer G.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Silva, Everton F.] Fed Uni Pelotas, Ctr Biotechnol, Rio Grande do Sul, Brazil.
   [Ko, Albert I.] Cornell Univ, Weill Med Coll, Div Infect Dis & Internal Med, New York, NY USA.
RP Reis, MG (corresponding author), Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
EM miter@bahia.fiocruz.br
RI Ko, Albert Icksang/P-2343-2015; McBride, Alan/D-4106-2012;
   Vannier-Santos, Marcos A/L-3649-2013; Vannier-Santos,
   Marcos/G-5517-2012; Athanazio, Daniel/P-6622-2014; Reis,
   Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; McBride,
   Alan/0000-0001-9682-540X; Reis, Mitermayer/0000-0002-3051-9060;
   Vannier-Santos, Marcos/0000-0001-9241-2261
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER; FIC NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [TW00919] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI052473] Funding Source:
   Medline
CR ALVES VAF, 1991, EXP PATHOL-JENA, V42, P81, DOI 10.1016/S0232-1513(11)80051-4
   BERTOK L, 1964, J PATHOL BACTERIOL, V88, P329, DOI 10.1002/path.1700880147
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Branger C, 2005, FEMS MICROBIOL LETT, V243, P437, DOI 10.1016/j.femsle.2005.01.007
   FAINE S, 1965, J CLIN PATHOL, V18, P381, DOI 10.1136/jcp.18.3.381
   FAINE S, 1957, BRIT J EXP PATHOL, V38, P8
   FAINE S., 1962, JOUR HYG, V60, P435
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Ido Y, 1917, J EXP MED, V26, P341, DOI 10.1084/jem.26.3.341
   MARSHALL RB, 1976, J MED MICROBIOL, V9, P149, DOI 10.1099/00222615-9-2-149
   Merien F, 1998, FEMS MICROBIOL LETT, V169, P95, DOI 10.1111/j.1574-6968.1998.tb13304.x
   MILLER NG, 1974, MED MICROBIOL IMMUN, V160, P269, DOI 10.1007/BF02121442
   Nally JE, 2005, INFECT IMMUN, V73, P7014, DOI 10.1128/IAI.73.10.7014-7017.2005
   Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005
   Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002
   PALMER MF, 1987, EPIDEMIOL INFECT, V98, P191, DOI 10.1017/S0950268800061902
   Pereira MM, 2005, AM J TROP MED HYG, V72, P13, DOI 10.4269/ajtmh.2005.72.13
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Silva EF, 2007, VACCINE, V25, P6277, DOI 10.1016/j.vaccine.2007.05.053
   Sunbul M, 2001, SCAND J INFECT DIS, V33, P896, DOI 10.1080/00365540110076796
   TABEL H, 1967, AM J EPIDEMIOL, V85, P9, DOI 10.1093/oxfordjournals.aje.a120679
   THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39
   THIERMANN AB, 1980, AM J VET RES, V41, P1655
   Viriyakosol S, 2006, INFECT IMMUN, V74, P887, DOI 10.1128/IAI.74.2.887-895.2006
NR 25
TC 87
Z9 88
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2008
VL 105
IS 2
BP 176
EP 180
DI 10.1016/j.actatropica.2007.10.012
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 264XI
UT WOS:000253323300011
PM 18093568
OA Green Published
DA 2020-11-30
ER

PT J
AU Hsieh, E
   Matthias, M
   Medeiros, M
   Ko, A
   Vinetz, J
AF Hsieh, E.
   Matthias, M.
   Medeiros, M.
   Ko, A.
   Vinetz, J.
TI Anti-Lig antibody response of leptospirosis patients from a hyperendemic
   region in the Peruvian Amazon
SO JOURNAL OF INVESTIGATIVE MEDICINE
LA English
DT Meeting Abstract
CT Western Regional Meeting of the American-Federation-for-Medical-Research
CY JAN 30-FEB 02, 2008
CL Carmel, CA
SP Amer Federat Med Res
C1 [Hsieh, E.] Univ Calif San Diego, SOM, La Jolla, CA USA.
   [Matthias, M.; Vinetz, J.] Univ Calif San Diego, La Jolla, CA USA.
   [Medeiros, M.; Ko, A.] Fiocruz MS, Salvador, BA, Brazil.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU B C DECKER INC
PI HAMILTON
PA 50 KING STREET EAST, 2ND FLOOR, PO BOX 620, L C D 1, HAMILTON, ONTARIO
   L8N 3K7, CANADA
SN 1081-5589
J9 J INVEST MED
JI J. Invest. Med.
PD JAN
PY 2008
VL 56
IS 1
MA 190
BP 166
EP 167
PG 2
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA 257IV
UT WOS:000252793300201
DA 2020-11-30
ER

PT J
AU Maciel, EAP
   de Carvalho, ALF
   Nascimento, SF
   de Matos, RB
   Gouveia, EL
   Reis, MG
   Ko, AI
AF Maciel, Elves A. P.
   de Carvalho, Ana Luiza F.
   Nascimento, Simone F.
   de Matos, Rosan B.
   Gouveia, Edilane L.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Household Transmission of Leptospira Infection in Urban Slum Communities
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RISK-FACTORS; OUTBREAK; IDENTIFICATION; BARBADOS; SEROVAR; HAWAII; WATER
AB Background: Leptospirosis, a spirochaetal zoonotic disease, is the cause of epidemics associated with high mortality in urban slum communities. Infection with pathogenic Leptospira occurs during environmental exposures and is traditionally associated with occupational risk activities. However, slum inhabitants reside in close proximity to environmental sources of contamination, suggesting that transmission during urban epidemics occurs in the household environment.
   Methods and Findings: A survey was performed to determine whether Leptospira infection clustered within households located in slum communities in the city of Salvador, Brazil. Hospital-based surveillance identified 89 confirmed cases of leptospirosis during an outbreak. Serum samples were obtained from members of 22 households with index cases of leptospirosis and 52 control households located in the same slum communities. The presence of anti-Leptospira agglutinating antibodies was used as a marker for previous infection. In households with index cases, 22 (30%) of 74 members had anti-Leptospira antibodies, whereas 16 (8%) of 195 members from control households had anti-Leptospira antibodies. Highest titres were directed against L. interrogans serovars of the Icterohaemorrhagiae serogroup in 95% and 100% of the subjects with agglutinating antibodies from case and control households, respectively. Residence in a household with an index case of leptospirosis was associated with increased risk (OR 5.29, 95% CI 2.13-13.12) of having had a Leptospira infection. Increased infection risk was found for all age groups who resided in a household with an index case, including children <15 years of age (P = 0.008).
   Conclusions: This study identified significant household clustering of Leptospira infection in slum communities where recurrent epidemics of leptospirosis occur. The findings support the hypothesis that the household environment is an important transmission determinant in the urban slum setting. Prevention therefore needs to target sources of contamination and risk activities which occur in the places where slum inhabitants reside.
C1 [Maciel, Elves A. P.; de Carvalho, Ana Luiza F.; Nascimento, Simone F.; de Matos, Rosan B.; Gouveia, Edilane L.; Reis, Mitermayer G.; Ko, Albert I.] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Nascimento, Simone F.] Municipal Secretary Hlth Salvador, Salvador, BA, Brazil.
   [de Matos, Rosan B.] State Secretary Hlth Bahia, Salvador, BA, Brazil.
   [Ko, Albert I.] Cornell Univ, Div Int Med & Infect Dis, Weill Med Coll, New York, NY 10021 USA.
RP Maciel, EAP (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339
FU Brazilian National Research CouncilNational Council for Scientific and
   Technological Development (CNPq) [300.861/1996, 554.788/2006]; National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI052473, TW00919];
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
FX This work was supported by the Brazilian National Research Council
   (grants 300.861/1996, 554.788/2006) and the National Institutes of
   Health (grants AI052473 and TW00919). The funding agencies had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Ashford DA, 2000, AM J TROP MED HYG, V63, P249, DOI 10.4269/ajtmh.2000.63.249
   Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59
   Barcellos C, 2000, INT J ENVIRON HEAL R, V10, P301, DOI 10.1080/0960312002001500
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Cumberland P, 2001, EUR J EPIDEMIOL, V17, P601, DOI 10.1023/A:1015509105668
   EVERARD COR, 1990, ANN TROP MED PARASIT, V84, P255, DOI 10.1080/00034983.1990.11812465
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FAINE S, 1982, GUIDELINES CONTROL L, P171
   FAINE S, 2003, HUM LEPT GUID DIAGN, P122
   Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308
   Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942
   Karande Sunil, 2002, Indian Journal of Pediatrics, V69, P855, DOI 10.1007/BF02723705
   Katz AR, 2003, TROP MED INT HEALTH, V8, P639, DOI 10.1046/j.1365-3156.2003.01071.x
   Katz AR, 2002, AM J TROP MED HYG, V66, P61, DOI 10.4269/ajtmh.2002.66.61
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   KUPERSTEIN M, 1991, NEURAL NETWORKS, V4, P131, DOI 10.1016/0893-6080(91)90001-L
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Levett PN, 2003, CLIN INFECT DIS, V36, P447, DOI 10.1086/346208
   Lingappa J, 2004, GENES IMMUN, V5, P197, DOI 10.1038/sj.gene.6364058
   LUPIDI R, 1991, J CLIN MICROBIOL, V29, P805, DOI 10.1128/JCM.29.4.805-809.1991
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615
   Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180
   Riley Lee W, 2007, BMC Int Health Hum Rights, V7, P2, DOI 10.1186/1472-698X-7-2
   Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Sejvar J, 2003, EMERG INFECT DIS, V9, P702
   Silva Hagamenon R., 2003, Rev. Soc. Bras. Med. Trop., V36, P227, DOI 10.1590/S0037-86822003000200006
   Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13
   TASSINARI WS, 1996, CAD SAUDE PUBLICA, V20, P1721
   *UN, 2003, CHALL SLUMS GLOB REP
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   Wangroongsarb P, 2007, FEMS MICROBIOL LETT, V271, P170, DOI 10.1111/j.1574-6968.2007.00711.x
NR 34
TC 74
Z9 76
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2008
VL 2
IS 1
AR e154
DI 10.1371/journal.pntd.0000154
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 385HX
UT WOS:000261806400005
PM 18357340
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Spichler, A
   Ko, AI
   Silva, EF
   De Brito, T
   Silva, AM
   Athanazio, D
   Silva, C
   Seguro, A
AF Spichler, Anne
   Ko, Albert I.
   Silva, Everton Fagonde
   De Brito, Thales
   Silva, Ana Maria
   Athanazio, Daniel
   Silva, Cleiton
   Seguro, Antonio
TI Reversal of renal tubule transporter downregulation during severe
   leptospirosis with antimicrobial therapy
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID THICK ASCENDING LIMB; GUINEA-PIG; NA-K-2CL COTRANSPORTER; SODIUM
   TRANSPORTERS; N-ACETYLCYSTEINE; KIDNEY; EXPRESSION; PATHOGENESIS;
   FAILURE; LIVER
AB Tubular dysfunction is a hallmark of severe leptospirosis. Antimicrobial therapy is thought to interfere on renal involvement. We evaluated the expression of a proximal tubule type-3 Na+/H+ exchanger (NHE3) and a thick ascending limb Na+-K+-2Cl(-) co-transporter (NKCC2) in controls and treated hamsters. Animals infected by a serovar Copenhageni isolate, were treated or not with ampicillin (AMP) and/or N-acetylcysteine (NAC). Leptospiral antigen(s) and expression of renal transporters were evaluated by immunohistochemistry, and serum thiobarbituric acid (TBARS) was quantified. Infected hamsters had high amounts of detectable leptospiral antigen(s) in target tissues while renal expression of NHE3 and NKCC2 decreased. Ampicillin treatment was associated with minimal or no detection of leptospiral antigens, normal expression of NHE3 and NKCC2 transporters, and reduced levels of TBARS. NAC effect was restricted to lowering TBARS. Early and late AMP treatment rescued tubular defects in severe leptospirosis disease, and there was no evidence of benefit from antioxidant therapy.
C1 [Spichler, Anne; Seguro, Antonio] Univ Sao Paulo, Dept Nephrol, Lab Pesquisa Basica LIM 12, Fac Med, BR-01246 Sao Paulo, Brazil.
   [Ko, Albert I.; Silva, Everton Fagonde; Silva, Cleiton] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40295 Salvador, BA, Brazil.
   [De Brito, Thales; Silva, Ana Maria] Univ Sao Paulo, Sch Med, Inst Trop Med, Sao Paulo, Brazil.
   [Athanazio, Daniel] Univ Fed Bahia, ICS, Dept Biointeracao, BR-40110 Salvador, BA, Brazil.
RP Spichler, A (corresponding author), Univ Sao Paulo, Dept Nephrol, Lab Pesquisa Basica LIM 12, Fac Med, Av Dr Arnaldo 455 3 Andar, BR-01246 Sao Paulo, Brazil.
EM annespichler@terra.com.br; aik2001@med.cornell.edu;
   efagonde@hotmail.com; thalesbr@usp.br; dathanazio@cpqgm.fiocruz.br;
   cleitonsilva@hotmail.com
RI da Silva, Ana Maria Goncalves/ABD-3920-2020; Athanazio,
   Daniel/P-6622-2014; Ko, Albert Icksang/P-2343-2015; De Brito,
   Thales/L-2865-2017
OI Ko, Albert Icksang/0000-0001-9023-2339; De Brito,
   Thales/0000-0003-1106-7254; Silva, Ana Maria/0000-0001-7554-0894
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW00919] Funding Source: Medline; NIAID NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [AI052473]
   Funding Source: Medline; PHS HHSUnited States Public Health Service
   [420067/2005-1, 300861/96-11] Funding Source: Medline; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
CR Abdulkader RCRM, 1996, AM J TROP MED HYG, V54, P1
   ALEXANDER AD, 1986, ANTIMICROB AGENTS CH, V30, P835, DOI 10.1128/AAC.30.6.835
   Alt DP, 1996, AM J VET RES, V57, P59
   Andrade L, 2007, AM J PHYSIOL-RENAL, V292, pF586, DOI 10.1152/ajprenal.00102.2006
   AREAN VM, 1962, AM J PATHOL, V40, P393
   AREAN VM, 1962, LAB INVEST, V11, P273
   Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Burth P, 2005, J INFECT DIS, V191, P51, DOI 10.1086/426455
   Costa Everaldo, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P141, DOI 10.1590/S0036-46652003000300005
   Covic A, 2003, NEPHROL DIAL TRANSPL, V18, P1128, DOI 10.1093/ndt/gfg095
   Daher Elizabeth De Francesco, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P327
   De Brito T, 2006, VIRCHOWS ARCH, V448, P576, DOI 10.1007/s00428-006-0163-z
   DEARRIAGA AJD, 1982, J PATHOL, V138, P145, DOI 10.1002/path.1711380205
   DEBRITO T, 1992, INT J EXP PATHOL, V73, P633
   DEBRITO T, 1966, VIRCHOWS ARCH A, V341, P64
   Elkjaer ML, 2002, AM J PHYSIOL-RENAL, V283, pF1376, DOI 10.1152/ajprenal.00186.2002
   FAINE S, 1955, J INFECT DIS, V97, P146, DOI 10.1093/infdis/97.2.146
   Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96
   Knepper MA, 2001, CURR OPIN NEPHROL HY, V10, P655, DOI 10.1097/00041552-200109000-00017
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lin CL, 1999, NEPHROL DIAL TRANSPL, V14, P193, DOI 10.1093/ndt/14.1.193
   LLAMA PF, 1998, KIDNEY INT, V54, P170
   Maciel EAP, 2006, ACTA TROP, V100, P256, DOI 10.1016/j.actatropica.2006.11.006
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   MILLER NG, 1974, MED MICROBIOL IMMUN, V160, P269, DOI 10.1007/BF02121442
   Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Oliva R, 1994, Arch Med Res, V25, P165
   Panaphut T, 2003, CLIN INFECT DIS, V36, P1507, DOI 10.1086/375226
   Ricaldi Jessica N, 2006, Curr Infect Dis Rep, V8, P51, DOI 10.1007/s11908-006-0035-3
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   SEGURO AC, 1990, NEPHRON, V55, P146, DOI 10.1159/000185943
   Sitpridja V, 2005, J POSTGRAD MED, V51, P184
   Sitprija V, 2006, NAT CLIN PRACT NEPHR, V2, P658, DOI 10.1038/ncpneph0326
   Spichler A., 2005, Braz J Infect Dis, V9, P336, DOI 10.1590/S1413-86702005000400011
   SPICHLER A, 2005, C SOC BRAS MED TROP, P459
   Suputtamongkol Y, 2004, CLIN INFECT DIS, V39, P1417, DOI 10.1086/425001
   Truccolo J, 2002, ANTIMICROB AGENTS CH, V46, P848, DOI 10.1128/AAC.46.3.848-853.2002
   Vinetz JM, 2003, CLIN INFECT DIS, V36, P1514, DOI 10.1086/375275
   Wang WD, 2002, AM J PHYSIOL-RENAL, V282, pF34, DOI 10.1152/ajprenal.0101.2001
   Watt G, 2002, QJM-INT J MED, V95, P285, DOI 10.1093/qjmed/95.5.285
   World Health Organization, 2003, HUM LEPT GUID DIAGN
   Wu MS, 2004, NEPHROL DIAL TRANSPL, V19, P2472, DOI 10.1093/ndt/gfh452
   Yang CW, 2000, J AM SOC NEPHROL, V11, P2017
   Yang CW, 2001, NEPHROL DIAL TRANSPL, V16, P73, DOI 10.1093/ndt/16.suppl_5.73
   YounesIbrahim M, 1997, BRAZ J MED BIOL RES, V30, P213, DOI 10.1590/S0100-879X1997000200009
   Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001
NR 49
TC 17
Z9 18
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2007
VL 77
IS 6
BP 1111
EP 1119
DI 10.4269/ajtmh.2007.77.1111
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 248AH
UT WOS:000252123200023
PM 18165532
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU McBride, FW
   Medeiros, M
   McBride, AJ
   Figueira, CP
   Esteves, G
   Chagas, A
   Santos, C
   Matsunaga, J
   Haake, D
   Homma, A
   Galler, R
   Reis, MG
   Ko, AI
AF McBride, Flavia W.
   Medeiros, Marco
   McBride, Alan J.
   Figueira, Claudio P.
   Esteves, Gabriela
   Chagas, Adenizar, Jr.
   Santos, Cleiton
   Matsunaga, James
   Haake, David
   Homma, Akira
   Galler, Ricardo
   Reis, Mitermayer G.
   Ko, Albert I.
TI Immunization with leptospiral immunoglobulin-like (LIG) protein with
   aluminium hydroxide adjuvant confers sterilizing immunity in the hamster
   model for leptospirosis
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 04-08, 2007
CL Philadelphia, PA
SP Amer Soc Trop Med & Hyg
C1 [McBride, Flavia W.; McBride, Alan J.; Figueira, Claudio P.; Chagas, Adenizar, Jr.; Santos, Cleiton; Reis, Mitermayer G.] Inst Oswaldo Fdn, Salvador, BA, Brazil.
   [Medeiros, Marco; Esteves, Gabriela; Homma, Akira; Galler, Ricardo] Inst Oswaldo Fdn, Rio De Janeiro, Brazil.
   [Matsunaga, James; Haake, David] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA.
   [Ko, Albert I.] Cornell Univ, Weil Med Coll, New York, NY USA.
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2007
VL 77
IS 5
SU S
MA 98
BP 29
EP 29
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 228UN
UT WOS:000250758200099
DA 2020-11-30
ER

PT J
AU Tucunduva de Faria, M
   Athanazio, DA
   Gonalves Ramos, EA
   Silva, EF
   Reis, MG
   Ko, AI
AF Tucunduva de Faria, M.
   Athanazio, D. A.
   Gonalves Ramos, E. A.
   Silva, E. F.
   Reis, M. G.
   Ko, A. I.
TI Morphological alterations in the kidney of rats with natural and
   experimental Leptospira infection
SO JOURNAL OF COMPARATIVE PATHOLOGY
LA English
DT Article
DE leptospirosis; Rattus norvegicus; interstitial nephritis; kidney
ID BORGPETERSENII SEROVAR HARDJO; TYPE-1 IMMUNE-RESPONSE; GAMMA-DELTA;
   INTERROGANS; POMONA; ICTEROHAEMORRHAGIAE; AMAZONENSIS; HEMORRHAGE;
   NEPHRITIS; CARRIER
AB Leptospirosis is a widespread anthropozoonosis, with a broad array of mammalian reservoirs, occurring as rural endemics, urban outbreaks related to floods, and emergent disease associated with water sports and recreational exposure in developed countries. Rats are the major source of human infection, particularly in urban areas; however few reports have focused on the pathology of leptospirosis in this host. This study reports pathological changes in 60 kidneys from captured wild rats and compares these with changes in the kidney of Wistar rats experimentally infected with Leptospira interrogans serovar Copenhageni strain FIOCRUZ L1-130. A broad range of morphological alterations were detected in the kidneys from captured rats but interstitial nephritis was the only feature reproduced under experimental conditions. The role of interstitial nephritis in the pathogenesis of leptospirosis is reviewed and it is suggested that rats may provide a potential tool for the study of colonization mechanisms and host resistance in acute leptospiral disease.
C1 Embrapa Amazonia Oriental, BR-66095 Belem, Para, Brazil.
   Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Minist Hlth, Salvador, BA, Brazil.
   Univ Fed Bahia, Salvador, BA, Brazil.
   Univ Fed Pelotas, Pelotas, RS, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med Infect Dis, New York, NY USA.
RP Tucunduva de Faria, M (corresponding author), Embrapa Amazonia Oriental, Trav Encas Pinheiro S-N,Caixa Postal 48, BR-66095 Belem, Para, Brazil.
EM tucun@cpatu.embrapa.br
RI Ko, Albert Icksang/P-2343-2015; Athanazio, Daniel/P-6622-2014; Reis,
   Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW00919] Funding Source: Medline; NIAID NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [AI052473]
   Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
CR Adamus C, 1997, J COMP PATHOL, V117, P311, DOI 10.1016/S0021-9975(97)80079-5
   AMATREDJO A, 1976, AUST VET J, V52, P398, DOI 10.1111/j.1751-0813.1976.tb09511.x
   BARRALNETTO M, 1987, ACTA TROP, V44, P5
   Bernstein J, 1992, URINARY TRACT PATHOL
   BERTOK L, 1964, J PATHOL BACTERIOL, V88, P329, DOI 10.1002/path.1700880147
   Boqvist S, 2003, VET MICROBIOL, V93, P361, DOI 10.1016/S0378-1135(03)00042-7
   Brown RA, 2003, VACCINE, V21, P4448, DOI 10.1016/S0264-410X(03)00439-0
   BURDIN M. L., 1963, RES VET SCI, V4, P423
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   FAINE S, 1965, J CLIN PATHOL, V18, P381, DOI 10.1136/jcp.18.3.381
   FAINE S., 1962, JOUR HYG, V60, P435
   Faine S., 1982, GUIDELINES CONTROL L
   FALCOFF R, 1991, PARASITE IMMUNOL, V13, P639, DOI 10.1111/j.1365-3024.1991.tb00559.x
   HADLOW WJ, 1955, AM J VET RES, V16, P45
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   LAURAIN AR, 1955, AM J PATHOL, V31, P501
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   MILLER NG, 1974, MED MICROBIOL IMMUN, V160, P269, DOI 10.1007/BF02121442
   Naiman BM, 2002, INFECT IMMUN, V70, P6147, DOI 10.1128/IAI.70.11.6147-6157.2002
   Naiman BM, 2001, INFECT IMMUN, V69, P7550, DOI 10.1128/IAI.69.12.7550-7558.2001
   Nally JE, 2005, INFECT IMMUN, V73, P7014, DOI 10.1128/IAI.73.10.7014-7017.2005
   Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005
   Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7
   Natarajaseenivasan K., 1997, Journal of Communicable Diseases, V29, P291
   Oliva R, 1994, Arch Med Res, V25, P165
   PIRANI CL, 1964, NEPHRON, V1, P230, DOI 10.1159/000179336
   STERLING CR, 1981, VET PATHOL, V18, P628, DOI 10.1177/030098588101800508
   Sunbul M, 2001, SCAND J INFECT DIS, V33, P896, DOI 10.1080/00365540110076796
   TABEL H, 1967, AM J EPIDEMIOL, V85, P9, DOI 10.1093/oxfordjournals.aje.a120679
   THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39
   Viriyakosol S, 2006, INFECT IMMUN, V74, P887, DOI 10.1128/IAI.74.2.887-895.2006
   Yener Z, 2001, J VET MED A, V48, P441, DOI 10.1046/j.1439-0442.2001.00355.x
NR 32
TC 44
Z9 45
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9975
EI 1532-3129
J9 J COMP PATHOL
JI J. Comp. Pathol.
PD NOV
PY 2007
VL 137
IS 4
BP 231
EP 238
DI 10.1016/j.jcpa.2007.08.001
PG 8
WC Pathology; Veterinary Sciences
SC Pathology; Veterinary Sciences
GA 236PK
UT WOS:000251315200004
PM 17996544
OA Green Published
DA 2020-11-30
ER

PT J
AU Cordeiro, SM
   Neves, AB
   Ribeiro, CT
   Petersen, ML
   Gouveia, EL
   Ribeiro, GS
   Loba, TS
   Reis, JN
   Salgado, KM
   Reis, MG
   Ko, AI
AF Cordeiro, Soraia M.
   Neves, Alan B.
   Ribeiro, Cassio T.
   Petersen, Maya L.
   Gouveia, Edilane L.
   Ribeiro, Guilherme S.
   Loba, Tatiana S.
   Reis, Joice N.
   Salgado, Katia M.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Hospital-based surveillance of meningococcal meningitis in Salvador,
   Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE meningococcal disease; meningitis; Neisseria Meningitidis; serogroup;
   epidemiology; Brazil
ID C NEISSERIA-MENINGITIDIS; SEROGROUP-B; PROTECTIVE EFFICACY; SAO-PAULO;
   DISEASE; VACCINE; EPIDEMIOLOGY; INFECTIONS; PREVENTION; DENMARK
AB This study aimed to describe the clinical, epidemiological and microbiological features of meningococcal meningitis in Salvador, Brazil. Between February 1996 and January 2001,a hospital-based surveillance prospectively identified cases of culture-positive meningo-coccal meningitis. Demographic and clinical data were collected through interview and medical chart review. Antisera and monoclonal antibodies were used to determine the serogroup and serotype:serosubtype of the isolates, respectively. Surveillance identified a total of 408 cases of meningococcal meningitis, with a case fatality rate of 8% (32/397). The mean annual incidence for the 304 cu Iture- positive cases residing in metropolitan Salvador was 1.71 cases per 100 000 population. Infants <1 year old presented the highest incidence (14.7 cases per 100 000 population). Of the 377 serogrouped isolates, 82%, 16%, 2% and 0.3% were serogroups B, C, W135 and Y, respectively. A single serotype:serosubtype (4,7:P1.19,15) accounted for 64% of all cases. Continued surveillance is necessary to characterise strains and to define future prevention and control strategies. (C) 2007 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, BR-40296710 Salvador, BA, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Joint Med Program, Berkeley, CA 94720 USA.
   Univ Fed Bahia, Sch Pharm, Salvador, BA, Brazil.
   Couto Maia Hosp, Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
RP Ko, AI (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Reis, Joice N/H-9227-2013; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020; Ribeiro, Guilherme/B-6624-2008
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Ribeiro, Guilherme/0000-0002-6798-2059
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01 TW007303, TW 00919, D43 TW000919, D43 TW000919-11, TW 007303]
   Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [R01TW007303, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, R01TW007303, D43TW000919, R01TW007303, D43TW000919,
   R01TW007303, D43TW000919, D43TW000919, R01TW007303] Funding Source: NIH
   RePORTER
CR Berry G, 1995, STATISTICIAN, V44, P417, DOI 10.2307/2348891
   BJUNE G, 1991, LANCET, V338, P1093, DOI 10.1016/0140-6736(91)91961-S
   *BRAZ I GEOGR STAT, 2002, AN EST BRAS
   Cartwright Keith, 2001, Vaccine, V19, P4347, DOI 10.1016/S0264-410X(01)00205-5
   CAUGANT DA, 1987, A VAN LEEUW J MICROB, V53, P389, DOI 10.1007/BF00415492
   Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x
   Costa ED, 1996, REV SAUDE PUBL, V30, P460
   DEMORAES JC, 1992, LANCET, V340, P1074
   Diermayer M, 1999, JAMA-J AM MED ASSOC, V281, P1493, DOI 10.1001/jama.281.16.1493
   EDWARDS MS, 1981, J PEDIATR-US, V99, P540, DOI 10.1016/S0022-3476(81)80250-8
   Flexner S, 1913, J EXP MED, V17, P553, DOI 10.1084/jem.17.5.553
   Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103
   Jackson Lisa A., 1993, Morbidity and Mortality Weekly Report, V42, P21
   Jensen ES, 2003, SCAND J INFECT DIS, V35, P226, DOI 10.1080/00365540310000265
   Kirsch EA, 1996, PEDIATR INFECT DIS J, V15, P967, DOI 10.1097/00006454-199611000-00009
   Lemos APS, 2006, J MED MICROBIOL, V55, P751, DOI 10.1099/jmm.0.46451-0
   Lind I, 2005, EPIDEMIOL INFECT, V133, P205, DOI 10.1017/S0950268804003413
   Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911
   National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1
   PELTOLA H, 1983, REV INFECT DIS, V5, P71
   Pollard AJ, 2000, PEDIATR INFECT DIS J, V19, P333, DOI 10.1097/00006454-200004000-00015
   POOLMAN JT, 1986, LANCET, V2, P555
   Rosenstein NE, 1999, J INFECT DIS, V180, P1894, DOI 10.1086/315158
   Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807
   SACCHI CT, 1992, J CLIN MICROBIOL, V30, P1282, DOI 10.1128/JCM.30.5.1282-1286.1992
   Sacchi CT, 2001, J CLIN MICROBIOL, V39, P2897, DOI 10.1128/JCM.39.8.2897-2903.2001
   SIERRA G V G, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P195
   *SVS MS, 2005, SER HIST CAS DOENC N
   Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520
   Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1
   Tsolia MN, 2006, EUR J CLIN MICROBIOL, V25, P449, DOI 10.1007/s10096-006-0155-6
   Wedege E, 1998, INFECT IMMUN, V66, P3223, DOI 10.1128/IAI.66.7.3223-3231.1998
   WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195
NR 33
TC 16
Z9 16
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD NOV
PY 2007
VL 101
IS 11
BP 1147
EP 1153
DI 10.1016/j.trstmh.2007.06.012
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 228KV
UT WOS:000250729700018
PM 17681359
OA Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Tomich, RGP
   Bomfim, MRQ
   Koury, MC
   Pellegrin, AO
   Pellegrin, LA
   Ko, AI
   Barbosa-Stancioli, EF
AF Pinto Tomich, Renata Graca
   Quaresma Bomfim, Maria Rosa
   Koury, Matilde Cota
   Pellegrin, Aiesca Oliveira
   Pellegrin, Luiz Alberto
   Ko, Albert Icksang
   Barbosa-Stancioli, Edel Figueiredo
TI Leptospirosis serosurvey in bovines from Brazilian pantanal using IGG
   ELISA with recombinant protein LIPL32 and microscopic agglutination test
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE bovine leptospirosis; IgG ELISA rLipL32; MAT
ID LINKED-IMMUNOSORBENT-ASSAY; ANTIBODIES; INTERROGANS; SEROPREVALENCE;
   SERODIAGNOSIS; PREVALENCE; DAIRY
AB This investigation was carried out in Brazilian Pantanal: region with important biodiversity. This region's climatic conditions, hydrology and geomorphology as well as the existence of great variety of wild species favor the maintenance of the Leptospira in the environment. The aim of this study was to evaluate IgG ELISA with recombinant protein LipL32 in comparison with microscopic agglutination test (MAT) and additionally contribute to the knowledge of the distribution of the one of most important worldwide zoonotic infection, assessing the seropositivity of bovine leptospirosis in beef cattle herds of Brazilian Pantanal, an important ecological preserved area, where cattle constitute not only the most important economic resource but also the major activity compatible of the conservation of natural resource of the region. Out of 282 samples of cattle serum analyzed, 143 (50.71%) were positive in MAT. The serovar Hardjo (genotypic Hardjoprajitno and Hardjobovis), Wolffi and Ballum showed the largest frequency of reactive samples. In the IgG ELISA rLipL32, 161 samples (57.09%) were positive. This result was higher than obtained by MAT (p< 0.001). The sensitivity of the ELISA test was 99.30% and the specificity was 86.33%, based on the MAT. This test was shown to be a more sensitive, specific and accurate test for the diagnosis of bovine leptospirosis compared to the MAT.
C1 [Pinto Tomich, Renata Graca; Quaresma Bomfim, Maria Rosa; Koury, Matilde Cota; Barbosa-Stancioli, Edel Figueiredo] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-31270901 Belo Horizonte, MG, Brazil.
   [Pinto Tomich, Renata Graca; Pellegrin, Aiesca Oliveira; Pellegrin, Luiz Alberto] Empresa Brasileira Pesquisa Agropecuaria, Corumba, MS, Brazil.
   [Ko, Albert Icksang] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [Ko, Albert Icksang] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
RP Barbosa-Stancioli, EF (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Cx P 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM edelfb@icb.ufmg.br
RI BOMFIM, MARIA ROSA/AAT-8359-2020; Barbosa-Stancioli, Edel F/J-7230-2012;
   Ko, Albert Icksang/P-2343-2015
OI BOMFIM, MARIA ROSA/0000-0001-5738-3952; Barbosa-Stancioli, Edel
   F/0000-0001-6584-4333; Ko, Albert Icksang/0000-0001-9023-2339
CR ABREU UGP, 2001, TECHNOLOGIAS APROPRI
   Alonso-Andicoberry C., 2001, Investigacion Agraria Produccion y Sanidad Animales, V16, P205
   Alonso-Andicoberry C, 2001, PREV VET MED, V52, P109, DOI 10.1016/S0167-5877(01)00249-5
   Araujo VEM, 2005, ARQ BRAS MED VET ZOO, V57, P430, DOI 10.1590/S0102-09352005000400002
   BELLO N. A., 1984, REV VET VENEZ, V278, P32
   Biswas D, 2005, INDIAN J MED RES, V121, P151
   Bomfim MRQ, 2005, VET MICROBIOL, V109, P89, DOI 10.1016/j.vetmic.2005.05.002
   *CLIVE, 2000, WIN EP 2
   CORDEIRO F, 1981, PESQUISA VET BRASIL, V1, P19
   Da Silva JD, 1998, PESQUI AGROPECU BRAS, V33, P1703
   Dey S, 2004, VET MICROBIOL, V103, P99, DOI 10.1016/j.vetmic.2004.07.018
   Ebani VV, 2003, J WILDLIFE DIS, V39, P718, DOI 10.7589/0090-3558-39.3.718
   ELLIS WA, 1994, VET CLIN N AM-FOOD A, V10, P463, DOI 10.1016/S0749-0720(15)30532-6
   Faine S., 1982, WHO OFFSET PUBLICATI, V67
   Favero Andrea Cecília Mercaldi, 2002, Cienc. Rural, V32, P613, DOI 10.1590/S0103-84782002000400011
   Favero M., 2001, Arquivos do Instituto Biologico (Sao Paulo), V68, P29
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 2005, INDIAN J MED RES, V121, P143
   Homem V S, 2001, Rev Soc Bras Med Trop, V34, P173, DOI 10.1590/S0037-86822001000200004
   Langoni H, 1999, PREV VET MED, V40, P271, DOI 10.1016/S0167-5877(99)00020-3
   Lilenbaum W, 2003, RES VET SCI, V75, P249, DOI 10.1016/S0034-5288(03)00114-0
   Lilenbaum W, 1996, VET REC, V138, P570, DOI 10.1136/vr.138.23.570
   Mathias LA, 1999, J WILDLIFE DIS, V35, P112, DOI 10.7589/0090-3558-35.1.112
   MOURAO GM, 2002, B EMBRAPA CPAP, V28
   National Research Council, 1996, GUID CAR US LAB AN
   O'Keefe JS, 2002, NEW ZEAL VET J, V50, P9, DOI 10.1080/00480169.2002.36242
   Oliveira AAF, 2001, ONDERSTEPOORT J VET, V68, P275
   PELLEGRINV AO, 1997, DOENCAS REPRODUCAO B
   RADOSTITS O. M., 2002, CLIN VET TRATADO DOE
   RIBEIRO JI, 2001, ANAL ESTATISTICAS SA
   SAMPAIO IBM, 1998, ESTATISTICA APLICADE
   Santana A. O. B., 1997, Revista Brasileira de Reproducao Animal, V21, P169
   SEIDL A, 2006, INCENTIVE MEASURES C
   Surujballi O, 2004, CAN J VET RES, V68, P1
   Surujballi O, 2001, CLIN DIAGN LAB IMMUN, V8, P40, DOI 10.1128/CDLI.8.1.40-43.2001
   Viegas S. A. R. A., 2001, REV BRASILEIRA SAUDE, V1, P1
   Yan KT, 1999, VET MICROBIOL, V69, P173, DOI 10.1016/S0378-1135(99)00103-0
NR 38
TC 13
Z9 15
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD OCT-DEC
PY 2007
VL 38
IS 4
BP 674
EP 680
DI 10.1590/S1517-83822007000400017
PG 7
WC Microbiology
SC Microbiology
GA 258VU
UT WOS:000252898500017
OA DOAJ Gold
DA 2020-11-30
ER

PT J
AU Matsunaga, J
   Medeiros, MA
   Sanchez, Y
   Werneid, KF
   Ko, AI
AF Matsunaga, James
   Medeiros, Marco A.
   Sanchez, Yolanda
   Werneid, Kristian F.
   Ko, Albert I.
TI Osmotic regulation of expression of two extracellular matrix-binding
   proteins and a haemolysin of Leptospira interrogans: differential
   effects on LigA and Sph2 extracellular release
SO MICROBIOLOGY-SGM
LA English
DT Article
ID SURFACE-EXPOSED LIPOPROTEIN; SEROVAR LAI; OUTER-MEMBRANE; MOLECULAR
   CHARACTERIZATION; FILAMENTOUS HEMAGGLUTININ; BORDETELLA-PERTUSSIS;
   MAMMALIAN INFECTION; SIGNAL-TRANSDUCTION; MYXOCOCCUS-XANTHUS;
   ADENYLYL-CYCLASE
AB The life cycle of the pathogen Leptospira interrogans involves stages outside and inside the host. Entry of L. interrogans from moist environments into the host is likely to be accompanied by the induction of genes encoding virulence determinants and the concomitant repression of genes encoding products required for survival outside of the host. The expression of the adhesin LigA, the haemolysin Sph2 (Lk73.5) and the outer-membrane lipoprotein LipL36 of pathogenic Leptospira species have been reported to be regulated by mammalian host signals. A previous study demonstrated that raising the osmolarity of the leptospiral growth medium to physiological levels encountered in the host by addition of various salts enhanced the levels of cell-associated LigA and LigB and extracellular LigA. In this study, we systematically examined the effects of osmotic upshift with ionic and non-ionic solutes on expression of the known mammalian host-regulated leptospiral genes. The levels of cell-associated LigA, LigB and Sph2 increased at physiological osmolarity, whereas LipL36 levels decreased, corresponding to changes in specific transcript levels. These changes in expression occurred irrespective of whether sodium chloride or sucrose was used as the solute. The increase of cellular LigA, LigB and Sph2 protein levels occurred within hours of adding sodium chloride. Extracellular Sph2 levels increased when either sodium chloride or sucrose was added to achieve physiological osmolarity. In contrast, enhanced levels of extracellular LigA were observed only with an increase in ionic strength. These results indicate that the mechanisms for release of LigA and Sph2 differ during host infection. Thus, osmolarity not only affects leptospiral gene expression by affecting transcript levels of putative virulence determinants but also affects the release of such proteins into the surroundings.
C1 Res Serv, VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   Brazilian Minist Hlth, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
   Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
RP Matsunaga, J (corresponding author), Res Serv, VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.
EM jamesm@ucla.edu
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW00919] Funding Source: Medline; NIAID NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [AI052473]
   Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473] Funding Source: NIH RePORTER
CR Abramson T, 2001, INFECT IMMUN, V69, P2650, DOI 10.1128/IAI.69.4.2650-2658.2001
   Artiushin S, 2004, INFECT IMMUN, V72, P742, DOI 10.1128/IAI.72.2.742-749.2004
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005
   Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   Coutte L, 2003, J EXP MED, V197, P735, DOI 10.1084/jem.20021153
   CRAWFORD RP, 1971, J AM VET MED ASSOC, V159, P1477
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003
   Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002
   ELLIS WA, 1986, AM J VET RES, V47, P1458
   Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998
   Heusipp G, 2003, FEMS MICROBIOL LETT, V226, P291, DOI 10.1016/S0378-1097(03)00613-X
   Jubelin G, 2005, J BACTERIOL, V187, P2038, DOI 10.1128/JB.187.6.2038-2049.2005
   Kimura Y, 2005, J BACTERIOL, V187, P3593, DOI 10.1128/JB.187.10.3593-3598.2005
   Kimura Y, 2002, J BACTERIOL, V184, P3578, DOI 10.1128/JB.184.13.3578-3585.2002
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016
   Lee SH, 2000, GENE, V254, P19, DOI 10.1016/S0378-1119(00)00293-6
   Lee SH, 2002, INFECT IMMUN, V70, P315, DOI 10.1128/IAI.70.1.315-322.2002
   Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0
   Lo M, 2006, INFECT IMMUN, V74, P5848, DOI 10.1128/IAI.00755-06
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2007, INFECT IMMUN, V75, P2864, DOI 10.1128/IAI.01619-06
   Matsunaga J, 2006, MICROBIOL-SGM, V152, P3777, DOI 10.1099/mic.0.29162-0
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McGuirk P, 2000, EUR J IMMUNOL, V30, P415, DOI 10.1002/1521-4141(200002)30:2<415::AID-IMMU415>3.0.CO;2-X
   Miller KJ, 1996, ANNU REV MICROBIOL, V50, P101, DOI 10.1146/annurev.micro.50.1.101
   Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005
   Nally JE, 2001, INFECT IMMUN, V69, P400, DOI 10.1128/IAI.69.1.400-404.2001
   Nally JE, 2001, INFECT IMMUN, V69, P7616, DOI 10.1128/IAI.69.12.7616-7624.2001
   Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   Qin JH, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-51
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   RYU E, 1966, JPN J MICROBIOL, V10, P51, DOI 10.1111/j.1348-0421.1966.tb00291.x
   Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996
   SHORTRIDGE VD, 1992, MOL MICROBIOL, V6, P863, DOI 10.1111/j.1365-2958.1992.tb01537.x
   SMITH CE, 1961, B WORLD HEALTH ORGAN, V24, P35
   TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255
   Zhang YX, 2005, ACTA PHARMACOL SIN, V26, P453, DOI 10.1111/j.1745-7254.2005.00075.x
   ZUERNER RL, 1991, MICROB PATHOGENESIS, V10, P311, DOI 10.1016/0882-4010(91)90014-2
NR 48
TC 32
Z9 32
U1 0
U2 2
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 1350-0872
EI 1465-2080
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD OCT
PY 2007
VL 153
BP 3390
EP 3398
DI 10.1099/mic.0.2007/007948-0
PN 10
PG 9
WC Microbiology
SC Microbiology
GA 222ES
UT WOS:000250279500019
PM 17906138
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU McBride, AJA
   Santos, BL
   Queiroz, A
   Santos, AC
   Hartskeerl, RA
   Reis, MG
   Ko, AI
AF McBride, Alan J. A.
   Santos, Balbino L.
   Queiroz, Adriano
   Santos, Andreia C.
   Hartskeerl, Rudy A.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Evaluation of four whole-cell Leptospira-based serological tests for
   diagnosis of urban leptospirosis
SO CLINICAL AND VACCINE IMMUNOLOGY
LA English
DT Article
ID INTERNATIONAL MULTICENTER EVALUATION; IMMUNOGLOBULIN-M ANTIBODIES;
   FEBRILE ILLNESS; DIPSTICK ASSAY; EPIDEMIC; OUTBREAK; IGM; SERODIAGNOSIS;
   INTERROGANS; THAILAND
AB Four serologic assays for leptospirosis had sensitivities of 72 to 88% and specificities of 88 to 100% in the setting of highly endemic urban transmission, indicating that assays using enzyme-linked immunosorbency and rapid formats may be used as alternatives to the microscopic agglutination test for diagnosing urban leptospirosis. Testing a second sample will be required in cases with an initial negative result, since sensitivity was low (46 to 68%) during the first week of illness.
C1 Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Hlth, BR-40295001 Salvador, BA, Brazil.
   Royal Trop Inst KIT, Dept Biomed Res, NL-1105 AZ Amsterdam, Netherlands.
   Cornell Univ, Weill Med Coll, Div Infect Dis & Internal Med, New York, NY USA.
RP Ko, AI (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Minist Hlth, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM aik200l@med.cornell.edu
RI Reis, Mitermayer/AAO-9742-2020; Queiroz, Adriano/AAQ-1164-2020; McBride,
   Alan/D-4106-2012; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Queiroz,
   Adriano/0000-0003-0080-6509; McBride, Alan/0000-0001-9682-540X; Ko,
   Albert Icksang/0000-0001-9023-2339; Santos, Balbino Lino
   dos/0000-0002-6430-229X
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER; FIC NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [TW00919, D43 TW000919]
   Funding Source: Medline; NIAID NIH HHSUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [AI052473, R01
   AI052473] Funding Source: Medline
CR ADLER B, 1978, J MED MICROBIOL, V11, P387, DOI 10.1099/00222615-11-4-387
   Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003
   Bharadwaj R, 2002, JPN J INFECT DIS, V55, P194
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Blacksell SD, 2006, CLIN VACCINE IMMUNOL, V13, P1166, DOI 10.1128/CVI.00219-06
   Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06
   Effler PV, 2000, J CLIN MICROBIOL, V38, P1081, DOI 10.1128/JCM.38.3.1081-1084.2000
   Effler PV, 2002, J CLIN MICROBIOL, V40, P1464, DOI 10.1128/JCM.40.4.1464-1469.2002
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Hull-Jackson C, 2006, J CLIN MICROBIOL, V44, P1853, DOI 10.1128/JCM.44.5.1853-1855.2006
   Ismail TF, 2006, AM J TROP MED HYG, V75, P1085, DOI 10.4269/ajtmh.2006.75.1085
   Karande Sunil, 2002, Indian Journal of Pediatrics, V69, P855, DOI 10.1007/BF02723705
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Levett PN, 2001, CLIN DIAGN LAB IMMUN, V8, P349, DOI 10.1128/CDLI.8.2.349-351.2001
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Matsuo K, 2000, J CLIN MICROBIOL, V38, P3750, DOI 10.1128/JCM.38.10.3750-3754.2000
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McBride AJA, 2007, ACTA TROP, V102, P206, DOI 10.1016/j.actatropica.2007.05.002
   Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670
   Myint KSA, 2007, AM J TROP MED HYG, V76, P135, DOI 10.4269/ajtmh.2007.76.135
   Ooteman MC, 2006, J MICROBIOL METH, V65, P247, DOI 10.1016/j.mimet.2005.07.015
   Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002
   Russell KL, 2003, AM J TROP MED HYG, V69, P53, DOI 10.4269/ajtmh.2003.69.53
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Sehgal SC, 2003, J MED MICROBIOL, V52, P897, DOI 10.1099/jmm.0.05064-0
   SILVA MV, 1995, J TROP MED HYG, V98, P268
   Smits HL, 1999, J CLIN MICROBIOL, V37, P2904, DOI 10.1128/JCM.37.9.2904-2909.1999
   Smits HL, 2000, TROP MED INT HEALTH, V5, P124, DOI 10.1046/j.1365-3156.2000.00525.x
   Vijayachari P, 2002, EPIDEMIOL INFECT, V129, P617, DOI 10.1017/S0950268802007537
   Wagenaar JFP, 2004, ANN TROP MED PARASIT, V98, P843, DOI 10.1179/000349804X3207
   Watt G, 2003, AM J TROP MED HYG, V68, P89, DOI 10.4269/ajtmh.2003.68.89
   World Health Organization, 2003, HUM LEPT GUID DIAG S
   Wuthiekanun V, 2007, EMERG INFECT DIS, V13, P124, DOI 10.3201/eid1301.060718
NR 39
TC 30
Z9 31
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1556-6811
EI 1556-679X
J9 CLIN VACCINE IMMUNOL
JI Clin. Vaccine Immunol.
PD SEP
PY 2007
VL 14
IS 9
BP 1245
EP 1248
DI 10.1128/CVI.00217-07
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 210XH
UT WOS:000249488400028
PM 17652521
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU Carvalho, M
   Sa, C
   Boaventura, E
   Ko, A
AF Carvalho, M.
   Sa, C.
   Boaventura, E.
   Ko, A.
TI Application of generalized additive mixed model: Modeling the effect of
   climatic covariates on leptospirosis incidence
SO EPIDEMIOLOGY
LA English
DT Meeting Abstract
CT 19th Annual Conference of the
   International-Society-for-Environmental-Epidemiology
CY SEP 05-09, 2007
CL Mexico City, MEXICO
SP Int Soc Environm Epidemiol
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1044-3983
J9 EPIDEMIOLOGY
JI Epidemiology
PD SEP
PY 2007
VL 18
IS 5
SU S
BP S41
EP S42
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 204BQ
UT WOS:000249018300125
DA 2020-11-30
ER

PT J
AU Dias, JP
   Teixeira, MG
   Costa, MCN
   Mendes, CMC
   Guimaraes, P
   Reis, MG
   Ko, A
   Barreto, ML
AF Dias, Juarez Pereira
   Teixeira, Maria Gloria
   Costa, Maria Conceicao Nascimento
   Mendes, Carlos Mauricio Cardeal
   Guimaraes, Patricia
   Reis, Mitermayer Galvo
   Ko, Albert
   Barreto, Mauricio Lima
TI Factors associated with Leptospira sp infection in a large urban center
   in northeastern Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE leptospirosis; seroprevalence; epidemiology; urban epidemics
ID RISK-FACTORS; EPIDEMIC; POPULATION; AREA; CITY
AB Leptospirosis is a zoonotic disease that has emerged to cause epidemics in urban communities in developing countries. However, little is known about the infection in the general population. A seroprevalence survey was performed on a random sample of l,390 subjects in Salvador, Brazil. Data on environmental and socioeconomic factors were collected. The microagglutination test of serum samples was used to show any prior Leptospira infection. The overall seroprevalence was 12.4%. Among the seropositive individuals, 111 (61%) had high titers for serovars of the lcterohaemorrbagiae serogroup. Seroprevalence increased with age and was similar for males and females. A positive correlation between Leptospira infection and low educational level was found. These findings indicate that a significant proportion of this urban population is exposed to pathogenic Leptospira. Public health actions for leptospirosis control will need to target not only the traditionalgroups at risk of infection with severe forms of this disease, but also the general population that is at risk.
C1 Univ Fed Bahia, Inst Saude Coletiva, BR-41110040 Salvador, BA, Brazil.
   Fdn Oswaldo Cruz Minist Saude, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
RP Dias, JP (corresponding author), Univ Fed Bahia, Inst Saude Coletiva, Basilio Gama S-N,Campus Univ Canela, BR-41110040 Salvador, BA, Brazil.
EM jucadias09@uol.com.br
RI Mendes, Carlos Mauricio Cardeal/R-3688-2017; Reis,
   Mitermayer/AAO-9742-2020; Barreto, Mauricio L/B-1752-2008; Ko, Albert
   Icksang/P-2343-2015; Mendes, Carlos Mauricio Cardeal/AAC-1635-2019
OI Mendes, Carlos Mauricio Cardeal/0000-0003-2089-5668; Reis,
   Mitermayer/0000-0002-3051-9060; Barreto, Mauricio L/0000-0002-0215-4930;
   Ko, Albert Icksang/0000-0001-9023-2339; Mendes, Carlos Mauricio
   Cardeal/0000-0003-2089-5668
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW 00919-07] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [AI
   052473-01A1] Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473] Funding Source: NIH RePORTER
CR ALMEIDA PA, 1994, REV SAUDE PUBL, V28, P76
   Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59
   BARRETO MI, 1997, BAHIA ANAL DADOS, V7, P24
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   CALDAS EM, 1979, INT J ZOONOSES, V6, P85
   Cochran W. G., 1997, SAMPLING TECHNIQUES
   DastisBendala C, 1996, EUR J EPIDEMIOL, V12, P257, DOI 10.1007/BF00145415
   Dupont H, 1997, CLIN INFECT DIS, V25, P720, DOI 10.1086/513767
   EVERARD COR, 1987, TROP GEOGR MED, V39, P126
   Faine S., 1993, LEPTOSPIRA LEPTOSPIR
   FAINE S, 1982, WHO OFFSET PUBLICATI
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   *I BRAS GEOGR EST, 1991, CENS POP BRAS DAD DE, P1
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Katz AR, 2002, AM J TROP MED HYG, V66, P61, DOI 10.4269/ajtmh.2002.66.61
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   LILMBAUM W, 1993, REV LATINO AM MICROB, V35, P357
   MACEDO NA, 1997, THESIS U SAO PAULO S
   MARTINS FSV, 1998, DOENCAS INFECCIOSAS, P145
   Milroy CA, 2001, ENVIRON URBAN, V13, P235, DOI 10.1177/095624780101300117
   MORSHED MG, 1994, EPIDEMIOL INFECT, V112, P527, DOI 10.1017/S0950268800051220
   Murhekar MV, 1998, INDIAN J MED RES, V107, P218
   PEREIRA MM, 1990, MEM I OSWALDO CRUZ, V85, P47, DOI 10.1590/S0074-02761990000100007
   Russell KL, 2003, AM J TROP MED HYG, V69, P53, DOI 10.4269/ajtmh.2003.69.53
   SANCHEZ EM, 1993, REV CUBANA MED TROPI, V45, P32
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Souza Doralice de, 1986, Rev Esc Enferm USP, V20, P243, DOI 10.1590/0080-6234198602000300243
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Teixeira Maria da Glória, 2002, Cad. Saúde Pública, V18, P1189, DOI 10.1590/S0102-311X2002000500011
   Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527, DOI 10.1097/00001432-200110000-00005
   ZAMORA J, 1990, REV MED CHILE, V118, P247
NR 32
TC 40
Z9 41
U1 0
U2 9
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD SEP-OCT
PY 2007
VL 40
IS 5
BP 499
EP 504
DI 10.1590/S0037-86822007000500002
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 230IE
UT WOS:000250869400002
PM 17992402
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Silva, EF
   Medeiros, MA
   McBride, AJA
   Matsunaga, J
   Esteves, GS
   Ramos, JGR
   Santos, CS
   Croda, J
   Homma, A
   Dellagostin, OA
   Haake, DA
   Reis, MG
   Ko, AI
AF Silva, Everton F.
   Medeiros, Marco A.
   McBride, Alan J. A.
   Matsunaga, Jim
   Esteves, Gabriela S.
   Ramos, Joao G. R.
   Santos, Cleiton S.
   Croda, Julio
   Homma, Akira
   Dellagostin, Odira A.
   Haake, David A.
   Reis, Mitermayer G.
   Ko, Albert I.
TI The terminal portion of leptospiral immunoglobulin-like protein LigA
   confers protective immunity against lethal infection in the hamster
   model of leptospirosis
SO VACCINE
LA English
DT Article
DE leptospirosis; subunit vaccine; leptospiral immunoglobulin-like protein;
   recombinant protein; immunity; antibodies; hamsters
ID OUTER-MEMBRANE PROTEINS; SEROVAR HARDJO; INTERROGANS; CHALLENGE; MICE;
   VACCINATION; EXPRESSION; VACCINES; DISEASE
AB Subunit vaccines are a potential intervention strategy against leptospirosis, which is a major public health problem in developing countries and a veterinary disease in livestock and companion animals worldwide. Leptospiral immunoglobulin-like (Lig) proteins are a family of surface-exposed determinants that have Ig-like repeat domains found in virulence factors such as intimin and invasin. We expressed fragments of the repeat domain regions of LigA and Lig]B from Leptospira interrogans serovar Copenhageni. Immunization of Golden Syrian hamsters with Lig fragments in Freund's adjuvant induced robust antibody responses against recombinant protein and native protein, as detected by ELISA and immunoblot, respectively. A single fragment, LigANI, which corresponds to the six carboxy-terminal Ig-like repeat domains of the LigA molecule, conferred immunoprotection against mortality (67-100%, P < 0.05) in hamsters which received a lethal inoculum of L. interrogans serovar Copenhageni. However, immunization with this fragment did not confer sterilizing immunity. These findings indicate that the carboxy-terminal portion of LigA is an immunoprotective domain and may serve as a vaccine candidate for human and veterinary leptospirosis. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, BR-40296710 Salvador, BA, Brazil.
   Brazilian Minst Hlth, Oswaldo Curz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   Univ Fed Pelotas, Ctr Biotechnol, Pelotas, Brazil.
   Vet Affairs Greater Los Angles Healthcare Syst, Los Angeles, CA USA.
   Univ Calif Los Angeles, David Giffen Sch Med, Dept Med, Los Angeles, CA USA.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
RP Ko, AI (corresponding author), Ctr Pesquisas Goncalo Moniz, Fundacao Oswaldo Cruz, Rua Waldemar Falcao,121, BR-40296710 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Dellagostin, Odir/C-2331-2009; Croda, Julio/I-5172-2013; McBride,
   Alan/D-4106-2012; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020
OI Dellagostin, Odir/0000-0003-2803-4088; Croda, Julio/0000-0002-6665-6825;
   McBride, Alan/0000-0001-9682-540X; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060;
   Esteves, Gabriela/0000-0002-0339-2826
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI034431, R01AI034431, R29AI034431,
   R01AI052473, R01AI034431, R01AI034431, R01AI052473, R01AI034431,
   R01AI034431, R01AI034431, R01AI034431, R29AI034431, R01AI034431,
   R29AI034431, R01AI052473, R29AI034431, R01AI052473, R01AI034431,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI034431,
   R01AI052473, R01AI034431, R29AI034431, R01AI034431, R21AI034431] Funding
   Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43 TW000919-10, TW00919, D43 TW000919]
   Funding Source: Medline; NIAID NIH HHSUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01 AI034431, R01
   AI052473, R21 AI034431, AI034431, R01 AI034431-10A1, AI052473, R29
   AI034431, R01 AI052473-04] Funding Source: Medline
CR ADLER B, 1980, J HYG-CAMBRIDGE, V84, P1, DOI 10.1017/S0022172400026450
   ADLER B, 1976, INFECT IMMUN, V14, P703, DOI 10.1128/IAI.14.3.703-708.1976
   ADLER B, 1977, INFECT IMMUN, V17, P67, DOI 10.1128/IAI.17.1.67-72.1977
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   BOLIN CA, 1989, AM J VET RES, V50, P2004
   Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001
   Branger C, 2005, INFECT IMMUN, V73, P4062, DOI 10.1128/IAI.73.7.4062-4069.2005
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   *CDCP, 2000, JAMA-J AM MED ASSOC, V284, P1646
   CHAPPEL RJ, 1992, VET MICROBIOL, V30, P151, DOI 10.1016/0378-1135(92)90110-F
   Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06
   Crowther J R, 1995, Methods Mol Biol, V42, P1
   Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   FREUDENSTEIN H, 1991, COMP IMMUNOL MICROB, V14, P229, DOI 10.1016/0147-9571(91)90003-V
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942
   Hotez PJ, 2006, VACCINE, V24, P5787, DOI 10.1016/j.vaccine.2006.05.008
   Ido Y, 1916, J EXP MED, V24, P471, DOI 10.1084/jem.24.5.471
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Meites E, 2004, EMERG INFECT DIS, V10, P406, DOI 10.3201/eid1003.030431
   MIDWINTER A, 1990, J MED MICROBIOL, V33, P199, DOI 10.1099/00222615-33-3-199
   Moore GE, 2006, EMERG INFECT DIS, V12, P501, DOI 10.3201/eid1203.050809
   Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615
   Naiman BM, 2002, INFECT IMMUN, V70, P6147, DOI 10.1128/IAI.70.11.6147-6157.2002
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Palaniappan RUM, 2006, INFECT IMMUN, V74, P1745, DOI 10.1128/IAI.74.3.1745-1750.2006
   Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Ricaldi Jessica N, 2006, Curr Infect Dis Rep, V8, P51, DOI 10.1007/s11908-006-0035-3
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Sejvar J, 2003, EMERG INFECT DIS, V9, P702
   Sonrier C, 2000, VACCINE, V19, P86, DOI 10.1016/S0264-410X(00)00129-8
   THIERMANN AB, 1984, J AM VET MED ASSOC, V184, P722
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   Viriyakosol S, 2006, INFECT IMMUN, V74, P887, DOI 10.1128/IAI.74.2.887-895.2006
   Wiwanitkit V, 2007, VACCINE, V25, P2768, DOI 10.1016/j.vaccine.2006.12.023
   World Health Organization, 2003, HUM LEPT GUID DIAGN
NR 48
TC 119
Z9 118
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD AUG 14
PY 2007
VL 25
IS 33
BP 6277
EP 6286
DI 10.1016/j.vaccine.2007.05.053
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 202MN
UT WOS:000248905900016
PM 17629368
OA Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Ristow, P
   Bourhy, P
   McBride, FWD
   Figueira, CP
   Huerre, M
   Ave, P
   Saint Girons, I
   Ko, AI
   Picardeau, M
AF Ristow, Paula
   Bourhy, Pascale
   da Cruz McBride, Flavia Weykamp
   Figueira, Claudio Pereira
   Huerre, Michel
   Ave, Patrick
   Saint Girons, Isabelle
   Ko, Albert I.
   Picardeau, Mathieu
TI The OmpA-like protein Loa22 is essential for leptospiral virulence
SO PLOS PATHOGENS
LA English
DT Article
ID POTENTIAL VACCINE CANDIDATES; ESCHERICHIA-COLI O157-H7; OUTER-MEMBRANE;
   INTERROGANS; LIPOPROTEIN; PREDICTION; BINDING; SURFACE; GROWTH; DOMAIN
AB Pathogenic mechanisms of Leptospira interrogans, the causal agent of leptospirosis, remain largely unknown. This is mainly due to the lack of tools for genetic manipulations of pathogenic species. In this study, we characterized a mutant obtained by insertion of the transposon Himar1 into a gene encoding a putative lipoprotein, Loa22, which has a predicted OmpA domain based on sequence identity. The resulting mutant did not express Loa22 and was attenuated in virulence in the guinea pig and hamster models of leptospirosis, whereas the genetically complemented strain was restored in Loa22 expression and virulence. Our results show that Loa22 was expressed during host infection and exposed on the cell surface. Loa22 is therefore necessary for virulence of L. interrogans in the animal model and represents, to our knowledge, the first genetically defined virulence factor in Leptospira species.
C1 Inst Pasteur, Unite Biol Spirochetes, Paris, France.
   Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil.
   Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   Inst Pasteur, Unite Rech & Expertise Histotechnol & Pathol, Paris, France.
   Cornell Univ, Weill Med Coll, Div Infect Dis & Internal Med, New York, NY USA.
RP Picardeau, M (corresponding author), Inst Pasteur, Unite Biol Spirochetes, Paris, France.
EM mpicard@pasteur.fr
RI Ristow, Paula/AAP-6522-2020; Ristow, Paula/D-1276-2013; Ko, Albert
   Icksang/P-2343-2015
OI Ristow, Paula/0000-0001-8494-361X; Ko, Albert
   Icksang/0000-0001-9023-2339
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER; FIC
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW00919, D43 TW000919] Funding Source: Medline
CR [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   BANCROFT JD, 1994, MANUAL HIST TECHNIQU
   Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005
   Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004
   Dabo SM, 2003, MICROB PATHOGENESIS, V35, P147, DOI 10.1016/S0882-4010(03)00098-6
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45
   FALKOW S, 1988, REV INFECT DIS, V10, pS274
   Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004
   Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002
   HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991
   Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703
   KOEBNIK R, 1995, MOL MICROBIOL, V12, P333
   Koizumi N, 2003, FEMS MICROBIOL LETT, V226, P215, DOI 10.1016/S0378-1097(03)00619-0
   Lee SH, 2002, INFECT IMMUN, V70, P315, DOI 10.1128/IAI.70.1.315-322.2002
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   LOUVEL H, 2007, CURRENT PROTOCOLS MI
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1016/S0378-1097(00)00044-6
   Nally JE, 2007, INFECT IMMUN, V75, P766, DOI 10.1128/IAI.00741-06
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983
   RAWLING EG, 1995, INFECT IMMUN, V63, P38, DOI 10.1128/IAI.63.1.38-42.1995
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0
   Shin S, 2005, BIOCHEM BIOPH RES CO, V330, P1199, DOI 10.1016/j.bbrc.2005.03.097
   Singh SP, 2003, INFECT IMMUN, V71, P3937, DOI 10.1128/IAI.71.7.3937-3946.2003
   Torres AG, 2006, INFECT IMMUN, V74, P2676, DOI 10.1128/IAI.74.5.2676-2685.2006
   Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005
   Yang HL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-293
NR 37
TC 143
Z9 150
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUL
PY 2007
VL 3
IS 7
BP 894
EP 903
AR e97
DI 10.1371/journal.ppat.0030097
PG 10
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 196VY
UT WOS:000248511600005
PM 17630832
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU McBride, AJA
   Pereira, FA
   da Silva, ED
   de Matos, RB
   da Silva, ED
   Ferreira, AGP
   Reis, MG
   Ko, AI
AF McBride, Alan J. A.
   Pereira, Fernanda A.
   da Silva, Emilson D.
   de Matos, Rosan B.
   da Silva, Edimilson D.
   Ferreira, Antonio G. P.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Evaluation of the EIE-IgM-Leptospirose assay for the serodiagnosis of
   leptospirosis
SO ACTA TROPICA
LA English
DT Article
DE leptospirosis; IgM ELISA; diagnosis; epidemics; urban; serovar;
   Leptospira; Copenhageni; Brazil
ID FEBRILE ILLNESS; URBAN EPIDEMIC; LATERAL-FLOW; DIAGNOSIS; OUTBREAK;
   PERSISTENCE; ANTIBODIES; ADULTS; DENGUE; TESTS
AB Access to low-cost, effective diagnosis for leptospirosis is urgently needed in developing countries. The EIE-IgM-Leptospirose, a kit produced for public health laboratories in Brazil, was shown to have a sensitivity of 76% (77 of 102 patients) and 100% (102 of 102 patients) during acute and convalescent-phase leptospirosis, respectively, and a specificity of 93-100% (total healthy and patient control subjects evaluated, 486). These findings indicate that the assay will be useful for diagnosis of this emerging infectious disease in Brazil and other developing countries. (C) 2007 Elsevier B.V. All rights reserved.
C1 Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   Brazilian Minist Hlth, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
RP Ko, AI (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020; McBride,
   Alan/D-4106-2012
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; McBride, Alan/0000-0001-9682-540X
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER; FIC NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [D43 TW000919-10, TW00919,
   D43 TW000919] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI052473, AI052473, R01 AI052473-05] Funding Source: Medline
CR ABDULKADER Regina C.R.M., 2002, Rev. Inst. Med. trop. S. Paulo, V44, P79, DOI 10.1590/S0036-46652002000200005
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   COLE JR, 1973, APPL MICROBIOL, V25, P976, DOI 10.1128/AEM.25.6.976-980.1973
   Cumberland P, 2001, EUR J EPIDEMIOL, V17, P601, DOI 10.1023/A:1015509105668
   DaSilva MV, 1997, AM J TROP MED HYG, V56, P650, DOI 10.4269/ajtmh.1997.56.650
   Effler PV, 2000, J CLIN MICROBIOL, V38, P1081, DOI 10.1128/JCM.38.3.1081-1084.2000
   Effler PV, 2002, J CLIN MICROBIOL, V40, P1464, DOI 10.1128/JCM.40.4.1464-1469.2002
   Ellis RD, 2006, AM J TROP MED HYG, V74, P108, DOI 10.4269/ajtmh.2006.74.108
   EVERARD COR, 1990, EUR J EPIDEMIOL, V6, P40, DOI 10.1007/BF00155547
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Finsterer Josef, 2005, J Infect, V51, pE67, DOI 10.1016/j.jinf.2004.08.019
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Karande S, 2005, J TROP PEDIATRICS, V51, P174, DOI 10.1093/tropej/fmh100
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Levett PN, 2002, AM J TROP MED HYG, V66, P745, DOI 10.4269/ajtmh.2002.66.745
   LUPIDI R, 1991, J CLIN MICROBIOL, V29, P805, DOI 10.1128/JCM.29.4.805-809.1991
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670
   Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002
   Russell KL, 2003, AM J TROP MED HYG, V69, P53, DOI 10.4269/ajtmh.2003.69.53
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   Sehgal SC, 2003, J MED MICROBIOL, V52, P897, DOI 10.1099/jmm.0.05064-0
   Smits HL, 2001, TROP MED INT HEALTH, V6, P114, DOI 10.1046/j.1365-3156.2001.00675.x
   Smits HL, 2001, CLIN DIAGN LAB IMMUN, V8, P166, DOI 10.1128/CDLI.8.1.166-169.2001
   Tassinari Wagner de Souza, 2004, Cad. Saúde Pública, V20, P1721, DOI 10.1590/S0102-311X2004000600031
   TERPSTRA WJ, 1985, J GEN MICROBIOL, V131, P377
   Vijayachari P, 2002, EPIDEMIOL INFECT, V129, P617, DOI 10.1017/S0950268802007537
   Wongsrichanalai C, 2003, AM J TROP MED HYG, V68, P583, DOI 10.4269/ajtmh.2003.68.583
   World Health Organization, 2003, HUM LEPT GUID DIAGN
NR 34
TC 14
Z9 14
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUN
PY 2007
VL 102
IS 3
BP 206
EP 211
DI 10.1016/j.actatropica.2007.05.002
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 200NZ
UT WOS:000248771400011
PM 17618860
OA Green Published, Green Accepted
DA 2020-11-30
ER

PT J
AU Ribeiro, GS
   Lima, JBT
   Reis, JN
   Gouveia, EL
   Cordeiro, SM
   Lobo, TS
   Pinheiro, RM
   Ribeiro, CT
   Neves, AB
   Salgado, K
   Silva, HR
   Reis, MG
   Ko, AI
AF Ribeiro, Guilherme S.
   Lima, Josilene B. T.
   Reis, Joice N.
   Gouveia, Edilane L.
   Cordeiro, Soraia M.
   Lobo, Tatiana S.
   Pinheiro, Ricardo M.
   Ribeiro, Cassio T.
   Neves, Alan B.
   Salgado, Katia
   Silva, Hagamenon R.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Haemophilus influenzae meningitis 5 years after introduction of the
   Haemophilus influenzae type b conjugate vaccine in Brazil
SO VACCINE
LA English
DT Article
DE Haemophilus influenzae; vaccine effectiveness; serotype replacement
ID HIB VACCINATION; EPIDEMIOLOGIC CHARACTERISTICS; HERD-IMMUNITY; A
   DISEASE; SEROTYPE; INFANTS; IMPACT; ERA; POLYSACCHARIDE; IMMUNIZATION
AB The long-term impact of Haemophilus influenzae type b (Hib) conjugate vaccine, introduced throughout Latin America in the late 1990s, has not been evaluated. Active surveillance for H. influenzae meningitis was performed from August 9, 1996 to August 8, 2004 in Metropolitan Salvador, Brazil. Five years after the introduction of Hib conjugate vaccine, Hib meningitis incidence decreased from 2.39 to 0.06 cases per 100,000 population (98%) overall, and from 60.9 to 3.1 cases per 100,000 population (95%) in children <1 year of age. A transient serotype replacement phenomenon was observed associated with a small increase of meningitis due to two H. influenzae type a clonal groups. These findings indicate that Hib immunization campaign has led to the virtual elimination of Hib disease in this region. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Ministerio Saude, Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   Univ Fed Bahia, Sch Pharm, Salvador, BA, Brazil.
   Hosp Couto Maia, Secretary Hlth State Bahia, Salvador, BA, Brazil.
   Univ Fed Bahia, Sch Med, Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Dept Med, Div Int Med & Infect Dis, Ithaca, NY 14853 USA.
RP Ko, AI (corresponding author), Ministerio Saude, Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020; Reis,
   Joice N/H-9227-2013; 2007, Secribsal/A-1556-2012; Ribeiro,
   Guilherme/B-6624-2008
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; Ribeiro, Guilherme/0000-0002-6798-2059
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01TW007303, R01TW007303, R01TW007303,
   R01TW007303, R01TW007303] Funding Source: NIH RePORTER; FIC NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW 007303, TW 00919] Funding Source: Medline
CR Adderson EE, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e18
   Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8
   Bajanca P, 2004, J CLIN MICROBIOL, V42, P807, DOI 10.1128/JCM.42.2.807-810.2004
   BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93
   *CENTR VIG EP EST, MEN DOENC MEN DAD ES
   *DAT MIN SAUD BRAS, INF SAUD EP MORB
   de Almeida AECC, 2005, BRAZ J MED BIOL RES, V38, P777, DOI 10.1590/S0100-879X2005000500016
   de Andrade ALSS, 2004, INT J EPIDEMIOL, V33, P173, DOI 10.1093/ije/dyh025
   Dickinson F O, 2001, Rev Panam Salud Publica, V10, P169, DOI 10.1590/S1020-49892001000900004
   *EP SURV DIV, 2005, IMM REC SALV BRAZ
   *EP SURV DIV, 2005, CAS NOT REC SALV BRA
   ESKOLA J, 1990, NEW ENGL J MED, V323, P1381, DOI 10.1056/NEJM199011153232004
   FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994
   Forleo-Neto E, 1999, J INFECT DIS, V180, P1153, DOI 10.1086/315018
   Freitas HSD, 2006, REV PANAM SALUD PUBL, V19, P33
   Hammitt LL, 2005, PEDIATR INFECT DIS J, V24, P453, DOI 10.1097/01.inf.0000160954.90881.29
   Heath PT, 2001, PEDIATR INFECT DIS J, V20, P300, DOI 10.1097/00006454-200103000-00016
   Hviid A, 2004, VACCINE, V22, P378, DOI 10.1016/j.vaccine.2003.08.001
   *I BRAS GEOGR EST, 2002, CENS DEM 2000 RES U
   Kmetzsch Claudete I., 2003, J. Pediatr. (Rio J.), V79, P530, DOI 10.1590/S0021-75572003000600012
   KROLL JS, 1994, J INFECT DIS, V169, P676, DOI 10.1093/infdis/169.3.676
   Lagos R, 1996, PEDIATR INFECT DIS J, V15, P216, DOI 10.1097/00006454-199603000-00008
   McVernon J, 2004, LANCET INFECT DIS, V4, P40, DOI 10.1016/S1473-3099(03)00859-4
   McVernon J, 2003, LANCET, V361, P1521, DOI 10.1016/S0140-6736(03)13171-6
   Millar EV, 2005, CLIN INFECT DIS, V40, P823, DOI 10.1086/428047
   Mitchell V, 2005, LANCET, V365, P936, DOI 10.1016/S0140-6736(05)71076-X
   Moulton LH, 2000, INT J EPIDEMIOL, V29, P753, DOI 10.1093/ije/29.4.753
   Ogilvie C, 2001, J INFECT DIS, V184, P144, DOI 10.1086/322001
   Omikunle A, 2002, J CLIN MICROBIOL, V40, P1264, DOI 10.1128/JCM.40.4.1264-1270.2002
   Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000
   Perdue DG, 2000, JAMA-J AM MED ASSOC, V283, P3089, DOI 10.1001/jama.283.23.3089
   Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997
   Ribeiro GS, 2003, J INFECT DIS, V187, P109, DOI 10.1086/345863
   Rijkers GT, 2003, LANCET, V361, P1563, DOI 10.1016/S0140-6736(03)13201-1
   Ruocco G, 1999, Rev Panam Salud Publica, V5, P197, DOI 10.1590/S1020-49891999000300021
   Rushdy A, 1999, J PEDIATR-US, V134, P253, DOI 10.1016/S0022-3476(99)70438-5
   SANTOSHAM M, 1991, NEW ENGL J MED, V324, P1767, DOI 10.1056/NEJM199106203242503
   Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404
   Simoes LLP, 2004, REV SAUDE PUBL, V38, P664, DOI [10.1590/S0034-89102004000500008, 10.1590/s0034-89102004000500008]
   TAKEMURA NS, 2001, BRAZIL J PEDIAT RIO, V77, P387
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995
   Trotter CL, 2003, LANCET, V361, P1523, DOI 10.1016/S0140-6736(03)13172-8
   Tsang RSW, 2006, J CLIN MICROBIOL, V44, P1530, DOI 10.1128/JCM.44.4.1530-1535.2006
   Urwin G, 1996, CLIN INFECT DIS, V22, P1069, DOI 10.1093/clinids/22.6.1069
   van Alphen L, 1997, J PEDIATR-US, V131, P869, DOI 10.1016/S0022-3476(97)70035-0
   WAGGONERFOUNTAIN LA, 1995, CLIN INFECT DIS, V21, P1322, DOI 10.1093/clinids/21.5.1322
   WHO, 2017, EST DIS BURD COST EF
   *WHO, 2004, WHO VACC PREV DIS MO
   World Health Organization /United Nations Children's Fund, WHO UNICEF REV NAT I
   2005, MMWR MORB MORTAL WKL, V54, P893
   2002, MMWR MORB MORTAL WKL, V51, P234
NR 51
TC 35
Z9 38
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAY 30
PY 2007
VL 25
IS 22
BP 4420
EP 4428
DI 10.1016/j.vaccine.2007.03.024
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 174JL
UT WOS:000246938100012
PM 17449150
OA Green Published
DA 2020-11-30
ER

PT J
AU Croda, J
   Ramos, JGR
   Matsunaga, J
   Queiroz, A
   Homma, A
   Riley, LW
   Haake, DA
   Reis, MG
   Ko, AI
AF Croda, Julio
   Ramos, Joao G. R.
   Matsunaga, James
   Queiroz, Adriano
   Homma, Akira
   Riley, Lee W.
   Haake, David A.
   Reis, Mitermayer G.
   Ko, Albert I.
TI Leptospira immunoglobulin-like proteins as a serodiagnostic marker for
   acute leptospirosis
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID LINKED IMMUNOSORBENT ASSAYS; HUMAN IMMUNE-RESPONSE;
   POLYMERASE-CHAIN-REACTION; OUTER-MEMBRANE PROTEIN; URBAN EPIDEMIC;
   BOVINE LEPTOSPIROSIS; RAPID SERODIAGNOSIS; DIPSTICK ASSAY; M ANTIBODIES;
   IGM-ELISA
AB There is an urgent need for improved diagnosis of leptospirosis, an emerging infectious disease which imparts a large disease burden in developing countries. We evaluated the use of Leptospira immunoglobulin (Ig)-like (Lig) proteins as a serodiagnostic marker for leptospirosis. Lig proteins have bacterial immunoglobulin-like (Big) tandem repeat domains, a moiety found in virulence factors in other pathogens. Sera from patients identified during urban outbreaks in Brazil reacted strongly with immunoblots of a recombinant fragment comprised of the second to sixth Big domains of LigB from L. interrogans serovar Copenhageni, the principal agent for transmission in this setting. Furthermore, the sera recognized an analogous LigB fragment derived from L. kirschneri serovar Grippotyphosa, a pathogenic serovar which is not endemic to the study area. The immunoblot assay detected anti-LigB IgM antibodies in sera from 92% (95% confidence interval, 85 to 96%) of patients during acute-phase leptospirosis. The assay had a sensitivity of 81% for sera from patients with less than 7 days of illness. Anti-LigB antibodies were found in sera from 57% of the patients who did not have detectable anti-whole-Leptospira responses as detected by IgM enzyme-linked immunosorbent assay and microagglutination test. The specificities of the assay were 93 to 100% and 90 to 97% among sera from healthy individuals and patients with diseases that have clinical presentations that overlap with those of leptospirosis, respectively. These findings indicate that the antibody response to this putative virulence determinant is a sensitive and specific marker for acute infection. The use of this marker may aid the prompt and timely diagnosis required to reduce the high mortality associated with severe forms of the disease.
C1 Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA.
   Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA.
   Brazilian Minist Hlth, Oswaldo Cruz Fdn, Biomanguinhos, Rio De Janeiro, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Ithaca, NY USA.
RP Ko, AI (corresponding author), Fdn OSwaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Croda, Julio/I-5172-2013; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020; Queiroz, Adriano/AAQ-1164-2020
OI Croda, Julio/0000-0002-6665-6825; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060;
   Queiroz, Adriano/0000-0003-0080-6509
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW000919, D43 TW000905, TW-00919, TW-00905] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI052473, R01 AI034431,
   R29 AI034431, R21 AI034431, AI-034431, R01 AI034431-10A1, AI-052473]
   Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [D43TW000919, D43TW000905,
   D43TW000919, D43TW000919, D43TW000919, D43TW000905, D43TW000919,
   D43TW000905, D43TW000905, D43TW000905, D43TW000919, D43TW000905,
   D43TW000919, D43TW000905, D43TW000919, D43TW000905, D43TW000905,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI034431, R01AI052473, R01AI034431,
   R21AI034431, R01AI052473, R01AI034431, R01AI052473, R29AI034431,
   R01AI034431, R01AI052473, R29AI034431, R01AI034431, R01AI034431,
   R01AI052473, R01AI034431, R29AI034431, R01AI052473, R29AI034431,
   R01AI034431, R01AI034431, R01AI034431, R01AI052473, R01AI034431,
   R01AI052473, R01AI052473, R01AI034431, R01AI034431, R29AI034431] Funding
   Source: NIH RePORTER
CR ABDULKADER Regina C.R.M., 2002, Rev. Inst. Med. trop. S. Paulo, V44, P79, DOI 10.1590/S0036-46652002000200005
   ADLER B, 1978, J MED MICROBIOL, V11, P387, DOI 10.1099/00222615-11-4-387
   Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Blacksell SD, 2006, CLIN VACCINE IMMUNOL, V13, P1166, DOI 10.1128/CVI.00219-06
   Bomfim MRQ, 2005, VET MICROBIOL, V109, P89, DOI 10.1016/j.vetmic.2005.05.002
   Boonyod D, 2005, ASIAN PAC J ALLERGY, V23, P133
   Bruce MG, 2005, ACTA TROP, V96, P36, DOI 10.1016/j.actatropica.2005.07.001
   Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103
   CHAPMAN AJ, 1991, EPIDEMIOL INFECT, V107, P143, DOI 10.1017/S0950268800048779
   CHAPMAN AJ, 1988, J MED MICROBIOL, V25, P269, DOI 10.1099/00222615-25-4-269
   Cumberland P, 2001, EUR J EPIDEMIOL, V17, P601, DOI 10.1023/A:1015509105668
   Cumberland P, 1999, AM J TROP MED HYG, V61, P731, DOI 10.4269/ajtmh.1999.61.731
   Effler PV, 2002, J CLIN MICROBIOL, V40, P1464, DOI 10.1128/JCM.40.4.1464-1469.2002
   ENGSTROM SM, 1995, J CLIN MICROBIOL, V33, P419, DOI 10.1128/JCM.33.2.419-427.1995
   EVERARD COR, 1985, T ROY SOC TROP MED H, V79, P96, DOI 10.1016/0035-9203(85)90246-9
   EVERARD COR, 1990, EUR J EPIDEMIOL, V6, P40, DOI 10.1007/BF00155547
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Fonseca CDA, 2006, TROP MED INT HEALTH, V11, P1699, DOI 10.1111/j.1365-3156.2006.01727.x
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Kaur I R, 2003, J Assoc Physicians India, V51, P249
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Levett PN, 2001, CLIN DIAGN LAB IMMUN, V8, P349, DOI 10.1128/CDLI.8.2.349-351.2001
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Levett PN, 1998, J CLIN MICROBIOL, V36, P11, DOI 10.1128/JCM.36.1.11-14.1998
   Levett PN, 2000, AM J TROP MED HYG, V62, P112, DOI 10.4269/ajtmh.2000.62.112
   LUPIDI R, 1991, J CLIN MICROBIOL, V29, P805, DOI 10.1128/JCM.29.4.805-809.1991
   Magnarelli LA, 2000, J CLIN MICROBIOL, V38, P1735, DOI 10.1128/JCM.38.5.1735-1739.2000
   Mariya R, 2006, COMP IMMUNOL MICROB, V29, P269, DOI 10.1016/j.cimid.2006.06.007
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsuo K, 2000, CARBOHYD RES, V328, P517, DOI 10.1016/S0008-6215(00)00143-9
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   MERIEN F, 1995, J INFECT DIS, V172, P281, DOI 10.1093/infdis/172.1.281
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Ooteman MC, 2006, J MICROBIOL METH, V65, P247, DOI 10.1016/j.mimet.2005.07.015
   Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002
   Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   Park SH, 1999, DNA CELL BIOL, V18, P903, DOI 10.1089/104454999314764
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Romero Eliete C., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P183, DOI 10.1590/S0036-46651998000300009
   Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Schmidt BL, 2000, J CLIN MICROBIOL, V38, P1279, DOI 10.1128/JCM.38.3.1279-1282.2000
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   Sehgal SC, 1999, EPIDEMIOL INFECT, V122, P423, DOI 10.1017/S0950268899002435
   Smits HL, 1999, J CLIN MICROBIOL, V37, P2904, DOI 10.1128/JCM.37.9.2904-2909.1999
   Smits HL, 2000, J CLIN MICROBIOL, V38, P1272, DOI 10.1128/JCM.38.3.1272-1275.2000
   Smits HL, 2001, TROP MED INT HEALTH, V6, P114, DOI 10.1046/j.1365-3156.2001.00675.x
   Smits HL, 2001, CLIN DIAGN LAB IMMUN, V8, P166, DOI 10.1128/CDLI.8.1.166-169.2001
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   VADO-SOLÍS Ignacio, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P335, DOI 10.1590/S0036-46652002000600008
   Wagenaar JFP, 2004, ANN TROP MED PARASIT, V98, P843, DOI 10.1179/000349804X3207
   World Health Organization, 2003, HUM LEPT GUID DIAGN
   Yu L, 2000, NATURE, V405, P1073, DOI 10.1038/35016618
NR 63
TC 64
Z9 66
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAY
PY 2007
VL 45
IS 5
BP 1528
EP 1534
DI 10.1128/JCM.02344-06
PG 7
WC Microbiology
SC Microbiology
GA 169OA
UT WOS:000246600300023
PM 17360842
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Picardeau, M
   Ristow, P
   Bourhy, P
   McBride, F
   Figueira, CP
   Huerre, M
   Ave, P
   Ko, A
AF Picardeau, M.
   Ristow, P.
   Bourhy, P.
   McBride, F.
   Figueira, C. Pereira
   Huerre, M.
   Ave, P.
   Ko, A.
TI Genetic studies in pathogenic Leptospira strains
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Meeting Abstract
C1 [Picardeau, M.; Ristow, P.; Bourhy, P.; Huerre, M.; Ave, P.] Inst Pasteur, Paris, France.
   [McBride, F.; Figueira, C. Pereira; Ko, A.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
RI Ko, Albert Icksang/P-2343-2015; Ristow, Paula/D-1276-2013; Ristow,
   Paula/AAP-6522-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Ristow,
   Paula/0000-0001-8494-361X; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD MAY
PY 2007
VL 12
SU 1
BP 14
EP 14
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 302FP
UT WOS:000255954500042
DA 2020-11-30
ER

PT J
AU Silva, EF
   Brod, CS
   Cerqueira, GM
   Bourscheidt, D
   Seyffert, N
   Queiroz, A
   Santos, CS
   Ko, AI
   Dellagostin, OA
AF Silva, Everton F.
   Brod, Claudiomar S.
   Cerqueira, Gustavo M.
   Bourscheidt, Debora
   Seyffert, Nubia
   Queiroz, Adriano
   Santos, Cleiton S.
   Ko, Albert I.
   Dellagostin, Odir A.
TI Isolation of Leptospira noguchii from sheep
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE leptospirosis; Leptospira noguchii; isolation; serogrouping; sheep;
   Brazil
ID MAINTENANCE HOST; ANTIBODIES
AB The main goal of this study was to obtain new isolates of Leptospira spp. from sheep. A total of 10 kidney samples and 44 blood samples were collected from sheep slaughtered in Pelotas, Southern Brazil. One isolate was obtained which was identified by 16S rRNA gene sequencing and serogrouping to be Leptospira noguchii serogroup Autumnalis. Microscopic agglutination test (MAT) evaluation revealed that 4.5% of the sheep sera reacted against the Autumnalis serogroup. This is the first report of isolation of L. noguchii from sheep. Together these findings indicate that L. noguchii infections may be a potentially important veterinary problem in this domestic animal species. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Fed Pelotas, Ctr Biotecnol, BR-96010900 Pelotas, RS, Brazil.
   Ctr Pesquisas Goncalo Moniz, Fdn Oswaldo Cruz, Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Ithaca, NY 14853 USA.
RP Silva, EF (corresponding author), Univ Fed Pelotas, Ctr Biotecnol, Campus Univ,Caixa Postal 354, BR-96010900 Pelotas, RS, Brazil.
EM efsilva@ufpel.edu.br
RI Dellagostin, Odir/C-2331-2009; Cerqueira, Gustavo/B-7180-2015; Ko,
   Albert Icksang/P-2343-2015; Seyffert, Nubia/N-6410-2014; Queiroz,
   Adriano/AAQ-1164-2020
OI Dellagostin, Odir/0000-0003-2803-4088; Cerqueira,
   Gustavo/0000-0002-3029-6899; Ko, Albert Icksang/0000-0001-9023-2339;
   Seyffert, Nubia/0000-0002-2193-6508; Queiroz,
   Adriano/0000-0003-0080-6509
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW000919] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI052473] Funding Source: Medline; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473] Funding Source: NIH
   RePORTER
CR Azevedo SS, 2004, ARQ I BIOL-SAO PAULO, V71, P383
   Bahaman A.R., 1980, NZ VET J, V28
   Ciceroni L, 1997, MICROBIOLOGICA, V20, P77
   Ciceroni L, 2000, J VET MED B, V47, P217, DOI 10.1046/j.1439-0450.2000.00333.x
   COUSINS DV, 1989, VET REC, V124, P123, DOI 10.1136/vr.124.5.123
   ELLIS WA, 1983, VET REC, V112, P291, DOI 10.1136/vr.112.13.291
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Faine S., 1982, GUIDELINES CONTROL L
   Favero Andrea Cecília Mercaldi, 2002, Cienc. Rural, V32, P613, DOI 10.1590/S0103-84782002000400011
   GERRITSEN MJ, 1994, AM J VET RES, V55, P1232
   HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991
   HATHAWAY SC, 1982, VET REC, V110, P99, DOI 10.1136/vr.110.5.99
   HERRMANN G. P., 2004, CIENCIA RURAL, V34, P443, DOI DOI 10.1590/S0103-84782004000200017
   IBGE, 2014, I BRAS GEOGR EST
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Natarajaseenivasan K, 1999, INDIAN J ANIM SCI, V69, P759
   ROSA SCA, 1963, ARQ I BIOL, V30, P93
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991
   World Health Organization, 2003, HUM LEPT GUID DIAGN
   Zamora J, 1999, Rev Latinoam Microbiol, V41, P73
NR 20
TC 37
Z9 40
U1 0
U2 16
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD MAR 31
PY 2007
VL 121
IS 1-2
BP 144
EP 149
DI 10.1016/j.vetmic.2006.11.010
PG 6
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA 152DN
UT WOS:000245341100016
PM 17222993
OA Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Fernandes, CPH
   Seixas, FK
   Coutinho, ML
   Vasconcellos, FA
   Seyffert, N
   Croda, J
   McBride, AJ
   Ko, AI
   Dellagostin, OA
   Aleixo, JAG
AF Fernandes, Claudia P. H.
   Seixas, Fabiana K.
   Coutinho, Mariana L.
   Vasconcellos, Flavia A.
   Seyffert, Nubia
   Croda, Julio
   McBride, Alan J.
   Ko, Albert I.
   Dellagostin, Odir A.
   Aleixo, Jose A. G.
TI Monoclonal antibodies against LipL32, the major outer membrane protein
   of pathogenic Leptospira: Production, characterization, and testing in
   diagnostic applications
SO HYBRIDOMA
LA English
DT Article
ID RECOMBINANT LIPL32; ANTIGEN; ASSAY; SERODIAGNOSIS; LIPOPROTEIN;
   SEPARATION; CAPTURE
AB Pathogenic serovars of Leptospira have a wide antigenic diversity attributed mainly to the lipopolysacharide present in the outer membrane. In contrast, antigens conserved among pathogenic serovars are mainly represented by outer membrane proteins. Surface exposure of a major and highly conserved outer membrane lipoprotein (LipL32) was recently demonstrated on pathogenic Leptospira. LipL32 in its recombinant form (rLipL32) was used to immunize BALB/c mice to develop murine monoclonal antibodies (MAbs). Three MAbs against rLipL32 were produced, isotyped, and evaluated for further use in diagnostic tests of leptospirosis using different approaches. MAbs were conjugated to peroxidase and evaluated in a native protein enzymelinked immunosorbent assay (ELISA) with intact and heat-treated leptospiral cells, conjugated to fluorescein isothiocyanate ( FITC) for indirect immunofluorescence with intact and methanol fixed cells and were used for LipL32 immunoprecipitation from leptospiral cells. rLipL32 MAbs conjugated to peroxidase or used as primary antibody bound to intact and heat-treated cells in ELISA, proving that they could be used in enzyme immunoassays for detection of the native protein. In immunofluorescence assay, MAbs labeled bacterial cells either intact or methanol fixed. Two MAbs were able to immunoprecipitate the native protein from live and motile leptospiral cells and, adsorbed onto magnetic beads, captured intact bacteria from artificially contaminated human sera for detection by polymerase chain reaction (PCR) amplification. Results of this study suggest that the MAbs produced can be useful for the development of diagnostic tests based on detection of LipL32 leptospiral antigen in biological fluids.
C1 Univ Fed Pelotas, Ctr Biotecnol, BR-96010900 Pelotas, RS, Brazil.
   Univ Fed Pelotas, Fac Med Vet, BR-96010900 Pelotas, RS, Brazil.
   Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Ithaca, NY 14853 USA.
RP Aleixo, JAG (corresponding author), Univ Fed Pelotas, Ctr Biotecnol, Caixa Postal 354, BR-96010900 Pelotas, RS, Brazil.
EM biotjaga@ufpel.tche.br
RI Croda, Julio/I-5172-2013; Dellagostin, Odir/C-2331-2009; Ko, Albert
   Icksang/P-2343-2015; Seyffert, Nubia/N-6410-2014; McBride,
   Alan/D-4106-2012; Vasconcellos, F A/E-4773-2016; Coutinho,
   Mariana/J-9024-2012; Seixas, Fabiana Kommling/X-2706-2018
OI Croda, Julio/0000-0002-6665-6825; Dellagostin, Odir/0000-0003-2803-4088;
   Ko, Albert Icksang/0000-0001-9023-2339; Seyffert,
   Nubia/0000-0002-2193-6508; McBride, Alan/0000-0001-9682-540X; Seixas,
   Fabiana Kommling/0000-0003-4204-2500
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI034431, R01AI034431, R29AI034431, R01AI034431, R01AI034431,
   R29AI034431, R01AI034431, R01AI034431, R01AI034431, R01AI034431,
   R01AI034431, R01AI034431, R01AI034431, R01AI034431, R29AI034431,
   R01AI034431, R29AI034431, R29AI034431, R01AI034431] Funding Source: NIH
   RePORTER; FIC NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [TW00919] Funding Source: Medline; NIAID NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI034431] Funding Source: Medline
CR Bomfim MRQ, 2005, VET MICROBIOL, V109, P89, DOI 10.1016/j.vetmic.2005.05.002
   Boonyod D, 2005, ASIAN PAC J ALLERGY, V23, P133
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bulach DM, 2000, J MOL MICROB BIOTECH, V2, P375
   Chambers MA, 1996, J VET DIAGN INVEST, V8, P196, DOI 10.1177/104063879600800209
   Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005
   Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002
   Dey S, 2004, VET MICROBIOL, V103, P99, DOI 10.1016/j.vetmic.2004.07.018
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Furdui VI, 2004, LAB CHIP, V4, P614, DOI 10.1039/b409366f
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Harlow E, 1988, ANTIBODIES LAB MANUA
   ITO F, 1992, J CLIN MICROBIOL, V30, P831, DOI 10.1128/JCM.30.4.831-838.1992
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   OLSVIK O, 1994, CLIN MICROBIOL REV, V7, P43, DOI 10.1128/CMR.7.1.43-54.1994
   Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001
   Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996
   Stark M, 1996, J CLIN MICROBIOL, V34, P778, DOI 10.1128/JCM.34.4.778-784.1996
   Tahiliani P, 2005, J Postgrad Med, V51, P164
   Taylor MJ, 1997, VET MICROBIOL, V56, P135, DOI 10.1016/S0378-1135(96)01351-X
   Tijssen P, 1985, LAB TECHNIQUES BIOCH, V15
   WINDSON BG, 2005, IMMUNOCHEMICAL PROTO, P131
NR 25
TC 23
Z9 25
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1554-0014
EI 1557-8348
J9 HYBRIDOMA
JI Hybridoma
PD FEB
PY 2007
VL 26
IS 1
BP 35
EP 41
DI 10.1089/hyb.2006.033
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Immunology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Immunology
GA 138ZU
UT WOS:000244402600006
PM 17316084
OA Green Published
DA 2020-11-30
ER

PT J
AU Coutinho, ML
   Vasconcellos, FA
   Fernandes, CPH
   Seyffert, N
   Seixas, FK
   Ko, AI
   Dellagostin, OA
   Aleixo, JAG
AF Coutinho, M. L.
   Vasconcellos, F. A.
   Fernandes, C. P. H.
   Seyffert, N.
   Seixas, F. K.
   Ko, A. I.
   Dellagostin, O. A.
   Aleixo, J. A. G.
TI Evaluation of the anti-LipL32 monoclonal antibodies potential for use in
   leptospirosis immunodiagnostic tests
SO JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
LA English
DT Article
DE Leptospira; recombinant antigens; antibody affinity; epitope mapping;
   ELISA; western blotting
ID LINKED-IMMUNOSORBENT-ASSAY; BORGPETERSENII SEROVAR HARDJO; ELISA;
   AFFINITY
AB LipL32 is the major lipoprotein in the membrane of pathogenic leptospira. In this work, we report on the production of monoclonal antibodies ( MAbs) against recombinant LipL32 (rLipL32) and on the evaluation of their potential for use as reagents in diagnostic tests for leptospirosis. The MAbs were all of the IgG2b isotype and reacted specifically with native LipL32 in pathogenic serovars only. MAbs reacted in the same region of the rLipL32 molecule and their affinity constant was between 5 x 10(7) M-1 and 6 x 10(6) M-1. These results suggest that although the MAbs cannot be used together, they are well suited for diagnostic tests of leptospirosis based on LipL32 detection.
C1 Univ Fed Pelotas, Ctr Biotechnol, Rio Grande Do Sul, Brazil.
   Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
RP Aleixo, JAG (corresponding author), Univ Fed Pelotas, Ctr Biotechnol, Rio Grande Do Sul, Brazil.
EM biotjaga@ufpel.edu.br
RI Seixas, Fabiana Kommling/X-2706-2018; Coutinho, Mariana/J-9024-2012;
   Vasconcellos, F A/E-4773-2016; Dellagostin, Odir/C-2331-2009; Ko, Albert
   Icksang/P-2343-2015; Seyffert, Nubia/N-6410-2014
OI Seixas, Fabiana Kommling/0000-0003-4204-2500; Dellagostin,
   Odir/0000-0003-2803-4088; Ko, Albert Icksang/0000-0001-9023-2339;
   Seyffert, Nubia/0000-0002-2193-6508
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW00919] Funding Source: Medline; NIAID NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [AI034431]
   Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI034431, R29AI034431, R01AI034431,
   R01AI034431, R29AI034431, R01AI034431, R01AI034431, R01AI034431,
   R29AI034431, R01AI034431, R01AI034431, R01AI034431, R01AI034431,
   R29AI034431, R01AI034431, R29AI034431, R01AI034431, R01AI034431,
   R01AI034431] Funding Source: NIH RePORTER
CR Bobrovnik SA, 2003, J BIOCHEM BIOPH METH, V57, P213, DOI 10.1016/S0165-022X(03)00145-3
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Eapen CK, 2002, DIAGN MICR INFEC DIS, V42, P221, DOI 10.1016/S0732-8893(01)00361-3
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FRIGUET B, 1983, J IMMUNOL METHODS, V60, P351, DOI 10.1016/0022-1759(83)90292-2
   FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Ludtke CB, 2003, BRAZ J MICROBIOL, V34, P1, DOI 10.1590/S1517-83822003000500001
   Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001
   Smits HL, 2001, CLIN DIAGN LAB IMMUN, V8, P166, DOI 10.1128/CDLI.8.1.166-169.2001
   Surujballi O, 2000, VET MICROBIOL, V71, P149, DOI 10.1016/S0378-1135(99)00177-7
   Taylor MJ, 1997, VET MICROBIOL, V56, P135, DOI 10.1016/S0378-1135(96)01351-X
   World Health Organization, 2003, HUM LEPT GUID DIAGN
   Yan KT, 1999, VET MICROBIOL, V69, P173, DOI 10.1016/S0378-1135(99)00103-0
NR 17
TC 4
Z9 5
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1532-1819
EI 1532-4230
J9 J IMMUNOASS IMMUNOCH
JI J. Immunoass. Immunoch.
PY 2007
VL 28
IS 3
BP 279
EP 288
DI 10.1080/15321810701454870
PG 10
WC Biochemical Research Methods; Immunology; Medical Laboratory Technology
SC Biochemistry & Molecular Biology; Immunology; Medical Laboratory
   Technology
GA 191FO
UT WOS:000248116300009
PM 17613673
OA Green Published
DA 2020-11-30
ER

PT J
AU Maciel, EAP
   Athanazio, DA
   Reis, EAG
   Cunha, FQ
   Queiroz, A
   Almeida, D
   McBride, AJA
   Ko, AI
   Reis, MG
AF Maciel, Elves A. P.
   Athanazio, Daniel A.
   Reis, Eliana A. G.
   Cunha, Fernando Q.
   Queiroz, Adriano
   Almeida, Deusdelia
   McBride, Alan J. A.
   Ko, Albert I.
   Reis, Mitermayer G.
TI High serum nitric oxide levels in patients with severe leptospirosis
SO ACTA TROPICA
LA English
DT Article
DE leptospirosis; nitric oxide; acute renal failure; pulmonary haemorrhage
ID MULTIPLE ORGAN DYSFUNCTION; NECROSIS-FACTOR-ALPHA; RISK-FACTORS;
   INTERROGANS; EXPRESSION; DISEASE; AGE
AB Leptospirosis is a globally distributed zoonosis of major public health importance and is associated with severe disease manifestations such as acute renal failure and pulmonary haemorrhage syndrome. However, the extent to which the pathogenesis of leptospirosis mimics sepsis caused by Gram-negative bacteria remains unknown. The aim of this study was to evaluate serum levels of nitric oxide (NO) in patients diagnosed with severe leptospirosis. Sera from 35 confirmed cases of severe leptospirosis and 13 healthy subjects were analysed. Patients with severe leptospirosis had significantly higher NO levels compared to healthy individuals (30.82 +/- 10.90 mu M versus 3.86 +/- 1.34 mu M, P < 0.00 1), indicating that this immune mediator plays a role in the underlying systemic inflammatory response. (c) 2006 Elsevier B.V. All rights reserved.
C1 Ctr Pesquisas Goncalo Moniz, Oswaldo Cruz Fdn, Minist Hlth, BR-40296710 Salvador, BA, Brazil.
   Univ Fed Bahia, Salvador, BA, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Ribeirao Preto, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
RP Reis, MG (corresponding author), Ctr Pesquisas Goncalo Moniz, Oswaldo Cruz Fdn, Minist Hlth, Rua Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM miter@cpqgm.fiocruz.br
RI Cunha, Fernando Q/M-3090-2014; McBride, Alan/D-4106-2012; Queiroz,
   Adriano/AAQ-1164-2020; Reis, Mitermayer/AAO-9742-2020; Athanazio,
   Daniel/P-6622-2014; Ko, Albert Icksang/P-2343-2015
OI McBride, Alan/0000-0001-9682-540X; Queiroz, Adriano/0000-0003-0080-6509;
   Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; Cunha, Fernando Queiroz/0000-0003-4755-1670
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER; FIC NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [D43 TW000919] Funding
   Source: Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI052473] Funding Source:
   Medline
CR Anstey NM, 1999, AM J TROP MED HYG, V61, P253, DOI 10.4269/ajtmh.1999.61.253
   Baines PB, 1999, CRIT CARE MED, V27, P1187, DOI 10.1097/00003246-199906000-00050
   Beltowski J, 2003, J PHYSIOL PHARMACOL, V54, P191
   Cinco M, 1996, FEMS MICROBIOL LETT, V138, P211, DOI 10.1111/j.1574-6968.1996.tb08159.x
   Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326
   Daher E, 1999, AM J TROP MED HYG, V61, P630, DOI 10.4269/ajtmh.1999.61.630
   DEBRITO T, 1979, J PATHOL, V128, P177, DOI 10.1002/path.1711280403
   Di Massimo C, 2006, LIFE SCI, V78, P1163, DOI 10.1016/j.lfs.2005.06.037
   Diament D, 2002, INFECT IMMUN, V70, P1677, DOI 10.1128/IAI.70.4.1677-1683.2002
   Dupont H, 1997, CLIN INFECT DIS, V25, P720, DOI 10.1086/513767
   Esen S, 2004, SWISS MED WKLY, V134, P347
   Fink MP, 2005, CRIT CARE CLIN, V21, P177, DOI 10.1016/j.ccc.2005.01.005
   GREEN LC, 1981, P NATL ACAD SCI-BIOL, V78, P7764, DOI 10.1073/pnas.78.12.7764
   Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942
   Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Karande S, 2003, ARCH DIS CHILD, V88, P1070, DOI 10.1136/adc.88.12.1070
   Kleinbongard P, 2006, FREE RADICAL BIO MED, V40, P295, DOI 10.1016/j.freeradbiomed.2005.08.025
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Lin CL, 1999, NEPHROL DIAL TRANSPL, V14, P193, DOI 10.1093/ndt/14.1.193
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   Mitaka C, 2003, SHOCK, V19, P305, DOI 10.1097/00024382-200304000-00002
   Nicodemo AC, 1997, AM J TROP MED HYG, V56, P181, DOI 10.4269/ajtmh.1997.56.181
   Panaphut Thanachai, 2002, International Journal of Infectious Diseases, V6, P52, DOI 10.1016/S1201-9712(02)90137-2
   Rath M, 1942, J PHARMACOL EXP THER, V76, P27
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Siriwanij T, 2005, NEPHROLOGY, V10, P1, DOI 10.1111/j.1440-1797.2005.00332.x
   Tajiki MH, 1996, CLIN INFECT DIS, V23, P1177, DOI 10.1093/clinids/23.5.1177
   TAJIKI MH, 1997, BRAZ J INFECT DIS, V1, P138
   Tantitanawat Sompong, 2003, J Med Assoc Thai, V86, P925
   Tavares-Murta BM, 2002, CRIT CARE MED, V30, P1056, DOI 10.1097/00003246-200205000-00017
   Toprakci M, 2000, INT J CLIN LAB RES, V30, P83
   Tsikas D, 2007, J CHROMATOGR B, V851, P51, DOI 10.1016/j.jchromb.2006.07.054
   Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354
   Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119
   Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62
   Yang GG, 2005, J FORMOS MED ASSOC, V104, P759
NR 38
TC 29
Z9 29
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD DEC
PY 2006
VL 100
IS 3
BP 256
EP 260
DI 10.1016/j.actatropica.2006.11.006
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 141IU
UT WOS:000244572800014
PM 17196920
OA Green Accepted, Green Published
DA 2020-11-30
ER

PT J
AU Spichler, A
   Ko, AI
   Fagonde, E
   De Brito, T
   Silva, AM
   Andrade, L
   Seguro, A
AF Spichler, Anne
   Ko, Albert I.
   Fagonde, Everton
   De Brito, Thales
   Silva, Ana Maria
   Andrade, Lucia
   Seguro, Antonio
TI Renal transporters in leptospiroses-induced acute renal failure and
   challenge of reversal after antimicrobial treatment
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.
   Cornell Univ, Weill Med Coll, Oswald Cruz Fdn, Salvador, BA, Brazil.
   Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   Univ Sao Paulo, Inst Trop Med, BR-05508 Sao Paulo, Brazil.
RI Andrade, Lucia C/C-5223-2014; Ko, Albert Icksang/P-2343-2015; De Brito,
   Thales/L-2865-2017
OI Andrade, Lucia C/0000-0002-3078-8957; Ko, Albert
   Icksang/0000-0001-9023-2339; De Brito, Thales/0000-0003-1106-7254
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2006
VL 75
IS 5
SU S
MA 81
BP 24
EP 25
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 109XW
UT WOS:000242343900082
DA 2020-11-30
ER

PT J
AU McBride, AJA
   Athanazio, DA
   Reis, MG
   Ko, AI
AF McBride, AJA
   Athanazio, DA
   Reis, MG
   Ko, AI
TI Leptospirosis
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE diagnosis; epidemiology; genome; Leptospira; leptospirosis; treatment;
   vaccine
ID ACUTE-RENAL-FAILURE; OUTER-MEMBRANE PROTEINS; TYPE-1 IMMUNE-RESPONSE;
   RISK-FACTORS; PATHOGENIC LEPTOSPIRA; PULMONARY HEMORRHAGE; FEBRILE
   ILLNESS; LATERAL-FLOW; INTERROGANS; OUTBREAK
AB Purpose of review Leptospirosis, a spirochaetal zoonotic disease, has been recognized as an important emerging infectious disease in the last 10 years. This review addresses the issues in the epidemiology, diagnosis and clinical management which confront public health responses, and highlights the progress made towards understanding the Leptospira genome, biology and pathogenesis.
   Recent findings Leptospirosis has spread from its traditional rural base to become the cause of epidemics in poor urban slum communities in developing countries. Mortality from severe disease forms, Weil's disease and severe pulmonary haemorrhage syndrome, is high (> 10% and > 50%, respectively) even when optimal treatment is provided. Moreover, the overall disease burden is underestimated, since leptospirosis is a significant cause of undifferentiated fever and frequently not recognized. Barriers to addressing this problem have been the-lack of an adequate diagnostic test and effective control measures. China and Brazil, countries. in Which leptospirosis is a major health problem, have completed the sequence of the Leptospira interrogans genome. Together with new genetic tools and proteomics, new insights have been made into the biology of Leptospira and the mechanisms used to adapt to host and external environments-. Surface-exposed proteins and putative virulence determinants have been identified which may serve as sub-unit vaccine candidates.
   Summary Major progress has been made in the basic research of leptospirosis. Future challenges will be to translate these advances into public health measures for developing countries. Yet the most effective responses may be interventions that directly address the determinants of poverty, such as poor sanitation, which are-often responsible for transmission.
C1 Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, BR-40295001 Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
RP Ko, AI (corresponding author), Fundacao Oswaldo Cruz, Minist Saude, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI McBride, Alan/D-4106-2012; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020; Athanazio, Daniel/P-6622-2014
OI McBride, Alan/0000-0001-9682-540X; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060; 
CR Abdulkader RCRM, 1996, AM J TROP MED HYG, V54, P1
   Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   Ashford DA, 2000, AM J TROP MED HYG, V63, P249, DOI 10.4269/ajtmh.2000.63.249
   Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003
   Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002
   Bauby H, 2003, MICROBIOL-SGM, V149, P689, DOI 10.1099/mic.0.26065-0
   Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2
   Bourhy P, 2005, J BACTERIOL, V187, P3255, DOI 10.1128/JB.187.9.3255-3258.2005
   Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001
   Brown RA, 2003, VACCINE, V21, P4448, DOI 10.1016/S0264-410X(03)00439-0
   Burth P, 2005, J INFECT DIS, V191, P51, DOI 10.1086/426455
   Chappel RJ, 2004, J CLIN MICROBIOL, V42, P5484, DOI 10.1128/JCM.42.12.5484-5488.2004
   Costa Everaldo, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P141, DOI 10.1590/S0036-46652003000300005
   Covic A, 2003, NEPHROL DIAL TRANSPL, V18, P1128, DOI 10.1093/ndt/gfg095
   Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003
   Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002
   CULLEN PA, IN PRESS INFECT IMMU
   Cumberland P, 2001, EUR J EPIDEMIOL, V17, P601, DOI 10.1023/A:1015509105668
   Daher E, 1999, AM J TROP MED HYG, V61, P630, DOI 10.4269/ajtmh.1999.61.630
   Daher Elizabeth De Francesco, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P327
   de Fost M, 2003, CLIN DIAGN LAB IMMUN, V10, P332, DOI 10.1128/CDLI.10.2.332-335.2003
   Diament D, 2002, INFECT IMMUN, V70, P1677, DOI 10.1128/IAI.70.4.1677-1683.2002
   Dupont H, 1997, CLIN INFECT DIS, V25, P720, DOI 10.1086/513767
   Effler PV, 2002, J CLIN MICROBIOL, V40, P1464, DOI 10.1128/JCM.40.4.1464-1469.2002
   Esen S, 2004, SWISS MED WKLY, V134, P347
   EVERARD COR, 1995, EUR J EPIDEMIOL, V11, P311, DOI 10.1007/BF01719436
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004
   Guegan R, 2003, MOL MICROBIOL, V49, P745, DOI 10.1046/j.1365-2958.2003.03589.x
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942
   Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002
   Jena AB, 2004, TROP MED INT HEALTH, V9, P1016, DOI 10.1111/j.1365-3156.2004.01293.x
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Karande S, 2005, J TROP PEDIATRICS, V51, P174, DOI 10.1093/tropej/fmh100
   Karande S, 2003, ARCH DIS CHILD, V88, P1070, DOI 10.1136/adc.88.12.1070
   Kariv R, 2001, EMERG INFECT DIS, V7, P990, DOI 10.3201/eid0706.010611
   Katz AR, 2003, TROP MED INT HEALTH, V8, P639, DOI 10.1046/j.1365-3156.2003.01071.x
   Klimpel GR, 2003, J IMMUNOL, V171, P1447, DOI 10.4049/jimmunol.171.3.1447
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007
   Laras K, 2002, AM J TROP MED HYG, V67, P278, DOI 10.4269/ajtmh.2002.67.278
   LaRocque RC, 2005, EMERG INFECT DIS, V11, P766, DOI 10.3201/eid1105.041212
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0
   Levett PN, 2003, CLIN INFECT DIS, V36, P447, DOI 10.1086/346208
   Levett PN, 2002, AM J TROP MED HYG, V66, P745, DOI 10.4269/ajtmh.2002.66.745
   Lingappa J, 2004, GENES IMMUN, V5, P197, DOI 10.1038/sj.gene.6364058
   Lopes Antonio Alberto, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P19, DOI 10.1590/S0036-46652004000100004
   Louvel H, 2005, J BACTERIOL, V187, P3249, DOI 10.1128/JB.187.9.3249-3254.2005
   MAGALDI AJ, 1992, NEPHRON, V62, P332, DOI 10.1159/000187069
   Majed Z, 2005, J CLIN MICROBIOL, V43, P539, DOI 10.1128/JCM.43.2.539-545.2005
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Martinez R, 2004, REV PANAM SALUD PUBL, V15, P249, DOI 10.1590/S1020-49892004000400005
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615
   Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670
   Naiman BM, 2002, INFECT IMMUN, V70, P6147, DOI 10.1128/IAI.70.11.6147-6157.2002
   Nally JE, 2005, INFECT IMMUN, V73, P3251, DOI 10.1128/IAI.73.6.3251-3260.2005
   Nally JE, 2005, PROTEOMICS, V5, P144, DOI 10.1002/pmic.200400880
   Nally JE, 2004, AM J PATHOL, V164, P1115, DOI 10.1016/S0002-9440(10)63198-7
   Nardone A, 2004, CLIN INFECT DIS, V39, P751, DOI 10.1086/423272
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Nicodemo AC, 1997, AM J TROP MED HYG, V56, P181, DOI 10.4269/ajtmh.1997.56.181
   Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002
   Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   Panaphut T, 2003, CLIN INFECT DIS, V36, P1507, DOI 10.1086/375226
   Panaphut Thanachai, 2002, International Journal of Infectious Diseases, V6, P52, DOI 10.1016/S1201-9712(02)90137-2
   Pereira MM, 2005, AM J TROP MED HYG, V72, P13, DOI 10.4269/ajtmh.2005.72.13
   Perrocheau A, 1997, EUR J EPIDEMIOL, V13, P161, DOI 10.1023/A:1007300514760
   Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180
   Phu NH, 2002, NEW ENGL J MED, V347, P895, DOI 10.1056/NEJMoa020074
   Picardeau M, 2003, FEMS MICROBIOL LETT, V225, P257, DOI 10.1016/S0378-1097(03)00529-9
   Que-Gewirth NLS, 2004, J BIOL CHEM, V279, P25420, DOI 10.1074/jbc.M400598200
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Rodriguez Andres Gonzalez, 2003, Rev Cubana Med Trop, V55, P146
   Romero Eliete Caló, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P245, DOI 10.1590/S0036-46652003000500002
   Russell KL, 2003, AM J TROP MED HYG, V69, P53, DOI 10.4269/ajtmh.2003.69.53
   Saengjaruk P, 2002, J CLIN MICROBIOL, V40, P480, DOI 10.1128/JCM.40.3.480-489.2002
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110
   SEGURO AC, 1990, NEPHRON, V55, P146, DOI 10.1159/000185943
   Sehgal SC, 2003, J MED MICROBIOL, V52, P897, DOI 10.1099/jmm.0.05064-0
   Sejvar J, 2003, EMERG INFECT DIS, V9, P702
   Smits HL, 2001, TROP MED INT HEALTH, V6, P114, DOI 10.1046/j.1365-3156.2001.00675.x
   Smits HL, 2001, CLIN DIAGN LAB IMMUN, V8, P166, DOI 10.1128/CDLI.8.1.166-169.2001
   Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13
   Suputtamongkol Y, 2004, CLIN INFECT DIS, V39, P1417, DOI 10.1086/425001
   Tajiki MH, 1996, CLIN INFECT DIS, V23, P1177, DOI 10.1093/clinids/23.5.1177
   Tassinari Wagner de Souza, 2004, Cad. Saúde Pública, V20, P1721, DOI 10.1590/S0102-311X2004000600031
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Truccolo J, 2001, FEMS MICROBIOL LETT, V204, P317, DOI 10.1111/j.1574-6968.2001.tb10904.x
   *UN, 2003, CHALL SLUMS GLOB REP
   Vieira Silvia R R, 2002, Braz J Infect Dis, V6, P135, DOI 10.1590/S1413-86702002000300006
   Vijayachari P, 2002, EPIDEMIOL INFECT, V129, P617, DOI 10.1017/S0950268802007537
   Vinetz JM, 2003, CLIN INFECT DIS, V36, P1514, DOI 10.1086/375275
   Vinetz JM, 2001, CURR OPIN INFECT DIS, V14, P527, DOI 10.1097/00001432-200110000-00005
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   Wagenaar JFP, 2004, ANN TROP MED PARASIT, V98, P843, DOI 10.1179/000349804X3207
   Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354
   Wongsrichanalai C, 2003, AM J TROP MED HYG, V68, P583, DOI 10.4269/ajtmh.2003.68.583
   World Health Organization, 2003, HUM LEPT GUID DIAGN
   Wu MS, 2004, NEPHROL DIAL TRANSPL, V19, P2472, DOI 10.1093/ndt/gfh452
   Xu H, 2004, J BACTERIOL, V186, P5400, DOI 10.1128/JB.186.16.5400-5409.2004
   Yan Youwang, 2003, J Chin Med Assoc, V66, P224
   Zhang YX, 2004, CELL RES, V14, P208, DOI 10.1038/sj.cr.7290221
NR 112
TC 413
Z9 442
U1 0
U2 97
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD OCT
PY 2005
VL 18
IS 5
BP 376
EP 386
DI 10.1097/01.qco.0000178824.05715.2c
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA 974PM
UT WOS:000232603900002
PM 16148523
DA 2020-11-30
ER

PT J
AU Bomfim, MRQ
   Ko, A
   Koury, MC
AF Bomfim, MRQ
   Ko, A
   Koury, MC
TI Evaluation of the recombinant LipL32 in enzyme-linked immunosorbent
   assay for the serodiagnosis of bovine leptospirosis
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Leptospira; rLipL32 IgG ELISA; MAT
ID INTERROGANS SEROVAR HARDJO; AGGLUTINATION-TEST; ANTIBODY-RESPONSE;
   POMONA; CATTLE; ELISA; DIAGNOSIS; SERA; IGM; INFECTION
AB The recombinant leptospiral protein LipL32 was evaluated for use in the diagnosis of bovine leptospirosis by enzyme-linked immunosorbent assay (rLipL32 IgG ELISA). The microscopic agglutination test (MAT) of 150 serum samples from cattle suspected of leptospirosis showed that 125 (83.3%) samples had positive reciprocal agglutination titres, which ranged from 100 to 1600. The highest titres were observed for the serovars Hardjoprajitno and Bratislava. In the rLipL32 IgG ELISA, 83.3% of the samples were positive. The sensitivity of IgG ELISA for 125 bovine sera, which had MAT titres of greater than or equal to 100, was 100%. ELISA showed a specificity of 100% with 58 bovine sera, which were negative at a 1:50 dilution in the MAT for Leptospira interrogans serovars. When analytical specificity of the IgG ELISA was evaluted using 60 bovine serum samples from animals showing serum antibodies to other pathogens that cause abortion in cattle, such as Babesia sp., Anaplasma sp. and Brucella sp. and no cross-reaction was observed. The recombinant LipL32 IgG ELISA can be an alternative to the MAT for diagnosis of leptospiral infection in cattle. (C) 2005 Elsevier B.V. All rights reserved.
C1 Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, BR-6627 Belo Horizonte, MG, Brazil.
   Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Ithaca, NY 14853 USA.
RP Koury, MC (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Av Antonio Carlos, BR-6627 Belo Horizonte, MG, Brazil.
EM kourymat@icb.ufmg.br
RI Ko, Albert Icksang/P-2343-2015; BOMFIM, MARIA ROSA/AAT-8359-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; BOMFIM, MARIA
   ROSA/0000-0001-5738-3952
CR ADLER B, 1982, VET MICROBIOL, V7, P577, DOI 10.1016/0378-1135(82)90050-5
   BERCOVICH Z, 1990, VET MICROBIOL, V21, P255, DOI 10.1016/0378-1135(90)90036-U
   CHO HJ, 1989, CAN J VET RES, V53, P285
   COUSINS DV, 1985, VET MICROBIOL, V10, P439, DOI 10.1016/0378-1135(85)90026-4
   Dey S, 2004, VET MICROBIOL, V103, P99, DOI 10.1016/j.vetmic.2004.07.018
   ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P39
   ELLIS WA, 1994, VET CLIN N AM-FOOD A, V10, P463, DOI 10.1016/S0749-0720(15)30532-6
   ELLIS WA, 1984, PREV VET MED, V2, P411, DOI 10.1016/0167-5877(84)90085-0
   Faine S, 1982, GUIDELINES CONTROL L, P67
   FAIRBROTHER JM, 1985, AM J VET RES, V46, P1422
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   GODDARD RD, 1991, VET MICROBIOL, V26, P191, DOI 10.1016/0378-1135(91)90055-K
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004
   Levett PN, 1998, J CLIN MICROBIOL, V36, P11, DOI 10.1128/JCM.36.1.11-14.1998
   National Research Council, 1996, GUID CAR US LAB AN
   Ramadass P, 1999, VET MICROBIOL, V70, P137, DOI 10.1016/S0378-1135(99)00133-9
   Surujballi O, 2004, CAN J VET RES, V68, P1
   Surujballi O, 1997, CAN J VET RES, V61, P267
   Surujballi O, 2001, CLIN DIAGN LAB IMMUN, V8, P40, DOI 10.1128/CDLI.8.1.40-43.2001
   Surujballi OP, 1997, CAN J VET RES, V61, P260
   THIERMANN AB, 1983, AM J VET RES, V44, P2244
   THIERMANN AB, 1983, AM J VET RES, V44, P884
   THIERMANN AB, 1984, J AM VET MED ASSOC, V184, P722
   THIERMANN AB, 1983, INT S VET LAB DIAG, V3, P97
   THIERMANN AB, 1984, MODERN VET PRACT, P758
   Trueba G A, 1990, J Vet Diagn Invest, V2, P323
   Vasconcellos S. A., 1997, Arquivos do Instituto Biologico (Sao Paulo), V64, P7
   Yan KT, 1999, VET MICROBIOL, V69, P173, DOI 10.1016/S0378-1135(99)00103-0
NR 29
TC 42
Z9 43
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD AUG 10
PY 2005
VL 109
IS 1-2
BP 89
EP 94
DI 10.1016/j.vetmic.2005.05.002
PG 6
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA 950BW
UT WOS:000230833600011
PM 15950404
OA Green Published
DA 2020-11-30
ER

PT J
AU Cullen, PA
   Xu, XY
   Matsunaga, J
   Sanchez, Y
   Ko, AI
   Haake, DA
   Adler, B
AF Cullen, PA
   Xu, XY
   Matsunaga, J
   Sanchez, Y
   Ko, AI
   Haake, DA
   Adler, B
TI Surfaceome of Leptospira spp.
SO INFECTION AND IMMUNITY
LA English
DT Article
ID OUTER-MEMBRANE PROTEINS; LIPOPOLYSACCHARIDE ANTIGENS; EXPOSED
   LIPOPROTEIN; MOLECULAR-CLONING; SEQUENCE-ANALYSIS; INTERROGANS;
   EXPRESSION; IDENTIFICATION; SEROVAR; OMPL1
AB The identification of the subset of outer membrane proteins exposed on the surface of a bacterial cell (the surfaceome) is critical to understanding the interactions of bacteria with their environments and greatly narrows the search for protective antigens of extracellular pathogens. The surfaceome of Leptospira was investigated by biotin labeling of viable leptospires, affinity capture of the biotinylated proteins, two-dimensional gel electrophoresis, and mass spectrometry (MS). The leptospiral surfaceome was found to be predominantly made up of a small number of already characterized proteins, being in order of relative abundance on the cell surface: LipL32 > LipL21 > LipL41. Of these proteins, only LipL32 had not been previously identified as surface exposed. LipL32 surface exposure was subsequently verified by three independent approaches: surface immunofluorescence, whole-cell enzyme-linked immunosorbent assay (ELISA), and immunoelectron microscopy. Three other proteins, Q8F8Q0 (a putative transmembrane outer membrane protein) and two proteins of 20 kDa and 55 kDa that could not be identified by MS, one of which demonstrated a high degree of labeling potentially representing an additional, as-yet-uncharacterized, surface-exposed protein. Minor labeling of p31(LipL45), GroEL, and FlaB1 was also observed. Expression of the surfaceome constituents remained unchanged under a range of conditions investigated, including temperature and the presence of serum or urine. Immunization of mice with affinity-captured surface components stimulated the production of antibodies that bound surface proteins from heterologous leptospiral strains. The surfaceomics approach is particularly amenable to protein expression profiling using small amounts of sample (< 10(7) cells) offering the potential to analyze bacterial surface expression during infection.
C1 Monash Univ, Dept Microbiol, Victorian Bioinformat Consortium, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia.
   Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA 90073 USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
   Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   Cornell Univ, Weil Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Adler, B (corresponding author), Monash Univ, Dept Microbiol, Victorian Bioinformat Consortium, Australian Bacterial Pathogenesis Program, Clayton, Vic 3800, Australia.
EM Ben.Adler@med.monash.edu.au
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI034431, K08AI001605, R01AI034431, R01AI034431, R01AI034431,
   R01AI034431, R01AI034431, R01AI034431, R01AI034431, R01AI034431,
   R01AI034431, R29AI034431, R29AI034431, R29AI034431, R21AI034431,
   R29AI034431, R01AI034431, R01AI034431, R01AI034431, K08AI001605,
   R29AI034431, K08AI001605] Funding Source: NIH RePORTER; NIAID NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI034431-08, AI-34431, R21 AI034431,
   AI-01605, R01 AI034431, R29 AI034431] Funding Source: Medline
CR ADLER B, 1983, PATHOLOGY, V15, P247, DOI 10.3109/00313028309083501
   ADLER B, 1977, INFECT IMMUN, V17, P67, DOI 10.1128/IAI.17.1.67-72.1977
   Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999
   Boyce JD, 2004, EMERG INFECT DIS, V10, P1357, DOI 10.3201/eid1008.031036
   Branger C, 2001, INFECT IMMUN, V69, P6831, DOI 10.1128/IAI.69.11.6831-6838.2001
   Coughenour HD, 2004, PROTEOMICS, V4, P3141, DOI 10.1002/pmic.200300817
   Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004
   Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003
   Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FARRELLY HE, 1987, J MED MICROBIOL, V23, P1, DOI 10.1099/00222615-23-1-1
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998
   HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993
   Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002
   HERRMANN JL, 1994, INT J SYST BACTERIOL, V44, P597, DOI 10.1099/00207713-44-3-597
   HERRMANN JL, 1994, INT J SYST BACTERIOL, V44, P362, DOI 10.1099/00207713-44-2-362
   JOHNSON RC, 1973, APPL MICROBIOL, V26, P118, DOI 10.1128/AEM.26.1.118-119.1973
   JOST BH, 1989, J MED MICROBIOL, V29, P115, DOI 10.1099/00222615-29-2-115
   JOST BH, 1986, J MED MICROBIOL, V22, P269, DOI 10.1099/00222615-22-3-269
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Matsunaga J, 2005, INFECT IMMUN, V73, P70, DOI 10.1128/IAI.73.1.70-78.2005
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Matsunaga J, 2002, INFECT IMMUN, V70, P323, DOI 10.1128/IAI.70.1.323-334.2002
   MCGRATH H, 1984, PATHOLOGY, V16, P243, DOI 10.3109/00313028409068531
   Molloy MP, 2003, PROTEOMICS, V3, P1912, DOI 10.1002/pmic.200300534
   Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002
   Nouwens AS, 2000, ELECTROPHORESIS, V21, P3797, DOI 10.1002/1522-2683(200011)21:17<3797::AID-ELPS3797>3.0.CO;2-P
   Palaniappan RUM, 2004, J MED MICROBIOL, V53, P975, DOI 10.1099/jmm.0.45568-0
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Perolat P, 1998, INT J SYST BACTERIOL, V48, P851, DOI 10.1099/00207713-48-3-851
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Sabarth N, 2002, J BIOL CHEM, V277, P27896, DOI 10.1074/jbc.M204473200
   SHANG ES, 1995, INFECT IMMUN, V63, P3174, DOI 10.1128/IAI.63.8.3174-3181.1995
   Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996
   TU V, 1982, PATHOLOGY, V14, P463, DOI 10.3109/00313028209092128
   van Montfort BA, 2002, J MASS SPECTROM, V37, P322, DOI 10.1002/jms.288
   Zuerner R, 2000, J MOL MICROB BIOTECH, V2, P455
NR 42
TC 136
Z9 147
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD AUG
PY 2005
VL 73
IS 8
BP 4853
EP 4863
DI 10.1128/IAI.73.8.4853-4863.2005
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 949BT
UT WOS:000230760600044
PM 16040999
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU Castellucci, LA
   Cheng, LH
   Araujo, C
   Guimaraes, LH
   Lessa, H
   Machado, P
   Almeida, MF
   Oliveira, A
   Ko, A
   Johnson, WD
   Wilson, ME
   Carvalho, EM
   De Jesus, AR
AF Castellucci, LA
   Cheng, LH
   Araujo, C
   Guimaraes, LH
   Lessa, H
   Machado, P
   Almeida, MF
   Oliveira, A
   Ko, A
   Johnson, WD
   Wilson, ME
   Carvalho, EM
   De Jesus, AR
TI Familial aggregation of mucosal leishmaniasis in Northeast Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID REGULATORY T-CELLS; MUCOCUTANEOUS LEISHMANIASIS; TEGUMENTARY
   LEISHMANIASIS; CHAGASI INFECTION; NEW-WORLD; SUSCEPTIBILITY;
   EPIDEMIOLOGY; POPULATION; MICE
AB To evaluate whether familial clustering occurs in mucosal leishmaniasis (ML), patients with ML (index cases) were randomly selected from medical records at a health post in an endemic area for Leishmania braziliensis infection. Control individuals (index controls) matched by age, gender, and place of residence to index cases were selected. Family members of index cases and controls were compared with respect to environmental factors and the incidence of cutaneous leishmaniasis (CL) and ML. Delayed type hypersensitivity test (DTH) to Leishmania antigen was tested in selected families. Among 289 members of 46 families enrolled, significant differences were found in the frequencies of CL (37% versus 20%) and ML (5% versus 0) in case versus control families, respectively. Families with 2 cases of ML had a higher frequency (29.6%) of DTH-positive individuals than control families (9.4%). These data demonstrate familial clustering of CL, ML, and positive DTH skin tests in an area endemic for L. braziliensis infection.
C1 Univ Fed Bahia, Serv Imunol, Hosp Univ Prof Edgard Santos, BR-40110160 Salvador, BA, Brazil.
   Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   Cornell Univ, Div Int Med & Infect Dis, Weill Med Coll, New York, NY USA.
   Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
RP De Jesus, AR (corresponding author), Univ Fed Bahia, Serv Imunol, Hosp Univ Prof Edgard Santos, 5 Andar,Rua Joao Botas S-N, BR-40110160 Salvador, BA, Brazil.
EM imuno@ufba.br; aik2001@med.cornell.edu; wdjohnso@med.cornell.edu;
   mary-wilson@uiowa.edu; imuno@ufba.br
RI Ko, Albert Icksang/P-2343-2015; Henrique, Luiz/ABA-2621-2020; MACHADO,
   PAULO ROBERTO LIMA/AAP-2642-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; MACHADO, PAULO ROBERTO
   LIMA/0000-0003-1894-6171; Wilson, Mary/0000-0001-8680-7275
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-30639-11A, AI048822] Funding Source:
   Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI030639, P50AI030639, R01AI048822, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   R01AI048822, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639] Funding Source: NIH RePORTER
CR Alcais A, 1997, AM J HUM GENET, V61, P968, DOI 10.1086/514882
   Almeida RP, 1996, AM J TROP MED HYG, V54, P178, DOI 10.4269/ajtmh.1996.54.178
   Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002
   Belkaid Y, 2003, EXPERT OPIN BIOL TH, V3, P875, DOI 10.1517/14712598.3.6.875
   Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152
   Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118
   BRETSCHER PA, 1997, BEHRING I MITT, V98, P153
   CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259
   Coffman RL, 1998, ADV EXP MED BIOL, V452, P61
   CONCEICAOSILVA F, 1990, CLIN EXP IMMUNOL, V79, P221, DOI 10.1111/j.1365-2249.1990.tb05182.x
   Cupolillo E, 1997, ANN TROP MED PARASIT, V91, P617, DOI 10.1080/00034989760716
   Desjeux P., 1992, World Health Statistics Quarterly, V45, P267
   DYE C, 1992, PARASITOLOGY, V104, pS7, DOI 10.1017/S0031182000075211
   Gillespie RD, 2000, PARASITE IMMUNOL, V22, P319, DOI 10.1046/j.1365-3024.2000.00309.x
   GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993
   GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002
   MARSDEN PD, 1986, T ROY SOC TROP MED H, V80, P859, DOI 10.1016/0035-9203(86)90243-9
   Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020
   Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933
   SARAVIA NG, 1989, J INFECT DIS, V159, P725, DOI 10.1093/infdis/159.4.725
   Schriefer A, 2004, INFECT IMMUN, V72, P508, DOI 10.1128/IAI.72.1.508-514.2004
NR 23
TC 21
Z9 22
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUL
PY 2005
VL 73
IS 1
BP 69
EP 73
DI 10.4269/ajtmh.2005.73.69
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 944TH
UT WOS:000230451900015
PM 16014836
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Santiago, M
   Martinelli, R
   Reis, MG
   Reis, EA
   Ko, A
   Fontes, RD
   Silva, MP
   Nascimento, EG
   de Jesus, R
   Pierangeli, S
   Espinola, R
   Gharavi, A
AF Santiago, M
   Martinelli, R
   Reis, MG
   Reis, EA
   Ko, A
   Fontes, RD
   Silva, MP
   Nascimento, EG
   de Jesus, R
   Pierangeli, S
   Espinola, R
   Gharavi, A
TI Diagnostic performance of anti-beta 2 glycoprotein I and anticardiolipin
   assays for clinical manifestations of the antiphospholipid syndrome
SO CLINICAL RHEUMATOLOGY
LA English
DT Article
DE anticardiolipin; antiphospholipid; diagnostic test; systemic lupus
   erythematosus
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; BETA-2-GLYCOPROTEIN-I APOLIPOPROTEIN-H;
   ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES; PHOSPHOLIPID SPECIFICITY;
   BETA(2)-GLYCOPROTEIN-I; CLASSIFICATION; COAGULATION; THROMBOSIS;
   INHIBITOR; CRITERIA
AB The objective of the present study was to analyse the performance of the tests for detection of anti-beta2 glycoprotein I (beta2 GP I) and anticardiolipin (aCL) antibodies for identification of clinical manifestations of the antiphospholipid syndrome (APS). Patients with systemic lupus erythematosus (SLE) as well as carriers of infectious diseases such as Kala-azar, syphilis and leptospirosis were studied. Particular interest was given to the presence of clinical complications related to APS. Anticardiolipin and anti-beta2 GP I antibodies were searched using an enzyme-linked immunosorbent assay ( ELISA) assay. Clinical manifestations of APS were observed in 34 of the 152 patients (22.3%) with SLE and no patient with infectious disease had such manifestations. Antibodies to cardiolipin in moderate or high levels and anti-beta2 GP I were detected in 55 of 152 (36.1%) and 36 of 152 (23.6%) patients with SLE, respectively, and in 2 of 30 (6.6%) and 16 of 30 (53.3%) patients with Kala-azar, in 9 of 39 (23%) and 6 of 34 (17.6%) patients with leptospirosis, and 14 of 74 (18.9%) and 8 of 70 (11.4%) cases of syphilis, respectively. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and likelihood ratio (LR) of the anti-beta2 GP I test for the identification of the clinical manifestation of APS were, respectively, 29% [95% confidence interval (CI)= 24% - 34%], 78% ( 95% CI = 73 - 83%), 15% ( 95% CI = 11 - 19%), 89% ( 95% CI = 85 - 93%) and 1.38. Regarding the aCL assay, the figure was 29% ( 95% CI = 24 - 34%), 76% ( 95% CI = 71 - 81%), 14% ( 95% CI = 10 - 18%), 89% ( 95% CI = 86 - 92%) and 1.26. As the validity and performance of the anti-beta2 GP I assay were similar to the aCL in demonstrating the presence of clinical phenomena associated with APS and due to the difficulties in performing as well as the lack of standardisation of the anti-beta2 GP I test, we suggest that the test for aCL should continue to be the first one performed when the presence of APS is suspected.
C1 Hosp Santa Izabel, Escola Bahiana Med & Saude Publ Nucl Reumatol, Serv Clin Med, BR-40000000 Salvador, BA, Brazil.
   Fdn Osvaldo Cruz, Ctr Pesquisas Goncalo Muniz, Salvador, BA, Brazil.
   Weill Med Coll, New York, NY USA.
   COAS, DST, SESAB, Salvador, BA, Brazil.
   PIEJ, SESAB, Jequie, Brazil.
   Morehouse Sch Med, Atlanta, GA 30310 USA.
RP Santiago, M (corresponding author), Hosp Santa Izabel, Escola Bahiana Med & Saude Publ Nucl Reumatol, Serv Clin Med, Praca Almeida Couto 500, BR-40000000 Salvador, BA, Brazil.
EM mitter@svn.com.br
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060
CR CABIEDES J, 1995, J RHEUMATOL, V22, P1899
   CABRAL AR, 1995, J RHEUMATOL, V22, P1894
   CONLEY CL, 1952, J CLIN INVEST, V31, P621
   COSTALLAT LTL, 1990, CLIN RHEUMATOL, V9, P489, DOI 10.1007/BF02030510
   Feinstein D I, 1972, Prog Hemost Thromb, V1, P75
   GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J
   GHARAVI AE, 1987, ANN RHEUM DIS, V46, P1, DOI 10.1136/ard.46.1.1
   Guerin J, 1997, CLIN EXP IMMUNOL, V109, P304, DOI 10.1046/j.1365-2249.1997.4601357.x
   HARRIS EN, 1986, ARCH INTERN MED, V146, P2153, DOI 10.1001/archinte.146.11.2153
   HUGHES GRV, 1986, J RHEUMATOL, V13, P486
   MARTINUZZO ME, 1995, BRIT J HAEMATOL, V89, P397, DOI 10.1111/j.1365-2141.1995.tb03317.x
   MATSUURA E, 1990, LANCET, V336, P177, DOI 10.1016/0140-6736(90)91697-9
   MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120
   MOORE JE, 1952, JAMA-J AM MED ASSOC, V150, P467, DOI 10.1001/jama.1952.03680050033010
   Pangborn MC, 1941, P SOC EXP BIOL MED, V48, P484
   ROUBEY RAS, 1995, J IMMUNOL, V154, P954
   Sanmarco M, 1997, J LAB CLIN MED, V129, P499, DOI 10.1016/S0022-2143(97)90004-4
   SANTIAGO MB, 1988, REV BRAS REUMATOL, V28, P37
   TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101
   THIAGARAJAN P, 1980, J CLIN INVEST, V66, P397, DOI 10.1172/JCI109869
   Wassermann A, 1906, DEUT MED WOCHENSCHR, V32, P0745, DOI 10.1055/s-0028-1142018
   Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
   WURM H, 1984, INT J BIOCHEM, V16, P511, DOI 10.1016/0020-711X(84)90168-X
NR 23
TC 6
Z9 8
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0770-3198
EI 1434-9949
J9 CLIN RHEUMATOL
JI Clin. Rheumatol.
PD DEC
PY 2004
VL 23
IS 6
BP 485
EP 489
DI 10.1007/s10067-004-0924-5
PG 5
WC Rheumatology
SC Rheumatology
GA 873TS
UT WOS:000225304600002
PM 15801067
DA 2020-11-30
ER

PT J
AU Nascimento, ALTO
   Ko, AI
   Martins, EAL
   Monteiro-Vitorello, CB
   Ho, PL
   Haake, DA
   Verjovski-Almeida, S
   Hartskeerl, RA
   Marques, MV
   Oliveira, MC
   Menck, CFM
   Leite, LCC
   Carrer, H
   Coutinho, LL
   Degrave, WM
   Dellagostin, OA
   El-Dorry, H
   Ferro, ES
   Ferro, MIT
   Furlan, LR
   Gamberini, M
   Giglioti, EA
   Goes-Neto, A
   Goldman, GH
   Goldman, MHS
   Harakava, R
   Jeronimo, SMB
   Junqueira-de-Azevedo, ILM
   Kimura, ET
   Kuramae, EE
   Lemos, EGM
   Lemos, MVF
   Marino, CL
   Nunes, LR
   de Oliveira, RC
   Pereira, GG
   Reis, MS
   Schriefer, A
   Siqueira, WJ
   Sommer, P
   Tsai, SM
   Simpson, AJG
   Ferro, JA
   Camargo, LEA
   Kitajima, JP
   Setubal, JC
   Van Sluys, MA
AF Nascimento, ALTO
   Ko, AI
   Martins, EAL
   Monteiro-Vitorello, CB
   Ho, PL
   Haake, DA
   Verjovski-Almeida, S
   Hartskeerl, RA
   Marques, MV
   Oliveira, MC
   Menck, CFM
   Leite, LCC
   Carrer, H
   Coutinho, LL
   Degrave, WM
   Dellagostin, OA
   El-Dorry, H
   Ferro, ES
   Ferro, MIT
   Furlan, LR
   Gamberini, M
   Giglioti, EA
   Goes-Neto, A
   Goldman, GH
   Goldman, MHS
   Harakava, R
   Jeronimo, SMB
   Junqueira-de-Azevedo, ILM
   Kimura, ET
   Kuramae, EE
   Lemos, EGM
   Lemos, MVF
   Marino, CL
   Nunes, LR
   de Oliveira, RC
   Pereira, GG
   Reis, MS
   Schriefer, A
   Siqueira, WJ
   Sommer, P
   Tsai, SM
   Simpson, AJG
   Ferro, JA
   Camargo, LEA
   Kitajima, JP
   Setubal, JC
   Van Sluys, MA
TI Comparative genomics of two Leptospira interrogans serovars reveals
   novel insights into physiology and pathogenesis
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID MOLECULAR CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; TREPONEMA-PALLIDUM;
   PROTEIN; IDENTIFICATION; GENE; BORGPETERSENII; BIOSYNTHESIS;
   LOCALIZATION; TRANSDUCTION
AB Leptospira species colonize a significant proportion of rodent populations worldwide and produce life-threatening infections in accidental hosts, including humans. Complete genome sequencing of Leptospira interrogans serovar Copenhageni and comparative analysis with the available Leptospira interrogans serovar Lai genome reveal that despite overall genetic similarity there are significant structural differences, including a large chromosomal inversion and extensive variation in the number and distribution of insertion sequence elements. Genome sequence analysis elucidates many of the novel aspects of leptospiral physiology relating to energy metabolism, oxygen tolerance, two-component signal transduction systems, and mechanisms of pathogenesis. A broad array of transcriptional regulation proteins and two new families of afimbrial adhesins which contribute to host tissue colonization in the early steps of infection were identified. Differences in genes involved in the biosynthesis of lipopolysaccharide 0 side chains between the Copenhageni and Lai serovars were identified, offering an important starting point for the elucidation of the organism's complex polysaccharide surface antigens. Differences in adhesins and in lipopolysaccharide might be associated with the adaptation of serovars Copenhageni and Lai to different animal hosts. Hundreds of genes encoding surface-exposed lipoproteins and transmembrane outer membrane proteins were identified as candidates for development of vaccines for the prevention of leptospirosis.
C1 Univ Sao Paulo, Ctr Biotechnol, Inst Butantan, BR-05503900 Sao Paulo, SP, Brazil.
   Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biociencias, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biol, Sao Paulo, Brazil.
   Univ Sao Paulo, Piracicaba, Brazil.
   Univ Estadual Paulista, Fac Ciencias Agrarias & Vet, Jaboticabal, Brazil.
   Univ Fed Sao Carlos, Ctr Ciencias Agrarias, Araras, Brazil.
   Fac Ciencias Farmaceut, Ribeirao Preto, Brazil.
   Fac Filosofia Ciencias & Letras, Ribeirao Preto, Brazil.
   Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil.
   Univ Mogi das Cruzes, Fac Ciencias Agron, Mogi Das Cruzes, Brazil.
   Univ Mogi das Cruzes, Inst Biociencias, Mogi Das Cruzes, Brazil.
   Univ Estadual Paulista, Botucatu, SP, Brazil.
   Univ Mogi das Cruzes, Nucleo Integrado Biotecnol, Mogi Das Cruzes, Brazil.
   Univ Estadual Paulista, Dept Genet & Evolucao, Campinas, SP, Brazil.
   Univ Estadual Paulista, Inst Computacao, Campinas, SP, Brazil.
   Univ Estadual Paulista, Inst Agron Campinas, Campinas, SP, Brazil.
   Univ Estadual Paulista, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil.
   Univ Fed Bahia, Serv Immunol, BR-41170290 Salvador, BA, Brazil.
   Univ Estadual Feira de Santana, LAPEM, Dept Ciencias Biol, Feira de Santana, BA, Brazil.
   Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-20001 Rio De Janeiro, Brazil.
   Univ Fed Pelotas, Ctr Biotechnol, Pelotas, Brazil.
   Univ Fed Rio Grande do Norte, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
   Ludwig Inst Canc Res, New York, NY USA.
   Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA.
   Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA.
   Koninklin Inst Tropen, Royal Trop Inst, KIT Biomed Res, Amsterdam, Netherlands.
RP Nascimento, ALTO (corresponding author), Univ Sao Paulo, Ctr Biotechnol, Inst Butantan, Avenida Vital Brazil 1500, BR-05503900 Sao Paulo, SP, Brazil.
EM tabet@usp.br
RI Carrer, Helaine/C-3159-2012; Nascimento, Ana Lucia/E-8488-2012;
   Dellagostin, Odir/C-2331-2009; Marino, Celso/L-2448-2013; Pereira,
   Goncalo A. G./B-7944-2012; Ferro, Jesus Aparecido/C-8251-2013; Degrave,
   Wim/B-4162-2009; Tsai, Siu Mui/C-2793-2012; Martins, Elizabeth
   AL/B-7135-2015; Camargo, Luis Eduardo Aranha/Y-9954-2019; Goldman, Maria
   Helena S./D-1424-2012; Harakava, Ricardo/C-4471-2012; Nascimento, Ana L.
   T. O./M-8663-2019; Setubal, Joao C/C-7305-2012; Van Sluys,
   Marie-Anne/A-8483-2012; Coutinho, Luiz/P-5233-2019; Costa de Oliveira,
   Regina/A-4571-2017; Schriefer, Albert/AAP-2765-2020; Marino,
   celso/AAH-2836-2020; Ferro, Emer S/D-3908-2012; Marques, Marilis
   V/C-3085-2013; Jeronimo, Selma/AAY-4033-2020; Camargo, Luis Eduardo
   A/C-2735-2012; FERRO, MARIA INES/D-3634-2012; Kuramae, Eiko
   Eurya/F-4738-2012; Kimura, Edna/D-7334-2012; Verjovski-Almeida,
   Sergio/AAI-2728-2020; Goes-Neto, Aristoteles/A-6955-2013; de Oliveira,
   Mariana Cabral/G-2512-2012; Monteiro-Vitorello, Claudia B/F-2436-2012;
   Ko, Albert Icksang/P-2343-2015; Leite, Luciana/D-1353-2012; Ho,
   Paulo/P-8267-2015; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020;
   Jeronimo, Selma M.B./M-8672-2014; Nunes, Luiz R/M-4804-2013; Goldman,
   Gustavo Henrique/F-1848-2013; Reis, Marcelo S./K-4075-2012; LEMOS,
   ELIANA GM/A-3604-2008; Verjovski-Almeida, Sergio/E-4082-2012;
   Junqueira-de-Azevedo, Inacio L. M./H-5239-2011; Coutinho, Luiz
   L/C-8455-2012; Menck, Carlos FM/G-6321-2011
OI Carrer, Helaine/0000-0002-9329-1841; Nascimento, Ana
   Lucia/0000-0003-4851-0870; Dellagostin, Odir/0000-0003-2803-4088; Ferro,
   Jesus Aparecido/0000-0002-3966-1303; Tsai, Siu Mui/0000-0002-3733-6312;
   Martins, Elizabeth AL/0000-0002-2333-9379; Camargo, Luis Eduardo
   Aranha/0000-0002-5650-5695; Goldman, Maria Helena
   S./0000-0002-6786-9320; Harakava, Ricardo/0000-0003-1431-2665;
   Nascimento, Ana L. T. O./0000-0003-4851-0870; Setubal, Joao
   C/0000-0001-9174-2816; Van Sluys, Marie-Anne/0000-0002-6506-2734;
   Coutinho, Luiz/0000-0002-7266-8881; Costa de Oliveira,
   Regina/0000-0002-2446-5510; Schriefer, Albert/0000-0002-5496-6789;
   Ferro, Emer S/0000-0003-1651-9192; Jeronimo, Selma/0000-0002-4784-9904;
   Camargo, Luis Eduardo A/0000-0002-5650-5695; Kuramae, Eiko
   Eurya/0000-0001-6701-8668; Kimura, Edna/0000-0001-8403-4459;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401; Goes-Neto,
   Aristoteles/0000-0002-7692-6243; de Oliveira, Mariana
   Cabral/0000-0001-8495-2962; Monteiro-Vitorello, Claudia
   B/0000-0002-1238-9354; Ko, Albert Icksang/0000-0001-9023-2339; Leite,
   Luciana/0000-0003-0156-1312; Ho, Paulo/0000-0003-3652-241X; de Macedo
   Lemos, Eliana Gertrudes/0000-0002-1119-7748; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Nunes, Luiz R/0000-0001-9619-269X; Goldman,
   Gustavo Henrique/0000-0002-2986-350X; Reis, Marcelo
   S./0000-0002-3754-9115; LEMOS, ELIANA GM/0000-0002-1119-7748;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401; Junqueira-de-Azevedo,
   Inacio L. M./0000-0003-4491-0180; Coutinho, Luiz L/0000-0002-7266-8881;
   Menck, Carlos FM/0000-0003-1941-0694; Tiraboschi Ferro, Maria
   Ines/0000-0003-3389-9131
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI034431, R01 AI034431-07] Funding
   Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI034431, R01AI034431, R01AI034431,
   R01AI034431, R01AI034431, R01AI034431, R01AI034431, R01AI034431,
   R01AI034431, R01AI034431, R01AI034431, R01AI034431, R01AI034431] Funding
   Source: NIH RePORTER
CR Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   BOURSAUXEUDE C, 1995, MICROBIOL-UK, V141, P2165, DOI 10.1099/13500872-141-9-2165
   Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359
   Chen CW, 2002, TRENDS GENET, V18, P522, DOI 10.1016/S0168-9525(02)02752-X
   COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9
   de la Pena-Moctezuma A, 1999, FEMS MICROBIOL LETT, V177, P319, DOI 10.1111/j.1574-6968.1999.tb13749.x
   Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369
   Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924
   DOLATA MM, 1993, J BIOL CHEM, V268, P14426
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   Durbin R., 1998, BIOL SEQUENCE ANAL P
   Eisen JA, 2000, GENOME BIOL, V1
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002
   Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551
   Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375
   FUKUNAGA M, 1989, J BACTERIOL, V171, P5763, DOI 10.1128/jb.171.11.5763-5767.1989
   FULOP V, 1995, STRUCTURE, V3, P1225, DOI 10.1016/S0969-2126(01)00258-1
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Gilges D, 2000, BIOCHEM J, V352, P49, DOI 10.1042/0264-6021:3520049
   Godfroid F, 1998, INFECT IMMUN, V66, P5485, DOI 10.1128/IAI.66.11.5485-5493.1998
   Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491
   HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993
   HENNEBERRY RC, 1970, CAN J MICROBIOL, V16, P41, DOI 10.1139/m70-007
   Howell ML, 2000, J BACTERIOL, V182, P4545, DOI 10.1128/JB.182.16.4545-4556.2000
   Hunnicutt DW, 2002, J BACTERIOL, V184, P2370, DOI 10.1128/JB.184.9.2370-2378.2002
   Jovanovic T, 2000, J BIOL CHEM, V275, P28439, DOI 10.1074/jbc.M003314200
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Lamothe GT, 2002, ARCH MICROBIOL, V178, P218, DOI 10.1007/s00203-002-0447-x
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lombard M, 2000, J BIOL CHEM, V275, P27021
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Meidanis J, 2002, MICROBIOL MOL BIOL R, V66, P272, DOI 10.1128/MMBR.66.2.272-299.2002
   Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   Paton AW, 1999, INFECT IMMUN, V67, P5930, DOI 10.1128/IAI.67.11.5930-5937.1999
   Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961
   Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816
   Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Santos JM, 2002, MOL MICROBIOL, V45, P1729, DOI 10.1046/j.1365-2958.2002.03131.x
   Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65
   Tang YXP, 1999, MOL MICROBIOL, V32, P139, DOI 10.1046/j.1365-2958.1999.01337.x
   Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003
   Vujaskovic Z, 2002, FREE RADICAL BIO MED, V33, P857, DOI 10.1016/S0891-5849(02)00980-2
   Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354
   Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x
   Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001
   Zuerner RL, 2002, FEMS MICROBIOL LETT, V215, P175, DOI 10.1111/j.1574-6968.2002.tb11388.x
   ZUERNER RL, 1994, PLASMID, V31, P1, DOI 10.1006/plas.1994.1001
NR 52
TC 302
Z9 692
U1 1
U2 54
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD APR
PY 2004
VL 186
IS 7
BP 2164
EP 2172
DI 10.1128/JB.186.7.2164-2172.2004
PG 9
WC Microbiology
SC Microbiology
GA 805JS
UT WOS:000220363200029
PM 15028702
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Ludtke, CB
   Coutinho, ML
   Jouglard, SDD
   Moreira, CN
   Fernandes, CHP
   Brod, CS
   Haake, DA
   Ko, AI
   Dellagostin, OA
   Aleixo, JAG
AF Luedtke, Charli Beatriz
   Coutinho, Mariana Loner
   Dorneles Jouglard, Sandra Denise
   Moreira, Cecilia Nunes
   Pinho Fernandes, Claudia Hartleben
   Brod, Claudiomar Soares
   Haake, David A.
   Ko, Albert Icksang
   Dellagostin, Odir Antonio
   Guimaraes Aleixo, Jose Antonio
TI MONOCLONAL ANTIBODIES AGAINST AN OUTER MEMBRANE PROTEIN FROM PATHOGENIC
   LEPTOSPIRA
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE leptospirosis; monoclonal antibodies; LipL32
ID DIAGNOSIS
AB Two hybridomas secreting monoclonal antibodies (MAbs) that react with a lipoprotein (LipL32) of the outer membrane of pathogenic Leptospira were obtained. For hybridoma production, spleen cells from BALB/c mice imunized with recombinant LipL32 (rLipL32) were fused to SP2/O-Ag14 cells, selected in HAT medium and screened in an indirect ELISA. One MAb produced was of the IgG2b isotype and the other was an IgM. MAbs specificity was confirmed by indirect ELISA and immunoblotting using purified rLipL32 and whole-cell antigen preparations from Escherichia coli (E. coli) expressing LipL32 and from pathogenic and nonpathogenic serovars. Both Mabs reacted with most of the pathogenic serovars tested and none reacted with non-pathogenic Leptospira. The MAbs described have potential for use in diagnostic tests for leptospirosis.
C1 [Luedtke, Charli Beatriz; Coutinho, Mariana Loner; Dorneles Jouglard, Sandra Denise; Moreira, Cecilia Nunes; Pinho Fernandes, Claudia Hartleben; Dellagostin, Odir Antonio; Guimaraes Aleixo, Jose Antonio] Univ Fed Pelotas, Ctr Biotecnol, BR-96019900 Pelotas, RS, Brazil.
   [Brod, Claudiomar Soares] Univ Fed Pelotas, Ctr Control Zoonoses, BR-96019900 Pelotas, RS, Brazil.
   [Haake, David A.] Univ Calif Los Angeles, Sch Med, Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA.
   [Haake, David A.] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA.
   [Ko, Albert Icksang] Fundacao Oswaldo Cruz, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Dellagostin, Odir Antonio] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Aleixo, JAG (corresponding author), Univ Fed Pelotas, Ctr Biotecnol, Campus Univ Capao Leao S-N, BR-96019900 Pelotas, RS, Brazil.
RI Ko, Albert Icksang/P-2343-2015; Coutinho, Mariana/J-9024-2012;
   Dellagostin, Odir/C-2331-2009
OI Ko, Albert Icksang/0000-0001-9023-2339; Dellagostin,
   Odir/0000-0003-2803-4088
CR ADLER B, 1980, J CLIN MICROBIOL, V11, P452, DOI 10.1128/JCM.11.5.452-457.1980
   APPASSAKIJ H, 1995, AM J TROP MED HYG, V52, P340, DOI 10.4269/ajtmh.1995.52.340
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BROWN JA, 1991, INFECT IMMUN, V59, P1772, DOI 10.1128/IAI.59.5.1772-1777.1991
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Harlow E, 1988, ANTIBODIES LAB MANUA
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Levett PN, 2001, CLIN DIAGN LAB IMMUN, V8, P349, DOI 10.1128/CDLI.8.2.349-351.2001
   LUPIDO R, 1991, J CLIN MICROBIOL, V29, P107
   Surujballi O, 2000, VET MICROBIOL, V71, P149, DOI 10.1016/S0378-1135(99)00177-7
   Taylor MJ, 1997, VET MICROBIOL, V56, P135, DOI 10.1016/S0378-1135(96)01351-X
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
NR 12
TC 5
Z9 5
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD NOV
PY 2003
VL 34
SU 1
BP 1
EP 4
DI 10.1590/S1517-83822003000500001
PG 4
WC Microbiology
SC Microbiology
GA V04NQ
UT WOS:000207065500001
OA DOAJ Gold, Green Published
DA 2020-11-30
ER

PT J
AU Ribeiro, GS
   Reis, JN
   Cordeiro, SM
   Lima, JBT
   Gouveia, EL
   Petersen, M
   Salgado, KT
   Silva, HR
   Zanella, RC
   Almeida, SCG
   Brandileone, MC
   Reis, MG
   Ko, AI
AF Ribeiro, GS
   Reis, JN
   Cordeiro, SM
   Lima, JBT
   Gouveia, EL
   Petersen, M
   Salgado, KT
   Silva, HR
   Zanella, RC
   Almeida, SCG
   Brandileone, MC
   Reis, MG
   Ko, AI
TI Prevention of Haemophilus influenzae type b (Hib) meningitis and
   emergence of serotype replacement with type a strains after introduction
   of Hib immunization in Brazil
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID FIELD GEL-ELECTROPHORESIS; CONJUGATE VACCINE; INVASIVE DISEASE;
   UNITED-STATES; CHILDREN; CARRIAGE; COLONIZATION; ERA
AB Surveillance for Haemophilus influenzae meningitis cases was performed in Salvador, Brazil, before and after introduction of H. influenzae type b (Hib) immunization. The incidence of Hib meningitis decreased 69% during the 1-year period after initiation of Hib immunization (from 2.62 to 0.81 cases/100,000 person-years; P < .001). In contrast, the incidence for H. influenzae type a meningitis increased 8-fold (from 0.02 to 0.16 cases/100,000 person-years; P = .008). Pulsed-field gel electrophoretic analysis demonstrated that H. influenzae type a isolates belonged to 2 clonally related groups, both of which were found before Hib immunization commenced. Therefore, Hib immunization contributed to an increased risk for H. influenzae type a meningitis through selection of circulating H. influenzae type a clones. The risk attributable to serotype replacement is small in comparison to the large reduction in Hib meningitis due to immunization. However, these findings highlight the need to maintain surveillance as the use of conjugate vaccines expands worldwide.
C1 Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, BR-40295001 Salvador, BA, Brazil.
   Univ Fed Bahia, Sch Pharm, Salvador, BA, Brazil.
   Secretary Hlth State Bahia, Hosp Couto Maia, Salvador, BA, Brazil.
   Univ Fed Bahia, Sch Med, Salvador, BA, Brazil.
   Secretary Hlth State Sao Paulo, Adolfo Lutz Inst, Sao Paulo, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   Cornell Univ, Weill Med Coll, Dept Med, Div Int Med & Infect Dis, New York, NY USA.
RP Ko, AI (corresponding author), Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Ribeiro, Guilherme/B-6624-2008; Almeida, Samanta C G/J-2798-2017; Ko,
   Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020; Reis, Joice
   N/H-9227-2013
OI Ribeiro, Guilherme/0000-0002-6798-2059; Almeida, Samanta C
   G/0000-0002-0714-8142; Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; 
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW-00919, TW-00905, TW-00018] Funding Source: Medline; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER
CR Adderson EE, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e18
   Barbour ML, 1996, EMERG INFECT DIS, V2, P176, DOI 10.3201/eid0203.960303
   BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93
   Bisgard KM, 1998, EMERG INFECT DIS, V4, P229, DOI 10.3201/eid0402.980210
   *CHILDR VACC IN, 1999, NEWSWATCH, P7
   CURRAN R, 1994, J MED MICROBIOL, V41, P120, DOI 10.1099/00222615-41-2-120
   FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994
   FALLA TJ, 1993, LANCET, V341, P851, DOI 10.1016/0140-6736(93)93059-A
   Forleo-Neto E, 1999, J INFECT DIS, V180, P1153, DOI 10.1086/315018
   Heath PT, 2001, PEDIATR INFECT DIS J, V20, P300, DOI 10.1097/00006454-200103000-00016
   *I BRAS GEOGR EST, 1996, AN EST BRAS, V56
   KROLL JS, 1994, J INFECT DIS, V169, P676, DOI 10.1093/infdis/169.3.676
   Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304
   Lipsitch M, 1997, P NATL ACAD SCI USA, V94, P6571, DOI 10.1073/pnas.94.12.6571
   MURPHY TV, 1993, J PEDIATR-US, V122, P517, DOI 10.1016/S0022-3476(05)83529-2
   NITTA DM, 1995, PEDIATR INFECT DIS J, V14, P157
   Ogilvie C, 2001, J INFECT DIS, V184, P144, DOI 10.1086/322001
   Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000
   Perdue DG, 2000, JAMA-J AM MED ASSOC, V283, P3089, DOI 10.1001/jama.283.23.3089
   RUTHERFORD GW, 1984, PEDIATR INFECT DIS J, V3, P575, DOI 10.1097/00006454-198411000-00020
   Saito M, 1999, J CLIN MICROBIOL, V37, P2142, DOI 10.1128/JCM.37.7.2142-2147.1999
   Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404
   *SECR HLTH STAT BA, 2001, IMM REC
   *SECR HLTH STAT BA, 2000, CAS NOT REC
   Slack MPE, 1998, PEDIATR INFECT DIS J, V17, pS204, DOI 10.1097/00006454-199809001-00026
   TAKALA AK, 1991, J INFECT DIS, V164, P982, DOI 10.1093/infdis/164.5.982
   TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995
   Urwin G, 1996, CLIN INFECT DIS, V22, P1069, DOI 10.1093/clinids/22.6.1069
   WAGGONERFOUNTAIN LA, 1995, CLIN INFECT DIS, V21, P1322, DOI 10.1093/clinids/21.5.1322
   WENGER JD, 1992, J INFECT DIS, V165, pS34, DOI 10.1093/infdis/165-Supplement_1-S34
   2002, MMWR MORB MORTAL WKL, V51, P234
   1996, MMWR MORB MORTAL WKL, V45, P901
NR 32
TC 87
Z9 96
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JAN 1
PY 2003
VL 187
IS 1
BP 109
EP 116
DI 10.1086/345863
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 625GZ
UT WOS:000179809900015
PM 12508153
OA Bronze
DA 2020-11-30
ER

PT J
AU Turetz, ML
   Machado, PR
   Ko, AI
   Alves, F
   Bittencourt, A
   Almeida, RP
   Mobashery, N
   Johnson, WD
   Carvalho, EM
AF Turetz, ML
   Machado, PR
   Ko, AI
   Alves, F
   Bittencourt, A
   Almeida, RP
   Mobashery, N
   Johnson, WD
   Carvalho, EM
TI Disseminated leishmaniasis: A new and emerging form of leishmaniasis
   observed in northeastern Brazil
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID DISSEMINATED CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS;
   INTERFERON-GAMMA; INTERLEUKIN-10; EPIDEMIOLOGY
AB During the past decade, there has been an increase in the number of patients with disseminated leishmaniasis (DL), which is characterized by a large number of acneiformand papular skin lesions, with very few or no parasites in the skin tissue. The present report describes 42 cases of DL identified between 1992 and 1998 in an area where Leishmania braziliensis transmission is endemic; 8 of the patients were prospectively diagnosed. In a contrast to localized cutaneous leishmaniasis (LCL), acquisition of DL was associated with age >19 years (P < .05), male sex (P < .05), and agricultural occupation (P < .001). Patients with DL presented with 10-300 lesions that were a mixture of acneiform, papular, nodular, and ulcerated types. Twelve (29%) of 42 patients had mucosal involvement. Patients with DL had lower levels of interferon-&gamma; (P < .005) and tumor necrosis factor-alpha (P < .05) production, compared with patients with LCL. DL is an emerging clinical distinct form of leishmaniasis associated with agricultural activities and host immunological response.
C1 Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
   Univ Maryland, Dept Internal Med, Baltimore, MD 21201 USA.
   Univ Fed Bahia, Serv Imunol, Hosp Univ Prof Edgard Santos, BR-40110160 Salvador, BA, Brazil.
   Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Carvalho, EM (corresponding author), Univ Fed Bahia, Serv Imunol, Hosp Univ Prof Edgard Santos, Rua Joao Botas S-N, BR-40110160 Salvador, BA, Brazil.
RI MACHADO, PAULO ROBERTO LIMA/AAP-2642-2020; Ko, Albert
   Icksang/P-2343-2015; almeida, roque/F-5609-2012
OI MACHADO, PAULO ROBERTO LIMA/0000-0003-1894-6171; Ko, Albert
   Icksang/0000-0001-9023-2339; 
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW-00919] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [AI-30639] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639] Funding Source: NIH RePORTER
CR Agostoni C, 1998, INFECTION, V26, P93, DOI 10.1007/BF02767767
   Akuffo H, 1997, J INFECT DIS, V175, P737, DOI 10.1093/infdis/175.3.737
   Almeida RP, 1996, AM J TROP MED HYG, V54, P178, DOI 10.4269/ajtmh.1996.54.178
   Bittencourt AL, 1996, PEDIATR DERMATOL, V13, P455, DOI 10.1111/j.1525-1470.1996.tb00724.x
   CARVALHO EM, 1994, ACTA TROP, V56, P315, DOI 10.1016/0001-706X(94)90103-1
   CONVIT J, 1972, T ROY SOC TROP MED H, V66, P603, DOI 10.1016/0035-9203(72)90306-9
   Correia D, 1996, Rev Soc Bras Med Trop, V29, P447, DOI 10.1590/S0037-86821996000500007
   COSTA JML, 1986, J TROP MED HYG, V89, P319
   Fernandes O, 1999, J PARASITOL, V85, P563, DOI 10.2307/3285798
   Galvao C E, 1993, Rev Soc Bras Med Trop, V26, P121, DOI 10.1590/S0037-86821993000200008
   HEINZEL FP, 1991, P NATL ACAD SCI USA, V88, P7011, DOI 10.1073/pnas.88.16.7011
   JONES TC, 1987, J INFECT DIS, V156, P73, DOI 10.1093/infdis/156.1.73
   LAINSON R, 1983, T ROY SOC TROP MED H, V77, P569, DOI 10.1016/0035-9203(83)90185-2
   MACHADO ES, 1992, MEM I OSWALDO CRUZ, V87, P487, DOI 10.1590/S0074-02761992000400005
   REED SG, 1986, AM J TROP MED HYG, V35, P79, DOI 10.4269/ajtmh.1986.35.79
   Romero GAS, 1999, MEM I OSWALDO CRUZ, V94, P505, DOI 10.1590/S0074-02761999000400014
NR 16
TC 109
Z9 112
U1 0
U2 3
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2002
VL 186
IS 12
BP 1829
EP 1834
DI 10.1086/345772
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 617ZW
UT WOS:000179392800017
PM 12447770
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Barocchi, MA
   Ko, AI
   Reis, MG
   McDonald, KL
   Riley, LW
AF Barocchi, MA
   Ko, AI
   Reis, MG
   McDonald, KL
   Riley, LW
TI Rapid translocation of polarized MDCK cell monolayers by Leptospira
   interrogans, an invasive but nonintracellular pathogen
SO INFECTION AND IMMUNITY
LA English
DT Article
ID ENTEROPATHOGENIC ESCHERICHIA-COLI; BORRELIA-BURGDORFERI;
   EPITHELIAL-CELLS; PENETRATION; SALMONELLA; ADHESION; VIRULENT; MOTILITY;
   POMONA
AB Pathogenic spirochetes of the genus Leptospira are a major cause of human zoonotic infectious disease worldwide. After gaining entry through the skin, the organism causes disease by hematogenously disseminating to multiple organs. The mechanism by which it penetrates the mammalian cell barriers to disseminate is not well understood. In this study, we used a low-passage-number isolate of Leptospira interrogans to elucidate the invasive potential of this spirochete. Quantification of bacteria by dark-field microscopy revealed that pathogenic spirochetes were able to translocate through polarized MDCK cell monolayers at a rate significantly greater than that of nonpathogenic Leptospira or a recognized invasive bacterial pathogen, Salmonella. In contrast to Salmonella, L. interrogans did not alter transepithelial electrical resistance during cell translocation. Both transmission and scanning electron microscopy revealed tight association of the extracellular spirochetes with the host cell plasma membrane, without membrane perturbations suggestive of cytoskeletal rearrangement. Spirochetes were not observed within intercellular junctions or membrane-bound compartments inside cells. They were found within the cytoplasm of only 8% of the counted cells. These results indicate that Leptospira is an invasive but not a facultative intracellular organism. We propose that the rapid translocation of mammalian cells by pathogenic Leptospira is a mechanism designed to evade killing by host cells that permits the organism to quickly reach the bloodstream and disseminate to multiple organs.
C1 Univ Calif Berkeley, Div Infect Dis & Immun, Sch Publ Hlth, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Electron Microscopy Lab, Berkeley, CA 94720 USA.
   Brazilian Minist Hlth, Goncalo Moniz Res Ctr, Oswaldo Cruz Fdn, BR-40001 Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Div Internal Med & Infect Dis, New York, NY 10021 USA.
RP Riley, LW (corresponding author), Univ Calif Berkeley, Div Infect Dis & Immun, Sch Publ Hlth, 140 Earl Warren Hall, Berkeley, CA 94720 USA.
EM lwriley@uclink4.berkeley.edu
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000905, D43TW000905, D43TW000905,
   D43TW000919, D43TW000919, D43TW000905, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000905, D43TW000905, D43TW000919,
   D43TW000919, D43TW000905, D43TW000905, D43TW000905, D43TW000919,
   D43TW000919, D43TW000919] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [K08AI001605, K08AI001605, K08AI001605] Funding Source: NIH RePORTER;
   FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW000905, D43 TW000919] Funding Source: Medline; NIAID NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [K08 AI01605] Funding Source: Medline
CR AREAN VM, 1962, AM J PATHOL, V40, P393
   BALLARD SA, 1986, J MED MICROBIOL, V21, P59, DOI 10.1099/00222615-21-1-59
   Brumell JH, 1999, CURR BIOL, V9, pR277, DOI 10.1016/S0960-9822(99)80178-X
   CHUNHAO L, 2000, J MOL MICROB BIOTECH, V2, P345
   COMSTOCK LE, 1989, INFECT IMMUN, V57, P1626, DOI 10.1128/IAI.57.5.1626-1628.1989
   FAINE S, 1957, BRIT J EXP PATHOL, V38, P1
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FALKOW S, 1992, ANNU REV CELL BIOL, V8, P333, DOI 10.1146/annurev.cb.08.110192.002001
   Finlay B. Brett, 1994, P249
   FINLAY BB, 1988, J CELL BIOL, V107, P221, DOI 10.1083/jcb.107.1.221
   FINLAY BB, 1992, INFECT IMMUN, V60, P2541, DOI 10.1128/IAI.60.6.2541-2543.1992
   GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778
   GONZALEZMARISCAL L, 1990, AM J PHYSIOL, V259, pC978
   GREENBERG EP, 1977, J BACTERIOL, V131, P960, DOI 10.1128/JB.131.3.960-969.1977
   HAAKE DA, 1994, METHOD ENZYMOL, V236, P447
   Inada R, 1916, J EXP MED, V23, P377, DOI 10.1084/jem.23.3.377
   ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z
   ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0
   JEPSON MA, 1995, INFECT IMMUN, V63, P356, DOI 10.1128/IAI.63.1.356-359.1995
   KNUTTON S, 1987, INFECT IMMUN, V55, P69, DOI 10.1128/IAI.55.1.69-77.1987
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   KURTTI TJ, 1993, J MED ENTOMOL, V30, P586, DOI 10.1093/jmedent/30.3.586
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lux R, 2001, INFECT IMMUN, V69, P6276, DOI 10.1128/IAI.69.10.6276-6283.2001
   MA Y, 1991, INFECT IMMUN, V59, P671, DOI 10.1128/IAI.59.2.671-678.1991
   Marangoni A, 2000, INFECT IMMUN, V68, P5408, DOI 10.1128/IAI.68.9.5408-5411.2000
   MARSHALL RB, 1976, J MED MICROBIOL, V9, P149, DOI 10.1099/00222615-9-2-149
   MARSHALL RB, 1974, J MED MICROBIOL, V7, P505, DOI 10.1099/00222615-7-4-505
   Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1016/S0378-1097(00)00044-6
   Merien F, 1997, INFECT IMMUN, V65, P729, DOI 10.1128/IAI.65.2.729-738.1997
   MILLER NB, 1962, J BACTERIOL, V84, P569, DOI 10.1128/JB.84.3.569-576.1962
   PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7
   RIVIERE GR, 1989, INFECT IMMUN, V57, P2267, DOI 10.1128/IAI.57.8.2267-2271.1989
   ROSE GW, 1966, AM J VET RES, V27, P1461
   SADZIENE A, 1991, J CLIN INVEST, V88, P82, DOI 10.1172/JCI115308
   THOMAS DD, 1990, INFECT IMMUN, V58, P581, DOI 10.1128/IAI.58.3.581-585.1990
   THOMAS DD, 1988, P NATL ACAD SCI USA, V85, P3608, DOI 10.1073/pnas.85.10.3608
   TSUCHIMOTO M, 1984, ZBL BAKT-INT J MED M, V258, P268, DOI 10.1016/S0176-6724(84)80044-9
   VINH T, 1984, J MED MICROBIOL, V18, P73, DOI 10.1099/00222615-18-1-73
   Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176
NR 40
TC 63
Z9 67
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD DEC
PY 2002
VL 70
IS 12
BP 6926
EP 6932
DI 10.1128/IAI.70.12.6926-6932.2002
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 617TU
UT WOS:000179377600053
PM 12438371
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Reis, JN
   Lima, JB
   Ribeiro, GS
   Corderio, SM
   Salgado, K
   Reis, MG
   Ko, AI
AF Reis, JN
   Lima, JB
   Ribeiro, GS
   Corderio, SM
   Salgado, K
   Reis, MG
   Ko, AI
TI Antimicrobial resistance in Haemophilus influenzae isolated during
   population-based surveillance for meningitis in Salvador, Brazil
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID STREPTOCOCCUS-PNEUMONIAE; SUSCEPTIBILITY
AB Antimicrobial susceptibility was determined for 150 Haemophilus inluenzae isolates obtained during population-based surveillance for meningitis in Salvador, Brazil. Ten (6.7%) isolates were resistant to ampicillin and chloramphenicol. Of these, two isolates, a beta-lactamase and non-beta-lactamase producer, were resistant to amoxacillin-clavulinic acid. These findings indicate that present antibiotic regimens in Brazil may not be appropriate for the treatment of H. influenzae meningitis.
C1 Fdn Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, BR-40295001 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Farm, BR-41170290 Salvador, BA, Brazil.
   Hosp Coutu Maia, Secretaria Saude Estado Bahia, Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Dept Med, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Ko, AI (corresponding author), Fdn Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Faldcao 121, BR-40295001 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Ribeiro, Guilherme/B-6624-2008; Reis, Joice N/H-9227-2013; Ko, Albert
   Icksang/P-2343-2015
OI Ribeiro, Guilherme/0000-0002-6798-2059; Ko, Albert
   Icksang/0000-0001-9023-2339
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW000919, D43 TW000905, TW-00905, TW-00919, TW-00018, D43 TW000018]
   Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [D43TW000018, D43TW000018,
   D43TW000018, D43TW000919, D43TW000905, D43TW000018, D43TW000905,
   D43TW000919, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000905, D43TW000919, D43TW000919, D43TW000018, D43TW000905,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000919, D43TW000018, D43TW000919,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000919,
   D43TW000018, D43TW000018, D43TW000919, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000905, D43TW000018, D43TW000919,
   D43TW000018, D43TW000018, D43TW000018, D43TW000905, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000919,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018, D43TW000919, D43TW000905,
   D43TW000905, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000905, D43TW000018, D43TW000018] Funding Source: NIH RePORTER
CR BARRY AL, 1993, ANTIMICROB AGENTS CH, V37, P14, DOI 10.1128/AAC.37.1.14
   Critchley IA, 2000, CLIN MICROBIOL INFEC, V6, P178, DOI 10.1046/j.1469-0691.2000.00063.x
   De Andrade ALSS, 2001, MICROB DRUG RESIST, V7, P403, DOI 10.1089/10766290152773419
   Di Fabio JL, 2001, PEDIATR INFECT DIS J, V20, P959, DOI 10.1097/00006454-200110000-00009
   Hart CA, 1998, BRIT MED J, V317, P647, DOI 10.1136/bmj.317.7159.647
   Hoban DJ, 2001, CLIN INFECT DIS, V32, pS81, DOI 10.1086/320181
   Lopez-Vidal Y, 2002, INT J ANTIMICROB AG, V19, P201, DOI 10.1016/S0924-8579(02)00004-3
   MENDELMAN PM, 1984, ANTIMICROB AGENTS CH, V26, P235, DOI 10.1128/AAC.26.2.235
   *MIN SAUD, 1998, GUIA VIG EP MEN GER
   *NAT COMM CLIN LAB, 2000, M7A5 NAT COMM CLIN L
   Peltola H, 2000, CLIN MICROBIOL REV, V13, P302, DOI 10.1128/CMR.13.2.302-317.2000
   Rojo P, 2001, Gac Sanit, V15, P540
   Ubukata Kimiko, 2002, Journal of Infection and Chemotherapy, V8, P50
   Zanella RC, 2002, MICROB DRUG RESIST, V8, P67, DOI 10.1089/10766290252913782
NR 14
TC 8
Z9 9
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD NOV
PY 2002
VL 46
IS 11
BP 3641
EP 3643
DI 10.1128/AAC.46.11.3641-3643.2002
PG 3
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 606BK
UT WOS:000178712800049
PM 12384381
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Sarkar, U
   Nascimento, SF
   Barbosa, R
   Martins, R
   Nuevo, H
   Kalafanos, I
   Grunstein, I
   Flannery, B
   Dias, J
   Riley, LW
   Reis, MG
   Ko, AI
AF Sarkar, U
   Nascimento, SF
   Barbosa, R
   Martins, R
   Nuevo, H
   Kalafanos, I
   Grunstein, I
   Flannery, B
   Dias, J
   Riley, LW
   Reis, MG
   Ko, AI
TI Population-based case-control investigation of risk factors for
   leptospirosis during an urban epidemic
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID FEATURES; DETROIT
AB Between March and October 2000, 157 suspected cases of leptospirosis hospitalized with complications of Weil's syndrome and a mortality of 8% were identified in Salvador, Brazil. We conducted a population-based case-control study to identify risk factors for acquisition of leptospirosis in neighborhoods with high endemicity during the rainy season-associated urban epidemic. Sixty-six (65%) of 101 laboratory-confirmed cases and 125 age and sex-matched healthy neighborhood controls were interviewed. Residence in proximity to an open sewer (matched odds ratio [OR]=5.15, 95% confidence interval [CI]=1.80-14.74), peri-domiciliary sighting of rats (OR=4.49, 95% CI=1.57-12.83), sighting groups of five or more rats (OR=3.90, 95% CI=1.35-11.27), and workplace exposure to contaminated environmental sources (OR=3.71, 95% CI=1.35-10.17) were found to be independent risk factors for acquiring disease. Some of these risk factors are amenable to focused interventions, which include provision of closed drainage systems for sewage and reduction of rodent populations in the peri-domicilary environment. Environmental control of transmission may help to greatly reduce the incidence of severe leptospirosis.
C1 Fdn Oswaldo Cruz MS, Brazilian Minist Hlth, Goncalo Moniz Res Ctr, Ctr Pesquisas Goncalo Moniz, BR-40295001 Salvador, BA, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   Secretary Hlth State Bahia, Dept Epidemiol Surveillance, Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
RP Ko, AI (corresponding author), Fdn Oswaldo Cruz MS, Brazilian Minist Hlth, Goncalo Moniz Res Ctr, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Ko, Albert Icksang/P-2343-2015; Reis, Mitermayer/AAO-9742-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; Reis,
   Mitermayer/0000-0002-3051-9060; KALOFONOS, IPPOLYTOS/0000-0002-4365-8473
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [K08AI001605, K08AI001605, K08AI001605] Funding Source: NIH RePORTER;
   FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW-00919, TW-00905] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [AI-01605] Funding Source: Medline
CR ADLER B, 1980, J CLIN MICROBIOL, V11, P452, DOI 10.1128/JCM.11.5.452-457.1980
   [Anonymous], 2000, Commun Dis Rep CDR Wkly, V10, P341
   Barcellos C, 2001, Cad Saude Publica, V17 Suppl, P59
   Barcellos C, 2000, INT J ENVIRON HEAL R, V10, P301, DOI 10.1080/0960312002001500
   CALDAS E M, 1978, Revista do Instituto de Medicina Tropical de Sao Paulo, V20, P164
   *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P619
   Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P585
   Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P577
   CHILDS JE, 1992, AM J PUBLIC HEALTH, V82, P597, DOI 10.2105/AJPH.82.4.597
   CORREA M O A, 1975, International Journal of Zoonoses, V2, P1
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   GONCALVES A, 1967, B CENT EST HOSP SERV, V19, P147
   Goncalves A J, 1992, Rev Soc Bras Med Trop, V25, P261
   *I BRAS GEOGR EST, 1996, AN EST BRAS
   KATZ AR, 1991, AM J PUBLIC HEALTH, V81, P1310, DOI 10.2105/AJPH.81.10.1310
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   KUPERSTEIN M, 1991, NEURAL NETWORKS, V4, P131, DOI 10.1016/0893-6080(91)90001-L
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lomar AV, 2000, INFECT DIS CLIN N AM, V14, P23, DOI 10.1016/S0891-5520(05)70216-6
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Nicodemo AC, 1997, AM J TROP MED HYG, V56, P181, DOI 10.4269/ajtmh.1997.56.181
   *PAN AM HLTH ORG, 1998, B EPIDEMIOL, V19, P1
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   SAKATA EE, 1992, REV I MED TROP, V34, P217, DOI 10.1590/S0036-46651992000300006
   Sanders EJ, 1999, AM J TROP MED HYG, V61, P399, DOI 10.4269/ajtmh.1999.61.399
   TERPSTRA WJ, 1985, J GEN MICROBIOL, V131, P377
   THIERMANN AB, 1980, INT J ZOONOSES, V7, P62
   THIERMANN AB, 1977, AM J TROP MED HYG, V26, P970, DOI 10.4269/ajtmh.1977.26.970
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   *WORLD BANK, 2000, WORLD DEV REP 1999 2
NR 31
TC 127
Z9 134
U1 0
U2 19
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAY
PY 2002
VL 66
IS 5
BP 605
EP 610
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 585AM
UT WOS:000177501000029
PM 12201599
DA 2020-11-30
ER

PT J
AU Reis, JN
   Cordeiro, SM
   Coppola, SJ
   Salgado, K
   Carvalho, MGS
   Teixeira, LM
   Thompson, TA
   Facklam, RR
   Reis, MG
   Ko, AI
AF Reis, JN
   Cordeiro, SM
   Coppola, SJ
   Salgado, K
   Carvalho, MGS
   Teixeira, LM
   Thompson, TA
   Facklam, RR
   Reis, MG
   Ko, AI
TI Population-based survey of antimicrobial susceptibility and serotype
   distribution of Streptococcus pneumoniae from meningitis patients in
   Salvador, Brazil
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID CONJUGATE VACCINE FORMULATION; NASOPHARYNGEAL CARRIAGE; PNEUMOCOCCAL
   SEROGROUPS; RESISTANCE; CHILDREN; INFECTIONS; DISEASE; EPIDEMIOLOGY;
   SURVEILLANCE; IMPACT
AB Penicillin-nonsusceptible strains were isolated from 15% of 303 individuals with pneumococcal meningitis identified during a 4-year surveillance study in Salvador, Brazil. The estimated rate of coverage of the seven-valent conjugate vaccine was 74% among patients <5 years of age and 94% among those infected with nonsusceptible isolates, indicating that the use of conjugate vaccines may be an approach to the control of emerging penicillin resistance in Brazil.
C1 Minist Saude, Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40295001 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil.
   Hosp Couto Maia, Secretaria Saude Estado Bahia, Salvador, BA, Brazil.
   Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil.
   Cornell Univ, Weill Med Coll, Dept Med, Div Int Med & Infect Dis, New York, NY 10021 USA.
   Ctr Dis Control & Prevent, Streptococcus Lab, Atlanta, GA 30333 USA.
RP Ko, AI (corresponding author), Minist Saude, Fdn Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
RI Teixeira, Lucia Martins/AAO-7988-2020; Reis, Joice N/H-9227-2013; Reis,
   Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000919, D43TW000018, D43TW000905, D43TW000905,
   D43TW000919, D43TW000018, D43TW000018, D43TW000919, D43TW000018,
   D43TW000905, D43TW000018, D43TW000919, D43TW000018, D43TW000018,
   D43TW000919, D43TW000018, D43TW000018, D43TW000905, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000905, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000919, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018, D43TW000919, D43TW000018,
   D43TW000905, D43TW000018, D43TW000905, D43TW000919, D43TW000018,
   D43TW000905, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000905, D43TW000018, D43TW000919, D43TW000919, D43TW000018,
   D43TW000018, D43TW000919, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43 TW000905, TW-00905, D43 TW000018,
   TW-00919, D43 TW000919, TW-00018] Funding Source: Medline; NIAID NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-30639, P50 AI030639] Funding Source:
   Medline
CR Appelbaum PC, 1996, PEDIATR INFECT DIS J, V15, P932, DOI 10.1097/00006454-199610000-00030
   Brandileone MCD, 1997, MICROB DRUG RESIST, V3, P141
   Castaneda E, 1997, MICROB DRUG RESIST, V3, P147, DOI 10.1089/mdr.1997.3.147
   Critchley IA, 2000, CLIN MICROBIOL INFEC, V6, P178, DOI 10.1046/j.1469-0691.2000.00063.x
   Dagan R, 1996, J INFECT DIS, V174, P1271, DOI 10.1093/infdis/174.6.1271
   Fenoll A, 1998, J CLIN MICROBIOL, V36, P3447, DOI 10.1128/JCM.36.12.3447-3454.1998
   FRIEDLAND IR, 1994, NEW ENGL J MED, V331, P377, DOI 10.1056/NEJM199408113310607
   *GUIA VIG EP, 1998, MEN GER
   Halsey NA, 1997, PEDIATRICS, V99, P289
   Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609
   Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608
   Hausdorff WP, 2001, LANCET, V357, P950, DOI 10.1016/S0140-6736(00)04222-7
   Hortal M, 1997, MICROB DRUG RESIST, V3, P159, DOI 10.1089/mdr.1997.3.159
   *I BRAS GEOGR EST, 1996, AN EST BRAS, V56
   Kertesz DA, 1998, CLIN INFECT DIS, V26, P1355, DOI 10.1086/516350
   Klugman KP, 1997, S AFR MED J, V87, P912
   Ko AI, 2000, CLIN INFECT DIS, V30, P78, DOI 10.1086/313619
   Levine MM, 1998, PEDIATR INFECT DIS J, V17, P287, DOI 10.1097/00006454-199804000-00005
   MARTON A, 1992, CLIN INFECT DIS, V15, P106, DOI 10.1093/clinids/15.1.106
   Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009
   *NAT COMM CLIN LAB, 1997, M7A4 NAT COMM CLIN L
   Obaro SK, 1996, BMJ-BRIT MED J, V312, P1521, DOI 10.1136/bmj.312.7045.1521
   Sleeman K, 2001, J INFECT DIS, V183, P239, DOI 10.1086/317924
   Teixeira LM, 1997, ADV EXP MED BIOL, V418, P269
   Thomas K, 1999, LANCET, V353, P1216, DOI 10.1016/S0140-6736(98)07228-6
   WRIGHT PF, 1989, B WORLD HEALTH ORGAN, V67, P479
NR 26
TC 19
Z9 20
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JAN
PY 2002
VL 40
IS 1
BP 275
EP 277
DI 10.1128/JCM.40.1.275-277.2002
PG 3
WC Microbiology
SC Microbiology
GA 509AK
UT WOS:000173121800049
PM 11773131
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Flannery, B
   Pereira, MM
   Velloso, LD
   Carvalho, CD
   De Codes, LG
   Orrico, GD
   Dourado, CMR
   Riley, LW
   Reis, MG
   Ko, AI
AF Flannery, B
   Pereira, MM
   Velloso, LD
   Carvalho, CD
   De Codes, LG
   Orrico, GD
   Dourado, CMR
   Riley, LW
   Reis, MG
   Ko, AI
TI Referral pattern of leptospirosis cases during a large urban epidemic of
   dengue
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID INTERNATIONAL MULTICENTER EVALUATION; IMMUNOGLOBULIN-M ANTIBODIES;
   PULMONARY HEMORRHAGE; DIPSTICK ASSAY; PENICILLIN; NICARAGUA; THERAPY
AB During heavy seasonal rainfall in 1996, concurrent epidemics of dengue and leptospirosis occurred in an urban center in northeastern Brazil. We interviewed 110 cases of leptospirosis hospitalized a median of seven days after the onset of illness to evaluate the impact of the dengue epidemic on the triage of suspected leptospirosis from ambulatory clinics to the infectious disease reference hospital. Within the first three days of illness, 46 (42%) cases sought their first medical evaluation, and 28 (61% of 46) received a diagnosis of dengue. Dengue diagnoses were associated with a median of five days delay in referral to the infectious disease hospital. Patients who reported initial diagnoses of dengue were more likely than other patients to have required admission to the intensive care unit (odds ratio [OR] = 2.7, 95% confidence interval [CI] = 0.8-9.5) and to have died during hospitalization (OR = 5.1, 95% CI = 0.8-55.0). These findings indicate that diagnostic confusion between the early symptoms of leptospirosis and dengue may have contributed to the high mortality observed during the leptospirosis epidemic.
C1 Univ Calif Berkeley, Sch Publ Hlth, Dept Publ Hlth Biol & Epidemiol, Berkeley, CA 94720 USA.
   Secretary Hlth State Bahia, Couto Maia Hosp, Salvador, BA, Brazil.
   Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Ko, AI (corresponding author), Fiocruz MS, Ctr Pesquisas Goncalo Moniz, R Waldemar Falcao,121 Brotas, BR-40295001 Salvador, BA, Brazil.
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW00905, D43 TW00919] Funding Source: Medline; NIAID NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [KO8 AI-01605, AI-30639] Funding Source: Medline;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, K08AI001605, K08AI001605, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, K08AI001605, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639] Funding Source: NIH RePORTER
CR [Anonymous], 2000, Wkly Epidemiol Rec, V75, P193
   AZEVEDO R, 1968, REV I A LUTZ, V28, P85
   Bounlu K, 1998, CLIN INFECT DIS, V27, P717, DOI 10.1086/514948
   CALDAS E. M., 1979, Revista do Instituto Adolfo Lutz, V39, P85
   CASTRO JSM, 1997, B EPIDEMIOL SESAB, V5, P2
   CORREA M O A, 1975, International Journal of Zoonoses, V2, P1
   EDWARDS CN, 1988, AM J TROP MED HYG, V39, P388, DOI 10.4269/ajtmh.1988.39.388
   EVERARD COR, 1995, EUR J EPIDEMIOL, V11, P311, DOI 10.1007/BF01719436
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   Gussenhoven GC, 1997, J CLIN MICROBIOL, V35, P92, DOI 10.1128/JCM.35.1.92-97.1997
   Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2000, AM J TROP MED HYG, V62, P112, DOI 10.4269/ajtmh.2000.62.112
   Lomar AV, 2000, INFECT DIS CLIN N AM, V14, P23, DOI 10.1016/S0891-5520(05)70216-6
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   MCCLAIN JBL, 1984, ANN INTERN MED, V100, P696, DOI 10.7326/0003-4819-100-5-696
   Merien F, 1996, AM J TROP MED HYG, V55, P174, DOI 10.4269/ajtmh.1996.55.174
   RIOSGONCALVES AJ, 1990, ARQ BRAS MED, V64, P389
   Sanders EJ, 1999, AM J TROP MED HYG, V61, P399, DOI 10.4269/ajtmh.1999.61.399
   Smits HL, 1999, J CLIN MICROBIOL, V37, P2904, DOI 10.1128/JCM.37.9.2904-2909.1999
   Smits HL, 2000, J CLIN MICROBIOL, V38, P1272, DOI 10.1128/JCM.38.3.1272-1275.2000
   Smits HL, 2000, TROP MED INT HEALTH, V5, P124, DOI 10.1046/j.1365-3156.2000.00525.x
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   WATT G, 1988, LANCET, V1, P433
   World Health Organization, 1982, GUID CONTR LEPT
   Yersin C, 2000, T ROY SOC TROP MED H, V94, P71, DOI 10.1016/S0035-9203(00)90445-0
   Zaki SR, 1996, LANCET, V347, P535, DOI 10.1016/S0140-6736(96)91167-8
NR 28
TC 42
Z9 48
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2001
VL 65
IS 5
BP 657
EP 663
DI 10.4269/ajtmh.2001.65.657
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 491ZD
UT WOS:000172139700046
PM 11716133
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Flannery, B
   Costa, D
   Carvalho, FP
   Guerreiro, H
   Matsunaga, J
   Da Silva, ED
   Ferreira, AGP
   Riley, LW
   Reis, MG
   Haake, DA
   Ko, AI
AF Flannery, B
   Costa, D
   Carvalho, FP
   Guerreiro, H
   Matsunaga, J
   Da Silva, ED
   Ferreira, AGP
   Riley, LW
   Reis, MG
   Haake, DA
   Ko, AI
TI Evaluation of recombinant Leptospira antigen-based enzyme-linked
   immunosorbent assays for the serodiagnosis of leptospirosis
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID INTERNATIONAL MULTICENTER EVALUATION; OUTER-MEMBRANE PROTEIN; HUMAN
   IMMUNE-RESPONSE; IMMUNOGLOBULIN-M; DIPSTICK ASSAY; PULMONARY HEMORRHAGE;
   MOLECULAR-CLONING; SEQUENCE-ANALYSIS; HUMAN-SERUM; DIAGNOSIS
AB There is an urgent need for development of new serodiagnostic strategies for leptospirosis, an emerging zoonosis with worldwide distribution. We have evaluated the diagnostic utility of five recombinant antigens in enzyme-linked immunosorbent assays (ELISAs) for serodiagnosis of leptospirosis. Sera from 50 healthy residents of a high-incidence region were used to determine cutoff values for 96% specificity. In paired sera from 50 cases of leptospirosis confirmed by the microscopic agglutination test, immunoglobulin G (IgG) but not IgM reacted with the recombinant leptospiral proteins. The recombinant LipL32 IgG ELISA had the highest sensitivities in the acute (56%) and convalescent (94%) phases of leptospirosis. ELISAs based on recombinant OmpL1, LipL41, and Hsp58 had sensitivities of 16, 24, and 18% during the acute phase and 72, 44, and 32% during convalescence, respectively. Compared to sera from healthy individuals, patient sera did not react significantly with recombinant LipL36 (P > 0.05). Recombinant LipL32 IgG ELISA demonstrated 95% specificity among 100 healthy individuals, and specificities ranging from 90 to 97% among 30 dengue patients, 30 hepatitis patients, and 16 patients with diseases initially thought to be leptospirosis. Among 39 Venereal Disease Research Laboratory test-positive individuals and 30 Lyme disease patients, 13 and 23% of sera, respectively, reacted positively with the rLipL32 antigen. These findings indicate that rLipL32 may be an useful antigen for the serodiagnosis of leptospirosis.
C1 Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, BR-40295001 Salvador, BA, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   Univ Fed Bahia, Sch Pharm, Salvador, BA, Brazil.
   Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA 90073 USA.
   Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA.
   Brazilian Minist HLth, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Ko, AI (corresponding author), Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015; COSTA,
   DIRCEU/W-8832-2019
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; COSTA, DIRCEU/0000-0002-0334-3899
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW-00919, TW-00905, D43 TW000905, D43 TW000919] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R21 AI034431-06, R21 AI034431,
   R29 AI034431, AI-01605, R01 AI034431, AI-34431] Funding Source: Medline;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000905,
   D43TW000905, D43TW000919, D43TW000919, D43TW000919, D43TW000905,
   D43TW000905, D43TW000919, D43TW000905, D43TW000919, D43TW000919,
   D43TW000905, D43TW000905, D43TW000905, D43TW000905, D43TW000919,
   D43TW000919, D43TW000919] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R29AI034431, R01AI034431, R01AI034431, K08AI001605, R29AI034431,
   R01AI034431, R01AI034431, K08AI001605, R01AI034431, R01AI034431,
   R01AI034431, R21AI034431, R01AI034431, R01AI034431, R01AI034431,
   R29AI034431, K08AI001605, R01AI034431, R01AI034431, R01AI034431,
   R29AI034431, R29AI034431] Funding Source: NIH RePORTER
CR ADLER B, 1980, J CLIN MICROBIOL, V11, P452, DOI 10.1128/JCM.11.5.452-457.1980
   [Anonymous], 1997, MMWR-MORBID MORTAL W, V46, P577
   BALLARD SA, 1993, MOL MICROBIOL, V8, P739, DOI 10.1111/j.1365-2958.1993.tb01617.x
   Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   Bounlu K, 1998, CLIN INFECT DIS, V27, P717, DOI 10.1086/514948
   Bughio NI, 1999, CLIN DIAGN LAB IMMUN, V6, P599, DOI 10.1128/CDLI.6.4.599-605.1999
   *CDC, 2000, MMWR-MORBID MORTAL W, V49, P816
   Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P585
   CHAPMAN AJ, 1991, EPIDEMIOL INFECT, V107, P143, DOI 10.1017/S0950268800048779
   CHAPMAN AJ, 1988, J MED MICROBIOL, V25, P269, DOI 10.1099/00222615-25-4-269
   Cumberland P, 1999, AM J TROP MED HYG, V61, P731, DOI 10.4269/ajtmh.1999.61.731
   ENGSTROM SM, 1995, J CLIN MICROBIOL, V33, P419, DOI 10.1128/JCM.33.2.419-427.1995
   EVERARD COR, 1995, EUR J EPIDEMIOL, V11, P311, DOI 10.1007/BF01719436
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   Goossens HAT, 1999, EUR J CLIN MICROBIOL, V18, P551, DOI 10.1007/s100960050347
   Guerreiro H, 2001, INFECT IMMUN, V69, P4958, DOI 10.1128/IAI.69.8.4958-4968.2001
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998
   HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993
   Hauser U, 1997, MED MICROBIOL IMMUN, V186, P145, DOI 10.1007/s004300050057
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Levett PN, 2001, CLIN DIAGN LAB IMMUN, V8, P349, DOI 10.1128/CDLI.8.2.349-351.2001
   Levett PN, 2000, AM J TROP MED HYG, V62, P112, DOI 10.4269/ajtmh.2000.62.112
   Lomar AV, 2000, INFECT DIS CLIN N AM, V14, P23, DOI 10.1016/S0891-5520(05)70216-6
   Magnarelli LA, 2000, J CLIN MICROBIOL, V38, P1735, DOI 10.1128/JCM.38.5.1735-1739.2000
   Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501
   Matsuo K, 2000, CARBOHYD RES, V328, P517, DOI 10.1016/S0008-6215(00)00143-9
   Matsuo K, 2000, J CLIN MICROBIOL, V38, P3750, DOI 10.1128/JCM.38.10.3750-3754.2000
   MCCLAIN JBL, 1984, ANN INTERN MED, V100, P696, DOI 10.7326/0003-4819-100-5-696
   Park SH, 1999, DNA CELL BIOL, V18, P903, DOI 10.1089/104454999314764
   PARK SK, 1989, AM J TROP MED HYG, V41, P345, DOI 10.4269/ajtmh.1989.41.345
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   RIOSGONCALVES AJ, 1990, ARQ BRAS MED, V64, P389
   SAKATA EE, 1992, REV I MED TROP, V34, P217, DOI 10.1590/S0036-46651992000300006
   Sanders EJ, 1999, AM J TROP MED HYG, V61, P399, DOI 10.4269/ajtmh.1999.61.399
   SASAKI DM, 1993, AM J TROP MED HYG, V48, P35, DOI 10.4269/ajtmh.1993.48.35
   Schmidt BL, 2000, J CLIN MICROBIOL, V38, P1279, DOI 10.1128/JCM.38.3.1279-1282.2000
   SEHGAL SC, 1995, INDIAN J MED RES, V102, P9
   Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Smits HL, 1999, J CLIN MICROBIOL, V37, P2904, DOI 10.1128/JCM.37.9.2904-2909.1999
   Smits HL, 2000, J CLIN MICROBIOL, V38, P1272, DOI 10.1128/JCM.38.3.1272-1275.2000
   Smits HL, 2000, TROP MED INT HEALTH, V5, P124, DOI 10.1046/j.1365-3156.2000.00525.x
   TERPSTRA WJ, 1985, J GEN MICROBIOL, V131, P377
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Winslow WE, 1997, J CLIN MICROBIOL, V35, P1938, DOI 10.1128/JCM.35.8.1938-1942.1997
   Yersin C, 1999, TROP MED INT HEALTH, V4, P38, DOI 10.1046/j.1365-3156.1999.00352.x
   Yersin C, 2000, T ROY SOC TROP MED H, V94, P71, DOI 10.1016/S0035-9203(00)90445-0
   ZUERNER RL, 1991, MICROB PATHOGENESIS, V10, P311, DOI 10.1016/0882-4010(91)90014-2
NR 51
TC 131
Z9 145
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD SEP
PY 2001
VL 39
IS 9
BP 3303
EP 3310
DI 10.1128/JCM.39.9.3303-3310.2001
PG 8
WC Microbiology
SC Microbiology
GA 469VV
UT WOS:000170837500045
PM 11526167
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Guerreiro, H
   Croda, J
   Flannery, B
   Mazel, M
   Matsunaga, J
   Reis, MG
   Levett, PN
   Ko, AI
   Haake, DA
AF Guerreiro, H
   Croda, J
   Flannery, B
   Mazel, M
   Matsunaga, J
   Reis, MG
   Levett, PN
   Ko, AI
   Haake, DA
TI Leptospiral proteins recognized during the humoral immune response to
   leptospirosis in humans
SO INFECTION AND IMMUNITY
LA English
DT Article
ID OUTER-MEMBRANE PROTEIN; IMMUNOGLOBULIN-M ANTIBODIES; 2-DIMENSIONAL
   ELECTROPHORESIS; MOLECULAR ANALYSIS; SEQUENCE-ANALYSIS; DIPSTICK ASSAY;
   HUMAN-SERUM; INTERROGANS; SEROVAR; DIAGNOSIS
AB Leptospirosis is an emerging zoonosis caused by pathogenic spirochetes belonging to the genus Leptospira. An understanding of leptospiral protein expression regulation is needed to develop new immunoprotective and serodiagnostic strategies. We used the humoral immune response during human leptospirosis as a reporter of protein antigens expressed during infection. Qualitative and quantitative immunoblot analysis was performed using sera from 105 patients from Brazil and Barbados. Sera from patients with other diseases and healthy individuals were evaluated as controls. Seven proteins, p76, p62, p48, p45, p41, p37, and p32, were identified as targets of the humoral response during natural infection. In both acute and convalescent phases of illness, antibodies to lipopolysaccharide were predominantly immunoglobulin M (IgM) while antibodies to proteins were exclusively IgG. Anti-p32 reactivity had the greatest sensitivity and specificity: positive reactions were observed in 37 and 84% of acute- and convalescent-phase sera, respectively, while only 5% of community control individuals demonstrated positive reactions. Six immunodominant antigens were expressed by all pathogenic leptospiral strains tested; only p37 was inconsistently expressed. Two-dimensional immunoblots identified four of the seven infection-associated antigens as being previously characterized proteins: LipL32 (the major outer membrane lipoprotein), LipL41 (a surface-exposed outer membrane lipoprotein), and heat shock proteins GroEL and DnaK. Fractionation studies demonstrated LipL32 and LipL41 reactivity in the outer membrane fraction and GroEL and DnaK in the cytoplasmic fraction, while p37 appeared to be a soluble periplasmic protein. Most of the other immunodominant proteins, including p48 and p45, were localized to the inner membrane. These findings indicate that leptospiral proteins recognized during natural infection are potentially useful for serodiagnosis and may serve as targets for vaccine design.
C1 Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, BR-40295001 Salvador, BA, Brazil.
   Univ Fed Bahia, Sch Pharm, BR-40000 Salvador, BA, Brazil.
   Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Sch Med, Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA 90095 USA.
   Univ W Indies, Sch Clin Med & Res, Bridgetown, Barbados.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Ko, AI (corresponding author), Fdn Oswaldo Cruz MS, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM aik2001@med.cornell.edu
RI Croda, Julio/I-5172-2013; Ko, Albert Icksang/P-2343-2015; Reis,
   Mitermayer/AAO-9742-2020
OI Croda, Julio/0000-0002-6665-6825; Ko, Albert
   Icksang/0000-0001-9023-2339; Reis, Mitermayer/0000-0002-3051-9060
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43 TW000905, TW-00919, TW-00905, D43 TW000919] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [AI-01605, R21 AI034431-06, R29
   AI034431, R01 AI034431, R21 AI034431, AI-34431] Funding Source: Medline;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000905, D43TW000919, D43TW000919,
   D43TW000919, D43TW000905, D43TW000905, D43TW000919, D43TW000905,
   D43TW000919, D43TW000905, D43TW000905, D43TW000905, D43TW000905,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000905, D43TW000919] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI034431, R01AI034431, R01AI034431, R29AI034431, R01AI034431,
   K08AI001605, R01AI034431, R01AI034431, R29AI034431, R01AI034431,
   R01AI034431, R29AI034431, R01AI034431, K08AI001605, R21AI034431,
   R01AI034431, R29AI034431, R01AI034431, K08AI001605, R01AI034431,
   R01AI034431, R29AI034431] Funding Source: NIH RePORTER
CR ADLER B, 1980, J CLIN MICROBIOL, V11, P452, DOI 10.1128/JCM.11.5.452-457.1980
   [Anonymous], 1999, Wkly Epidemiol Rec, V74, P237
   ARIMITSU Y, 1982, J CLIN MICROBIOL, V15, P835, DOI 10.1128/JCM.15.5.835-841.1982
   Ballard SA, 1998, GENE, V216, P21, DOI 10.1016/S0378-1119(98)00329-1
   BALLARD SA, 1993, MOL MICROBIOL, V8, P739, DOI 10.1111/j.1365-2958.1993.tb01617.x
   Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999
   Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839
   CHAPMAN AJ, 1991, EPIDEMIOL INFECT, V107, P143, DOI 10.1017/S0950268800048779
   CHAPMAN AJ, 1988, J MED MICROBIOL, V25, P269, DOI 10.1099/00222615-25-4-269
   ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   GORG A, 1985, ELECTROPHORESIS, V6, P599, DOI 10.1002/elps.1150061206
   GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913
   GUPTA RS, 1995, MOL MICROBIOL, V15, P1, DOI 10.1111/j.1365-2958.1995.tb02216.x
   Gussenhoven GC, 1997, J CLIN MICROBIOL, V35, P92, DOI 10.1128/JCM.35.1.92-97.1997
   Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000
   Haake DA, 1999, INFECT IMMUN, V67, P6572
   Haake DA, 1998, INFECT IMMUN, V66, P1579, DOI 10.1128/IAI.66.4.1579-1587.1998
   HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993
   HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991
   JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967
   JONES CJ, 1984, J CLIN MICROBIOL, V19, P946, DOI 10.1128/JCM.19.6.946-.1984
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEONG MML, 1990, METHOD ENZYMOL, V184, P442
   Letocart M, 1999, INT J SYST BACTERIOL, V49, P231, DOI 10.1099/00207713-49-1-231
   Levett PN, 2001, CLIN DIAGN LAB IMMUN, V8, P349, DOI 10.1128/CDLI.8.2.349-351.2001
   Levett PN, 1998, J CLIN MICROBIOL, V36, P11, DOI 10.1128/JCM.36.1.11-14.1998
   Levett PN, 2000, AM J TROP MED HYG, V62, P112, DOI 10.4269/ajtmh.2000.62.112
   Lomar AV, 2000, INFECT DIS CLIN N AM, V14, P23, DOI 10.1016/S0891-5520(05)70216-6
   Matsuo K, 2000, J CLIN MICROBIOL, V38, P3750, DOI 10.1128/JCM.38.10.3750-3754.2000
   MAZZONELLI J, 1974, MED MALADIES INFECT, V4, P253, DOI 10.1016/S0399-077X(74)80135-6
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Park SH, 1999, DNA CELL BIOL, V18, P903, DOI 10.1089/104454999314764
   Sambrook J., 1989, MOL CLONING LAB MANU
   Sanders EJ, 1999, AM J TROP MED HYG, V61, P399, DOI 10.4269/ajtmh.1999.61.399
   SHANG ES, 1995, INFECT IMMUN, V63, P3174, DOI 10.1128/IAI.63.8.3174-3181.1995
   Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996
   Smits HL, 1999, J CLIN MICROBIOL, V37, P2904, DOI 10.1128/JCM.37.9.2904-2909.1999
   Sonrier C, 2000, VACCINE, V19, P86, DOI 10.1016/S0264-410X(00)00129-8
   STAMM LV, 1991, INFECT IMMUN, V59, P1572, DOI 10.1128/IAI.59.4.1572-1575.1991
   THIERMAN AB, 1984, P ANN M AM ASS VET L, V27, P233
   Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   Winslow WE, 1997, J CLIN MICROBIOL, V35, P1938, DOI 10.1128/JCM.35.8.1938-1942.1997
   WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0
   Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19
NR 47
TC 137
Z9 169
U1 0
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD AUG
PY 2001
VL 69
IS 8
BP 4958
EP 4968
DI 10.1128/IAI.69.8.4958-4968.2001
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 456UP
UT WOS:000170100900034
PM 11447174
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU Santiago, M
   Martinelli, R
   Ko, A
   Reis, EA
   Fontes, RD
   Nascimento, EG
   Pierangeli, S
   Espinola, R
   Gharavi, A
AF Santiago, M
   Martinelli, R
   Ko, A
   Reis, EA
   Fontes, RD
   Nascimento, EG
   Pierangeli, S
   Espinola, R
   Gharavi, A
TI Anti-beta 2 glycoprotein I and anticardiolipin antibodies in
   leptospirosis, syphilis and Kala-azar
SO CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
LA English
DT Article
DE antiphospholipid antibodies; anticardiolipin antibodies; anti-beta 2
   glycoprotein I; syphilis; leptospirosis; Kala-azar
ID SYSTEMIC LUPUS-ERYTHEMATOSUS; BETA-2-GLYCOPROTEIN-I APOLIPOPROTEIN-H;
   PRIMARY ANTIPHOSPHOLIPID SYNDROME; PARVOVIRUS B19 INFECTION;
   ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES; RECOGNIZE
   BETA(2)-GLYCOPROTEIN-I; CARDIOLIPIN; THROMBOSIS; BINDING; AUTOANTIBODIES
AB Objective Reports have shown that anticardiolipin (aCL) antibodies present in patients with autoimmune diseases are dependent on the cofactor beta2 glycoprotein I (beta2 GPI), as opposed to aCL antibodies seen in infectious diseases such as syphilis, HIV hepatitis C, etc. The assay for anti-beta 2GPI antibodies has been reported to be more specific for antiphospholipid syndrome (APS). However; the prevalence of these antibodies in diseases such as leishmaniasis and leptospirosis remains unknown. The aim of the present study was determine the prevalence of antibodies to cardiolipin and to beta 2GPI in patients with different infectious diseases, including leptospirosis, syphilis and leishmaniasis.
   Methods Samples from patients with Kala-azar (visceral leishmaniasis), syphilis or leptospirosis were tested for IgG and IgM anticardiolipin and IgG anti-beta 2GPI antibodies by ELISA.
   Results In patients with Kala-azar the prevalence of lgG aCL, IgM aCL and anti-beta 2GPI was 6% (2/30), 3% (1/30) and 53% (16/30), respectively. In syphilis the prevalence was 18% (14/74), 13% (10/74) and 10% (8/70), respectively. In leptospirosis the frequency of these antibodies was 23% (9/39), 10% (4/39) and 17% (6/34), respectively. There Was no statistical correlation between aCL and anti-beta 2GPI antibodies in these diseases.
   Discussion This study clearly shows a significant prevalence of anti-beta 2GPI antibodies in leptospirosis and leishmaniasis and syphilis. This indicates that the assay for anti-beta 2GPI antibodies should be thoroughly validated before it is introduced as a definitive tool for the diagnosis of APS, testing a larger number of sera from patients with a wider range of clinical conditions.
C1 Hosp Santa Izabel, Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.
   Fundacao Osvaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   SESAB, DST, COAS, Salvador, BA, Brazil.
   SESAB, PIEJ, Salvador, BA, Brazil.
   Cornell Univ, Weill Med Coll, New York, NY USA.
   Morehouse Sch Med, Atlanta, GA 30310 USA.
RP Santiago, M (corresponding author), Hosp Santa Izabel, Escola Bahiana Med & Saude Publ, BR-40000000 Nazare Salvador, BA, Brazil.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
CR ASHERSON RA, 1988, J RHEUMATOL, V15, P1742
   CABRAL AR, 1995, J RHEUMATOL, V22, P1894
   Chou TNK, 2000, LUPUS, V9, P551, DOI 10.1177/096120330000900714
   Faghiri Z, 1999, LUPUS, V8, P210, DOI 10.1191/096120399678847731
   Forastiero RR, 1996, THROMB HAEMOSTASIS, V75, P717
   GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J
   GHARAVI AE, 1987, ANN RHEUM DIS, V46, P1, DOI 10.1136/ard.46.1.1
   GHARAVI AE, 1992, J CLIN INVEST, V90, P1105, DOI 10.1172/JCI115927
   Guerin J, 1997, CLIN EXP IMMUNOL, V109, P304, DOI 10.1046/j.1365-2249.1997.4601357.x
   Guerin V, 1999, LUPUS, V8, P490, DOI 10.1177/096120339900800618
   HARRIS EN, 1983, LANCET, V2, P1211
   HUNT J, 1994, J IMMUNOL, V152, P653
   JAKOBSEN PH, 1993, IMMUNOLOGY, V79, P653
   LOCKSHIN MD, 1985, NEW ENGL J MED, V313, P152, DOI 10.1056/NEJM198507183130304
   Loizou S, 1997, ARTHRITIS RHEUM-US, V40, P103, DOI 10.1002/art.1780400115
   MACKWORTHYOUNG CG, 1988, ARTHRITIS RHEUM, V31, P1052, DOI 10.1002/art.1780310818
   MARTINUZZO ME, 1995, BRIT J HAEMATOL, V89, P397, DOI 10.1111/j.1365-2141.1995.tb03317.x
   MATSUURA E, 1994, J EXP MED, V179, P457, DOI 10.1084/jem.179.2.457
   MATSUURA E, 1990, LANCET, V336, P177, DOI 10.1016/0140-6736(90)91697-9
   MCNALLY T, 1995, BRIT J HAEMATOL, V91, P471, DOI 10.1111/j.1365-2141.1995.tb05324.x
   MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120
   NIMPF J, 1987, ATHEROSCLEROSIS, V63, P109, DOI 10.1016/0021-9150(87)90110-9
   ROUBEY RAS, 1995, J IMMUNOL, V154, P954
   RUGMAN FP, 1991, J CLIN PATHOL, V44, P517, DOI 10.1136/jcp.44.6.517
   Sanmarco M, 1997, J LAB CLIN MED, V129, P499, DOI 10.1016/S0022-2143(97)90004-4
   SANTIAGO MB, 1989, CLIN RHEUMATOL, V8, P23, DOI 10.1007/BF02031064
   SANTIAGO MB, 1990, BRAZ J MED BIOL RES, V23, P397
   SCHOUSBOE I, 1985, BLOOD, V66, P1086
   SNOWDEN N, 1990, POSTGRAD MED J, V66, P356, DOI 10.1136/pgmj.66.775.356
   Tsutsumi A, 1996, ARTHRITIS RHEUM-US, V39, P1466, DOI 10.1002/art.1780390905
   VAARALA O, 1986, CLIN IMMUNOL IMMUNOP, V41, P8, DOI 10.1016/0090-1229(86)90046-2
   WEISS L, 1995, CLIN IMMUNOL IMMUNOP, V77, P69, DOI 10.1016/0090-1229(95)90138-8
   Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
   WURM H, 1984, INT J BIOCHEM, V16, P511, DOI 10.1016/0020-711X(84)90168-X
NR 34
TC 47
Z9 51
U1 0
U2 3
PU CLINICAL & EXPER RHEUMATOLOGY
PI PISA
PA VIA SANTA MARIA 31, 56126 PISA, ITALY
SN 0392-856X
J9 CLIN EXP RHEUMATOL
JI Clin. Exp. Rheumatol.
PD JUL-AUG
PY 2001
VL 19
IS 4
BP 425
EP 430
PG 6
WC Rheumatology
SC Rheumatology
GA 454XT
UT WOS:000169997600010
PM 11491498
DA 2020-11-30
ER

PT J
AU Barocchi, MA
   Ko, AI
   Ferrer, SR
   Faria, MT
   Reis, MG
   Riley, LW
AF Barocchi, MA
   Ko, AI
   Ferrer, SR
   Faria, MT
   Reis, MG
   Riley, LW
TI Identification of new repetitive element in Leptospira interrogans
   serovar copenhageni and its application to PCR-based differentiation of
   Leptospira serogroups
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID RESTRICTION-ENDONUCLEASE ANALYSIS; ARBITRARILY PRIMED PCR;
   FRAGMENT-LENGTH-POLYMORPHISMS; RAPID IDENTIFICATION;
   GEL-ELECTROPHORESIS; DNA; SEQUENCE; HARDJO; BORGPETERSENII;
   HARDJOPRAJITNO
AB A new repetitive DNA element was identified in an isolate of Leptospira interrogans serovar copenhageni from a patient in Salvador, Brazil. A Sau3A genomic library from this strain was constructed and screened for repetitive DNA elements. An insert of 438 bp (Rep1) from one library clone hybridized to multiple chromosomal DNA fragments resolved electrophoretically after digestion with BamHI, HindIII, and MfeI. A single oligonucleotide primer, designated iRe1, was designed to generate multiple PCR amplicons of various electrophoretic mobilities in a PCR typing method. The method distinguished strains belonging to the eight pathogenic and three saprophytic species of the genus Leptospira. Clinical isolates obtained during urban epidemics between 1996 and 1998 in Salvador, Brazil, were analyzed by this PCR method. Although the iRep1 primer was unable to discriminate strains among L. interrogans serovar copenhageni isolates, it was able to differentiate strains belonging to different species and serogroups of Leptospira identified in Salvador. This PCR-based method may provide a faster and less expensive alternative to serologic tests used in reference laboratories.
C1 Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Immun, Berkeley, CA 94720 USA.
   Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, BR-40295001 Salvador, BA, Brazil.
   Cornell Univ, Weil Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Riley, LW (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Immun, 140 Warren Hall, Berkeley, CA 94720 USA.
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000905, D43TW000919, D43TW000919,
   D43TW000905, D43TW000919, D43TW000905, D43TW000905, D43TW000905,
   D43TW000905, D43TW000919, D43TW000919, D43TW000919, D43TW000905,
   D43TW000905, D43TW000905, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [TW00905, TW00919, D43 TW000905, D43
   TW000919] Funding Source: Medline; NIAID NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [AI30639,
   P50 AI030639] Funding Source: Medline
CR BARANTON G, 1995, B I PASTEUR, V93, P63, DOI 10.1016/0020-2452(96)81485-0
   Boursaux-Eude C, 1998, ELECTROPHORESIS, V19, P589, DOI 10.1002/elps.1150190421
   Brown PD, 1997, J MED MICROBIOL, V46, P173, DOI 10.1099/00222615-46-2-173
   Corney BG, 1997, J MED MICROBIOL, V46, P927, DOI 10.1099/00222615-46-11-927
   de la Pena-Moctezuma A, 1999, FEMS MICROBIOL LETT, V177, P319, DOI 10.1111/j.1574-6968.1999.tb13749.x
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FERESU SB, 1994, INT J SYST BACTERIOL, V44, P541, DOI 10.1099/00207713-44-3-541
   GERRITSEN MA, 1995, J MED MICROBIOL, V42, P336, DOI 10.1099/00222615-42-5-336
   GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691
   HAAKE DA, 2000, J CLIN MICROBIOL, V68, P2276
   HERRMANN JL, 1992, J CLIN MICROBIOL, V30, P1696, DOI 10.1128/JCM.30.7.1696-1702.1992
   HERRMANN JL, 1991, J BACTERIOL, V173, P7582, DOI 10.1128/jb.173.23.7582-7588.1991
   HERRMANN JL, 1993, PATHOL BIOL, V41, P943
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   LAWRENCE JG, 1989, MOL BIOL EVOL, V6, P1
   Letocart M, 1997, J CLIN MICROBIOL, V35, P248, DOI 10.1128/JCM.35.1.248-253.1997
   MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219
   PACCIARINI ML, 1992, J CLIN MICROBIOL, V30, P1243, DOI 10.1128/JCM.30.5.1243-1249.1992
   PEROLAT P, 1994, J CLIN MICROBIOL, V32, P1949, DOI 10.1128/JCM.32.8.1949-1957.1994
   RALPH D, 1994, J BACTERIOL, V176, P5982, DOI 10.1128/jb.176.19.5982-5987.1994
   RAMADASS P, 1992, INT J SYST BACTERIOL, V42, P215, DOI 10.1099/00207713-42-2-215
   Rantakokko-Jalava K, 2000, J CLIN MICROBIOL, V38, P32
   Romero EC, 1998, J CLIN MICROBIOL, V36, P1453, DOI 10.1128/JCM.36.5.1453-1455.1998
   SAVIO ML, 1994, J CLIN MICROBIOL, V32, P935, DOI 10.1128/JCM.32.4.935-941.1994
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Takahashi Y, 1999, MICROBIOL IMMUNOL, V43, P669, DOI 10.1111/j.1348-0421.1999.tb02455.x
   THIERMANN AB, 1985, J CLIN MICROBIOL, V21, P585, DOI 10.1128/JCM.21.4.585-587.1985
   van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998
   VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823
   Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002
   Woo THS, 1997, FEMS MICROBIOL LETT, V155, P169, DOI 10.1016/S0378-1097(97)00383-2
   YASUDA PH, 1987, INT J SYST BACTERIOL, V37, P407, DOI 10.1099/00207713-37-4-407
   ZUERNER RL, 1995, J CLIN MICROBIOL, V33, P3284, DOI 10.1128/JCM.33.12.3284-3289.1995
   ZUERNER RL, 1990, VET MICROBIOL, V24, P355, DOI 10.1016/0378-1135(90)90183-V
   ZUERNER RL, 1993, J CLIN MICROBIOL, V31, P578, DOI 10.1128/JCM.31.3.578-583.1993
   Zuerner RL, 1997, J CLIN MICROBIOL, V35, P2612, DOI 10.1128/JCM.35.10.2612-2617.1997
   ZUERNER RL, 1993, J CELL BIOCH E, V17, P309
NR 37
TC 33
Z9 35
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JAN
PY 2001
VL 39
IS 1
BP 191
EP 195
DI 10.1128/JCM.39.1.191-195.2001
PG 5
WC Microbiology
SC Microbiology
GA 393KZ
UT WOS:000166468900031
PM 11136769
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU Ko, AI
   Reis, JN
   Coppola, SJ
   Gouveia, EL
   Cordeiro, SM
   Lobo, TS
   Pinheiro, RM
   Salgado, K
   Dourado, CMR
   Tavares-Neto, J
   Rocha, H
   Reis, MG
   Johnson, WD
   Riley, LW
AF Ko, AI
   Reis, JN
   Coppola, SJ
   Gouveia, EL
   Cordeiro, SM
   Lobo, TS
   Pinheiro, RM
   Salgado, K
   Dourado, CMR
   Tavares-Neto, J
   Rocha, H
   Reis, MG
   Johnson, WD
   Riley, LW
TI Clonally related penicillin-nonsusceptible Streptococcus pneumoniae
   serotype 14 from cases of meningitis in Salvador, Brazil
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID RESISTANT PNEUMOCOCCAL MENINGITIS; POLYMERASE CHAIN-REACTION;
   ANTIMICROBIAL RESISTANCE; RISK-FACTORS; GEOGRAPHIC-DISTRIBUTION;
   MULTIRESISTANT CLONE; INVASIVE INFECTIONS; STRAINS; THERAPY; PREVALENCE
AB Active hospital-based surveillance in the city of Salvador, Brazil, from December 1995 through October 1998, identified 221 patients with confirmed pneumococcal meningitis. Of these 221 patients, 29 (13%) had isolates with intermediate-level resistance to penicillin. Infection with these penicillin-nonsusceptible isolates was significantly associated with age of <2 years (P < .0019), previous antibiotic use (P < .0006), and coresistance to trimethoprim-sulfamethoxazole (P < .0000). Serotype 14 was the most prevalent serotype (55.2%) of penicillin-nonsusceptible isolates. Strain typing by repetitive element BOX polymerase chain reaction (PCR) analysis showed that penicillin-nonsusceptible serotype 14 isolates had closely related BOX PCR patterns, whereas penicillin-susceptible serotype 14 isolates each had distinct, unrelated patterns. Penicillin-nonsusceptible serotype 14 isolates from Salvador and other Brazilian cities had similar BOX PCR patterns. These observations indicate that in Brazil a large proportion of cases of penicillin-nonsusceptible pneumococcal meningitis appear to be caused by a closely related group of serotype 14 strains that may have disseminated to widely separate geographic areas.
C1 Minist Saude, Fdn Oswaldo, Ctr Pesquisas Goncalo Moniz, BR-40295001 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Farm, BR-41170290 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Med, BR-41170290 Salvador, BA, Brazil.
   Secretaria Saude Estado Bahia, Hosp Couto Maia, Salvador, BA, Brazil.
   Cornell Univ, Coll Med, Div Int Med & Infect Dis, Dept Med, New York, NY USA.
   Univ Calif Berkeley, Sch Publ Hlth, Div Publ Hlth Biol & Epidemiol, Berkeley, CA 94720 USA.
RP Ko, AI (corresponding author), Minist Saude, Fdn Oswaldo, Ctr Pesquisas Goncalo Moniz, Rua Waldemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
RI Reis, Mitermayer/AAO-9742-2020; Ko, Albert Icksang/P-2343-2015; Reis,
   Joice N/H-9227-2013
OI Reis, Mitermayer/0000-0002-3051-9060; Ko, Albert
   Icksang/0000-0001-9023-2339; 
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000018, D43TW000919, D43TW000018,
   D43TW000919, D43TW000018, D43TW000919, D43TW000018, D43TW000018,
   D43TW000919, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018, D43TW000919, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000919, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000919, D43TW000018, D43TW000018, D43TW000919,
   D43TW000018, D43TW000919, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000919,
   D43TW000018, D43TW000018, D43TW000018, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000919, D43TW000018, D43TW000018,
   D43TW000018, D43TW000018, D43TW000018] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43 TW00018, D43 TW00919] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50 AI30639] Funding Source:
   Medline
CR APPELBAUM PC, 1992, CLIN INFECT DIS, V15, P77, DOI 10.1093/clinids/15.1.77
   Arason VA, 1996, BMJ-BRIT MED J, V313, P387
   Bedos JP, 1996, CLIN INFECT DIS, V22, P63, DOI 10.1093/clinids/22.1.63
   Berezin EN, 1996, PEDIATR INFECT DIS J, V15, P1051, DOI 10.1097/00006454-199611000-00027
   Brandileone MCD, 1997, MICROB DRUG RESIST, V3, P141
   Brandileone MCD, 1998, MICROB DRUG RESIST, V4, P209
   BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401
   Coffey TJ, 1996, MICROBIOL-UK, V142, P2747, DOI 10.1099/13500872-142-10-2747
   DEMORAES JC, 1990, REV SAUDE PUBL, V24, P348, DOI 10.1590/S0034-89101990000500002
   Ertugrul N, 1997, J INFECT DIS, V176, P1401, DOI 10.1086/517331
   Figueiredo AMS, 1995, MICROB DRUG RESIST, V1, P71
   FRIEDLAND IR, 1992, LANCET, V339, P405, DOI 10.1016/0140-6736(92)90087-J
   FRIEDLAND IR, 1994, NEW ENGL J MED, V331, P377, DOI 10.1056/NEJM199408113310607
   Guillemot D, 1998, JAMA-J AM MED ASSOC, V279, P365, DOI 10.1001/jama.279.5.365
   HAKENBECK R, 1991, J INFECT DIS, V164, P313, DOI 10.1093/infdis/164.2.313
   HEFRON R, 1979, PNEUMONIA SPECIAL RE
   HERMANS PWM, 1995, J CLIN MICROBIOL, V33, P1606, DOI 10.1128/JCM.33.6.1606-1612.1995
   *I BRAS GEOGR EST, 1991, AN EST BRAS, V56
   JABES D, 1989, J INFECT DIS, V159, P16, DOI 10.1093/infdis/159.1.16
   JACKSON MA, 1984, PEDIATR INFECT DIS J, V3, P129, DOI 10.1097/00006454-198403000-00010
   JORGENSEN JH, 1994, J CLIN MICROBIOL, V32, P159, DOI 10.1128/JCM.32.1.159-163.1994
   Kertesz DA, 1998, CLIN INFECT DIS, V26, P1355, DOI 10.1086/516350
   Klugman KP, 1997, LANCET, V350, P1176, DOI 10.1016/S0140-6736(05)63822-6
   Lalitha MK, 1999, APMIS, V107, P389, DOI 10.1111/j.1699-0463.1999.tb01570.x
   Low DE, 1998, JAMA-J AM MED ASSOC, V279, P394, DOI 10.1001/jama.279.5.394
   MARQUES HHD, 1988, PEDIATR INFECT DIS J, V7, P433, DOI 10.1097/00006454-198806000-00017
   MCCRACKEN GH, 1983, J ANTIMICROB CHEMOTH, V12, P97, DOI 10.1093/jac/12.suppl_D.97
   Melander E, 1998, EUR J CLIN MICROBIOL, V17, P834, DOI 10.1007/s100960050202
   MUNOZ R, 1992, CLIN INFECT DIS, V15, P112, DOI 10.1093/clinids/15.1.112
   MUNOZ R, 1991, J INFECT DIS, V164, P302, DOI 10.1093/infdis/164.2.302
   *NAT COMM CLIN LAB, 1994, M100S5 NCCLS
   *NAT COMM CLIN LAB, 1997, PERF STAND ANT SUS S
   Obaro SK, 1996, BMJ-BRIT MED J, V312, P1521, DOI 10.1136/bmj.312.7045.1521
   PALLARES R, 1987, NEW ENGL J MED, V317, P18, DOI 10.1056/NEJM198707023170104
   Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361
   RodriguezBarradas MC, 1997, J INFECT DIS, V175, P590, DOI 10.1093/infdis/175.3.590
   *SECR SAUD EST BAH, 1998, REL GEST
   Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701
   SKULNICK M, 1995, J CLIN MICROBIOL, V33, P2334, DOI 10.1128/JCM.33.9.2334-2337.1995
   SOARES S, 1993, J INFECT DIS, V168, P158, DOI 10.1093/infdis/168.1.158
   Tarasi A, 1995, MICROB DRUG RESIST, V1, P169, DOI 10.1089/mdr.1995.1.169
   Teixeira LM, 1997, ADV EXP MED BIOL, V418, P269
   Tomasz A, 1997, CLIN INFECT DIS, V24, pS85, DOI 10.1093/clinids/24.Supplement_1.S85
   vanBelkum A, 1996, J CLIN MICROBIOL, V34, P1176, DOI 10.1128/JCM.34.5.1176-1179.1996
   WRIGHT PF, 1989, B WORLD HEALTH ORGAN, V67, P479
NR 45
TC 19
Z9 23
U1 0
U2 0
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA
SN 1058-4838
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JAN
PY 2000
VL 30
IS 1
BP 78
EP 86
DI 10.1086/313619
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 278TJ
UT WOS:000085004800016
PM 10619737
OA Bronze, Green Published
DA 2020-11-30
ER

PT J
AU Almeida, R
   D'Oliveira, A
   Machado, P
   Bacellar, O
   Ko, AI
   de Jesus, AR
   Mobashery, N
   Santos, JB
   Carvalho, EM
AF Almeida, R
   D'Oliveira, A
   Machado, P
   Bacellar, O
   Ko, AI
   de Jesus, AR
   Mobashery, N
   Santos, JB
   Carvalho, EM
TI Randomized, double-blind study of stibogluconate plus human granulocyte
   macrophage colony-stimulating factor versus stibogluconate alone in the
   treatment of cutaneous leishmaniasis
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article; Proceedings Paper
CT 25th Annual Meeting in Chagas Disease
CY NOV   14, 1998
CL CAXAMBU, BRAZIL
ID CSF; PENTAMIDINE; INFECTION; DONOVANI; THERAPY
AB The response to recombinant human granulocyte macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis was evaluated. Twenty patients with cutaneous leishmaniasis who had lesions for 60 days were enrolled in a double-blind placebo trial of GM-CSF with standard parenteral sodium stibogluconate (20 mg/kg(-1)/day(-1)) for 20 days. Ten patients were randomized to receive intralesionally injected GM-CSF (200 mu g) at enrollment and 1 week after, and 10 patients received saline as placebo. GM-CSF- and antimony-treated patients healed faster than patients who received antimony alone (49 +/- 32.8 vs. 110 +/- 61.6 days, P<.05). Seven of 10 patients were healed of their lesions before 40 days after therapy in the GM-CSF group, compared with only 1 of 10 patients in the placebo group (relative risk, 7; 95% confidence interval, 1.04-47.00), Thus, GM-CSF plus antimony significantly increased the chance of lesion healing in 40 days.
C1 Hosp Univ Prof Edgard Santos, Serv Immunol, BR-40110160 Salvador, BA, Brazil.
   Cornell Univ, Coll Med, New York Hosp, Div Int Hlth & Infect Dis,Dept Med, New York, NY 10021 USA.
RP Carvalho, EM (corresponding author), Hosp Univ Prof Edgard Santos, Serv Immunol, 3 Andar Rua Joao Botas,S N Canela, BR-40110160 Salvador, BA, Brazil.
RI Ko, Albert Icksang/P-2343-2015; MACHADO, PAULO ROBERTO
   LIMA/AAP-2642-2020
OI Ko, Albert Icksang/0000-0001-9023-2339; MACHADO, PAULO ROBERTO
   LIMA/0000-0003-1894-6171
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [AI-30639] Funding
   Source: Medline
CR AlZamel F, 1996, ZBL BAKT-INT J MED M, V285, P92, DOI 10.1016/S0934-8840(96)80027-2
   BARRAL A, 1995, AM J TROP MED HYG, V53, P256, DOI 10.4269/ajtmh.1995.53.256
   Berman JD, 1997, CLIN INFECT DIS, V24, P684, DOI 10.1093/clind/24.4.684
   BOENTE P, 1993, LANCET, V341, P1154, DOI 10.1016/0140-6736(93)93174-Y
   BRYCESON ADM, 1985, T ROY SOC TROP MED H, V79, P705, DOI 10.1016/0035-9203(85)90199-3
   DOHERTY TM, 1993, J IMMUNOL, V150, P5476
   HO JL, 1990, J INFECT DIS, V162, P224, DOI 10.1093/infdis/162.1.224
   JONES TC, 1993, EUR J CANCER, V29A, pS10, DOI 10.1016/0959-8049(93)90625-P
   Jones TC, 1996, MED ONCOL, V13, P141, DOI 10.1007/BF02990842
   LIESCHKE GJ, 1992, NEW ENGL J MED, V327, P99
   Modabber F., 1987, Tropical disease research: a global partnership. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases 8th Programme Report: the first ten years, with highlights of the 1985-86 biennium.., P99
   PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538
   SAMPAIO S A P, 1971, International Journal of Dermatology, V10, P179, DOI 10.1111/j.1365-4362.1971.tb01694.x
   SOTOMANCIPE J, 1993, CLIN INFECT DIS, V16, P417, DOI 10.1093/clind/16.3.417
   WEISER WY, 1987, J EXP MED, V166, P1436, DOI 10.1084/jem.166.5.1436
NR 15
TC 33
Z9 33
U1 0
U2 0
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV
PY 1999
VL 180
IS 5
BP 1735
EP 1737
DI 10.1086/315082
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 252TZ
UT WOS:000083519500047
PM 10515844
OA Bronze
DA 2020-11-30
ER

PT J
AU BENATAR, SR
   MARK, EJ
   MCLOUD, TC
   KESSELMAN, H
   KO, A
AF BENATAR, SR
   MARK, EJ
   MCLOUD, TC
   KESSELMAN, H
   KO, A
TI A 44-YEAR-OLD WOMAN WITH PULMONARY-INFILTRATES, RESPIRATORY-FAILURE, AND
   PANCYTOPENIA - PULMONARY TUBERCULOSIS, NONREACTIVE AND MILIARY, WITH
   DIFFUSE ALVEOLAR DAMAGE (ADULT RESPIRATOR DISTRESS SYNDROME), WITH
   MILIARY TUBERCULOSIS IN THE LIVER, SPLEEN, ADRENAL-GLANDS, BONE-MARROW,
   AND KIDNEYS - KAPOSIS-SARCOMA OF THE JEJUNUM
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Discussion
ID HEMATOLOGIC ABNORMALITIES
C1 UNIV CAPE TOWN,GROOTE SCHUUR HOSP,CAPE TOWN,SOUTH AFRICA.
RP BENATAR, SR (corresponding author), UNIV CAPE TOWN,SCH MED,DEPT MED,CAPE TOWN 7925,SOUTH AFRICA.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
CR AHUJA SS, 1992, CRIT CARE MED, V20, P901, DOI 10.1097/00003246-199206000-00031
   BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457
   BRAIDY J, 1981, CAN MED ASSOC J, V124, P748
   CHAPMAN CB, 1946, NEW ENGL J MED, V235, P239, DOI 10.1056/NEJM194608222350801
   CLOSE PM, 1993, AM J CLIN PATHOL, V99, P631, DOI 10.1093/ajcp/99.5.631
   DYER RA, 1985, CRIT CARE MED, V13, P12, DOI 10.1097/00003246-198501000-00004
   EBRAHIM O, IN PRESS EUR J HAEMA
   GLASSER RM, 1970, ARCH INTERN MED, V125, P691, DOI 10.1001/archinte.125.4.691
   HEAP MJ, 1989, RESP MED, V83, P153, DOI 10.1016/S0954-6111(89)80234-3
   HUNT BJ, 1987, POSTGRAD MED J, V63, P801, DOI 10.1136/pgmj.63.743.801
   HUSEBY JS, 1976, ANN INTERN MED, V85, P609, DOI 10.7326/0003-4819-85-5-609
   KATARIA YP, 1981, SOUTHERN MED J, V74, P534, DOI 10.1097/00007611-198105000-00007
   KATZEN H, 1980, JAMA-J AM MED ASSOC, V244, P2438, DOI 10.1001/jama.244.21.2438
   KEIPER MD, 1995, CHEST, V107, P74, DOI 10.1378/chest.107.1.74
   KHAN FA, 1980, CHEST, V77, P76, DOI 10.1378/chest.77.1.76
   LINTIN SN, 1988, INTENS CARE MED, V14, P672
   MAARTENS G, 1990, AM J MED, V89, P291, DOI 10.1016/0002-9343(90)90340-J
   MEDD WE, 1955, Q J MED, V24, P351
   MORENO C, 1989, CLIN EXP IMMUNOL, V76, P240
   MURRAY HW, 1978, CHEST, V73, P37, DOI 10.1378/chest.73.1.37
   PIQUERAS AR, 1987, INTENS CARE MED, V13, P175
   PROUDFOOT AT, 1969, BMJ-BRIT MED J, V2, P273, DOI 10.1136/bmj.2.5652.273
   PROUDFOOT AT, 1971, BR J HOSP MED, V5, P773
   RICHTER C, 1994, CHEST, V106, P1471, DOI 10.1378/chest.106.5.1471
   SINGH R, 1989, THORAX, V44, P952, DOI 10.1136/thx.44.11.952
   SO SY, 1981, TUBERCLE, V62, P49, DOI 10.1016/0041-3879(81)90036-2
   SYDOW M, 1992, RESP MED, V86, P517, DOI 10.1016/S0954-6111(96)80014-X
NR 27
TC 5
Z9 5
U1 0
U2 0
PU MASS MEDICAL SOC
PI BOSTON
PA 10 SHATTUCK, BOSTON, MA 02115
SN 0028-4793
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD JUL 27
PY 1995
VL 333
IS 4
BP 241
EP 248
DI 10.1056/NEJM199507273330408
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA RK423
UT WOS:A1995RK42300008
DA 2020-11-30
ER

PT J
AU KO, AI
   DRAGER, UC
   HARN, DA
AF KO, AI
   DRAGER, UC
   HARN, DA
TI A SCHISTOSOMA-MANSONI EPITOPE RECOGNIZED BY A PROTECTIVE
   MONOCLONAL-ANTIBODY IS IDENTICAL TO THE STAGE-SPECIFIC EMBRYONIC
   ANTIGEN-1
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
C1 HARVARD UNIV,SCH MED,DEPT NEUROBIOL,BOSTON,MA 02115.
RP KO, AI (corresponding author), HARVARD UNIV,SCH PUBL HLTH,DEPT TROP PUBL HLTH,BOSTON,MA 02115, USA.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Drager, Ursula
   C/0000-0003-1815-190X
CR BALL ED, 1983, BLOOD, V62, P1203
   BICKLE QD, 1986, PARASITE IMMUNOL, V8, P95, DOI 10.1111/j.1365-3024.1986.tb00836.x
   BUTTERWORTH AE, 1985, T ROY SOC TROP MED H, V79, P393, DOI 10.1016/0035-9203(85)90391-8
   BUTTERWORTH AE, 1987, PARASITOLOGY, V94, P281, DOI 10.1017/S0031182000053956
   CAPRON A, 1987, SCIENCE, V238, P1065, DOI 10.1126/science.3317823
   DAMIAN RT, 1987, PARASITOL TODAY, V3, P263, DOI 10.1016/0169-4758(87)90102-5
   DEAN DA, 1983, EXP PARASITOL, V55, P1, DOI 10.1016/0014-4894(83)90002-4
   DISSOUS C, 1986, NATURE, V323, P443, DOI 10.1038/323443a0
   DRAGER UC, 1984, J NEUROSCI, V4, P2025
   FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5
   FOX N, 1983, CANCER RES, V43, P669
   GOOI HC, 1981, NATURE, V292, P156, DOI 10.1038/292156a0
   GREGOIRE RJ, 1987, J IMMUNOL, V139, P3792
   GRZYCH JM, 1984, J IMMUNOL, V133, P998
   HARN D, 1987, P55
   HARN DA, 1984, J EXP MED, V159, P1371, DOI 10.1084/jem.159.5.1371
   HARN DA, 1987, J IMMUNOL, V138, P1571
   JAMRA M, 1964, Rev Inst Med Trop Sao Paulo, V6, P126
   KANNAGI R, 1982, J BIOL CHEM, V257, P14365
   KHALIFE J, 1986, J EXP MED, V164, P1626, DOI 10.1084/jem.164.5.1626
   Ko A I, 1987, Mem Inst Oswaldo Cruz, V82 Suppl 4, P115, DOI 10.1590/S0074-02761987000800019
   LOVERDE P, 1989, J PARASITOL, V75, P252
   OMERALI P, 1988, J IMMUNOL, V140, P258
   OMERALI P, 1986, J IMMUNOL, V137, P3601
   OWEN WF, 1987, J EXP MED, V166, P129, DOI 10.1084/jem.166.1.129
   PESSOA S. B., 1952, Folia Clinica et Biologica, V18, P199
   SILBERSTEIN DS, 1986, J IMMUNOL, V137, P3290
   SMITH MA, 1982, PARASITOLOGY, V84, P83, DOI 10.1017/S0031182000051684
   Smithers S.R., 1976, Advances Parasit, V14, P399, DOI 10.1016/S0065-308X(08)60518-7
   SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565
   UMEDA M, 1986, J IMMUNOL, V137, P3264
   YAMAMOTO M, 1985, P NATL ACAD SCI USA, V82, P3045, DOI 10.1073/pnas.82.9.3045
   YANG HJ, 1971, J BIOL CHEM, V246, P1192
NR 33
TC 110
Z9 111
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN
PY 1990
VL 87
IS 11
BP 4159
EP 4163
DI 10.1073/pnas.87.11.4159
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG092
UT WOS:A1990DG09200029
PM 1971946
OA Green Published, Bronze
DA 2020-11-30
ER

PT J
AU KO, AI
   DAVID, JR
   HARN, DA
AF KO, AI
   DAVID, JR
   HARN, DA
TI A PROTECTIVE MONOCLONAL-ANTIBODY AGAINST SCHISTOSOMA-MANSONI RECOGNIZES
   A CARBOHYDRATE EPITOPE
SO FEDERATION PROCEEDINGS
LA English
DT Meeting Abstract
C1 HARVARD UNIV,SCH MED,BOSTON,MA 02115.
   HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0014-9446
J9 FASEB J
PD MAR 1
PY 1987
VL 46
IS 3
BP 761
EP 761
PG 1
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA G3234
UT WOS:A1987G323402603
DA 2020-11-30
ER

PT J
AU HARN, DA
   QUINN, JJ
   CIANCI, CM
   KO, AI
AF HARN, DA
   QUINN, JJ
   CIANCI, CM
   KO, AI
TI EVIDENCE THAT A PROTECTIVE MEMBRANE EPITOPE IS INVOLVED IN EARLY BUT NOT
   LATE PHASE IMMUNITY IN SCHISTOSOMA-MASONI
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
C1 BRIGHAM & WOMENS HOSP, DEPT RHEUMATOL & IMMUNOL, DIV TROP MED, BOSTON, MA 02115 USA.
   HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA.
   HARVARD UNIV, SCH MED, PROGRAM IMMUNOL, BOSTON, MA 02115 USA.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI22794, AI16479] Funding Source: Medline;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P01AI022794, P01AI022794, P01AI022794, P01AI022794, P01AI022794,
   P01AI022794, P01AI022794, P01AI022794, P01AI022794, P01AI022794,
   P01AI022794, P01AI022794, P01AI022794, P01AI022794, P01AI022794,
   P01AI022794, P01AI022794, P01AI022794, P01AI022794, P01AI022794,
   P01AI022794, P01AI022794, P01AI022794, P01AI022794, P01AI022794,
   P01AI022794, P01AI022794, P01AI022794, P01AI022794, P01AI022794,
   P01AI022794, P01AI022794, P01AI022794, P01AI022794, P01AI022794,
   P01AI022794, P01AI022794, P01AI022794, P01AI022794, P01AI022794,
   P01AI022794, P01AI022794, P01AI022794, P01AI022794, P01AI022794] Funding
   Source: NIH RePORTER
CR AMANTE L, 1972, Journal of Immunological Methods, V1, P289, DOI 10.1016/0022-1759(72)90006-3
   ARONSTEIN WS, 1983, J PARASITOL, V69, P1027, DOI 10.2307/3280857
   BICKLE QD, 1985, PARASITOLOGY, V90, P301, DOI 10.1017/S0031182000051003
   BICKLE QD, 1982, J IMMUNOL, V128, P2101
   BICKLE QD, 1983, PARASITE IMMUNOL, V5, P499, DOI 10.1111/j.1365-3024.1983.tb00764.x
   BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   COKER CM, 1956, P SOC EXP BIOL MED, V92, P780, DOI 10.3181/00379727-92-22612
   DAMIAN RT, 1984, P NATL ACAD SCI-BIOL, V81, P3552, DOI 10.1073/pnas.81.11.3552
   DEAN DA, 1984, AM J TROP MED HYG, V33, P89, DOI 10.4269/ajtmh.1984.33.89
   DEAN DA, 1977, J PARASITOL, V63, P418, DOI 10.2307/3279991
   DISSOUS C, 1982, J IMMUNOL, V129, P2232
   EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6
   FORD MJ, 1984, PARASITOLOGY, V89, P461, DOI 10.1017/S0031182000056705
   GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291
   GRZYCH JM, 1982, J IMMUNOL, V129, P2739
   HANG LM, 1974, EXP PARASITOL, V35, P288, DOI 10.1016/0014-4894(74)90035-6
   HARN DA, 1984, J EXP MED, V159, P1371, DOI 10.1084/jem.159.5.1371
   HARN DA, 1985, J IMMUNOL, V135, P2115
   IMOHIOSEN EAE, 1978, PARASITOLOGY, V76, P317, DOI 10.1017/S0031182000048198
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAZDINS JK, 1982, EXP PARASITOL, V53, P39, DOI 10.1016/0014-4894(82)90090-X
   MANGOLD BL, 1981, PARASITOLOGY, V83, P559, DOI 10.1017/S0031182000080537
   MASTIN AJ, 1983, PARASITOLOGY, V87, P87, DOI 10.1017/S0031182000052446
   MCLAREN DJ, 1985, EXP PARASITOL, V60, P1, DOI 10.1016/S0014-4894(85)80017-5
   MILLER KL, 1981, PARASITE IMMUNOL, V3, P25, DOI 10.1111/j.1365-3024.1981.tb00382.x
   NAKANE PK, 1974, J HISTOCHEM CYTOCHEM, V22, P1084, DOI 10.1177/22.12.1084
   PEARCE EJ, 1986, PARASITE IMMUNOL, V8, P79, DOI 10.1111/j.1365-3024.1986.tb00835.x
   RAMALHOPINTO FJ, 1974, EXP PARASITOL, V36, P360, DOI 10.1016/0014-4894(74)90076-9
   SAMUELSON JC, 1985, J CELL BIOL, V100, P1423, DOI 10.1083/jcb.100.5.1423
   SAMUELSON JC, 1980, EXP PARASITOL, V50, P369, DOI 10.1016/0014-4894(80)90040-5
   SHER A, 1975, PARASITOLOGY, V70, P347, DOI 10.1017/S0031182000052124
   SHER A, 1974, J INFECT DIS, V130, P626, DOI 10.1093/infdis/130.6.626
   SMITH MA, 1982, PARASITOLOGY, V84, P83, DOI 10.1017/S0031182000051684
   SMITHERS SR, 1980, PARASITOLOGY, V80, P289, DOI 10.1017/S0031182000000755
   STIREWALT MA, 1951, AM J TROP MED, V31, P57
   TARRABHAZDAI R, 1985, J IMMUNOL, V135, P2772
   VONLICHTENBERG F, 1967, LAB INVEST, V16, P892
   WARREN KS, 1970, EXP PARASITOL, V27, P60, DOI 10.1016/S0014-4894(70)80010-8
   WARREN KS, 1967, AM J TROP MED HYG, V16, P718, DOI 10.4269/ajtmh.1967.16.718
   ZODDA DM, 1982, J IMMUNOL, V129, P2326
NR 42
TC 38
Z9 38
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAR 1
PY 1987
VL 138
IS 5
BP 1571
EP 1580
PG 10
WC Immunology
SC Immunology
GA G2687
UT WOS:A1987G268700042
PM 2433351
DA 2020-11-30
ER

PT J
AU HARN, DA
   OLIGINO, L
   KO, A
   STEIN, LD
AF HARN, DA
   OLIGINO, L
   KO, A
   STEIN, LD
TI CANDIDATE EPITOPES FOR VACCINATION AGAINST SCHISTOSOMIASIS-MANSONI
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Meeting Abstract
C1 HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115.
   HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
CR HARN DA, 1985, MOL BIOCHEM PARASIT, V16, P345, DOI 10.1016/0166-6851(85)90075-1
   HARN DA, 1984, J EXP MED, V159, P1371, DOI 10.1084/jem.159.5.1371
   HARN DA, 1985, J IMMUNOL, V135, P2115
   HARN DA, 1986, IN PRESS J IMMUNOL
NR 4
TC 1
Z9 1
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0730-2312
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PY 1987
SU 11A
BP 151
EP 151
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA G1082
UT WOS:A1987G108200388
DA 2020-11-30
ER

PT J
AU EKAPANYAKUL, G
   FLISSER, A
   KO, A
   HARN, D
AF EKAPANYAKUL, G
   FLISSER, A
   KO, A
   HARN, D
TI IGE MONOCLONAL-ANTIBODIES PRODUCED FROM MICE IMMUNIZED WITH IRRADIATED
   CERCARIAE OF SCHISTOSOMA-MANSONI
SO BIOLOGICAL BULLETIN
LA English
DT Meeting Abstract
C1 HARVARD UNIV,SCH MED,BOSTON,MA 02115.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARINE BIOLOGICAL LABORATORY
PI WOODS HOLE
PA 7 MBL ST, WOODS HOLE, MA 02543
SN 0006-3185
J9 BIOL BULL
JI Biol. Bull.
PY 1983
VL 165
IS 2
BP 534
EP 535
PG 2
WC Biology; Marine & Freshwater Biology
SC Life Sciences & Biomedicine - Other Topics; Marine & Freshwater Biology
GA RR866
UT WOS:A1983RR86600129
DA 2020-11-30
ER

PT J
AU SWISTON, L
   KO, A
   HARN, D
AF SWISTON, L
   KO, A
   HARN, D
TI INHIBITION OF A SURFACE BINDING MONOCLONAL-ANTIBODY TO SCHISTOSOMULA OF
   SCHISTOSOMA-MANSONI BY LECTINS
SO BIOLOGICAL BULLETIN
LA English
DT Meeting Abstract
C1 HARVARD UNIV,SCH MED,BOSTON,MA 02115.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
CR SIMPSON, 1983, MOL BIOCH PARASITOL, V8, P191
NR 1
TC 0
Z9 0
U1 0
U2 0
PU MARINE BIOLOGICAL LABORATORY
PI WOODS HOLE
PA 7 MBL ST, WOODS HOLE, MA 02543
SN 0006-3185
J9 BIOL BULL
JI Biol. Bull.
PY 1983
VL 165
IS 2
BP 538
EP 538
PG 1
WC Biology; Marine & Freshwater Biology
SC Life Sciences & Biomedicine - Other Topics; Marine & Freshwater Biology
GA RR866
UT WOS:A1983RR86600137
DA 2020-11-30
ER

PT J
AU WAXMAN, DJ
   KO, A
   WALSH, C
AF WAXMAN, DJ
   KO, A
   WALSH, C
TI REGIOSELECTIVITY AND STEREOSELECTIVITY OF ANDROGEN HYDROXYLATIONS
   CATALYZED BY CYTOCHROME-P-450 ISOZYMES PURIFIED FROM
   PHENOBARBITAL-INDUCED RAT-LIVER
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
C1 MIT,DEPT CHEM,CAMBRIDGE,MA 02139.
   MIT,DEPT BIOL,CAMBRIDGE,MA 02139.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339; Waxman,
   David/0000-0001-7982-9206
FU NCI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [5-P01-CA26731-03] Funding Source: Medline; NIGMS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS) [GM
   20011, GM 21643] Funding Source: Medline; NATIONAL CANCER
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731,
   P01CA026731, P01CA026731, P01CA026731, P01CA026731, P01CA026731] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM021643, R01GM021643, R37GM020011,
   R01GM020011, R37GM020011, R01GM020011, R01GM021643, R01GM020011,
   R01GM020011, R37GM020011, R01GM020011, R01GM021643, R01GM020011,
   R01GM020011, R37GM020011, R37GM020011, R37GM020011, R37GM020011,
   R01GM020011, R01GM020011, R01GM021643, R01GM021643, R01GM020011,
   R37GM020011, R01GM021643, R01GM021643, R37GM020011, R01GM020011,
   R01GM020011, R01GM020011, R01GM020011, R01GM021643, R37GM020011,
   R01GM020011, R01GM020011, R37GM020011, R01GM020011, R01GM020011,
   R01GM020011, R01GM020011] Funding Source: NIH RePORTER
CR Colby H., 1980, ADV SEX HORMONE RES, V4, P27
   CONNEY AH, 1963, J BIOL CHEM, V238, P1611
   DANIELSSON H, 1975, ANNU REV BIOCHEM, V44, P233, DOI 10.1146/annurev.bi.44.070175.001313
   DANNAN GA, 1983, J BIOL CHEM, V258, P1282
   DEMONTELLANO PRO, 1981, ARCH BIOCHEM BIOPHYS, V210, P717, DOI 10.1016/0003-9861(81)90239-3
   DEMONTELLANO PRO, 1979, P NATL ACAD SCI USA, V76, P746
   DEMONTELLANO PRO, 1980, J BIOL CHEM, V255, P5578
   ELSHOURBAGY NA, 1980, J BIOL CHEM, V255, P1279
   FISHMAN J, 1960, J AM CHEM SOC, V82, P6143, DOI 10.1021/ja01508a043
   GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P6019, DOI 10.1021/bi00266a045
   Gustafsson J A, 1978, Methods Enzymol, V52, P377
   GUSTAFSSON JA, 1982, MICROSOMES DRUG OXID, P281
   HAUGEN DA, 1975, J BIOL CHEM, V250, P3567
   HEINRICHS WL, 1966, STEROIDS, V13, P91
   HEUMAN DM, 1982, MOL PHARMACOL, V21, P753
   HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X
   HRYCAY EG, 1976, EUR J BIOCHEM, V61, P43, DOI 10.1111/j.1432-1033.1976.tb09995.x
   HUANG MT, 1976, J BIOL CHEM, V251, P4659
   IMAI Y, 1981, J BIOCHEM-TOKYO, V89, P351, DOI 10.1093/oxfordjournals.jbchem.a133209
   JACOBSON M, 1969, STEROIDS, V13, P327, DOI 10.1016/0039-128X(69)90042-7
   JOHNSON WS, 1957, J AM CHEM SOC, V79, P1991, DOI 10.1021/ja01565a064
   KUNTZMAN R, 1965, MOL PHARMACOL, V1, P163
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEMM U, 1978, H-S Z PHYSIOL CHEM, V359, P81
   LISBOA BP, 1968, EUR J BIOCHEM, V4, P496, DOI 10.1111/j.1432-1033.1968.tb00240.x
   LU AYH, 1972, J BIOL CHEM, V247, P1727
   MURAKAMI K, 1981, J BIOL CHEM, V256, P8658
   MURPHY MJ, 1981, ARCH BIOCHEM BIOPHYS, V212, P360, DOI 10.1016/0003-9861(81)90376-3
   MYANT NB, 1977, J LIPID RES, V18, P135
   NAKAMURA Y, 1980, BIOCHEM BIOPH RES CO, V93, P1014, DOI 10.1016/0006-291X(80)90590-2
   NAKAMURA Y, 1982, MICROSOMES DRUG OXID, P405
   NETTER KJ, 1980, PHARMACOL THERAPEUT, V10, P515, DOI 10.1016/0163-7258(80)90029-7
   NOSHIRO M, 1981, EUR J BIOCHEM, V116, P521, DOI 10.1111/j.1432-1033.1981.tb05367.x
   ORRENIUS S, 1969, FEBS S, V16, P143
   ORTON TC, 1980, J STEROID BIOCHEM, V13, P873, DOI 10.1016/0022-4731(80)90160-0
   RYAN DE, 1979, J BIOL CHEM, V254, P1365
   RYAN DE, 1982, ARCH BIOCHEM BIOPHYS, V216, P272, DOI 10.1016/0003-9861(82)90212-0
   SCHWARTZ MA, 1983, J LIPID RES, V24, P28
   SHIVERICK KT, 1979, DRUG METAB DISPOS, V7, P290
   THOMAS PE, 1981, J BIOL CHEM, V256, P1044
   VANDERHOEVEN T, 1981, BIOCHEM BIOPH RES CO, V100, P1285, DOI 10.1016/0006-291X(81)91963-X
   VLASUK GP, 1982, ARCH BIOCHEM BIOPHYS, V214, P248, DOI 10.1016/0003-9861(82)90028-5
   WAXMAN DJ, 1982, BIOCHEMISTRY-US, V21, P2499, DOI 10.1021/bi00539a032
   WAXMAN DJ, 1982, J BIOL CHEM, V257, P446
   WAXMAN DJ, 1983, BIOCHEMISTRY, V22
   WAXMAN DJ, 1982, CYTOCHROME P450 BIOC, P311
   WENZEL M, 1976, H-S Z PHYSIOL CHEM, V357, P1145, DOI 10.1515/bchm2.1976.357.2.1145
   WEST SB, 1979, ARCH BIOCHEM BIOPHYS, V193, P42, DOI 10.1016/0003-9861(79)90006-7
   WHITE INH, 1977, BIOCHEM J, V166, P57, DOI 10.1042/bj1660057
NR 49
TC 433
Z9 434
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PY 1983
VL 258
IS 19
BP 1937
EP 1947
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA RL316
UT WOS:A1983RL31600084
PM 6619150
DA 2020-11-30
ER

PT J
AU ROUSH, WR
   GILLIS, HR
   KO, AI
AF ROUSH, WR
   GILLIS, HR
   KO, AI
TI STEREOCHEMICAL ASPECTS OF THE INTRAMOLECULAR DIELS-ALDER REACTIONS OF
   DECA-2,7,9-TRIENOATE ESTERS .3. THERMAL, LEWIS ACID-CATALYZED, AND
   ASYMMETRIC CYCLIZATIONS
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
RP ROUSH, WR (corresponding author), MIT,DEPT CHEM,CAMBRIDGE,MA 02139, USA.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
CR AYCARD JP, 1973, CAN J CHEM, V51, P741, DOI 10.1139/v73-111
   AYCARD JP, 1975, ORG MAGN RESONANCE, V7, P226, DOI 10.1002/mrc.1270070506
   BARTON DHR, 1975, J CHEM SOC PERK T 1, P1574, DOI 10.1039/p19750001574
   BENEDETT.E, 1972, J PHYS CHEM-US, V76, P790, DOI 10.1021/j100649a030
   BOECKMAN RK, 1980, J AM CHEM SOC, V102, P7146, DOI 10.1021/ja00543a063
   BOECKMAN RK, J AM CHEM SOC
   BOURN PM, 1960, J CHEM SOC, P2044, DOI 10.1039/jr9600002044
   BRIEGER G, 1980, CHEM REV, V80, P63, DOI 10.1021/cr60323a004
   BUCHI G, 1969, J ORG CHEM, V34, P1122
   CARLSEN PHJ, 1981, J ORG CHEM, V46, P3936, DOI 10.1021/jo00332a045
   Carlson R. G., 1974, ANNU REP MED CHEM, V9, P270
   DECLERCQ PJ, 1979, SYNTHETIC COMMUN, V9, P771, DOI 10.1080/00397917908064193
   ENSLEY HE, 1978, J ORG CHEM, V43, P1610, DOI 10.1021/jo00402a037
   FLEMING I, 1976, FRONTIER ORBITALS OR, P161
   FOUQUET G, 1974, ANGEW CHEM INT EDIT, V13, P82, DOI 10.1002/anie.197400821
   FUNK RL, 1982, J ORG CHEM, V47, P180, DOI 10.1021/jo00340a050
   FUNK RL, 1980, CHEM SOC REV, V9, P41, DOI 10.1039/cs9800900041
   FUSON RC, 1945, J ORG CHEM, V10, P121, DOI 10.1021/jo01178a005
   GRIECO PA, 1976, J ORG CHEM, V41, P1485, DOI 10.1021/jo00870a052
   GSCHWEND HW, 1973, J ORG CHEM, V38, P2169, DOI 10.1021/jo00952a013
   GSCHWEND HW, 1972, ANGEW CHEM, V84, P291
   HASHIMOTO S, 1979, J CHEM SOC CHEM COMM, P437, DOI 10.1039/c39790000437
   HAYAKAWA Y, 1967, J POLYM SCI A1, V5, P2099, DOI 10.1002/pol.1967.150050826
   HOUK KN, 1973, J AM CHEM SOC, V95, P4092, DOI 10.1021/ja00793a069
   HOUK KN, 1973, J AM CHEM SOC, V95, P4094, DOI 10.1021/ja00793a070
   HOUK KN, 1975, ACCOUNTS CHEM RES, V8, P361, DOI 10.1021/ar50095a001
   HOUSE HO, 1965, J ORG CHEM, V30, P1061, DOI 10.1021/jo01015a026
   HOUSE HO, 1963, J ORG CHEM, V28, P31, DOI 10.1021/jo01036a006
   HOUSE HO, 1964, J ORG CHEM, V29, P3327, DOI 10.1021/jo01034a049
   HUDLICKY T, 1980, Journal of Organic Chemistry, V45, P5020, DOI 10.1021/jo01313a003
   ICHIHARA A, 1980, J AM CHEM SOC, V102, P6353, DOI 10.1021/ja00540a037
   INOUYE Y, 1967, TETRAHEDRON, V23, P3237, DOI 10.1016/S0040-4020(01)92293-8
   JOHNSON WS, 1970, J AM CHEM SOC, V92, P741, DOI 10.1021/ja00706a074
   KIKUCHI O, 1971, TETRAHEDRON, V27, P2791, DOI 10.1016/S0040-4020(01)98070-6
   LUTZ EF, 1963, J ORG CHEM, V28, P912, DOI 10.1021/jo01039a007
   MARTIN SF, 1980, J AM CHEM SOC, V102, P5274, DOI 10.1021/ja00536a026
   MCIVER JW, 1974, ACCOUNTS CHEM RES, V7, P72, DOI 10.1021/ar50075a002
   MIYAJIMA S, 1972, B CHEM SOC JPN, V45, P1553, DOI 10.1246/bcsj.45.1553
   MORRISON JD, 1971, ASYMMETRIC ORGANIC R, P252
   MUKAIYAMA T, 1979, CHEM LETT, P1175, DOI 10.1246/cl.1979.1175
   MUKAIYAMA T, 1979, CHEM LETT, P697, DOI 10.1246/cl.1979.697
   MUKAIYAMA T, 1981, CHEM LETT, V29
   NADER B, 1980, J AM CHEM SOC, V102, P1153, DOI 10.1021/ja00523a037
   OMURA K, 1976, J ORG CHEM, V41, P957, DOI 10.1021/jo00868a012
   Onishenko AS, 1964, DIENE SYNTHESIS
   OPPOLZER W, 1974, TETRAHEDRON LETT, P1001
   OPPOLZER W, 1981, TETRAHEDRON LETT, V22, P2545, DOI 10.1016/S0040-4039(01)90516-7
   OPPOLZER W, 1980, HELV CHIM ACTA, V63, P2010, DOI 10.1002/hlca.19800630728
   OPPOLZER W, 1975, HELV CHIM ACTA, V58, P590, DOI 10.1002/hlca.19750580231
   OPPOLZER W, 1980, HELV CHIM ACTA, V63, P2015, DOI 10.1002/hlca.19800630729
   OPPOLZER W, 1971, J AM CHEM SOC, V93, P3836, DOI 10.1021/ja00744a085
   OPPOLZER W, 1977, ANGEW CHEM INT EDIT, V16, P10, DOI 10.1002/anie.197700101
   OPPOLZER W, 1977, HELV CHIM ACTA, V60, P204, DOI 10.1002/hlca.19770600123
   OPPOLZER W, 1978, SYNTHESIS-STUTTGART, P793
   PARKER KA, 1978, TETRAHEDRON LETT, P1689
   PYNE SG, 1980, J AM CHEM SOC, V102, P5960, DOI 10.1021/ja00538a068
   QUINKERT G, 1980, ANGEW CHEM INT EDIT, V19, P1029, DOI 10.1002/anie.198010291
   RAMSDEN HE, 1957, J ORG CHEM, V22, P1602, DOI 10.1021/jo01363a018
   ROBINSON R, 1960, Patent No. 853840
   ROSSITER BE, 1981, J AM CHEM SOC, V103, P464, DOI 10.1021/ja00392a038
   ROUSH WR, 1980, J ORG CHEM, V45, P4267, DOI 10.1021/jo01309a055
   ROUSH WR, 1979, J ORG CHEM, V44, P4008, DOI 10.1021/jo01336a067
   ROUSH WR, 1980, J ORG CHEM, V45, P4264, DOI 10.1021/jo01309a054
   ROUSH WR, 1981, J AM CHEM SOC, V103, P6696, DOI 10.1021/ja00412a027
   ROUSH WR, 1980, J AM CHEM SOC, V102, P1390, DOI 10.1021/ja00524a027
   ROUSH WR, 1980, J ORG CHEM, V45, P4283, DOI 10.1021/jo01310a006
   ROUSH WR, 1981, J ORG CHEM, V46, P1509, DOI 10.1021/jo00320a060
   ROUSH WR, 1981, J AM CHEM SOC, V103, P5200, DOI 10.1021/ja00407a042
   ROUSH WR, 1978, J AM CHEM SOC, V100, P3599, DOI 10.1021/ja00479a053
   SAMAIN D, 1978, SYNTHESIS-STUTTGART, P388
   SAUER J, 1967, ANGEW CHEM INT EDIT, V6, P16, DOI 10.1002/anie.196700161
   SAUER J, 1980, ANGEW CHEM INT EDIT, V19, P779, DOI 10.1002/anie.198007791
   SCHMIDLIN T, 1981, HELV CHIM ACTA, V64, P235, DOI 10.1002/hlca.19810640125
   SCHMITTHENNER HF, 1980, J ORG CHEM, V45, P3372, DOI 10.1021/jo01304a054
   SHARPLESS KB, 1975, J ORG CHEM, V40, P947, DOI 10.1021/jo00895a030
   SNIDER BB, 1979, J AM CHEM SOC, V101, P5283, DOI 10.1021/ja00512a029
   SNIDER BB, 1980, ACCOUNTS CHEM RES, V13, P426, DOI 10.1021/ar50155a007
   SNIDER BB, 1980, J ORG CHEM, V45, P3461, DOI 10.1021/jo01305a018
   SNOWDEN RL, 1981, TETRAHEDRON LETT, V22, P101, DOI 10.1016/0040-4039(81)80159-1
   SNOWDEN RL, 1981, TETRAHEDRON LETT, V22, P97, DOI 10.1016/0040-4039(81)80158-X
   STORK G, 1981, J AM CHEM SOC, V103, P4948, DOI 10.1021/ja00406a050
   STORK G, 1979, J AM CHEM SOC, V101, P5081, DOI 10.1021/ja00511a057
   TABER DF, 1980, J AM CHEM SOC, V102, P5085, DOI 10.1021/ja00535a046
   TAMURA M, 1971, SYNTH-INT J METHODS, P303
   TIETZE LF, 1981, TETRAHEDRON LETT, V22, P219, DOI 10.1016/0040-4039(81)80059-7
   TOWNSHEND RE, 1976, J AM CHEM SOC, V98, P2190, DOI 10.1021/ja00424a031
   TROST BM, 1980, J AM CHEM SOC, V102, P7595, DOI 10.1021/ja00545a049
   VIG OP, 1977, INDIAN J CHEM B, V15, P319
   WALBORSKY HM, 1963, TETRAHEDRON, V19, P2333, DOI 10.1016/0040-4020(63)85050-4
   WEINREB SM, 1979, J AM CHEM SOC, V101, P5073, DOI 10.1021/ja00511a052
   Wenkert E., 1973, SYN COMMUN, V3, P45, DOI 10.1080/00397917308062002
   WHITE JD, 1981, J ORG CHEM, V46, P2273, DOI 10.1021/jo00324a014
   WILSON SR, 1980, J ORG CHEM, V45, P5079, DOI 10.1021/jo01313a013
   WOLLWEBER H, 1972, DIELS ALDER REAKTON
   WOODS GF, 1946, J AM CHEM SOC, V68, P2483, DOI 10.1021/ja01216a011
   ZAKHARKIN LI, 1957, DOKL AKAD NAUK SSSR+, V116, P422
NR 96
TC 157
Z9 157
U1 2
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PY 1982
VL 104
IS 8
BP 2269
EP 2283
DI 10.1021/ja00372a027
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA NL637
UT WOS:A1982NL63700027
DA 2020-11-30
ER

PT J
AU ROUSH, WR
   GILLIS, HR
   KO, AI
AF ROUSH, WR
   GILLIS, HR
   KO, AI
TI STEREOCHEMICAL ASPECTS OF THE INTRAMOLECULAR DIELS-ALDER REACTIONS OF
   METHYL DECA-2,7,9-TRIENOATES - FAILURE OF THE ENDO RULE
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 MIT,DEPT CHEM,CAMBRIDGE,MA 02139.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1980
VL 180
IS AUG
BP 304
EP ORGN
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA LG433
UT WOS:A1980LG43300304
DA 2020-11-30
ER

PT J
AU ROUSH, WR
   KO, AI
   GILLIS, HR
AF ROUSH, WR
   KO, AI
   GILLIS, HR
TI STEREOCHEMICAL ASPECTS OF THE INTRAMOLECULAR DIELS-ALDER REACTIONS OF
   METHYL DECA-2,7,9-TRIENOATES .1. THERMAL CYCLIZATIONS
SO JOURNAL OF ORGANIC CHEMISTRY
LA English
DT Letter
RP ROUSH, WR (corresponding author), MIT,DEPT CHEM,CAMBRIDGE,MA 02139, USA.
RI Ko, Albert Icksang/P-2343-2015
OI Ko, Albert Icksang/0000-0001-9023-2339
CR AUERBACH J, 1975, J ORG CHEM, V40, P3311, DOI 10.1021/jo00910a044
   BAJOREK JJS, 1975, J CHEM SOC PERK T 1, P1559, DOI 10.1039/p19750001559
   BARTON DHR, 1975, J CHEM SOC PERK T 1, P1574, DOI 10.1039/p19750001574
   BERSON JA, 1962, J AM CHEM SOC, V84, P297, DOI 10.1021/ja00861a033
   BRIEGER G, 1980, CHEM REV, V80, P63, DOI 10.1021/cr60323a004
   Carlson R. G., 1974, ANNU REP MED CHEM, V9, P270
   COX TT, 1975, J CHEM SOC CHEM COMM, P903
   GSCHWEND HW, 1973, HELV CHIM ACTA, V56, P1763, DOI 10.1002/hlca.19730560536
   GSCHWEND HW, 1973, J ORG CHEM, V38, P2169, DOI 10.1021/jo00952a013
   GSCHWEND HW, 1972, ANGEW CHEM, V84, P281
   HOUSE HO, 1965, J ORG CHEM, V30, P1061, DOI 10.1021/jo01015a026
   HOUSE HO, 1964, J ORG CHEM, V29, P3327, DOI 10.1021/jo01034a049
   JOHNSON WS, 1970, J AM CHEM SOC, V92, P741, DOI 10.1021/ja00706a074
   MARTIN JG, 1961, CHEM REV, V61, P537, DOI 10.1021/cr60214a001
   MEHTA G, 1976, J CHEM EDUC, V53, P551, DOI 10.1021/ed053p551
   Onishenko AS, 1964, DIENE SYNTHESIS
   OPPOLZER W, 1977, ANGEW CHEM INT EDIT, V16, P10, DOI 10.1002/anie.197700101
   OPPOLZER W, 1977, HELV CHIM ACTA, V60, P48, DOI 10.1002/hlca.19770600108
   OPPOLZER W, 1980, SYNTHESIS, P793
   RAMSDEN HE, 1957, J ORG CHEM, V22, P1602, DOI 10.1021/jo01363a018
   ROUSH WR, 1980, J ORG CHEM, V45, P4267, DOI 10.1021/jo01309a055
   ROUSH WR, 1979, J ORG CHEM, V44, P4008, DOI 10.1021/jo01336a067
   ROUSH WR, 1980, J AM CHEM SOC, V102, P1390, DOI 10.1021/ja00524a027
   ROUSH WR, J ORG CHEM
   ROUSH WR, UNPUBLISHED
   SAUER J, 1967, ANGEW CHEM INT EDIT, V6, P16, DOI 10.1002/anie.196700161
   WHITE JD, 1978, TETRAHEDRON LETT, P5189
NR 27
TC 45
Z9 45
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0022-3263
J9 J ORG CHEM
JI J. Org. Chem.
PY 1980
VL 45
IS 21
BP 4264
EP 4267
DI 10.1021/jo01309a054
PG 4
WC Chemistry, Organic
SC Chemistry
GA KL070
UT WOS:A1980KL07000054
DA 2020-11-30
ER

EF